Citrus Sinensis ID: 041285
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.970 | 0.844 | 0.339 | 1e-113 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.972 | 0.807 | 0.336 | 1e-101 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.957 | 0.835 | 0.315 | 1e-92 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.955 | 0.835 | 0.304 | 3e-84 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.849 | 0.752 | 0.315 | 6e-81 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.900 | 0.818 | 0.302 | 4e-79 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.935 | 0.812 | 0.295 | 4e-75 | |
| O64784 | 821 | G-type lectin S-receptor- | no | no | 0.928 | 0.818 | 0.303 | 1e-72 | |
| Q9SY95 | 802 | G-type lectin S-receptor- | no | no | 0.924 | 0.834 | 0.294 | 4e-72 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.930 | 0.833 | 0.290 | 8e-72 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 408 bits (1048), Expect = e-113, Method: Compositional matrix adjust.
Identities = 273/804 (33%), Positives = 418/804 (51%), Gaps = 101/804 (12%)
Query: 4 HSNINIGSSLSPNGN----SSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV---- 55
+ ++ +G SL+ + + SSW SPSG +AFGF + + + ++ I +K +
Sbjct: 29 NGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPNDGFTLSIWFDKISDKTIVWHA 88
Query: 56 ---------------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLY-- 92
G +V+ + +GQ+ A S S D G+FVL+
Sbjct: 89 QAVNTTTGLVPNGSKVTLTADGGLVI-ADPRGQELWRALSGGSVSRGRFTDDGNFVLFRD 147
Query: 93 ---DSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQY 149
DSD +V+W +F++PTDT+LP Q + G L ++T G+F L++++DGNL +
Sbjct: 148 GSEDSD-EVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQLH 206
Query: 150 PKNTPDTAPYS------YWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPT 203
N +TA S Y ++ D + L +++G +++L N R + + +P
Sbjct: 207 SLNA-ETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVLQRN--NSRFVVKDRDPD 263
Query: 204 EGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDP---LG--LCGFNSFCIL- 257
+ I + + R+ +L + C P LG CG+N+ C L
Sbjct: 264 FSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDNMCSPDDALGNMACGYNNICSLG 323
Query: 258 NDQTPDCICLPGFVPIIQGNWSSGCARNYTAESC------SNKAIE-----ELKNTVWED 306
N++ P C C FV N C ++ ++C +N + L+ T W
Sbjct: 324 NNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPF 383
Query: 307 VSYSVLSKTTEQNCQEACLKDCNCEAALY---KDEECKMQRLPLRFGRRKLSDSDIAFIK 363
Y + E+ C+ +CL DC C A ++ +D +C ++ PL G R FIK
Sbjct: 384 GDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIK 443
Query: 364 VDATASSNSGKPFSRDGKKAQRKDIVIISCLFVALIILILATFGIF----IYRYRVRS-- 417
V + ++ P + G +A++ D +II+C ++L + F IF YR +S
Sbjct: 444 VRNRSIADV--PVT--GNRAKKLDWLIIACS----VLLGTSAFVIFDTSCSYRKTKKSKN 495
Query: 418 -----YRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTM-INGK 471
R I + ++ L F+Y EL + T F EE+GRG+ G VYKG + + G
Sbjct: 496 MMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGG 555
Query: 472 ---FVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528
VAVK+L ++ + E+EF+ E+K IG+ HH+NLVRL+G+ + ++++VYE++ G+
Sbjct: 556 SEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGT 615
Query: 529 LADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581
LA+ P KN + IARGILYLH+EC QIIHCDIKPQNIL+DE +ISD
Sbjct: 616 LANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISD 675
Query: 582 FALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ 641
F LAKL+ +QT T T IRGT+GYVAPEW N PIT+K DVYS+GV+LLEI+CC++ D
Sbjct: 676 FGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL 735
Query: 642 NLPEDQVILEEWVYQCFENGNLGQLIEDEDV---DKKQLERMIKVALWCILDEPSLRPSM 698
ED VIL W Y CF G L L ED+ D + +ER +K+A+WCI +E +RP+M
Sbjct: 736 ---EDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNM 792
Query: 699 KKVLLMLEGTMDIPIPPNPTSLLT 722
+ V MLEG + + PPNP+ T
Sbjct: 793 RNVTQMLEGVIQVFDPPNPSPYST 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 272/808 (33%), Positives = 417/808 (51%), Gaps = 104/808 (12%)
Query: 6 NINIGSSL-SPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIP-----------EK 53
+I +GS L + N +W+S +G +A GF + + + ++ A +P
Sbjct: 29 HIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNS 88
Query: 54 NVGRIVLRSTEQGQDSIIAD----------DSQSASSASMLDSGSFVLYDSD---GKVIW 100
V + + E + +++D + SA M +SG+F+L ++ G IW
Sbjct: 89 PVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIW 148
Query: 101 QTFDHPTDTILPTQRLLAGMELFPGISKTDPST-GKFRLKM-QNDGNL---IQYPKNTPD 155
Q+F P+DT+LP Q L +EL S PS G + LKM Q +L + Y N
Sbjct: 149 QSFSQPSDTLLPNQPLTVSLEL---TSNPSPSRHGHYSLKMLQQHTSLSLGLTYNINLDP 205
Query: 156 TAPYSYWTS--FTDGKGDNVSLNLDENGHLFLL------------------NSTGFNIRN 195
A YSYW+ ++ GD V+ LD+ G ++ N N N
Sbjct: 206 HANYSYWSGPDISNVTGD-VTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNYNNSSN 264
Query: 196 LTEGENPTEGMMYLMKIDSDGIFRLYSY-NLRRQNSTWQVLWESTNEKCDPLGLCGFNSF 254
L +NP ++ + ++++G RLY + N +S W W + + CD G+CG N
Sbjct: 265 LGLTKNP---VLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICG-NGV 320
Query: 255 CILN--DQTPDCICLPGFVPIIQGNWSSGCARNYT----AESCSNKAIEELKNTVWEDVS 308
C L+ + DC+CLPG V + + C+ N + ES N+ +TV E
Sbjct: 321 CNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSFKISTVQETNY 380
Query: 309 Y----SVLSKTTE----QNCQEACLKDCNCEAALY--KDEE--CKMQRLPLRFGRRKLSD 356
Y SV+ ++ + C E CL DC C A++Y DE+ C + + L FG +
Sbjct: 381 YFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILK-SLNFGGFRDPG 439
Query: 357 SDIAFIKVDATASSNSGKPFSRDGKKAQ---RKDIVIISCLFVALIILILATFGIFIYRY 413
S + F+K A S S + + R+ +++I + V +++L+ A G+ +Y Y
Sbjct: 440 STL-FVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIP-IVVGMLVLV-ALLGMLLY-Y 495
Query: 414 RVRSYRII--PGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGK 471
+ R + S C+ + +SF+Y +L+ T+ F + +G G GTVYKGT+
Sbjct: 496 NLDRKRTLKRAAKNSLILCD--SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGET 553
Query: 472 FVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD 531
VAVKRL + L+ GEREF TE+ IG HH NLVRL GY + S+++LVYEYM NGSL
Sbjct: 554 LVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDK 613
Query: 532 -VYSSPPKNNL----------IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS 580
++SS NL + A+GI Y H++C ++IIHCDIKP+NIL+D+N K+S
Sbjct: 614 WIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVS 673
Query: 581 DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
DF LAK+M + + T IRGTRGY+APEW N PIT KADVYS+G++LLEI+ RR D
Sbjct: 674 DFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLD 733
Query: 641 QNLPEDQVILEEWVYQCFENGNLGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPS 697
+ + W Y+ NG + ++ +++++ + +KVA WCI DE S+RPS
Sbjct: 734 MSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPS 793
Query: 698 MKKVLLMLEGTMD-IPIPPNPTSLLTTI 724
M +V+ +LEGT D I +PP P ++L I
Sbjct: 794 MGEVVKLLEGTSDEINLPPMPQTILELI 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 243/770 (31%), Positives = 380/770 (49%), Gaps = 77/770 (10%)
Query: 5 SNINIGSSLSPNG-NSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAG-IPEKNVGRIVLRS 62
S I +GS + +G N +W SP+ ++ F + +S+ V AG +P + G + R
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGTVDSRG 84
Query: 63 T-----------EQGQDSIIAD---DSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTD 108
+ G + + D D +S S+ D+G F+L ++ +W +FD+PTD
Sbjct: 85 SLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTD 144
Query: 109 TILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDG 168
TI+ +Q AG L G+ + +++ GNL NT YW +
Sbjct: 145 TIVQSQNFTAGKILRSGL---------YSFQLERSGNLT-LRWNTSAI----YWNHGLNS 190
Query: 169 KGDNVS----LNLDENGHLFLLNSTGFNIRNLT-EGENPTEGMMYLMKIDSDGIFRLYSY 223
+ L+L NG + + S + G+ +K+D DG R+YS
Sbjct: 191 SFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSS 250
Query: 224 NLRRQ---NSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGN-WS 279
R N+ W + ++C G CG C ND P C C + N
Sbjct: 251 ASRNSGPVNAHWSAV-----DQCLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRR 305
Query: 280 SGCARNYTAESCS-NKAIEELKNT---VWEDVSYSVLSKTTEQNCQEACLKDCNCEAALY 335
GC R CS N + +L +T +ED S C+ CL C A++
Sbjct: 306 KGCKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVS 365
Query: 336 KDEECK--MQRLPLRF--GRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVII 391
+ Q+ P F G + S +++KV +N+ + ++ + + I+
Sbjct: 366 MSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIV 425
Query: 392 SCLFVA-LIILILATFGIFIYRYRVRSYRIIPGNGSARYC----EDIALLSFSYAELEKM 446
+ +A L+ L+ G++ R ++ R G S+ Y A + F+Y EL++
Sbjct: 426 AVAVIAGLLGLVAVEIGLWWCCCR-KNPRF--GTLSSHYTLLEYASGAPVQFTYKELQRC 482
Query: 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
T FKE++G G GTVY+G + N VAVK+L+ + +GE++F+ E+ I THH NLVR
Sbjct: 483 TKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVR 541
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADVYSSPPK----------NNLIGIARGILYLHDECE 556
L+G+ +++LVYE+M NGSL + + N +G A+GI YLH+EC
Sbjct: 542 LIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECR 601
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLP 615
I+HCDIKP+NIL+D+N AK+SDF LAKL+ P R + +RGTRGY+APEW NLP
Sbjct: 602 DCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLP 661
Query: 616 ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI-----EDE 670
IT+K+DVYS+G+VLLE++ +R FD + + W Y+ FE GN ++ ED+
Sbjct: 662 ITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQ 721
Query: 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSL 720
VD +Q+ RM+K + WCI ++P RP+M KV+ MLEG +I P P ++
Sbjct: 722 TVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTI 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (802), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 241/791 (30%), Positives = 382/791 (48%), Gaps = 99/791 (12%)
Query: 2 QGHSNIN-IGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLA------------ 48
G S ++ I + +G+ + +S G Y GF++ + S++Y+G++
Sbjct: 18 HGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANR 77
Query: 49 --GIPEKNV-------GRIVL----RSTEQGQDSIIADDSQSASSASMLDSGSFVLYDS- 94
+ +KN G ++L T + + S SA A + D G+ VL
Sbjct: 78 DKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGG 137
Query: 95 ---DGKVIWQTFDHPTDTILP------TQRLLAGMELFPGISKTDPSTGKFRLKMQNDGN 145
V+WQ+FDHP DT LP +R L S DPS G F L++
Sbjct: 138 SSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTA 197
Query: 146 ---LIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENP 202
L + P++ + D + + LN N F + + ++ N
Sbjct: 198 YKILWNGSNEYWSSGPWNPQSRIFDSVPE-MRLNYIYNFSFFSNTTDSYFTYSIYNQLNV 256
Query: 203 TEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQT- 261
+ +M D G + +++ N W + W ++C CG SF I +D++
Sbjct: 257 SRFVM-----DVSGQIKQFTW--LEGNKAWNLFWSQPRQQCQVYRYCG--SFGICSDKSE 307
Query: 262 PDCICLPGFVPIIQGNW-----SSGCARNYTAESCSNKAIEE---LKNTVWEDVSYSVLS 313
P C C GF P+ Q +W S+GC R T CS I + L N D S VL+
Sbjct: 308 PFCRCPQGFRPMSQKDWDLKDYSAGCVRK-TELQCSRGDINQFFRLPNMKLADNS-EVLT 365
Query: 314 KTTEQNCQEACLKDCNCEAALYKDEECK-----MQRLPLRFGRRKLSDSDIAFIKVDATA 368
+T+ C AC DC+C+A Y + K L L+ + S+ +I ++++ A+
Sbjct: 366 RTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASD 425
Query: 369 SSNSGKPFSRDGKKAQRKDIVIISCLFVALIILILATFGIFIYRYRVRSYRIIPGNGSAR 428
N G K+ K ++ + +L + G+ + V +
Sbjct: 426 VPNVGA-----SGKSNNKGLIFGA---------VLGSLGVIVLVLLVVILILRYRRRKRM 471
Query: 429 YCE--DIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGE 486
E D L +FSY EL+ T F +++G G G+V+KG + + +AVKRL+ +++GE
Sbjct: 472 RGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEG-ISQGE 530
Query: 487 REFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL-ADVYSSPPKNNLI--- 542
++F+TE+ IG H NLVRL G+ + S K+LVY+YM NGSL + ++ + + ++
Sbjct: 531 KQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGW 590
Query: 543 --------GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594
G ARG+ YLHDEC IIHCDIKP+NIL+D K++DF LAKL+ D +R
Sbjct: 591 KLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSR 650
Query: 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV 654
T +RGTRGY+APEW + ITAKADVYS+G++L E++ RR +Q+ E W
Sbjct: 651 VLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWA 710
Query: 655 YQCF-ENGNLGQLI----EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709
++G++ L+ E + VD +++ R KVA WCI DE S RP+M +V+ +LEG +
Sbjct: 711 ATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVL 770
Query: 710 DIPIPPNPTSL 720
++ PP P S+
Sbjct: 771 EVNPPPFPRSI 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 217/688 (31%), Positives = 331/688 (48%), Gaps = 73/688 (10%)
Query: 81 ASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKM 140
A +LD+G+ V+ DS G +WQ+FD PTDT LPTQ + A L P P FR
Sbjct: 135 ARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSD 194
Query: 141 QNDGNLIQYPKNTPDTAPYSYWTS-----FTDGKGDNVSLNLDENGHLFLLNSTGFNIRN 195
+ +LI + D YW + DG+ S L +L S+ F
Sbjct: 195 LSVLSLIYHVPQVSDI----YWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSDFADGQ 250
Query: 196 LTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFC 255
+ G+ + +D DG RLYS N + +W V + + C+ GLCG N C
Sbjct: 251 ALVASDVGPGVKRRLTLDPDGNLRLYSMN--DSDGSWSVSMVAMTQPCNIHGLCGPNGIC 308
Query: 256 ILNDQTPDCICLPGFVPIIQGNWSSGCAR--NYTAESCSNKAIE--ELKNTVWEDVSYSV 311
+ TP C C PG+ GNW+ GC N T + +++ L NT +
Sbjct: 309 HYS-PTPTCSCPPGYATRNPGNWTEGCMAIVNTTCDRYDKRSMRFVRLPNTDFWGSDQQH 367
Query: 312 LSKTTEQNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRKLSDSDI--AFIKVDATAS 369
L + + C++ C+ DC C+ Y++ F R SD+ ++K+ S
Sbjct: 368 LLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRTIYLKLPTGVS 427
Query: 370 SNSG-------------------------KPFSRDGKKAQRKDIVIISCLFVALIILILA 404
++ +PF K + F+A ++
Sbjct: 428 VSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEV 487
Query: 405 TFGIFIYRYRVRSYRIIPGNGSARYCEDIALLS----FSYAELEKMTDGFKEEIGRGSSG 460
+F F + + V + P A A+ S +SY EL K T FK E+GRG SG
Sbjct: 488 SFISFAWFF-VLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESG 546
Query: 461 TVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520
TVYKG + + + VAVK+L+ + +G+ FQ E+ IGR +H NLVR+ G+ + S+++LV
Sbjct: 547 TVYKGVLEDDRHVAVKKLEN-VRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLV 605
Query: 521 YEYMSNGSLADVYSSPPKNNLI----------GIARGILYLHDECESQIIHCDIKPQNIL 570
EY+ NGSLA++ S N L+ G+A+G+ YLH EC +IHCD+KP+NIL
Sbjct: 606 SEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENIL 665
Query: 571 MDENRYAKISDFALAKLM-KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVL 629
+D+ KI+DF L KL+ + T+ + +RGT GY+APEW +LPITAK DVYS+GVVL
Sbjct: 666 LDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVL 725
Query: 630 LEIICCRRCFDQNLPEDQV--ILEEWVY----------QCFENGNLGQLIEDEDVDKKQL 677
LE++ R + D+V +L + V Q + +G L + + V+ Q
Sbjct: 726 LELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKL-NRPVNYVQA 784
Query: 678 ERMIKVALWCILDEPSLRPSMKKVLLML 705
+IK+A+ C+ ++ S RP+M+ + L
Sbjct: 785 RTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 227/751 (30%), Positives = 347/751 (46%), Gaps = 99/751 (13%)
Query: 17 GNSSWLSPSGIYAFGFYQQSNGSS-YYVGVFLAGIPEKN----VGRI---------VLRS 62
GN + LS I+ GF+ +NGSS +Y+G+ A +P RI L
Sbjct: 29 GNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLEL 88
Query: 63 TEQG-------QDSII--ADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPT 113
T G +D ++ D+ Q + ++G+ +L + DG +WQ+FD+PTDT LP
Sbjct: 89 TSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPG 148
Query: 114 QRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQ--YPKNTPDTAPYSYWTSFTDGKGD 171
+ + S DPS G + L++ N Q Y TP YW+ T
Sbjct: 149 MNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTP------YWS--TGNWTG 200
Query: 172 NVSLNLDENGHLFLLNSTGFNIRNLTEG--------ENPTEGMMYLMKIDSDGIFRLYSY 223
+ + E ++ N T ++ +E + + ++G + Y++
Sbjct: 201 EAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTW 260
Query: 224 NLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW----- 278
+ Q +W + W + C LCG FC P C C+ GF P W
Sbjct: 261 D--PQTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKP-CACIRGFRPRNDAAWRSDDY 317
Query: 279 SSGCARNYTAESCSNKAIEELKNTVWE-DVSYSVLSKTTEQNCQEACLKDCNCEAALYKD 337
S GC R + E + + ++ DV S L + ++ +C + CL + +C Y
Sbjct: 318 SDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRL-QVSKSSCAKTCLGNSSC-VGFYHK 375
Query: 338 EECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVA 397
E+ + ++ L P + K +II C V
Sbjct: 376 EKSNLCKILLE-------------------------SPNNLKNSKGNISKSIIILCSVVG 410
Query: 398 LIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRG 457
I ++ T + + + R + L FS+ EL+ T+GF +++G G
Sbjct: 411 SISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHG 470
Query: 458 SSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516
G V+KGT+ + FVAVKRL++ GE EF+ E+ IG H NLVRL G+ + +
Sbjct: 471 GFGAVFKGTLPGSSTFVAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLH 529
Query: 517 KILVYEYMSNGSLADVYS-SPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQ 567
++LVY+YM GSL+ S + PK +G A+GI YLH+ C IIHCDIKP+
Sbjct: 530 RLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPE 589
Query: 568 NILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGV 627
NIL+D + AK+SDF LAKL+ D +R +RGT GYVAPEW LPIT KADVYSFG+
Sbjct: 590 NILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGM 649
Query: 628 VLLEIICCRRCFDQN---LPEDQVILEEWVYQCFE-----NGNLGQLIEDE---DVDKKQ 676
LLE+I RR N L E + E+W + + GN+ +++ + + ++
Sbjct: 650 TLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEE 709
Query: 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEG 707
+ RM VA+WCI D +RP+M V+ MLEG
Sbjct: 710 VTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 4e-75, Method: Compositional matrix adjust.
Identities = 232/785 (29%), Positives = 370/785 (47%), Gaps = 108/785 (13%)
Query: 22 LSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRS------------TEQGQDS 69
LS +AFGF+ + YVG++ A I ++ + + R + +G S
Sbjct: 35 LSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPINDTSGMVKFSNRGNLS 94
Query: 70 IIADDSQSA------SSASML---------DSGSFVLYDS-DGKVIWQTFDHPTDTILPT 113
+ A D+++ S SML D G+ VL+D G+ W++FDHPTDT LP
Sbjct: 95 VYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRSFWESFDHPTDTFLPF 154
Query: 114 QRLLAGMELFPGISKT--------DPSTGKFRLKMQNDG--NLIQYPKNTPDTAPYSYWT 163
RL G G+ ++ DP +G L+M+ G LI Y TP W
Sbjct: 155 MRL--GFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTP-------WW 205
Query: 164 SFTDGKGDNVSLNLDENGHLFLLNSTGFNIRN---LTEGENPTEGMMYLMKIDSDGIFRL 220
G S + E ++ N++ N + T G + M ++ G
Sbjct: 206 RMGSWTGHRWS-GVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTM-VNETGTMHR 263
Query: 221 YSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFC-ILNDQTPDCICLPGFVPIIQGNW- 278
+++ R + W W E+CD CG N +C + +T +C CLPGF P +W
Sbjct: 264 FTWIAR--DKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWF 321
Query: 279 ----SSGCARNYTAESCSNK-AIEELKNTVWEDVS-YSVLSKTTEQNCQEACLKDCNCEA 332
S GC + A CS K +LK D S SV T + C++ CLK+C+C A
Sbjct: 322 LRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVA 381
Query: 333 ---ALYKDEECKMQRLPLRFG----RRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQR 385
A ++ + + L G R L+ +I+VD + ++R+G +R
Sbjct: 382 YASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELAR----WNRNGLSGKR 437
Query: 386 KDIVIISCLFVALIILILATFGIFIYRYRVRSYRIIPGN---------GSARYCEDIA-- 434
+ ++I+ L A+++L + F + R + +R N S R+ +D A
Sbjct: 438 RVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARN 497
Query: 435 --LLSFSYAELEKMTDGF--KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQ 490
L F + T+ F + ++G G G VYKG + N +AVKRL + +G EF+
Sbjct: 498 RELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFK 557
Query: 491 TEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVY----------SSPPKNN 540
E+K I + HRNLVR+LG ++ K+LVYEY+ N SL D + P +
Sbjct: 558 NEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSL-DYFIFHEEQRAELDWPKRME 616
Query: 541 LI-GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG- 598
++ GIARGILYLH + +IIH D+K NIL+D KISDF +A++ +Q T
Sbjct: 617 IVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSR 676
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658
+ GT GY+APE+ + K+DVYSFGV++LEII ++ + E+ L ++ +
Sbjct: 677 VVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKK--NSAFHEESSNLVGHIWDLW 734
Query: 659 ENGNLGQLIED----EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML-EGTMDIPI 713
ENG ++I++ E D++++ + I++ L C+ + S R M V++ML ++P
Sbjct: 735 ENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPN 794
Query: 714 PPNPT 718
P +P
Sbjct: 795 PKHPA 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64784|Y1136_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61360 OS=Arabidopsis thaliana GN=At1g61360 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (703), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 246/811 (30%), Positives = 370/811 (45%), Gaps = 139/811 (17%)
Query: 5 SNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIP----------EKN 54
S ++IG +LS SP G Y GF+ +N + YVG++ + EK
Sbjct: 26 SPLSIGVTLS--------SPGGSYELGFFSSNNSGNQYVGIWFKKVTPRVIVWVANREKP 77
Query: 55 VGRIVLRSTEQGQDSIIADDSQ-------------SASSASMLDSGSFVLYDS-DGKVIW 100
V + T S+I DS+ + A +LD+G+ V+ D+ G +W
Sbjct: 78 VSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTSNKCRAELLDTGNLVVVDNVTGNYLW 137
Query: 101 QTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGKFRLKMQNDGNLIQYPKN-- 152
Q+F+H DT+LP L+ + L S+TDPS G+F ++ Q P
Sbjct: 138 QSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPSPGEFVAEITP-----QVPSQGL 192
Query: 153 -TPDTAPY---SYW--TSFT-----DGKGDN-VSLNLDENGHLFLLNSTGF----NIRNL 196
++PY W T FT D N + + DE +N TG +RN
Sbjct: 193 IRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQDE------VNGTGVFAFCVLRNF 246
Query: 197 TEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCI 256
+ +K+ +G R+ R + W +E CD G CG C+
Sbjct: 247 N---------LSYIKLTPEGSLRI----TRNNGTDWIKHFEGPLTSCDLYGRCGPFGLCV 293
Query: 257 LNDQTPDCICLPGFVPII-----QGNWSSGCARNYTAESCSNKAIE----------ELKN 301
TP C CL GF P GNWS GC R N ++E + N
Sbjct: 294 -RSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVFYHVSN 352
Query: 302 TVWEDVSYSVLSKTTEQNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRKLSDSDIAF 361
D SY + S + E+ C + CL++C+C A Y + + ++L D+ + F
Sbjct: 353 IKPPD-SYELASFSNEEQCHQGCLRNCSCTAFSY------VSGIGCLVWNQELLDT-VKF 404
Query: 362 IKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVAL-IILILATFGIFIYRYRVR---S 417
I T S + RK I II+ ++L + LIL +RYRV+ S
Sbjct: 405 IGGGETLSLRLAHS-----ELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQNGS 459
Query: 418 YRIIPGNGSARYCEDI------ALLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMIN 469
+ N + D+ L F +L+ T+ F ++G+G GTVYKG + +
Sbjct: 460 SLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQD 519
Query: 470 GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529
GK +AVKRL +G EF EIK I + HRNL+RLLG D K+LVYEYM N SL
Sbjct: 520 GKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSL 579
Query: 530 ADVYSSPPK-----------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAK 578
D++ K N + GIARG+LYLH + +++H D+K NIL+DE K
Sbjct: 580 -DIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPK 638
Query: 579 ISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRR 637
ISDF LA+L +Q + TG + GT GY++PE+ W + K+D+YSFGV++LEII +
Sbjct: 639 ISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKE 698
Query: 638 CFDQNLPEDQVILEEWVYQCF-ENGNLG----QLIEDEDVDKKQLERMIKVALWCILDEP 692
+ +D L + + + ENG + L + + V+ + R + + L C+ +
Sbjct: 699 ISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQA 758
Query: 693 SLRPSMKKVLLMLEGTMDIPIPPNPTSLLTT 723
RP++K+V+ ML T D+P P P +L T
Sbjct: 759 IDRPNIKQVMSMLTSTTDLPKPTQPMFVLET 789
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY95|Y1155_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 OS=Arabidopsis thaliana GN=At1g61550 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 4e-72, Method: Compositional matrix adjust.
Identities = 237/804 (29%), Positives = 379/804 (47%), Gaps = 135/804 (16%)
Query: 5 SNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRS-- 62
S ++IG +LS SP+GI+ GF+ +N + YVG++ GI + V + R
Sbjct: 25 SPLSIGQTLS--------SPNGIFELGFFSPNNSRNLYVGIWFKGIIPRTVVWVANRENS 76
Query: 63 -TEQGQDSIIADD--------------------SQSASSASMLDSGSFVLYDS-DGKVIW 100
T+ D I+ + + + SSA + DSG+ ++ D G +W
Sbjct: 77 VTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSSAELSDSGNLLVIDKVSGITLW 136
Query: 101 QTFDHPTDTILPTQRLLAGMELFPGI----------SKTDPSTGKF----RLKMQNDGNL 146
Q+F+H DT+LP L+ PG S TDP G+F ++ G +
Sbjct: 137 QSFEHLGDTMLPYSSLMYN----PGTGEKRVLSSWKSYTDPLPGEFVGYITTQVPPQGFI 192
Query: 147 IQYPKNTPDTAPYSYWTSFT------DGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGE 200
++ K + P++ T FT + S+ D NG ++ + RN
Sbjct: 193 MRGSKPYWRSGPWAK-TRFTGVPLTDESYTHPFSVQQDANGSVYFSHLQ----RNFKRS- 246
Query: 201 NPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQ 260
L+ + S+G ++ +N + W + + CD G+CG C+++
Sbjct: 247 --------LLVLTSEGSLKVTHHN----GTDWVLNIDVPANTCDFYGVCGPFGLCVMS-I 293
Query: 261 TPDCICLPGFVPII-----QGNWSSGCARNYTAESCSNKAIEELKNTVWEDVS------- 308
P C C GFVP +GNW+ GC R T C + N V+ V+
Sbjct: 294 PPKCKCFKGFVPQFSEEWKRGNWTGGCVRR-TELLCQGNSTGRHVN-VFHPVANIKPPDF 351
Query: 309 YSVLSKTTEQNCQEACLKDCNCEAALYKDE-ECKMQRLPLRFGRRKLSDSDIAFIKVDAT 367
Y +S + + C ++CL +C+C A Y + C + L + ++ I++
Sbjct: 352 YEFVSSGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQELMDVMQFSVGGELLSIRL--- 408
Query: 368 ASSNSGKPFSRDGKKAQRKDIVIISCLFVALII-LILATFGIFIYRYRVRSYRIIPG--- 423
ASS G QRK +I S + ++L + L A FG +RYR++ I+
Sbjct: 409 ASSEMGG--------NQRKKTIIASIVSISLFVTLASAAFGF--WRYRLKHNAIVSKVSL 458
Query: 424 NGSAR---YCEDIA-LLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKR 477
G+ R ED++ L F +E T+ F ++G+G G VYKG + +GK +AVKR
Sbjct: 459 QGAWRNDLKSEDVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKR 518
Query: 478 LQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSS- 535
L +G+ EF EI I + H NLVR+LG + ++LVYE+M N SL ++ S
Sbjct: 519 LSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSR 578
Query: 536 -------PPKNNLI-GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587
P + ++I GIARG+LYLH + +IIH D+K NIL+D+ KISDF LA++
Sbjct: 579 KRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARM 638
Query: 588 MK----PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC--FDQ 641
+ D TR I GT GY++PE+ W + K+D YSFGV+LLE+I + F
Sbjct: 639 YEGTKYQDNTRR---IVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSY 695
Query: 642 NLPEDQVILEEWVYQCFENGNLGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMK 699
+ ++ W C ENG +G L +D + ++ R +++ L C+ +P+ RP+
Sbjct: 696 DKERKNLLAYAWESWC-ENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTL 754
Query: 700 KVLLMLEGTMDIPIPPNPTSLLTT 723
++L ML T D+P+P PT + T
Sbjct: 755 ELLSMLTTTSDLPLPKEPTFAVHT 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 233/801 (29%), Positives = 377/801 (47%), Gaps = 127/801 (15%)
Query: 5 SNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRS-- 62
S ++IG +LS S +G+Y GF+ +N + YVG++ GI + V + R
Sbjct: 30 SPLSIGKTLS--------SSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVVVWVANREKP 81
Query: 63 -TEQGQDSIIADD--------------------SQSASSASMLDSGSFVLYDSD-GKVIW 100
T+ + I+ + + + S A + D+G+ V+ D++ G+ +W
Sbjct: 82 VTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRAELTDNGNLVVIDNNSGRTLW 141
Query: 101 QTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGKFRLKMQ----NDGNLIQYP 150
++F+H DT+LP L+ + L S TDPS G F +++ + ++
Sbjct: 142 ESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQITPQVPSQACTMRGS 201
Query: 151 KNTPDTAPYSYWTSFT------DGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTE 204
K + P++ T FT D SL D NG S + RN
Sbjct: 202 KTYWRSGPWAK-TRFTGIPVMDDTYTSPFSLQQDTNGS----GSFTYFERNFK------- 249
Query: 205 GMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDC 264
+ Y+M I S+G +++ +N W++ +E+ CD G CG C+++ P C
Sbjct: 250 -LSYIM-ITSEGSLKIFQHN----GMDWELNFEAPENSCDIYGFCGPFGICVMS-VPPKC 302
Query: 265 ICLPGFVP-----IIQGNWSSGCARNYTAESCSNKAIEELKNTVWEDVS------YSVLS 313
C GFVP +GNW+ GC R +T C + N + + Y S
Sbjct: 303 KCFKGFVPKSIEEWKRGNWTDGCVR-HTELHCQGNTNGKTVNGFYHVANIKPPDFYEFAS 361
Query: 314 KTTEQNCQEACLKDCNCEAALYKDE-ECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNS 372
+ C + CL +C+C A Y + C M L + + +I I++ ASS
Sbjct: 362 FVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSAGGEILSIRL---ASSEL 418
Query: 373 GKPFSRDGKKAQRKDIVIISCLFVALIILILATFGIFIY-RYRVR---SYRIIPGNGSAR 428
G G K R I++ S V+L + ++ F F + RY+V+ S +I
Sbjct: 419 G------GNK--RNKIIVAS--IVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEA 468
Query: 429 YCEDI------ALLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQK 480
+ D+ L F ++ TD F ++G+G G+VYKG + +GK +AVKRL
Sbjct: 469 WNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSS 528
Query: 481 MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSS---- 535
+G+ EF EI I + H+NLVR+LG + ++LVYE++ N SL ++ S
Sbjct: 529 SSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRL 588
Query: 536 ----PPKNNLI-GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK- 589
P + N+I GIARG+ YLH + ++IH D+K NIL+DE KISDF LA++ +
Sbjct: 589 EIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQG 648
Query: 590 ---PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC--FDQNLP 644
D TR + GT GY+APE+ W + K+D+YSFGV+LLEII + F
Sbjct: 649 TEYQDNTRR---VAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQ 705
Query: 645 EDQVILEEWVYQCFENGNLGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
++ W C E+G + L +D + ++ER +++ L C+ +P+ RP+ ++L
Sbjct: 706 GKTLLAYAWESWC-ESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTMELL 764
Query: 703 LMLEGTMDIPIPPNPTSLLTT 723
ML T D+ P PT ++ T
Sbjct: 765 SMLTTTSDLTSPKQPTFVVHT 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | ||||||
| 359477044 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.924 | 0.586 | 0.0 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 0.990 | 0.926 | 0.580 | 0.0 | |
| 255582003 | 817 | ATP binding protein, putative [Ricinus c | 0.991 | 0.878 | 0.583 | 0.0 | |
| 255582007 | 783 | ATP binding protein, putative [Ricinus c | 0.993 | 0.918 | 0.580 | 0.0 | |
| 225431551 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.982 | 0.925 | 0.574 | 0.0 | |
| 225431549 | 772 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.919 | 0.543 | 0.0 | |
| 147857245 | 726 | hypothetical protein VITISV_039751 [Viti | 0.924 | 0.921 | 0.544 | 0.0 | |
| 147838246 | 760 | hypothetical protein VITISV_031648 [Viti | 0.965 | 0.919 | 0.528 | 0.0 | |
| 359493028 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.845 | 0.521 | 0.0 | |
| 296088586 | 653 | unnamed protein product [Vitis vinifera] | 0.871 | 0.966 | 0.566 | 0.0 |
| >gi|359477044|ref|XP_002275760.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2293), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/762 (58%), Positives = 561/762 (73%), Gaps = 52/762 (6%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ SNI+ GSSL+P NS WLSP+ YAFGFY Q +G YY+G+FL GIP+K V
Sbjct: 21 QQRGSNISRGSSLTPTSNSYWLSPNRQYAFGFYNQGDG--YYLGIFLKGIPQKTVVWTAN 78
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
GR+ L++ QGQ IA+ S SA SASML+SG+FVLY+SDG +
Sbjct: 79 RDDLPVPSTATLHFTSEGRLRLQT--QGQQKEIAN-SASAYSASMLNSGNFVLYNSDGDI 135
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
+WQ+FD PTDT+LP QRL AG EL +S+T+PSTG FRLKMQNDGNL+QYP PDTA
Sbjct: 136 VWQSFDLPTDTLLPGQRLSAGKELLSSMSETNPSTGLFRLKMQNDGNLVQYPVEAPDTAT 195
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNST-GFNIRNLTEGENPTEGMMYLMKIDSDGI 217
Y+Y+ S TDGKGDNV+LNLD+ GHL+LLN+T G NI+N+T+G N +Y ++ID DGI
Sbjct: 196 YAYYASGTDGKGDNVTLNLDDEGHLYLLNNTNGSNIKNITDGYNNEN--LYRLRIDPDGI 253
Query: 218 FRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGN 277
F+LYS++L QN +W +LW S+ +KC P GLCG N FC+L D DC+CLPGF ++ N
Sbjct: 254 FKLYSHDLG-QNGSWSILWRSSADKCAPKGLCGVNGFCVLLDDRADCVCLPGFDFVVASN 312
Query: 278 WSSGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCE 331
WSSGC RN+ + C +K + L NT WED SYS LS T+++C++ACL+DCNCE
Sbjct: 313 WSSGCIRNFEEDICKSKDGSTKYTMSTLDNTWWEDASYSTLSLPTQEDCEQACLEDCNCE 372
Query: 332 AALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVII 391
AAL++D C+ QRLPLRFGRR LS+S+I F+KV +T S G KK R DI++I
Sbjct: 373 AALFEDGSCRKQRLPLRFGRRSLSNSNILFVKVGSTEVSQQGT------KKEIRTDILVI 426
Query: 392 SCLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFK 451
S + ++IL G+ I+R + +Y+ I G+ E +AL SF+Y ELEK+T+GFK
Sbjct: 427 SVSLASFALIILVISGVLIHRKNLWAYKKISETGNVGLTEGVALRSFTYMELEKVTNGFK 486
Query: 452 EEIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
EEIG+G+SGTVYKG + N + VAVK+L+K+LAEG+REFQ E+K IGRTHHRNLVRLLGY
Sbjct: 487 EEIGKGASGTVYKGAISNSQRIVAVKKLEKVLAEGQREFQNELKVIGRTHHRNLVRLLGY 546
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHC 562
+ N++LVYEYMSNGSLAD+ +P K + +ARG+LYLH+ECE+QIIHC
Sbjct: 547 CLEGPNRLLVYEYMSNGSLADLLFTPGKQPCWIERMGIALNVARGVLYLHEECETQIIHC 606
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
DIKPQNILMDE + AKISDF LAKL+ DQT TFTGIRGTRGYVAPEWH LP+T KADV
Sbjct: 607 DIKPQNILMDEYKRAKISDFGLAKLLMHDQTNTFTGIRGTRGYVAPEWHRKLPVTVKADV 666
Query: 623 YSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682
YS+G+VLLE ICCR+ D +LPE++ ILEEWVY CFE G LG+L+ DE+VDK+QLERM+K
Sbjct: 667 YSYGIVLLETICCRKNVDWSLPEEEAILEEWVYHCFEAGELGKLVGDEEVDKRQLERMVK 726
Query: 683 VALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
V LWCILDEPSLRPSMKKVLLMLEGT+DIP+PP+P S L+ I
Sbjct: 727 VGLWCILDEPSLRPSMKKVLLMLEGTVDIPVPPSPVSFLSAI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/761 (58%), Positives = 554/761 (72%), Gaps = 44/761 (5%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ SNI+ GSSL+P NS WLSP+ +YAFGFY+Q +G YY+G+FL GIP+K V
Sbjct: 21 QQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGDG--YYLGIFLNGIPQKTVVWTAN 78
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
GR+ L++ QGQ IA+ S SAS ASMLDSG+FVLY SDG +
Sbjct: 79 RDDPPVPSTAALHFTSEGRLRLQT--QGQQKEIAN-STSASFASMLDSGNFVLYSSDGDM 135
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
+WQ+FD PTDT+L QRLLAG ELF +S+T+PSTG FRLKMQNDGNL+QYP TPD
Sbjct: 136 VWQSFDLPTDTLLLGQRLLAGKELFSSVSETNPSTGMFRLKMQNDGNLVQYPVKTPDAPT 195
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIF 218
Y+Y+ S T G GDNV+L+LD GHL+LLN+ G NI+N+T+G E + YL++ID DGIF
Sbjct: 196 YAYYASETGGVGDNVTLHLDGGGHLYLLNTNGSNIKNITDGGYDNENL-YLLRIDPDGIF 254
Query: 219 RLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW 278
+LYS++ QN +W +LW S N+KC P GLCG N FC+L D PDC CLPGF ++ NW
Sbjct: 255 KLYSHD-SGQNGSWSILWRSLNDKCAPKGLCGVNGFCVLLDDRPDCRCLPGFDFVVASNW 313
Query: 279 SSGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEA 332
SSGC RN+ E C +K + L+NT WED SYS LS T+++C++ACL+DCNCEA
Sbjct: 314 SSGCIRNFQQEICKSKDGSTKYTMSTLENTWWEDASYSTLSIPTQEDCEQACLEDCNCEA 373
Query: 333 ALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
AL+KD CK QR PLRFGRR L DS+I F+K+ ++ ++ S + K KDI++IS
Sbjct: 374 ALFKDGSCKKQRFPLRFGRRSLGDSNILFVKMGSSTATPSLQNPQDKRKSPGAKDILVIS 433
Query: 393 CLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKE 452
+ ++ILA G+ I R + +Y+ I + ED+AL SF+Y ELEK+T+GF E
Sbjct: 434 VSLASFALIILAISGVLIRRNNLWAYKKISETVNVELTEDVALRSFTYMELEKVTNGFME 493
Query: 453 EIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
EIG+G+SGTVYKG NG + VAVK+L+K+LAEGE EFQ E+K IGRTHHRNLVRLLGY
Sbjct: 494 EIGKGASGTVYKGATSNGQRIVAVKKLEKVLAEGEIEFQNELKVIGRTHHRNLVRLLGYC 553
Query: 512 FDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCD 563
D N++LVYEYMSNGSLAD +P K + +ARGILYLH+ECE+ IIHCD
Sbjct: 554 LDGPNRLLVYEYMSNGSLADWLFTPGKQPRWSERMGIALNVARGILYLHEECETCIIHCD 613
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IKPQNILMDE R AKISDF LAKL+ DQT T TGIRGTRGYVAPEWH P++ KADVY
Sbjct: 614 IKPQNILMDEYRCAKISDFGLAKLLMHDQTNTSTGIRGTRGYVAPEWHRKQPVSVKADVY 673
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
S+G+VLLE ICCRR D +LP+++VILEEWVYQCFE G LG+L+ DE+VD++QL+ M+KV
Sbjct: 674 SYGIVLLETICCRRNVDWSLPDEEVILEEWVYQCFEAGELGKLVGDEEVDRRQLDMMVKV 733
Query: 684 ALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
LWCILD+PSLRPSMKKVLLMLEGT+DIP+PP+P S L++I
Sbjct: 734 GLWCILDDPSLRPSMKKVLLMLEGTVDIPVPPSPVSFLSSI 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582003|ref|XP_002531799.1| ATP binding protein, putative [Ricinus communis] gi|223528565|gb|EEF30587.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/762 (58%), Positives = 558/762 (73%), Gaps = 44/762 (5%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ +NI++GSSL+P NSSWLSPSG+YAFGFYQQ NG Y VGVFLAG P+K V
Sbjct: 28 QQRQTNISLGSSLTPTKNSSWLSPSGLYAFGFYQQGNG--YAVGVFLAGAPQKTVVWTAN 85
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
VL+S S+ QSASSA++ DSG+FVLY+S+ +
Sbjct: 86 RDDPPVSKDVTLLFTSDSGFVLQSASGQNSSVFISADQSASSAALFDSGNFVLYNSERDI 145
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
IWQ+FD+P DT+LPTQRL AG EL +S TD STG FRLKMQ+DGNL+QYP T DTA
Sbjct: 146 IWQSFDNPIDTLLPTQRLEAGNELISSVSATDHSTGIFRLKMQDDGNLVQYPVRTLDTAA 205
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIF 218
++YW S T+G GDNV+LNLD +G L+LLN+TGFNIRN+TEG P + +Y++++D DGIF
Sbjct: 206 FAYWASGTNGAGDNVTLNLDHDGRLYLLNNTGFNIRNITEGGFPVQETIYMIRLDFDGIF 265
Query: 219 RLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW 278
RLYSY+L ++N W VL ST+++C P GLCG NS+CILNDQ P+CICLPGF + +GNW
Sbjct: 266 RLYSYDL-KENGNWSVLHSSTDDRCAPKGLCGLNSYCILNDQEPECICLPGFGFVSEGNW 324
Query: 279 SSGCARNYTAESC-----SNKAIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAA 333
++GC RN ESC SN+ I+EL NTVW D +Y VLS +++C++ACL+DCNC+AA
Sbjct: 325 TAGCERNSITESCKGDNVSNR-IQELTNTVWLDNTYFVLSSYNKEDCEKACLEDCNCDAA 383
Query: 334 LYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASS-NSGKPFSRDGKKAQRKDIVIIS 392
Y EC+ Q LPLR+GRR L DS++A IKV + S+ N +P + KK K ++I+S
Sbjct: 384 FYNSGECRKQGLPLRYGRRDLRDSNLALIKVGRSVSNPNIIEPIKK--KKEPGKVLLIVS 441
Query: 393 CLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKE 452
+ L+L GI IYRY V++Y+ I N E++A LSF+YAELE++TDGFKE
Sbjct: 442 ASVIGFGFLVLTVIGIMIYRYHVKAYKRISSNEHMGLSEEVAPLSFTYAELERVTDGFKE 501
Query: 453 EIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
EIGRGS GTVYKG + + K VAVK+L+++LA+G+REFQTE+K IG+THHRNLV LLGY
Sbjct: 502 EIGRGSFGTVYKGLLSSSQKVVAVKKLERVLADGDREFQTEMKVIGKTHHRNLVCLLGYC 561
Query: 512 FDVSNKILVYEYMSNGSLADVYSSPPKNNLI--------GIARGILYLHDECESQIIHCD 563
+ N++LVY++MSNGSL+DV SP K IARGILYLH+ECE+QIIHCD
Sbjct: 562 NEGLNRLLVYDFMSNGSLSDVLFSPEKRPCFTERIEIARNIARGILYLHEECETQIIHCD 621
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IKP+NILMD KISDF LAKL+KPDQT+T TGIRGTRGYVAPEWH LP+T KADVY
Sbjct: 622 IKPENILMDAYMCPKISDFGLAKLLKPDQTKTMTGIRGTRGYVAPEWHRKLPVTTKADVY 681
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI-EDEDVDKKQLERMIK 682
SFG+VLLEI CCR+ D + PE + IL EWVY CFENG L +L+ +D++VDK+Q+ RMIK
Sbjct: 682 SFGIVLLEIACCRKHVDLSAPEHECILVEWVYNCFENGELDELVGDDKEVDKRQMNRMIK 741
Query: 683 VALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
V LWC LDEPSLRPSMKKVLLMLEGT+DIP PP+PTS L+ I
Sbjct: 742 VGLWCTLDEPSLRPSMKKVLLMLEGTVDIPTPPSPTSFLSCI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582007|ref|XP_002531801.1| ATP binding protein, putative [Ricinus communis] gi|223528567|gb|EEF30589.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/761 (58%), Positives = 551/761 (72%), Gaps = 42/761 (5%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ +NI++GSSL+P NSSWLSPSG+YAFGFYQQ NG Y VGVFLAG P+K V
Sbjct: 28 QQRQTNISLGSSLTPTKNSSWLSPSGLYAFGFYQQGNG--YAVGVFLAGAPQKTVIWTAN 85
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
VL+S S+ QSA+SA++ DSG+FVLY+S+ +
Sbjct: 86 RDDPPVSRDVTLLFTSDSGFVLQSARGQNSSVSISAVQSAASAALFDSGNFVLYNSERDI 145
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
IWQ+FD PTDT+LPTQRL AG EL +S TD STG FRLKMQ+DGNL+QYP T DTA
Sbjct: 146 IWQSFDSPTDTLLPTQRLQAGDELISSVSATDHSTGIFRLKMQDDGNLVQYPVRTMDTAA 205
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIF 218
++YW S T+G G+NV+LNLD +G L+LLN+TGFNI+N+T G P + +Y+++ID DGIF
Sbjct: 206 FAYWASGTNGAGNNVTLNLDHDGRLYLLNNTGFNIKNITGGGFPMQEAIYIIRIDFDGIF 265
Query: 219 RLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW 278
RLYSY+L ++N W VLW S+N+KCDP GLCG NS C+LNDQ C+CLPGF + +GNW
Sbjct: 266 RLYSYDL-KENGNWSVLWSSSNDKCDPKGLCGLNSCCVLNDQEAKCVCLPGFAFVSEGNW 324
Query: 279 SSGCARNYTAESC----SNKAIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAAL 334
++GC RN ESC + I EL NT+WE +YS++S + +++C++ACL+DCNC+AA
Sbjct: 325 TAGCERNSVPESCKGDDARNTIRELPNTIWEVNTYSLMSFSVKEDCEKACLEDCNCDAAF 384
Query: 335 YKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATAS-SNSGKPFSRDGKKAQRKDIVIISC 393
+ EC QRLPLR+GRR LS+ + A IKV A+ S N P D KK K I+I+S
Sbjct: 385 FSSGECAKQRLPLRYGRRDLSNPNSALIKVRASTSIPNIIDP--TDKKKEPGKGILIVSA 442
Query: 394 LFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEE 453
+L L GI IYRY VR+Y+ I N E++A LSF+YAELE++TDGFKEE
Sbjct: 443 SIFGFGLLALTIAGIMIYRYHVRAYKRISSNEHIGLSEEVAPLSFTYAELERVTDGFKEE 502
Query: 454 IGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
IGRGS GTVYKG + K VAVK+L+++LA+G+REFQTE+KAIG+THH+NLVRLLGY
Sbjct: 503 IGRGSFGTVYKGLLSRSQKVVAVKKLERVLADGDREFQTEMKAIGKTHHKNLVRLLGYCN 562
Query: 513 DVSNKILVYEYMSNGSLADVYSSPPKNNLIG--------IARGILYLHDECESQIIHCDI 564
+ N++LVYE+MSNGSL+DV SP IARGILYLH+ECE+QIIHCDI
Sbjct: 563 EGPNRLLVYEFMSNGSLSDVLFSPENRPCFAERIEIARNIARGILYLHEECETQIIHCDI 622
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
KP+NILMD KISDF LAKL+KPDQT+T T IRGTRGYVAPEWH LP+T KADVYS
Sbjct: 623 KPENILMDAYMCPKISDFGLAKLLKPDQTKTMTDIRGTRGYVAPEWHRKLPVTVKADVYS 682
Query: 625 FGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI-EDEDVDKKQLERMIKV 683
FG+VLLEI CCR+ D + PE + IL EWVY CF +G L +L+ +DE+VDK+Q+ RMIKV
Sbjct: 683 FGIVLLEITCCRKNVDLSAPERECILVEWVYDCFASGELDKLVGDDEEVDKRQMNRMIKV 742
Query: 684 ALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
LWC LDEPSLRPSMKKVLLMLEGT+DIPIPP+PTS L+ I
Sbjct: 743 GLWCTLDEPSLRPSMKKVLLMLEGTVDIPIPPSPTSFLSCI 783
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431551|ref|XP_002275615.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2252), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/761 (57%), Positives = 557/761 (73%), Gaps = 50/761 (6%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ SNI+ GSSL+P NS WLSP+ +YAFGFY+Q +G YYVG+FL GIP+K V
Sbjct: 21 QQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGDG--YYVGIFLNGIPQKTVVWTAN 78
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
GR+ L++ Q ++ + +S SASSASMLDSG+FVLY+SDG +
Sbjct: 79 RDDPPVPSNVTLHFTSEGRLRLQTQAQQKEIV---NSASASSASMLDSGNFVLYNSDGDM 135
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
+WQ+FD PTDT+L QRL AG ELF +S+T+PSTG FRLKMQ+DGNL+QYP TPDT
Sbjct: 136 VWQSFDLPTDTLLLGQRLSAGKELFSIVSETNPSTGMFRLKMQHDGNLVQYPVKTPDTET 195
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIF 218
Y+Y+ + T G GDNV+L+LD GHL+L+N+ GFNI N+T+G E + YL++ID DGIF
Sbjct: 196 YAYYATNTGGVGDNVTLHLDGGGHLYLVNTNGFNIVNITDGGYDNENL-YLLRIDPDGIF 254
Query: 219 RLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW 278
+LYS++L QN +W +LW S+N+KC P GLCG N FC++ D C CLPGF ++ NW
Sbjct: 255 KLYSHDLG-QNGSWSILWRSSNDKCAPKGLCGVNGFCVVLDDRRGCECLPGFDFVVASNW 313
Query: 279 SSGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEA 332
S GC RN+ E C +K + L+NT WED SYS LS +T+++C++ACL+DCNCEA
Sbjct: 314 SLGCIRNFQEEICKSKDGSTKFTMSTLENTWWEDASYSALSLSTQEDCEQACLEDCNCEA 373
Query: 333 ALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
AL++D CK QRLPLRFGRR LSDS+I F+KV + S G KK R +I++IS
Sbjct: 374 ALFEDGSCKKQRLPLRFGRRSLSDSNILFVKVGSPEVSRQGS------KKELRTNILVIS 427
Query: 393 CLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKE 452
+ ++ILA G+ I+R + +Y+ I G+ ED+AL SF+Y ELEK+T+ FKE
Sbjct: 428 VSLASFTLIILAISGVLIHRKNLLAYKKISETGNVGLTEDVALRSFTYMELEKVTNCFKE 487
Query: 453 EIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
EIG+G+SGTVYKG + NG + VAVK+ +K+LAE +REFQ E+K +GRTHHRNLVRLLGY
Sbjct: 488 EIGKGASGTVYKGAISNGQRIVAVKKQEKVLAEWQREFQNELKVLGRTHHRNLVRLLGYC 547
Query: 512 FDVSNKILVYEYMSNGSLADVYSSPPKNNL--------IGIARGILYLHDECESQIIHCD 563
D N++LVYEYMSNGSLAD+ +P K + +A+G+LYLH+ECE+QIIHCD
Sbjct: 548 LDGRNRLLVYEYMSNGSLADLLFTPAKQPCWVERVRIALNVAKGVLYLHEECETQIIHCD 607
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IKPQNILMDE R AKISDF LAKL+ DQT TFTGIRGTRGYVAPEWH L +T KADVY
Sbjct: 608 IKPQNILMDEYRCAKISDFGLAKLLMHDQTNTFTGIRGTRGYVAPEWHRKLAVTVKADVY 667
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
S+G+VLLE ICCRR D +LPE++ ILEEWVY C E G LG+L+ DE+VDK+QLERM+KV
Sbjct: 668 SYGIVLLETICCRRNVDWSLPEEEAILEEWVYHCLEAGELGKLVGDEEVDKRQLERMVKV 727
Query: 684 ALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
LWCILDEPSLRPSM KVLL+LEGT+DIP+PP+P S L++I
Sbjct: 728 GLWCILDEPSLRPSMNKVLLILEGTVDIPVPPSPGSFLSSI 768
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431549|ref|XP_002275592.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/756 (54%), Positives = 533/756 (70%), Gaps = 46/756 (6%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKN------ 54
QQ HSNI+ SSL+P +S W SPSG +AFGFY G + +G+ L G P+
Sbjct: 20 QQRHSNISKTSSLTPTTDSLWFSPSGFFAFGFYHAEGG--FAIGIILVGNPQNTIVWTAN 77
Query: 55 ---------------VGRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVI 99
V +VLR T QG++ I D Q+ASSASMLDSG+FVLY+S ++I
Sbjct: 78 RDEPPVSSNVSLVFTVHGLVLR-TSQGREISIIDPHQNASSASMLDSGNFVLYNSKQEII 136
Query: 100 WQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPY 159
WQ+FDHPTDT+L QRL AG EL +S+ + STG F+LKMQ+DGNL+QYP N P+ Y
Sbjct: 137 WQSFDHPTDTLLSGQRLQAGAELVSSVSEKNYSTGMFQLKMQHDGNLVQYPTNVPEVVEY 196
Query: 160 SYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFR 219
+YW S T G+GDN +LNLD +G+L+LLN+TGFNI+NLT+G P E +YLMKID DGIFR
Sbjct: 197 AYWASDTHGEGDNATLNLDADGYLYLLNATGFNIKNLTDGGGPQEETIYLMKIDVDGIFR 256
Query: 220 LYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNWS 279
LYS L Q+S W V W S+ +KCDP GLCG NS+C L DQ P C CLPGF + + S
Sbjct: 257 LYSRGLD-QSSEWSVEWSSSIDKCDPKGLCGLNSYCSLMDQEPVCTCLPGFDFVDKSQKS 315
Query: 280 SGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAA 333
GC RN+ AE+C N +IE L++ +WED SY V+S TE+NC EACL+DCNCEAA
Sbjct: 316 WGCERNFVAEACKNNDGSIEYSIESLQSVMWEDDSYLVISSRTEENCIEACLEDCNCEAA 375
Query: 334 LYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISC 393
L+K+ EC+ Q+LP RFGRR LSD AF+KV +S + + ++ KK RKDI+IISC
Sbjct: 376 LFKNSECRKQKLPSRFGRRSLSDETTAFVKV---GTSTATRRAPKESKKEWRKDILIISC 432
Query: 394 LFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEE 453
+AL ++LA G+ IYR R + + + G+ R E L SF+Y EL+K+T+GF E
Sbjct: 433 SLLALACIVLAISGLLIYRNRGCTLKKVSKQGNLRLTEGATLQSFTYQELKKVTNGFTEV 492
Query: 454 IGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
+G+G GTVYKG M NG + VAVK+L ++ GE+EF+TE+KA+ THHRNLV+LLGY
Sbjct: 493 LGKGGFGTVYKGAMSNGQRLVAVKKLN--VSTGEKEFRTEMKALAGTHHRNLVQLLGYCL 550
Query: 513 DVSNKILVYEYMSNGSLADVYSSPPK----NNLIGIA----RGILYLHDECESQIIHCDI 564
+ N+ LVYEY+SNGSLA++ +P K + +GIA RGILYLH+ECE+QI+HCDI
Sbjct: 551 EGPNRFLVYEYISNGSLANLLFTPAKWPRWDERMGIAQNVARGILYLHEECETQIMHCDI 610
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
KPQNILMDE AKIS F LAK +K QT T IRGT+GY+APEW N P+T K DVYS
Sbjct: 611 KPQNILMDEYGGAKISSFGLAKRLKHGQTSTLAEIRGTKGYIAPEWFRNQPVTVKVDVYS 670
Query: 625 FGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684
FG++LL+IICCR+ FD +LP++++ L EWV CFE G LG+L++DE+VDK++LERM+KV
Sbjct: 671 FGIMLLQIICCRKNFDLSLPDEEIGLNEWVSHCFEAGELGKLVDDEEVDKRELERMVKVG 730
Query: 685 LWCILDEPSLRPSMKKVLLMLEGT-MDIPIPPNPTS 719
LWCI DEP RPS+KKVLLMLEG+ +DIP+PP+ ++
Sbjct: 731 LWCIQDEPLFRPSIKKVLLMLEGSIIDIPVPPSTST 766
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857245|emb|CAN79207.1| hypothetical protein VITISV_039751 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2034), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/761 (54%), Positives = 521/761 (68%), Gaps = 92/761 (12%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
QQ SNI+ GSSL+P NS WLSP+ +YAFGFY+Q NG YY+G+FL GIP+K V
Sbjct: 21 QQRGSNISRGSSLTPTSNSFWLSPNRLYAFGFYKQGNG--YYLGIFLIGIPQKTVVWTAN 78
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
GR+ L++ QGQ IA+ S SASSASMLDSG+FVLY+SDG +
Sbjct: 79 RDDPPVPSTATLHFTSEGRLRLQT--QGQQKEIAN-SASASSASMLDSGNFVLYNSDGDI 135
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158
+WQ+FD TDT+LP R K PSTG FRLKMQN+GNL+QYP TPD
Sbjct: 136 VWQSFDLQTDTLLPVCR------------KLTPSTGMFRLKMQNNGNLVQYPVKTPDAPT 183
Query: 159 YSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIF 218
Y+Y+TS T G GDNV+L LD GHL+LLN+ G NI N+T+G E ++L+KID DGIF
Sbjct: 184 YAYYTSETGGVGDNVTLLLDGGGHLYLLNTNGSNILNITDGGYDNEN-LHLLKIDPDGIF 242
Query: 219 RLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNW 278
+LYS++ QN +W +LW S+N+KC P GLCG N FCIL D+ PDC CLPGF +++ NW
Sbjct: 243 KLYSHD-SGQNGSWSILWRSSNDKCAPKGLCGVNGFCILLDERPDCKCLPGFXFVVESNW 301
Query: 279 SSGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEA 332
SSGC RN+ E C + + L+NT WE+ SYS LS T+++C++ACL+DCNCEA
Sbjct: 302 SSGCIRNFKEEICKSNDGRTKYTMSTLENTRWEEASYSNLSVPTQEDCEQACLEDCNCEA 361
Query: 333 ALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
AL++D CK QRLPLRFGRR L DS+I F+K+ + S G KK R DI++IS
Sbjct: 362 ALFEDGSCKKQRLPLRFGRRSLGDSNILFVKMGSPEVSPHGS------KKELRTDILVIS 415
Query: 393 CLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKE 452
+ ++ILA G+ I R + +Y+ I G+ ED+AL SF+Y ELEK+TDGFKE
Sbjct: 416 VSLASFALIILAISGVLIRRKNLWAYKKISETGNVGLTEDVALRSFTYMELEKVTDGFKE 475
Query: 453 EIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
EIG+G+SGTVYKG + NG + VAVK+L K LAEG+REFQ E+K IGRTHHRNLVRLLGY
Sbjct: 476 EIGKGASGTVYKGAISNGQRIVAVKKLAKELAEGQREFQNELKVIGRTHHRNLVRLLGYC 535
Query: 512 FDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCD 563
D NK+LVY+YMSNGSLAD+ +P K + +ARGILYLH+E
Sbjct: 536 LDGQNKLLVYQYMSNGSLADLLFTPGKQPRWIERMGIALNVARGILYLHEE--------- 586
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+KL+ DQT T TGIRGTRGYVAPEWH P++ KADVY
Sbjct: 587 ---------------------SKLLMHDQTNTSTGIRGTRGYVAPEWHRKQPVSVKADVY 625
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
S+G+VLLE ICCRR D +LPE++VILEEWVYQCFE G LG+L+ DE+VD++QL+RM+KV
Sbjct: 626 SYGIVLLETICCRRNVDWSLPEEEVILEEWVYQCFEAGQLGKLVGDEEVDRRQLDRMVKV 685
Query: 684 ALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
LWCILDEPSLRPSMKKVL+ML GT+DIP+PP+P S L++I
Sbjct: 686 GLWCILDEPSLRPSMKKVLMMLGGTVDIPVPPSPGSFLSSI 726
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147838246|emb|CAN72121.1| hypothetical protein VITISV_031648 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/755 (52%), Positives = 518/755 (68%), Gaps = 56/755 (7%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVL 60
QQ HSNI+ SSL+P +S W SPSG +AFGFY G + +G+ L G P+ V
Sbjct: 20 QQRHSNISKTSSLTPTTDSLWFSPSGFFAFGFYHAEGG--FAIGIILVGNPQNTVVWTAN 77
Query: 61 R--------------------STEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIW 100
R T QG++ I D Q+ASSASMLDSG+FVLY+S ++IW
Sbjct: 78 RDEPPVSSNVSLVFTVHGLVLXTSQGREISIIDPHQNASSASMLDSGNFVLYNSKQEIIW 137
Query: 101 QTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYS 160
Q+FDHPTDT+L QRL AG EL +S+ + STG F+LKMQ+DGNL+QYP N P+ Y+
Sbjct: 138 QSFDHPTDTLLSGQRLQAGAELVSSVSEKNYSTGMFQLKMQHDGNLVQYPTNVPEVVEYA 197
Query: 161 YWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRL 220
YW S T G+GDN +LNLD +G+L+LLN+TGFNI+NLT+G P E +YLMKID DGIFRL
Sbjct: 198 YWASDTHGEGDNATLNLDADGYLYLLNATGFNIKNLTDGGGPQEETIYLMKIDVDGIFRL 257
Query: 221 YSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGNWSS 280
YS L Q+S W V W S+ +KCDP GLCG NS+C L DQ P C CLPGF + + S
Sbjct: 258 YSRGL-DQSSEWSVEWSSSIDKCDPKGLCGLNSYCSLMDQEPVCTCLPGFDFVDKSQKSW 316
Query: 281 GCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAAL 334
GC RN+ AE+C N +IE L++ +WED SY V+S TE+NC EACL+DCNCEAAL
Sbjct: 317 GCERNFVAEACKNNDGSIEYSIESLQSVMWEDDSYLVISSRTEENCIEACLEDCNCEAAL 376
Query: 335 YKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCL 394
+K+ EC+ Q+LP RFGRR LSD AF+KV +S + + ++ KK RKDI+IISC
Sbjct: 377 FKNSECRKQKLPSRFGRRSLSDETTAFVKV---GTSTATRRAPKESKKEWRKDILIISCS 433
Query: 395 FVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEEI 454
+AL ++LA G+ IYR R + + + G+ R E L SF+Y EL+K+T+GF E +
Sbjct: 434 LLALACIVLAISGLLIYRNRGCTLKKVSKQGNLRLTEGATLQSFTYQELKKVTNGFTEVL 493
Query: 455 GRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD 513
G+G GTVYKG M NG + VAVK+L ++ GE+EF+TE+KA+ THHRNLV+LLGY +
Sbjct: 494 GKGGFGTVYKGAMSNGQRLVAVKKLN--VSTGEKEFRTEMKALAGTHHRNLVQLLGYCLE 551
Query: 514 VSNKILVYEYMSNGSLADVYSSPPK----NNLIGI----ARGILYLHDECESQIIHCDIK 565
N+ LVYEY+SNGSLA++ +P K + +GI ARGILYLH+ECE+QI+HCDIK
Sbjct: 552 GPNRFLVYEYISNGSLANLLFTPAKWPRWDERMGIAQNVARGILYLHEECETQIMHCDIK 611
Query: 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSF 625
PQNILMDE AKIS F LAK +K QT T IRGT+GY+APEW N P+T K
Sbjct: 612 PQNILMDEYGGAKISSFGLAKRLKHGQTSTLAEIRGTKGYIAPEWFRNQPVTVK------ 665
Query: 626 GVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVAL 685
IICCR+ FD +JP++++ L EWV CFE G LG+L++ E+VDK++LERM+KV L
Sbjct: 666 ------IICCRKNFDLSJPDEEIGLNEWVSHCFEAGELGKLVDGEEVDKRELERMVKVGL 719
Query: 686 WCILDEPSLRPSMKKVLLMLEGT-MDIPIPPNPTS 719
WCI DEP RPS+KKVLLMLEG+ +DIP+PP+ ++
Sbjct: 720 WCIQDEPLFRPSIKKVLLMLEGSIIDIPVPPSTST 754
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493028|ref|XP_002264274.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/751 (52%), Positives = 503/751 (66%), Gaps = 62/751 (8%)
Query: 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV----- 55
Q G+S+I +GSSLSP G S+W S SG +AFGFYQ+ G Y VG++ I + V
Sbjct: 77 QLGNSSITLGSSLSPTGPSNWSSHSGQFAFGFYQKGKG--YAVGIWFNRISRRTVIWTAN 134
Query: 56 -----------------GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKV 98
G+++L+ + SI+ D ASSASMLD G+FVL +S V
Sbjct: 135 RDAAPLSRDVQLIFTSDGKLILQQNQGESISIVDRDLPPASSASMLDDGNFVLKNSSSSV 194
Query: 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNT--PDT 156
IWQ+FD PTDTILP Q LLAG +L +S+T+ S GKF+L MQ+DGNL+QYP + P+T
Sbjct: 195 IWQSFDTPTDTILPGQPLLAGQKLVSSVSETNHSAGKFQLIMQSDGNLVQYPIDVAKPET 254
Query: 157 APYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDG 216
A YW + T G VSLNLD NG L+L N TGFNI NL EG +P +Y + ID+DG
Sbjct: 255 A---YWNTSTFTAGATVSLNLDVNGKLYLRNGTGFNIMNLYEG-SPFSTGIYRLTIDADG 310
Query: 217 IFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQG 276
I RLYS + QN W V W T +C P GLCG N +C+L +Q P C+CLPGF G
Sbjct: 311 ILRLYSSS-SDQNGDWTVEWSPTTNRCVPRGLCGLNGYCLLTNQNPQCVCLPGFYLTKPG 369
Query: 277 NWSSGCARNYTAESCSNKAIE----ELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEA 332
+S C RN + N IE L++ WED YSVLS T Q C E CL D NCEA
Sbjct: 370 QNNSDCERNVSMSK--NGDIEYNIIALEDITWEDDPYSVLS-MTRQACIENCLSDGNCEA 426
Query: 333 ALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
ALYK+++C+ Q LPLRFG ++ KV FS GK++ RK++ II
Sbjct: 427 ALYKNQQCRKQTLPLRFGSQE--GGVTTLFKVGN---------FSSVGKES-RKELRIIV 474
Query: 393 CLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKE 452
L + I LA G+ IYRY +++ + G+ R+ ED+AL F+Y ELEK T+GF++
Sbjct: 475 ILSTS-ISFFLAISGVVIYRY---AFKRVSNQGNDRWAEDVALRPFTYHELEKATNGFRD 530
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
E+G+G+ GTV+KG + NGK VA+KRL+KM+AEGE EFQ E+K+IGRTHH+NLVRLLGY
Sbjct: 531 EVGKGAFGTVFKGAISNGKTVAIKRLEKMMAEGEWEFQNEMKSIGRTHHKNLVRLLGYCH 590
Query: 513 DVSNKILVYEYMSNGSLADVYSSPPKNNL--------IGIARGILYLHDECESQIIHCDI 564
D SN++LVYEYM+NGSLAD + + + +ARGILYLH+ECE+QIIHCDI
Sbjct: 591 DGSNRLLVYEYMTNGSLADFLFKSERKPIWEERIEIALSVARGILYLHEECETQIIHCDI 650
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
KP+NILMDE AKI+DF LAKL+ P+QTRT+TGIRGTRGYVAPEWH NLPIT KADVYS
Sbjct: 651 KPENILMDEKGCAKIADFGLAKLLMPNQTRTYTGIRGTRGYVAPEWHRNLPITVKADVYS 710
Query: 625 FGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684
FG++L+EIICCRR D ++ E++V+L ++VY CFE L +L+ DE+VD +L+RM+KV
Sbjct: 711 FGIMLMEIICCRRSLDMDVSENEVVLVDYVYDCFEARELDKLVRDEEVDGMKLQRMVKVG 770
Query: 685 LWCILDEPSLRPSMKKVLLMLEGTMDIPIPP 715
LWCI DEPS+RP MKKV+LM+EGT+DIP PP
Sbjct: 771 LWCIQDEPSVRPLMKKVVLMMEGTVDIPAPP 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088586|emb|CBI37577.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/653 (56%), Positives = 480/653 (73%), Gaps = 22/653 (3%)
Query: 83 MLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQN 142
MLDSG+FVLY+S ++IWQ+FDHPTDT+L QRL AG EL +S+ + STG F+LKMQ+
Sbjct: 1 MLDSGNFVLYNSKQEIIWQSFDHPTDTLLSGQRLQAGAELVSSVSEKNYSTGMFQLKMQH 60
Query: 143 DGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENP 202
DGNL+QYP N P+ Y+YW S T G+GDN +LNLD +G+L+LLN+TGFNI+NLT+G P
Sbjct: 61 DGNLVQYPTNVPEVVEYAYWASDTHGEGDNATLNLDADGYLYLLNATGFNIKNLTDGGGP 120
Query: 203 TEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTP 262
E +YLMKID DGIFRLYS L Q+S W V W S+ +KCDP GLCG NS+C L DQ P
Sbjct: 121 QEETIYLMKIDVDGIFRLYSRGLD-QSSEWSVEWSSSIDKCDPKGLCGLNSYCSLMDQEP 179
Query: 263 DCICLPGFVPIIQGNWSSGCARNYTAESCSNK------AIEELKNTVWEDVSYSVLSKTT 316
C CLPGF + + S GC RN+ AE+C N +IE L++ +WED SY V+S T
Sbjct: 180 VCTCLPGFDFVDKSQKSWGCERNFVAEACKNNDGSIEYSIESLQSVMWEDDSYLVISSRT 239
Query: 317 EQNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPF 376
E+NC EACL+DCNCEAAL+K+ EC+ Q+LP RFGRR LSD AF+KV +S + +
Sbjct: 240 EENCIEACLEDCNCEAALFKNSECRKQKLPSRFGRRSLSDETTAFVKV---GTSTATRRA 296
Query: 377 SRDGKKAQRKDIVIISCLFVALIILILATFGIFIYRYRVRSYRIIPGNGSARYCEDIALL 436
++ KK RKDI+IISC +AL ++LA G+ IYR R + + + G+ R E L
Sbjct: 297 PKESKKEWRKDILIISCSLLALACIVLAISGLLIYRNRGCTLKKVSKQGNLRLTEGATLQ 356
Query: 437 SFSYAELEKMTDGFKEEIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKA 495
SF+Y EL+K+T+GF E +G+G GTVYKG M NG + VAVK+L ++ GE+EF+TE+KA
Sbjct: 357 SFTYQELKKVTNGFTEVLGKGGFGTVYKGAMSNGQRLVAVKKLN--VSTGEKEFRTEMKA 414
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK----NNLIGIA----RG 547
+ THHRNLV+LLGY + N+ LVYEY+SNGSLA++ +P K + +GIA RG
Sbjct: 415 LAGTHHRNLVQLLGYCLEGPNRFLVYEYISNGSLANLLFTPAKWPRWDERMGIAQNVARG 474
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
ILYLH+ECE+QI+HCDIKPQNILMDE AKIS F LAK +K QT T IRGT+GY+A
Sbjct: 475 ILYLHEECETQIMHCDIKPQNILMDEYGGAKISSFGLAKRLKHGQTSTLAEIRGTKGYIA 534
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667
PEW N P+T K DVYSFG++LL+IICCR+ FD +LP++++ L EWV CFE G LG+L+
Sbjct: 535 PEWFRNQPVTVKVDVYSFGIMLLQIICCRKNFDLSLPDEEIGLNEWVSHCFEAGELGKLV 594
Query: 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT-MDIPIPPNPTS 719
+DE+VDK++LERM+KV LWCI DEP RPS+KKVLLMLEG+ +DIP+PP+ ++
Sbjct: 595 DDEEVDKRELERMVKVGLWCIQDEPLFRPSIKKVLLMLEGSIIDIPVPPSTST 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 724 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.958 | 0.837 | 0.306 | 8.2e-83 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.843 | 0.737 | 0.314 | 7.3e-75 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.853 | 0.752 | 0.312 | 2e-71 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.849 | 0.760 | 0.291 | 6.8e-69 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.845 | 0.745 | 0.284 | 3.5e-68 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.893 | 0.801 | 0.293 | 2.6e-67 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.832 | 0.75 | 0.291 | 3.3e-65 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.843 | 0.758 | 0.287 | 4.2e-65 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.656 | 0.590 | 0.314 | 1.6e-63 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.838 | 0.745 | 0.285 | 2e-63 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 236/769 (30%), Positives = 369/769 (47%)
Query: 5 SNINIGSSLSPNG-NSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAG-IPEKNVGRI---- 58
S I +GS + +G N +W SP+ ++ F + +S+ V AG +P + G +
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGTVDSRG 84
Query: 59 --------VLRSTE-QGXXXXXXXXXXXXXXXXML-DSGSFVLYDSDGKVIWQTFDHPTD 108
LR T G + D+G F+L ++ +W +FD+PTD
Sbjct: 85 SLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTD 144
Query: 109 TILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNL-IQYPKNTPDTAPYSYWT-SFT 166
TI+ +Q AG L G+ + +++ GNL +++ NT YW
Sbjct: 145 TIVQSQNFTAGKILRSGL---------YSFQLERSGNLTLRW--NTSAI----YWNHGLN 189
Query: 167 DGKGDNVS---LNLDENGHLFLLNSTGFNIRNLT-EGENPTEGMMYLMKIDSDGIFRLYS 222
N+S L+L NG + + S + G+ +K+D DG R+YS
Sbjct: 190 SSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYS 249
Query: 223 YNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGN-WSSG 281
+ R + W + ++ C G CG C ND P C C + N G
Sbjct: 250 -SASRNSGPVNAHWSAVDQ-CLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRKG 307
Query: 282 CARNYTAESCS-NKAIEELKNT---VWEDVSYSVLSKTTEQNCQEACLKDCNCEAALYKD 337
C R CS N + +L +T +ED S C+ CL C A++
Sbjct: 308 CKRKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMS 367
Query: 338 E---ECKMQRLPLRF--GRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
+ C Q+ P F G + S +++KV +N+ + ++ + + I++
Sbjct: 368 DGSGNC-WQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVA 426
Query: 393 CLFVA-LIILILATFGXXXXXXXXXXXXXXPGNGSARYC----EDIALLSFSYAELEKMT 447
+A L+ L+ G G S+ Y A + F+Y EL++ T
Sbjct: 427 VAVIAGLLGLVAVEIGLWWCCCRKNPRF---GTLSSHYTLLEYASGAPVQFTYKELQRCT 483
Query: 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
FKE++G G GTVY+G + N VAVK+L+ + +GE++F+ E+ I THH NLVRL
Sbjct: 484 KSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRL 542
Query: 508 LGYSFDVSNKILVYEYMSNGSLAD-VYSSPPK---------NNLIGIARGILYLHDECES 557
+G+ +++LVYE+M NGSL + ++++ N +G A+GI YLH+EC
Sbjct: 543 IGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRD 602
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKP-DQXXXXXXXXXXXXYVAPEWHWNLPI 616
I+HCDIKP+NIL+D+N AK+SDF LAKL+ P D Y+APEW NLPI
Sbjct: 603 CIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPI 662
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI-----EDED 671
T+K+DVYS+G+VLLE++ +R FD + + W Y+ FE GN ++ ED+
Sbjct: 663 TSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQT 722
Query: 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSL 720
VD +Q+ RM+K + WCI ++P RP+M KV+ MLEG +I P P ++
Sbjct: 723 VDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTI 771
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 7.3e-75, P = 7.3e-75
Identities = 214/680 (31%), Positives = 337/680 (49%)
Query: 85 DSGSFVLYDS----DGKVIWQTFDHPTDTILP------TQRLLAGMELFPGISKTDPSTG 134
D G+ VL V+WQ+FDHP DT LP +R L S DPS G
Sbjct: 127 DDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPG 186
Query: 135 KFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIR 194
F L++ ++ + N + YW+S + ++ E ++ N + F+
Sbjct: 187 LFSLEL-DESTAYKILWNGSN----EYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFS-- 239
Query: 195 NLTEG--ENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFN 252
N T+ + + + D ++ + N W + W ++C CG
Sbjct: 240 NTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCG-- 297
Query: 253 SFCILNDQT-PDCICLPGFVPIIQGNW-----SSGCARNYTAESCSNKAIEE---LKNTV 303
SF I +D++ P C C GF P+ Q +W S+GC R T CS I + L N
Sbjct: 298 SFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRK-TELQCSRGDINQFFRLPNMK 356
Query: 304 WEDVSYSVLSKTTEQNCQEACLKDCNCEAALYKD--EECKMQR---LPLRFGRRKLSDSD 358
D S VL++T+ C AC DC+C+A Y + +C + L L+ + S+ +
Sbjct: 357 LADNS-EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGN 415
Query: 359 IAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCL-FVALIILILATFGXXXXXXXXXX 417
I ++++ A+ N G GK + K ++ + L + +I+L+L
Sbjct: 416 IFYLRLAASDVPNVGA----SGK-SNNKGLIFGAVLGSLGVIVLVLLVVILILRYRRRKR 470
Query: 418 XXXXPGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKR 477
G+G+ L +FSY EL+ T F +++G G G+V+KG + + +AVKR
Sbjct: 471 MRGEKGDGT--------LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKR 522
Query: 478 LQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL-ADVYSSP 536
L+ +++GE++F+TE+ IG H NLVRL G+ + S K+LVY+YM NGSL + ++ +
Sbjct: 523 LEG-ISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQ 581
Query: 537 PKNNLI-----------GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585
+ ++ G ARG+ YLHDEC IIHCDIKP+NIL+D K++DF LA
Sbjct: 582 VEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLA 641
Query: 586 KLMKPDQXXXXXXXXXXXXYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE 645
KL+ D Y+APEW + ITAKADVYS+G++L E++ RR +Q+ E
Sbjct: 642 KLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENE 701
Query: 646 DQVILEEWVYQCF-ENGNLGQLI----EDEDVDKKQLERMIKVALWCILDEPSLRPSMKK 700
W ++G++ L+ E + VD +++ R KVA WCI DE S RP+M +
Sbjct: 702 KVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQ 761
Query: 701 VLLMLEGTMDIPIPPNPTSL 720
V+ +LEG +++ PP P S+
Sbjct: 762 VVQILEGVLEVNPPPFPRSI 781
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 657 (236.3 bits), Expect = 2.0e-71, Sum P(2) = 2.0e-71
Identities = 217/694 (31%), Positives = 334/694 (48%)
Query: 83 MLDSGSFVLYDS-DGKVIWQTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGK 135
+LD+G+ V+ D+ G +WQ+F+H DT+LP L+ + L S+TDPS G+
Sbjct: 119 LLDTGNLVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPSPGE 178
Query: 136 F--RLKMQNDGNLIQYPKNTP--DTAPYSYWTSFTDGKGDNVSLNLDENGHLF-LLNSTG 190
F + Q + ++P + P++ T FT G + + ++ G + +N TG
Sbjct: 179 FVAEITPQVPSQGLIRKGSSPYWRSGPWA-GTRFT-GIPEMDASYVNPLGMVQDEVNGTG 236
Query: 191 FNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNST-WQVLWESTNEKCDPLGLC 249
+ N + Y+ K+ +G R+ R N T W +E CD G C
Sbjct: 237 VFAFCVLRNFN----LSYI-KLTPEGSLRI-----TRNNGTDWIKHFEGPLTSCDLYGRC 286
Query: 250 GFNSFCILNDQTPDCICLPGFVPIIQ-----GNWSSGCARNYTAESCS-NKAIE-ELKNT 302
G C+ + TP C CL GF P GNWS GC R T SC N ++E + K+
Sbjct: 287 GPFGLCVRSG-TPMCQCLKGFEPKSDEEWRSGNWSRGCVRR-TNLSCQGNSSVETQGKDR 344
Query: 303 -VWEDVS-------YSVLSKTTEQNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRKL 354
V+ VS Y + S + E+ C + CL++C+C A Y + + ++L
Sbjct: 345 DVFYHVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSY------VSGIGCLVWNQEL 398
Query: 355 SDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVALIILILATFGXXXXXXX 414
D+ + FI T S G+K + V L V LI++++A
Sbjct: 399 LDT-VKFIGGGETLSLRLAHS-ELTGRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQ 456
Query: 415 XXXXXXXPGNGSARY-----CEDIALLSF-SYAELEKMTDGFK--EEIGRGSSGTVYKGT 466
N + +D++ L+F +L+ T+ F ++G+G GTVYKG
Sbjct: 457 NGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGK 516
Query: 467 MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526
+ +GK +AVKRL +G EF EIK I + HRNL+RLLG D K+LVYEYM N
Sbjct: 517 LQDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVN 576
Query: 527 GSLADVYSSPPKN----------NLI-GIARGILYLHDECESQIIHCDIKPQNILMDENR 575
SL D++ K N+I GIARG+LYLH + +++H D+K NIL+DE
Sbjct: 577 KSL-DIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKM 635
Query: 576 YAKISDFALAKLMKPDQXXXXXXXXXXXX-YVAPEWHWNLPITAKADVYSFGVVLLEIIC 634
KISDF LA+L +Q Y++PE+ W + K+D+YSFGV++LEII
Sbjct: 636 NPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIIT 695
Query: 635 CRRCFDQNLPEDQVILEEWVYQCF-ENGN---LGQLIEDED-VDKKQLERMIKVALWCIL 689
+ + +D L + + + ENG L Q ++D D V+ + R + + L C+
Sbjct: 696 GKEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQ 755
Query: 690 DEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTT 723
+ RP++K+V+ ML T D+P P P +L T
Sbjct: 756 HQAIDRPNIKQVMSMLTSTTDLPKPTQPMFVLET 789
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 6.8e-69, Sum P(2) = 6.8e-69
Identities = 201/689 (29%), Positives = 324/689 (47%)
Query: 83 MLDSGSFVLYDSD-GKVIWQTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGK 135
+ D+G+ V+ D++ G+ +W++F+H DT+LP L+ + L S TDPS G
Sbjct: 123 LTDNGNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGD 182
Query: 136 FRLKMQNDGNLIQYPKNTPDT-APYSYWTSFTDGKGDNVSLNLDENGHL--FLLNSTGFN 192
F +++ Q P +YW S K + + ++ + F L
Sbjct: 183 FTVQITP-----QVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTNG 237
Query: 193 IRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFN 252
+ T E + + Y+M I S+G +++ +N W++ +E+ CD G CG
Sbjct: 238 SGSFTYFERNFK-LSYIM-ITSEGSLKIFQHN----GMDWELNFEAPENSCDIYGFCGPF 291
Query: 253 SFCILNDQTPDCICLPGFVP-IIQ----GNWSSGCARNYTAESCSNKAIEELKNTVWEDV 307
C+++ P C C GFVP I+ GNW+ GC R +T C + N +
Sbjct: 292 GICVMS-VPPKCKCFKGFVPKSIEEWKRGNWTDGCVR-HTELHCQGNTNGKTVNGFYHVA 349
Query: 308 S------YSVLSKTTEQNCQEACLKDCNCEAALYKDE-ECKMQRLPLRFGRRKLSDSDIA 360
+ Y S + C + CL +C+C A Y + C M L + + +I
Sbjct: 350 NIKPPDFYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQFSAGGEIL 409
Query: 361 FIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVAL-IILILATFGXXXXXXXXXXXX 419
I++ ASS G G K R I++ S + ++L +IL A F
Sbjct: 410 SIRL---ASSELG------GNK--RNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSA 458
Query: 420 XXPGNGSARYC------EDIALLSF-SYAELEKMTDGFK--EEIGRGSSGTVYKGTMING 470
S +D++ L F ++ TD F ++G+G G+VYKG + +G
Sbjct: 459 KISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDG 518
Query: 471 KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530
K +AVKRL +G+ EF EI I + H+NLVR+LG + ++LVYE++ N SL
Sbjct: 519 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLD 578
Query: 531 D-VYSS--------PPKNNLI-GIARGILYLH-DECESQIIHCDIKPQNILMDENRYAKI 579
++ S P + N+I GIARG+ YLH D C ++IH D+K NIL+DE KI
Sbjct: 579 TFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSC-LRVIHRDLKVSNILLDEKMNPKI 637
Query: 580 SDFALAKLMK-PDQXXXXXXXXXXXXYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC 638
SDF LA++ + + Y+APE+ W + K+D+YSFGV+LLEII +
Sbjct: 638 SDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKI 697
Query: 639 --FDQNLPEDQVILEEWVYQCFENGNLGQLIED--EDVDKKQLERMIKVALWCILDEPSL 694
F ++ W C E+G + L +D + ++ER +++ L C+ +P+
Sbjct: 698 SRFSYGRQGKTLLAYAWESWC-ESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPAD 756
Query: 695 RPSMKKVLLMLEGTMDIPIPPNPTSLLTT 723
RP+ ++L ML T D+ P PT ++ T
Sbjct: 757 RPNTMELLSMLTTTSDLTSPKQPTFVVHT 785
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
Identities = 192/675 (28%), Positives = 333/675 (49%)
Query: 85 DSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDG 144
DSG+ V+ DG IW++FDHPTDT++ Q GM+L S S + L++++
Sbjct: 129 DSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKL---TSSPSSSNMTYALEIKSGD 185
Query: 145 NLIQYPKNTPDTAPYSYWTSFT--------DGKGDNVSLNLDENGHLFLLNSTGFNIRNL 196
++ TP YW+ DG G S +L N F + +
Sbjct: 186 MVLSVNSLTPQV----YWSMANARERIINKDG-GVVTSSSLLGNSWRFF-DQKQVLLWQF 239
Query: 197 TEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCI 256
+N + ++ + ++G+ +S NL S + ++ C CG C
Sbjct: 240 VFSDNKDDNTTWIAVLGNNGVIS-FS-NLGSGASAADSSTKIPSDLCGTPEPCGPYYVC- 296
Query: 257 LNDQTPDCICLPGFVPIIQGNWSSGCARNYTA---ESCSNKAIEELKNTVWEDVSYSVL- 312
+ C C+ G S C T+ ++ N + + + V Y L
Sbjct: 297 --SGSKVCGCVSGL-----SRARSDCKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALG 349
Query: 313 -----SKTTE-QNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRKLSDSD----IAFI 362
SK T+ +C+E C +C+C +++ G K S + +++I
Sbjct: 350 YAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDY-IGSFKTSGNGGSGFVSYI 408
Query: 363 KVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVALIILILATFGXXXXXXXXXXXXXXP 422
K+ A+ S G DGK I+++ +F+ + +LI F
Sbjct: 409 KI-ASTGSGGGDNGEDDGKHFPYVVIIVVVTVFI-IAVLIFVAF-RIHKRKKMILEAPQE 465
Query: 423 GNGSARYCEDIA--LLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQK 480
+ + E+++ + F+Y +L+ T+ F ++G+G G+VY+GT+ +G +AVK+L+
Sbjct: 466 SSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEG 525
Query: 481 MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL---------AD 531
+ +G++EF+ E+ IG HH +LVRL G+ + ++++L YE++S GSL D
Sbjct: 526 -IGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGD 584
Query: 532 VYSS-PPKNNL-IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589
V + N+ +G A+G+ YLH++C+++I+HCDIKP+NIL+D+N AK+SDF LAKLM
Sbjct: 585 VLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMT 644
Query: 590 PDQXXXXXXXXXXXXYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649
+Q Y+APEW N I+ K+DVYS+G+VLLE+I R+ +D + ++
Sbjct: 645 REQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 650 LEEWVYQCFENGNLGQLIEDE----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+ ++ E G L +++ + DV ++++R +K ALWCI ++ RPSM KV+ ML
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
Query: 706 EGTMDIPIPPNPTSL 720
EG + PP+ +++
Sbjct: 765 EGVFPVVQPPSSSTM 779
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 637 (229.3 bits), Expect = 2.6e-67, Sum P(2) = 2.6e-67
Identities = 210/716 (29%), Positives = 330/716 (46%)
Query: 48 AGIPEKNVGRIVLRSTEQGXXXXXXXXXXXXXXXXML-DSGSFVLYDS-DGKVIWQTFDH 105
A + N G ++L + + G L D+G+ ++ D+ G+ +WQ+FDH
Sbjct: 87 ANLAISNNGSLLLFNGKHGVAWSSGEALVSNGSRAELSDTGNLIVIDNFSGRTLWQSFDH 146
Query: 106 PTDTILPTQRL---LAGME---LFPGISKTDPSTGKFRLKM--QNDGNLIQYPKNTP--D 155
DT+LP+ L LA E L S TDPS G F L++ Q ++ +TP
Sbjct: 147 LGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQITPQVPTQVLVTKGSTPYYR 206
Query: 156 TAPYSYWTSFTDGKGDNVSLNLDE-NGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDS 214
+ P++ T FT + L D G + + T + +LT N + + M + S
Sbjct: 207 SGPWAK-TRFT-----GIPLMDDTFTGPVSVQQDTNGS-GSLTY-LNRNDRLQRTM-LTS 257
Query: 215 DGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVP-I 273
G L +N + W + + + CD G+CG C+ P C C GFVP +
Sbjct: 258 KGTQELSWHN----GTDWVLNFVAPEHSCDYYGVCGPFGLCV-KSVPPKCTCFKGFVPKL 312
Query: 274 IQ----GNWSSGCARNYTAESCSNKAIEELKNTVWEDVS-------YSVLSKTTEQNCQE 322
I+ GNW+ GC R T C + + N V+ V+ Y S + CQ+
Sbjct: 313 IEEWKRGNWTGGCVRR-TELYCQGNSTGKYAN-VFHPVARIKPPDFYEFASFVNVEECQK 370
Query: 323 ACLKDCNCEAALYKDE-ECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGK 381
+CL +C+C A Y D C M L + ++ I++ A S G K
Sbjct: 371 SCLHNCSCLAFAYIDGIGCLMWNQDLMDAVQFSEGGELLSIRL---ARSELG---GNKRK 424
Query: 382 KAQRKDIVIISCL-FVALIILILATFGXXXXXXXXXXXXXXPGNGSARYCEDIALLSF-S 439
KA IV +S + +A + + + +D+ L F
Sbjct: 425 KAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQVSWRNDLKP-QDVPGLDFFD 483
Query: 440 YAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIG 497
++ T+ F ++G+G G VYKG + +GK +AVKRL +G+ EF EI I
Sbjct: 484 MHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLIS 543
Query: 498 RTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSS--------PPKNNLI-GIARG 547
+ H+NLVR+LG + K+L+YE+M N SL ++ S P + ++I GIARG
Sbjct: 544 KLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQGIARG 603
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQXXXXXXXXXXXXYV 606
I YLH + ++IH D+K NIL+DE KISDF LA++ + + Y+
Sbjct: 604 IHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYM 663
Query: 607 APEWHWNLPITAKADVYSFGVVLLEIICCRRC--FDQNLPEDQVILEEWVYQCFENGNLG 664
APE+ W + K+D+YSFGV++LEII + F E +I W C + G +
Sbjct: 664 APEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWC-DTGGID 722
Query: 665 QLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPT 718
L +D + ++ER +++ L C+ +P+ RP+ ++L ML T D+P P PT
Sbjct: 723 LLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPPPEQPT 778
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 3.3e-65, Sum P(2) = 3.3e-65
Identities = 200/685 (29%), Positives = 324/685 (47%)
Query: 83 MLDSGSFVLYDS-DGKVIWQTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGK 135
+ D+G+ V+ D+ G+ +W++F+H DT+LP L+ + L + TDPS G
Sbjct: 123 LTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGV 182
Query: 136 F--RLKMQNDGNLIQYPKNTP--DTAPYSYWTSFT------DGKGDNVSLNLDENGHLFL 185
F ++ Q ++ +T T P++ T FT D SL D NG F
Sbjct: 183 FVGQITPQVPSQVLIMRGSTRYYRTGPWAK-TRFTGIPLMDDTYASPFSLQQDANGSGFF 241
Query: 186 LNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDP 245
T F+ R+ + + I S+G + + +N + W++ + + CD
Sbjct: 242 ---TYFD-RSFK---------LSRIIISSEGSMKRFRHN----GTDWELSYMAPANSCDI 284
Query: 246 LGLCGFNSFCILNDQTP-DCICLPGFVPII-----QGNWSSGCARNYTAESCSNKAIEEL 299
G+CG CI++ P C CL GFVP +GNW+ GCAR T C + +
Sbjct: 285 YGVCGPFGLCIVS--VPLKCKCLKGFVPHSTEEWKRGNWTGGCAR-LTELHCQGNSTGKD 341
Query: 300 KNTVWEDVS-------YSVLSKTTEQNCQEACLKDCNCEAALY-KDEECKMQRLPLRFGR 351
N ++ V+ Y S + C ++CL +C+C A Y C + L
Sbjct: 342 VN-IFHPVTNVKLPDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQNLMDAV 400
Query: 352 RKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVAL-IILILATFGXXX 410
+ + +I I++ A S G G K R I++ S + ++L +IL A FG
Sbjct: 401 QFSAGGEILSIRL---AHSELG------GNK--RNKIIVASTVSLSLFVILTSAAFGFWR 449
Query: 411 XXXXXXXXXXXPG-NGSARYCEDIALLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTM 467
+ E L F ++ T+ F ++G+G G+VYKG +
Sbjct: 450 YRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKL 509
Query: 468 INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527
+GK +AVK+L +G+ EF EI I + HRNLVR+LG + K+L+YE+M N
Sbjct: 510 QDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNK 569
Query: 528 SLAD-VYSS--------PPKNNLI-GIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577
SL V+ + P + +++ GIARG+LYLH + ++IH D+K NIL+DE
Sbjct: 570 SLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNP 629
Query: 578 KISDFALAKLMKPDQ-XXXXXXXXXXXXYVAPEWHWNLPITAKADVYSFGVVLLEIICCR 636
KISDF LA++ + Q Y++PE+ W + K+D+YSFGV+LLEII
Sbjct: 630 KISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGE 689
Query: 637 RCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK-KQLE--RMIKVALWCILDEPS 693
+ + E+ L + ++ + L++ + D + LE R +++ L C+ +P+
Sbjct: 690 KISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPA 749
Query: 694 LRPSMKKVLLMLEGTMDIPIPPNPT 718
RP+ ++L ML T D+P P PT
Sbjct: 750 DRPNTLELLAMLTTTSDLPSPKQPT 774
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 4.2e-65, Sum P(2) = 4.2e-65
Identities = 198/689 (28%), Positives = 324/689 (47%)
Query: 83 MLDSGSFVLYDS-DGKVIWQTFDHPTDTILPTQ----RLLAGME--LFPGISKTDPSTGK 135
+ D G+ V D G+ +WQ+F+H +T+LPT L+AG + L S TDPS G+
Sbjct: 123 LTDHGNLVFIDKVSGRTLWQSFEHLGNTLLPTSIMMYNLVAGEKRGLTAWKSYTDPSPGE 182
Query: 136 FRL----KMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDEN-GHLFLLNS-- 188
F ++ + G +++ T P++ T FT S +DE+ F+L
Sbjct: 183 FVALITPQVPSQGIIMRGSTRYYRTGPWAK-TRFTG------SPQMDESYTSPFILTQDV 235
Query: 189 TGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGL 248
G + E P+ M + S+G ++ +N W+ +E CD G+
Sbjct: 236 NGSGYFSFVERGKPSR-----MILTSEGTMKVLVHN----GMDWESTYEGPANSCDIYGV 286
Query: 249 CGFNSFCILNDQTPDCICLPGFVPII-----QGNWSSGCARNYTAESCSNKAIEELKNTV 303
CG C+++ P C C GFVP +GNW+SGC R T C + + N
Sbjct: 287 CGPFGLCVVSIP-PKCKCFKGFVPKFAKEWKKGNWTSGCVRR-TELHCQGNSSGKDANVF 344
Query: 304 WE--DVS----YSVLSKTTEQNCQEACLKDCNCEAALY-KDEECKMQRLPLRFGRRKLSD 356
+ ++ Y + + C + CL +C+C A Y C M L R+ +
Sbjct: 345 YTVPNIKPPDFYEYANSQNAEECHQNCLHNCSCLAFSYIPGIGCLMWSKDLMDTRQFSAA 404
Query: 357 SDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVALIILI-LATFGXXXXXXXX 415
++ I++ A S D K RK ++ S + + L ++ A FG
Sbjct: 405 GELLSIRL---ARSEL------DVNK--RKMTIVASTVSLTLFVIFGFAAFGFWRCRVEH 453
Query: 416 XXXXXXPGNGSARYCEDIALLSF-SYAELEKMTDGFK--EEIGRGSSGTVYK---GTMIN 469
+ +D+ L F ++ T+ F ++G G G+VYK G + +
Sbjct: 454 NAHISNDAWRNFLQSQDVPGLEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQD 513
Query: 470 GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529
G+ +AVKRL +G++EF EI I + HRNLVR+LG + + K+L+Y ++ N SL
Sbjct: 514 GREIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSL 573
Query: 530 AD-VYSS--------PPKNNLI-GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579
V+ + P + +I GIARG+LYLH + ++IH D+K NIL+DE KI
Sbjct: 574 DTFVFDARKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKI 633
Query: 580 SDFALAKLMKPDQXXXXXXXXXXXX-YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC 638
SDF LA++ + Q Y++PE+ W + K+D+YSFGV+LLEII ++
Sbjct: 634 SDFGLARMFQGTQYQEKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGKKI 693
Query: 639 FDQNLPEDQVILEEWVYQCF----ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSL 694
+ E+ L + ++C+ E L Q + D ++ R +++ L C+ EP+
Sbjct: 694 SSFSYGEEGKALLAYAWECWCETREVNFLDQALADSS-HPSEVGRCVQIGLLCVQHEPAD 752
Query: 695 RPSMKKVLLMLEGTMDIPIPPNPTSLLTT 723
RP+ ++L ML T D+P+P PT ++ T
Sbjct: 753 RPNTLELLSMLTTTSDLPLPKKPTFVVHT 781
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 1.6e-63, Sum P(2) = 1.6e-63
Identities = 167/531 (31%), Positives = 253/531 (47%)
Query: 230 STWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPII-----QGNWSSGCAR 284
+ W++ CD G CG C+ +D P C CL GFVP +GNW+SGC R
Sbjct: 268 NNWKLHLSLPENPCDLYGRCGPYGLCVRSDP-PKCECLKGFVPKSDEEWGKGNWTSGCVR 326
Query: 285 NYTAESCSNKAIEELKNTVWEDVSYSVLS-KTTE----------QNCQEACLKDCNCEAA 333
T SC K+ + + D+ Y + KT + + C + CL +C+C A
Sbjct: 327 R-TKLSCQAKSSMKTQGKD-TDIFYRMTDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAF 384
Query: 334 LY-KDEECKMQRLPLRFGRRKLSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIIS 392
Y C + L + LS + FI++ ++ + S + RK IV +
Sbjct: 385 AYISGIGCLVWNGELADTVQFLSSGEFLFIRLASSELAGSSR----------RKIIVGTT 434
Query: 393 CLFVALIILILATFGXXXXXXXXXXXXXXPGNGSARYCEDIALLSF-SYAELEKMTDGFK 451
V+L I ++ F NG R +D++ ++F + T+ F
Sbjct: 435 ---VSLSIFLILVFAAIMLWRYRAKQNDAWKNGFER--QDVSGVNFFEMHTIRTATNNFS 489
Query: 452 --EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
++G+G G VYKG +++GK + VKRL +G EF EI I + HRNLVRLLG
Sbjct: 490 PSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLG 549
Query: 510 YSFDVSNKILVYEYMSNGSLADVYS-SP--------PKN-NLI-GIARGILYLHDECESQ 558
Y D K+L+YE+M N SL D++ P PK N+I GIARG+LYLH + +
Sbjct: 550 YCIDGEEKLLIYEFMVNKSL-DIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLR 608
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQXXXXXXXXXXXX-YVAPEWHWNLPIT 617
+IH D+K NIL+D+ KISDF LA++ + Q Y++PE+ W +
Sbjct: 609 VIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGLFS 668
Query: 618 AKADVYSFGVVLLEIICCRRC--FDQNLPEDQVILEEWVYQCFENGNLGQLIED--EDVD 673
K+D+YSFGV++LEII +R F ++ W C E G L D +
Sbjct: 669 EKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWC-ETGGSNLLDRDLTDTCQ 727
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLTTI 724
++ R +++ L C+ E RP+ +VL ML D+P+P P + T+
Sbjct: 728 AFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPIFAVHTL 778
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
Identities = 197/689 (28%), Positives = 333/689 (48%)
Query: 83 MLDSGSFVLYDS-DGKVIWQTFDHPTDTILPTQRLLAGME------LFPGISKTDPSTGK 135
+L++G+ VL D + +W++F+H DT+L ++ + L + TDPS G+
Sbjct: 124 LLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPGE 183
Query: 136 FRLKMQND----GNLIQYPKNTPDTAPYSY--WTSFTDGKGDNVS-LNLDENGHLFLLNS 188
F ++ G +++ + P++ +T + G +VS ++ ++ +
Sbjct: 184 FVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQD----VAAG 239
Query: 189 TGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGL 248
TG +L E + Y + S G ++ N S W E+ CD
Sbjct: 240 TGSLTYSL---ERRNSNLSYTT-LTSAGSLKIIWNN----GSGWVTDLEAPVSSCDVYNT 291
Query: 249 CGFNSFCILNDQTPDCICLPGFVPII-----QGNWSSGCARNYTAESC--SNKAIEELKN 301
CG CI ++ P C CL GFVP + NW+ GC R T SC ++ A + N
Sbjct: 292 CGPFGLCIRSNP-PKCECLKGFVPKSDEEWNKRNWTGGCMRR-TNLSCDVNSSATAQANN 349
Query: 302 -TVWEDVS-------YSVLSKTTEQNCQEACLKDCNCEAALYKDEECKMQRLPLRFGRRK 353
+++ V+ Y LS E++CQ+ CL +C+C A Y ++++ R+
Sbjct: 350 GDIFDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCTAFSY------IEQIGCLVWNRE 403
Query: 354 LSDSDIAFIKVDATASSNSGKPFSRDGKKAQRKDIVIISCLFVAL-IILILATFGXXXXX 412
L D + F+ T S S + + R I++ S + +++ +IL+ A++
Sbjct: 404 LVDV-MQFVAGGETLSIRLA---SSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYK 459
Query: 413 XXXXXXXXXPGNGSA-RYCEDIALLSFSYAELEKM---TDGFKEE--IGRGSSGTVYKGT 466
P S + E + ++ +++ + T+ F E +G+G G VYKG
Sbjct: 460 AKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGN 519
Query: 467 MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526
+ +GK +A+KRL +G EF EI I + HRNLVRLLG + K+L+YE+M+N
Sbjct: 520 LQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMAN 579
Query: 527 GSLAD-VYSS--------PPKNNLI-GIARGILYLH-DECESQIIHCDIKPQNILMDENR 575
SL ++ S P + +I GIA G+LYLH D C +++H D+K NIL+DE
Sbjct: 580 KSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSC-LRVVHRDMKVSNILLDEEM 638
Query: 576 YAKISDFALAKLMKPDQXXXXXXXXXXXX-YVAPEWHWNLPITAKADVYSFGVVLLEIIC 634
KISDF LA++ + Q Y++PE+ W + K+D+Y+FGV+LLEII
Sbjct: 639 NPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIIT 698
Query: 635 CRRCFDQNLPED-QVILE-EWVYQCFENGNLGQLIEDEDVD----KKQLERMIKVALWCI 688
+R + E+ + +LE W C E+G G + D+D+ + ++ R +++ L CI
Sbjct: 699 GKRISSFTIGEEGKTLLEFAWDSWC-ESG--GSDLLDQDISSSGSESEVARCVQIGLLCI 755
Query: 689 LDEPSLRPSMKKVLLMLEGTMDIPIPPNP 717
+ RP++ +V+ ML TMD+P P P
Sbjct: 756 QQQAGDRPNIAQVMSMLTTTMDLPKPKQP 784
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3395 | 0.9709 | 0.8449 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00034863001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (775 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 724 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-08 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-08 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-06 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| pfam09716 | 82 | pfam09716, ETRAMP, Malarial early transcribed memb | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-47
Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLGYS 511
+G G GTVY GK VA+K ++K + E EI+ + + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 512 FDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCD 563
D ++ LV EY GSL D+ L+ I G+ YLH + IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 564 IKPQNILMDENRY-AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPITAKAD 621
+KP+NIL+D + K++DF L+KL+ I GT Y+APE + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 622 VYSFGVVLLEIICC----RRCFDQN 642
++S GV+L E+ R+ ++
Sbjct: 177 IWSLGVILYELPELKDLIRKMLQKD 201
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
E++G GS G VY GK VA+K ++K + +RE EIK + + H N+VRL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPK--NNLIG-----IARGILYLHDECESQI 559
F+ +K+ LV EY G L D+ + + I + YLH + I
Sbjct: 63 YD-VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
+H D+KP+NIL+DE+ + K++DF LA+ + P + T GT Y+APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK--KQL 677
D++S GV+L E++ + F + + +++ + D+ K L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 678 -ERMIKVALWCILDEPSLRPSMKKVL 702
+++ +P R + ++ L
Sbjct: 231 IRKLLVK-------DPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 87/268 (32%), Positives = 125/268 (46%), Gaps = 30/268 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
++G GS GTVYK GK VAVK L+K ++ ++ + EI+ + R H N+VR
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG----------IARGILYLHDEC 555
L+ +F+ + + LV EY G L D S + + I RG+ YLH
Sbjct: 63 LID-AFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN- 117
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH-WNL 614
IIH D+KP+NIL+DEN KI+DF LAK + + T GT Y+APE
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGN 174
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
K DV+S GV+L E++ + F DQ Q L DE
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-------LQLIRRILGPPLEFDEPKWS 227
Query: 675 KQLERMIKVALWCILDEPSLRPSMKKVL 702
E + C+ +PS RP+ +++L
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 452 EEIGRGSSGTVYKGTM-INGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E +GRGS G+VY G+ +AVK L E + EI+ + H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 509 GYSFDVSNK-ILVY-EYMSNGSLADVYSS--PPKNNLIG-----IARGILYLHDECESQI 559
G D + ++ EY+S GSL+ + +I I G+ YLH I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPITA 618
+H DIK NIL+D + K++DF AK + +T TG +RGT ++APE
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 619 KADVYSFGVVLLEIIC 634
AD++S G ++E+
Sbjct: 183 AADIWSLGCTVIEMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 57/284 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
+++G G+ G VYKG + VAVK L++ +E + EF E + + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDE 554
+V+LLG + +V EYM G L Y + L + IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLS-YLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
IH D+ +N L+ EN KISDF L++ + D RG + L
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGK----------L 165
Query: 615 PI-------------TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661
PI T+K+DV+SFGV+L EI P + EE V + +NG
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEI--FTLGE---QPYPGMSNEE-VLEYLKNG 219
Query: 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+ + + L C ++P RP+ +++ +L
Sbjct: 220 YR-LPQPPNCPPE-----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 76/284 (26%), Positives = 119/284 (41%), Gaps = 56/284 (19%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKM-LAEGEREFQTEIKAIGRTHHRN 503
+++G G+ G VYKGT+ VAVK L++ + EF E + + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDE 554
+V+LLG + ++V EYM G L D L + IARG+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
IH D+ +N L+ EN KISDF L++ + D + G L
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-----YKVKGG--------KL 166
Query: 615 PI-------------TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661
PI T+K+DV+SFGV+L EI P + E V + + G
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEI--FTLGE---EPYPGMSNAE-VLEYLKKG 220
Query: 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+ + K+ L C ++P RP+ +++ +L
Sbjct: 221 YR-LPKPPNCPPE-----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
+++G G+ G VYKGT+ VAVK L++ +E ER EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHDE 554
+VRLLG +V EYM G L + +L+ IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDL-LDFLRKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVAPE 609
+H D+ +N L+ EN KISDF L++ + D G I+ ++APE
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174
Query: 610 -WHWNLPITAKADVYSFGVVLLEIIC 634
T+K+DV+SFGV+L EI
Sbjct: 175 SLKDGK-FTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 81/299 (27%)
Query: 452 EEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVR 506
+++G G+ G VYKG + VAVK L++ +E ER +F E + + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 507 LLGYSFDVSNKILVYEYMSNGSL-------ADVYSSPPKNNL---------IGIARGILY 550
LLG + LV EYM G L V+ SP K+ L I IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGY 605
L + +H D+ +N L+ E+ KISDF L++ + D IR +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 606 VAPEWHWNLPI-----TAKADVYSFGVVLLEIICCRRCFD------QNLPEDQVILEEWV 654
+APE + T+K+DV+SFGV+L EI F L ++V+ E++
Sbjct: 174 MAPE-----SLKDGIFTSKSDVWSFGVLLWEI------FTLGATPYPGLSNEEVL--EYL 220
Query: 655 YQCFENGNLGQLIEDEDVDKKQLER-------MIKVALWCILDEPSLRPSMKKVLLMLE 706
G +L + + ++ L C +P RP+ +++ LE
Sbjct: 221 ----RKGY-------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 68/191 (35%), Positives = 99/191 (51%), Gaps = 18/191 (9%)
Query: 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQ-KMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+G+GSSG VYK GK A+K++ E ++ E+K + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG- 66
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPK---NNLIGIARGIL----YLHDECESQIIHC 562
+F +I +V EYM GSLAD+ K L IAR IL YLH + IIH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHR 124
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKP--DQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
DIKP N+L++ KI+DF ++K+++ DQ TF GT Y++PE + A
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPERIQGESYSYAA 181
Query: 621 DVYSFGVVLLE 631
D++S G+ LLE
Sbjct: 182 DIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 33/237 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
+ IGRG+ G VYKG + G FVA+K+ L+K+ E + EI + H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADVY--SSPPKNNLIG-----IARGILYLHDECESQI 559
+G + ++ EY NGSL + P +L+ + +G+ YLH++ +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GV 120
Query: 560 IHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
IH DIK NIL ++ K++DF +A KL D ++ + GT ++APE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 619 KADVYSFGVVLLEIICC--------------RRCFDQN--LPED-QVILEEWVYQCF 658
+D++S G ++E++ R D + LPE L++++ QCF
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 18/192 (9%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
E+IG+G G VYK GK VA+K ++ E + + EI+ + + H N+V+ G
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 510 YSFDVSNKI-LVYEYMSNGSLADVYSS---PPKNNLIG-IARGIL----YLHDECESQII 560
S+ +++ +V E+ S GSL D+ S + I + + +L YLH II
Sbjct: 65 -SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAK 619
H DIK NIL+ + K+ DF L+ + + R T GT ++APE P K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDYK 177
Query: 620 ADVYSFGVVLLE 631
AD++S G+ +E
Sbjct: 178 ADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 72/278 (25%), Positives = 114/278 (41%), Gaps = 31/278 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML---AEGEREFQTEIKAIGR-THHRNLV 505
++G GS G VY + K VA+K L K L ++ F EI+ + H N+V
Sbjct: 4 ILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN----------LIGIARGILYLHDEC 555
+L + D + LV EY+ GSL D+ + L I + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--- 118
Query: 556 ESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRT-----FTGIRGTRGYVAPE 609
IIH DIKP+NIL+D + R K+ DF LAKL+ + + + GT GY+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 610 WHWNL---PITAKADVYSFGVVLLEIICCRRCFD-QNLPEDQVILEEWVYQCFENGNLGQ 665
L ++ +D++S G+ L E++ F+ + + + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703
L + + + +P R S L
Sbjct: 239 LSPSNPELI--SKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 76/266 (28%), Positives = 121/266 (45%), Gaps = 30/266 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG+G G V G K VAVK L K + + F E + H NLV+LLG
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-VAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSP-----PKNNLIGIAR----GILYLHDECESQII 560
+ +V EYM+ GSL D S +G A G+ YL E +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H D+ +N+L+ E+ AK+SDF LAK + ++ + + APE + K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680
DV+SFG++L EI R +P ++ L++ V E G +E + ++ ++
Sbjct: 181 DVWSFGILLWEIYSFGR-----VPYPRIPLKD-VVPHVEK---GYRMEAPEGCPPEVYKV 231
Query: 681 IKVALWCILDEPSLRPSMKKVLLMLE 706
+K W + +P+ RP+ K++ L
Sbjct: 232 MKDC-WEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQ-KMLAEGEREF-QTEIKAIGRTHHRNLVRL 507
++IG+GS G VY +GK +K + ++E ERE E+K + + +H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 508 LGYSFDVSNKIL-VYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHDEC 555
SF+ K+ V EY G L+ K + + + YLH
Sbjct: 65 YE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR- 122
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLM--KPDQTRTFTGIRGTRGYVAPE-WHW 612
+I+H DIKPQNI + N K+ DF ++K++ D +T GT Y++PE
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQ- 176
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFD-QNLPE 645
N P K+D++S G VL E+ + F+ +NL E
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 78/273 (28%), Positives = 126/273 (46%), Gaps = 35/273 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
E IG G++ VY + N + VA+KR L+K + E + E++A+ + +H N+V+
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVK 63
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADV--YSSPPKNN--------LIGIARGILYLHDEC 555
SF V +++ LV Y+S GSL D+ S P L + +G+ YLH
Sbjct: 64 YYT-SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFAL-AKLMKP--DQTRTFTGIRGTRGYVAPE-WH 611
IH DIK NIL+ E+ KI+DF + A L + GT ++APE
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671
KAD++SFG+ +E+ + P +V++ + L D
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKVLMLTL------QNDPPSLETGAD 232
Query: 672 VDK--KQLERMIKVALWCILDEPSLRPSMKKVL 702
K K +MI + C+ +PS RP+ +++L
Sbjct: 233 YKKYSKSFRKMISL---CLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEG-EREFQTEIKAIGR-THHRNL 504
F + IG GS TV K A+K L K ++ E + + E + + R H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 505 VRLLGYSF-DVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIARGIL----YLHDECE 556
++L Y+F D N V EY NG L Y S + A IL YLH +
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-------------------TRTFT 597
IIH D+KP+NIL+D++ + KI+DF AK++ P+ R F
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ 641
GT YV+PE P +D+++ G ++ +++ + F
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 36/270 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+EIG G G V+ G + + VA+K +++ A E +F E + + + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSP----PKNNLIG----IARGILYLHDECESQIIH 561
+ S LV+E+M +G L+D + + L+G + G+ YL +IH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+ +N L+ EN+ K+SDF + + + DQ + TG + + +PE ++K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 622 VYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL---- 677
V+SFGV++ E+ + P +EN + +++E + +
Sbjct: 184 VWSFGVLMWEVFS-----EGKTP-------------YENRSNSEVVETINAGFRLYKPRL 225
Query: 678 --ERMIKVALWCILDEPSLRPSMKKVLLML 705
+ + ++ C + P RPS +L L
Sbjct: 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 25/200 (12%)
Query: 452 EEIGRGSSGTVYKGTM-INGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVR 506
+ IG G G V +G + + GK VA+K L+ ++ +R +F TE +G+ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 507 LLGYSFDVSNKILVYEYMSNGSL------ADVYSSPPK--NNLIGIARGILYLHDECESQ 558
L G +++ EYM NGSL D + + L GIA G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTG----IRGTRGYVAPEWHWN 613
+H D+ +NIL++ N K+SDF L++ L + T T G IR T APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 614 LPITAKADVYSFGVVLLEII 633
T+ +DV+SFG+V+ E++
Sbjct: 183 RKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 65/194 (33%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+ ++G G G V+ GT VAVK L+ M E F E + + + H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRHDKLVQLY 67
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-----LIG----IARGILYLHDECESQI 559
+ +V EYMS GSL D S L+ IA G+ YL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNY 124
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
IH D+ +NIL+ EN KI+DF LA+L++ D+ G + + APE T K
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 620 ADVYSFGVVLLEII 633
+DV+SFG++L EI+
Sbjct: 185 SDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 66/199 (33%), Positives = 95/199 (47%), Gaps = 29/199 (14%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAIGRTHHRNLVR 506
+G+GS G V K T GK A+K L+K ++ E E TE + R +H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIAR----------GILYLHDEC 555
L Y+F K+ LV EY G L S K R + YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSL- 112
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
II+ D+KP+NIL+D + + K++DF LAK + + +RT T GT Y+APE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 616 ITAKADVYSFGVVLLEIIC 634
D +S GV+L E++
Sbjct: 170 YGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 21/193 (10%)
Query: 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQT----EIKAIGRTHHRNLVRL 507
E+G G+SG V K GK +AVK + E Q E+ + + + +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKT---IRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSP----PKNNLIGIARGIL----YLHDECESQI 559
G ++ + + EYM GSL + P+ L IA +L YLH++ +I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
IH D+KP NIL++ K+ DF ++ + +TF GT Y+APE + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVK 179
Query: 620 ADVYSFGVVLLEI 632
+D++S G+ L+E+
Sbjct: 180 SDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
IG G+ G VY + G+ +AVK R+Q + +E E+K + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 511 SFDVSNKILVYEYMSNGSLADV--YSSPPKNNLIG-----IARGILYLHDECESQIIHCD 563
+ EY S G+L ++ + ++I + G+ YLH I+H D
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRD 124
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG---YVAPEWHWNLPITAK- 619
IKP NI +D N K+ DF A +K + T ++ G Y+APE
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184
Query: 620 --ADVYSFGVVLLEIICCRR 637
AD++S G V+LE+ +R
Sbjct: 185 RAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQT--EIKAIGRTHHRNLVRLLGY 510
IG G+ G V+K G+ VA+K++ EG Q EIKA+ H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 511 SFDVSNKILVYEYMSNGSLADV---YSSPP-----KNNLIGIARGILYLHDECESQIIHC 562
S +LV EYM L++V P K+ + + +G+ Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP-ITAKAD 621
D+KP N+L+ + KI+DF LA+L ++ R ++ TR Y APE + D
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 622 VYSFGVVLLEIICCRRCFD 640
+++ G + E++ F
Sbjct: 184 LWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 20/196 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E+IG G+SG VYK T GK VA+K++ ++ + + EI + H N+V
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 509 GYSFDVSNKI-LVYEYMSNGSLADV-YSSPPKNNLIGIA-------RGILYLHDECESQ- 558
S+ V +++ +V EYM GSL D+ + + N IA +G+ YLH SQ
Sbjct: 82 D-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQN 136
Query: 559 IIHCDIKPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+IH DIK NIL+ ++ K++DF A+L K R + GT ++APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKDYG 194
Query: 618 AKADVYSFGVVLLEII 633
K D++S G++ +E+
Sbjct: 195 PKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
F +++G G G V G+ VAVK L E R +F+ EI+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 504 LVRLLGYSFDVSNKI--LVYEYMSNGSLAD-VYSSPPKNNLI-------GIARGILYLHD 553
+V+ G + L+ EY+ +GSL D + + NL I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG----YVAPE 609
+ + IH D+ +NIL++ KISDF LAK+ + + + ++ + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKV--LPEDKDYYYVKEPGESPIFWYAPE 182
Query: 610 WHWNLPITAKADVYSFGVVLLEI 632
++ +DV+SFGV L E+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-21
Identities = 95/377 (25%), Positives = 166/377 (44%), Gaps = 43/377 (11%)
Query: 360 AFIKVDATA----------SSNSGKPFSRDGKKAQRKDIVIISCLFVALIILILATFG-I 408
AF+ ++A+A + SG P + +K I+C A ++L L FG +
Sbjct: 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSW-WFYITCTLGAFLVLALVAFGFV 650
Query: 409 FIYRYRVRSYRIIP---GNGSARYCEDIALLSFSYAELEKMTDGFKEE--IGRGSSGTVY 463
FI + + G ++ + S + + + KEE I RG G Y
Sbjct: 651 FIRGRNNLELKRVENEDGTWELQFFDSKVSKSIT---INDILSSLKEENVISRGKKGASY 707
Query: 464 KGTMING--KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521
KG I +FV VK + + + +EI +G+ H N+V+L+G L++
Sbjct: 708 KGKSIKNGMQFV-VKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762
Query: 522 EYMSNGSLADVYSSPP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577
EY+ +L++V + + IGIA+ + +LH C ++ ++ P+ I++D
Sbjct: 763 EYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----- 817
Query: 578 KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRR 637
D +L P T T + YVAPE IT K+D+Y FG++L+E++ +
Sbjct: 818 -GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 638 CFDQNLPEDQVILEEWVYQCFENGNLGQLIE-----DEDVDKKQLERMIKVALWCILDEP 692
D I+ EW C+ + +L I+ D V++ ++ ++ +AL C +P
Sbjct: 877 PADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935
Query: 693 SLRPSMKKVLLMLEGTM 709
+ RP VL LE
Sbjct: 936 TARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQ--KMLAEGEREFQT-EIKAIGRTHHRNLVRL 507
E IG+GS GTV K + GK + K + M E E++ E+ + H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 508 LGYSFDVSNKIL--VYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDEC--- 555
D SN+ L V EY G LA + K + I +L EC
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 556 ---ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ--TRTFTGIRGTRGYVAPEW 610
+ ++H D+KP NI +D N K+ DF LAK++ D +T+ GT Y++PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---GTPYYMSPEQ 181
Query: 611 HWNLPITAKADVYSFGVVLLEI 632
++ K+D++S G ++ E+
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 15/191 (7%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
++G G G V++G N VA+K L+ +++FQ E++A+ R H++L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 512 FDVSNKILVYEYMSNGSLADVYSSP-----PKNNLIGI----ARGILYLHDECESQIIHC 562
++ E M GSL SP P +LI + A G+ YL E IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+ +NIL+ E+ K++DF LA+L+K D + I + APE + + K+D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSD 186
Query: 622 VYSFGVVLLEI 632
V+SFG++L E+
Sbjct: 187 VWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 18/195 (9%)
Query: 454 IGRGSSGTVYKGTM-INGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLL 508
IG G G V++G + + G+ VA+K L+ E +R +F +E +G+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 509 GYSFDVSNKILVYEYMSNGSL--------ADVYSSPPKNNLIGIARGILYLHDECESQII 560
G +++ EYM NG+L + S L GIA G+ YL D +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H D+ +NIL++ N K+SDF L+++++ P+ T T +G + + APE T+
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 619 KADVYSFGVVLLEII 633
+DV+SFG+V+ E++
Sbjct: 190 ASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 23/266 (8%)
Query: 452 EEIGRGSSGTVYKGTMINGKFV-AVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLG 509
+G G+ G+V K + N + A+K + + +++ E++ +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 510 -YSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIG-IARGIL----YLHDECE 556
+ + S+ I + EY GSL +Y K ++G IA +L YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S 123
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+IIH DIKP NIL+ K+ DF ++ + TFT GT Y+APE P
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPY 180
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676
+ +DV+S G+ LLE+ R F +E Y N +L ++ K
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--IVNMPNPELKDEPGNGIKW 238
Query: 677 LERMIKVALWCILDEPSLRPSMKKVL 702
E C+ +P+ RP+ +L
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 41/271 (15%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGE-----REFQTEIKAIGRTHHRNLV 505
E +G GS G+VY+G + +G F AVK + ++ + EI + + H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIARGIL----YLHDECESQ 558
+ LG + N + E + GSLA + Y S P+ + R IL YLHD
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---N 122
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEW-----HW 612
+H DIK NIL+D N K++DF +AK +++ ++F +G+ ++APE +
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQGGY 179
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672
L AD++S G +LE+ + + Q E V F+ G +L D
Sbjct: 180 GLA----ADIWSLGCTVLEMATGKPPWSQ---------LEGVAAVFKIGRSKELPPIPDH 226
Query: 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703
+ + I L C+ +PSLRP+ ++L
Sbjct: 227 LSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTH 500
E+E+ K ++G G G VY+G VAVK L++ E E EF E +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG---------IARGILYL 551
H NLV+LLG ++ E+M+ G+L D + + I+ + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+ IH D+ +N L+ EN K++DF L++LM D G + + APE
Sbjct: 121 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 612 WNLPITAKADVYSFGVVLLEI 632
+ K+DV++FGV+L EI
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 33/263 (12%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQ-KMLAEGEREFQ-TEIKAIGRTHHRNLVRLLGY 510
+G+GS G+VYK + + +F A+K + +++ ERE EI+ + +H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSPPK-----------NNLIGIARGILYLHDECESQI 559
D + +V EY G L+ S K I + RG+ LH++ +I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
+H D+K NIL+ N KI D ++K++K + +T GT Y+APE P + K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYSYK 181
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679
+D++S G +L E+ F+ +D + + G + D
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYPPIPPIYSQD------ 228
Query: 680 MIKVALWCILDEPSLRPSMKKVL 702
+ + +P LRP+ K+L
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQ-KMLAEGEREFQTEIKAIGRTH 500
L+K+T G E IG G G V +G G+ VAVK ++ + A+ F E + + H
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLH 57
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECE---- 556
H+NLVRLLG I V E MS G+L + + + L+ + + + + D E
Sbjct: 58 HKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEY 115
Query: 557 ---SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+++H D+ +NIL+ E+ AK+SDF LA++ + ++ T APE +
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKH 171
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673
++K+DV+S+GV+L E+ R P ++ L+E V +C E G + E D
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRA-----PYPKMSLKE-VKECVEKGYRMEPPEGCPAD 225
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
L C EP RPS K+ LE
Sbjct: 226 VYVLMTS------CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 30/202 (14%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGERE-F-QT---EIKAIGRTHHRNLV 505
+IG G+ G VYK G+ VA+K K+ E E+E F T EIK + + H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 506 RLLG--YSFDVSNKILVYEYMS---NGSLA--DVYSSPP--KNNLIGIARGILYLHDECE 556
RL S + +V+EYM G L +V + K + + G+ YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--- 118
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW-----H 611
+ I+H DIK NIL++ + K++DF LA+ + +T T Y PE
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 612 WNLPITAKADVYSFGVVLLEII 633
+ + D++S G +L E+
Sbjct: 179 YGPEV----DMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---EIKAIGRTHHRNLVR 506
E++G G+ G VYK G+ VA+K++ ++ E E T EI + H N+V+
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 507 LLGYSFDVSNKILVYEYMSN--GSLADVYSSPPKNNLIG-----IARGILYLHDECESQI 559
LL LV+EY D P NLI + RG+ Y H +I
Sbjct: 63 LLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RI 119
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-----WHWNL 614
+H D+KPQNIL++ + K++DF LA+ RT+T T Y APE H++
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 615 PITAKADVYSFGVVLLEII 633
+ D++S G + E+I
Sbjct: 179 AV----DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 36/206 (17%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE------REFQTEIKAIGRTHHRNL 504
EIG G+ GTVYK + G+FVA+K+++ L+E RE +K + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNI 63
Query: 505 VRLLGYSFDVSNKI---------LVYEYMSNGSLADVYSSPPK--------NNLIG-IAR 546
VRLL DV + LV+E++ LA S PK +L+ + R
Sbjct: 64 VRLL----DVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYV 606
G+ +LH I+H D+KPQNIL+ + KI+DF LA++ T + T Y
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 607 APEWHWNLPITAKADVYSFGVVLLEI 632
APE D++S G + E+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 62/290 (21%)
Query: 453 EIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEGER-EFQTE---IKAIGRTHHR 502
E+G+GS G VY+G VA+K + + + ER EF E +K HH
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHH- 70
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD-------------VYSSPPKNNLIG----IA 545
+VRLLG ++V E M+ G L P I IA
Sbjct: 71 -VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM-KPDQTRTFTGIRGTRG 604
G+ YL + +H D+ +N ++ E+ KI DF + + + + D R +G +G
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKG 181
Query: 605 -----YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659
++APE + T K+DV+SFGVVL E+ L E YQ
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM---------------ATLAEQPYQGLS 226
Query: 660 NGNLGQLIEDEDVDKKQL---ERMIKVALWCILDEPSLRPSMKKVLLMLE 706
N + + + D ++++++ C P +RP+ +++ L+
Sbjct: 227 NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRL---QKMLAEGEREFQT---EIKAIGRTHHRNL 504
+++G G+ + Y+ + G +AVK++ + +E E + EI+ + R +H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVYSS--PPKNNLI-----GIARGILYLHDECES 557
+R+LG + + S+ L E+M+ GS++ + S K +I + RG+ YLH+ +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---N 122
Query: 558 QIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRT--FTG-IRGTRGYVAPEWHWN 613
QIIH D+K N+L+D + +I+DF A + T F G + GT ++APE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 614 LPITAKADVYSFGVVLLEIIC 634
DV+S G V++E+
Sbjct: 183 EQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 443 LEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRT 499
++ F +E+G G G V+ G VA+K M+ EG E +F E K + +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIK----MIREGAMSEDDFIEEAKVMMKL 56
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK--------NNLIGIARGILYL 551
H NLV+L G +V EYM+NG L + + + + YL
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+ IH D+ +N L+ E+ K+SDF LA+ + DQ + G + + PE
Sbjct: 117 E---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 612 WNLPITAKADVYSFGVVLLEIICC 635
++K+DV+SFGV++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 441 AELEKMTDGFKEEIGRGSSGTVYKGTMI----NGKF-VAVKRLQKMLA-EGEREFQTEIK 494
ELEK+ + +G G+ GTVYKG I K VA+K L++ + + +E E
Sbjct: 7 TELEKI-----KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 495 AIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIA 545
+ H ++VRLLG S L+ + M G L D Y K+N+ + IA
Sbjct: 62 VMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIA 119
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRG 604
+G+ YL E +++H D+ +N+L+ ++ KI+DF LAKL+ D+ G +
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 605 YVAPEWHWNLPITAKADVYSFGVVLLEII 633
++A E + T K+DV+S+GV + E++
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 33/206 (16%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVK-------------RLQKMLAEGEREFQTEIKAIGRT 499
IG GS G+VY G +G+ +AVK R + ML RE I +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE----IALLKEL 63
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLA---DVYSSPP----KNNLIGIARGILYLH 552
H N+V+ LG S D + + EY+ GS+A + Y + +N + I +G+ YLH
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVA 607
+ IIH DIK NIL+D KISDF ++K ++ + T T ++G+ ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 608 PEWHWNLPITAKADVYSFGVVLLEII 633
PE T KAD++S G +++E++
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH 501
E+++ + ++G G G V++G N VAVK L+ + + +F E + + + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-----LIG----IARGILYLH 552
L++L +V E M GSL + LI +A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL- 119
Query: 553 DECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
E+Q IH D+ +N+L+ EN K++DF LA+++K D G + + APE
Sbjct: 120 ---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 612 WNLPITAKADVYSFGVVLLEII 633
+ K+DV+SFG++L EI+
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 62/192 (32%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+++G G G V+ G VA+K L++ E F E + + H LVRL Y+
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YA 68
Query: 512 FDVSNKI-LVYEYMSNGSLADVYSSP-----PKNNLIG----IARGILYLHDECESQIIH 561
I ++ EYM NGSL D +P N LI IA G+ ++ IH
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D++ NIL+ E KI+DF LA+L++ ++ G + + APE T K+D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 622 VYSFGVVLLEII 633
V+SFG++L EI+
Sbjct: 186 VWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 23/197 (11%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRL-QKMLAEG-EREFQTEIKAIGRTHHRNLVRLL 508
+IG G+ G VYK + G+ VA+K++ + +EG + EIK + +H N+++LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYS---------SPP--KNNLIGIARGILYLHDECES 557
+ LV+E+M D+Y K+ L + +G+ + H
Sbjct: 65 DVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI- 616
I+H D+KP+N+L++ K++DF LA+ R +T TR Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 617 TAKADVYSFGVVLLEII 633
+ D++S G + E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 40/207 (19%)
Query: 450 FKEEIGRGSSGTV----YKGTMINGKFVAVKRL--QKMLAEGEREFQT--EIKAIGRTHH 501
F + +G GS G V +KG+ GK+ A+K L K++ + E E + + H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIRH 60
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARG 547
LV L G D SN LV EY+ G L A Y++ +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-------VVLA 113
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
+ YLH I++ D+KP+N+L+D + Y KI+DF AK +K RT+T + GT Y+A
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYT-LCGTPEYLA 166
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIIC 634
PE + D ++ G+++ E++
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 18/194 (9%)
Query: 452 EEIGRGSSGTVYKGT--MINGKF--VAVKRL-QKMLAEGEREFQTEIKAIGRTHHRNLVR 506
+E+G G+ G+V KG M +GK VAVK L Q+ +A G++EF E + + H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLI----GIARGILYLHDECESQI 559
L+G +LV E G L P ++L +A G+ YL
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHF 116
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPIT 617
+H D+ +N+L+ AKISDF +++ + R T R + APE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 618 AKADVYSFGVVLLE 631
+K+DV+S+GV L E
Sbjct: 177 SKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 19/194 (9%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQK-MLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+ G VYKG + VAVK + + + +R+F E + + + H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSP----PKNNLIGI----ARGILYLHDECESQIIHC 562
+V E + GSL L+ + A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR----GYVAPEWHWNLPITA 618
D+ +N L+ EN KISDF ++ + ++ +T G + + APE T+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 619 KADVYSFGVVLLEI 632
++DV+S+G++L E
Sbjct: 175 ESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-REFQTEIKAIGRTHHRNLVRL 507
E++G GS G+VYK G+ VA+K + E + +E EI + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIK---VVPVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKN--------NLIGIARGILYLHDECESQI 559
G F ++ +V EY GS++D+ K L +G+ YLH ++
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKK 120
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
IH DIK NIL++E AK++DF ++ + + T I GT ++APE + K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNK 179
Query: 620 ADVYSFGVVLLEI 632
AD++S G+ +E+
Sbjct: 180 ADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLL 508
E IG G+ G VYK G+ VA+K + ++ + E E + E + + ++H N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 509 GYSFDVSNKI------LVYEYMSNGSLADV------YSSPPKNNLIG-----IARGILYL 551
G + LV E GS+ D+ K I RG+ YL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-- 609
H E+++IH DIK QNIL+ +N K+ DF ++ + R T I GT ++APE
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVI 185
Query: 610 ---WHWNLPITAKADVYSFGVVLLE 631
+ A++DV+S G+ +E
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+IG+GS G V+K + + A+K+ L KM E E + + + ++R
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSP-----PKNNL----IGIARGILYLHDECESQ 558
D +V EY NG L + P++ + I I G+ +LH + +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
I+H DIK N+ +D KI D +AKL+ T I GT Y++PE + P
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 619 KADVYSFGVVLLEIICCRRCFDQN 642
K+DV++ GVVL E + FD N
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-18
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 454 IGRGSSGTVYKGTMING-KFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+GRG+ G V+ K V +K++ ++M + Q E + + H N++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---EY 64
Query: 511 --SFDVSNKI-LVYEYMSNGSLADVYSS------PPKNNLIGIARGILYLHDECESQIIH 561
+F + +V EY G+LA+ L + +L LH I+H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 562 CDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
D+K QNIL+D+++ KI DF ++K++ +++ +T + GT Y++PE P K+
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGKPYNQKS 182
Query: 621 DVYSFGVVLLEIICCRRCFD-QNLP 644
D+++ G VL E+ +R F+ NLP
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHR 502
K E+G G+ G V+ G + + VAVK L++ + ++F+ E + + H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS------------PPKNNL--------- 541
N+V+ G + I+V+EYM +G L S P L
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 542 IGIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGI 599
+ IA G++YL SQ +H D+ +N L+ + KI DF M D T + +
Sbjct: 129 VQIASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFG----MSRDVYTTDYYRV 180
Query: 600 RGTR----GYVAPEWHWNLPITAKADVYSFGVVLLEI 632
G ++ PE T ++DV+SFGVVL EI
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+ IG G+ G VYK I G+ VA+K ++ + Q EI + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 509 GYSFDVSNKI-LVYEYMSNGSLADVYS---SPPKNNLIG-IAR----GILYLHDECESQI 559
G S+ +K+ +V EY GSL D+Y P I + R G+ YLH E+
Sbjct: 67 G-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGK 122
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW---HWNLPI 616
IH DIK NIL+ E+ K++DF ++ + + + I GT ++APE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 617 TAKADVYSFGVVLLE 631
K D+++ G+ +E
Sbjct: 182 DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 38/209 (18%)
Query: 450 FKEEIGRGSSGTV----YKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL 504
F +++G+G+ G+V Y N G+ VAVK+LQ AE R+F+ EI+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 505 VRLLG--YSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG---------IARGILYLHD 553
V+ G YS N LV EY+ GSL D Y + L I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRD-YLQKHRERLDHRKLLLYASQICKGMEYLG- 125
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLM----------KPDQTRTFTGIRGTR 603
+ +H D+ +NIL++ KI DF L K++ +P ++ F
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF------- 176
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEI 632
+ APE + +DV+SFGVVL E+
Sbjct: 177 -WYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 28/204 (13%)
Query: 451 KEEIGRGSSGTVYKGTM-INGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLV 505
+E IG G G V +G + + GK FVA+K L+ E +R +F +E +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------------LIGIARGILYLHD 553
L G +++ E+M NG+L S + N L GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGAL----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTR---GYVAPE 609
E +H D+ +NIL++ N K+SDF L++ ++ D + T+T G + + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 610 WHWNLPITAKADVYSFGVVLLEII 633
T+ +DV+S+G+V+ E++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 44/207 (21%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQ----KMLAEG-EREFQTEIKAIGRTHHRNLVRL 507
+G G+ VYK G+ VA+K+++ K +G EIK + H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 508 LGYSFDV----SNKILVYEYMS--------NGSL----ADVYSSPPKNNLIGIARGILYL 551
L DV SN LV+E+M + S+ AD+ K+ ++ RG+ YL
Sbjct: 68 L----DVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI-----KSYMLMTLRGLEYL 118
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
H + I+H D+KP N+L+ + K++DF LA+ R T TR Y APE
Sbjct: 119 HS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPE-- 172
Query: 612 WNLPITAK-----ADVYSFGVVLLEII 633
L A+ D++S G + E++
Sbjct: 173 --LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 454 IGRGSSG--TVYK----GTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+G+G+ G T+Y+ +++ K V + RL + + R+ EI + H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 508 LGYSFDVSNKILV-YEYMSNGSLADVYSSPPKNN---------LIGIARGILYLHDECES 557
F N +L+ EY + G+L D L I + Y+H ++
Sbjct: 65 YN-HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KA 120
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
I+H DIK NI + + K+ DF ++K++ + + T + GT Y++PE +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 618 AKADVYSFGVVLLEIICCRRCFD-QNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676
K+D+++ G VL E++ +R FD N L + Q V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLN----LVVKIVQG----------NYTPVVSVY 225
Query: 677 LERMIKVALWCILDEPSLRPSMKKVLLML 705
+I + + +P RP+ +VL
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 46/207 (22%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
+G+G+ G VY + +A+K + + + + EI HRN+V+ LG S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74
Query: 513 DVSNKILVY-EYMSNGSLADVYSS-----PPKNNLIG-----IARGILYLHDECESQIIH 561
+ ++ E + GSL+ + S I I G+ YLHD QI+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 562 CDIKPQNILMDENRYA---KISDFALAKLM---KPDQTRTFTGI----------RGTRGY 605
DIK N+L+ N Y+ KISDF +K + P T TFTG +G RGY
Sbjct: 132 RDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGY 188
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEI 632
AP AD++S G ++E+
Sbjct: 189 GAP-----------ADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGERE-----FQTEIKAIGRTHHRNLV 505
+G G+ G V K G+ VA+K K + E E+K + + H N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECES 557
L +F ++ LV+EY+ L + +SP ++ + + + I Y H
Sbjct: 64 NLKE-AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
IIH DIKP+NIL+ E+ K+ DF A+ ++ T TR Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 618 AKA-DVYSFGVVLLEII 633
K DV++ G ++ E++
Sbjct: 180 GKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 59/194 (30%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE---FQTEIKAIGRTHHRNLVRL 507
E IG+GS G VYK + VA+K + L E E E Q EI+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVY-SSPPKNNLIG-IARGIL----YLHDECESQIIH 561
G S ++ EY GS D+ I I R +L YLH+E IH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTR--TFTGIRGTRGYVAPEWHWNLPITAK 619
DIK NIL+ E K++DF ++ + ++ TF GT ++APE K
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFWMAPEVIKQSGYDEK 178
Query: 620 ADVYSFGVVLLEII 633
AD++S G+ +E+
Sbjct: 179 ADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 32/202 (15%)
Query: 454 IGRGSSGTVYKGTM-INGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLL 508
IG G G V G + + GK VA+K L+ E +R +F +E +G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHDECES 557
G ++V EYM NGSL D + K++ L GIA G+ YL D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLR--KHDGQFTVIQLVGMLRGIASGMKYLSD---M 125
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG------YVAPEWH 611
+H D+ +NIL++ N K+SDF L+++++ D +T TRG + APE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEAI 181
Query: 612 WNLPITAKADVYSFGVVLLEII 633
T+ +DV+S+G+V+ E++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 43/213 (20%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE-----REFQTEIKAIGR-THHRNL 504
+++G G+ G+VY G+ VA+K+++K E RE +K++ + H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE----VKSLRKLNEHPNI 60
Query: 505 VRLLGYSFDV--SNKIL--VYEYMSNGSLADVYSS------PP---KNNLIGIARGILYL 551
V+L +V N L V+EYM G+L + ++ + I +G+ ++
Sbjct: 61 VKL----KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW- 610
H H D+KP+N+L+ KI+DF LA+ ++ +T TR Y APE
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRAPEIL 170
Query: 611 ----HWNLPITAKADVYSFGVVLLEIICCRRCF 639
++ P+ D+++ G ++ E+ R F
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 66/218 (30%), Positives = 90/218 (41%), Gaps = 36/218 (16%)
Query: 454 IGRGSSGTV----YKGT--------MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH 501
IG+G+ G V + T M K V ++ +L ER E+ H
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL--NERRILQELN------H 59
Query: 502 RNLVRLLGYSF-DVSNKILVYEYMSNGSL------ADVYS-SPPKNNLIGIARGILYLHD 553
LV L YSF D N LV + + G L +S K + I + YLH
Sbjct: 60 PFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
IIH DIKP NIL+DE + I+DF +A + PD T GT GY+APE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR 173
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFD--QNLPEDQVI 649
+ D +S GV E + +R + DQ+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 454 IGRGSSGTVYKGTMI----NGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLL 508
IG+G G VY GT+I AVK L ++ E E F E + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 509 GYSFDVSNKILV-YEYMSNGSLADVYSSPPKN----NLIG----IARGILYLHDECESQI 559
G LV YM +G L + S N +LIG +A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKF 119
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLM---KPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H D+ +N ++DE+ K++DF LA+ + + TG + ++A E
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 617 TAKADVYSFGVVLLEII 633
T K+DV+SFGV+L E++
Sbjct: 180 TTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVRLLG 509
I +G+ G V+ + G A+K ++K + + TE + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 510 YSF-DVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQIIHCDI 564
YSF N LV EY+ G LA + + I IA +L L + IIH D+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 565 KPQNILMDENRYAKISDFALAK-------LMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
KP NIL+D N + K++DF L+K + D + I GT Y+APE +
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179
Query: 618 AKADVYSFGVVLLEIIC 634
D +S G +L E +
Sbjct: 180 KTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 50/236 (21%)
Query: 470 GKFVAVKRLQKMLAEGERE---FQTEIKAIGRTHHRNLVRLL-------GYSFDVSNKIL 519
G VA+K L+ E E + F+ E R +H N+V LL G F
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF------A 56
Query: 520 VYEYMSNGSLADVYSS----PPKNN---LIGIARGILYLHDECESQIIHCDIKPQNILM- 571
V+EY+ +L +V ++ P ++ + + H++ I+H D+KPQNI++
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 572 --DENRYAKISDFALAKLMKPD------QTRTFTG-IRGTRGYVAPEWHWNLPITAKADV 622
+AK+ DF + L+ P T T T + GT Y APE P+T +D+
Sbjct: 114 QTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 623 YSFGVVLLEIICCRRCFD---------QNLPEDQVILEEWVYQCFENGNLGQLIED 669
Y++G++ LE + +R Q L V L W+ LGQ++
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI----AGHPLGQVLRK 224
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 58/190 (30%), Positives = 101/190 (53%), Gaps = 13/190 (6%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTVY + G+ VA+K++ + EI + H N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD- 83
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP--PKNNLIGIARGIL----YLHDECESQIIHCD 563
S+ V +++ +V EY++ GSL DV + + + + R L +LH +Q+IH D
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 140
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK NIL+ + K++DF + P+Q++ T + GT ++APE K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 624 SFGVVLLEII 633
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQ----------TEIKAIGRTH 500
E IG+G+ G VY + G+ +AVK+++ R +EI+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK--NNLIG-----IARGILYLHD 553
H N+V+ LG+ + EY+ GS+ + + L+ + G+ YLH
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAK----LMKPDQTRTFTGIRGTRGYVAPE 609
+ I+H D+K N+L+D + KISDF ++K + DQ ++G+ ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMAPE 180
Query: 610 W--HWNLPITAKADVYSFGVVLLEIICCRR 637
++ +AK D++S G V+LE+ RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH 501
E+ + + +++G G G V+ G N VAVK L K + F E + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLI---------GIARGILYLH 552
LVRL ++ EYM+ GSL D S ++ IA G+ Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
IH D++ N+L+ E+ KI+DF LA++++ ++ G + + APE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 613 NLPITAKADVYSFGVVLLEII 633
T K+DV+SFG++L EI+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-16
Identities = 34/82 (41%), Positives = 43/82 (52%), Gaps = 13/82 (15%)
Query: 56 GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQR 115
GR+V S G S A + D G+ VLYD+ GKV+WQ+FDHPTDT+LP Q+
Sbjct: 36 GRVVWSSNTSG--------KGSGCVAVLQDDGNLVLYDNSGKVLWQSFDHPTDTLLPGQK 87
Query: 116 L---LAGMELFPGI--SKTDPS 132
+ G S TDPS
Sbjct: 88 DGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 44/219 (20%)
Query: 450 FKEEIGRGSSGTVYKG------TMINGKFVAVKRLQKMLAEG--EREFQTEIKAIGRTHH 501
F EE+G G+ G VYKG ++ VA+K L++ AE ++EF+ E + + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQH 67
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNNL---------- 541
N+V LLG +++EY+++G L +DV + +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 542 ---IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD-----QT 593
I IA G+ YL +H D+ +N L+ E KISDF L++ + Q+
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++ +R ++ PE T ++D++SFGVVL EI
Sbjct: 185 KSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 66/264 (25%), Positives = 127/264 (48%), Gaps = 28/264 (10%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQ-KMLAEGEREFQTEIKAIGRTHHRNLVRL 507
++E +G G+ GTVYK ++ + +AVK + + E +++ +E++ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL----IGIARGILYLHDECESQIIHC 562
G +F V N+I + E+M GSL DVY P++ L + + +G+ YL +I+H
Sbjct: 65 YG-AFFVENRISICTEFMDGGSL-DVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHR 119
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D+KP N+L++ K+ DF ++ + +T+ GT Y+APE +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYGIHSDV 176
Query: 623 YSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV----DKKQLE 678
+S G+ +E+ R + Q ++ + QC I DED + E
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC---------IVDEDPPVLPVGQFSE 227
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+ + C+ +P RP+ + ++
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 42/279 (15%)
Query: 452 EEIGRGSSGTVYKGTMING--KFVAVKR-------LQKMLAEGEREFQ---TEIKAIGRT 499
E +G G+ G VYK N +A+K K E ++ +E+ I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 500 -HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK-----------NNLIGIARG 547
H N+VR + +V + + L + ++S + N + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
+ YLH E +I+H D+ P NI++ E+ I+DF LAK +P+ T + GT Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSC 181
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCF-DQNLPEDQVILEEWVYQCFENGNLGQL 666
PE N P KADV++FG +L ++ + F N+ + E VY+ G +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED 241
Query: 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+ D +I C+ + RP + +V M+
Sbjct: 242 VTD----------VIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIG---RTHHRNLVRL 507
E+IG G+ G VYK + + +A+K++ ++ E E T I+ I H N+VRL
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQI 559
LV+EY+ + SSP K L I RGI Y H ++
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RV 123
Query: 560 IHCDIKPQNILMDENRYA-KISDFALAKLMK-PDQTRTFTGIRGTRGYVAPEW-----HW 612
+H D+KPQN+L+D A K++DF LA+ P RTFT T Y APE H+
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE 651
+ P+ D++S G + E++ + F P D I E
Sbjct: 182 STPV----DIWSVGCIFAEMVNQKPLF----PGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHR-----N 503
+ I +G+ G+VY G + A+K L+K M+A+ + T +KA
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ---VTNVKAERAIMMIQGESPY 58
Query: 504 LVRLLGYSFDVSNKI-LVYEYMSNG---SLADVYSSPP----KNNLIGIARGILYLHDEC 555
+ +L YSF + + LV EY++ G SL P K + + G+ LH
Sbjct: 59 VAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR- 116
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWN 613
IIH DIKP+N+L+D+ + K++DF L++ L GT Y+APE
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETILG 167
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFDQNLPE 645
+ +D +S G V+ E + F P+
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 44/209 (21%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLL- 508
IG G+ G V G+ VA+K++ + L + +R + EIK + H N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 509 ------GYSF-DVSNKILVYEYMSNGSLAD----VYSSPPKNN------LIGIARGILYL 551
F DV +V E M D + S P + L I RG+ YL
Sbjct: 67 ILRPPSPEDFNDV---YIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ--TRTFTGIRGTRGYVAPE 609
H + +IH D+KP NIL++ N KI DF LA+ + PD+ T TR Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 610 -----WHWNLPITAKADVYSFGVVLLEII 633
+ I D++S G + E++
Sbjct: 177 LLLSSSRYTKAI----DIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQTEIKAIG---RTHHRNLVRL 507
E+IG G+ G VYK + G+ VA+K++ ++ E E T I+ I +H N+V+L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 508 LGYSFDV---SNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDEC 555
L DV NK+ LV+E++ + +SP K+ L + +G+ + H
Sbjct: 65 L----DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQTRTFTGIRGTRGYVAPEWHWNL 614
+++H D+KPQN+L++ K++DF LA+ P RT+T T Y APE
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGC 175
Query: 615 PITAKA-DVYSFGVVLLEIICCRRCFDQNLPEDQV 648
+ A D++S G + E++ R F + DQ+
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 1e-15
Identities = 58/187 (31%), Positives = 99/187 (52%), Gaps = 7/187 (3%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTVY I G+ VA+K++ + EI + + N+V L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 83
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP--PKNNLIGIARGILYLHDECES-QIIHCDIKP 566
S+ V +++ +V EY++ GSL DV + + + + R L D S Q+IH DIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143
Query: 567 QNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFG 626
NIL+ + K++DF + P+Q++ T + GT ++APE K D++S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 627 VVLLEII 633
++ +E++
Sbjct: 203 IMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 20/197 (10%)
Query: 452 EEIGRGSSGTVYKG--TMINGKF--VAVKRLQK-MLAEGEREFQTEIKAIGRTHHRNLVR 506
+++G GS G V +G + GK VAVK L+ L++ +F E + H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECES 557
L G +V E GSL D + + IA G+ YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTGIRGTRGYVAPEWHWNLP 615
+ IH D+ +NIL+ + KI DF L + + D ++ + APE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 616 ITAKADVYSFGVVLLEI 632
+ +DV+ FGV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/189 (32%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 452 EEIGRGSSGTVYKGTMINGK-FVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
E IG+GS G VYKG K VA+K + AE E E Q EI + + + R G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCD 563
+ ++ EY+ GS D+ P L I +G+ YLH E + IH D
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRD 126
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK N+L+ E K++DF +A + Q + T + GT ++APE KAD++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIW 185
Query: 624 SFGVVLLEI 632
S G+ +E+
Sbjct: 186 SLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 454 IGRGSSGTVYKGTMINGKF------VAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVR 506
+G G+ G VY+G VAVK L + +E E +F E + + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 507 LLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNNLIGIAR----GILYLH 552
L+G SF+ + ++ E M+ G L + SS +L+ AR G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 553 DECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQTRTFTGIRGTRG----- 604
E+ IH DI +N L+ R AKI+DF +A+ D R +G R
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186
Query: 605 YVAPEWHWNLPITAKADVYSFGVVLLEI 632
++ PE + T+K DV+SFGV+L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 60/250 (24%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + GK A K+L K +GE+ E K + + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 510 YSFDVSNKI-LVYEYMSNGSL----------------ADVYSSPPKNNLIGIARGILYLH 552
Y+F+ + + LV M+ G L A Y++ I G+ +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-------IICGLEHLH 112
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
+I++ D+KP+N+L+D++ +ISD LA + + G GT GY+APE
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKI-KGRAGTPGYMAPEVLQ 167
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672
D ++ G L E+I R F Q E V
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQR--------------------------KEKV 201
Query: 673 DKKQLERMIK 682
+K++L+R
Sbjct: 202 EKEELKRRTL 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 432 DIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRLQ---KMLAEGER 487
+IA L FS + EK+ +E IG GS G VY + + VA+K++ K E +
Sbjct: 3 EIAEL-FSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 60
Query: 488 EFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM--SNGSLADVYSSPPKNNLI--- 542
+ E++ + + H N + G LV EY S + +V+ P + I
Sbjct: 61 DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI 120
Query: 543 --GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
G +G+ YLH IH DIK NIL+ E K++DF A L+ P +F
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--SFV--- 172
Query: 601 GTRGYVAPEWHWNL---PITAKADVYSFGVVLLEI 632
GT ++APE + K DV+S G+ +E+
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVR 506
F +E+G G G V G VA+K M+ EG E EF E K + + H LV+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIK----MIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLI----GIARGILYLHDECESQ 558
L G +V EYMSNG L + + L+ + G+ YL + Q
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
IH D+ +N L+D+ K+SDF L++ + D+ + G + + PE ++
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 619 KADVYSFGVVLLEI 632
K+DV++FGV++ E+
Sbjct: 181 KSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 71/232 (30%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 422 PGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYK----GTMINGKFVAVKR 477
+ SA A S S ELE++ IG G+ GTVYK T G+ A+K
Sbjct: 57 SSSSSASGSAPSAAKSLS--ELERV-----NRIGSGAGGTVYKVIHRPT---GRLYALKV 106
Query: 478 LQKMLAEG-EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSL--ADVY 533
+ + R+ EI+ + +H N+V+ FD + +I ++ E+M GSL +
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 534 SSPPKNNLIGIAR----GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA----LA 585
L +AR GI YLH I+H DIKP N+L++ + KI+DF LA
Sbjct: 166 DEQ---FLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219
Query: 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA------DVYSFGVVLLE 631
+ M P + GT Y++PE N + A D++S GV +LE
Sbjct: 220 QTMDPCNSSV-----GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+++G G G V+ GT VAVK L+ E F E + + + H LV+L Y+
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL--YA 68
Query: 512 FDVSNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQIIH 561
I +V EYMS GSL D L +A G+ Y+ IH
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D++ NIL+ + KI+DF LA+L++ ++ G + + APE T K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 622 VYSFGVVLLEII 633
V+SFG++L E++
Sbjct: 186 VWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 454 IGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVRLLG 509
+G+G G V M GK A K+L K + + ++ E + + + H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSSPPKNNLIGIARGILY----------LHDECES 557
Y+F + LV M+ G L +Y+ +N R Y LH +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+II+ D+KP+N+L+D + +ISD LA +K Q++T G GT G++APE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQGEEYD 175
Query: 618 AKADVYSFGVVLLEIICCRRCF 639
D ++ GV L E+I R F
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 53/190 (27%), Positives = 97/190 (51%), Gaps = 15/190 (7%)
Query: 453 EIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGY 510
+IG GS+G V T + G+ VAVK++ + + RE I R H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMD-LRKQQRRELLFNEVVIMRDYQHPNIVEMYS- 83
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKN--NLIGIARGIL----YLHDECESQIIHCD 563
S+ V +++ +V E++ G+L D+ + N + + +L +LH + +IH D
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK +IL+ + K+SDF + + R + GT ++APE LP + D++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 624 SFGVVLLEII 633
S G++++E++
Sbjct: 200 SLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 452 EEIGRGSSGTVYKGTMINGK---FVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
E IG+GS G V+KG I+ + VA+K + AE E E Q EI + + + +
Sbjct: 10 ERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIH 561
G + ++ EY+ GS D+ + P + L I +G+ YLH E + IH
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIH 124
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
DIK N+L+ E K++DF +A + Q + T + GT ++APE +KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 622 VYSFGVVLLEI 632
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 56/190 (29%), Positives = 101/190 (53%), Gaps = 13/190 (6%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTV+ + G+ VA+K++ + EI + + N+V L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD- 83
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP--PKNNLIGIARGIL----YLHDECESQIIHCD 563
SF V +++ +V EY++ GSL DV + + + + R L +LH +Q+IH D
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRD 140
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK N+L+ + K++DF + P+Q++ T + GT ++APE K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 624 SFGVVLLEII 633
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 73/259 (28%), Positives = 116/259 (44%), Gaps = 25/259 (9%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
E+IG+GS G V+KG K VA+K + AE E E Q EI + + + + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCD 563
+ ++ EY+ GS D+ P + L I +G+ YLH E + IH D
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRD 126
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK N+L+ E+ K++DF +A + Q + GT ++APE +KAD++
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
S G+ +E+ + P + V N L E K L+ ++
Sbjct: 186 SLGITAIELA-------KGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLKEFVEA 235
Query: 684 ALWCILDEPSLRPSMKKVL 702
C+ EPS RP+ K++L
Sbjct: 236 ---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 454 IGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF- 512
IG+G G V G G VAVK ++ + F E + + H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 513 DVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECES-------QIIHCDIK 565
+ +V EYM+ GSL D S ++ ++G + + D CE+ +H D+
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLA 129
Query: 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSF 625
+N+L+ E+ AK+SDF L K Q ++ T APE + K+DV+SF
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSF 185
Query: 626 GVVLLEI 632
G++L EI
Sbjct: 186 GILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-F----QTEIKAIGRTHHRNLV 505
++G G+ G VYK I G+ VA+K K+L E++ F EIK + + H N+V
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 506 RLLGYSFDVSNKI--------LVYEYMS---NGSLA--DVYSSPP--KNNLIGIARGILY 550
L+ + + +K +V YM +G L V + K ++ + GI Y
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALA--------KLMKPDQ--TRTFTGIR 600
LH E+ I+H DIK NIL+D KI+DF LA TR +T +
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 601 GTRGYVAPEW--HWNLPITAKADVYSFGVVLLEII 633
TR Y PE TA D++ G V E+
Sbjct: 188 VTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-14
Identities = 56/190 (29%), Positives = 101/190 (53%), Gaps = 13/190 (6%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTVY + G+ VA++++ + EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP--PKNNLIGIARGIL----YLHDECESQIIHCD 563
S+ V +++ +V EY++ GSL DV + + + + R L +LH +Q+IH D
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK NIL+ + K++DF + P+Q++ + + GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 624 SFGVVLLEII 633
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/190 (31%), Positives = 91/190 (47%), Gaps = 16/190 (8%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
++G+G G V+ GT VA+K L+ E F E + + + H LV+L Y+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 513 DVSNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQIIHC 562
I +V EYMS GSL D L IA G+ Y+ +H
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D++ NIL+ EN K++DF LA+L++ ++ G + + APE T K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 623 YSFGVVLLEI 632
+SFG++L E+
Sbjct: 187 WSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKA----IGRTHHRNLVRLL 508
+G G G V + + + A+K ++K E Q I + + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-RHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG-------IARGIL---YLHDECESQ 558
D ++ EY G L + L IA +L YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---G 113
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
II+ D+KP+N+L+D N Y K+ DF AK +K Q +T+T GT YVAPE N
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDF 171
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652
D +S G++L E++ R F ++ + I +
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIG---RTHHRNLVRL 507
E+IG G+ G VYKG G+ VA+K++ ++ +E E T I+ I H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPP---------KNNLIGIARGILYLHDECESQ 558
S L++E++S + S P K+ L I +GIL+ H +
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQTRTFTGIRGTRGYVAPE-----WHW 612
++H D+KPQN+L+D K++DF LA+ P R +T T Y APE +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
+ P+ D++S G + E+ + F + DQ+
Sbjct: 180 STPV----DIWSIGTIFAEMATKKPLFHGDSEIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V+ T +GK VA+K++ + L +R F+ E+K + H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 510 Y----SFDVSNKILVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQ 558
D +I V + L + SP K L I RG+ YLH +
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAG 123
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW-----HWN 613
I+H DIKP N+L++ N KI DF LA++ +PD+++ T T+ Y APE H+
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY- 182
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
T+ D++S G + E++ R F P Q+
Sbjct: 183 ---TSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 21/196 (10%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-----GEREFQTEIKAIGRTHHRNLVRL 507
+G G+ GTVYKG + G+ V + K+L E EF E + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQ 558
LG + + LV + M +G L D Y K+N+ + IA+G++YL E +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLD-YVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPIT 617
++H D+ +N+L+ + KI+DF LA+L++ D+ G + ++A E T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 618 AKADVYSFGVVLLEII 633
++DV+S+GV + E++
Sbjct: 190 HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 39/212 (18%)
Query: 454 IGRGSSGTVYKGTMIN-------GKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLV 505
+G G+ G VY+GT + VAVK L+K + E+ EF E + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 506 RLLGYSFDVSNKILVYEYMSNGSL------ADVYSSPPK--------NNLIGIARGILYL 551
+LLG + ++ E M G L A V P + + +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 552 HDECESQIIHCDIKPQNILMDE-----NRYAKISDFALAK-LMKPDQTRTFTGIRGTR-- 603
IH D+ +N L+ E +R KI DF LA+ + K D R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEGLL 175
Query: 604 --GYVAPEWHWNLPITAKADVYSFGVVLLEII 633
++APE + T ++DV+SFGV++ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 65/196 (33%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKA-----IGRTHHRNLVRL 507
IG+GS G V +GKF AVK LQK ++E Q I A + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 508 LGYSFDVSNKI-LVYEYMSNGSL-----ADVYSSPPKNNLIG--IARGILYLHDECESQI 559
YSF ++K+ V +Y++ G L + P+ IA + YLH I
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNI 117
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
I+ D+KP+NIL+D + ++DF L K + T TF GT Y+APE P
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRKQPYD 174
Query: 618 AKADVYSFGVVLLEII 633
D + G VL E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRL-----QKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+G GS G V K G+ VA+K+ KM+ ++ EI+ + + H NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV---KKIAMREIRMLKQLRHENLVNL 65
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQI 559
+ F ++ LV+E++ + L D+ P + L I RGI + H I
Sbjct: 66 IEV-FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
IH DIKP+NIL+ ++ K+ DF A+ L P + +T TR Y APE
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYG 179
Query: 619 KA-DVYSFGVVLLEII 633
+A D+++ G ++ E++
Sbjct: 180 RAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT-------EIKAIGRTHHRNLV 505
IG G+ G V T G VA+K++ E QT EIK + R H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPF------EHQTFCQRTLREIKILRRFKHENII 66
Query: 506 RLLGY----SFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDE 554
+L SF+ N + +V E M L + + +N L I RG+ Y+H
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH-- 123
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP--DQTRTFTGIRGTRGYVAPEWHW 612
+ ++H D+KP N+L++ N KI DF LA++ P D T T TR Y APE
Sbjct: 124 -SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 613 NLPITAKA-DVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650
N KA D++S G +L E++ R F Q+ L
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 21/199 (10%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQ-----KMLAEGE-REFQTEIKAIGRTHHRNLV 505
E +G+G+ GTVY G G+ +AVK+++ + AE E + Q E+ + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIARGIL----YLHDECESQ 558
+ LG D + + E++ GS++ + + P+ + IL YLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLM-----KPDQTRTFTGIRGTRGYVAPEWHWN 613
++H DIK N+++ N K+ DF A+ + + + GT ++APE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 614 LPITAKADVYSFGVVLLEI 632
K+D++S G + E+
Sbjct: 183 SGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 454 IGRGSSGTVY--KGTMINGKFVAVK-RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
IG GS G +Y K + V + L KM + + + E+ + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA- 66
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP-----PKNNLIG----IARGILYLHDECESQII 560
SF + ++ +V EY G L + ++ ++ I+ G+ ++HD +I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KIL 123
Query: 561 HCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
H DIK QNI + +N AK+ DF +A+ + +T + GT Y++PE N P K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPYNNK 182
Query: 620 ADVYSFGVVLLEIICCRRCFDQN 642
D++S G VL E+ + F+ N
Sbjct: 183 TDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQ-----KMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+G+G+ G VY ++ G+ +AVK++ + + EI+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSS--PPKNNLIG-----IARGILYLHDECESQII 560
G D + EYM GS+ D + + I G+ YLH + I+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIV 126
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR---GTRGYVAPEWHWNLPIT 617
H DIK NIL D K+ DF +K ++ + TG++ GT +++PE
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEGYG 185
Query: 618 AKADVYSFGVVLLEII 633
KADV+S G ++E++
Sbjct: 186 RKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 69/252 (27%), Positives = 103/252 (40%), Gaps = 69/252 (27%)
Query: 450 FKEEIGRGSSGTVY------------KGTMINGK-----FVAVKRLQKMLAEGER-EFQT 491
F E++G G G V+ K N VAVK L+ ++ R +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 492 EIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYS--------------SPP 537
E+K + R N+ RLLG ++ EYM NG L S
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 538 KNNLI----GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQ 592
+ L+ IA G+ YL +H D+ +N L+ +N KI+DF +++ L D
Sbjct: 129 FSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 593 TRTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEI--ICCRR 637
R ++G AP LPI T K+DV++FGV L EI +C +
Sbjct: 186 YR----VQGR----AP-----LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
Query: 638 CFDQNLPEDQVI 649
++ L + QVI
Sbjct: 233 PYEH-LTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 7e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLLGY 510
E +G G+ G VYKG + +A ++ + + E E + EI + + +HHRN+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG- 70
Query: 511 SFDVSNK-------ILVYEYMSNGSLADVYSSPPKNNLIG---------IARGILYLHDE 554
+F N LV E+ GS+ D+ + N L I RG+ +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE----- 609
+ ++IH DIK QN+L+ EN K+ DF ++ + R T I GT ++APE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 610 WHWNLPITAKADVYSFGVVLLEI 632
+ + K+D++S G+ +E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGERE-----FQTE 492
S E EK+ IG G+ G VY+ +G+ VA+K++ +M + ER+ E
Sbjct: 5 SVTEFEKLN-----RIGEGTYGIVYRARDTTSGEIVALKKV-RM--DNERDGIPISSLRE 56
Query: 493 IKAIGRTHHRNLVRLL----GYSFDVSNKILVYEYMSN--GSLADVYSSP-----PKNNL 541
I + H N+V L G D + LV EY SL D +P K +
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 542 IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQTRTFTGIR 600
+ + RG+ YLH+ IIH D+K N+L+ + KI+DF LA+ P + T +
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 601 GTRGYVAPEWHWNLPITAKA-DVYSFGVVLLEII 633
T Y APE A D+++ G +L E++
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 52/190 (27%), Positives = 97/190 (51%), Gaps = 15/190 (7%)
Query: 453 EIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+IG GS+G V T+ +GK VAVK++ + E+ + H N+V + S
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-S 85
Query: 512 FDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCDI 564
+ V +++ +V E++ G+L D+ + N + + + + LH + +IH DI
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142
Query: 565 KPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
K +IL+ + K+SDF A++ K R + GT ++APE LP + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 624 SFGVVLLEII 633
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 33/263 (12%)
Query: 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEI-KAIGRTHHRN---LVRL 507
++G G+ G+V K I G +A K + + + +I + + H +V
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYS--SPPKNNLIG-----IARGILYLHDECESQII 560
G + +N + E+M GSL +Y P ++G + G+ YL++ +I+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIM 126
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H DIKP NIL++ K+ DF ++ + TF GT Y++PE T K+
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKYTVKS 183
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQV------ILEEWVYQCFENGNLGQLIEDEDVDK 674
DV+S G+ ++E+ + F + +D IL+ + Q +L +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--LLQQIVQEPPPRLPSSD--FP 239
Query: 675 KQLERMIKVALWCILDEPSLRPS 697
+ L + C+L +P+ RP+
Sbjct: 240 EDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 81/295 (27%), Positives = 126/295 (42%), Gaps = 70/295 (23%)
Query: 450 FKEEIGRGSSGTVYKG-----TMINGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRN 503
F EE+G + G +YKG M + + VA+K L+ + + EFQ E + HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLAD--VYSSPP-------------KNNL------- 541
+V LLG +++EY++ G L + + SP K++L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 542 --IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPD----QTR 594
I IA G+ YL +H D+ +NIL+ E + KISD L++ + D Q +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV 654
+ IR ++ PE ++ +D++SFGVVL EI F L
Sbjct: 186 SLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQP--------- 226
Query: 655 YQCFENGNLGQLIEDEDVDKKQL--------ERMIKVALWCILDEPSLRPSMKKV 701
Y F N + ++ V K+QL RM + C + PS RP K +
Sbjct: 227 YYGFSNQEVIEM-----VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQ--KMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
++G+G G V+ GT VA+K L+ M+ E F E + + + H LV L Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--Y 67
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQII 560
+ I +V E+M GSL D L IA G+ Y+ I
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H D++ NIL+ +N KI+DF LA+L++ ++ G + + APE T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 621 DVYSFGVVLLEII 633
DV+SFG++L E++
Sbjct: 185 DVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 50/288 (17%)
Query: 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
K E+G G+ G V+ N VAVK L+ ++F E + + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSS------------PP----KNNLIGIAR- 546
+V+ G + I+V+EYM +G L + P ++ ++ IA+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 547 ---GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTR----TFTG 598
G++YL + +H D+ +N L+ EN KI DF +++ + D R T
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658
IR ++ PE T ++DV+S GVVL EI + L ++VI +C
Sbjct: 186 IR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------ECI 235
Query: 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
G + Q + + + + L C EP +R ++K++ +L+
Sbjct: 236 TQGRVLQR------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 15/190 (7%)
Query: 453 EIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+IG GS+G V T + GK VAVK++ + E+ + HH N+V + S
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-S 87
Query: 512 FDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCDI 564
+ V +++ +V E++ G+L D+ + N + + R + YLH++ +IH DI
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDI 144
Query: 565 KPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
K +IL+ + K+SDF A++ K R + GT ++APE LP + D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK--SLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 624 SFGVVLLEII 633
S G++++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 28/200 (14%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQTEIKAIG---RTHHRNLVRL 507
E+IG G+ G VYK + G+ VA+K++ ++ E E T I+ I +H N+VRL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 508 LGYSFDVSNKILVYEYMSNG------SLADVYSSPP--KNNLIGIARGILYLHDECESQI 559
L + LV+E++ S PP K+ L + +GI Y H ++
Sbjct: 64 LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RV 120
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMK-PDQTRTFTGIRGTRGYVAPEW-----HWN 613
+H D+KPQN+L+D K++DF LA+ P RT+T T Y APE ++
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYS 178
Query: 614 LPITAKADVYSFGVVLLEII 633
P+ D++S G + E++
Sbjct: 179 TPV----DIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 26/198 (13%)
Query: 453 EIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL-GY 510
E+G G+ G VYK G F A K +Q E +F EI + H N+V L Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 511 SFDVSNKILVY-EYMSNGSLADVYS------SPPKNNLIG--IARGILYLHDECESQIIH 561
++ NK+ + E+ G+L + + P+ + + + +LH ++IH
Sbjct: 72 FYE--NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 562 CDIKPQNILMDENRYAKISDFAL-AKLMKPDQTR-TFTGIRGTRGYVAP-----EWHWNL 614
D+K NIL+ + K++DF + AK Q R TF GT ++AP E +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDN 183
Query: 615 PITAKADVYSFGVVLLEI 632
P KAD++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 34/229 (14%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQT-EIKAI 496
++ +LEK+ G G+ TVYKG G+ VA+K + EG EI +
Sbjct: 1 NFKQLEKL--------GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM 52
Query: 497 GRTHHRNLVRLLGYSFDV----SNKILVYEYM---------SNGSLADVYSSPPKNNLIG 543
H N+VRL DV + +LV+EYM ++G + + K+
Sbjct: 53 KELKHENIVRL----HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ 108
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQTRTFTGIRGT 602
+ +GI + H E++++H D+KPQN+L+++ K++DF LA+ P TF+ T
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVT 163
Query: 603 RGYVAPE-WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650
Y AP+ + + D++S G ++ E+I R F EDQ++
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
F +E+G G G V+ G VA+K + + A E +F E K + + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 510 YSFDVSNKILVYEYMSNGSLADV----YSSPPKNNLIGIAR----GILYLHDECESQIIH 561
+V E+M NG L + K+ L+ + + G+ YL + IH
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPITAKA 620
D+ +N L+ K+SDF + + + D+ + +G + + PE ++++ ++K+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKS 182
Query: 621 DVYSFGVVLLEI 632
DV+SFGV++ E+
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 25/194 (12%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT--EIKAIGRTHHRNLVRLLGY 510
+G G+ G V + G+ VA+K++ K + +T E+K + H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCD 563
I V E + L + +S P L I RG+ Y+H + ++H D
Sbjct: 78 FISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRD 133
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE----WHWNLPITAK 619
+KP NIL++EN KI DF LA++ P TG TR Y APE W +
Sbjct: 134 LKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQ---KYDVE 186
Query: 620 ADVYSFGVVLLEII 633
D++S G + E++
Sbjct: 187 VDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 43/227 (18%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGE-REFQTEI- 493
+++T G + +G G+ G V K + VAVK L+ E + + +E+
Sbjct: 10 PRDRLTLG--KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 494 --KAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIG---- 543
K IG+ H+N++ LLG +V EY ++G+L D + +
Sbjct: 68 MMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 544 ---------------IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAK- 586
+ARG+ +L S+ IH D+ +N+L+ E+ KI+DF LA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
+ D R T R ++APE ++ T ++DV+SFGV+L EI
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREF-QTE--IKAIGRTHHRNL 504
+G+GS G V KGT + AVK L+K +L + + E TE + A+ H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILY 550
+L V EY++ G L A Y++ I G+ +
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE-------IVLGLQF 111
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAP 608
LH E II+ D+K N+L+D + KI+DF + K ++ T TF G T Y+AP
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG---TPDYIAP 165
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFD--------QNLPEDQVILEEW 653
E P D ++ GV+L E++ + F+ Q++ ED+V W
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLLGY 510
E +G G+ G VYKG + +A ++ + + E E + EI + + +HHRN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 511 SFDVS------NKILVYEYMSNGSLADVYSSPPKNNLIG---------IARGILYLHDEC 555
S LV E+ GS+ D+ + N L I RG+ +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-----W 610
++IH DIK QN+L+ EN K+ DF ++ + R T I GT ++APE
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197
Query: 611 HWNLPITAKADVYSFGVVLLEI 632
+ + ++D++S G+ +E+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 15/217 (6%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF--VAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNL 504
F +G GS G V T N F VA+KR +K +++ +E K + +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK-NNLIGI--ARGILYLHDECES-QII 560
V L G D S LV E++ G + N +G A I+ + + +S I+
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
+ D+KP+N+L+D++ + K++DF AK++ TRT+T + GT Y+APE N+ A
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHGKAA 209
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPE--DQVILEEWVY 655
D ++ G+ + EI+ F N P Q ILE +Y
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY 246
|
Length = 340 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 453 EIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQT----EIKAIGRTHHRNLVR 506
+IG G+ G VYK G+ VA+K+++ + E+E F EIK + + +HRN+V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 507 L----------LGYSFDVSNKILVYEYMSN---GSLADVYSSPPKNNLIGIAR----GIL 549
L L + D LV+EYM + G L ++++ + G+
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
Y H + +H DIK NIL++ K++DF LA+L +++R +T T Y PE
Sbjct: 131 YCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 610 WHWNLPITAKA-DVYSFGVVLLEIICCRRCFDQN 642
A DV+S G +L E+ + F N
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 452 EEIGRGSSGTV--YKGTMIN---GKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLV 505
+G G G V Y N G+ VAVK L++ + ++ EI + +H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 506 RLLGYSFDVSNKI--LVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECE------- 556
+ G + K L+ EY+ GSL D PK+ + +A+ +L+ CE
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHK-LNLAQLLLFAQQICEGMAYLHS 125
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG--YVAPEWHWNL 614
IH D+ +N+L+D +R KI DF LAK + G + A E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 615 PITAKADVYSFGVVLLEII 633
+ +DV+SFGV L E++
Sbjct: 186 KFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 33/274 (12%)
Query: 447 TDGFKEE--IGRGSSGTVYKGT-MINGKFVAVKRLQ--KMLAEGERE-FQTEIKAIGRTH 500
FK E IG+G VYK +++G+ VA+K++Q +M+ R+ EI + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 501 HRNLVRLLGYSFDVSNK-ILVYEYMSNGSLADVYSSPPK-----------NNLIGIARGI 548
H N+++ L SF +N+ +V E G L+ + K + + +
Sbjct: 61 HPNVIKYLA-SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
++H +I+H DIKP N+ + K+ D L + T + + GT Y++P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668
E K+D++S G +L E+ + F D++ L + + E + L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYS-LCKKIEKCDYPPL-- 228
Query: 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
D ++L ++ CI +P RP + VL
Sbjct: 229 PADHYSEELRDLVSR---CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 56/287 (19%)
Query: 453 EIGRGSSGTVYKGT---MINGKF---VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLV 505
E+G+GS G VY+G +I G+ VAVK + + + ER EF E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSS--PPKNNLIG---------------IARGI 548
RLLG ++V E M++G L S P N G IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRG--- 604
YL+ + + +H D+ +N ++ + KI DF + + + + D R +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 605 --YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN 662
++APE + T +D++SFGVVL EI L E YQ N
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 229
Query: 663 LGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + + D D ER+ + C P +RP+ +++ +L+
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAI----GRTHHRN 503
+GRG G V YK T G+ A+K L+K ++A E E K I H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 504 LVRLLGYSFDVSNKI-LVYEYMSNGSL-----ADVYSSPPKNNLIG-IARGILYLHDECE 556
LV L F + + V EY + G L DV+S P + G+ YLH E
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---E 119
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVAPEWHWNL 614
++I++ D+K N+L+D + KI+DF L K M D+T TF GT ++APE
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPEVLTET 176
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660
T D + GV++ E++ F P D EE V+ N
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPF----PGDD---EEEVFDSIVN 215
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH 501
E+ + + ++++G G G V+ T VAVK ++ E F E + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQH 60
Query: 502 RNLVRLLGYSFDVSNKILVY---EYMSNGSLADVYSSPPKN-----NLIG----IARGIL 549
LV+L V K +Y E+M+ GSL D S + LI IA G+
Sbjct: 61 DKLVKLHA----VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
++ + IH D++ NIL+ + KI+DF LA++++ ++ G + + APE
Sbjct: 117 FIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 610 WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669
T K+DV+SFG++L+EI+ R + +VI + E G E+
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYRMPRPEN 227
Query: 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
E + + + C + P RP+ + + +L+
Sbjct: 228 CP------EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQT------EIKAIGRTHHRNL 504
+IG GS G V+K G+ VA+K+ E E + EI+ + + H NL
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNLIGIARGILYLHDECESQ-I 559
V L+ F K+ LV+EY + L ++ +P P++ + I L + C
Sbjct: 63 VNLIEV-FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW-----HWNL 614
IH D+KP+NIL+ + K+ DF A+++ +T TR Y APE +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 615 PITAKADVYSFGVVLLEIIC 634
P+ DV++ G V E++
Sbjct: 181 PV----DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/196 (33%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKA-----IGRTHHRNLVRL 507
IG+GS G V +G F AVK LQK ++E Q I A + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGL 61
Query: 508 LGYSFDVSNKI-LVYEYMSNGSL-----ADVYSSPPKNNLIG--IARGILYLHDECESQI 559
YSF + K+ V +Y++ G L + P+ +A I YLH I
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NI 117
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVAPEWHWNLPIT 617
I+ D+KP+NIL+D + ++DF L K ++P + T TF GT Y+APE P
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVLRKEPYD 174
Query: 618 AKADVYSFGVVLLEII 633
D + G VL E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/196 (32%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKA-----IGRTHHRNLVRL 507
IG+GS G V ++GK AVK LQK + +E Q I A + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 508 LGYSFDVSNKI-LVYEYMSNGSL------ADVYSSPPKNNLIG-IARGILYLHDECESQI 559
YSF + K+ V ++++ G L + P IA + YLH I
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
++ D+KP+NIL+D + ++DF L K + + D T TF GT Y+APE P
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEVIRKQPYD 174
Query: 618 AKADVYSFGVVLLEII 633
D + G VL E++
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 454 IGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGE-REFQTEIKAIGRTHHRNLVR 506
+G G G V K T K VAVK L++ + E R+ +E + + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 507 LLGYSFDVSNKILVYEYMSNGSL------------ADVYSSPPKNN-------------- 540
L G +L+ EY GSL + + S +N+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 541 -LIG----IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595
LI I+RG+ YL E +++H D+ +N+L+ E R KISDF L++ + + +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY- 183
Query: 596 FTGIRGTRG-----YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650
++ ++G ++A E ++ T ++DV+SFGV+L EI V L
Sbjct: 184 ---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI---------------VTL 225
Query: 651 EEWVYQCFENGNLGQLIED---EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707
Y L L++ + + E M + L C EP RP+ + LE
Sbjct: 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285
Query: 708 TM 709
M
Sbjct: 286 MM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 438 FSYAELEKMTDGFKEEIGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGE-REFQTEI 493
F+ +L+ + EIGRG+ GTV K M++ G +AVKR++ + E E + ++
Sbjct: 1 FTAEDLKDL-----GEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 494 KAIGRTHH-RNLVRLLGYSFDVSNKILVYEYMSNGSLADVY--------SSPPKNNLIGI 544
+ R+ +V+ G F + + E M SL Y S P+ L I
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 545 A----RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
A + + YL +E +IIH D+KP NIL+D N K+ DF ++ + +T
Sbjct: 113 AVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-- 168
Query: 601 GTRGYVAPEW---HWNLPITAKADVYSFGVVLLEIICCRRCFDQ-NLPEDQVILEEWVYQ 656
G R Y+APE ++DV+S G+ L E+ + + + N DQ L + V
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ--LTQVVK- 225
Query: 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704
G+ L +++ + C++ + S RP K++L
Sbjct: 226 ----GDPPIL--SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 33/202 (16%)
Query: 454 IGRGSSGTVYKGTMI----NGKF-VAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRL 507
+G G+ GTVYKG I K VA+K L++ + + +E E + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQ 558
LG S L+ + M G L D Y K+N+ + IA+G+ YL E +
Sbjct: 75 LGICL-TSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERR 129
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW-------H 611
++H D+ +N+L+ ++ KI+DF LAKL+ D+ G V +W H
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKWMALESILH 185
Query: 612 WNLPITAKADVYSFGVVLLEII 633
T ++DV+S+GV + E++
Sbjct: 186 RIY--THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 53/290 (18%)
Query: 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
K E+G G+ G V+ N VAVK L+ ++FQ E + + H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLI--------------------- 542
+V+ G D I+V+EYM +G L + + +I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 543 --GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTR----T 595
IA G++YL + +H D+ +N L+ N KI DF +++ + D R T
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY 655
IR ++ PE T ++DV+SFGV+L EI + L +VI
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ 235
Query: 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+C G+++E V K++ + L C EP R ++K++ +L
Sbjct: 236 ECITQ---GRVLERPRVCPKEV---YDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRL 507
E IG G+ G V +GK VA+K++ + +R + E+K + H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAI 69
Query: 508 L------GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDEC 555
G F + +V + M + ++S P L + RG+ Y+H
Sbjct: 70 RDILRPPGADFK--DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH--- 124
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLM--KPDQTRTF-TGIRGTRGYVAPEWHW 612
+ +IH D+KP N+L++E+ +I DF +A+ + P + + F T TR Y APE
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 613 NLP-ITAKADVYSFGVVLLEIICCRRCF 639
+LP T D++S G + E++ R+ F
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL----MKPDQTRTFTGIRGTR 603
+L +H +IH DIK NIL+ N K+ DF +K+ + D RTF G T
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG---TP 209
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
YVAPE P + KAD++S GV+L E++ +R FD
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 453 EIGRGSSGTVYKGTMIN--GKFVAVKRLQKMLAEGEREFQT-----EIKAIGRTHHRNLV 505
EIG G+ G V+K + G+FVA+KR++ E T ++ + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 506 RLLGYSFDV---------SNKILVYE--------YMSNGSLADVYSSPPKNNLIGIARGI 548
RL FDV + LV+E Y+ V + K+ + + RG+
Sbjct: 68 RL----FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
+LH +++H D+KPQNIL+ + K++DF LA++ T + T Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 178
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
E D++S G + E+ + F + DQ+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 71/297 (23%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF---VAVKRLQKMLAEGE-REFQTEIKAIGRT-HHRNL 504
F++ IG G+ G V K + A+KR+++ ++ + R+F E++ + + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPP-------------KNNLIG-- 543
+ LLG L EY +G+L D V + P L+
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 544 --IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601
+ARG+ YL + Q IH D+ +NIL+ EN AKI+DF L++ + ++
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKK 180
Query: 602 TRGYVAPEW----HWNLPI-TAKADVYSFGVVLLEII-------CCRRCFDQNLPEDQVI 649
T G + W N + T +DV+S+GV+L EI+ C C
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------- 229
Query: 650 LEEWVYQCFENGNLGQLIEDE-DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705
+ +E G +E + D + + M + C ++P RPS ++L+ L
Sbjct: 230 -----AELYEKLPQGYRLEKPLNCDDEVYDLMRQ----CWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 54/290 (18%)
Query: 444 EKMTDGFKEEIGRGSSGTVYKGTMINGKF-------VAVKRLQKMLAEGER-EFQTEIKA 495
EK+T E+G+GS G VY+G + G VA+K + + + ER EF E
Sbjct: 6 EKIT--MSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-------------VYSSPPKNNLI 542
+ + ++VRLLG +++ E M+ G L V + P +I
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 543 G----IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFT 597
IA G+ YL+ ++ +H D+ +N ++ E+ KI DF + + + + D R
Sbjct: 123 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 176
Query: 598 GIRGTRG-----YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652
+G +G +++PE + T +DV+SFGVVL EI Q + +QV+
Sbjct: 177 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL--R 232
Query: 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+V + G L++ D L ++++ C P +RPS +++
Sbjct: 233 FVME-------GGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 30/201 (14%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE-REFQTEIKAIGRTHH---RNLVR 506
E IGRG+ G VY+G + G+ VA+K + + + + Q E+ + + N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 507 LLGYSFDVSNKILVYEYMSNGSLADVY-SSPPKNNLIG-IARGIL----YLHDECESQII 560
G ++ EY GS+ + + P I I R +L Y+H + +I
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVI 123
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTR--TFTGIRGTRGYVAPEWHWNLPIT- 617
H DIK NIL+ K+ DF +A L+ + ++ TF GT ++APE IT
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GTPYWMAPE-----VITE 175
Query: 618 -----AKADVYSFGVVLLEII 633
KAD++S G+ + E+
Sbjct: 176 GKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH 500
E+E + +E+G+G+ G+VYK G +A+K ++ L E +F I + H
Sbjct: 2 EIEVL-----DELGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILH 54
Query: 501 HRN---LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSP------PKNNLIGIA----RG 547
+V G F + EYM GSL +Y+ P++ L I +G
Sbjct: 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
+ +L +E IIH D+KP N+L++ N K+ DF ++ + +T G + Y+A
Sbjct: 115 LKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMA 169
Query: 608 PE------WHWNLPITAKADVYSFGVVLLEI 632
PE + N T ++DV+S G+ +LE+
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 453 EIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQT--EIKAIGRTH---HRNLVR 506
EIG G+ GTVYK +G FVA+K ++ E T E+ + R H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 507 LLGY----SFDVSNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHD 553
L+ D K+ LV+E++ + PP K+ + RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
C I+H D+KP+NIL+ K++DF LA++ T + T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ 181
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
D++S G + E+ + F N DQ+
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/194 (30%), Positives = 86/194 (44%), Gaps = 22/194 (11%)
Query: 453 EIGRGSSGTVYKGT-MINGKFVAVKRLQ---KMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EIG GS G VY T + VAVK++ K E ++ E+K + + H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 509 GYSFDVSNKILVYEYM--SNGSLADVYSSPPKNNLI-----GIARGILYLHDECESQIIH 561
G LV EY S L +V+ P + I G +G+ YLH +IH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL---PITA 618
DIK NIL+ E K++DF A P +F GT ++APE +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFV---GTPYWMAPEVILAMDEGQYDG 199
Query: 619 KADVYSFGVVLLEI 632
K DV+S G+ +E+
Sbjct: 200 KVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 25/198 (12%)
Query: 454 IGRGSSGTVYKGTMI-NGKF----VAVKRLQKMLAEGEREFQT---EIKAIGRTHHRNLV 505
+G G GTV+KG I G VA+K +Q G + FQ + A+G H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECE 556
RLLG S + LV + GSL D + +++L + IA+G+ YL +
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLD-HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGYVAPEWHWNLP 615
++H ++ +NIL+ + +I+DF +A L+ PD + F + + ++A E
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 616 ITAKADVYSFGVVLLEII 633
T ++DV+S+GV + E++
Sbjct: 188 YTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 541 LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
+ IA + YLH E I+H D+K QN+ + K+ D +A++++ +Q + +
Sbjct: 108 FVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI 163
Query: 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660
GT Y++PE N P K+DV++ G + E+ + F+ +D + VY+ E
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA---KD---MNSLVYRIIE- 216
Query: 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
G L + +D +L +I L P RPS+K +L
Sbjct: 217 GKLPPMPKDYS---PELGELIATML---SKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 35/165 (21%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQ-KMLAEGEREFQT-EIKA 495
Y +LEK IG G+ GTV+K + VA+KR++ EG EI
Sbjct: 1 KYEKLEK--------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL 52
Query: 496 IGRTHHRNLVRLLGYSFDV--SNK--ILVYEYMS----------NGSLADVYSSPPKNNL 541
+ H+N+VRL +DV S+K LV+EY NG D+ K+ +
Sbjct: 53 LKELKHKNIVRL----YDVLHSDKKLTLVFEYCDQDLKKYFDSCNG---DIDPEIVKSFM 105
Query: 542 IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586
+ +G+ + H ++H D+KPQN+L+++N K++DF LA+
Sbjct: 106 FQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 49/285 (17%)
Query: 452 EEIGRGSSGTVYKG---TMINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRL 507
+EIG G G V G ++ V VK L+ E+ F E++ +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSS--------PPKNNLI----GIARGILYLHDEC 555
LG + +LV E+ G L + S K+ L +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD-----QTRTFTGIRGTRGYVAPEW 610
++ IH D+ +N + + KI D+ LA P+ + +R +
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 611 HWNL---PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667
+L T K++++S GV + E+ +L ++QV L Q++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--------------LKQVV 223
Query: 668 EDEDV--DKKQL-----ERMIKVALWCILDEPSLRPSMKKVLLML 705
++D+ K QL +R +V +C LD P RP+ ++V +L
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 44/294 (14%)
Query: 437 SFSYAELEKMTDGFKEEIGRGSSGTVYKGTMING------KFVAVKRLQKMLAEG-EREF 489
+F + L+++T +GRG G V+ V VK LQK E + EF
Sbjct: 1 AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55
Query: 490 QTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL---------ADVYSSPPKNN 540
+ E+ + H+N+VRLLG + ++ EY G L D PP +
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 541 LIG-------IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
IA G+ +L + ++ +H D+ +N L+ R K+S +L+K + +
Sbjct: 116 TKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN-LPEDQVILEE 652
++APE + K+DV+SFGV++ E+ F Q LP + EE
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV------FTQGELPFYGLSDEE 226
Query: 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + + G L + + R+ K+ C P RPS +++ L
Sbjct: 227 VLNR-LQAGKLELPVPE-----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 34/199 (17%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT---------HHRN 503
E+G G+ G V K + ++L + EIK R H N
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHL----------EIKPAIRNQIIRELKVLHECN 57
Query: 504 LVRLLGY--SFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNL----IGIARGILYLHD 553
++G+ +F +I + E+M GSL V P+N L I + RG+ YL +
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ +I+H D+KP NIL++ K+ DF ++ + +F GTR Y++PE
Sbjct: 118 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 172
Query: 614 LPITAKADVYSFGVVLLEI 632
T ++D++S G+ L+E+
Sbjct: 173 THYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQ---KMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EIG GS G VY + N + VA+K++ K E ++ E++ + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 509 GYSFDVSNKILVYEYM--SNGSLADVYSSPPKNNLI-----GIARGILYLHDECESQIIH 561
G LV EY S L +V+ P + I G +G+ YLH +IH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIH 138
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL---PITA 618
D+K NIL+ E K+ DF A +M P GT ++APE +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQYDG 193
Query: 619 KADVYSFGVVLLEI 632
K DV+S G+ +E+
Sbjct: 194 KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
IG+G+ G VY K T + A+K L K ++E E + RT
Sbjct: 1 IGKGTFGQVYQVRKKDT---RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 507 LLG--YSFDVSNKI-LVYEYMSNGSL----ADVYSSPPKNNLIGIARGILYLHDECESQI 559
++G +SF + + LV +YMS G L IA +L L + I
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLP-I 616
++ D+KP+NIL+D + + DF L+K L T TF GT Y+APE +
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEKGY 174
Query: 617 TAKADVYSFGVVLLEIIC 634
T D +S GV++ E+ C
Sbjct: 175 TKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
K E+G G+ G V+ N VAVK L++ ++FQ E + + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSSPPKNNLIG------------------- 543
+VR G + ++V+EYM +G L + S P ++
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 544 --IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQ----TRTF 596
IA G++YL +H D+ +N L+ + KI DF +++ + D RT
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
IR ++ PE T ++D++SFGVVL EI
Sbjct: 186 LPIR----WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
+GRG G V K T G A+K ++K +LA+ F E + I + +
Sbjct: 9 VGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 508 LGYSF-DVSNKILVYEYMSNG---SLADVYSSPPKNNLIG--IARGILYLHDECESQIIH 561
L Y+F D N LV EY G SL + Y ++ +A +L +H + +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA- 620
DIKP+N+L+D + K++DF A + ++ GT Y+APE + K
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 621 -----DVYSFGVVLLEIICCRRCFDQ 641
D +S GV+ E+I R F +
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+ IG G+ G VYK +N G+ A+K ++ E Q EI + H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 511 SFDVSNKILVYEYMSNGSLADVY--SSPPKNNLIGIA-----RGILYLHDECESQIIHCD 563
+ E+ GSL D+Y + P + I +G+ YLH + + +H D
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
IK NIL+ +N + K++DF ++ + + + I GT ++APE
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVR 506
+G E +G G+ + + VAVK L+ + + R +F EIK + R + N++R
Sbjct: 27 EGLAEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81
Query: 507 LLGYSFDVSNKILVYEYMSNGSL------ADVYSSPPKNNLI-------------GIARG 547
LLG ++ EYM NG L ++ S+ N I IA G
Sbjct: 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYV 606
+ YL +H D+ +N L+ + KI+DF +++ L D R I+G R +
Sbjct: 142 MKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR----IQG-RAVL 193
Query: 607 APEWH-WNLPITAK----ADVYSFGVVLLEI-ICCRRCFDQNLPEDQVI 649
W W + K +DV++FGV L E+ C+ L ++QVI
Sbjct: 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 454 IGRGSSGTVYKGTM-INGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + GK A K+L+K + GE E + + + + R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSSPPKNNLIGIARGILYLHDEC-------ESQII 560
Y+++ + + LV M+ G L +Y R + Y + C + +I+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
+ D+KP+NIL+D++ + +ISD LA + Q T G GT GY+APE N T
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 621 DVYSFGVVLLEIICCRRCFDQ 641
D ++ G +L E+I + F Q
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 50/223 (22%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEG-------EREFQTEIKAIGRTHHRN 503
IGRG+ G V+ G+ A+K L+K M+ ER+ + +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS------PW 62
Query: 504 LVRLLGYSF-DVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQ 558
+V+L YSF D + LV EYM G L ++ P + IA +L L +
Sbjct: 63 IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR------------------ 600
IH DIKP NIL+D + + K++DF L K M + R +
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 601 ----------GTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
GT Y+APE P + D +S GV+L E++
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 39/115 (33%), Positives = 61/115 (53%), Gaps = 10/115 (8%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRG 601
IA G+ +LH + II+ D+K N+++D + KI+DF + K + TRTF G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG--- 163
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEEWV 654
T Y+APE P D ++FGV+L E++ + FD ++ Q I+E V
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 33/201 (16%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRNLV 505
I G+ G VY+ G+ VA+K+L KM E E RE +K H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKL----QHPNIV 67
Query: 506 RL----LGYSFDVSNKI-LVYEYMSNG--SLADVYSSP-----PKNNLIGIARGILYLHD 553
+ +G +KI +V EY+ + SL + P K ++ + G+ +LHD
Sbjct: 68 TVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ I+H D+K N+L++ KI DF LA+ + +T + T Y APE
Sbjct: 125 ---NWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLLG 180
Query: 614 LPI-TAKADVYSFGVVLLEII 633
+ D++S G + E++
Sbjct: 181 AKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E +G+G+ G V+KGT+ + VAVK ++ L E + +F +E + + + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQIIH 561
+V E + G + K+ L + A G+ YL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLS-FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIH 116
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR-GYVAPEWHWNLPITAKA 620
D+ +N L+ EN KISDF +++ + D + +G++ + APE ++++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 621 DVYSFGVVLLEIICCRRC 638
DV+S+G++L E C
Sbjct: 176 DVWSYGILLWETFSLGVC 193
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
+G+G+ G V K T GK+ A+K L+K + + E TE + + T H L
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYS-----SPPKNNLIG--IARGILYLHDECESQ 558
L YSF +++ V EY + G L S S + G I + YLH
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+++ D+K +N+++D++ + KI+DF L K + +TF GT Y+APE +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 172
Query: 617 TAKADVYSFGVVLLEIICCRRCF 639
D + GVV+ E++C R F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEI----KAIGRTHH-RNLV 505
EIG G+ G VYK G +AVK+ M G +E I + ++H +V
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQ---MRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 506 RLLGYSFDVSNKILVYEYMS---NGSLADVYSSPPKNNL----IGIARGILYLHDECESQ 558
+ GY S+ + E MS + L + P++ L + I + + YL ++
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HG 135
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE------WHW 612
+IH D+KP NIL+D + K+ DF ++ + + +T + G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPPDPNP 193
Query: 613 NLPITAKADVYSFGVVLLEI 632
I +ADV+S G+ L+E+
Sbjct: 194 KYDI--RADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + N GK A K+L K + GE+ E + + + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSSPPK----NNLI----GIARGILYLHDECESQI 559
Y+F+ + LV M+ G L +Y+ + +I I GIL+LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
++ D+KP+N+L+D+ ++SD LA +K +T T GT GY+APE P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 620 ADVYSFGVVLLEIICCRRCF 639
D ++ G + E++ R F
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 65/232 (28%), Positives = 97/232 (41%), Gaps = 66/232 (28%)
Query: 454 IGRGSSGTVYKGTMINGK-FVAVKRLQKMLAEGEREFQTEIKAIGRT----------HHR 502
+G G+ G V VA+K+L R FQ+ I A RT H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHA-KRTYRELRLLKHMDHE 74
Query: 503 NLVRLLG-YSFDVSNK-----ILVYEYMSNGSLADVYSSPPKNNLIG------------- 543
N++ LL ++ S + LV M AD+ NN++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADL------NNIVKCQKLSDDHIQFLV 124
Query: 544 --IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601
I RG+ Y+H + IIH D+KP NI ++E+ KI DF LA+ + TG
Sbjct: 125 YQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVA 177
Query: 602 TRGYVAPE----W-HWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
TR Y APE W H+N D++S G ++ E++ + F + DQ+
Sbjct: 178 TRWYRAPEIMLNWMHYN----QTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 432 DIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQ---KMLAEGER 487
+IA L F + EK+ +E IG GS G VY + + VA+K++ K E +
Sbjct: 13 EIAELFFK-EDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 70
Query: 488 EFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM--SNGSLADVYSSPPKNNLI--- 542
+ E+K + R H N + G LV EY S L +V+ P + I
Sbjct: 71 DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 130
Query: 543 --GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
G +G+ YLH +IH DIK NIL+ E K++DF A + P +
Sbjct: 131 THGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FV 182
Query: 601 GTRGYVAPEWHWNL---PITAKADVYSFGVVLLEI 632
GT ++APE + K DV+S G+ +E+
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY-- 510
E+G G+ G V K + ++L + + Q I+ + H N ++G+
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-IRELQVLHECNSPYIVGFYG 70
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNL----IGIARGILYLHDECESQIIHC 562
+F +I + E+M GSL V P+ L I + RG+ YL ++ QI+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHR 128
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D+KP NIL++ K+ DF ++ + +F GTR Y++PE + ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDI 185
Query: 623 YSFGVVLLEIICCR 636
+S G+ L+E+ R
Sbjct: 186 WSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 80/311 (25%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK-----------------FVAVKRLQKMLAEGER-EFQT 491
FKE++G G G V+ ++N + VAVK L+ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 492 EIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS--------------PP 537
E+K + R N++RLLG D ++ EYM NG L SS PP
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 538 KNNLIG------------IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585
+ L IA G+ YL +H D+ +N L+ EN KI+DF ++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 586 K-LMKPD----QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII-CCRRCF 639
+ L D Q R IR ++A E T +DV++FGV L EI+ C+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 640 DQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL---------ERMIKVALWCILD 690
L ++QVI N G+ D+ +Q+ + + ++ L C
Sbjct: 242 YGELTDEQVI-----------ENAGEFFRDQ---GRQVYLFRPPPCPQGLYELMLQCWSR 287
Query: 691 EPSLRPSMKKV 701
+ RPS +
Sbjct: 288 DCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 43/217 (19%)
Query: 450 FKEEIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLAEGE-REFQTEIKAIGRT-HHRNL 504
F++ IG G+ G V + + A+K L++ +E + R+F E++ + + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPK-----------------NNL 541
+ LLG + + EY G+L D V + P
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 542 IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601
+A G+ YL ++ Q IH D+ +N+L+ EN +KI+DF L++ + ++
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKK 175
Query: 602 TRGYVAPEW----HWNLPI-TAKADVYSFGVVLLEII 633
T G + W N + T K+DV+SFGV+L EI+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQT--EIKA 495
SY +LEK+ G GS TVYKG + +NGK VA+K ++ EG F E
Sbjct: 6 SYEKLEKL--------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASL 56
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSP----PKNN---LIGIARGI 548
+ H N+V L LV+EY+ + P P+N L + RG+
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
Y+H + I+H D+KPQN+L+ + K++DF LA+ K + T++ T Y P
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPP 172
Query: 609 E-WHWNLPITAKADVYSFGVVLLEII 633
+ + + D++ G + +E+I
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 35/189 (18%)
Query: 473 VAVKRL-----QKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527
VAVK L +K L++ E + +K IG+ H+N++ LLG ++ EY S G
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEM-MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 528 SLADVYSS--PPK-----------------NNLIG----IARGILYLHDECESQIIHCDI 564
+L + + PP +L+ +ARG+ YL + + IH D+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163
Query: 565 KPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+N+L+ EN KI+DF LA+ + D + T R ++APE ++ T ++DV+
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223
Query: 624 SFGVVLLEI 632
SFGV++ EI
Sbjct: 224 SFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 37/202 (18%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQ-TEIKAIGR-THHRNLVRLLGY 510
IG G+ V K GK+ A+K ++K E+ EI+A+ R + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 511 SFDVSNKIL----------VYEYMSNGSLADVYSSPP---KNNLIGIARGILYLHDECES 557
FD L +YE + P K+ + + + + ++H +
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMH---RN 119
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE------WH 611
I H DIKP+NIL+ ++ K++DF + + +T TR Y APE ++
Sbjct: 120 GIFHRDIKPENILIKDDI-LKLADFGSCRGI--YSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 612 WNLPITAKADVYSFGVVLLEII 633
K D+++ G V EI+
Sbjct: 177 -----GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 452 EEIGRGSSGTVYKGTMI----NGKFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLV 505
++IG GS G K ++ +GK +K + KM + E + E+ + H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDE--------C-- 555
+ + N +V +Y G D+Y I RG+L+ D+ C
Sbjct: 63 QYQESFEENGNLYIVMDYCEGG---DLYK------KINAQRGVLFPEDQILDWFVQICLA 113
Query: 556 -----ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW 610
+ +I+H DIK QNI + ++ K+ DF +A+++ T I GT Y++PE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 611 HWNLPITAKADVYSFGVVLLEIICCRRCFD 640
N P K+D+++ G VL E+ + F+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLGYS 511
E+G G+ G VYK +A ++ +E E E + EI + H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 512 FDVSNKILVYEYMSNGSLADVY---SSPPKNNLIGIA-----RGILYLHDECESQIIHCD 563
+ +N ++ E+ + G++ V P I + + YLH E++IIH D
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128
Query: 564 IKPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTRGYVAP-----EWHWNLPIT 617
+K NIL + K++DF + AK + Q R GT ++AP E + P
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 618 AKADVYSFGVVLLEI 632
KADV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-----GEREFQTEIKA 495
EL+K+ + +G G+ GTVYKG I +G+ V + K+L E +E E
Sbjct: 8 ELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 62
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIAR 546
+ + RLLG S LV + M G L D Y K+ + + IA+
Sbjct: 63 MAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAK 120
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT-GIRGTRGY 605
G+ YL E +++H D+ +N+L+ + KI+DF LA+L+ D+T G + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEII 633
+A E + T ++DV+S+GV + E++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLLG 509
E++G G+ TV+KG + + VA+K ++ EG E+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 510 YSFDVSNKILVYEYMSN---------GSLADVYSSPPKNNLIGIARGILYLHDECESQII 560
+ LV+EY+ G++ +++ K L I RG+ Y H +++
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNV--KIFLYQILRGLAYCH---RRKVL 126
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPITAK 619
H D+KPQN+L++E K++DF LA+ K T+T++ T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650
D++ G + E+ R F + ED++ L
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQ---KMLAEGEREFQTEIKAIGRTHHRNLVR 506
+++IGRG VY+ T +++ K VA+K++Q M A+ ++ EI + + +H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIARGIL-YLHDECES------- 557
L SF N++ +V E G L+ + K + R + Y C +
Sbjct: 67 YLD-SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+++H DIKP N+ + K+ D L + T + + GT Y++PE
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYN 184
Query: 618 AKADVYSFGVVLLEI 632
K+D++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 58/226 (25%)
Query: 453 EIGRGSSGTVYKGT---MINGK---FVAVKRLQKMLAEG-----EREFQTEIKAIGRTHH 501
+IG+G+ G V++ ++ + VAVK ML E + +FQ E + H
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVK----MLKEEASADMQADFQREAALMAEFDH 67
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLAD--------------------VYSSPPKNNL 541
N+V+LLG L++EYM+ G L + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 542 ---------IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM---- 588
+A G+ YL E + +H D+ +N L+ EN KI+DF L++ +
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 589 --KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
K + IR ++ PE + T ++DV+++GVVL EI
Sbjct: 185 YYKASEN-DAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 454 IGRGSSGTV-YKGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVRLLG 509
+G+G+ G V +GK+ A+K L+K + + E TE + + T H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 510 YSFDVSNKI-LVYEYMSNGSLADVYS-----SPPKNNLIG--IARGILYLHDECESQIIH 561
YSF +++ V EY++ G L S S + G I + YLH +I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVY 118
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+K +N+++D++ + KI+DF L K D T GT Y+APE + D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 622 VYSFGVVLLEIICCRRCF 639
+ GVV+ E++C R F
Sbjct: 178 WWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 44/206 (21%)
Query: 429 YCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGER 487
+C++++ Y +L K IG+G+ G V+K + VA+K K+L E E+
Sbjct: 7 FCDEVS----KYEKLAK--------IGQGTFGEVFKARHKKTKQIVALK---KVLMENEK 51
Query: 488 E-FQT----EIKAIGRTHHRNLVRLL--------GYSFDVSNKILVYEYMSNGSLADVYS 534
E F EIK + H N+V L+ Y+ + LV+E+ + LA + S
Sbjct: 52 EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS 110
Query: 535 SPP-KNNLIGIAR-------GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586
+ K L I + G+ Y+H ++I+H D+K NIL+ ++ K++DF LA+
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
Query: 587 ---LMKPDQTRTFTGIRGTRGYVAPE 609
L K + +T T Y PE
Sbjct: 168 AFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 453 EIGRGSSGTVYKG---TMINGKFVAVKRLQKMLAEG--EREFQTEIKAIGRTHHRNLVRL 507
E+G G+ GTV KG + K VAVK L+ + + E E + + + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKN----NLI----GIARGILYLHDECESQI 559
+G + + +LV E G L + + K+ N+ ++ G+ YL E+
Sbjct: 62 IGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNF 116
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPIT 617
+H D+ +N+L+ YAKISDF L+K + D+ + T + + APE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 618 AKADVYSFGVVLLE 631
+K+DV+SFGV++ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/167 (32%), Positives = 74/167 (44%), Gaps = 25/167 (14%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQT--EIKA 495
SY LEK+ G GS TVYKG + ING+ VA+K + M E F E
Sbjct: 6 SYLNLEKL--------GEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASL 56
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKN--------NLIGIARG 547
+ H N+V L V+EYM LA P + + RG
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRG 115
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-PDQT 593
+ Y+H + I+H D+KPQN+L+ K++DF LA+ P QT
Sbjct: 116 LAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 32/206 (15%)
Query: 454 IGRGSSGTVYKGTMINGKF-VAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLL- 508
+G G+ G+V VAVK+L + + +R ++ E++ + H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 509 ----GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQ 558
S + N + + ++ L ++ + + I RG+ Y+H +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 140
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE----W-HWN 613
IIH D+KP N+ ++E+ KI DF LA+ + TG TR Y APE W H+N
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYN 196
Query: 614 LPITAKADVYSFGVVLLEIICCRRCF 639
+ D++S G ++ E++ R F
Sbjct: 197 QTV----DIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 453 EIGRGSSGTVYKGTMINGKF---VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLL 508
E+G G+ G V KG K VA+K L+ + R E E + + + + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSP----PKNNLI----GIARGILYLHDECESQII 560
G + +LV E S G L S +N++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPITA 618
H D+ +N+L+ YAKISDF L+K + D + + + + + APE ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 619 KADVYSFGVVLLE 631
++DV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLLG 509
+++G G+ TV+KG + + VA+K ++ EG E+ + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 510 YSFDVSNKILVYEYMSN---------GSLADVYSSPPKNNLIGIARGILYLHDECESQII 560
LV+EY+ + G+L +++ K + + RG+ Y H + +I+
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNV--KIFMFQLLRGLSYCH---KRKIL 125
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-----WHWNLP 615
H D+KPQN+L++E K++DF LA+ K T+T++ T Y P+ ++ P
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 616 ITAKADVYSFGVVLLEIICCRRCF 639
I D++ G +L E+ R F
Sbjct: 185 I----DMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 30/197 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRL---------QKMLAEGEREFQTEIKAIGRTHHRN 503
+G G+ G V+ I+ + A+K + Q+ E+ E+ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPF 62
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK-NNLIG------IARGILYLHDECE 556
++RL D ++ EY+ G L + + +N G I + YLH +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK-- 120
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+I++ D+KP+NIL+D+ + K++DF AK ++ RT+T + GT Y+APE +
Sbjct: 121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWT-LCGTPEYLAPEVIQSKGH 175
Query: 617 TAKADVYSFGVVLLEII 633
D ++ G+++ E++
Sbjct: 176 NKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 31/200 (15%)
Query: 454 IGRGSSGTVYKGTMINGK----FVAVKRLQK--------MLAEGEREFQTEIKAIGRTHH 501
+G+GS G V+ I G A+K L+K + + ER+ E+ +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 502 RNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHD 553
+V+L Y+F K+ L+ +++ G L S K L +A + +LH
Sbjct: 58 PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
II+ D+KP+NIL+DE + K++DF L+K + + ++ GT Y+APE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNR 172
Query: 614 LPITAKADVYSFGVVLLEII 633
T AD +SFGV++ E++
Sbjct: 173 RGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKF-----VAVKRLQKMLAEGERE-FQTEIKAIGRTH-- 500
F + +G G+ G V + T K VAVK L+ ERE +E+K + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 501 -HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK-----NNLIG----IARGILY 550
H N+V LLG +++ EY G L + + +L+ +A+G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPE 609
L + IH D+ +N+L+ + KI DF LA+ + D G R ++APE
Sbjct: 157 LASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 610 WHWNLPITAKADVYSFGVVLLEI 632
+N T ++DV+S+G++L EI
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 18/193 (9%)
Query: 454 IGRGSSGTVYKGTM-INGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + GK A K+L+K + GE E + + + + R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSSPPKNNLIGIARGILY-------LHDECESQII 560
Y+++ + + LV M+ G L +Y+ N R I Y L D +I+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
+ D+KP+NIL+D+ + +ISD LA ++ + T G GT GY+APE N T
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 621 DVYSFGVVLLEII 633
D + G ++ E+I
Sbjct: 183 DWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
+G+G+ G V K T G++ A+K L+K + + E TE + + T H L
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYS-----SPPKNNLIG--IARGILYLHDECESQ 558
L Y+F +++ V EY + G L S + + G I + YLH
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---D 115
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPI 616
+++ DIK +N+++D++ + KI+DF L K D +TF GT Y+APE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 172
Query: 617 TAKADVYSFGVVLLEIICCRRCF---DQNLPEDQVILEE 652
D + GVV+ E++C R F D + +++EE
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 35/189 (18%)
Query: 473 VAVKRL-----QKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527
VAVK L +K L++ E + +K IG+ H+N++ LLG ++ EY S G
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEM-MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 528 SLADV----------YSSPPKNN---------LIG----IARGILYLHDECESQIIHCDI 564
+L + Y P L+ +ARG+ YL + IH D+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166
Query: 565 KPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+N+L+ E+ KI+DF LA+ + D + T R ++APE ++ T ++DV+
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226
Query: 624 SFGVVLLEI 632
SFGV+L EI
Sbjct: 227 SFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 453 EIGRGSSGTV----YKGTMINGKFVAVKRL-----QKMLAEGEREFQTEIKAIGRTH--- 500
E+G+G+ G V T VA+K++ +K+LA+ R + E+K + H
Sbjct: 7 ELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAK--RALR-ELKLL--RHFRG 60
Query: 501 HRNLVRLLGYSFDVS-----NKILVYEYMSNGSLADV-YSSPPKNN------LIGIARGI 548
H+N+ L Y D+ N++ +YE + L + S P + + I G+
Sbjct: 61 HKNITCL--YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT---FTGIRGTRGY 605
Y+H + ++H D+KP N+L++ + KI DF LA+ + T TR Y
Sbjct: 119 KYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 606 VAPEWHW-NLPITAKADVYSFGVVLLEII 633
APE T DV+S G +L E++
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+ +G G+ G VYK ++ G+ AVK ++ + Q EI + H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIA-------RGILYLHDECESQIIHCD 563
+ EY GSL D+Y + + IA +G+ YLH + + +H D
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
IK NIL+ +N K++DF +A + + + I GT ++APE
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTM-INGK---FVAVKRLQKMLAEGERE-FQTEIKAI 496
EL+ + + +G G G + +G + + K VA+ L+ ++ +R F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 497 GRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL--------ADVYSSPPKNNLIGIARGI 548
G+ H N+VRL G + ++V EYMSNG+L + + L G+A G+
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
YL E +H + +L++ + KIS F + K + T + + AP
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E ++ +DV+SFG+V+ E++
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
+G+G+ G V K T G++ A+K L+K + + E TE + + + H L
Sbjct: 3 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSL-----ADVYSSPPKNNLIG--IARGILYLHDECESQ 558
L YSF +++ V EY + G L + S + G I + YLH E
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPD--QTRTFTGIRGTRGYVAPEWHWNLPI 616
+++ D+K +N+++D++ + KI+DF L K D +TF GT Y+APE +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDY 173
Query: 617 TAKADVYSFGVVLLEIICCRRCF 639
D + GVV+ E++C R F
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 69/243 (28%), Positives = 104/243 (42%), Gaps = 51/243 (20%)
Query: 450 FKEEIGRGSSGTVY------------KGTMINGK-----FVAVKRLQKMLAEGER-EFQT 491
FKE++G G G V+ K ++ VAVK L++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 492 EIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS-PPKN----------- 539
EIK + R N++RLL ++ EYM NG L S P+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 540 --NLIG----IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQ 592
LI IA G+ YL +H D+ +N L+ +N KI+DF +++ L D
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 593 TRTFTGIRGTRGYVAPEW-HWNLPITAK----ADVYSFGVVLLEIIC-CRRCFDQNLPED 646
R I+G R + W W + K +DV++FGV L EI+ C+ L ++
Sbjct: 186 YR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 647 QVI 649
QVI
Sbjct: 241 QVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 454 IGRGSSGTVYKGTMINGK-FVAVKRLQKMLAEGEREFQT----EIKAIGRTHHRNLVRLL 508
+G G+ G V K K VA+K+ + +E E + E+K + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLKQENIVEL- 65
Query: 509 GYSFDVSNKI-LVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQII 560
+F K+ LV+EY+ L + P ++ + + + I + H ++ I+
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIV 122
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H DIKP+N+L+ N K+ DF A+ + +T TR Y +PE P
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 621 DVYSFGVVLLEI 632
D++S G +L E+
Sbjct: 183 DMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 452 EEIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVRLLG 509
+++G G+ TVYKG + + VA+K ++ EG E+ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 510 YSFDVSNKILVYEYMSN---------GSLADVYSSPPKNNLIGIARGILYLHDECESQII 560
+ LV+EY+ G+ ++++ K L + RG+ Y H +++
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV--KLFLFQLLRGLNYCH---RRKVL 126
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPITAK 619
H D+KPQN+L++E K++DF LA+ K T+T++ T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
D++ G + E+ R F + E+Q+
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 448 DGFKE--EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLV 505
D F++ E+G G+ G V+K + + ++L + + Q I+ + H N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-IRELQVLHECNSP 63
Query: 506 RLLGY--SFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNL----IGIARGILYLHDEC 555
++G+ +F +I + E+M GSL V P+ L I + +G+ YL ++
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 122
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
+I+H D+KP NIL++ K+ DF ++ + +F GTR Y++PE
Sbjct: 123 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH 178
Query: 616 ITAKADVYSFGVVLLEIICCR 636
+ ++D++S G+ L+E+ R
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 43/213 (20%)
Query: 454 IGRGSSGTVYKGTMINGKF---VAVKRLQKMLAEGE-REFQTEIKAIGRT-HHRNLVRLL 508
IG G+ G V K + A+KR+++ ++ + R+F E++ + + HH N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 509 GYSFDVSNKILVYEYMSNGSLAD-------------------VYSSPPKNNLIGIA---- 545
G L EY +G+L D S+ L+ A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGY 605
RG+ YL + Q IH D+ +NIL+ EN AKI+DF L++ + ++ T G
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMGR 172
Query: 606 VAPEW----HWNLPI-TAKADVYSFGVVLLEII 633
+ W N + T +DV+S+GV+L EI+
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 20/194 (10%)
Query: 452 EEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLG 509
E IGRG+ G V+ G + + VAVK ++ L + + +F E + + + H N+VRL+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 510 YSFDVSNKILVYEYMSNGS-LADVYSSPPK---NNLIGI----ARGILYLHDECESQIIH 561
+V E + G L + + P+ LI + A G+ YL + IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR----GYVAPEWHWNLPIT 617
D+ +N L+ E KISDF +++ + D TG G + + APE +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTG--GMKQIPVKWTAPEALNYGRYS 174
Query: 618 AKADVYSFGVVLLE 631
+++DV+SFG++L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRL----- 507
+G GS+G V+ + K VAVK++ + + EIK I R H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 508 ---------LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLH 552
+G ++++ +V EYM LA+V P + + + RG+ Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIH 131
Query: 553 DECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPD--------QTRTFTGIRGTR 603
+ ++H D+KP N+ ++ E+ KI DF LA+++ P + R R
Sbjct: 132 ---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF--DQNLPEDQVILE 651
++P + T D+++ G + E++ + F L + Q+ILE
Sbjct: 189 LLLSPNNY-----TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYV 606
G+ ++H++ +++H DIK +NI + +N K+ DF A+L+ T + GT YV
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 607 APEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN 642
PE N+P K+D++S G +L E+ + F N
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 35/189 (18%)
Query: 473 VAVKRLQ-----KMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527
VAVK L+ K LA+ E + +K IG+ H+N++ LLG ++ EY + G
Sbjct: 47 VAVKMLKDNATDKDLADLISEMEL-MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKG 103
Query: 528 SLADVYSS--PPKNNLI---------------------GIARGILYLHDECESQIIHCDI 564
+L + + PP + +ARG+ YL + IH D+
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL 160
Query: 565 KPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+N+L+ E+ KI+DF LA+ + D + + R ++APE ++ T ++DV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 624 SFGVVLLEI 632
SFG+++ EI
Sbjct: 221 SFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 453 EIGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGEREFQTEIKAIG---RTHHRNLVR 506
IGRG+ G VYK N GK A+K+ + + Q+ + I H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 507 LLGYSFDVSNKI--LVYEY--------MSNGSLADVYSSPP---KNNLIGIARGILYLHD 553
L+ + ++K L+++Y + A S PP K+ L I G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125
Query: 554 ECESQIIHCDIKPQNILM----DENRYAKISDFALAKL 587
+ ++H D+KP NIL+ E KI D LA+L
Sbjct: 126 --SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 35/189 (18%)
Query: 473 VAVKRLQ-----KMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527
VAVK L+ K L++ E + +K IG+ H+N++ LLG ++ EY S G
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEM-MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 528 SLADVYSS--PPK-----------------NNLIG----IARGILYLHDECESQIIHCDI 564
+L + + PP +L+ +ARG+ YL + + IH D+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDL 160
Query: 565 KPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+N+L+ E+ KI+DF LA+ + D + T R ++APE ++ T ++DV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 624 SFGVVLLEI 632
SFGV+L EI
Sbjct: 221 SFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG+GS G V KF AVK LQK + + E+ +E + + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 510 YSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHDE 554
+SF ++K+ V +Y++ G L A Y++ IA + YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------IASALGYLH-- 113
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPD-QTRTFTGIRGTRGYVAPEWHW 612
I++ D+KP+NIL+D + ++DF L K ++ + T TF GT Y+APE
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---GTPEYLAPEVLH 169
Query: 613 NLPITAKADVYSFGVVLLEII 633
P D + G VL E++
Sbjct: 170 KQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 453 EIGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
E+G G+ G VYK G A K ++ E ++ EI+ + +H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 512 FDVSNKILVYEYMSNGSL------ADVYSSPPKNNLI--GIARGILYLHDECESQIIHCD 563
+ ++ E+ G++ D + P+ +I + + YLH +IIH D
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 564 IKPQNILMDENRYAKISDFAL-AKLMKPDQTR-TFTGIRGTRGYVAP-----EWHWNLPI 616
+K N+L+ + K++DF + AK +K Q R +F GT ++AP E + P
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMKDTPY 192
Query: 617 TAKADVYSFGVVLLEI 632
KAD++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQK--MLAEGEREFQTEIKA----IGRTHHRNLVR 506
IGRG+ G V + G A+K+L+K ML E+E ++A + + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML---EKEQVAHVRAERDILAEADNPWVVK 65
Query: 507 LLGYSF-DVSNKILVYEYMSNGSLA------DVYSSPPKNNLIGIARGILYLHDECESQI 559
L YSF D + L+ EY+ G + D ++ + IA IL + +
Sbjct: 66 LY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE--EETRFYIAETILAIDSIHKLGY 122
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596
IH DIKP N+L+D + K+SDF L +K F
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE-REFQTEIKAIGRTHH-RNLVRLL 508
EE+GRG+ G V K + G +AVKR++ + E + ++ R+ V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL-----------IGIARGILYLHDECES 557
G F + + E M SL Y L + I + + YLH +
Sbjct: 67 GALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-- 123
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-------- 609
+IH D+KP N+L++ N K+ DF ++ + +T G + Y+APE
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPYMAPERINPELNQ 181
Query: 610 WHWNLPITAKADVYSFGVVLLEI 632
+++ K+DV+S G+ ++E+
Sbjct: 182 KGYDV----KSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 35/175 (20%)
Query: 439 SYAELEKMTDGFKEEIGRGSSGTVYKG-TMINGKFVAVK--RLQKMLAEGE-----REFQ 490
+Y +L+K+ G GS TVYKG + + G+ VA+K RL+ EG RE
Sbjct: 6 TYKKLDKL--------GEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREAS 55
Query: 491 TEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK----NN----LI 542
+K + H N+V L LV+EY+ L +N L
Sbjct: 56 L-LKDL---KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 543 GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597
+ RG+ Y H +++H D+KPQN+L+ E K++DF LA+ K ++T++
Sbjct: 111 QLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYS 161
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 9/165 (5%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
IGRG+ G V M N G+ A+K L K ML E E + + R + L Y
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 511 SF-DVSNKILVYEYMSNGSLADVYSS-----PPKNNLIGIARGILYLHDECESQIIHCDI 564
+F D +N LV +Y G L + S P +A +L + + +H DI
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
KP N+L+D+N + +++DF + D T GT Y++PE
Sbjct: 129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 20/194 (10%)
Query: 454 IGRGSSGTVYKGTM-INGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + GK A K+L+K + GE E + + + + R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSS-----PPKNNLIGIAR---GILYLHDECESQI 559
Y+++ + + LV M+ G L +Y+ + + A G+ LH E +I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
++ D+KP+NIL+D+ + +ISD LA + + T G GT GY+APE N T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 620 ADVYSFGVVLLEII 633
D + G ++ E+I
Sbjct: 182 PDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAI-GRTHHRNLVRLLG 509
E IG+G+ G VYK T +G AVK L +++ + E + E + +H N+V+ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 510 YSFDVSNKI-----LVYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHD 553
+ + LV E + GS+ ++ L G G+ +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP----- 608
++IIH D+K NIL+ K+ DF ++ + + R T + GT ++AP
Sbjct: 147 ---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202
Query: 609 EWHWNLPITAKADVYSFGVVLLEI 632
E ++ A+ DV+S G+ +E+
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 42/232 (18%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G+GS G V + +G+ AVK L+K +L + + E TE + + + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 510 YSFDVSNKIL-VYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHDE 554
F +++ V E+++ G L A Y++ I +++LHD+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHDK 115
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHW 612
II+ D+K N+L+D + K++DF + K + T TF GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GTPDYIAPEILQ 169
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFD--------QNLPEDQVILEEWVYQ 656
+ D ++ GV+L E++C F+ + + D+V+ W+ Q
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 453 EIGRGSSGTV-YKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGY 510
+IG GS+G V +G+ VAVK + + + RE I R + H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK- 85
Query: 511 SFDVSNKILV-YEYMSNGSLADVYSSPPKN--NLIGIARGIL----YLHDECESQIIHCD 563
S+ V ++ V E++ G+L D+ S N + + +L YLH + +IH D
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRD 142
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK +IL+ + K+SDF + D + + GT ++APE P + D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 624 SFGVVLLEII 633
S G++++E++
Sbjct: 202 SLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQ--KMLAEGERE---FQTEIKAIGRTHHRNLVRL 507
+G+G+ G VY ++ G+ +A K++Q E +E + EI+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 508 LGYSFDVSNKILV--YEYMSNGSLAD-------VYSSPPKNNLIGIARGILYLHDECESQ 558
G D + K L EYM GS+ D + S + I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NM 126
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIR---GTRGYVAPEWHWN 613
I+H DIK NIL D K+ DF +K + QT + TGIR GT +++PE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 614 LPITAKADVYSFGVVLLEII 633
KADV+S G ++E++
Sbjct: 184 EGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE---GEREFQTEIKA------IGRTHH 501
++ +G+GS GTVY + + K VA +RL K+L E GE ++A + + H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERL-KVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-----------LIGIARGILY 550
+V+ + ++ EY L I + G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM--KPDQTRTFTGIRGTRGYVAP 608
+H + +I+H D+K +NI + N KI DF +++L+ D TFTG T Y++P
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSP 174
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCF 639
E + +K+D++S G +L E+ C F
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 452 EEIGRGSSGTVYKG---TMINGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRL 507
+EIG G G V G + V VK L+ + + + +F E + H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG------------IARGILYLHDEC 555
LG +V+ +LV E+ G L S K L+ IA G+L+LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKL-------MKPDQTRTFTGIRGTRGYVAP 608
++ IH D+ +N L+ + KI D+ L+ + PDQ + +R ++AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLR----WIAP 171
Query: 609 EW----HWNLPI---TAKADVYSFGVVLLEI 632
E H NL + T +++V+S GV + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 36/208 (17%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V + G+ VA+K+L + + +R ++ E+ + +H+N++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 510 YSF-------DVSNKILVYEYMSNGSLADVYSSPPKNN-----LIGIARGILYLHDECES 557
F + + LV E M + +L V + L + GI +LH +
Sbjct: 83 -VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---A 137
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAK------LMKPDQTRTFTGIRGTRGYVAPEWH 611
IIH D+KP NI++ + KI DF LA+ +M P TR Y APE
Sbjct: 138 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--------TRYYRAPEVI 189
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCF 639
+ D++S G ++ E+I F
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 59/232 (25%), Positives = 92/232 (39%), Gaps = 62/232 (26%)
Query: 452 EEIGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNL 504
+ +G+G G V+ KGT GK A+K L K + + TE + + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL-IGIAR--------GILYLHDE 554
L SF + LV +Y G L + P L +AR + YLH
Sbjct: 64 PTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKL--------------------MKPDQTR 594
I++ D+KP+NIL+ E+ + +SDF L+K + +
Sbjct: 121 LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 595 TF---TGIR-----GTRGYVAPE-----WHWNLPITAKADVYSFGVVLLEII 633
TF R GT Y+APE H + D ++ G++L E++
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGH-----GSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQ--KMLAEGERE---FQTEIKAIGRTHHRNLVRL 507
+G+G+ G VY + G+ +AVK++Q E +E + EI+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 508 LGYSFDVSNKIL--VYEYMSNGSLAD---VYSSPPKNNLIGIAR----GILYLHDECESQ 558
G D + L E+M GS+ D Y + +N R G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNM 126
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVAPEWHWN 613
I+H DIK NIL D K+ DF +K + QT +G + GT +++PE
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 614 LPITAKADVYSFGVVLLEII 633
KAD++S G ++E++
Sbjct: 184 EGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 27/113 (23%), Positives = 43/113 (38%), Gaps = 23/113 (20%)
Query: 16 NGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEK---------NVGRI-VLRSTEQ 65
+ + +S ++ GF++ S Y + G G L
Sbjct: 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSD 64
Query: 66 GQDSIIADDSQSA------------SSASMLDSGSFVLYDSDGKVIWQTFDHP 106
G + +I D S + +LD G+ VLYDSDG +WQ+FD+P
Sbjct: 65 G-NLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQ---KMLAEGEREFQTEIKAIGRTHHRNLVR 506
+++IGRG VY+ T +++G VA+K++Q M A+ + EI + + +H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIARGIL-YLHDECES------- 557
SF N++ +V E G L+ + K + + + Y C +
Sbjct: 67 YYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+++H DIKP N+ + K+ D L + T + + GT Y++PE
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYN 184
Query: 618 AKADVYSFGVVLLEIICCRRCF 639
K+D++S G +L E+ + F
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 454 IGRGSSGTVYKGTMINGKF---VAVKRLQ-KMLAEGERE-FQTEIKAIGRTHHRNLVRLL 508
+G G G+V +G + VAVK ++ + E E F +E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 509 GYSFDVSNK------ILVYEYMSNGSLAD--VYS----SP---PKNNLI----GIARGIL 549
G +++ +M +G L +YS P P L+ IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRGYVAP 608
YL + IH D+ +N +++EN ++DF L+ K+ D R + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 609 EWHWNLPITAKADVYSFGVVLLEI 632
E + T K+DV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 454 IGRGSSGTVYKGTM-INGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLG 509
+G+G G V + GK A KRL+K + GE E + + + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 510 YSFDVSNKI-LVYEYMSNGSLA-DVYSSPPKNNLIGIARGILY-------LHDECESQII 560
Y+++ + + LV M+ G L +Y+ N R + Y L D +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
+ D+KP+NIL+D+ + +ISD LA +K + + G GT GY+APE N T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSP 182
Query: 621 DVYSFGVVLLEII 633
D + G ++ E+I
Sbjct: 183 DYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 26/197 (13%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVR 506
+G+GS G V+ KGT +F A+K L+K +L + + E E + + +
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 507 LLGYSFDV-SNKILVYEYMSNGSLADVYSSPPKNNL-------IGIARGILYLHDECESQ 558
L +F N V EY++ G L S K +L I G+ +LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
I++ D+K NIL+D + + KI+DF + K ++ +T TF GT Y+APE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPEILLGQKY 173
Query: 617 TAKADVYSFGVVLLEII 633
D +SFGV+L E++
Sbjct: 174 NTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF---QTEIKAIGRT--HHRNLVRL 507
IGRGS V + + A+K ++K L + + QTE K + T +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTE-KHVFETASNHPFLVGL 61
Query: 508 LGYSFDVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHD 553
S V E++S G L A YS+ I+ + +LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLALNFLH- 113
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWH 611
E II+ D+K N+L+D + K++D+ + K + D T TF GT Y+APE
Sbjct: 114 --ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEIL 168
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFD----QNLPED-------QVILEE 652
D ++ GV++ E++ R FD + P+ QVILE+
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 457 GSSGTVYKGTMINGKFVAVKR-LQKMLAEGEREFQ-----TEIKAIGRTHHRNLVRLLGY 510
G+ G ++ G +I+ K + K + + E Q E + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 511 SFDVSNKILV-YEYMSNGSLADVYSSP---PKNNL------------IGIARGILYLHDE 554
+ V Y YM+ G+L NN I IA G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR--GYVAPEWHW 612
+ +IH DI +N ++DE KI+D AL++ + P G R ++A E
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-GDNENRPVKWMALESLV 192
Query: 613 NLPITAKADVYSFGVVLLEII 633
N ++ +DV+SFGV+L E++
Sbjct: 193 NKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 49/214 (22%)
Query: 454 IGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGEREFQTEIKA---------IGRTHH 501
+G G+ G+V + I+ G+ VA+K+L R FQ+EI A + H
Sbjct: 23 VGSGAYGSVC--SAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 502 RNLVRLL-----GYSFD-VSNKILVYEYMSNGSLADVYSSPPKNNLIG-----IARGILY 550
N++ LL S D + LV YM L + P + + + G+ Y
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE- 609
+H + IIH D+KP N+ ++E+ KI DF LA+ + TG TR Y APE
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 185
Query: 610 ---W-HWNLPITAKADVYSFGVVLLEIICCRRCF 639
W H+N + D++S G ++ E++ + F
Sbjct: 186 ILNWMHYNQTV----DIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 33/202 (16%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRL-- 507
IGRG+ G V + VA+K++ + +R + EIK + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 508 -----LGYSF-DVSNKILVYEYM---------SNGSLADVYSSPPKNNLIGIARGILYLH 552
+F DV +VYE M S+ +L+D + + L + RG+ Y+H
Sbjct: 72 IMPPPHREAFNDV---YIVYELMDTDLHQIIRSSQTLSDDHC---QYFLYQLLRGLKYIH 125
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
+ ++H D+KP N+L++ N KI DF LA+ ++ T TR Y APE
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 613 NLP-ITAKADVYSFGVVLLEII 633
N T DV+S G + E++
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 454 IGRGSSGTVYKGTM-----INGKFVAVKRLQ-KMLAEGE-REFQTEIKAIGRTHHRNLVR 506
+G G G+V +G + K VAVK ++ + E EF +E + H N+++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 507 LLGYSFDVSNK------ILVYEYMSNGSL---------ADVYSSPPKNNLI----GIARG 547
L+G F+ S+ +++ +M +G L + P L+ IA G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRGYV 606
+ YL + IH D+ +N ++ E+ ++DF L+ K+ D R + ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 607 APEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666
A E + T+K+DV++FGV + EI + P V E +Y +GN +L
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQT-----PYPGVENHE-IYDYLRHGN--RL 234
Query: 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709
+ ED + + M C +P RP+ K+ +LE +
Sbjct: 235 KQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRG 601
+ARG+ +L + IH D+ +NIL+ EN KI DF LA+ PD R + R
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-RL 238
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++APE ++ T ++DV+SFGV+L EI
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 447 TDGFKEEIGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRT 499
F +G+GS G V KGT + A+K L+K + + + + E + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 500 HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGI 544
+ L F +++ V EY++ G L A Y++ I
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE-------I 110
Query: 545 ARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGT 602
+ G+ +LH II+ D+K N+++D + KI+DF + K ++ TRTF GT
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GT 164
Query: 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
Y+APE P D +++GV+L E++ + FD
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 53/222 (23%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQ---KMLAEGEREFQTEIKAIGR-THHRNLV 505
+++G+G+ G V+K + VA+K++ + + +R F+ EI + H N+V
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIV 70
Query: 506 RLLGYSFDV---SNKI---LVYEYMSNGSLADVYSSPPKNNLIGI---------ARGILY 550
+LL +V N LV+EYM D+++ N L + + + Y
Sbjct: 71 KLL----NVIKAENDKDIYLVFEYME----TDLHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG------ 604
+H +IH D+KP NIL++ + K++DF LA R+ + +
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA--------RSLSELEENPENPVLTD 171
Query: 605 YVAPEWHWNLPITAKADVYSFGV-------VLLEIICCRRCF 639
YVA W+ I + Y+ GV +L E++ + F
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 48/165 (29%), Positives = 67/165 (40%), Gaps = 16/165 (9%)
Query: 485 GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG-----SLADVYSSPPKN 539
G + EI + HR ++ L+ +++ K V M + D P
Sbjct: 129 GGKTPGREIDILKTISHRAIINLI-HAY--RWKSTVCMVMPKYKCDLFTYVDRSGPLPLE 185
Query: 540 NLIGIARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTR 594
I I R +L YLH IIH D+K +NI +DE A + DF A KL T
Sbjct: 186 QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF 639
G GT +PE P AK D++S G+VL E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 34/202 (16%)
Query: 451 KEEIGRGSSGTV----YKGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRN 503
E +G GS G V +KGT G++ A+K L+K ++ Q E + H
Sbjct: 23 GETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK--NNLIGI--ARGIL---YLHDECE 556
+V ++ D + + E++ G L + N++ A +L YLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---S 136
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
II+ D+KP+N+L+D + K++DF AK + PD RTFT + GT Y+APE I
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PD--RTFT-LCGTPEYLAPE-----VI 187
Query: 617 TAKA-----DVYSFGVVLLEII 633
+K D ++ GV+L E I
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 26/182 (14%)
Query: 470 GKFVAVKRLQKMLAEGE-REFQTEIKAIGRTHHRNLVRLLGY-SFDVSNKI-LVYEYMSN 526
G+ VAVK L+ + + EI+ + +H N+V+ G + D N I L+ E++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 527 GSLADVYSSPPKN----NL-------IGIARGILYLHDECESQIIHCDIKPQNILMDENR 575
GSL + P+N NL + I +G+ YL Q +H D+ +N+L++
Sbjct: 93 GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 576 YAKISDFALAKLMKPDQTRTFTGIRGTRG----YVAPEWHWNLPITAKADVYSFGVVLLE 631
KI DF L K ++ D + + ++ + APE +DV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 632 II 633
++
Sbjct: 205 LL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 19/63 (30%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 210 MKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPG 269
+ + S+G +++ Q+ W + W + ++CD G CG +C +N +P C C+ G
Sbjct: 49 LTLSSEGSLERFTWIPNSQD--WNLFWSAPKDQCDVYGRCGPYGYCDVNT-SPKCNCIKG 105
Query: 270 FVP 272
FVP
Sbjct: 106 FVP 108
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 34/207 (16%)
Query: 452 EEIGRGSSGTVYK-GTMINGKFVAVKRLQKMLAEGEREFQTE---IKAIGRTHHRNLVRL 507
E IG+G+ G V+K NG AVK L + + + E + E +KA+ + H N+V+
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKAL--SDHPNVVKF 80
Query: 508 LG--YSFDVSNK---ILVYEYMSNGSLADVYSSPPK-----NNLIGIA-------RGILY 550
G Y DV N LV E + GS+ D+ K I IA G+ +
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-IAYILHEALMGLQH 139
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP-- 608
LH ++ IH D+K NIL+ K+ DF ++ + + R T + GT ++AP
Sbjct: 140 LH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 195
Query: 609 ---EWHWNLPITAKADVYSFGVVLLEI 632
E + A+ DV+S G+ +E+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-08
Identities = 21/111 (18%), Positives = 45/111 (40%), Gaps = 22/111 (19%)
Query: 16 NGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGI------------PEKNVGRIVLRST 63
+ + +S + ++ GF+ + Y + P + + L+S
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSD 63
Query: 64 ------EQGQDSIIADDSQSASS---ASMLDSGSFVLYDSDGKVIWQTFDH 105
+ + + ++ A+ +LD G+ V+YDSDG +WQ+FD+
Sbjct: 64 GNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMK-PDQTRTFTGIRG 601
+ARG+ +L + IH D+ +NIL+ EN KI DF LA+ + K PD R R
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 237
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++APE ++ T ++DV+SFGV+L EI
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTE--IKAIGRTHHRNLVRL 507
IGRG G VY + GK A+K L K + +GE E + ++ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLA------DVYSSPPKNNLIGIARGILYLHDECESQII 560
+ Y+F +K+ + + M+ G L V+S K IL L ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE--KEMRFYATEIILGLEHMHNRFVV 119
Query: 561 HCDIKPQNILMDENRYAKISDFALA---KLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPI 616
+ D+KP NIL+DE+ + +ISD LA KP + GT GY+APE
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHGYMAPEVLQKGTAY 173
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQ 647
+ AD +S G +L +++ F Q+ +D+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL--MKPDQTRTFTGIRG 601
A + L + + +I+ D+KP+NIL+D + + DF L KL D+T TF G
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---G 155
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF-DQNLPE 645
T Y+APE T D ++ GV+L E++ F D+N+ E
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 9/165 (5%)
Query: 454 IGRGSSGTVYKGTMINGKFV-AVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
IGRG+ G V M + + + A+K L K ML E E + + + L Y
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSS-----PPKNNLIGIARGILYLHDECESQIIHCDI 564
+F N + LV +Y G L + S P IA +L +H + +H DI
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
KP N+L+D N + +++DF M D T + GT Y++PE
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 452 EEIGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNL 504
++G+G G V+ K T G+ VA+KR++K L E + TE + T L
Sbjct: 7 TQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 505 VRLLGYSF-DVSNKILVYEYM----------SNGSLADVYSSPPKNNLIGIARGILYLHD 553
V+LL Y+F D L EY+ + G L++ ++ + + + + LH
Sbjct: 64 VKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA---RFYMAEMFEAVDALH- 118
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT-GIRGTRGYVAPEWHW 612
E IH D+KP+N L+D + + K++DF L+K T+ + G+ Y+APE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLR 171
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPED 646
D +S G +L E +C F + P +
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 16/195 (8%)
Query: 454 IGRGSSGTVYKGTMING-KFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
IGRG+ G V + N K A+K L K ML E E + + + L Y
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 511 SF-DVSNKILVYEYMSNGSLADVYSS-----PPKNNLIGIARGILYLHDECESQIIHCDI 564
+F D +N LV +Y G L + S P +A ++ + + +H DI
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDI 128
Query: 565 KPQNILMDENRYAKISDF-ALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP-----ITA 618
KP NILMD N + +++DF + KLM+ ++ + GT Y++PE +
Sbjct: 129 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGKGKYGP 187
Query: 619 KADVYSFGVVLLEII 633
+ D +S GV + E++
Sbjct: 188 ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF---QTEIKAIGRTHHRNLVRLLG 509
IGRGS V + N + A+K ++K L + + QTE + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 510 YSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHDE 554
F ++++ LV EY++ G L A Y++ I + +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE-------ICIALNFLH-- 113
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHW 612
E II+ D+K N+L+D + + K++D+ + K L D T TF GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILR 169
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656
D ++ GV++ E++ R FD + E++++Q
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 454 IGRGSSGTVYKG--TMINGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+G G+ G+V T + K VAVK+L + L R ++ E++ + H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG---------------IARGILYLHD 553
DV E + L NN++ + RG+ Y+H
Sbjct: 81 ----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH- 135
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE---- 609
+ IIH D+KP N+ ++E+ +I DF LA+ + TG TR Y APE
Sbjct: 136 --SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLN 189
Query: 610 W-HWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
W H+N + D++S G ++ E++ + F N DQ+
Sbjct: 190 WMHYNQTV----DIWSVGCIMAELLKGKALFPGNDYIDQL 225
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 51/187 (27%)
Query: 454 IGRGSSGTVYKGTMI----NGKFVAVKRLQKML----------AEGEREFQTEIKAIGRT 499
+G+G G V++ + GK A+K L+K + ER +K
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK----- 58
Query: 500 HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGI 544
H +V L+ Y+F K+ L+ EY+S G L A Y L I
Sbjct: 59 -HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY-------LSEI 109
Query: 545 ARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGT 602
+ + +LH + II+ D+KP+NIL+D + K++DF L K + + T TF GT
Sbjct: 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GT 163
Query: 603 RGYVAPE 609
Y+APE
Sbjct: 164 IEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRG 601
+A+G+ +L + IH D+ +NIL+ EN KI DF LA+ PD R R
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RL 243
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++APE ++ T ++DV+SFGV+L EI
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 26/200 (13%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRL--QKMLAEGERE---FQTEIKAIGRTHHRNLVRL 507
+GRG+ G VY + G+ +AVK++ E +E + EI+ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 508 LGYSFDVSNKIL--VYEYMSNGSLAD---VYSSPPKN----NLIGIARGILYLHDECESQ 558
G D K L EYM GS+ D Y + +N I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NM 126
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVAPEWHWN 613
I+H DIK NIL D K+ DF +K + QT +G + GT +++PE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 614 LPITAKADVYSFGVVLLEII 633
KADV+S ++E++
Sbjct: 184 EGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
IGRG+ G V +K T K A+K L K M+ + F E + I + V
Sbjct: 51 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 508 LGYSF-DVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIARGILYLHDECESQIIHCD 563
L Y+F D +V EYM G L ++ Y P K A +L L IH D
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 564 IKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRGYVAPE 609
+KP N+L+D++ + K++DF K+ K R T + GT Y++PE
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 12/108 (11%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT-FTGIRGT 602
+ +G+ Y+H + IIH D+KP N+ ++E+ KI DF LA+ QT + TG T
Sbjct: 127 MLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178
Query: 603 RGYVAPE--WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648
R Y APE +W + T D++S G ++ E++ + F + DQ+
Sbjct: 179 RWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTE--IKAIGRTHHRNLVRL 507
IGRG G VY + GK A+K L K + +GE E + ++ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLA------DVYSSPPKNNLIGIARGILYLHDECESQII 560
+ Y+F +K+ + + M+ G L V+S A IL L ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--AEMRFYAAEIILGLEHMHNRFVV 119
Query: 561 HCDIKPQNILMDENRYAKISDFALA---KLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPI 616
+ D+KP NIL+DE+ + +ISD LA KP + GT GY+APE +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHGYMAPEVLQKGVAY 173
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQ 647
+ AD +S G +L +++ F Q+ +D+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 50/216 (23%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREF--QTEIKAIG----RTHHRNL 504
E+IG G+ G VYK N GK VA+K K E + E T ++ I + +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 505 VRLLGYSFDVSNKI---------LVYEYMSNG--SLADVYSSPP---------KNNLIGI 544
VRLL DV + LV+EY+ + D P K+ + +
Sbjct: 64 VRLL----DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 545 ARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMK-PDQTRTFTGIRGT 602
+G+ + H + ++H D+KPQN+L+D+ + KI+D L + P ++ T + T
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--T 174
Query: 603 RGYVAPE-----WHWNLPITAKADVYSFGVVLLEII 633
Y APE H++ P+ D++S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
IGRG+ G V +K + + A+K L K M+ + F E + I + +
Sbjct: 51 IGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 508 LGYSF-DVSNKILVYEYMSNGSLADVYSS---PPKNNLIGIARGILYLHDECESQIIHCD 563
L Y+F D +V EYM G L ++ S+ P K A +L L IH D
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGIRGTRGYVAPEWHWNLPITA---- 618
+KP N+L+D++ + K++DF M + R T + GT Y++PE +
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR 226
Query: 619 KADVYSFGVVLLEII 633
+ D +S GV L E++
Sbjct: 227 ECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKM-------LAEGEREFQTEIKAIGRTHHR 502
+G G+ G V+ G GK A+K L+K AE R + ++A+ R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF- 66
Query: 503 NLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL----IGIARGILYLHDECES 557
LV L Y+F K+ L+ +Y++ G L + IA +L L +
Sbjct: 67 -LVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
II+ DIK +NIL+D + ++DF L+K ++ GT Y+APE
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR 603
I G+ YLH + +IIH D+K +NI +++ I D A+ P F G+ GT
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEII 633
APE +KAD++S G+VL E++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 454 IGRGSSGTVYKGTMING----KFVAVKRLQKML----AEGEREFQTEIKAIGRTHHRNLV 505
+G G+ G V+ ++G K A+K L+K A+ +TE + + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPP--KNNLIGIARG--ILYLHDECESQII 560
L Y+F K+ L+ +Y++ G L S K + I G +L L + II
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA-- 618
+ DIK +NIL+D N + ++DF L+K D+ GT Y+AP+ I
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD------IVRGG 181
Query: 619 -----KA-DVYSFGVVLLEII 633
KA D +S GV++ E++
Sbjct: 182 DGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD--QTRTFTGIRG 601
IA G+ +LH + II+ D+K N+++D + KI+DF + K D T+TF G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---G 163
Query: 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
T Y+APE P D ++FGV+L E++ + F+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 48/220 (21%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQ----KMLAEGERE--------FQT--EIKAIGR 498
+G G+ G V K + GK VA+K+++ +R+ F T E+K +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 499 THHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYS-------SPPKNNLIGIARGILYL 551
H N++ L+ + LV + M+ L V S K L+ I G+ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALA-------------KLMKPDQTRTFTG 598
H + +H D+ P NI ++ KI+DF LA K + T
Sbjct: 136 H---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 599 IRGTRGYVAPEWHWNLPITAKA-----DVYSFGVVLLEII 633
T Y APE L + A+ D++S G + E++
Sbjct: 193 KVVTLWYRAPE----LLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 72/293 (24%), Positives = 109/293 (37%), Gaps = 80/293 (27%)
Query: 452 EEIGRGSSGTVYKGTMIN-------GKFVAVKRLQKMLAEGER---EFQTEIKAIGRTHH 501
E +G+G+ +YKG + G V + K+L R F + + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN---------LIGIARGILYLH 552
++LV+L G N I+V EY+ G L DV+ KNN +A + YL
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTRGY------ 605
D+ +++H ++ +NIL+ RY + KL P T +R
Sbjct: 119 DK---KLVHGNVCGKNILV--ARYGLNEGYVPFIKLSDPGIPITV----LSREERVERIP 169
Query: 606 -VAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLP-------------EDQVI 649
+APE N +T AD +SFG LLEI C + P +DQ
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI-----CSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
L + L LI C +P+ RPS + +L
Sbjct: 225 LPM-----PDCAELANLINQ-----------------CWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 34/201 (16%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G+GS G V + G++ AVK L+K +L + + E E + + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 510 YSFDVSNKIL-VYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHDE 554
+F + V E+++ G L A Y++ I G+ +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE-------IVCGLQFLHSK 115
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHW 612
II+ D+K N+++D + + KI+DF + K + ++ TF G T Y+APE
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG---TPDYIAPEILQ 169
Query: 613 NLPITAKADVYSFGVVLLEII 633
L T D +SFGV+L E++
Sbjct: 170 GLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGT 602
+A+G+ +L IH D+ +NIL+ R KI DF LA+ ++ D G R
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++APE +N T ++DV+S+G++L EI
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 51/284 (17%)
Query: 454 IGRGSSGTVYKG--TMINGKF--VAVKRLQKMLAEGE--REFQTEIKAIGRTHHRNLVRL 507
+G+G G+V + +G F VAVK L+ + EF E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 508 LGYSFDVSNK------ILVYEYMSNGSL------ADVYSSP---PKNNL----IGIARGI 548
+G S K +++ +M +G L + + P P L I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRGYVA 607
YL + IH D+ +N +++EN ++DF L+ K+ D R + ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL-GQL 666
E + T +DV++FGV + EI + + Y EN + L
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEI---------------MTRGQTPYAGVENSEIYNYL 228
Query: 667 IEDEDVDKKQ----LERMIKVALWCILDEPSLRPSMKKVLLMLE 706
I+ + KQ LE + ++ C EP RPS + + LE
Sbjct: 229 IKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 15/195 (7%)
Query: 451 KEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLV 505
IG G G VY+G ++ + VAVK + + RE F E + + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECES-------Q 558
+L+G + I V E G L Y K +L +A ILY + + +
Sbjct: 71 KLIGVITENPVWI-VMELAPLGELRS-YLQVNKYSL-DLASLILYSYQLSTALAYLESKR 127
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
+H DI +N+L+ K+ DF L++ ++ + + + ++APE T+
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 619 KADVYSFGVVLLEII 633
+DV+ FGV + EI+
Sbjct: 188 ASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE---FQTEIKAIGRTHHRNL 504
+G+GS G V KGT +F A+K L+K +L + + E + + A+ H L
Sbjct: 3 LGKGSFGKVMLAELKGT---NEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFL 58
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL-------IGIARGILYLHDECES 557
L + V EY++ G L S + + I G+ +LH +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
II+ D+K N+L+D++ + KI+DF + K + + TF GT Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC---GTPDYIAPEILKGQK 172
Query: 616 ITAKADVYSFGVVLLEII 633
D +SFGV+L E++
Sbjct: 173 YNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
IGRG+ G V +K + K A+K L K M+ + F E + I + V
Sbjct: 51 IGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 508 LGYSF-DVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIARGILYLHDECESQIIHCD 563
L +F D +V EYM G L ++ Y P K A +L L +IH D
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQT---RTFTGIRGTRGYVAPE 609
+KP N+L+D++ + K++DF MK D+T R T + GT Y++PE
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRL 507
E IG+GS G V G+ VA+K++ + +++ R + EIK + H ++V +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEI 64
Query: 508 LGYSFDVSNK-----ILVYEYMSNGSLADVYSSPPKNN----------LIGIARGILYLH 552
S + +V+E M +D++ N+ L + R + Y+H
Sbjct: 65 KHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTF-TGIRGTRGYVAPEW 610
+ + H D+KP+NIL + + KI DF LA++ D T F T TR Y APE
Sbjct: 121 ---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 611 HWNL--PITAKADVYSFGVVLLEIICCRRCF 639
+ T D++S G + E++ + F
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 442 ELEKMTDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEG--EREFQTEI 493
E+ T F EE+G G VYKG + + VA+K L K AEG EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEA 59
Query: 494 KAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSS-------- 535
R H N+V LLG +++ Y S+ L +DV S+
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 536 ---PPK--NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590
P + + IA G+ +L ++H D+ +N+L+ + KISD L + +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 591 DQTRTFTG-----IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
G IR +++PE + +D++S+GVVL E+
Sbjct: 177 ADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 454 IGRGSSGTVYKGTMING----KFVAVKRLQKML----AEGEREFQTEIKAIGRTHHRNLV 505
+G G+ G V+ + G K A+K LQK A+ +TE + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSL------ADVYSSPPKNNLIG-IARGILYLHDECES 557
L Y+F K+ L+ +Y+S G + D +S G I + +LH +
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KL 124
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
I++ DIK +NIL+D + ++DF L+K + ++ RT++ GT Y+APE
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGG 183
Query: 617 TAKA-DVYSFGVVLLEII 633
KA D +S G+++ E++
Sbjct: 184 HGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 16/146 (10%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQK--MLAEG-EREFQTEIKAIGRTHHRNLVRLLG 509
I RG+ G VY G N K AVK ++K M+ + + Q E A+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 510 YSFDVSNKI-LVYEYMSNG---SLADVY---SSPPKNNLIG-IARGILYLHDECESQIIH 561
YS +N + LV EY+ G SL +Y I +A + YLH IIH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 562 CDIKPQNILMDENRYAKISDFALAKL 587
D+KP N+L+ + K++DF L+K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 47/234 (20%)
Query: 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF---QTEIKAIGRTHHRNLVRLLG 509
IGRGS V + + A+K ++K L + + QTE + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 510 YSFDVSNKIL-VYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLHDE 554
F +++ V EY++ G L A YS+ I+ + YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISLALNYLH-- 113
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPEWHW 612
E II+ D+K N+L+D + K++D+ + K L D T TF GT Y+APE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILR 169
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCF---------DQNLPED---QVILEEWV 654
D ++ GV++ E++ R F DQN ED QVILE+ +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-TEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 44/219 (20%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE---FQTEIKAIGRTHHRNL 504
+G+GS G V KGT + A+K L+K +L + + + + I A+ H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PF 57
Query: 505 VRLLGYSFDVSNKIL-VYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
+ L F +++ V EY++ G L + Y++ + ++
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE-------VTLALM 110
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVA 607
+LH +I+ D+K NIL+D + K++DF + K ++ T TF GT Y+A
Sbjct: 111 FLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIA 164
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED 646
PE L D ++ GV++ E++ + F+ + +D
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 18/60 (30%), Positives = 30/60 (50%), Gaps = 7/60 (11%)
Query: 132 STGKFRLKMQNDGNLIQY-PKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTG 190
+ + L +Q+DGNL+ Y W+S T GKG L ++G+L L +++G
Sbjct: 15 TDSSYTLILQSDGNLVLYDGNGRV------VWSSNTSGKGSGCVAVLQDDGNLVLYDNSG 68
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 44/207 (21%), Positives = 75/207 (36%), Gaps = 34/207 (16%)
Query: 453 EIGRGSSG----TVYKGTMINGKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
IG+ + K VAVK+ L E + Q EI + H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 507 LLGYSFDVSNKI-LVYEYMSNGS----LADVYSSPPKNNLI-----GIARGILYLHDECE 556
+ SF V +++ +V M+ GS L + I + + Y+H +
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK-- 120
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLM-KPDQTRTF-----TGIRGTRGYVAPE- 609
IH +K +IL+ + +S + M K + + +++PE
Sbjct: 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 610 WHWNLP-ITAKADVYSFGVVLLEIICC 635
NL K+D+YS G I C
Sbjct: 180 LQQNLQGYNEKSDIYSVG-----ITAC 201
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 32/201 (15%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V I + VA+K+L + +R ++ E+ + +H+N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 510 Y-----SFDVSNKILVYEYMSNGSLADVYSSPPKNN-----LIGIARGILYLHDECESQI 559
S + + + + + +L V + L + GI +LH + I
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGI 147
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK------LMKPDQTRTFTGIRGTRGYVAPEWHWN 613
IH D+KP NI++ + KI DF LA+ +M P TR Y APE
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--------TRYYRAPEVILG 199
Query: 614 LPITAKADVYSFGVVLLEIIC 634
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 52/243 (21%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQKMLAEGER---EFQTEIKAIGRTHHRNLVRLLG 509
IG+G G VY + + VA+K++++ L+E F E K H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67
Query: 510 YSFDVSNKILVY---EYMSNGSLADVYSSP------PKNNLIG------------IARGI 548
YS S+ VY Y+ +L + S K I I
Sbjct: 68 YSI-CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDF--ALAKLMKPDQ-------------- 592
Y+H + ++H D+KP NIL+ I D+ A+ K ++ +
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 593 TRTFTG-IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC----RRCFDQNLPEDQ 647
+ T G I GT Y+APE +P + D+Y+ GV+L +++ RR + +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD 243
Query: 648 VIL 650
VIL
Sbjct: 244 VIL 246
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 1/74 (1%)
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPITA 618
IH D+ +N+L+ + R AKI DF LA+ + D G R ++APE ++ T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 619 KADVYSFGVVLLEI 632
++DV+S+G++L EI
Sbjct: 294 QSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V + G VAVK+L + +R ++ E+ + +H+N++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 510 YSF------DVSNKILVYEYMSNGSLADVYSSPPKNN-----LIGIARGILYLHDECESQ 558
+ + LV E M + +L V + L + GI +LH +
Sbjct: 88 VFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 143
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
IIH D+KP NI++ + KI DF LA+ + T + TR Y APE +
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKE 201
Query: 619 KADVYSFGVVLLEII 633
D++S G ++ E++
Sbjct: 202 NVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-----RTFTG 598
+ARG+ +L +H D+ +N+L+ + + KI DF LA+ + D TF
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658
++ ++APE ++ T +DV+S+G++L EI P +I++ Y
Sbjct: 303 VK----WMAPESIFDNLYTTLSDVWSYGILLWEIFSL-----GGTPYPGMIVDSTFYNKI 353
Query: 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS 697
++G ++ + + ++ + M+K C EP RPS
Sbjct: 354 KSGY--RMAKPDHATQEVYDIMVK----CWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 19/109 (17%)
Query: 134 GKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVS-LNLDENGHLFLLNSTGFN 192
G F L MQND NLI Y ++ W + D + L L +G+L L + G
Sbjct: 20 GFFTLIMQNDYNLILYKSSS----RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRV 75
Query: 193 I--RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWEST 239
+ N T Y++ + DG +Y S LW+S
Sbjct: 76 VWSSNTTGANGN-----YVLVLLDDGNLVIYD-------SDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 31/93 (33%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR 603
+ R I YLH E++IIH DIK +NI ++ + DF A + G GT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEIICCR 636
APE P D++S G+VL E+ C
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-----RTFTG 598
+A G+ +L +H D+ +N+L+ E + KI DF LA+ + D TF
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632
++ ++APE +N T +DV+SFG++L EI
Sbjct: 305 LK----WMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 14/59 (23%), Positives = 28/59 (47%), Gaps = 2/59 (3%)
Query: 308 SYSVLSKTTEQNCQEACLKDCNCEAALYKDEE--CKMQRLPLRFGRRKLSDSDIAFIKV 364
+ S ++ + + C+EACL +C+C A Y + C + L R S ++++
Sbjct: 25 NASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 30/153 (19%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKM-----LAEGEREFQTEIKAIGRTHHRNL-- 504
+ I RG+ +Y G + K V R+ K L E R +T R R +
Sbjct: 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERT------RREARIMSR 55
Query: 505 VRLLG------YSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIAR--GILY--LHDE 554
R G Y D N I+V EY+ L D+ +S + ++R G L LH
Sbjct: 56 ARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-MEELELSREIGRLVGKLH-- 112
Query: 555 CESQIIHCDIKPQNILMDENR-YAKISDFALAK 586
+ IIH D+ N+++ + Y + DF LA+
Sbjct: 113 -SAGIIHGDLTTSNMILSGGKIY--LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 518 ILVYEYMSNGSLADVYSSPPKNNL--IGIARGILYLH-----DECESQ-IIHCDIKPQNI 569
+L+ EY S G L K +L G+L+ DE S+ ++H D+K NI
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANI 200
Query: 570 LMDENRYAKISDFALAKL----MKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSF 625
+ K+ DF +K + D +F G T Y+APE + KAD++S
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG---TPYYLAPELWERKRYSKKADMWSL 257
Query: 626 GVVLLEIICCRRCFDQNLPEDQVILEEWVY 655
GV+L E++ R F P + I+++ +Y
Sbjct: 258 GVILYELLTLHRPFKG--PSQREIMQQVLY 285
|
Length = 478 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
IG GS G VY+ I+ + VA+K K+L + + + E+ + +H N++ L Y +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQYK-NRELLIMKNLNHINIIFLKDYYY 129
Query: 513 DVS----------NKIL------VYEYMSNGS---------LADVYSSPPKNNLIGIARG 547
N ++ V++YM + + L +YS + R
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------LCRA 182
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYV 606
+ Y+H + I H D+KPQN+L+D N + K+ DF AK + Q R+ + I +R Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CSRFYR 237
Query: 607 APEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649
APE T D++S G ++ E+I F DQ++
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 22/195 (11%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V + + VA+K+L + +R ++ E+ + +H+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 510 YSF------DVSNKILVYEYMSNGSLADVYSSPPKNN-----LIGIARGILYLHDECESQ 558
+ + LV E M + +L V + L + GI +LH +
Sbjct: 84 VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 139
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
IIH D+KP NI++ + KI DF LA+ + T TR Y APE +
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 619 KADVYSFGVVLLEII 633
D++S G ++ E++
Sbjct: 198 NVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 27/161 (16%)
Query: 519 LVYEYMSNGSLADVYSS----PPKNNLIGIARGIL---YLHDECESQIIHCDIKPQNILM 571
+V EY+ G A + + P + A +L YLH+ I+H D+KP N+L+
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLI 134
Query: 572 DENRYAKISDFALAK--LMK----------PDQTRTFTG--IRGTRGYVAPEWHWNLPIT 617
+ K++DF L+K LM TR F + GT Y+APE
Sbjct: 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG 194
Query: 618 AKADVYSFGVVLLEIICCRRCFDQNLPED---QVILEEWVY 655
D ++ G++L E + F + PE+ QVI ++ +
Sbjct: 195 KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 544 IARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT-G 598
+AR +L Y+H E IIH DIK +N+L++ + DF A + + F G
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLE 631
I GT APE P T D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 476 KRLQKMLAEGER---EFQTEIKAIGRTHHRNLV------RLLGYSFDVSNKIL--VYEYM 524
+ + K + G R + + EI A+GR +H N++ R ++ ++ K +Y +M
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
Query: 525 SNGSLADVYSSPPKNNLIGIARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKIS 580
+ + D P I + +L Y+HD+ ++IH DIK +NI ++ + +
Sbjct: 254 YDEAF-DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309
Query: 581 DFALA-KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
DF A K + + G GT +PE D++S G++LL+++
Sbjct: 310 DFGTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 452 EEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLAEGEREFQTEI----KAIGRTHHRN 503
E +G+G+ ++KG G+ + L K+L + R + + + H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL-----IGIARGILY-LHDECES 557
LV G I+V EY+ GSL D Y KN + + +A+ + + LH +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG--IRGTR-GYVAPEW---- 610
+ H ++ +N+L+ K + KL P + T I R +V PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 611 -HWNLPITAKADVYSFGVVLLEIIC 634
+ +L AD +SFG L EI
Sbjct: 180 QNLSLA----ADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG-EREFQTEIKAIGRTHHRNLVRLLGYS 511
++GRG+ G VYK +GK L+++ G EI + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 512 FDVSNK--ILVYEYM---------------SNGSLADVYSSPPKNNLIGIARGILYLHDE 554
S++ L+++Y +N + S K+ L I GI YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 555 CESQIIHCDIKPQNILM----DENRYAKISDFALAKL----MKPDQTRTFTGIRGTRGYV 606
+ ++H D+KP NIL+ E KI+D A+L +KP + T Y
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWYR 182
Query: 607 APEWHWNLPITAKA-DVYSFGVVLLEIICCRRCF 639
APE KA D+++ G + E++ F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 66/247 (26%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAE-------GEREFQTEIKAIGRTH 500
IGRG+ G V K T G A+K L+K ML + ER+ E ++
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW--- 62
Query: 501 HRNLVRLLGYSF-DVSNKILVYEYMSNGSLADVYSSPPKNNLIG------IARGILYLHD 553
+V++ YSF D N L+ E++ G + + K+ L IA +L +
Sbjct: 63 ---VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDS 116
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIR------------ 600
+ IH DIKP N+L+D + K+SDF L L K +T + +
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 601 ---------------------GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF 639
GT Y+APE D +S GV++ E++ F
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 640 DQNLPED 646
P++
Sbjct: 237 CSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 64/246 (26%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNL--- 504
IGRG+ G V K T G A+K L+K ML E+E I+A R++
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKILRKADML---EKEQVAHIRA-----ERDILVE 57
Query: 505 -----VRLLGYSF-DVSNKILVYEYMSNGSLADVY----SSPPKNNLIGIARGILYLHDE 554
V + YSF D N L+ E++ G + + + + IA +L +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMK--------------PDQTRTFTGIR 600
+ IH DIKP N+L+D + K+SDF L +K P +F +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 601 --------------------GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
GT Y+APE D +S GV++ E++ F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 641 QNLPED 646
P++
Sbjct: 238 SETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 23/188 (12%)
Query: 462 VYKGTMINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRLLGYSFDVSNK- 517
+YKG + N K V ++ +K + + EIK + R N++++ G+ D+ +
Sbjct: 36 IYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 518 ---ILVYEYMSNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQIIHCDIKPQ 567
L+ EY + G L +V + I +G+ L+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 568 NILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL--PITAKADVYSF 625
+ L+ EN KI L K++ + F + Y + + ++ T K D+YS
Sbjct: 153 SFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 626 GVVLLEII 633
GVVL EI
Sbjct: 209 GVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|220357 pfam09716, ETRAMP, Malarial early transcribed membrane protein (ETRAMP) | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 381 KKAQRKDIVIISCLFVALIILILATFGIFIYRYR 414
KK + K +IIS + L +LI G+ Y+ +
Sbjct: 46 KKKKNKKKIIISSIASGLALLIGTALGLGYYKKK 79
|
These sequences represent a family of proteins from the malaria parasite Plasmodium falciparum, several of which have been shown to be expressed specifically in the ring stage as well as the rodent parasite Plasmodium yoelii. A homologue from Plasmodium chabaudi was localized to the parasitophorous vacuole membrane. Members have an initial hydrophobic, Phe/Tyr-rich, stretch long enough to span the membrane, a highly charged region rich in Lys, a second putative transmembrane region and a second highly charged, low complexity sequence region. Some members have up to 100 residues of additional C-terminal sequence. These genes have been shown to be found in the sub-telomeric regions of both Plasmodium falciparum and P. yoelii chromosomes. Length = 82 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 41/147 (27%), Positives = 62/147 (42%), Gaps = 23/147 (15%)
Query: 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKM-----LAEGEREFQT--EIKAIGRTHHRNLV 505
I +G+ +Y G + K V +R+ K L E R +T E + + R
Sbjct: 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSR------A 54
Query: 506 RLLG------YSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQI 559
R G Y D NK +V EY+ L DV L I R + LH ++ I
Sbjct: 55 RKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGNDELLREIGRLVGKLH---KAGI 111
Query: 560 IHCDIKPQNILMDENRYAKISDFALAK 586
+H D+ NI++ +++ I DF L K
Sbjct: 112 VHGDLTTSNIIVRDDKLYLI-DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 61/243 (25%), Positives = 90/243 (37%), Gaps = 74/243 (30%)
Query: 454 IGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+G G+ G VYK +++N +K+ + G E + R N
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY---GAVEIWMNERV--RRACPNSCADF 194
Query: 509 GYSF--DVSNK-----ILVYEYMSNGSLADVYSS------------------PP----KN 539
Y F VS+K LV+ Y +LAD+ S P +N
Sbjct: 195 VYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLEREN 254
Query: 540 NLIG-IARGILY----LHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAK------- 586
+I I R IL+ LH + I+H D+KPQNI+ E + KI D A
Sbjct: 255 KIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN 311
Query: 587 ------LMKPDQTRTFTGIRGTRGYVAPE-----------WHWNLPITAKADVYSFGVVL 629
L+ P I T+ AP W NLP + D+YS G++
Sbjct: 312 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP--DRFDIYSAGLIF 369
Query: 630 LEI 632
L++
Sbjct: 370 LQM 372
|
Length = 566 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.71 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.71 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.36 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.05 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.81 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.78 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.33 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.08 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.98 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.05 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.03 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 96.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.59 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.9 | |
| PLN02236 | 344 | choline kinase | 95.82 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.05 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.26 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-53 Score=445.60 Aligned_cols=277 Identities=45% Similarity=0.749 Sum_probs=242.1
Q ss_pred cccccCHHHHHHhhcccc--cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEE
Q 041285 434 ALLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511 (724)
Q Consensus 434 ~~~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 511 (724)
....|++.||.+||++|+ +.||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 467799999999999999 589999999999999999999999998764333156799999999999999999999999
Q ss_pred eccc-ceEEEEeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 512 FDVS-NKILVYEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 512 ~~~~-~~~lv~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
.+.+ +++||||||++|+|.++|... .| +++.++|+||+|||+.+.+.|+|||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999999998543 45 3489999999999999988999999999999999999999999
Q ss_pred ccCccccCC-CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 582 FALAKLMKP-DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 582 fgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
||+++.... ....... ..||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....+..|+...+.+
T Consensus 221 FGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976554 2221111 17999999999999999999999999999999999999988876555555689999999999
Q ss_pred CCccccccccc---c-CH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 661 GNLGQLIEDED---V-DK-KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 661 ~~~~~~~~~~~---~-~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
+.+.+++|+.. . .. +++.++.+++.+|++.+|.+||+|.||+++|+.....
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999873 2 32 6889999999999999999999999999999765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=369.81 Aligned_cols=244 Identities=34% Similarity=0.498 Sum_probs=196.9
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccch--hHHHHHHHHHhhcccCcCceeeeeeEEeccc-ceEEEEeeccCC
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE--GEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-NKILVYEYMSNG 527 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~~~g 527 (724)
.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3559999999999999965555999999764322 2568999999999999999999999999988 799999999999
Q ss_pred ChhhhcCCC-----Cc----chHHHHHHHcccccccCCCc-eEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCccee
Q 041285 528 SLADVYSSP-----PK----NNLIGIARGILYLHDECESQ-IIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 528 sL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~-i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|.+++... .+ .++.+||+||.|||+. + ||||||||+|||++.+. ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999552 11 2278999999999998 6 99999999999999997 99999999998654322 233
Q ss_pred eccccCccccCccccc--CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 597 TGIRGTRGYVAPEWHW--NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
+...||+.|||||++. ...++.|+|||||||+||||+||+.||..... .+ .+......+.-..+ ..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-----~~~~v~~~~~Rp~~------p~ 269 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-----VASAVVVGGLRPPI------PK 269 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-----HHHHHHhcCCCCCC------Cc
Confidence 4468999999999999 56999999999999999999999999986543 11 11222222221111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.....+..++..||+.||++||++.+++.+|+....
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 245568888999999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=366.50 Aligned_cols=253 Identities=29% Similarity=0.416 Sum_probs=207.6
Q ss_pred HHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
++......+.++||+|-||+||.|.+.....||||.++.. ....+.|.+|+++|.+|+|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3444444566889999999999999987779999999874 456678999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCCcc---------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 522 EYMSNGSLADVYSSPPKN---------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~~~---------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|||++|+|.++|...... .+.|||+||+||+++ ++|||||.++|||++++..+||+|||||+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999999762221 178999999999998 99999999999999999999999999999776666
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHHcC-Ccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENG-NLGQLIEDE 670 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~ 670 (724)
........-+..|.|||.+..+.|+.|||||||||+||||+|- +.|+.... ..+ +.+.+..| ++..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~e-v~~~le~GyRlp~----- 425 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEE-VLELLERGYRLPR----- 425 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHH-HHHHHhccCcCCC-----
Confidence 6566666778999999999999999999999999999999994 44443322 112 22333333 2221
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
+...+..+.+|+..||+.+|++|||++.+...|+......
T Consensus 426 --P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 426 --PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred --CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 2234556888999999999999999999999998765443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=373.81 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=205.0
Q ss_pred cccccccCcCccceEEEEEeeC------CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
-.|.++||+|+||.||+|+... ...||||.|++.... ...+|++|+++++.++|||||+|+|.|.+++.+++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 3466889999999999998643 458999999986655 667999999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCC-----------CC----c------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 521 YEYMSNGSLADVYSS-----------PP----K------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~-----------~~----~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
+|||..|+|.+||.. .+ . .++.|||.||.||-+. .+|||||.++|+|+.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999931 11 1 1278999999999988 9999999999999999999999
Q ss_pred ccccCccccCCCCcceee-ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHH
Q 041285 580 SDFALAKLMKPDQTRTFT-GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQC 657 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 657 (724)
+||||++..-..+..... +..-+.+||+||.+..++|+.+||||||||+|||+++ |+.|+.+-..++ +-+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~ 717 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIEC 717 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHH
Confidence 999999876544443333 3445789999999999999999999999999999998 666766543322 4466
Q ss_pred HHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 658 FENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
+..|++.. . +...+..+..|+..||+.+|++||+++||-..|+.....
T Consensus 718 i~~g~lL~---~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 IRAGQLLS---C---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHcCCccc---C---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 77776622 1 223455699999999999999999999999999865443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=336.00 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=199.5
Q ss_pred ccCHHHHHHhhcccccccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecc
Q 041285 437 SFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV 514 (724)
Q Consensus 437 ~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 514 (724)
.++..||+.. ..||+|..|+|||+.++ .++.+|+|.+... ...-.+++.+|++++.+.+||+||+++|.|...
T Consensus 75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 3556666654 57999999999999885 5789999999543 234457899999999999999999999999988
Q ss_pred c-ceEEEEeeccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 515 S-NKILVYEYMSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 515 ~-~~~lv~e~~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
. ...++||||++|||++++.. .+.. ++.+|++||.|||+. .+|+||||||+|||++..|.+||+|||.+.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 59999999999999999874 2222 278999999999964 399999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.+-.. .....+||..|||||-+.+..|+.++||||||+.++|+.+|+.|+....+.. ....+. ...+..+..+.+
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~L-l~~Iv~~ppP~l 302 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFEL-LCAIVDEPPPRL 302 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHH-HHHHhcCCCCCC
Confidence 76543 3345789999999999999999999999999999999999999987642111 111111 122333322222
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
-+ .....++..++..||+.||.+||++.|+++
T Consensus 303 P~-----~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 303 PE-----GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred Cc-----ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 135667999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.91 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=195.6
Q ss_pred HhhcccccccCcCccceEEEEEee-CCcEEEEEEcccccch-------hHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-------GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
...+-+.+.||+|+||.|-+|.-. +++.||||.+++.... ......+|+++|++|+|||||++.+++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345556789999999999999764 5899999999752111 12345799999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcCC-------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCcc
Q 041285 517 KILVYEYMSNGSLADVYSS-------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAK 586 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~-------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~ 586 (724)
.|+|+|||++|.|.+++-. ..+..+.|++.|+.|||+. +|+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999998732 1223378999999999999 99999999999999765 679999999999
Q ss_pred ccCCCCcceeeccccCccccCcccccCCC---CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
..+ ....+....||+.|.|||++.+.. +..|.|+||+||+||-+++|..||........ ..+.+..|+.
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~G~y 399 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILKGRY 399 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhcCcc
Confidence 875 334455678999999999998765 33588999999999999999999986543221 2234444433
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..- .....+..++..+++.+||..||++|||+.|+++
T Consensus 400 ~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 AFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 221 1233455677899999999999999999999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.52 Aligned_cols=189 Identities=34% Similarity=0.498 Sum_probs=164.6
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.++||+|+|++||+|++.+ +.+||||.+... .....+-+..|+.+|+.++|||||++++++..++..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 45679999999999999864 789999998764 344556688999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC---cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC------CCeEEccccCccccCCCCc
Q 041285 527 GSLADVYSSPP---KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDEN------RYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 527 gsL~~~l~~~~---~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~------~~~kl~Dfgl~~~~~~~~~ 593 (724)
|+|.+|++... .. .+.|||.||++||++ +|+||||||+||||... -.+||+|||+|+.+....
T Consensus 94 GDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~- 169 (429)
T KOG0595|consen 94 GDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS- 169 (429)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh-
Confidence 99999996542 22 278999999999999 99999999999999764 568999999999876332
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL 643 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~ 643 (724)
......|++-|||||++...+|+.|+|+||+|++|||+++|+.||....
T Consensus 170 -~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 170 -MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred -HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2234679999999999999999999999999999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.70 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=209.9
Q ss_pred cccCHHHHHHhhccc-----------ccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhccc
Q 041285 436 LSFSYAELEKMTDGF-----------KEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRT 499 (724)
Q Consensus 436 ~~~~~~el~~~t~~f-----------~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l 499 (724)
..++|++.-+|...| .+.||.|.||.|++|.++- ...||||.|+... +...++|+.|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 347777766665554 3569999999999999853 3589999998754 34456899999999999
Q ss_pred CcCceeeeeeEEecccceEEEEeeccCCChhhhcCCCCcch--------HHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 500 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
+||||++|.|........++|+|||+||+|+.||+....+. +.+||.||+||.+. ++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheee
Confidence 99999999999999999999999999999999998765443 67899999999988 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCccee--eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchh
Q 041285 572 DENRYAKISDFALAKLMKPDQTRTF--TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQV 648 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~ 648 (724)
+.+..+||+||||++.+.++..... ....-+.+|.|||.+..++++.++|||||||+|||.++ |.+|+-.....+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-- 842 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 842 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--
Confidence 9999999999999998765543222 22345789999999999999999999999999999987 778876543322
Q ss_pred cHHHHHHHHHHcC-CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 649 ILEEWVYQCFENG-NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 649 ~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+.+.+++| +++. +.+.+..|.+|+++|||.|..+||.+.+|+.+|++..
T Consensus 843 -----VIkaIe~gyRLPp-------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 -----VIKAIEQGYRLPP-------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -----HHHHHHhccCCCC-------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 22233322 3333 3345678999999999999999999999999987643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=344.69 Aligned_cols=239 Identities=26% Similarity=0.372 Sum_probs=197.1
Q ss_pred hcccccccCcCccceEEEEEe-eCCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
++.-.+.||+|||+.||.++. ..|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.+..|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 344457899999999999998 67999999999762 23445678999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+|++++|..++++.. ...+.||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+..+....
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999999986311 12278999999999998 99999999999999999999999999999887554433
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....|||.|+|||++.....+..+||||+||+||.||.|++||+.....+ ....++..+- ..+..
T Consensus 176 -~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y-------~~P~~ 240 (592)
T KOG0575|consen 176 -KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY-------SMPSH 240 (592)
T ss_pred -ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc-------ccccc
Confidence 34689999999999999999999999999999999999999998653211 1122221111 11223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++..+|+.+|.+|||+++|+.
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4455778888999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.57 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=197.8
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccc--ccchhHHHHHHHHHhhcccCcCceeeeee-EEecccc-eEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLG-YSFDVSN-KILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lv~e 522 (724)
+.+.++||+|.||+|||+.. .+|..||.|.++- ......+....|+.+|++|+|||||++++ .+.+..+ +++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 34557899999999999964 6899999998873 23444567899999999999999999999 4555555 899999
Q ss_pred eccCCChhhhcC-----------CCCcchHHHHHHHcccccccCCC-ceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 523 YMSNGSLADVYS-----------SPPKNNLIGIARGILYLHDECES-QIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 523 ~~~~gsL~~~l~-----------~~~~~~~~~ia~~l~yLH~~~~~-~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
|+..|+|...++ ...|+.+.|+++||..+|..... -|.||||||.||+|+.+|.+||+|||+++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999998873 23455689999999999984322 388999999999999999999999999999876
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
..+.. ...+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||.+.. +.. ..+.+..++...+
T Consensus 181 ~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-L~~KI~qgd~~~~---- 248 (375)
T KOG0591|consen 181 KTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-LCKKIEQGDYPPL---- 248 (375)
T ss_pred hhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-HHHHHHcCCCCCC----
Confidence 54432 34689999999999999999999999999999999999999998651 111 2345555544322
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+...+..+..|+..|+..||+.||+...++.-+..
T Consensus 249 -p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 -PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 224567789999999999999999996555555443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=355.43 Aligned_cols=248 Identities=28% Similarity=0.467 Sum_probs=197.8
Q ss_pred HhhcccccccCcCccceEEEEEeeC--Cc----EEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccce
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMIN--GK----FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 517 (724)
...-.+.+.||+|+||.||.|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|.|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3344456789999999999999864 33 4999999875 345567899999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcCCC------Ccc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 518 ILVYEYMSNGSLADVYSSP------PKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~------~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
++++|||++|+|..||+.. ... .+.+||+|+.||+++ ++|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999654 111 168999999999998 99999999999999999999999999
Q ss_pred CccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccc-cCCCCCCCcchhcHHHHHHH-HHHc
Q 041285 584 LAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCR-RCFDQNLPEDQVILEEWVYQ-CFEN 660 (724)
Q Consensus 584 l~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~-~p~~~~~~~~~~~l~~~~~~-~~~~ 660 (724)
||+.+.+.+. .......-+..|||||.+..+.|+.|+|||||||+|||++|.. .|+......+ +.. ....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhC
Confidence 9995543333 2222234578999999999999999999999999999999954 5554332211 222 2334
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
|++ ++.. .....+.+++..||+.+|++||++..+++.++.+.
T Consensus 921 gRL----~~P~---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 921 GRL----DPPS---YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred Ccc----CCCC---CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 433 3222 23456889999999999999999999999887654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.26 Aligned_cols=257 Identities=27% Similarity=0.355 Sum_probs=204.0
Q ss_pred HHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchh-HHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG-EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
|.-...-.|.++||+|-||.|.+.....+..||||.++...... .++|.+|+++|.+++|||||+|+|.|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 33334445778999999999999999878999999998755443 47999999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCCC--c-------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 521 YEYMSNGSLADVYSSPP--K-------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~--~-------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+|||++|+|..|+..+. . .++.|||.||+||.+- ++|||||.++|+|++.++++||+|||+++.+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999995431 1 2378999999999988 9999999999999999999999999999966444
Q ss_pred Cc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc--cccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 592 QT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC--CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 592 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
+. ..-...+-+.+|||||.+..++++.++|||+||+.|||+++ ..+|+.....+. ..+-.......+.....+.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceecc
Confidence 43 33344667899999999999999999999999999999954 566765432211 1122222222222222222
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.. .-....+.++++.||..+-++||+++++..-|+.
T Consensus 768 ~P---~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 768 RP---PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CC---CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 22 2233457799999999999999999999998865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.58 Aligned_cols=230 Identities=26% Similarity=0.324 Sum_probs=186.2
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||+++..+ ++.+|+|.+++. .....+..++|..+|.+++||.||+++-.+++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 44789999999999998765 789999999763 23345678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSPP---KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~~---~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
||.|.-+|.+.. .. .+.+|+.||.|||+. +|+||||||+|||||++|.++|+||||++........ ...
T Consensus 109 GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~-t~t 184 (357)
T KOG0598|consen 109 GGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA-TRT 184 (357)
T ss_pred CccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc-ccc
Confidence 999999996432 12 278999999999998 9999999999999999999999999999865433222 223
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..||+.|||||++.+..++..+|.||+|+++|||++|.+||..... ..+. +.+..+.+ ..+. .-...
T Consensus 185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~-~~I~~~k~---~~~p---~~ls~ 251 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMY-DKILKGKL---PLPP---GYLSE 251 (357)
T ss_pred ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHH-HHHhcCcC---CCCC---ccCCH
Confidence 7899999999999999999999999999999999999999986432 1222 22333321 1111 11233
Q ss_pred HHHHHHHHcccCCCCCCC
Q 041285 679 RMIKVALWCILDEPSLRP 696 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RP 696 (724)
...+++...++.+|++|.
T Consensus 252 ~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHHHHhccCHHHhc
Confidence 467788888999999996
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.78 Aligned_cols=250 Identities=29% Similarity=0.359 Sum_probs=196.6
Q ss_pred hcccccccCcCccceEEEEEeeCC----cE-EEEEEccc---ccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMING----KF-VAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
.-.+.++||+|+||.||+|.+..+ .. ||||..+. .......+|++|+++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 334458899999999999998642 23 89999884 33566789999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCCcc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 519 LVYEYMSNGSLADVYSSPPKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+|||+|+||+|.++|...... .+.+.|+||+|||++ +++||||.++|+|+..+..+||+||||++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999999765432 178999999999998 999999999999999999999999999875431
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHH-HcCCcccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCF-ENGNLGQLIE 668 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~ 668 (724)
..... ....-+..|+|||.+....++.++|||||||++||+++ |..|+...... . +...+ .++ .....
T Consensus 315 ~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~-v~~kI~~~~-~r~~~- 384 (474)
T KOG0194|consen 315 YVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E-VKAKIVKNG-YRMPI- 384 (474)
T ss_pred eeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H-HHHHHHhcC-ccCCC-
Confidence 11111 11245789999999999999999999999999999998 67777653321 1 22223 222 11111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPI 713 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 713 (724)
+......+..++..||..+|++||+|.++.+.|+.+.....
T Consensus 385 ----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 ----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11334557777889999999999999999999987554433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.13 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=194.7
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.+.||+|.||+||+|.+.. .||||.++-. ..+..+.|++|+..+++-+|.||+-+.|+|..... .+|+.+|+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 3456789999999999999843 6999999753 34456789999999999999999999999999877 99999999
Q ss_pred CCChhhhcCCCCcc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC-ccee
Q 041285 526 NGSLADVYSSPPKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~~~ 596 (724)
+.+|..+++....+ ++.|||+||.|||.+ +|||||||..||+|.+++++||+||||+..-..-. ....
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 99999999754432 378999999999998 99999999999999999999999999986432211 1111
Q ss_pred eccccCccccCcccccCC---CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 597 TGIRGTRGYVAPEWHWNL---PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
..-.|...|||||+++.. +|+..+||||||+++|||++|..|+. ....++.++ .+..|.+ +.|.....
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif------mVGrG~l--~pd~s~~~ 618 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF------MVGRGYL--MPDLSKIR 618 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE------Eeccccc--Cccchhhh
Confidence 123478899999998754 68999999999999999999999998 333332221 1112211 11222223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
......+.+|+..||..++++||.+.+|+.+|+....
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 3455678888899999999999999999998876554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=319.25 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=192.3
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhc--ccCcCceeeeeeEEeccc----ceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIG--RTHHRNLVRLLGYSFDVS----NKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~~~~----~~~lv~e~ 523 (724)
+.+.||+|+||.||||.+ +++.||||++.. +..+.|.+|-++.+ .++|+||+++++.-.... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 457899999999999999 459999999974 44556788766665 458999999999876555 88999999
Q ss_pred ccCCChhhhcCCCCcch------HHHHHHHcccccccC------CCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 524 MSNGSLADVYSSPPKNN------LIGIARGILYLHDEC------ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~~------~~~ia~~l~yLH~~~------~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
.++|+|.++|....... +..+++||+|||+.. ++.|+|||||.+|||+.+|+++.|+|||+|..+...
T Consensus 290 h~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 290 HPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred ccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 99999999997654332 678999999999764 568999999999999999999999999999988754
Q ss_pred Ccce-eeccccCccccCcccccCCC-CC-----cccceeehhHHHHHhhccccCCC-CCCCcchhc----------HHHH
Q 041285 592 QTRT-FTGIRGTRGYVAPEWHWNLP-IT-----AKADVYSFGVVLLEIICCRRCFD-QNLPEDQVI----------LEEW 653 (724)
Q Consensus 592 ~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~k~Dv~S~Gvll~elltg~~p~~-~~~~~~~~~----------l~~~ 653 (724)
.... ....+||.+|||||++.+.. +. .+.||||+|.|||||+++-.... ...++-+.. +.+.
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 4322 23478999999999987653 22 37899999999999999765543 222221211 2221
Q ss_pred HHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
...+...+....+.........+..+.+.+..||..||+-|.|+.=|-+.+....-+.
T Consensus 450 -q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 450 -QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred -HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1122111111111111222356778999999999999999999988888776544433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.88 Aligned_cols=242 Identities=28% Similarity=0.432 Sum_probs=190.3
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc--ceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--NKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~~~~ 526 (724)
..+.||+|.||+||++...+ |+..|||.+........+.+.+|+++|.+++|||||+++|.....+ .++++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 45789999999999999865 8999999887643333567899999999999999999999855555 58999999999
Q ss_pred CChhhhcCCCC----cch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCC--CCcce
Q 041285 527 GSLADVYSSPP----KNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKP--DQTRT 595 (724)
Q Consensus 527 gsL~~~l~~~~----~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~--~~~~~ 595 (724)
|+|.+++.... ... ..||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~ 177 (313)
T KOG0198|consen 101 GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS 177 (313)
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence 99999996543 211 67999999999988 9999999999999999 79999999999987763 22222
Q ss_pred eeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....||+.|||||++..+ ....++|||||||++.||+||+.|+... .....+..........+ ..+.
T Consensus 178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P------~ip~ 246 (313)
T KOG0198|consen 178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP------EIPD 246 (313)
T ss_pred cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC------CCCc
Confidence 3347899999999999864 3445999999999999999999998753 11112222222222222 1222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
.......+++..|++.+|++|||+.++++..
T Consensus 247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 3455688899999999999999999998765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.94 Aligned_cols=239 Identities=29% Similarity=0.488 Sum_probs=192.3
Q ss_pred cCHHHHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccce
Q 041285 438 FSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 438 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 517 (724)
+.++++.+. +=||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.+.|+|....-+
T Consensus 121 iPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 121 IPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred CCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 344555443 3599999999999999 56899999987532 3568889999999999999999999999
Q ss_pred EEEEeeccCCChhhhcCCCCc-------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 518 ILVYEYMSNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
++|||||+.|-|..+|+.... .+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999965332 2267999999999998 999999999999999999999999999987653
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
. .....+.||..|||||+++..+.++|+|||||||||||||||..|+........ ++ .+....+. +
T Consensus 265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------Iw-GVGsNsL~-L---- 330 (904)
T KOG4721|consen 265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IW-GVGSNSLH-L---- 330 (904)
T ss_pred h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EE-eccCCccc-c----
Confidence 3 334457899999999999999999999999999999999999999864321100 00 01111111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.++....+-+.-|+++||+..|..||++++++.-|+
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 123344556777888899999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.90 Aligned_cols=266 Identities=26% Similarity=0.353 Sum_probs=203.6
Q ss_pred cccCcCccceEEEEEe-eCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTM-INGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~~~ 526 (724)
++||+|.||.||+++. .+|+.||+|+++... ........+||.+|++|+||||++|.+...+. ...|||+|||++
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 5799999999999976 468999999987543 33445677999999999999999999998876 689999999976
Q ss_pred CChhhhcCCCCcc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSPPKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|..++.....+ .+.|++.||.|||.. +|+|||||.+|||||.+|.+||+|||||+++........+.
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~ 278 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTS 278 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCccccc
Confidence 677777553222 278999999999998 99999999999999999999999999999988777777777
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH-----HHHHHcCCccc--ccccc
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV-----YQCFENGNLGQ--LIEDE 670 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~-----~~~~~~~~~~~--~~~~~ 670 (724)
.+-|.-|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.+....++......+ ...|....+.. .+.+.
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~ 358 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ 358 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence 8889999999999876 5999999999999999999999999876544433221110 01111111221 11111
Q ss_pred -c-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCcc
Q 041285 671 -D-------VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLLT 722 (724)
Q Consensus 671 -~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p~~~~~ 722 (724)
. .-.......++|+..+|..||++|.|+.++++. +-....+.|..|..|.+
T Consensus 359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s-eyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS-EYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC-cccccCCCCCCcccCCC
Confidence 0 011123557888888999999999999998753 22345566666666543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.62 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=190.9
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEeccc-ceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVS-NKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~~ 518 (724)
..+.++||+|+||.||++... .++.||||++..... ...+.+.+|+.++.++ +||||++++++|.... ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 445688999999999999742 346899999875322 3345789999999999 8999999999987654 578
Q ss_pred EEEeeccCCChhhhcCCCC-------------------------------------------------------------
Q 041285 519 LVYEYMSNGSLADVYSSPP------------------------------------------------------------- 537 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 537 (724)
+||||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999998874311
Q ss_pred --------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-eeeccccCccccCc
Q 041285 538 --------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAP 608 (724)
Q Consensus 538 --------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aP 608 (724)
...+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 01256999999999998 9999999999999999999999999999865433221 11223467889999
Q ss_pred ccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHc
Q 041285 609 EWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWC 687 (724)
Q Consensus 609 E~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 687 (724)
|.+.+..++.++||||||+++|||++ |..||........ .......+..... + ......+.+++.+|
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~--~----~~~~~~l~~li~~c 313 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMRA--P----ENATPEIYRIMLAC 313 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCCC--C----CCCCHHHHHHHHHH
Confidence 99999999999999999999999997 8888865432211 1222333322111 1 12234688999999
Q ss_pred ccCCCCCCCCHHHHHHHhccCC
Q 041285 688 ILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 688 l~~~p~~RPs~~evl~~L~~~~ 709 (724)
|+.+|++||++.|++++|+.+.
T Consensus 314 l~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 314 WQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.56 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=194.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
++||+|+.|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||+++..+...+++++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 57999999999999754 57899999997654455566889999999999999999999999999999999999999999
Q ss_pred hhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 531 DVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 531 ~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+.+..... .+..++++||+|||.+ +|+|||||.+||||+.++.+||+|||++..+..... .....+||+.
T Consensus 359 DvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPY 434 (550)
T KOG0578|consen 359 DVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPY 434 (550)
T ss_pred hhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCC
Confidence 99865422 2256899999999999 999999999999999999999999999987765544 3345789999
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|||||++....|..|.||||||++++||+-|.+||-...+... .+....+| ...+-.+ ......+.+++
T Consensus 435 WMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng-~P~lk~~----~klS~~~kdFL 503 (550)
T KOG0578|consen 435 WMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TPKLKNP----EKLSPELKDFL 503 (550)
T ss_pred ccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcC-CCCcCCc----cccCHHHHHHH
Confidence 9999999999999999999999999999999999865332211 11111222 2222222 22345688999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~ 703 (724)
.+||+.|+++||++.|+|+
T Consensus 504 ~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcchhcCCCHHHHhc
Confidence 9999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=297.46 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=190.6
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccc-h-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA-E-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
-++|+|+||.|||.+.++ |+.||||++....+ . -.+-.++|+++|++++|+|||.|+..|.....++||+||++..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 469999999999999865 89999999865322 2 23457899999999999999999999999999999999998876
Q ss_pred hhhhcCC-------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 529 LADVYSS-------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 529 L~~~l~~-------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
|.++-+. ...+.+.|+++|+.|+|++ +++||||||+|||++.++.+||+|||+|+.+.. .....+..+.
T Consensus 88 L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVA 163 (396)
T KOG0593|consen 88 LHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVA 163 (396)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhhh
Confidence 6655422 1223488999999999999 999999999999999999999999999998763 2233445677
Q ss_pred CccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH--------HHHHH-cCCccccccccc
Q 041285 602 TRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV--------YQCFE-NGNLGQLIEDED 671 (724)
Q Consensus 602 t~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~--------~~~~~-~~~~~~~~~~~~ 671 (724)
|..|.|||.+.+ .+|....|||++||++.||++|.+.|-+..+.++..+.... .+.+. ++.+..+.-+..
T Consensus 164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~ 243 (396)
T KOG0593|consen 164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP 243 (396)
T ss_pred hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence 999999999988 68999999999999999999999988766544443322110 11111 111111111111
Q ss_pred c--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 V--------DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~--------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. -+....-+++++..|++.||++|++-+|++.
T Consensus 244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 1223446899999999999999999999873
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=366.32 Aligned_cols=261 Identities=26% Similarity=0.492 Sum_probs=204.2
Q ss_pred cCHHHHHHhhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 438 FSYAELEKMTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 438 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
++++++.... ...+.||+|+||.||+|.. .++..||||++...... ..+|++.+++++|||||+++|+|.+.+.
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 4455554432 2345799999999999987 46889999998753221 2356889999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 517 KILVYEYMSNGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
.++||||+++|+|.++++...+.. +.|||+||+|||..+.++|+||||||+||+++.++.+++. |+.......+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999999999997665543 7899999999997777799999999999999999988876 6655433221
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc--
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE-- 670 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-- 670 (724)
....+++.|+|||++.+..++.|+|||||||++|||++|+.|+...... ...+.+|+............+++.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence 1235789999999999999999999999999999999999998644322 233555655444333333333332
Q ss_pred ---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 671 ---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 671 ---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
....++...+.+++.+||+.+|++||+|+||+++|+....
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2345667789999999999999999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=314.54 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=189.5
Q ss_pred cccccccCcCccceEEEEEeeC-----------------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-----------------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLG 509 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 509 (724)
..+.++||+|+||.||++...+ +..||||.+.... .....+|.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3456889999999999997532 2369999987532 233467999999999999999999999
Q ss_pred EEecccceEEEEeeccCCChhhhcCCCC--------------------------cchHHHHHHHcccccccCCCceEeCC
Q 041285 510 YSFDVSNKILVYEYMSNGSLADVYSSPP--------------------------KNNLIGIARGILYLHDECESQIIHCD 563 (724)
Q Consensus 510 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------~~~~~~ia~~l~yLH~~~~~~i~H~d 563 (724)
++.+.+..++||||+++++|.+++.... ...+.||+.||.|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 9999999999999999999998873211 13478999999999998 999999
Q ss_pred CCCCCeeeCCCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhcc--ccCCC
Q 041285 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC--RRCFD 640 (724)
Q Consensus 564 lk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg--~~p~~ 640 (724)
|||+|||++.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||+++ ..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999998654332221 1223457899999999888999999999999999999874 45555
Q ss_pred CCCCcchhcHHHHHHHHHHcCCcc-ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 641 QNLPEDQVILEEWVYQCFENGNLG-QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 641 ~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...... ....+.......... ....+ ......+.+++.+||+.+|++||||.+|.+.|++
T Consensus 244 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQ---VIENAGEFFRDQGRQVYLFRP----PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHH---HHHHHHHHhhhccccccccCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 432111 111111211111111 11111 1223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.06 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=193.8
Q ss_pred hcccccccCcCccceEEEEEe-eCCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
-+.+.++||.|.-++||+|.. +.++.||||++.-.. ....+++++|+..+..++||||++++..|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 345678999999999999976 567999999986432 334688999999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-Cc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSP-PK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~-~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
.+||+.++++.. ++ .++.++++||.|||.+ +.||||||+.||||+.+|.+||+|||.+..+.....+.
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999988431 11 1257899999999999 99999999999999999999999999987654333222
Q ss_pred ---eeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc---c
Q 041285 596 ---FTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL---I 667 (724)
Q Consensus 596 ---~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~ 667 (724)
+....|++.|||||+++.. .|+.|+||||||+..+||.+|..||..-.+- +..+ ..+ .+..+.+ .
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-kvLl-----~tL-qn~pp~~~t~~ 256 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-KVLL-----LTL-QNDPPTLLTSG 256 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-HHHH-----HHh-cCCCCCccccc
Confidence 2446899999999996543 5899999999999999999999999754322 1111 111 1222111 1
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+.+........+.+++..|++.||.+|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112223334457889999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.91 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=192.5
Q ss_pred cccCHHHHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchh---HHHHHHHHHhhcccCcCceeeeeeEEe
Q 041285 436 LSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVRLLGYSF 512 (724)
Q Consensus 436 ~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~ 512 (724)
..++.++++..+ ...|++|+++.||+|.+ +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.
T Consensus 13 ~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 13 KCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred eecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 334555553221 13689999999999998 78899999997643222 467889999999999999999999987
Q ss_pred c----ccceEEEEeeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 513 D----VSNKILVYEYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 513 ~----~~~~~lv~e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
+ ....++||||+++|+|.+++... . ...+.+++.||.|||+. .+++||||||+|||+++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcc
Confidence 6 34678999999999999998542 1 22367999999999973 2677999999999999999999999
Q ss_pred ccCccccCCCCcceeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH
Q 041285 582 FALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 582 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
||+++...... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ... ..+.
T Consensus 167 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~-~~i~ 235 (283)
T PHA02988 167 HGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIY-DLII 235 (283)
T ss_pred cchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHH
Confidence 99998654322 12357889999999976 67899999999999999999999999754211 111 1121
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+.....+ +......+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 236 ~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 236 NKNNSLKL-----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred hcCCCCCC-----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111111 112345688999999999999999999999999754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=308.05 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=193.3
Q ss_pred HhhcccccccCcCccceEEEEEee----CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.....+.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+..+.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344567789999999999999764 35689999987642 2334578999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 520 VYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
||||+++++|.+++... .+ ..+.+++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999988542 11 2267999999999998 9999999999999999999999999987654322
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.|+......+ ..+.+.++....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRLP----- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC-----
Confidence 2211122345678999999999999999999999999999775 999886542211 112222221111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
........+.+++..||+.+|++||++.++++.|++.
T Consensus 229 -~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122345688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.97 Aligned_cols=239 Identities=27% Similarity=0.366 Sum_probs=192.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.|.+.||+|+|++|++++.. .++++|||++.+. .+...+-...|-..|.+| .||.|++|+-.|.+...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 47789999999999999865 4789999999763 233345677888999999 899999999999999999999999
Q ss_pred ccCCChhhhcCCCCc-------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc--
Q 041285 524 MSNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-- 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~-------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-- 594 (724)
+++|+|.+++.+... -.+.+|+.||+|||+. +||||||||+|||||.|+.+||+|||-|+.+......
T Consensus 156 A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred cCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 999999999965322 1278999999999998 9999999999999999999999999999987532211
Q ss_pred --------ee--eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 595 --------TF--TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 595 --------~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.. ..++||..|.+||.+.....+..+|+|+|||+||+|+.|.+||....+. .. .+.+..- .
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--li-----FqkI~~l--~ 303 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LI-----FQKIQAL--D 303 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HH-----HHHHHHh--c
Confidence 11 3478999999999999999999999999999999999999999764321 11 1222111 1
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
. ...+...+.+.+|+.+.|..||.+|++.++|-+-
T Consensus 304 y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 Y-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred c-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 1122223557788888899999999999888654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.33 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=209.4
Q ss_pred cCHHHHHHhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 438 FSYAELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 438 ~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
.+..|+++-.-.+.++||-|.||.||.|+++. .-.||||.|+.+ ....++|++|..+|+.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35566766666677899999999999999975 468999999875 5667899999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCCcch---------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 517 KILVYEYMSNGSLADVYSSPPKNN---------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~~~~---------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
.|+|+|||..|+|.+||+...... +.||+.||.||..+ ++|||||.++|+|+.++..+||+||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999997654432 67999999999988 999999999999999999999999999999
Q ss_pred cCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
+..+.........-++-|.|||.+.-..++.|+|||+|||+||||.| |..|+-... + ..++..++.| ..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqVY~LLEkg---yR 484 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYGLLEKG---YR 484 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHHHHHHhcc---cc
Confidence 87776655555667889999999999999999999999999999988 445543321 1 1133444333 22
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
++.. ..+...+.+|++.||+.+|.+||+++|+-+.+|..
T Consensus 485 M~~P---eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 485 MDGP---EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccCC---CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 2221 23445689999999999999999999998888753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.27 Aligned_cols=257 Identities=28% Similarity=0.351 Sum_probs=195.1
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhc--ccCcCceeeeeeEEeccc----ceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIG--RTHHRNLVRLLGYSFDVS----NKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~~~~----~~~lv~e 522 (724)
.+.+.||+|.||.||+|.+ .|+.||||.+.. .+++.+.+|.++.+ .|+|+||+.+++.-..+. .++||++
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 3557899999999999999 578899999974 34566777766665 459999999999866543 5799999
Q ss_pred eccCCChhhhcCCCCcch------HHHHHHHccccccc-----CCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 523 YMSNGSLADVYSSPPKNN------LIGIARGILYLHDE-----CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~------~~~ia~~l~yLH~~-----~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|.++|||.|||.+..... +..+|.||++||-+ .++.|.|||||.+|||+..++.+.|+|+|||.....+
T Consensus 290 YHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999999997755433 77899999999954 3678999999999999999999999999999876544
Q ss_pred Cc---ceeeccccCccccCcccccCCC----C--CcccceeehhHHHHHhhccc----------cCCCCCCCcchhcHHH
Q 041285 592 QT---RTFTGIRGTRGYVAPEWHWNLP----I--TAKADVYSFGVVLLEIICCR----------RCFDQNLPEDQVILEE 652 (724)
Q Consensus 592 ~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~k~Dv~S~Gvll~elltg~----------~p~~~~~~~~~~~l~~ 652 (724)
.. ......+||.+|||||++...- | -..+||||||+|+||+...- .||....+.+. .+++
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~ee 448 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-SFEE 448 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-CHHH
Confidence 22 2223468999999999986542 2 23699999999999997632 24433322222 1111
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
.++.+-..++...++....+.+.+..+.++++.||..||.-|-|+-.+-+.|.+..+.
T Consensus 449 -MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 449 -MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred -HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 1222222334444445556677889999999999999999999999999988876543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.09 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=190.3
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
..+.+.||+|+||.||+++.. .+..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 455689999999999999742 35689999987532 23345788999999999 89999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC--------------------------------------------------------------
Q 041285 520 VYEYMSNGSLADVYSSPP-------------------------------------------------------------- 537 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 537 (724)
||||+++|+|.+++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999988874211
Q ss_pred --------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce-e
Q 041285 538 --------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT-F 596 (724)
Q Consensus 538 --------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-~ 596 (724)
...+.+|++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 01257999999999998 99999999999999999999999999998664432211 1
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ..+.+..+.... .+. .
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~--~~~----~ 341 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML--SPE----C 341 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC--CCC----C
Confidence 12345678999999999999999999999999999998 777775432211 1 112222221111 111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....+.+++.+||+.+|++||++.||+++|+..
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 134588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=298.82 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=191.6
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.+.||+|+||.||++...++..+|+|.+... ....+++.+|++++++++||||+++++++.+....++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 355789999999999999988889999988643 3345678999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++... .+. .+.+++.||+|||+. +++|+||+|+||++++++.+||+|||++...............
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 99988532 222 267899999999998 9999999999999999999999999998865433322222334
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
++..|+|||.+....++.++||||||+++|||++ |+.|+...... .. ...+..+.. ...+.. ....
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~-~~~i~~~~~--~~~~~~----~~~~ 229 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EV-VEMISRGFR--LYRPKL----ASMT 229 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCCCC--CCCCCC----CCHH
Confidence 5678999999988889999999999999999999 88888643221 11 122222211 111111 2346
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+||+.+|++||++.|++++|.
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.42 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=191.4
Q ss_pred hcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 518 (724)
...+.+.||+|+||.||++... ++..||||++.... ......+.+|+++++++ +|+||++++++|.+....+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4456688999999999998742 23579999997532 22345688999999999 8999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC-------------------------------------------------------------
Q 041285 519 LVYEYMSNGSLADVYSSPP------------------------------------------------------------- 537 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 537 (724)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999998873210
Q ss_pred ----------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee-eccc
Q 041285 538 ----------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIR 600 (724)
Q Consensus 538 ----------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~ 600 (724)
...+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.......... ....
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 12267899999999998 999999999999999999999999999986543322211 1234
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
++..|+|||++....++.++||||||+++|||++ |+.||........ .......+. ....+.. ....
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~--~~~~~~~----~~~~ 343 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY--QMSRPDF----APPE 343 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc--CccCCCC----CCHH
Confidence 5678999999988899999999999999999997 9999865432111 112222211 0111111 1345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+.+++.+||+.+|++||++.+|+++|+.++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=279.69 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=197.6
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc-chh-HHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEG-EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.++||+|.||.||+|+.. .|+.||||+++... .++ .....+|++.|+.++|+||+.+++++...+.+-||+|||+ .
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-T 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-c
Confidence 467999999999999864 58999999987532 111 3467899999999999999999999999999999999995 5
Q ss_pred ChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|...++... +..+.++++|++|||.+ .|+||||||.|+|+++++.+||+|||+++.+....... +..
T Consensus 86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~~ 161 (318)
T KOG0659|consen 86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-THQ 161 (318)
T ss_pred cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-ccc
Confidence 7887775432 22378999999999998 99999999999999999999999999999887544322 223
Q ss_pred ccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccccc---ccc---
Q 041285 600 RGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQL---IED--- 669 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~---~~~--- 669 (724)
+-|.-|.|||.+.+. .|+...|+||.||++.||+-|.+-+.+..+-++... +...+... ..+++ -|.
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCccccccccHHHH
Confidence 568999999998775 589999999999999999999877765543333221 11111111 11111 110
Q ss_pred ----c----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCc
Q 041285 670 ----E----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLL 721 (724)
Q Consensus 670 ----~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p~~~~ 721 (724)
. ..-......+++++..++..||.+|++++|++++= -....|.|..|..+.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLP 297 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCc
Confidence 0 01122345679999999999999999999999763 345566666665443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=300.04 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=193.2
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.++||+|++|.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++++||+++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 455889999999999999888889999998753 2345689999999999999999999999999999999999999999
Q ss_pred hhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 529 LADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 529 L~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|.+++.... ...+.++++||+|||+. +++|+||||+||+++.++.+||+|||++..............
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 999884321 12267999999999998 999999999999999999999999999987654332222233
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
.++..|+|||.+....++.++||||||+++|||++ |..|+....... ....+..+.... .......
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~ 231 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRMP------RMENCPD 231 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC------CCCCCCH
Confidence 45778999999988889999999999999999998 888885432111 111222221110 0112234
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+.+++.+|++.+|++||++++++++|+.
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 58899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.94 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=195.2
Q ss_pred HhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.....+.+.||+|++|.||++...+++.||||.++.. ....+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3445667899999999999999877889999998753 234567999999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++++|.+++.... + ..+.+++.||.|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999985432 1 2267899999999998 99999999999999999999999999998765332222
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
......+..|+|||.+....++.++||||||+++|||++ |+.|+....... ....+.... .. ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~-~~-----~~~~ 227 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY-RM-----PCPP 227 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-CC-----CCCC
Confidence 222233568999999998899999999999999999999 888875432111 112222211 00 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.69 Aligned_cols=240 Identities=33% Similarity=0.502 Sum_probs=183.0
Q ss_pred cccccCcCccceEEEEEee-----CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 24689999996532 33467899999999999999999999999988889999999
Q ss_pred ccCCChhhhcCCC---Cc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 524 MSNGSLADVYSSP---PK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
+++|+|.+++... .. ..+.||++||+|||+. +++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998543 21 2278999999999998 999999999999999999999999999987632222
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
...........|+|||.+....++.++||||||+++|||++ |+.|+.... ..... ..+.++..... +
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~-~~~~~~~~~~~--~--- 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEII-EKLKQGQRLPI--P--- 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHH-HHHHTTEETTS--B---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-cccccccccee--c---
Confidence 22223456789999999999889999999999999999999 667765431 11112 22233322111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
......+.+++..||+.+|++||+|.++++.|
T Consensus 228 -~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11234588999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=302.75 Aligned_cols=236 Identities=28% Similarity=0.385 Sum_probs=195.1
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.||+|.||.||+|... .++.||+|.+.-. ......+..+|+.++.+++++||.+++|.+..+..++++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 378999999999999874 4789999998753 33445678999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCc-------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 529 LADVYSSPPK-------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 529 L~~~l~~~~~-------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+.+.++.... -++.++..|+.|||.+ +.+|||||+.|||+..++.+||+|||++..+....... ...+|
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvG 173 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVG 173 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccc
Confidence 9999864322 1278999999999998 99999999999999999999999999998776544433 45789
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
|+-|||||++....|+.|+||||||+..+||.+|.+|+....+.....+ + .+- .+...+......+.
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------I-----pk~-~PP~L~~~~S~~~k 240 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------I-----PKS-APPRLDGDFSPPFK 240 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------c-----cCC-CCCccccccCHHHH
Confidence 9999999999988999999999999999999999999876554221111 0 000 11122234556689
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+++..|++.+|+.||++.++++
T Consensus 241 EFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 241 EFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHHhhcCcccCcCHHHHhh
Confidence 9999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.58 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=191.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc----cc-hhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM----LA-EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|.||.|+.|... .++.||||.+.+. .. ...+.+.+|+.++++++ ||||++++.++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4456688999999999999764 5799999976652 11 23456778999999998 9999999999999999999
Q ss_pred EEeeccCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCccccCCC
Q 041285 520 VYEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~ 591 (724)
||||+.+|+|.+++... ....+.|++.|++|||+. +|+||||||+|||++.+ +++||+|||++.... .
T Consensus 98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~ 173 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G 173 (370)
T ss_pred EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence 99999999999998541 122378999999999998 99999999999999999 999999999999874 1
Q ss_pred CcceeeccccCccccCcccccCCC-CC-cccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLP-IT-AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .. ....+..+...- +
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~-l~~ki~~~~~~~---p 243 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PN-LYRKIRKGEFKI---P 243 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HH-HHHHHhcCCccC---C
Confidence 222334467999999999999977 75 789999999999999999999986321 11 112233332211 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
.... ...+..++..|++.+|.+|+++.+|+
T Consensus 244 ~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 244 SYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 45688999999999999999999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.48 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=193.1
Q ss_pred ccccccCcCccceEEEEEeeCC------cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMING------KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~------~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
.+.+.||+|+||.||+|..... ..||+|.+.... .....+|.+|++++.+++||||+++++++.+....+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 3557899999999999987432 579999987532 233457899999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeE
Q 041285 522 EYMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAK 578 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~k 578 (724)
||+++++|.+++.... ...+.++++||.|||+. +++|+||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 9999999999884321 12378999999999998 999999999999999999999
Q ss_pred EccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHH
Q 041285 579 ISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQ 656 (724)
Q Consensus 579 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~ 656 (724)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+ ...
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~~~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VIE 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 999999986543322 12223456788999999988899999999999999999998 988886543211 122
Q ss_pred HHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+..+..... .......+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~i~~~~~~~~------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLLPC------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCC------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2333322211 22344668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.62 Aligned_cols=244 Identities=28% Similarity=0.379 Sum_probs=192.4
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..+.++||+|++|.||++...+ ++.||+|.+... ....+++.+|++++++++|+||+++++++......+++|||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 3456789999999999998754 788999998753 34456799999999999999999999999999999999999999
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... .+ ..+.|+++||+|||+. +++||||||+||++++++.+||+|||++............
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999988432 11 1267999999999988 9999999999999999999999999999866433222212
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...++..|+|||.+.+..++.++||||||+++|||++ |..|+...... + .......+... ......
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~------~~~~~~ 230 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------Q-VYELLEKGYRM------ERPEGC 230 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHCCCCC------CCCCCC
Confidence 2234678999999998899999999999999999998 88887543211 1 11222221111 111122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+.+++.+|++.+|++||++.+++++|+..
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 35688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.99 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=201.5
Q ss_pred HHHhhcccccccCcCccceEEEEEeeC---C--cEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 443 LEKMTDGFKEEIGRGSSGTVYKGTMIN---G--KFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 443 l~~~t~~f~~~lg~G~~g~Vy~~~~~~---~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
|.++.-..++.||.|-||.||+|+..+ | -.||||..+.+ .....+.|+.|..+|++++|||||+|+|.|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 334444456789999999999998743 3 36899998863 34556789999999999999999999999987 46
Q ss_pred eEEEEeeccCCChhhhcCCCCcch--------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 517 KILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~~~~--------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
.++|||.++-|.|..||....... ..||..+|+|||+. ..|||||.++|||+.....+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 899999999999999996533222 67999999999998 9999999999999999999999999999999
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
.++.....+...-+.-|||||.+.-++++.++|||-|||.|||++. |..||......+.. -.+++|
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnG------ 608 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENG------ 608 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCC------
Confidence 8887776666677899999999999999999999999999999976 88898764322210 011111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
++-..++..+..+..++.+||..+|.+||.+.|+...|+.
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 1112345566778999999999999999999988766543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=281.16 Aligned_cols=224 Identities=26% Similarity=0.320 Sum_probs=184.6
Q ss_pred ccccCcCccceEEEEEeeC-CcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 451 KEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.||.|+||.|.+++.+. |..+|+|++.+..- .+.+...+|..+|+.+.||.++++.+.+.+...++|||||+++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 3679999999999998764 78999999986432 3345678899999999999999999999999999999999999
Q ss_pred CChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|.|..++++.. . -.+.+|+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+..... ....
T Consensus 129 GElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~Tl 201 (355)
T KOG0616|consen 129 GELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTL 201 (355)
T ss_pred ccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEe
Confidence 99999996422 1 2278999999999998 9999999999999999999999999999987543 2346
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.||+.|+|||.+...++..++|.|+|||++|||+.|..||....+. -..+.+.++++.. |.- ....
T Consensus 202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v~f---P~~----fs~~ 267 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKVKF---PSY----FSSD 267 (355)
T ss_pred cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcccC---Ccc----cCHH
Confidence 7999999999999999999999999999999999999999865431 1334555554322 112 2234
Q ss_pred HHHHHHHcccCCCCCC
Q 041285 680 MIKVALWCILDEPSLR 695 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~R 695 (724)
+.+|+...++.|-.+|
T Consensus 268 ~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHhhhhHhh
Confidence 6677777788888888
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.27 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=194.6
Q ss_pred hhcccccccCcCccceEEEEEeeC------CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
....+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 345566889999999999998743 478999998764433 4578999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC---------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCe
Q 041285 519 LVYEYMSNGSLADVYSSPP---------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~---------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
+||||+++++|.+++.... ...+.+++.|+.|||+. +++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999884321 11267899999999998 99999999999999999999
Q ss_pred EEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHH
Q 041285 578 KISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVY 655 (724)
Q Consensus 578 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~ 655 (724)
||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+ ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999976533222 11122345788999999999999999999999999999998 998886543211 11
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.....+..... .......+.+++..||+.+|++||++.||+++|++
T Consensus 235 ~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22223322211 11234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.71 Aligned_cols=239 Identities=25% Similarity=0.287 Sum_probs=187.2
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.||+|+||.||++... +++.||||.+.... ......+.+|++++.+++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999874 68899999886432 2233467899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|+|..++... .. ..+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TV 158 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--ee
Confidence 99998776321 11 1267999999999998 99999999999999999999999999998654322 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ............. ......
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~ 228 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE-------EYSEKF 228 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc-------cCCccC
Confidence 334689999999999999999999999999999999999999976432211 1111111111111 111223
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
...+.+++..||+.+|.+||+ ++++++
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 446888999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.09 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=193.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..+.||+|.||.||||+-+ +.+.||+|.+.+.. +...+.+++|++++++++|||||.++.+++...++++|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 3478999999999999875 46899999987632 33456789999999999999999999999999999999999977
Q ss_pred CChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|..++.. .+.. ++.++..||.|||+. +|.|||+||+||||+..+++|++|||+|+-+..+ +...+.+
T Consensus 86 -~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsi 160 (808)
T KOG0597|consen 86 -DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSI 160 (808)
T ss_pred -hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeec
Confidence 99999843 3333 377899999999999 9999999999999999999999999999977653 4455678
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.||+-|||||.+.+.+|+..+|+||+||++||+.+|++||.... +...+.. +.. |+...+......
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~-I~~-------d~v~~p~~~S~~ 226 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKS-ILK-------DPVKPPSTASSS 226 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHH-Hhc-------CCCCCcccccHH
Confidence 99999999999999999999999999999999999999996421 1111211 111 121223355667
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+..++...++.||.+|.+-.+++.
T Consensus 227 f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 227 FVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHhhcChhhcccHHHHhc
Confidence 888999999999999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.67 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=190.1
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||+++..+ ++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 355789999999999999864 7899999987532 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 84 ~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 84 PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 999999998532 11 2267999999999998 999999999999999999999999999976543 223
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-CccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG-NLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~ 676 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ .+.... ........
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~~~~~~~-~~~~~~~~ 229 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKETLQRPV-YDDPRFNL 229 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhccccccCCC-CCcccccc
Confidence 35689999999999999999999999999999999999999975432211 01111100 011000 00001123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++..|++.+|.+||++.++++.
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 4567889999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.21 Aligned_cols=241 Identities=26% Similarity=0.384 Sum_probs=191.9
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.+.||+|+||.||++...++..+|||.+... .....+|.+|+.++.+++||||+++++++.+....++||||+++++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 456789999999999998877778999998753 3345679999999999999999999999999889999999999999
Q ss_pred hhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++... . +..+.+|+.||+|||+. +++|+||||+||+++.++.+||+|||+++..............
T Consensus 86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 99988432 1 22378999999999998 9999999999999999999999999998866443322222334
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . .......+..... +. .....
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~~--~~----~~~~~ 229 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------E-TVEKVSQGLRLYR--PH----LASEK 229 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHhcCCCCCC--CC----CCCHH
Confidence 5678999999988889999999999999999998 88887643211 1 1112222211111 11 12456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.59 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=198.7
Q ss_pred ccccccCcCccceEEEEEe-eCCcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||.|+.|.|-.|+. ..|+.+|||.+.+... .....+.+|+-+|+.+.|||++++++.+.+..++|||.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 3457899999999999987 4699999999976422 22346789999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|-|.+++-.. ..+.+.||+.|+.|+|.. +|+||||||+|+|||.+.++||+|||+|.+-..+. ...
T Consensus 95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--lLe 169 (786)
T KOG0588|consen 95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--LLE 169 (786)
T ss_pred CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc--ccc
Confidence 999999998321 223378999999999998 99999999999999999999999999998643322 223
Q ss_pred ccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...|++.|++||++.+.+| ..++||||.|||||.||+|+.||+... +.. ....+..|.++.. ...
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~-LLlKV~~G~f~MP-------s~I 235 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRV-LLLKVQRGVFEMP-------SNI 235 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHH-HHHHHHcCcccCC-------CcC
Confidence 4579999999999999998 469999999999999999999998432 111 2344556654332 223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDIPIP 714 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~~p 714 (724)
..++.+|+..|+..||++|.|++||++- |.+...++.+
T Consensus 236 s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 236 SSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred CHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 4457888999999999999999999985 3455554443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.29 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=195.8
Q ss_pred ccccccCcCccceEEEEEee------CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 34578999999999999753 345799999876555556789999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 523 YMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
|+++++|.+++.... ...+.+|+.||+|||++ +++||||||+|||++.++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 999999999884321 12267999999999998 9999999999999999999999
Q ss_pred ccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHH
Q 041285 580 SDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQC 657 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 657 (724)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..+.
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~ 237 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIEC 237 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999976543322 11223456788999999999999999999999999999998 888876533211 1122
Q ss_pred HHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 658 FENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
...+...... ......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 238 ~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLERP------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCCCCCCC------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 3333222211 1124568899999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.36 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=191.2
Q ss_pred hcccccccCcCccceEEEEEeeC------CcEEEEEEcccccc-hhHHHHHHHHHhhcccC-cCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 518 (724)
...+.+.||+|+||.||+|+... +..||||++..... ...+.+.+|+++++++. ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 34456889999999999998632 34799999975332 23457999999999995 999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC-------------------------------------------------------------
Q 041285 519 LVYEYMSNGSLADVYSSPP------------------------------------------------------------- 537 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 537 (724)
+||||+++|+|.+++....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999988763210
Q ss_pred ------------------------------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC
Q 041285 538 ------------------------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR 575 (724)
Q Consensus 538 ------------------------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~ 575 (724)
...+.||++||+|||+. +|+|+||||+|||++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 01256899999999998 999999999999999999
Q ss_pred CeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHH
Q 041285 576 YAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEW 653 (724)
Q Consensus 576 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~ 653 (724)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------ 348 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------ 348 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------
Confidence 9999999999865432221 1122346788999999998899999999999999999997 8888764322111
Q ss_pred HHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.......+.... ........+.+++.+||+.+|++||++.+|+++|+...
T Consensus 349 ~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCCC------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 112222221110 11123456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.16 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=192.0
Q ss_pred ccccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++.+++|+||+++++++.+.+..+++|||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 456889999999999998743 3579999987532 33446789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-c
Q 041285 524 MSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-R 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 594 (724)
+++++|.+++.... + ..+.+++.||+|||+. +|+|+||||+|||+++++.+||+|||++........ .
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 87 MENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred CCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 99999999985422 1 2267999999999998 999999999999999999999999999987752222 1
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+....++.++||||||+++|||++ |..|+....... ....+..+.... ..
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~ 230 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLP------PP 230 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC------CC
Confidence 1122345678999999998899999999999999999998 888875432111 112222221110 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++.+|++.+|++||++.||+++|+..
T Consensus 231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.42 Aligned_cols=234 Identities=24% Similarity=0.296 Sum_probs=185.1
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||++... +++.||||.++... ......+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999874 57899999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 528 SLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 528 sL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+|.+++... .. ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 998887432 11 1267999999999998 99999999999999999999999999987532211 1122356
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..+... ........+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~-~~~~~~~~~~~-------~p~~~~~~~ 222 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K-LFELILMEEIR-------FPRTLSPEA 222 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcCCCC-------CCCCCCHHH
Confidence 899999999999999999999999999999999999999653211 1 11112222111 111234457
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 681 IKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 8899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.62 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=187.8
Q ss_pred hcccccccCcCccceEEEEEeeC---------------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN---------------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGY 510 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~ 510 (724)
...+.++||+|+||.||++...+ ...||||.++... ......|.+|++++.+++|+||++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 34556889999999999987642 1358999987532 2334579999999999999999999999
Q ss_pred EecccceEEEEeeccCCChhhhcCCC---------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 511 SFDVSNKILVYEYMSNGSLADVYSSP---------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 511 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
+......++||||+++++|.+++... .+ ..+.++++||+|||+. +++|+||||+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEE
Confidence 99999999999999999999887431 11 1267999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc--cccCCCCCCCcchh
Q 041285 572 DENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC--CRRCFDQNLPEDQV 648 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~ 648 (724)
++++.+||+|||++.......... .....++..|+|||.+....++.++||||||++++||++ +..|+.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 999999999999997654332211 122345778999999998899999999999999999998 445554332211
Q ss_pred cHHHHHHHHHHcC-CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 649 ILEEWVYQCFENG-NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 649 ~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.+. ...+..... .......+. .....+.+++.+|++.+|++||+|.+|++.|+
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIE-NTGEFFRNQGRQIYLSQTP----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH-HHHHhhhhccccccCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 111111111 111111111 12356999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.76 Aligned_cols=230 Identities=21% Similarity=0.228 Sum_probs=181.1
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998653 233445788999999999999999999999999999999999999999
Q ss_pred hhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 530 ADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 530 ~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
.+++.... . ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ......|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCC
Confidence 98884321 1 1267999999999998 999999999999999999999999999875432221 22335689
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (724)
+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.. +....+... ........+.+
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~-~~~~~~~~~-------~~~~~~~~~~~ 222 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMY-RKILQEPLR-------FPDGFDRDAKD 222 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHH-HHHHcCCCC-------CCCcCCHHHHH
Confidence 999999999999999999999999999999999999975321 1111 122222111 11122345788
Q ss_pred HHHHcccCCCCCCCCHHHH
Q 041285 683 VALWCILDEPSLRPSMKKV 701 (724)
Q Consensus 683 l~~~Cl~~~p~~RPs~~ev 701 (724)
++..||+.+|++||++..+
T Consensus 223 li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHcCCCHHHcCCCCCH
Confidence 9999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.88 Aligned_cols=243 Identities=28% Similarity=0.386 Sum_probs=195.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.++||.|+||.||+|...+++.+|+|.+.........++.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 34568899999999999999889999999998765545678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... ...+.+++.||.|||+. +++|+||+|+||++++++.+||+|||++......... ...
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 9999985422 12267999999999998 9999999999999999999999999999866432221 123
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||.+....++.++||||||+++++|++ |+.|+......+ .. .....+... .......
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~------~~~~~~~ 230 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VY-DQITAGYRM------PCPAKCP 230 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HH-HHHHhCCcC------CCCCCCC
Confidence 346778999999988899999999999999999998 788886433111 11 111111110 0112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+|++.+|++||+++++++.|++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.25 Aligned_cols=235 Identities=23% Similarity=0.297 Sum_probs=188.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345688999999999999885 47899999987532 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++... ... .+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 100 VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred CCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 9999999888532 111 267999999999998 99999999999999999999999999998654322
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+.+.. +.. .
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~~~---p~~----~ 238 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGRLKF---PNW----F 238 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCCcCC---CCC----C
Confidence 1246899999999999999999999999999999999999998653211 1 122233332211 111 2
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
...+.+++..||+.||.+||+ ++++++
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 245788999999999999997 677763
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.58 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=194.6
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
..+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++......++|+
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 345678999999999999752 24568999987655555678999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCC----------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 522 EYMSNGSLADVYSSP----------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 522 e~~~~gsL~~~l~~~----------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
||+++++|.+++... .+ ..+.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 999999999887421 11 1267999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 582 FALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 582 fgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
||++........ .......++..|+|||.+.+..++.++||||||++++||++ |..|+....... ....+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence 999986543322 11222345778999999998889999999999999999998 888876433211 112233
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.+..... +. .....+.+++.+||+.+|.+||++.||++.|+.+..
T Consensus 237 ~~~~~~~--~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 QGRVLQR--PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCcCCC--CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 3322211 11 123458999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.14 Aligned_cols=240 Identities=29% Similarity=0.409 Sum_probs=193.6
Q ss_pred cccCcCccceEEEEEe-eCC----cEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTM-ING----KFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~-~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
++||+|+||+||+|.+ ++| -+||+|.+... ..++..+++.|+..|.+++||||+||+|+|.... +.||++|||
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 5799999999999986 344 47999988753 4455689999999999999999999999999876 889999999
Q ss_pred CCChhhhcCCCCcch--------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~~~~--------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
.|+|.++++.....+ ..|||+||.|||++ +++||||.++|||+..-..+||.|||+++.+..+...-..
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 999999996544332 68999999999988 9999999999999999999999999999998766553332
Q ss_pred -ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 598 -GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 598 -~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
...-.+-|||-|.+....++.++|||||||.+||++| |..|++....++ +-+.++.|+- +-.+ +.
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR--LsqP----pi 924 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER--LSQP----PI 924 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc--CCCC----CC
Confidence 2344678999999999999999999999999999998 777776543222 2223333321 2122 23
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...++..++.+||..|++.||.++++...+...
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 345688899999999999999999988776543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.38 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=190.4
Q ss_pred cccccccCcCccceEEEEEe-----eCCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
..+.++||+|+||.||+|.. ..+..||+|.+.... .+...++.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 34668899999999999985 245789999987532 334467899999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCC--------------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCe
Q 041285 522 EYMSNGSLADVYSSP--------------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 522 e~~~~gsL~~~l~~~--------------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
||+++++|.+++... . ...+.+++.||+|||+. +++|+||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 999999999987311 1 11367999999999998 99999999999999999999
Q ss_pred EEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHH
Q 041285 578 KISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVY 655 (724)
Q Consensus 578 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~ 655 (724)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~~~ 236 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVI 236 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999986543322 11222345778999999988889999999999999999998 88887543211 112
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
+....+.... ........+.+++.+|++.+|++||++.+|+++|.+
T Consensus 237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222222111 111223468889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.93 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=188.6
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||+++.. +++.+|||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 45678999999999999986 47899999987532 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++.+..+.... . ...+.||+.||.|||+. +++||||||+||+++.++.+||+|||++.............
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 84 KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 98776554321 1 12378999999999988 99999999999999999999999999998764333323334
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH---------HHHHHHHcCCccccccc
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE---------WVYQCFENGNLGQLIED 669 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~---------~~~~~~~~~~~~~~~~~ 669 (724)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...... ................+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFP 240 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccC
Confidence 568999999999998889999999999999999999999987543221110000 00000000000000000
Q ss_pred cc---------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 ED---------VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ........+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 241 AVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=292.47 Aligned_cols=241 Identities=28% Similarity=0.412 Sum_probs=189.5
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.+.||+|+||.||++....+..+|+|.+... .....++.+|++++++++|+||+++++++.+....++|+||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 356789999999999999877778999988643 2334578899999999999999999999999999999999999999
Q ss_pred hhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++.... + ..+.++++||+|||+. +++|+||||+||++++++.+||+|||+++..............
T Consensus 86 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 162 (256)
T cd05059 86 LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK 162 (256)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence 999885321 1 2367999999999998 9999999999999999999999999998765432222222223
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .......+.. ...+ ......
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--~~~~----~~~~~~ 229 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGYR--LYRP----KLAPTE 229 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCCc--CCCC----CCCCHH
Confidence 4568999999998899999999999999999999 788876432211 1111222110 0011 123456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+||+.+|++||+|.|++++|.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.87 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=188.5
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999875432 23346889999999999999999999999999999999999999999
Q ss_pred hhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 531 DVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 531 ~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
+++.... + ..+.+++.+|.|||+. +++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9874321 1 2267899999999988 999999999999999999999999999875433222111222346
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
..|+|||++....++.++||||||+++||+++ |..|+....... .......+.... ........+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~ 224 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMS------CPQKCPDDVY 224 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCC------CCCCCCHHHH
Confidence 78999999998889999999999999999998 888886432111 112222221111 1112345688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 682 KVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+++.+|++.+|++||++.|++++|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=306.77 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=184.4
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.++||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999875 57899999986432 2334678999999999999999999999999999999999999999
Q ss_pred hhhhcCCC---CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccc
Q 041285 529 LADVYSSP---PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGY 605 (724)
Q Consensus 529 L~~~l~~~---~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 605 (724)
|.+..... ....+.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... ......|+..|
T Consensus 159 L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y 234 (353)
T PLN00034 159 LEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAY 234 (353)
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCccc
Confidence 97654322 123478999999999998 999999999999999999999999999986643221 12234689999
Q ss_pred cCcccccCC-----CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 606 VAPEWHWNL-----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 606 ~aPE~~~~~-----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
+|||.+... ..+.++|||||||++|||++|+.||......+ ........ ..... ..........+
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~-~~~~~------~~~~~~~~~~l 304 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAI-CMSQP------PEAPATASREF 304 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHH-hccCC------CCCCCccCHHH
Confidence 999987432 23568999999999999999999997432211 11111111 11100 11112234568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+++.+||+.+|++||++.|+++.
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=295.87 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=188.8
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.++||+|+||.||+|... .+..||||.+.... .....++.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 445678999999999998753 24679999886432 23345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCCC-------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 521 YEYMSNGSLADVYSSPP-------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~-------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
+||+++++|.+++.... + ..+.++++||.|||+. +++|+||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999874311 1 1256899999999998 99999999999999999999999999
Q ss_pred CccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . ..+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~-~~~~~~~~ 237 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------Q-VLRFVMEG 237 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcC
Confidence 987654322211 112345778999999998889999999999999999999 67777543211 1 11222222
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..... .......+.+++.+|++.+|++||++.|++++|++
T Consensus 238 ~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22111 11223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.46 Aligned_cols=248 Identities=22% Similarity=0.350 Sum_probs=188.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 34578999999999999875 47889999887532 23346799999999999999999999999999999999999999
Q ss_pred CChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++... . ...+.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++....... ....
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 162 (331)
T cd06649 88 GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSF 162 (331)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccC
Confidence 9999988532 1 12367999999999975 259999999999999999999999999987653321 1234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---c-------------
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---L------------- 663 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~------------- 663 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ +..........+. .
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccccccccc
Confidence 68999999999999999999999999999999999999986432211 1000000000000 0
Q ss_pred ------------------cccc---cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 ------------------GQLI---EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 ------------------~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..++ .+..........+.+++.+||+.||++||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000011234568999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.20 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=193.9
Q ss_pred HHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 444 EKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 444 ~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
......+.++||+|+||.||++...+++.||+|.+... .....++.+|+.++++++|+||+++++++. .+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 34556677899999999999999888899999998754 234567999999999999999999999864 4578999999
Q ss_pred ccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 524 MSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++++|.+++... .+ ..+.+++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999987432 11 1267999999999988 9999999999999999999999999999876533322
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ....+..+.... ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~ 225 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYRMP------RP 225 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCCCC------CC
Confidence 2223345778999999988889999999999999999999 898886432111 111122221111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
......+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1223468999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=301.82 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=188.9
Q ss_pred cccccccCcCccceEEEEEeeC-Cc----EEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GK----FVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
....+.||+|+||.||+|++.. ++ .||||.++... ....+++.+|+.+++.++|+||++++|+|... ..++++
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 3345789999999999998643 33 48999987532 34456799999999999999999999999874 578999
Q ss_pred eeccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++|+|.+++.... ...+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 9999999999885432 12367999999999998 999999999999999999999999999987654332
Q ss_pred ce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 RT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 ~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. ......+..|+|||.+....++.++||||||+++|||++ |+.|+...... . .......+... ..+.
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~--~~~~- 234 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL--PQPP- 234 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC--CCCC-
Confidence 21 122334678999999999999999999999999999998 88888643211 1 11222222111 1111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.....+.+++..||+.+|++||++.+++..|....
T Consensus 235 ---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 235 ---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12345788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.11 Aligned_cols=232 Identities=23% Similarity=0.319 Sum_probs=187.5
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.|...||+|.||.|+++.++. ++.+|||.+++.. +.+.+..+.|-+++... +||.|+.|+.++...++++.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 355789999999999998864 6899999998742 44556788898888877 599999999999999999999999
Q ss_pred ccCCChhhhcCCCCcc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 524 MSNGSLADVYSSPPKN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+.||++..+.+..... .+..|+.||.|||++ +||+||||.+|||||.+|.+||+||||++.--.... ...
T Consensus 451 ~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-~Ts 526 (694)
T KOG0694|consen 451 VAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-RTS 526 (694)
T ss_pred cCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC-ccc
Confidence 9999965555432221 267899999999999 999999999999999999999999999986432222 234
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...||+.|||||++.+..|+..+|.|||||+|||||.|..||.+...++ +.+.+.. |...++.-..
T Consensus 527 TfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~-------d~~~yP~~ls 592 (694)
T KOG0694|consen 527 TFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVN-------DEVRYPRFLS 592 (694)
T ss_pred cccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhc-------CCCCCCCccc
Confidence 5789999999999999999999999999999999999999998654332 1222222 1222333445
Q ss_pred HHHHHHHHHcccCCCCCCCCH
Q 041285 678 ERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
.+.+.|+...+..+|++|.-+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 568889999999999999977
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=292.04 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=191.8
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.++||+|+||.||+|+..+...||+|.++.. ....++|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 35577899999999999998877778999999753 2345678999999999999999999998754 567999999999
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... .+ ..+.++++||+|||+. +++|+||||+||++++++.+||+|||++..+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 9999998542 11 2267999999999998 9999999999999999999999999999866543322222
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...++..|+|||......++.++||||||+++|||++ |..|+....... .......+... ....+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~ 228 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM------PCPPEC 228 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCCC------CCcccc
Confidence 3446778999999988899999999999999999999 777775432111 11112211110 112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+.+++.+|++.+|++||++.+++++|+..
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 55688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.39 Aligned_cols=235 Identities=21% Similarity=0.275 Sum_probs=187.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 35578999999999999875 57899999986422 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++.... ...+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----~ 156 (291)
T cd05612 84 PGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----W 156 (291)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----c
Confidence 9999999884321 12367999999999998 99999999999999999999999999998654321 2
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.+..+... ......
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~-------~~~~~~ 222 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLE-------FPRHLD 222 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcC-------CCccCC
Confidence 2458999999999998889999999999999999999999987543211 11222222211 111123
Q ss_pred HHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPS-----MKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 704 (724)
..+.+++.+|++.||.+||+ +.|+++.
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 45788999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.93 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=190.5
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccc-hhHHHHHHHHHhhcccC-cCceeeeeeEEeccc-ceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVS-NKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lv~e~ 523 (724)
+...++||.|.||.||+|+- ..++.||||++++... ..+-.=.+|+..|++|+ |||||+|...+.+.+ .+++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 44557899999999999985 4588999999986432 22334568999999998 999999999999988 89999999
Q ss_pred ccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
| ..+|.++++... ..++.||++||+|+|.+ ++.|||+||+|||+..+..+||+|||+|+.+.....
T Consensus 92 M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP-- 165 (538)
T KOG0661|consen 92 M-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP-- 165 (538)
T ss_pred h-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCC--
Confidence 9 457888775432 22378999999999999 999999999999999999999999999998765433
Q ss_pred eeccccCccccCccccc-CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-------------
Q 041285 596 FTGIRGTRGYVAPEWHW-NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG------------- 661 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------------- 661 (724)
.+..+.|.-|.|||++. .+-|+.+.|+|++|||++||.+-++.|-+...-++.. -+.+.+...
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhCCCccccchhHHHHHH
Confidence 44567799999999865 5679999999999999999999988876554332211 011111110
Q ss_pred ----Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 662 ----NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 662 ----~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
++.+..-.. ..-+.....+++++..|++.||++|||+.|.+++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111100 1122367789999999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=291.60 Aligned_cols=239 Identities=24% Similarity=0.340 Sum_probs=186.1
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999876432 33456799999999999999999999999999999999999999999
Q ss_pred hhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee-eccc
Q 041285 530 ADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIR 600 (724)
Q Consensus 530 ~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~ 600 (724)
.+++... .+ ..+.|++.||+|||+. +++|+||||+|||++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9988432 11 2267999999999998 999999999999999999999999999875432211111 1112
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ........... .........
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~ 224 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL------PCPELCPDA 224 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC------CCcccCCHH
Confidence 3567999999998899999999999999999998 777775432111 11112111110 111122456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+|++.+|++||++.+++++|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.66 Aligned_cols=235 Identities=24% Similarity=0.309 Sum_probs=185.5
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 57899999987532 233457889999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 528 SLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 528 sL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 9988874321 1 2267999999999998 99999999999999999999999999987543221 1223356
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. .+.+..+.. .........+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~-~~~~~~~~~-------~~p~~~~~~~ 222 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KL-FELILMEDI-------KFPRTLSADA 222 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HH-HHHhccCCc-------cCCCCCCHHH
Confidence 899999999999989999999999999999999999999653221 11 111111111 0111223457
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 681 IKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
.+++.+||+.+|++|| ++.|+++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 8899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.21 Aligned_cols=240 Identities=23% Similarity=0.378 Sum_probs=197.9
Q ss_pred HhhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
+..+.|.+.||+|.||.|-++.. ..|+.||||.+++..- ++.-.+++|+++|..|+||||+.++.+|.+.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45566778999999999999976 5699999999986433 3444688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||..+|.|.+|+... ....+.||..|+.|+|.+ +++|||||.+|||||+|+++||+|||++-.+.....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 9999999999999532 223378999999999999 999999999999999999999999999987754432
Q ss_pred ceeeccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
...+.|++-|.+||++.+.+| .+..|.|||||+||.|+.|..||++.+. . . ....+..|...+.
T Consensus 209 --LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k---~-lvrQIs~GaYrEP------ 273 (668)
T KOG0611|consen 209 --LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---K---R-LVRQISRGAYREP------ 273 (668)
T ss_pred --HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---H---H-HHHHhhcccccCC------
Confidence 345789999999999999997 5789999999999999999999986431 1 1 1233444544332
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+......-++.|||..||++|.|+.+|...
T Consensus 274 --~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 --ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 223346778999999999999999999753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=303.54 Aligned_cols=236 Identities=26% Similarity=0.306 Sum_probs=188.0
Q ss_pred cccccccCcCccceEEEEEeeC--CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN--GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.+.||+|+||.||++.... +..||||++.... ....+.+.+|+.++..++||||+++++++.+....++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4556889999999999998654 3689999986432 2334568899999999999999999999999999999999
Q ss_pred eccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
|+++|+|.+++... .. ..+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--- 185 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--- 185 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc---
Confidence 99999999988532 11 2267999999999998 99999999999999999999999999998654321
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.+..+... . +..
T Consensus 186 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~--~-p~~---- 250 (340)
T PTZ00426 186 -YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGIIY--F-PKF---- 250 (340)
T ss_pred -ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCC--C-CCC----
Confidence 2346899999999999888999999999999999999999999754221 112222222211 0 111
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
....+.+++.+|++.+|++|+ +++++++.
T Consensus 251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 223477899999999999995 89988764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=296.11 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=190.5
Q ss_pred cccccccCcCccceEEEEEeeC------CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.++||+|+||.||+|...+ ++.||||.+...... ..+.+.+|+.++.+++|+||+++++++.+....+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 3456789999999999998643 468999999754332 235688999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCC-------------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCe
Q 041285 521 YEYMSNGSLADVYSSP-------------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-------------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
+||+++++|.+++... . ...+.|++.||.|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 9999999999887310 1 11267999999999988 99999999999999999999
Q ss_pred EEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHH
Q 041285 578 KISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVY 655 (724)
Q Consensus 578 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~ 655 (724)
||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |..|+...... . ..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D-VI 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HH
Confidence 99999998865433221 1223345789999999988889999999999999999998 77776543211 1 12
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
+.+..+..... .......+.+++..|++.+|++||++.+|+..|+.
T Consensus 237 ~~i~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22333322211 11234558899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=317.84 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=189.3
Q ss_pred cccccccCcCccceEEEEEeeC--CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN--GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|++|.||++.... ++.||+|.+..........+++|+.++++++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 4566889999999999997643 56788887765444445678899999999999999999999999999999999999
Q ss_pred CCChhhhcCC-----CCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 526 NGSLADVYSS-----PPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 526 ~gsL~~~l~~-----~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
+|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999887632 111 1267999999999998 999999999999999999999999999987654322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... .....+.... ..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~-~~~~~~~~~~------~~ 292 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIM-QQVLYGKYDP------FP 292 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCCC------CC
Confidence 1223356899999999999999999999999999999999999998653211 111 1122222211 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++..||+.+|++||++.+++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 122345889999999999999999998864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.82 Aligned_cols=234 Identities=24% Similarity=0.302 Sum_probs=184.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999874 57899999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 528 SLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 528 sL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+|..++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 998877432 11 2267999999999998 99999999999999999999999999987532221 1222356
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.+..+... ........+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~~-------~p~~~~~~~ 222 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR-------FPRTLSPEA 222 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC-------CCCCCCHHH
Confidence 8999999999999999999999999999999999999986543211 11111111111 111223457
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 681 IKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
.+++..||+.+|++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 8899999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.91 Aligned_cols=244 Identities=21% Similarity=0.230 Sum_probs=188.2
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
..+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 345578999999999999875 47899999986421 22334578999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCCc--c----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 524 MSNGSLADVYSSPPK--N----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~--~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++|+|.+++..... . .+.+|+.||+|||+. +|+||||||+|||++.++.+||+|||++............
T Consensus 125 ~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 125 MPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred CCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 999999998854321 1 267999999999998 9999999999999999999999999999876443322223
Q ss_pred ccccCccccCcccccCC----CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 598 GIRGTRGYVAPEWHWNL----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
...|++.|+|||.+.+. .++.++||||||+++|||++|+.||...... . ....+...... +..+. .
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~~-~~~~~--~ 271 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKNS-LTFPD--D 271 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCCc-CCCCC--c
Confidence 45689999999998653 3788999999999999999999999754321 1 11222211110 10111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSL--RPSMKKVLLM 704 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 704 (724)
......+.+++..|++.+|++ ||++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 122456788899999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=269.13 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=191.5
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|.||.||.|+.+. +-.||+|++.+.. .+-++++++|+++-..|+||||+++++++.+....||++||.+
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 45789999999999998764 5789999997632 2335789999999999999999999999999999999999999
Q ss_pred CCChhhhcCC---------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSS---------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~---------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|.|...|.. ..+..+.|+|.||.|+|.. +++||||||+|+|++.++..||+|||.+.....+ ..
T Consensus 106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~---kR 179 (281)
T KOG0580|consen 106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN---KR 179 (281)
T ss_pred CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC---Cc
Confidence 9999988852 2233488999999999998 9999999999999999999999999998765422 22
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||..|.+||...+...+.+.|+|++|++.||++.|.+||+.....+ ..+.+..- ++.++. ..
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~---~~~~p~----~i 245 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKV---DLKFPS----TI 245 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHc---cccCCc----cc
Confidence 33678999999999999999999999999999999999999998654111 12222211 222222 23
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..|+..+|.+|.+..||+.
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhh
Confidence 345788899999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.58 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc-cceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV-SNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~~ 518 (724)
..+.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 445688999999999999643 24789999987532 22345688899999999 899999999988754 5678
Q ss_pred EEEeeccCCChhhhcCCCC-------------------------------------------------------------
Q 041285 519 LVYEYMSNGSLADVYSSPP------------------------------------------------------------- 537 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 537 (724)
+++||+++++|.+++....
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999988873211
Q ss_pred ---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ceeeccccCccccCcc
Q 041285 538 ---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPE 609 (724)
Q Consensus 538 ---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE 609 (724)
+ ..+.+|+.||+|||+. +|+||||||+|||+++++.+||+|||++..+..... .......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 1 1257999999999998 999999999999999999999999999987643222 1122245677899999
Q ss_pred cccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcc
Q 041285 610 WHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCI 688 (724)
Q Consensus 610 ~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 688 (724)
++.+..++.++|||||||++|||++ |..|+......+. .......+.... .+ ......+.+++.+||
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~--~~----~~~~~~~~~l~~~cl 313 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR--AP----EYATPEIYSIMLDCW 313 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC--CC----ccCCHHHHHHHHHHc
Confidence 9999999999999999999999997 8888865332211 112222221111 11 122356889999999
Q ss_pred cCCCCCCCCHHHHHHHhccCCC
Q 041285 689 LDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 689 ~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+.+|++||++.|++++|+.++.
T Consensus 314 ~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 314 HNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.91 Aligned_cols=241 Identities=23% Similarity=0.265 Sum_probs=187.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +++.||||.++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45678999999999999875 57899999987532 234456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++++|.+++... ... .+.||++||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999988543 111 267999999999998 999999999999999999999999999987654433333
Q ss_pred eccccCccccCccccc------CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 597 TGIRGTRGYVAPEWHW------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
....|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ..............-+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~~~- 233 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKFPED- 233 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCCCCC-
Confidence 3356899999999986 4567889999999999999999999997543211 11122111111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++..|++ +|++||++.++++
T Consensus 234 ---~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 234 ---PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1123457788888998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=301.00 Aligned_cols=234 Identities=24% Similarity=0.295 Sum_probs=184.1
Q ss_pred cccCcCccceEEEEEee----CCcEEEEEEccccc----chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.||+|+||.||++... .++.||||.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 47899999987531 12334678899999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.... . ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999998884322 1 1267999999999998 999999999999999999999999999875432221 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..+... + ....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~-~~~~~~~~~~~--~-----~~~~ 223 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------K-TIDKILKGKLN--L-----PPYL 223 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC--C-----CCCC
Confidence 2346899999999999888999999999999999999999999754321 1 11222222211 1 1112
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
...+.+++.+|++.+|++|| ++.++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 34578999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.22 Aligned_cols=242 Identities=27% Similarity=0.380 Sum_probs=190.5
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.++||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 45568899999999999998888889999987532 34567999999999999999999999875 45689999999999
Q ss_pred ChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++... . ...+.+++.||+|||+. +++|+||||+||++++++.++|+|||++..+..........
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 999988532 1 12267999999999998 99999999999999999999999999998765433222222
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+...... +.. ..+..+... .......
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~------~~~~~~~ 229 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVL-EQVERGYRM------PCPQDCP 229 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCCC------CCCCcCC
Confidence 345678999999988889999999999999999999 78887543211 111 112211110 1112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.88 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=187.6
Q ss_pred cccccCcCccceEEEEEee-CCc----EEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGK----FVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+..+++++|+||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 3478999999999999874 343 478888764322 234678888999999999999999998864 457889999
Q ss_pred ccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-c
Q 041285 524 MSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-R 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~ 594 (724)
+++|+|.+++.... + ..+.||+.||+|||+. +++|+||||+|||+++++.+||+|||+++....... .
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 99999999985322 1 2367999999999998 999999999999999999999999999986643322 2
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..+.+..+.... .+..
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~~~-- 235 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--QPQI-- 235 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--CCCC--
Confidence 2233456789999999998899999999999999999998 888886543211 122233332211 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
....+.+++..|+..+|++||++.|+++.|+....
T Consensus 236 --~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 --CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 12346788899999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.04 Aligned_cols=238 Identities=27% Similarity=0.368 Sum_probs=186.0
Q ss_pred ccCcCccceEEEEEee---CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 453 EIGRGSSGTVYKGTMI---NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 46889999986432 233567999999999999999999999885 45678999999999
Q ss_pred ChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee--ec
Q 041285 528 SLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF--TG 598 (724)
Q Consensus 528 sL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--~~ 598 (724)
+|.+++.... ...+.|++.||+|||+. +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999884321 12267999999999988 999999999999999999999999999987654332211 12
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||.+....++.++|+||||+++|||++ |..||...... . ..+.+..+..... + ....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~i~~~~~~~~--~----~~~~ 224 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------E-VTQMIESGERMEC--P----QRCP 224 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHCCCCCCC--C----CCCC
Confidence 334678999999988889999999999999999998 88888643221 1 1122333221111 1 1233
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+||+.+|++||++.+|+++|++
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 458899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.04 Aligned_cols=242 Identities=27% Similarity=0.388 Sum_probs=189.8
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.+.||+|++|.||++....+..+|+|.+... ....+.+.+|++++++++|+|++++++++. ....+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 4566889999999999999877778999988653 233467899999999999999999999875 45688999999999
Q ss_pred ChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... + ..+.+++.||.|||+. +++|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9999885421 1 2267999999999988 99999999999999999999999999998664332222222
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||......++.++||||||+++|||++ |..|+......+ .......+.. . .......
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-~-----~~~~~~~ 229 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYR-M-----PCPQGCP 229 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-C-----CCCcccC
Confidence 345778999999988889999999999999999999 888876432111 1111222111 0 1112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+|++.+|++||++++|++.|+.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.87 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=193.2
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||+|... +++.||||.+... .......+.+|++++++++||||+++++++.+.+..++++||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45678999999999999875 5789999987542 2233456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC-----C--C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 525 SNGSLADVYSS-----P--P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 525 ~~gsL~~~l~~-----~--~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
++++|.+++.. . . ...+.++++||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999887731 1 1 12367999999999998 999999999999999999999999999887643322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..+ ...+..... +....
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~-~~~~~~~~~-----~~~~~ 230 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSL-CQKIEQCDY-----PPLPT 230 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHH-HHHHhcCCC-----CCCCh
Confidence 1122457889999999988889999999999999999999999986432211 111 122222111 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 23446688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.77 Aligned_cols=191 Identities=24% Similarity=0.393 Sum_probs=160.4
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence 3445678999999999999876 47889999886532 233457899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++.... . ..+.++++||.|||+. .+++|+||||+|||++.++.+||+|||++....... ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~ 160 (333)
T cd06650 86 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160 (333)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---cc
Confidence 9999999885322 1 2267899999999974 269999999999999999999999999987553221 12
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
...|+..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 246889999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=297.38 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=184.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||.||++... +++.||+|.++... ......+.+|++++++++|+||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 345578999999999999875 57899999986432 2234567899999999999999999999999889999999997
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~ 161 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYS 161 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cccc
Confidence 5 8888774321 1 1267999999999998 99999999999999999999999999997643222 1123
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc------------CCcc
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN------------GNLG 664 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------~~~~ 664 (724)
...+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.... ....... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccchhhh
Confidence 3467899999998865 5689999999999999999999999875432221110 0000000 0000
Q ss_pred ccccccc-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIEDED-------VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~~~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.. ........+.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.84 Aligned_cols=235 Identities=25% Similarity=0.311 Sum_probs=181.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 47899999987532 23345678888888777 899999999999999999999999999
Q ss_pred CChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++... . ...+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccc
Confidence 9998877432 1 12367999999999998 999999999999999999999999999875322211 12235
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCc--chhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE--DQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......+..+.+..+... .+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~p~~~~ 229 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------IPRSLS 229 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-------CCCCCC
Confidence 6899999999999999999999999999999999999999642211 1111222333333332221 111223
Q ss_pred HHHHHHHHHcccCCCCCCCC
Q 041285 678 ERMIKVALWCILDEPSLRPS 697 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs 697 (724)
..+.+++..||+.+|++||+
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCC
Confidence 45788999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.42 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=188.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--------------hhHHHHHHHHHhhcccCcCceeeeeeEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--------------EGEREFQTEIKAIGRTHHRNLVRLLGYSF 512 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 512 (724)
+.+.+.||+|.||.|-++... +++.||||++.+... ...+..++|+.+|++++|+|||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 344578999999999999864 588999999865211 11347889999999999999999999988
Q ss_pred cc--cceEEEEeeccCCChhhhcC-------CCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 513 DV--SNKILVYEYMSNGSLADVYS-------SPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 513 ~~--~~~~lv~e~~~~gsL~~~l~-------~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
+. +..|||+|||..|.+...=. ...++.+.++..||+|||.+ +|+||||||+|+||++++++||+|||
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccc
Confidence 64 57899999999988754322 22344578999999999998 99999999999999999999999999
Q ss_pred CccccCCC----CcceeeccccCccccCcccccCCC----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH
Q 041285 584 LAKLMKPD----QTRTFTGIRGTRGYVAPEWHWNLP----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY 655 (724)
Q Consensus 584 l~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~ 655 (724)
.+..+... .........||+.|+|||...++. .+.+.||||+||.||.|+.|+.||...... . ..
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-----~--l~ 328 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-----E--LF 328 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-----H--HH
Confidence 99877322 112233478999999999887643 356889999999999999999999754311 1 22
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
+.+.+..+... ..++..+++.+|++.+|+.||++|.+..+|....
T Consensus 329 ~KIvn~pL~fP-----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 DKIVNDPLEFP-----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHhcCcccCC-----CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 33333333221 1224566788999999999999999999998665
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.82 Aligned_cols=243 Identities=28% Similarity=0.451 Sum_probs=190.1
Q ss_pred cccccCcCccceEEEEEeeC-C---cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-G---KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
..+.||+|+||.||+|+... + ..+|||.+.... ....+++.+|++++.+++|+|++++++++.+.+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 45789999999999998853 3 379999987542 333467899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++++|.+++.... ...+.+++.||+|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (268)
T cd05063 89 ENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165 (268)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence 9999999884321 12267899999999998 999999999999999999999999999986643322211
Q ss_pred e--ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 597 T--GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 597 ~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
. ....+..|+|||.+....++.++||||||+++|||++ |+.|+...... + ....+..+... ...
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~-~~~~i~~~~~~------~~~ 232 (268)
T cd05063 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------E-VMKAINDGFRL------PAP 232 (268)
T ss_pred eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------H-HHHHHhcCCCC------CCC
Confidence 1 1223567999999988889999999999999999997 99998643221 1 11222222110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.53 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=186.5
Q ss_pred cccccCcCccceEEEEEeeCCc---EEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceE
Q 041285 450 FKEEIGRGSSGTVYKGTMINGK---FVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKI 518 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 518 (724)
+.+.||+|+||.||+|+..+.. .+|||.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999986532 6899988643 234456789999999999999999999988542 2468
Q ss_pred EEEeeccCCChhhhcCC---------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCc
Q 041285 519 LVYEYMSNGSLADVYSS---------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~---------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
+++||+++|+|.+++.. ..+ ..+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999887621 111 1267999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 586 KLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 586 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
+.+....... .....+++.|++||.+.+..++.++||||||+++|||++ |+.|+..... .. ..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcCCC
Confidence 8764332211 112345778999999999999999999999999999999 7777754221 11 1223333322
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
... + ......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 233 ~~~--~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQ--P----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC--C----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1 12234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=304.04 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=181.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||+||++... +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999874 47899999986532 2334578999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-----
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT----- 593 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 593 (724)
+|+|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 85 GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999988432 11 1267999999999998 999999999999999999999999999764321000
Q ss_pred -----------------------------------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHh
Q 041285 594 -----------------------------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632 (724)
Q Consensus 594 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~el 632 (724)
.......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 000124689999999999988899999999999999999
Q ss_pred hccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 041285 633 ICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALW--CILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 633 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~evl~~ 704 (724)
++|+.||........ .............-...... ..+.+++.+ |+..+|..||++.|+++.
T Consensus 242 ltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 242 LVGQPPFLAPTPTET------QLKVINWENTLHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HhCCCCCcCCCHHHH------HHHHHccccccCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999976432211 11111101000110001122 234455544 667777789999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.65 Aligned_cols=237 Identities=22% Similarity=0.322 Sum_probs=183.9
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..||+|+||.||+++.++ |+.+|+|+|++.. ..+.+..++|-.+|....++.||+|+..|.+.+.+||||||+|||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 579999999999998765 8999999998742 344567889999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC----------
Q 041285 528 SLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP---------- 590 (724)
Q Consensus 528 sL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~---------- 590 (724)
++..+|... ... .+.+.+-||.-||+. ++|||||||+|+|||..|++||+||||+.-+..
T Consensus 227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~ 303 (550)
T KOG0605|consen 227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLD 303 (550)
T ss_pred cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcch
Confidence 999988542 222 277888999999998 999999999999999999999999999853210
Q ss_pred -------------CCcc----e-------------------eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc
Q 041285 591 -------------DQTR----T-------------------FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC 634 (724)
Q Consensus 591 -------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt 634 (724)
+... . ....+|||.|||||++.+..++..+|.||+||||||||.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv 383 (550)
T KOG0605|consen 304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV 383 (550)
T ss_pred hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh
Confidence 0000 0 011359999999999999999999999999999999999
Q ss_pred cccCCCCCCCcch-hcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 041285 635 CRRCFDQNLPEDQ-VILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS---MKKVLL 703 (724)
Q Consensus 635 g~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 703 (724)
|-+||....+.+. ..+..|.. .+.. +... ....++.+++.+|+. ||++|.- +.||-+
T Consensus 384 GyPPF~s~tp~~T~rkI~nwr~------~l~f---P~~~--~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 384 GYPPFCSETPQETYRKIVNWRE------TLKF---PEEV--DLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CCCCCCCCCHHHHHHHHHHHhh------hccC---CCcC--cccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999987665432 11111111 1111 1111 112557778888888 9999975 556543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.65 Aligned_cols=244 Identities=27% Similarity=0.407 Sum_probs=189.9
Q ss_pred cccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.||+|+||.||+|.... ...+|+|.+.... .....++.+|+.++++++||||+++++.+...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 45789999999999998632 2578999886533 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC-------------------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 523 YMSNGSLADVYSSPP-------------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-------------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
|+++++|.+++.... ...+.+++.||+|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999998874211 12267999999999988 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..|+....+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 99999999999999865433221 1122345678999999988889999999999999999998 888885432211
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+....+... + ........+.+++.+|++.+|++||++.|+++.|++..
T Consensus 238 ----~~~~~~~~~~~---~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 ----LFNLLKTGYRM---E---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ----HHHHHhCCCCC---C---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 12222222111 0 11122346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=289.51 Aligned_cols=243 Identities=24% Similarity=0.394 Sum_probs=187.9
Q ss_pred cccccCcCccceEEEEEeeC----CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccc------e
Q 041285 450 FKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN------K 517 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 517 (724)
+.+.||+|+||.||+|.+.. +..||||+++... .....++.+|++.++.++|+||+++++++.+.+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998753 3679999987532 2334679999999999999999999999876554 7
Q ss_pred EEEEeeccCCChhhhcCCC---------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 518 ILVYEYMSNGSLADVYSSP---------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~---------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
++++||+++++|..++... .. ..+.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 9999999999998887321 11 1268999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCC
Q 041285 585 AKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGN 662 (724)
Q Consensus 585 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 662 (724)
++......... ......+..|+|||.+....++.++||||||+++|||++ |..|+...... + ..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------E-IYDYLRHGN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCC
Confidence 98664332211 112234678999999988889999999999999999999 77777543211 1 112222222
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.... .......+.+++.+|++.+|++||++.||++.|+..
T Consensus 233 ~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLKQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.53 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=192.9
Q ss_pred HhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.....+.++||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4455677899999999999999877788999988753 2345678999999999999999999999887 7789999999
Q ss_pred cCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++++|.+++.... + ..+.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 9999999985421 1 1267999999999988 99999999999999999999999999998664332222
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....++..|+|||.+....++.++|+||||+++|++++ |+.|+...... .+ ...+..+.... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~~------~~~ 226 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EV----IRALERGYRMP------RPE 226 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhCCCCCC------Ccc
Confidence 222345678999999988889999999999999999998 88887643211 11 12222221111 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.....+.+++.+|++.+|++||++.+++++|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 233568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.56 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=191.8
Q ss_pred HhhcccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhcccC-cCceeeeeeEEecccc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSN 516 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 516 (724)
.....+.++||+|+||.||++... .++.||||+++.... ...+.+.+|++++.++. |+||++++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 333445689999999999999863 246899999975422 22347889999999997 9999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCC-----------------------------------------------------------
Q 041285 517 KILVYEYMSNGSLADVYSSPP----------------------------------------------------------- 537 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 537 (724)
.++|+||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999998874311
Q ss_pred ----------------------------------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 538 ----------------------------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 538 ----------------------------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
...+.++++||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 01246899999999987 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999986533221 11122346788999999998889999999999999999998 788875432111
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.....+..+.. ...+. .....+.+++..||+.+|.+||+++||++.|+.++
T Consensus 350 ---~~~~~~~~~~~--~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---QFYNAIKRGYR--MAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHHcCCC--CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11122222211 11111 12356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.19 Aligned_cols=244 Identities=30% Similarity=0.418 Sum_probs=193.6
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.+.||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++......++||||+++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 34566889999999999999887889999998753 34456899999999999999999999999998999999999999
Q ss_pred CChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... + ..+.+++.||.|||+. +++|+||||+||++++++.+||+|||++..+.........
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 99999985432 1 2267899999999998 9999999999999999999999999999876543222222
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+..|+|||.+.+..++.++||||||++++||++ |+.|+...... . ..+....+ .. ...+ ...
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~-----~~~~~~~~-~~-~~~~----~~~ 229 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--E-----VLEQVERG-YR-MPRP----PNC 229 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H-----HHHHHHcC-CC-CCCC----CCC
Confidence 2345678999999998889999999999999999998 88888543211 1 11112111 10 0011 112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...+.+++.+|++.+|++||+++++++.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 4568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.62 Aligned_cols=243 Identities=26% Similarity=0.340 Sum_probs=181.3
Q ss_pred cccCcCccceEEEEEeeC---CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN---GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998654 3579999887543 233457889999999999999999999999999999999999999
Q ss_pred ChhhhcCCC--------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 528 SLADVYSSP--------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 528 sL~~~l~~~--------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+|.+++... .+ ..+.|+++||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999887421 11 1267999999999998 99999999999999999999999999987543332211
Q ss_pred -eeccccCccccCcccccCC-------CCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 596 -FTGIRGTRGYVAPEWHWNL-------PITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 596 -~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.....++..|+|||++... .++.++|+||||+++|||++ |+.||......+. . . .... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~-~---~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--L-T---YTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--H-H---HHhh-cccCCC
Confidence 1224567889999988642 35789999999999999996 9988865332211 1 0 1111 111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.++. ........+.+++..|+ .+|++||++.||++.|+
T Consensus 231 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 11112334677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.86 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=185.7
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.||||.++... ....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999875 47899999997532 23345688899999888 799999999999999999999999999
Q ss_pred CChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++... .. ..+.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 9998877432 22 2267999999999998 99999999999999999999999999987432211 112235
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc--hhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+..+.+..+... + +. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-p~----~~~ 229 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--I-PR----SLS 229 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--C-CC----CCC
Confidence 68999999999999999999999999999999999999996432111 111223333333333221 0 11 123
Q ss_pred HHHHHHHHHcccCCCCCCCC------HHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPS------MKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs------~~evl~ 703 (724)
..+.+++.+|++.+|.+||+ +.++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 45788999999999999997 667753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.23 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=189.7
Q ss_pred cccccCcCccceEEEEEee------CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++.+....++++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 4578999999999999643 3568999998766555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC------------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 524 MSNGSLADVYSSPP------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 524 ~~~gsL~~~l~~~~------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
+++++|.+++.... + ..+.|++.||+|||+. +++|+||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence 99999998874321 1 1257999999999988 999999999999999999999999
Q ss_pred ccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 582 FALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 582 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+ ......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~ 238 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AIECIT 238 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HHHHHH
Confidence 9999765432221 1122345678999999998999999999999999999998 888875432211 111122
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+.... .+. .....+.+++.+||+.+|.+||++.||++.|+.
T Consensus 239 ~~~~~~--~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGRELE--RPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCccCC--CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 221111 111 123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.03 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=191.3
Q ss_pred ccccccCcCccceEEEEEeeC-C--cEEEEEEcccc-cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-G--KFVAVKRLQKM-LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 356789999999999998754 3 35788888743 233456789999999999 799999999999999999999999
Q ss_pred ccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEc
Q 041285 524 MSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS 580 (724)
Q Consensus 524 ~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~ 580 (724)
+++++|.+++.... ...+.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999884311 12267999999999988 99999999999999999999999
Q ss_pred cccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 581 DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 581 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
|||++...... ........+..|+|||.+....++.++||||||+++|||++ |..||...... .. .....
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~-~~~~~ 232 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------EL-YEKLP 232 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHh
Confidence 99998643211 11111223567999999988889999999999999999997 88888653321 11 11222
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNP 717 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p 717 (724)
.+.... ........+.+++..|++.+|.+||++.+++++|+.......+.-+
T Consensus 233 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 233 QGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred cCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 211100 0112234588999999999999999999999999887665544433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.22 Aligned_cols=246 Identities=20% Similarity=0.181 Sum_probs=182.7
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.++||+|+||.||++... .++.||+|.... ..+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 3455688999999999999874 478999997542 356789999999999999999999999999999999985
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|..++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 6787776332 11 2267999999999998 99999999999999999999999999997543322222334
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc-----hhcHHHHHHHHH---------------
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED-----QVILEEWVYQCF--------------- 658 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~-----~~~l~~~~~~~~--------------- 658 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ...+.. +....
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhHHH
Confidence 578999999999999999999999999999999999998765432110 000000 00000
Q ss_pred -------HcCCcccccccc-c-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 659 -------ENGNLGQLIEDE-D-VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 659 -------~~~~~~~~~~~~-~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
............ . ........+.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 0 01123456889999999999999999999985
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=296.27 Aligned_cols=251 Identities=28% Similarity=0.387 Sum_probs=188.4
Q ss_pred ccccccCcCccceEEEEEee-----CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 521 (724)
.+.+.||+|+||.||++... +++.||||++........+.+.+|++++++++|+||+++++++... ...++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 34578999999999999753 4789999998766555667899999999999999999999987643 4678999
Q ss_pred eeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++++|.+++... .+ ..+.++++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 87 EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999998532 11 2267999999999998 999999999999999999999999999987643322
Q ss_pred cee--eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc--------h-hcHHHHHHHHHHcCC
Q 041285 594 RTF--TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--------Q-VILEEWVYQCFENGN 662 (724)
Q Consensus 594 ~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~--------~-~~l~~~~~~~~~~~~ 662 (724)
... ....++..|+|||.+.+..++.++||||||++++||++|..+........ . ........+....+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 111 11223456999999988889999999999999999999876653221000 0 000001111111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.. .........+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 244 ~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 244 RL------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.20 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=190.9
Q ss_pred cccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++.+++|+||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3455789999999999998753 3689999987532 23345789999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCC-------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 521 YEYMSNGSLADVYSSP-------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
|||+++++|.+++... . ...+.+++.||.|||+. +++|+||||+|||++.++.+||+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcc
Confidence 9999999999988431 1 11267999999999988 99999999999999999999999999
Q ss_pred CccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~ 237 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDG 237 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhcC
Confidence 9876543322 11222346788999999988889999999999999999998 888875432211 11222222
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..... + ......+.+++..||+.+|++|||+.++++.|+.
T Consensus 238 ~~~~~--~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDL--P----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCC--C----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 21111 1 1124568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=286.22 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=185.2
Q ss_pred ccCcCccceEEEEEee---CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 453 EIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.||+|+||.||+|.+. .+..||||.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 345799999875432 33467999999999999999999999885 457899999999999
Q ss_pred hhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--eec
Q 041285 529 LADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT--FTG 598 (724)
Q Consensus 529 L~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~~ 598 (724)
|.+++.... ...+.++++||+|||+. +++|+||||+|||++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999885321 12278999999999998 99999999999999999999999999998654332211 112
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||.+....++.++||||||+++||+++ |..|+......+ +...+..+.... .+....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~ 224 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD------CPAECP 224 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC------CCCCCC
Confidence 234678999999988889999999999999999996 888886542211 112222222111 112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
..+.+++..||+.+|++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=273.66 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=194.9
Q ss_pred hcccccccCcCccceEEEEE-eeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc-----ceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-----NKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 520 (724)
.+.+.++||+|||+.||.++ +.+++.+|+|++.....++.+..++|++..++++||||+++++++.... +.|++
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 45567899999999999997 4568899999998877778889999999999999999999999876433 48999
Q ss_pred EeeccCCChhhhcCCCCc-----------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSPPK-----------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~-----------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
+.|...|+|.+.++.... .++.+|.+||++||+. .++++||||||.|||+.+.+.++|.|||.+...+
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 999999999998853221 1267999999999997 3469999999999999999999999999987653
Q ss_pred CCC-----c---ceeeccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH
Q 041285 590 PDQ-----T---RTFTGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 590 ~~~-----~---~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
-.- . ........|..|.|||.+.- ..+++++|||||||+||+|+.|..||+.....
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------------- 247 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------------- 247 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------------
Confidence 211 0 11223457999999998764 45789999999999999999999999753221
Q ss_pred HcCCcccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 659 ENGNLGQLIEDE----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 659 ~~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+.+.-.+... .......+.+.+++++|++.||.+||++.+++..++..
T Consensus 248 -GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 -GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111110 01122677899999999999999999999999988754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.21 Aligned_cols=235 Identities=23% Similarity=0.290 Sum_probs=184.2
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||++... +++.||+|.+.... .....++.+|++++.+++|+||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 57899999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---Cc----chHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP---PK----NNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~---~~----~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|..++... .. ..+.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 998887432 11 226799999999996 5 899999999999999999999999999875432211 12234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.+..+... -+ ......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~~---~p----~~~~~~ 222 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEIR---FP----RTLSPE 222 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCCC---CC----CCCCHH
Confidence 68999999999999999999999999999999999999996533211 11111111111 01 112345
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 680 MIKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
+.+++.+|++.||++|+ ++.++++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 78899999999999997 89998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.27 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=189.8
Q ss_pred cccccccCcCccceEEEEEeeC-----------------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-----------------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLG 509 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 509 (724)
..+.++||+|+||.||++...+ +..||+|.+.... ....+++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3456889999999999987643 2468999987542 234567999999999999999999999
Q ss_pred EEecccceEEEEeeccCCChhhhcCCCC------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 510 YSFDVSNKILVYEYMSNGSLADVYSSPP------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 510 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
++......++++||+++++|.+++.... +..+.+++.||+|||+. +++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence 9999999999999999999999884322 12267999999999988 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc--cccCCCCCCCcchh
Q 041285 572 DENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC--CRRCFDQNLPEDQV 648 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~ 648 (724)
+.++.++|+|||++......... ......+++.|+|||.+....++.++||||||+++|||++ +..|+..... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--~~ 241 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--QQ 241 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--HH
Confidence 99999999999998765433221 1223446788999999988889999999999999999998 5566643221 11
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
. ...+............... .......+.+++.+|++.+|++||++.||++.|+.
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 V-IENAGHFFRDDGRQIYLPR---PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H-HHHHHhccccccccccCCC---ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111111111111111 11223568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=286.22 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=187.9
Q ss_pred cccCcCccceEEEEEeeC----CcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997633 26899999876433 34567999999999999999999999876 4568999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee--e
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF--T 597 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--~ 597 (724)
++|.+++.... ...+.|++.+|+|||+. +++|+||||+|||++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999985432 22378999999999988 999999999999999999999999999986644332211 1
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...++..|+|||.+....++.++||||||+++|||++ |..|+...... .+ ...+..+... .. ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~--~~----~~~~ 223 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV----IAMLESGERL--PR----PEEC 223 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCcC--CC----CCCC
Confidence 2234568999999998899999999999999999998 88888654221 11 1222222111 11 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
...+.+++.+|++.+|++||++.+|+++|++..
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.65 Aligned_cols=244 Identities=22% Similarity=0.231 Sum_probs=185.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 345578999999999999875 47899999986421 22345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 524 MSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++|+|.+++..... ..+.||+.||+|||+. +|+||||||+|||+++++.+||+|||++............
T Consensus 125 ~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 125 MPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred CCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 999999998854321 1267999999999998 9999999999999999999999999999876433322223
Q ss_pred ccccCccccCcccccCCC----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 598 GIRGTRGYVAPEWHWNLP----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
...||+.|+|||.+.... ++.++||||||+++|||++|+.||...... ............... +. .
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--p~--~ 271 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNF--PE--D 271 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCC--CC--c
Confidence 456899999999987543 788999999999999999999999754321 111122111111111 11 1
Q ss_pred HHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSL--RPSMKKVLLM 704 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 704 (724)
......+.+++..|++.++.+ ||++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 122345667778888765543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.11 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=191.1
Q ss_pred cccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
..+.+.||+|+||.||++...+ ...+|+|.+.... .....++.+|++++.++ +|+||+++++++.+....++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3455789999999999998643 3689999987532 23445788999999999 89999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC
Q 041285 520 VYEYMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY 576 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~ 576 (724)
+|||+++++|.+++.... ...+.|++.||.|||+. +|+|+||||+|||+++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 999999999998884211 11367999999999988 9999999999999999999
Q ss_pred eEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHH
Q 041285 577 AKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWV 654 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~ 654 (724)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ .
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~ 243 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------L 243 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------H
Confidence 9999999998764332211 122345678999999988899999999999999999998 888775432111 1
Q ss_pred HHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.+....+.... ........+.+++.+|++.+|++|||+.|+++.|+...
T Consensus 244 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 12222221111 11122456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.31 Aligned_cols=240 Identities=25% Similarity=0.331 Sum_probs=189.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 35678999999999999875 58899999987532 234467899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC-----
Q 041285 525 SNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ----- 592 (724)
Q Consensus 525 ~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~----- 592 (724)
++++|.+++... .. ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 84 PGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999988543 11 2267999999999997 99999999999999999999999999998664332
Q ss_pred -----------------------cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc
Q 041285 593 -----------------------TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649 (724)
Q Consensus 593 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~ 649 (724)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--- 237 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE--- 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH---
Confidence 011223468999999999999999999999999999999999999997543211
Q ss_pred HHHHHHHHHHc--CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 041285 650 LEEWVYQCFEN--GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS-MKKVLLM 704 (724)
Q Consensus 650 l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~ 704 (724)
....+.. ..+.. +.. ......+.+++..|++ +|.+||+ +.|+++.
T Consensus 238 ----~~~~i~~~~~~~~~---p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 ----TYNKIINWKESLRF---PPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHHHHhccCCcccC---CCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111 11110 100 0124557788889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.73 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=188.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++.+++||||+++++++...+..++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 4578999999999999864 5789999988653 2334567999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 528 SLADVYSSP---PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 528 sL~~~l~~~---~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+|..+.... ....+.+++.||.|||+. +|+|+||||+|||++.++.+||+|||++....... .....++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~ 158 (279)
T cd06619 85 SLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTNA 158 (279)
T ss_pred ChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCCChh
Confidence 997654321 123378999999999998 99999999999999999999999999997654321 123467899
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|+|||.+.+..++.++||||||+++|||++|+.||................+.........+ ........+.+++
T Consensus 159 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li 233 (279)
T cd06619 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-----PVGQFSEKFVHFI 233 (279)
T ss_pred hcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-----CCCcCCHHHHHHH
Confidence 99999999889999999999999999999999998653322111111111111111111111 1112234578999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+|++.+|++||+++|+++.
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhhCChhhCCCHHHHhcC
Confidence 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.91 Aligned_cols=236 Identities=25% Similarity=0.388 Sum_probs=191.1
Q ss_pred ccccCcCccceEEEEEeeC--Cc--EEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMIN--GK--FVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
-|+||+|.||.|++|.+.. |+ .||||.++..... ...+|.+|+..|.+|+|+|++||+|...+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4789999999999998853 43 6899999875443 56789999999999999999999999998 78899999999
Q ss_pred CCChhhhcCCCCcc---------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ce
Q 041285 526 NGSLADVYSSPPKN---------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RT 595 (724)
Q Consensus 526 ~gsL~~~l~~~~~~---------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~ 595 (724)
.|||.+.|+..... .+.|||.||.||..+ ++|||||.++|+||.....+||+||||.+-+..++. ..
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999762221 168999999999998 999999999999999999999999999998765443 33
Q ss_pred eec-cccCccccCcccccCCCCCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 596 FTG-IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 596 ~~~-~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
+.. ..-.+.|.|||.+....|+.++|||+|||.||||+++ ..|+-+..... +.+.+.+++ .+. -.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL~~iD~~e---rLp---RP 337 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------ILKNIDAGE---RLP---RP 337 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HHHhccccc---cCC---CC
Confidence 333 4467899999999999999999999999999999984 45665432211 112222221 111 23
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+...+++.++++.||..+|++||++..+.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 445778999999999999999999999973
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=285.50 Aligned_cols=232 Identities=21% Similarity=0.326 Sum_probs=178.7
Q ss_pred cccCcCccceEEEEEeeC-------------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 452 EEIGRGSSGTVYKGTMIN-------------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
+.||+|+||.||+|.... ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998632 2258999887654444567889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC-------eEEcccc
Q 041285 519 LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY-------AKISDFA 583 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~-------~kl~Dfg 583 (724)
+||||+++++|..++.... ...+.||++||+|||+. +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999998875321 12378999999999998 9999999999999986654 8999999
Q ss_pred CccccCCCCcceeeccccCccccCccccc-CCCCCcccceeehhHHHHHhh-ccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQTRTFTGIRGTRGYVAPEWHW-NLPITAKADVYSFGVVLLEII-CCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvll~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
++....... ...++..|+|||.+. ...++.++||||||+++|||+ .|..|+......+. .....+
T Consensus 158 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~~ 224 (262)
T cd05077 158 IPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYEG 224 (262)
T ss_pred CCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHhc
Confidence 987543221 234678899999886 466889999999999999998 57777654321110 111111
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
... ... .....+.+++.+||+.+|.+||++.++++.|+
T Consensus 225 ~~~-~~~------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QCM-LVT------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Ccc-CCC------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 111 11345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.45 Aligned_cols=233 Identities=23% Similarity=0.310 Sum_probs=179.3
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++...+ ++.||||.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998754 7889999987532 22334556677777654 899999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|+|..++.... ...+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99998874321 12268999999999998 99999999999999999999999999997543222 222335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+..... ..+......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~-~~i~~~~~-------~~~~~~~~~ 222 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELF-DSILNDRP-------HFPRWISKE 222 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHcCCC-------CCCCCCCHH
Confidence 6899999999999989999999999999999999999999754321 111 11211111 011112345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHH
Q 041285 680 MIKVALWCILDEPSLRPSMK-KVL 702 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~-evl 702 (724)
+.+++..||+.+|++||++. +++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 77889999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.43 Aligned_cols=242 Identities=21% Similarity=0.229 Sum_probs=185.2
Q ss_pred ccccccCcCccceEEEEEee----CCcEEEEEEccccc----chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML----AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.||+|+||.||+++.. .++.||+|.+.... ....+.+..|+.++.++ +|+||+++++++.+....++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 35678999999999998753 57899999986521 22335678899999999 59999999999999999999
Q ss_pred EEeeccCCChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||||+++|+|.+++... ... .+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999999887432 121 256999999999998 99999999999999999999999999998654433
Q ss_pred cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
........||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ ... +...+..... .
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~-~~~~~~~~~~-------~ 229 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSE-VSRRILKCDP-------P 229 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHH-HHHHHhcCCC-------C
Confidence 3333345789999999998765 478899999999999999999999965332111 111 1121211111 0
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
........+.+++.+||+.+|++|| +++++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1112234578899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=284.43 Aligned_cols=241 Identities=27% Similarity=0.461 Sum_probs=190.6
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.+.||+|+||.||++...+++.+|+|.+... .....+|.+|++++++++|+|++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 456889999999999999877889999988753 2334679999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++... .+. .+.+++.+|+|||+. +++|+||||+||+++.++.+||+|||++...............
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 99888432 222 267899999999988 9999999999999999999999999998765433222222233
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
++.+|+|||.+.+..++.++||||||+++|||++ |..|+...... ... +....+. ....+.. ....
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~-~~~~~~~--~~~~~~~----~~~~ 229 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVV-ETINAGF--RLYKPRL----ASQS 229 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHH-HHHhCCC--CCCCCCC----CCHH
Confidence 5678999999988889999999999999999998 88887643211 111 1122211 1111111 2356
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+||+.+|++||++.|++++|.
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.37 Aligned_cols=240 Identities=29% Similarity=0.392 Sum_probs=184.6
Q ss_pred cccCcCccceEEEEEeeC-Cc--EEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GK--FVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||+|.+.+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999854 33 57889887532 33456789999999999 899999999999999999999999999
Q ss_pred CChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 527 GSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 527 gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
++|.+++.... ...+.+++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999874311 12267899999999987 99999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCC
Q 041285 584 LAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGN 662 (724)
Q Consensus 584 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 662 (724)
++...... ........+..|+|||++....++.++||||||++++||++ |..||...... .. ......+.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~-~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEKLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HH-HHHHhCCC
Confidence 98632211 11111223567999999988889999999999999999997 88888543211 11 11122211
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.. + ........+.+++..|++.+|.+||++.+++++|+.+.
T Consensus 229 ~~---~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL---E---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---C---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 1 01112345889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=295.99 Aligned_cols=235 Identities=21% Similarity=0.299 Sum_probs=183.4
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||+|+... ++.||||.+.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998754 6899999987532 23345677888888866 899999999999999999999999999
Q ss_pred CChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++... . ...+.+|++||.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccccc
Confidence 9998877432 1 12268999999999998 999999999999999999999999999875432221 12335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+.+..+.. ..+.. ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~---~~p~~----~~~~ 222 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV---LYPVW----LSKE 222 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---CCCCC----CCHH
Confidence 68999999999999899999999999999999999999997543211 1122222211 11111 2345
Q ss_pred HHHHHHHcccCCCCCCC-------CHHHHHHH
Q 041285 680 MIKVALWCILDEPSLRP-------SMKKVLLM 704 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RP-------s~~evl~~ 704 (724)
+.+++..|++.+|++|| ++.++++.
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 78899999999999999 77877643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.31 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=179.6
Q ss_pred cccccccCcCccceEEEEEee--CCcEEEEEEccccc--chhHHHHHHHHHhhccc---CcCceeeeeeEEec-----cc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI--NGKFVAVKRLQKML--AEGEREFQTEIKAIGRT---HHRNLVRLLGYSFD-----VS 515 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 515 (724)
+.+.+.||+|+||.||++... +++.||||.++... ......+.+|+.+++++ +||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 345678999999999999863 46789999886432 12234566777766655 69999999999852 34
Q ss_pred ceEEEEeeccCCChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 516 NKILVYEYMSNGSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..++|+||++ ++|.+++.... ...+.||++||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 68888874321 12378999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc---CCc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN---GNL 663 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 663 (724)
..... .......|++.|+|||.+....++.++||||||+++|||++|+.||......+. +...+ ..... ...
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~-~~~~~~~~~~~ 233 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKIL-DVIGLPGEEDW 233 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHH-HHhCCCChhhc
Confidence 65433 122335689999999999888999999999999999999999999876432211 11111 10000 000
Q ss_pred c-------cccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 G-------QLIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~-------~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ...... .........+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000 001122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.44 Aligned_cols=190 Identities=25% Similarity=0.317 Sum_probs=160.0
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||+||++... .++.||||.+.... ......+++|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999875 47899999987532 2233568889999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-----
Q 041285 526 NGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT----- 593 (724)
Q Consensus 526 ~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 593 (724)
+|+|.+++.... . ..+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 161 (363)
T cd05628 85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161 (363)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence 999999885321 1 1267999999999998 999999999999999999999999999875432110
Q ss_pred -----------------------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 594 -----------------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 594 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=289.51 Aligned_cols=240 Identities=26% Similarity=0.302 Sum_probs=187.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
...+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34578999999999999874 57899999986532 122345788999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++++|.+++... .. ..+.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05605 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-- 157 (285)
T ss_pred CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--
Confidence 999998877321 11 1267999999999998 999999999999999999999999999986543222
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . +.+...+..+.. .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~-------~~~~~ 227 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--R-EEVERRVKEDQE-------EYSEK 227 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--H-HHHHHHhhhccc-------ccCcc
Confidence 1234689999999999988999999999999999999999999975432111 1 111111111111 11222
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
....+.+++..|++.||++|| ++.++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 345688999999999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.27 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=189.0
Q ss_pred ccccccCcCccceEEEEEe-----eCCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 520 (724)
.+.+.||+|+||+||++.. .+++.||+|.+.... ......|.+|++++++++|+||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3557899999999988653 346789999987532 23456789999999999999999999998764 357899
Q ss_pred EeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|||+++++|.+++..... ..+.++++||.|||+. +++|+||||+|||+++++.+||+|||++.........
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 999999999998854322 2267999999999998 9999999999999999999999999999866432221
Q ss_pred e--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc--
Q 041285 595 T--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE-- 670 (724)
Q Consensus 595 ~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-- 670 (724)
. .....++..|+|||.+....++.++||||||++++||++|..|+..........+ ...........+...++..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCCC
Confidence 1 1122356679999999888899999999999999999999998764321100000 0000000000000111100
Q ss_pred -ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 671 -DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 671 -~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.........+.+++..||+.+|++||++++|+++|+...
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011223456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.79 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=190.6
Q ss_pred hcccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
...+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++++++|+||+++++++.+....++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 34556889999999999997642 4589999886432 2233468899999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC-----------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 520 VYEYMSNGSLADVYSSPP-----------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-----------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
||||+++|+|.+++.... ...+.+++.||.|||+. +++||||||+|||+++++.+||+||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcC
Confidence 999999999999984311 11367899999999988 9999999999999999999999999
Q ss_pred cCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 583 ALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 583 gl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... + ..+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~-~~~~~~~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------Q-VLKFVMD 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHc
Confidence 99886543222 11122345678999999998899999999999999999998 67777543211 1 1122222
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+..... .......+.+++.+|++.+|++||++.++++.|++..
T Consensus 237 ~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 221111 1112357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.77 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=195.3
Q ss_pred HhhcccccccCcCccceEEEEEee--------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV 514 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 514 (724)
.....+.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 344456688999999999999742 23579999887532 34456799999999999 899999999999999
Q ss_pred cceEEEEeeccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 515 SNKILVYEYMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
...++||||+++++|.+++.... ...+.||++||.|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999884321 01256999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 999999999999998764332221 222345678999999988889999999999999999998 666664321
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIP 714 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 714 (724)
..+. .+.+..+.... . .......+.+++..||+.+|++||+|.|+++.|+.+..+...
T Consensus 245 ~~~~-~~~~~~~~~~~--~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 245 VEEL-FKLLKEGHRMD--K----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHH-HHHHHcCCcCC--C----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1111 12222221111 1 112345688899999999999999999999999987665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.09 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=187.8
Q ss_pred cccccccCcCccceEEEEEee-----------------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-----------------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLG 509 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 509 (724)
..+.++||+|+||.||++... +...+|+|.+.... .....++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345688999999999998532 23468999987542 334467999999999999999999999
Q ss_pred EEecccceEEEEeeccCCChhhhcCCCC------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 510 YSFDVSNKILVYEYMSNGSLADVYSSPP------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 510 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
++...+..++||||+++++|.+++.... ...+.+++.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 9999999999999999999999884321 12267999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCccee-eccccCccccCcccccCCCCCcccceeehhHHHHHhhc--cccCCCCCCCcchh
Q 041285 572 DENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC--CRRCFDQNLPEDQV 648 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt--g~~p~~~~~~~~~~ 648 (724)
+.++.++|+|||++..+........ ....++..|++||......++.++||||||+++|||++ |..|+......+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-- 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-- 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--
Confidence 9999999999999986543322111 12234678999999888889999999999999999998 566765432211
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.. ....+............. .......+.+++.+||+.+|.+||+|.||++.|+
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VI-ENTGEFFRDQGRQVYLPK---PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH-HHHHHHHhhccccccCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 111111111111111111 1122356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=283.69 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=191.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++... +++.|++|.+... .....+++.+|++++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35578999999999999875 5789999987642 23445679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++... . +..+.++++||.|||+. +++|+||+|+||+++.++.+||+|||++......... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 99999988432 1 12367999999999988 9999999999999999999999999998866433221 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+++.|+|||++.+..++.++|+||||++++||++|+.|+...... ........+..... ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~------~~~~ 225 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPPV------SQMY 225 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCC------cccc
Confidence 2345788999999999999999999999999999999999998654311 11122222222111 1123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 4568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=275.37 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=194.2
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccch-h-HHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-G-EREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 526 (724)
++|++|.||.||+|+.+ +++.||+|+++...+. + .-.-.+|+.+|.+++|||||.+-.+... -+..|+|||||++
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 57999999999999875 4789999999753211 1 1235799999999999999999888764 4578999999965
Q ss_pred CChhhhcCCCCcc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSPPKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|..++...... ...|+++|++|||.+ .|+|||||++|+|+.+.|.+||+|||+|+.++.. ....+.
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~ 236 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTP 236 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccCcc
Confidence 777777543321 278999999999999 9999999999999999999999999999988654 334556
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccccc--------
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQL-------- 666 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~-------- 666 (724)
.+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++.|.+....++.... ...+... ..+..
T Consensus 237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCCCccccCCCccccchhhc
Confidence 6779999999998876 5899999999999999999999988776544332211 1111100 00000
Q ss_pred cc--ccc-------cC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCc
Q 041285 667 IE--DED-------VD-KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLL 721 (724)
Q Consensus 667 ~~--~~~-------~~-~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p~~~~ 721 (724)
+. ... +. ....+.-.+++...+..||.+|.|++|.++. +-..+.|.|..|..+.
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMFP 377 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhcC
Confidence 00 000 00 0023556777888899999999999998754 2356777787776654
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.53 Aligned_cols=231 Identities=25% Similarity=0.289 Sum_probs=181.7
Q ss_pred cccCcCccceEEEEEe----eCCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTM----INGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.||+|+||.||++.. ..++.+|+|++..... .....+..|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999875 2578999999875321 233457789999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++... . ...+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceec
Confidence 99999887432 1 12378999999999998 999999999999999999999999999876543321 2233
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+...... .+.....
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~~-------~p~~~~~ 223 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKLG-------MPQFLSP 223 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCCC-------CCCCCCH
Confidence 568999999999998889999999999999999999999987542111 11112222111 1111234
Q ss_pred HHHHHHHHcccCCCCCCCCHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
.+.+++.+||+.+|++||++.+
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCC
Confidence 5778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=294.66 Aligned_cols=236 Identities=25% Similarity=0.299 Sum_probs=183.0
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.+|||.++... ....+.+..|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 46899999997532 23345688999999888 699999999999999999999999999
Q ss_pred CChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 999887743 222 2378999999999998 99999999999999999999999999987532211 112335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||++.+..++.++||||||+++|||++|+.||.............+..+........ .+......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~p~~~~~~ 229 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-------IPRFLSVK 229 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-------CCCCCCHH
Confidence 68999999999999999999999999999999999999997543222222223333333322211 11112345
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 041285 680 MIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~ 698 (724)
+.+++..||+.||++||++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 7789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=287.32 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=189.7
Q ss_pred cccccccCcCccceEEEEEeeC-C---cEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-G---KFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4567889999999999998753 2 36999998753 23345689999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+++++|.+++..... ..+.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 9999999998854221 2267899999999998 9999999999999999999999999998765432211
Q ss_pred -eeec-c--ccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC-Ccccccc
Q 041285 595 -TFTG-I--RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG-NLGQLIE 668 (724)
Q Consensus 595 -~~~~-~--~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~ 668 (724)
.... . ..+..|+|||.+....++.++||||||+++||+++ |..|+...... .. .+.+... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~----~~~i~~~~~~~---- 231 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DV----INAIEQDYRLP---- 231 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcCCcCC----
Confidence 1111 1 12457999999998899999999999999999886 88888643221 11 1111111 111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+....+.+++..||+.+|++||+|.+|+++|++.
T Consensus 232 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=288.03 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=190.6
Q ss_pred hcccccccCcCccceEEEEEee-----CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 518 (724)
+....+.||+|+||.||++... .++.||+|.++... ......+.+|++++++++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3344578999999999999742 46789999987542 33346799999999999999999999998875 5679
Q ss_pred EEEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 519 LVYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+||||+++++|.+++... .+ ..+.+++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999988432 11 2267999999999998 999999999999999999999999999987653
Q ss_pred CCcc--eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCc---------chhcHHHHHHHHHH
Q 041285 591 DQTR--TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE---------DQVILEEWVYQCFE 659 (724)
Q Consensus 591 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~---------~~~~l~~~~~~~~~ 659 (724)
.... ......++..|+|||.+.+..++.++||||||+++|||++++.|....... ........ .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HHHHH
Confidence 3221 112345677899999998888999999999999999999987654322100 01111111 11222
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+.... ........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 241 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 221111 1112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=289.09 Aligned_cols=230 Identities=23% Similarity=0.363 Sum_probs=177.4
Q ss_pred ccCcCccceEEEEEeeC-------------------------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeee
Q 041285 453 EIGRGSSGTVYKGTMIN-------------------------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 507 (724)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998531 13589999876544445678999999999999999999
Q ss_pred eeEEecccceEEEEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----
Q 041285 508 LGYSFDVSNKILVYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---- 575 (724)
Q Consensus 508 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---- 575 (724)
+++|.+....++||||+++++|..++... .. ..+.||++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999888432 11 1278999999999988 999999999999997643
Q ss_pred ---CeEEccccCccccCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhh-ccccCCCCCCCcchhcH
Q 041285 576 ---YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEII-CCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 576 ---~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~ell-tg~~p~~~~~~~~~~~l 650 (724)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|..|+......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 37999999976432221 1246788999998865 56899999999999999994 68888765432211
Q ss_pred HHHHHHHHHc-CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 651 EEWVYQCFEN-GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 651 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
. ..... .... .. ....+.+++..||+.+|++||++.+|++.|.
T Consensus 231 ~----~~~~~~~~~~-----~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E----RFYEKKHRLP-----EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----HHHHhccCCC-----CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11111 0111 11 1235888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=285.46 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=183.2
Q ss_pred cccCcCccceEEEEEeeC----CcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEec-ccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMIN----GKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~~ 525 (724)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ....++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 357999998642 23345678899999999999999999998764 446789999999
Q ss_pred CCChhhhcCCCC----cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--
Q 041285 526 NGSLADVYSSPP----KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT-- 595 (724)
Q Consensus 526 ~gsL~~~l~~~~----~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-- 595 (724)
+++|.+++.... .. .+.++++||.|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999985422 11 256999999999998 99999999999999999999999999997654322111
Q ss_pred -eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 -FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 -~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....++..|+|||.+....++.++||||||+++|||++|..|+..... ...+ . .....+.... .+ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~---~-~~~~~~~~~~--~~----~ 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDI---T-VYLLQGRRLL--QP----E 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH---H-HHHhcCCCCC--CC----C
Confidence 1123457789999999888999999999999999999996554322211 1111 1 1122221110 11 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.....+.+++..||+.+|++||++.||++.|+...
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 12346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.85 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=182.2
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 520 (724)
.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 45678999999999999865 57899999987432 23345688999999999999999999988643 247999
Q ss_pred EeeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||+. ++|.+++... .+ ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 83 FELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99995 6888877432 22 2267999999999998 999999999999999999999999999986432221
Q ss_pred --ceeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH--------HHHHHHHcC
Q 041285 594 --RTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE--------WVYQCFENG 661 (724)
Q Consensus 594 --~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~--------~~~~~~~~~ 661 (724)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||............. .....+...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 11233568999999999866 578999999999999999999999986543211100000 000000000
Q ss_pred Ccc----cccccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 662 NLG----QLIEDEDV-----DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 662 ~~~----~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... .+...... .......+.+++..||+.+|++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00000000 00123457899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.09 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=189.9
Q ss_pred ccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
.+.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++++++|+||+++++++.++...++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999864 35789999987532 234567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC-----------------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 522 EYMSNGSLADVYSSPP-----------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~-----------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
||+++++|.+++.... ...+.+++.||+|||+. +++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEec
Confidence 9999999999884211 12378999999999998 999999999999999
Q ss_pred CCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcH
Q 041285 573 ENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVIL 650 (724)
Q Consensus 573 ~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l 650 (724)
+++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~----- 239 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE----- 239 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999876533221 11112234678999999988899999999999999999997 77777543211
Q ss_pred HHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 651 EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
+ ....+..+..... .......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 240 -~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -E-VIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -H-HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1122333332211 11223568899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=287.64 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=179.6
Q ss_pred cccCcCccceEEEEEeeC---CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN---GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
++||+|+||.||+|.... ...+|+|.+.... .....+|.+|++.++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997654 3478889876432 233457889999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-
Q 041285 528 SLADVYSSPP------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR- 594 (724)
Q Consensus 528 sL~~~l~~~~------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 594 (724)
+|.+++.... ...+.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999884321 12267999999999998 9999999999999999999999999998754332211
Q ss_pred eeeccccCccccCcccccC-------CCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 595 TFTGIRGTRGYVAPEWHWN-------LPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+......+ . .......+.. .+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~----~~~~~~~~~~-~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--V----LKQVVREQDI-KL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H----HHHHhhccCc-cC
Confidence 1122345778999998643 356789999999999999999 666765432111 1 1122222211 11
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
..+ .........+.+++..|+ .+|++||+++||+++|.
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 112223345667777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=286.45 Aligned_cols=242 Identities=28% Similarity=0.336 Sum_probs=179.3
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc-----ceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-----NKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~e~~~ 525 (724)
+.+|.|+||.||+|++.. ++.||||+.-...+ .-.+|+++|+++.|||||+|+-++.... ...||+||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 679999999999999865 68999998754322 2357999999999999999999886432 2358999997
Q ss_pred CCChhhhcCC-----CCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYSS-----PPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~~-----~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~~~ 593 (724)
. +|.++++. ... -...||.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|+.+...+.
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 6 67776642 111 1168999999999997 99999999999999975 8999999999998876554
Q ss_pred ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH-----HHHHHcCC-----
Q 041285 594 RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV-----YQCFENGN----- 662 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~-----~~~~~~~~----- 662 (724)
... ..-|.-|.|||.+.+. .|+.+.||||.||++.||+-|+..|.+....++....--+ .+.+....
T Consensus 182 niS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 182 NIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred cee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 332 2347889999998875 6999999999999999999999998775544332211100 01111111
Q ss_pred --cccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 --LGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 --~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..++.... ........++++++.++++.+|.+|.++.|++.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111 122334566889999999999999999998874
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.05 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=192.4
Q ss_pred ccccccCcCccceEEEEEe-eCCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|++|.||++.. .+++.+|||.+... ......++.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 3457899999999999986 46889999987642 1233457889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 525 SNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 525 ~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
++++|.+++.. ..+ ..+.+|++||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999988742 111 2267999999999998 999999999999999999999999999876643322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+.+..++.++|+||||+++|||++|..|+........ .. .+...... .+....
T Consensus 162 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~~~~~-----~~~~~~ 230 (267)
T cd08229 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKIEQCD-----YPPLPS 230 (267)
T ss_pred -ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HH-hhhhhcCC-----CCCCCc
Confidence 11234578899999999988899999999999999999999999864322111 11 11111111 111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++.+|++.+|++||||.+|+++++..
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 23445688999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=295.21 Aligned_cols=229 Identities=23% Similarity=0.355 Sum_probs=180.2
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.||||.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 47899999987532 23345677888888876 799999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++.... ...+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99998874321 12267999999999998 99999999999999999999999999987543221 112235
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+... .+. .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~~~---~~~----~~~~~ 222 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEVV---YPT----WLSQD 222 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCCC---CCC----CCCHH
Confidence 6899999999999989999999999999999999999999754321 1 11222222211 111 12345
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 041285 680 MIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~ 698 (724)
+.+++..|++.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 7889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=287.93 Aligned_cols=236 Identities=27% Similarity=0.328 Sum_probs=183.1
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||+||++... +++.+|||.+.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 57899999986532 12335678899999999999999999999999999999999999999
Q ss_pred hhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 530 ADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 530 ~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
..++.. ... ..+.||+.||.|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 877621 111 1267999999999998 999999999999999999999999999976543322 1223
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ......... .........
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~-------~~~~~~~~~ 226 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRILNDS-------VTYPDKFSP 226 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-HHHhhcccC-------CCCcccCCH
Confidence 4689999999999999999999999999999999999999975432111 001 111111111 011222345
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
.+.+++..|++.+|++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 688999999999999999 7778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=293.87 Aligned_cols=236 Identities=23% Similarity=0.300 Sum_probs=181.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhh---cccCcCceeeeeeEEecccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAI---GRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.||+|+||.||++... +++.||||.++... ....+.+..|++++ .+++||||+++++++.+.+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999875 57899999987532 22234566666554 56789999999999999999999999
Q ss_pred eccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 523 YMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+++++|..++..... ..+.+|+.||.|||+. +++||||||+|||++.++.+||+|||++........ ..
T Consensus 83 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 158 (324)
T cd05589 83 YAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-RT 158 (324)
T ss_pred CCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-cc
Confidence 9999999888754221 2278999999999998 999999999999999999999999999875322211 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+... .+ ...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~~---~p----~~~ 224 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEVR---YP----RFL 224 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC---CC----CCC
Confidence 23568999999999999999999999999999999999999987543211 11122222111 11 112
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 34578899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=289.42 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=193.0
Q ss_pred hhcccccccCcCccceEEEEEeeC-----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEec-ccceE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKI 518 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 518 (724)
....+.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 344566889999999999999866 6889999987532 3335678899999999999999999999876 46789
Q ss_pred EEEeeccCCChhhhcCCC-----------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 519 LVYEYMSNGSLADVYSSP-----------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~-----------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
+++||+++++|.+++... .+ ..+.+++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999987432 11 1267999999999988 99999999999999999999999999
Q ss_pred CccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
+++.+....... .....++..|+|||.+....++.++||||||+++||+++ |+.|+...... .+ ...+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~ 235 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EM----AAYLKDG 235 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHcC
Confidence 998654333221 122345778999999988889999999999999999999 89888653221 11 1222222
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.... .. ......+.+++.+||+.+|++||++.+++++|+...
T Consensus 236 ~~~~--~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 236 YRLA--QP----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCC--CC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1100 11 112346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=284.68 Aligned_cols=238 Identities=30% Similarity=0.393 Sum_probs=191.1
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.+.||+|++|.||++.. .++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 34568899999999999987 478999999986533 5678999999999999999999999999989999999999999
Q ss_pred ChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... ...+.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~ 158 (256)
T cd05039 86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----S 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----c
Confidence 9999885322 12378999999999998 999999999999999999999999999986632221 2
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...+..|+|||.+....++.++||||||++++|+++ |..|+...... . .......+..... .....
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~~------~~~~~ 225 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----VVPHVEKGYRMEA------PEGCP 225 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCCCCC------ccCCC
Confidence 234678999999988889999999999999999997 88887543211 1 1122222211111 11224
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+|++.+|++||++.|++++|++
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.36 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=188.0
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc--------
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-------- 515 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 515 (724)
.+.+.+.||+|+||+||++... +++.||||.+... .......+.+|+..+..++|+|++++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 4456689999999999999864 6899999998643 2334457889999999999999999988765432
Q ss_pred ceEEEEeeccCCChhhhcCCCC-----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 516 NKILVYEYMSNGSLADVYSSPP-----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
..++||||+++|+|.+++.... ...+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 3679999999999998874311 11267999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 585 AKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 585 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.. .....+..
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~-~~~~~~~~ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVM-HKTLAGRY 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHhcCCC
Confidence 987643322 122335689999999999999999999999999999999999999865321 1111 22222222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.. ........+.+++..||+.+|++||++.++++.
T Consensus 263 ~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 112234568899999999999999999999864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=287.52 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=188.9
Q ss_pred HHHhhcccc--cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 443 LEKMTDGFK--EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 443 l~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
++.+++++. ..||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344555554 47999999999999865 467899999876555566789999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCC------Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSSP------PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~------~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~ 588 (724)
|+||+++++|.+++... ... .+.||++||+|||+. +|+|+||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999988532 111 256999999999988 9999999999999976 678999999998765
Q ss_pred CCCCcceeeccccCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
..... ......++..|+|||++.... ++.++||||||+++|||++|+.|+........ ..+..... ...
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~--~~~--- 230 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF--KIH--- 230 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh--ccC---
Confidence 43221 122245789999999986643 78899999999999999999999864321111 00100000 000
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..........+.+++.+||+.+|++||++.|++.
T Consensus 231 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 ---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0112223456888999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.27 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=188.9
Q ss_pred hcccccccCcCccceEEEEEe------eCCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc-cce
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM------INGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV-SNK 517 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~ 517 (724)
...+.+.||+|+||.||++.. ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 345678999999999999973 346789999997532 23345788999999999 789999999988754 467
Q ss_pred EEEEeeccCCChhhhcCCCC------------------------------------------------------------
Q 041285 518 ILVYEYMSNGSLADVYSSPP------------------------------------------------------------ 537 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 537 (724)
++++||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999998873210
Q ss_pred --------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ceeeccccC
Q 041285 538 --------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGT 602 (724)
Q Consensus 538 --------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt 602 (724)
...+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ .......++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 01256999999999998 999999999999999999999999999986533222 111223456
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
..|+|||.+.+..++.++||||||+++|||++ |..|+........ .......+..... +.. ....+.
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~--~~~----~~~~~~ 312 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA--PDY----TTPEMY 312 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCCC--CCC----CCHHHH
Confidence 78999999988899999999999999999997 8888754322111 1122222221111 111 123588
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 682 KVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+++..||+.+|++||++.||++.|+.+++
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=293.27 Aligned_cols=233 Identities=25% Similarity=0.338 Sum_probs=181.0
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||+|...+ ++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998754 6899999987532 23344567778888764 899999999999999999999999999
Q ss_pred CChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|+|.+++... . ...+.|+++||.|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence 9999888532 1 12268999999999998 999999999999999999999999999875322111 12235
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..... ..+. .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~-~~~~i~~~~~---~~~~----~~~~~ 222 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------E-LFQSIRMDNP---CYPR----WLTRE 222 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC---CCCc----cCCHH
Confidence 6899999999999989999999999999999999999998753211 1 1111221111 1111 12345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHH
Q 041285 680 MIKVALWCILDEPSLRPSMK-KVL 702 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~-evl 702 (724)
+.+++.+||+.+|++||++. ++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHH
Confidence 78889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.60 Aligned_cols=240 Identities=26% Similarity=0.366 Sum_probs=188.2
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
++||+|++|.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988764332 4568999999999999999999999999999999999999999999
Q ss_pred hhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee-ecccc
Q 041285 531 DVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRG 601 (724)
Q Consensus 531 ~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~~g 601 (724)
+++... .. ..+.+++.+|.|||++ +++||||+|+||+++.++.+||+|||++........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 988432 11 1256899999999998 999999999999999999999999999976542221111 11234
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
+..|+|||.+.+..++.++|+||||+++|||++ |..|+....... ....+..+. ... ........+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~--~~~----~~~~~~~~~ 224 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGY--RMP----APQLCPEEI 224 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCC--CCC----CCccCCHHH
Confidence 667999999988889999999999999999999 777775432111 111122111 010 111234568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+++.+|++.+|++||++.|+++.|+.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.99 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=190.2
Q ss_pred ccccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||+|.... +..+|+|.++... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 456789999999999998742 3479999987532 23346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++++|.+++.... ...+.+++.||+|||+. +++|+||||+|||++.++.++|+|||++..+.......
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 99999999985432 12267899999999998 99999999999999999999999999998765433222
Q ss_pred ee--ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FT--GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.. ...++..|+|||.+.+..++.++||||||+++||+++ |..|+......+ ....+.++.. . ..
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~--~----~~ 230 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR--L----PA 230 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc--C----CC
Confidence 11 1233568999999998889999999999999999886 998886533211 1111222210 0 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.......+.+++.+|++.+|.+||+|.+++++|+..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.51 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=182.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 345678999999999999876 578999999875322 223467889999999999999999999999999999999995
Q ss_pred CCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... ...+.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....... ....
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 161 (303)
T cd07869 87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYS 161 (303)
T ss_pred -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCC
Confidence 67776664321 12267999999999998 99999999999999999999999999987543221 1223
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---------cccc-
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---------LGQL- 666 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~~- 666 (724)
...+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .+.. ......... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLER-IFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHH-HHHHhCCCChhhccchhhccccc
Confidence 34578999999988654 578899999999999999999999975422111 1111 111000000 0000
Q ss_pred ------cccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 ------IEDEDV-----DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ------~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+... .......+.+++..|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0011245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=282.05 Aligned_cols=239 Identities=32% Similarity=0.467 Sum_probs=191.9
Q ss_pred cccCcCccceEEEEEeeC----CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++.... +..+|||.+...... ..+.+.+|++.+.+++|+||+++++++.+....++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998864 778999999764333 267899999999999999999999999999999999999999
Q ss_pred CChhhhcCCC---------C-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 527 GSLADVYSSP---------P-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 527 gsL~~~l~~~---------~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
++|.+++... . +..+.++++||+|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998653 1 12278999999999998 999999999999999999999999999987754
Q ss_pred CCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 591 DQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 591 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
... .......++..|+|||.+....++.++||||||++++||++ |..|+...... . ..+....+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~--~~~ 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------E-VLEYLRKGYR--LPK 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCC--CCC
Confidence 332 12223457889999999988889999999999999999999 58888654211 1 1222222211 111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.......+.+++.+|++.+|++||++.|+++.|+
T Consensus 229 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 ----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122456889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=298.83 Aligned_cols=245 Identities=21% Similarity=0.218 Sum_probs=185.8
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3345578999999999999876 47899999986421 2234567889999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 523 YMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+++|+|.+++..... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 124 y~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 124 YMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 9999999998854321 1267999999999998 999999999999999999999999999987654333233
Q ss_pred eccccCccccCcccccCCC----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 597 TGIRGTRGYVAPEWHWNLP----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
....||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ................+.
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~--- 271 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTFPDD--- 271 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccCCCc---
Confidence 3456899999999987543 788999999999999999999999754321 111122111111111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSL--RPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 704 (724)
......+.+++..|++.++.+ ||++.|+++.
T Consensus 272 -~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 272 -NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 123445777888899854443 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=283.97 Aligned_cols=239 Identities=26% Similarity=0.368 Sum_probs=188.4
Q ss_pred cccCcCccceEEEEEeeC--C--cEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN--G--KFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998754 2 3699999987544 556789999999999999999999999988 889999999999
Q ss_pred CChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc--e
Q 041285 527 GSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR--T 595 (724)
Q Consensus 527 gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~--~ 595 (724)
++|.+++.... + ..+.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999885432 1 1267999999999998 9999999999999999999999999999876543221 1
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....++..|+|||.+....++.++||||||+++|||++ |..|+......+ ........... ... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--~~~----~~ 224 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER--LER----PE 224 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc--CCC----Cc
Confidence 112456789999999998899999999999999999998 999886432211 11111111111 111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.....+.+++.+|++.+|++||++.+|++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 23456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=299.82 Aligned_cols=240 Identities=23% Similarity=0.270 Sum_probs=183.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4578999999999999875 57899999997531 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc----
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR---- 594 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~---- 594 (724)
+|+|.+++... .. ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 99999988432 11 2267999999999998 9999999999999999999999999998754321100
Q ss_pred ---------------------------------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCC
Q 041285 595 ---------------------------------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ 641 (724)
Q Consensus 595 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~ 641 (724)
......||+.|+|||++....++.++|||||||++|||++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence 00123589999999999999999999999999999999999999975
Q ss_pred CCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 041285 642 NLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS---MKKVLL 703 (724)
Q Consensus 642 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 703 (724)
..... .. ..+..... .+..+... .....+.+++..|+. +|.+|++ +.|+++
T Consensus 242 ~~~~~------~~-~~i~~~~~-~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 242 DNPQE------TY-RKIINWKE-TLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCHHH------HH-HHHHcCCC-ccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 43211 11 11111110 01111110 123346677777886 8999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.36 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=181.8
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||.||++... +|+.+|+|.+.... ....+.+..|++++.+++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 48999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hhhcCCC-----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 530 ADVYSSP-----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 530 ~~~l~~~-----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
.+++... .+. .+.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 8877321 111 257999999999998 99999999999999999999999999988664322 222346
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ...... .......... . .......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~-~~~~~~~~~~--~----~~~~~~~~ 226 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELK-RRTLEDEVKF--E----HQNFTEES 226 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHH-HHhhcccccc--c----cccCCHHH
Confidence 8999999999998889999999999999999999999986432211 111111 1111111110 0 01224457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+++..||+.+|++||+++|+++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchh
Confidence 89999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=278.27 Aligned_cols=249 Identities=25% Similarity=0.304 Sum_probs=189.2
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec-----ccceEEEEe
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-----VSNKILVYE 522 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~e 522 (724)
.+.||+|++|.|..+... +|+.||||++... .....++..+|+.+|+.++|+||+.+...+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 367999999999999874 5899999999843 33445778899999999999999999998765 356899999
Q ss_pred eccCCChhhhcCCCC-cc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC-cc
Q 041285 523 YMSNGSLADVYSSPP-KN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~-~~ 594 (724)
+| ..+|...++... .. .+.|+++||+|+|+. +|+||||||+|+|++.+...||+|||+|+...... ..
T Consensus 107 lM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred HH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 99 778988886544 21 178999999999998 99999999999999999999999999999875431 23
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH-----------------HHHH
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE-----------------WVYQ 656 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~-----------------~~~~ 656 (724)
.++..+-|.-|.|||.+.. ..|+...||||.|||+.||++|+..|-+.....+..+.- .++.
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 3456678999999998754 579999999999999999999999987654333322110 1111
Q ss_pred HHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+..-.......-...-+......++++.+||..||.+|+|++|.+.
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111000000000011123456889999999999999999999874
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.93 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=194.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|++|.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 345688999999999999986 6889999988632 123356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC-------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 524 MSNGSLADVYSSP-------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 524 ~~~gsL~~~l~~~-------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+++++|.+++... . ...+.++++||.|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999887421 1 12267899999999998 99999999999999999999999999987654332
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... +... .+....+..... .
T Consensus 161 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~~-----~ 229 (267)
T cd08224 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDYPPL-----P 229 (267)
T ss_pred c-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCCCCC-----C
Confidence 1 112245788999999998888999999999999999999999998643211 1111 112222221111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.......+.+++.+|++.+|++||++.+|+++|++.
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345688999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.43 Aligned_cols=232 Identities=23% Similarity=0.319 Sum_probs=178.8
Q ss_pred cccCcCccceEEEEEeeC--------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.||+|+||.||+|.... ...+|+|.+........+++.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 235888888655445556889999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC--------eEEccccCccc
Q 041285 524 MSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY--------AKISDFALAKL 587 (724)
Q Consensus 524 ~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~--------~kl~Dfgl~~~ 587 (724)
+++|+|.+++.... + ..+.||+.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999985422 1 1267999999999998 9999999999999987765 69999999865
Q ss_pred cCCCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhcccc-CCCCCCCcchhcHHHHHHHHHHcCCccc
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRR-CFDQNLPEDQVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 665 (724)
..... ...++..|+|||++.+. .++.++||||||+++|||++|.. |+....... .. .... ... .
T Consensus 158 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~-~~~-~ 223 (258)
T cd05078 158 VLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYE-DRH-Q 223 (258)
T ss_pred cCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHH-ccc-c
Confidence 43221 23467889999998764 57899999999999999999964 443221111 00 1111 110 0
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 666 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
........+.+++..||+.+|++||+++++++.|+
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 ------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11112245889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.98 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=177.8
Q ss_pred ccCcCccceEEEEEeeCC---cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 453 EIGRGSSGTVYKGTMING---KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976543 356677665432 2345689999999999999999999999999999999999999999
Q ss_pred hhhhcCCCC-----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-cee
Q 041285 529 LADVYSSPP-----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTF 596 (724)
Q Consensus 529 L~~~l~~~~-----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~ 596 (724)
|.+++.... ...+.||++||+|||+. +++|+||||+|||++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999885321 12267899999999988 999999999999999999999999999864322111 112
Q ss_pred eccccCccccCcccccC-------CCCCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 597 TGIRGTRGYVAPEWHWN-------LPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .+........ ....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccCC
Confidence 23457889999998743 2457899999999999999975 556543221 1111222222 1222222
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.. .......+.+++..|| .+|++||++++|+++|.
T Consensus 232 ~~~-~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL-ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc-CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 211 1113345777888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.86 Aligned_cols=236 Identities=28% Similarity=0.397 Sum_probs=193.3
Q ss_pred ccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChhh
Q 041285 453 EIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD 531 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 531 (724)
.||+|.+|+||.|+..+ ...+|||.+.....+..+-+.+|+.+-++|+|+|||+++|.|.+++..-+.||.+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999998765 45899999987555666779999999999999999999999999999999999999999999
Q ss_pred hcCCC--Cc----ch----HHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCccccCCCCcceeeccc
Q 041285 532 VYSSP--PK----NN----LIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 532 ~l~~~--~~----~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+|+.. +. .. -.||++||.|||++ .|||||||-.|||++ -.|.+||+|||-++.+..-.. ....+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccc
Confidence 98531 11 11 57999999999999 999999999999996 578999999999987653322 223367
Q ss_pred cCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 601 GTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 601 gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
||..|||||++..++ |..++|||||||.+.||.||++||........ ..++-|... .....+.+..+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmyK---vHP~iPeelsa 806 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMYK---VHPPIPEELSA 806 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhccee---cCCCCcHHHHH
Confidence 899999999998764 88999999999999999999999976433221 222222221 12245667788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+..++++|+.++|.+||+++++++
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhcc
Confidence 8999999999999999999999874
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.07 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=192.4
Q ss_pred ccccccCcCccceEEEEEee-----CCcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 520 (724)
.+.+.||+|+||.||+++.. .++.+|||.+...... ..++|.+|++++++++|+||+++++++.. ....+++
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 34578999999999999864 3578999999764332 46789999999999999999999999887 5578999
Q ss_pred EeeccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+||+++++|.+++.... ...+.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999985433 22378999999999998 99999999999999999999999999998765322
Q ss_pred cc-e-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcch---------hcHHHHHHHHHHcC
Q 041285 593 TR-T-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ---------VILEEWVYQCFENG 661 (724)
Q Consensus 593 ~~-~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~---------~~l~~~~~~~~~~~ 661 (724)
.. . .....++..|++||.+.+..++.++||||||++++||++|+.|+........ ...... .+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-LELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH-HHHHHcC
Confidence 21 1 1123446679999999888999999999999999999999988764321110 011111 1111111
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
... .........+.+++.+|++.+|++||+|.||+++|+.+
T Consensus 243 ~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 ERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 100 01112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=289.96 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=190.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||+|++|.||+|+.. +++.||+|.+..........+.+|+.+++.++|+||+++++++......++||||++++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 34577999999999999864 57899999987654455567899999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 528 SLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 528 sL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+|.+++..... ..+.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ......+
T Consensus 103 ~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 178 (296)
T cd06654 103 SLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 178 (296)
T ss_pred CHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccC
Confidence 99998854321 2267899999999998 999999999999999999999999999876543221 1122457
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
++.|+|||.+.+..++.++||||||+++|||++|+.||....+... .......+ ....- ........+.
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~~~~----~~~~~~~~l~ 247 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPELQ----NPEKLSAIFR 247 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-CCCCC----CccccCHHHH
Confidence 8899999999888899999999999999999999999965432111 11111111 11111 1122345588
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+++.+||+.+|++||++.|+++.
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhC
Confidence 89999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=290.68 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=191.2
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
..+.+.||+|+||.||++... .+..||||.++... ....+.+.+|+++++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 445678999999999999752 24579999887532 23345789999999999 79999999999999999999
Q ss_pred EEeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 520 VYEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
|+||+++++|.+++... .+ ..+.+++.||+|||+. +++|+||||+|||++.++.+||+|||++.....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999988532 21 1267899999999998 999999999999999999999999999986643
Q ss_pred CCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 591 DQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 591 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
..... .....++..|+|||.+....++.++||||||+++|||++ |..|+........ .......+.... .
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~--~ 265 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYRMA--Q 265 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCcCC--C
Confidence 32211 122345778999999999999999999999999999998 8888764322111 112222221110 1
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
+ ......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 266 ~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 P----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 11234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=286.54 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=187.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||+|+.. +++.||+|++........+.+++|+.++.+++|+||+++++++...+..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 345678999999999999874 5789999998754444556788999999999999999999999999999999999999
Q ss_pred CChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++... .. ..+.|+++||.|||+. +|+|+||+|+||+++.++.+||+|||++........ .....
T Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 166 (267)
T cd06646 91 GSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSF 166 (267)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCcc
Confidence 9999987432 11 1267999999999998 999999999999999999999999999986643221 11224
Q ss_pred ccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 600 RGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 600 ~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
.+++.|+|||.+. ...++.++||||||+++|||++|+.|+....+.... ........... ........
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~ 237 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSNFQPP--KLKDKTKW 237 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCCCCCC--CCcccccc
Confidence 5788999999874 345788999999999999999999988543221110 00000111000 00001122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
...+.+++..||+.+|++||+++++++.|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 45688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.64 Aligned_cols=241 Identities=21% Similarity=0.224 Sum_probs=181.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||++... +++.||||.+.... ....+.+++|++++.+++||||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4578999999999999864 57899999986531 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc----
Q 041285 526 NGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR---- 594 (724)
Q Consensus 526 ~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~---- 594 (724)
+|+|.+++.... . ..+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 999999884321 1 2267999999999998 9999999999999999999999999998643211000
Q ss_pred ------------------------------------------eeeccccCccccCcccccCCCCCcccceeehhHHHHHh
Q 041285 595 ------------------------------------------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632 (724)
Q Consensus 595 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~el 632 (724)
......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhh
Confidence 00013589999999999998999999999999999999
Q ss_pred hccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 041285 633 ICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLR---PSMKKVLLM 704 (724)
Q Consensus 633 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~~ 704 (724)
++|+.||......+. ............. +.. ......+.+++..|++ +|.+| |++.|+++.
T Consensus 242 ltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 242 LIGWPPFCSENSHET------YRKIINWRETLYF--PDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCCCCCHHHH------HHHHHccCCccCC--CCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999975432111 1111111111111 110 0123446778888887 66665 699998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.06 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=189.9
Q ss_pred ccccccCcCccceEEEEEee-CCc----EEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGK----FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||.||+|... +++ .||||.++.. .....+++.+|+.++..++|+||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 34578999999999999853 444 4899998653 23345678999999999999999999999976 45789999
Q ss_pred eccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+++|+|.+++..... ..+.||++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 9999999999854221 2278999999999998 9999999999999999999999999999876533221
Q ss_pred e-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 595 T-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 595 ~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
. .....++..|+|||...+..++.++||||||+++|||++ |..|+..... ..+ ...+..+.....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~~~------ 232 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REI----PDLLEKGERLPQ------ 232 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCCcCCC------
Confidence 1 122345678999999988899999999999999999998 8888754321 111 122222211111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
.......+.+++..||+.+|++||++.++++.|+.....+
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1122346788999999999999999999999998765444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=282.31 Aligned_cols=230 Identities=23% Similarity=0.360 Sum_probs=179.1
Q ss_pred cccCcCccceEEEEEeeCCc-----------EEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 452 EEIGRGSSGTVYKGTMINGK-----------FVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5788877654332 6789999999999999999999999988 778999
Q ss_pred EeeccCCChhhhcCCCC----cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-------CeEEccccCc
Q 041285 521 YEYMSNGSLADVYSSPP----KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-------YAKISDFALA 585 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~----~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-------~~kl~Dfgl~ 585 (724)
+||+++++|.+++.... .. .+.||+.||+|||+. +|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999985422 11 267999999999988 999999999999999887 7999999998
Q ss_pred cccCCCCcceeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHHcCC
Q 041285 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENGN 662 (724)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~ 662 (724)
...... ....++..|+|||++... .++.++||||||+++|||++| ..|+........ . ..+....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~-~~~~~~~ 223 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------E-RFYQDQH 223 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------H-HHHhcCC
Confidence 865431 123456789999998876 789999999999999999995 556544321111 0 1111110
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
. . .. .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 ~--~-~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 R--L-PM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--C-CC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 00 01157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=285.64 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=190.6
Q ss_pred hcccccccCcCccceEEEEEeeCC----cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMING----KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||+|...+. ..||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 344668899999999999987542 478999887543 3445689999999999999999999998875 4578999
Q ss_pred eeccCCChhhhcCCCC----cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP----KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~----~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++++|.+++.... +. .+.+++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999985422 21 267999999999988 999999999999999999999999999986654432
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......++..|+|||.+....++.++||||||++++|+++ |..||......+. . ..+..+.... .+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~-~~~~~~~~~~--~~--- 230 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------I-GRIENGERLP--MP--- 230 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHHcCCcCC--CC---
Confidence 22222344578999999988889999999999999999986 9999865432111 1 1122221111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
......+.+++.+|+..+|++||++.++++.|++..
T Consensus 231 -~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 231 -PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122346888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=287.29 Aligned_cols=241 Identities=26% Similarity=0.367 Sum_probs=186.0
Q ss_pred cccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.||+|++|.||++.... +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 34789999999999998854 4678999886433 3334579999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC----------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---CeEEccccCc
Q 041285 523 YMSNGSLADVYSSPP----------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---YAKISDFALA 585 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~----------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfgl~ 585 (724)
|+++++|.+++.... + ..+.+|++||+|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 999999999874321 1 1367999999999998 999999999999998654 5999999999
Q ss_pred cccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 586 KLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 586 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
+......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||....... . ...+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~-~~~~~~~~~ 239 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------V-MEFVTGGGR 239 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHHcCCc
Confidence 8763322111 112233568999999998999999999999999999997 888886533211 1 111211111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.. ........+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10 11122356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.50 Aligned_cols=190 Identities=24% Similarity=0.328 Sum_probs=158.9
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.++||+|+||.||++... .++.+|||.+.... ......+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4578999999999999875 47899999987532 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-----
Q 041285 526 NGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT----- 593 (724)
Q Consensus 526 ~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 593 (724)
+|+|.+++.... . ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 85 GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 999999885421 1 1267999999999998 999999999999999999999999999753311000
Q ss_pred -----------------------------------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHh
Q 041285 594 -----------------------------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEI 632 (724)
Q Consensus 594 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~el 632 (724)
.......||+.|+|||.+.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 001124689999999999999999999999999999999
Q ss_pred hccccCCCCC
Q 041285 633 ICCRRCFDQN 642 (724)
Q Consensus 633 ltg~~p~~~~ 642 (724)
++|+.||...
T Consensus 242 ltG~~Pf~~~ 251 (382)
T cd05625 242 LVGQPPFLAQ 251 (382)
T ss_pred HhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=292.96 Aligned_cols=234 Identities=23% Similarity=0.310 Sum_probs=183.7
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++.... ++.||||.++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998764 6899999987532 23345677888888887 799999999999999999999999999
Q ss_pred CChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++... .+. .+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccce
Confidence 9998887432 222 267999999999998 999999999999999999999999999875322211 12234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||...... . ....+...... .+ ......
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~~~---~~----~~~~~~ 222 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDEVR---YP----RWLSKE 222 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCCC---CC----CcCCHH
Confidence 5899999999999999999999999999999999999999653211 1 11222222111 11 122345
Q ss_pred HHHHHHHcccCCCCCCCCH-----HHHHH
Q 041285 680 MIKVALWCILDEPSLRPSM-----KKVLL 703 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~-----~evl~ 703 (724)
+.+++.+||+.+|.+||++ .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 7899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.59 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccc--ccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|.|+.||+... +.|+.+|+|.+.. ....+.+++.+|+++-+.|+|||||+|.....+....++|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 33457899999999999865 4688888887643 33446788999999999999999999999999999999999999
Q ss_pred cCCChhhhc-CC-----CC-cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCcc
Q 041285 525 SNGSLADVY-SS-----PP-KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 525 ~~gsL~~~l-~~-----~~-~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
.|+.|..-+ .+ .. ...+.||+++|.|+|.+ +|+|||+||.|+||.. ...+||+|||++..+. ...
T Consensus 93 ~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~ 167 (355)
T KOG0033|consen 93 TGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGE 167 (355)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--Ccc
Confidence 999997544 11 11 11267999999999999 9999999999999954 3458999999999887 233
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
...+..|||+|||||++...+++..+|||+.||+||-|+.|..||.... +.. +.+.+..+.... ++ ....
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~r----lye~I~~g~yd~--~~-~~w~ 237 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHR----LYEQIKAGAYDY--PS-PEWD 237 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHH----HHHHHhccccCC--CC-cccC
Confidence 3455789999999999999999999999999999999999999997632 111 334444443321 11 1222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+...+++.+|+..||.+|.|+.|.++
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 33455778889999999999999998764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.85 Aligned_cols=237 Identities=29% Similarity=0.388 Sum_probs=185.7
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEe-cccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF-DVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~~ 526 (724)
..+.+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++++++|+|++++++++. +....++++||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 44568899999999999977 4778999988653 23467899999999999999999999765 45678999999999
Q ss_pred CChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... ...+.+++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC----
Confidence 99999885322 12367999999999998 999999999999999999999999999875433221
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+..|+|||++....++.++||||||+++|||++ |+.|+.... +.... ..+..+..... ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~-~~~~~~~~~~~------~~~~ 224 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVV-PRVEKGYKMDA------PDGC 224 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHhcCCCCCC------CCCC
Confidence 1234568999999988889999999999999999997 888875432 11111 11222211111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...+.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 4568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=293.99 Aligned_cols=231 Identities=26% Similarity=0.290 Sum_probs=178.1
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHH-hhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIK-AIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||+++.. +++.+|||.+.... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999864 58899999986532 223345556654 46778999999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++.... ...+.||++||.|||+. +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 99988774321 12267999999999998 99999999999999999999999999987532211 112335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... + ..+.+..+.+. +. ......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~-~~~~~~~~~~~--~~-----~~~~~~ 222 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------E-MYDNILHKPLV--LR-----PGASLT 222 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------H-HHHHHHcCCcc--CC-----CCCCHH
Confidence 6899999999999999999999999999999999999999754211 1 11222222111 11 122345
Q ss_pred HHHHHHHcccCCCCCCCCHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~e 700 (724)
+.+++..|++.+|.+||++++
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCC
Confidence 778899999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.71 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=180.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.||||.++... ......+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 47899999987532 22345567788887754 899999999999999999999999999
Q ss_pred CChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++... .. ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 9998887432 11 1267999999999998 99999999999999999999999999987432111 122335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+.. ..+. .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~-~~~~~~~~~~---~~~~----~~~~~ 222 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------E-LFESIRVDTP---HYPR----WITKE 222 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC---CCCC----CCCHH
Confidence 6899999999999999999999999999999999999999654211 1 1122221111 0011 12345
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHH
Q 041285 680 MIKVALWCILDEPSLRPSMK-KVL 702 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~-evl 702 (724)
+.+++..||+.||++||++. +++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 77899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=300.31 Aligned_cols=241 Identities=21% Similarity=0.263 Sum_probs=181.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||+++.. .++.||||.+.... ......+.+|++++.+++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999875 47899999986532 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc----
Q 041285 525 SNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT---- 593 (724)
Q Consensus 525 ~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~---- 593 (724)
++|+|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 84 PGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999885422 1 1267999999999998 999999999999999999999999999753320000
Q ss_pred --------------------------------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhcc
Q 041285 594 --------------------------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC 635 (724)
Q Consensus 594 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg 635 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 001124689999999999999999999999999999999999
Q ss_pred ccCCCCCCCcchhcHHHHHHHHHHcCCcc-ccccccccCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 041285 636 RRCFDQNLPEDQVILEEWVYQCFENGNLG-QLIEDEDVDKKQLERMIKVALWCILDEPSLRP---SMKKVLLM 704 (724)
Q Consensus 636 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~evl~~ 704 (724)
+.||......+. ... +...... ......... ..+.+++..|+ .+|.+|+ ++.|+++.
T Consensus 241 ~~Pf~~~~~~~~------~~~-i~~~~~~~~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAET------QLK-VINWETTLHIPSQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHH------HHH-HhccCccccCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999976432211 111 1111110 111111122 23455555555 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=291.26 Aligned_cols=242 Identities=29% Similarity=0.393 Sum_probs=185.3
Q ss_pred ccccccCcCccceEEEEEeeC-Cc--EEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GK--FVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||++...+ +. .+|+|.+.... ....+++.+|++++.++ +|+||+++++++.+....++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 456889999999999998753 43 46888776432 33456789999999999 899999999999999999999999
Q ss_pred ccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEc
Q 041285 524 MSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS 580 (724)
Q Consensus 524 ~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~ 580 (724)
+++++|.+++.... ...+.|+++||+|||+. +++||||||+|||++.++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 99999999884211 11267999999999988 99999999999999999999999
Q ss_pred cccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 581 DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 581 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
|||++...... .......++..|+|||.+....++.++||||||+++|||++ |..|+...... +. .+...
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~-~~~~~ 237 (303)
T cd05088 167 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEKLP 237 (303)
T ss_pred ccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HH-HHHHh
Confidence 99998642211 01111224668999999988889999999999999999998 88888643221 11 11111
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+.... ........+.+++.+|++.+|++||++.+++++|+.+
T Consensus 238 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 238 QGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred cCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111000 0111234578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.20 Aligned_cols=230 Identities=27% Similarity=0.314 Sum_probs=177.9
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHH-hhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIK-AIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.||||.+.... ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999875 58899999987532 122334555554 56788999999999999999999999999999
Q ss_pred CChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|..++.... . ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence 99988874321 1 1268999999999998 99999999999999999999999999987532211 122335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +. .+.+..+... + .......
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~-~~~i~~~~~~--~-----~~~~~~~ 222 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EM-YDNILNKPLR--L-----KPNISVS 222 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HH-HHHHHcCCCC--C-----CCCCCHH
Confidence 6899999999999999999999999999999999999998753211 11 1222222111 1 1112455
Q ss_pred HHHHHHHcccCCCCCCCCHH
Q 041285 680 MIKVALWCILDEPSLRPSMK 699 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~ 699 (724)
+.+++.+|++.+|.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 88899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=291.80 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=191.4
Q ss_pred HhhcccccccCcCccceEEEEEeeC--------CcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV 514 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 514 (724)
...+.+.+.||+|+||.||++.... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3455677899999999999997532 2469999987532 33446788999999999 799999999999999
Q ss_pred cceEEEEeeccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 515 SNKILVYEYMSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
...++|+||+++++|.+++... .+ ..+.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999998432 11 1267999999999988 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
+.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999987654322111 112234578999999988889999999999999999998 7777754221
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.. .......+.... ........+.+++..|++.+|++||+|.+|++.|+.+.
T Consensus 249 -~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 -EE-LFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HH-HHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 112222221111 11123456788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.77 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=194.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccc-eEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN-KILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~ 524 (724)
...+.+|+|+||.++..+.+ +++.+++|.+.-. .....+....|+.++++++|||||.+.+.+.+.+. .++||+|+
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 34578999999999988765 4678999987642 23333467899999999999999999999999988 89999999
Q ss_pred cCCChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+||+|.+.+.... ...+.|++.|+.|||++ .|+|||||+.|||++.+..+||+|||+|+.+..+...
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~- 162 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL- 162 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhh-
Confidence 9999999884432 22378999999999988 9999999999999999999999999999998766522
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.||+||.+.+.+|..|+|||||||++|||++-+++|..... ...+.+..... ++ ..+..
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~~-----~~--Plp~~ 229 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRGL-----YS--PLPSM 229 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhcc-----CC--CCCcc
Confidence 2346899999999999999999999999999999999999999876432 22222222211 11 22334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+..++..|++.+|..||++.+++.+
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 55668889999999999999999999865
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.51 Aligned_cols=230 Identities=26% Similarity=0.298 Sum_probs=177.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHH-hhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIK-AIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||+++.. +++.||+|.+.... .....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 47899999986532 122334555554 57888999999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|...+.... ...+.||++||.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 99988774321 12267999999999988 99999999999999999999999999987532211 122335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... .+.+..+... ........
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~-~~~i~~~~~~-------~~~~~~~~ 222 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQM-YDNILHKPLQ-------LPGGKTVA 222 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHH-HHHHhcCCCC-------CCCCCCHH
Confidence 689999999999988999999999999999999999999975421 111 1222222111 11123445
Q ss_pred HHHHHHHcccCCCCCCCCHH
Q 041285 680 MIKVALWCILDEPSLRPSMK 699 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~ 699 (724)
+.+++.+|++.+|.+||+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 88999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=284.58 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=186.4
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.++||+|+||.||+|.... ++.+|+|.+........+.+.+|+.++++++|+||+++++++......++||||++++
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGG 94 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence 355789999999999998754 7899999987655556678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|..++... .+ ..+.|++++|+|||+. +++||||||+||+++.++.+||+|||++....... ......
T Consensus 95 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 170 (292)
T cd06644 95 AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF 170 (292)
T ss_pred cHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccccee
Confidence 998876321 11 2278999999999998 99999999999999999999999999987543221 111234
Q ss_pred ccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 600 RGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 600 ~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... ..... ...........+ .
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~----~ 239 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLSQP----S 239 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHH-HhcCCCccCCCC----c
Confidence 5788999999885 345678999999999999999999998653221 11111 111111111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 22345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.96 Aligned_cols=232 Identities=24% Similarity=0.326 Sum_probs=180.4
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCc-CceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHH-RNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||+|...+ ++.||||.+.... ....+.+..|.+++..++| ++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 356789999999999998754 6789999987532 2344568889999999965 5688899999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++... .. ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 158 (324)
T cd05587 83 VNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTT 158 (324)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cce
Confidence 9999999887432 11 1267999999999998 99999999999999999999999999987432211 122
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+...... .....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~-------~~~~~ 224 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVS-------YPKSL 224 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC-------CCCCC
Confidence 33568999999999999999999999999999999999999997543211 11222222111 01112
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 041285 677 LERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
...+.+++..|++.+|.+||+.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCC
Confidence 3457889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.99 Aligned_cols=238 Identities=26% Similarity=0.404 Sum_probs=189.2
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||+|++|.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 345789999999999999865 78999999875422 678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... .+ ..+.++++||.|||+. +++|+||+|+||+++.++.+||+|||++........ .....
T Consensus 84 ~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 159 (256)
T cd06612 84 SVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV 159 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence 999988432 11 2378999999999998 999999999999999999999999999987643321 12224
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ........... .........
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~~~~ 228 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPPPTL----SDPEKWSPE 228 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCCCCC----CchhhcCHH
Confidence 4788999999998889999999999999999999999998754321110 00111111110 111223356
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.+++..|++.+|++||++.||++
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhc
Confidence 888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.88 Aligned_cols=233 Identities=26% Similarity=0.293 Sum_probs=178.5
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHH-hhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIK-AIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.+|+|.+.... .....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 46789999987532 122334444544 56778999999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++.... ...+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 99998885422 11267999999999998 99999999999999999999999999987543221 122335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +.. +.+...... ........
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-~~i~~~~~~-------~~~~~~~~ 222 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMY-DNILNKPLQ-------LKPNITNS 222 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHH-HHHHhCCcC-------CCCCCCHH
Confidence 6899999999999999999999999999999999999999753211 111 111111111 11122345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
+.+++..|++.+|.+||++.+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCH
Confidence 78899999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=299.27 Aligned_cols=251 Identities=27% Similarity=0.336 Sum_probs=185.1
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc-----ceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-----NKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~ 521 (724)
..+.||+|+||.||++... +++.||||++... .....+++.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 3478999999999999864 6889999998653 2234467889999999999999999999998776 789999
Q ss_pred eeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+. ++|.+++... .. ..+.||++||.|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred eccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9996 5777766332 11 2267999999999998 9999999999999999999999999999865443333
Q ss_pred eeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHH----------H------HHHHH
Q 041285 595 TFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE----------E------WVYQC 657 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~----------~------~~~~~ 657 (724)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||............ . .....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 33345678999999998774 4789999999999999999999999754322111000 0 00011
Q ss_pred HHcCCccc-cc-cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 658 FENGNLGQ-LI-EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 658 ~~~~~~~~-~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+....... .. ............+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 10000000 00 0000111224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.87 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=194.4
Q ss_pred HHHHhhcccccccCcCccceEEEEEeeC--------CcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYS 511 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 511 (724)
++......+.+.||+|+||.||++.... +..||+|.++... ....+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3444456677899999999999997531 2368999887532 33456899999999999 899999999999
Q ss_pred ecccceEEEEeeccCCChhhhcCCCC-------------------c----chHHHHHHHcccccccCCCceEeCCCCCCC
Q 041285 512 FDVSNKILVYEYMSNGSLADVYSSPP-------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQN 568 (724)
Q Consensus 512 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~N 568 (724)
.+....++++||+++++|.+++.... + ..+.|+++||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999874311 1 1267999999999998 99999999999
Q ss_pred eeeCCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcc
Q 041285 569 ILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPED 646 (724)
Q Consensus 569 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~ 646 (724)
||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865432211 1122334578999999999999999999999999999998 7777754321
Q ss_pred hhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 647 QVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 647 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
.+. ...+..+..... .......+.+++..|++.+|++||++.|+++.|+.+...
T Consensus 243 ----~~~-~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 ----EEL-FKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ----HHH-HHHHHcCCCCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111 122222211111 112234688999999999999999999999999976643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.97 Aligned_cols=232 Identities=24% Similarity=0.328 Sum_probs=180.7
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+||.||++.... ++.||||.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 356789999999999998754 6799999987532 22334567788888777 689999999999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++... .. ..+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~ 158 (323)
T cd05616 83 VNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TT 158 (323)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-cc
Confidence 9999999887432 11 2278999999999998 999999999999999999999999999875432211 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ..+.+...... .+...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~~-------~p~~~ 224 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA-------YPKSM 224 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------CCCcC
Confidence 23568999999999999999999999999999999999999997543211 11222222211 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 041285 677 LERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
...+.+++.+|++.+|++|++.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCC
Confidence 3457889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.24 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=188.7
Q ss_pred ccccCcCccceEEEEEee------CCcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 451 KEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.||+|+||.||+++.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999864 2467999988754333 346799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC------------cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 524 MSNGSLADVYSSPP------------KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 524 ~~~gsL~~~l~~~~------------~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+++++|.+++.... +. .+.+++.+|+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999885322 11 267999999999998 999999999999999999999999999875
Q ss_pred cCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.............++..|+|||.+.+...+.++||||||+++++|++ |..|+...... . .......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~-~~~~~~~~~~~~~ 239 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------E-VLNRLQAGKLELP 239 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------H-HHHHHHcCCcCCC
Confidence 43332222233456778999999988888999999999999999998 66777532211 1 1122232332221
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.. ......+.+++.+|++.+|++||++.|++++|.
T Consensus 240 ~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VP-----EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11 122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=282.43 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=185.9
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+||+++++++......++|+||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 34679999999999998864 67889998876545556789999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|..++... .+ ..+.|+++||.|||+. +++|+||||+|||++.++.+||+|||++....... .......
T Consensus 89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 164 (282)
T cd06643 89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI 164 (282)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence 98876431 22 2267999999999998 99999999999999999999999999987543221 1122346
Q ss_pred cCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 601 GTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 601 gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ...... .........+ ..
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~~~----~~ 233 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSEPPTLAQP----SR 233 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHh-hcCCCCCCCc----cc
Confidence 789999999874 3457789999999999999999999986532111 111111 1111111111 12
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+||+.+|.+||++.++++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23468899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.87 Aligned_cols=244 Identities=21% Similarity=0.212 Sum_probs=183.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||+++.. .++.||||.+... .......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999875 4788999998652 1223445888999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|+|.+++... .. ..+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999998532 11 1267999999999998 999999999999999999999999999987654433333
Q ss_pred eccccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 597 TGIRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +............ .+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-~~p~-- 231 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF-QFPS-- 231 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc-cCCC--
Confidence 33568999999999875 46788999999999999999999999753321 1111111111100 0111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSL--RPSMKKVLLM 704 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 704 (724)
........+.+++.+|++..+.+ |++++++++.
T Consensus 232 ~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01112345777788888765544 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=288.78 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=189.1
Q ss_pred cccccccCcCccceEEEEEee--------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
..+.++||+|+||.||++... ....+|+|.++... .....++.+|++++.++ +|+||+++++++.+....
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 346688999999999999742 24579999887532 33456788999999999 699999999999998899
Q ss_pred EEEEeeccCCChhhhcCCCC-------------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC
Q 041285 518 ILVYEYMSNGSLADVYSSPP-------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN 574 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~-------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~ 574 (724)
++++||+++++|.+++.... + ..+.|++.||.|||+. +++||||||+|||++++
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCC
Confidence 99999999999999884311 1 1267999999999988 99999999999999999
Q ss_pred CCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHH
Q 041285 575 RYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~ 652 (724)
+.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~ 244 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE------E 244 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 999999999998654322111 112234567999999988889999999999999999999 77777543211 1
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+......+..... .......+.+++.+|++.+|++||++.|+++.|++..
T Consensus 245 -~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 -LFKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -HHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1122222221111 1122345778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=290.95 Aligned_cols=244 Identities=21% Similarity=0.264 Sum_probs=181.6
Q ss_pred cccccCcC--ccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 450 FKEEIGRG--SSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.++||+| +|++||++... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999874 57899999987532 233456788999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc--
Q 041285 525 SNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-- 593 (724)
Q Consensus 525 ~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 593 (724)
++++|.+++... .+ ..+.|++.||+|||+. +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999988431 11 2267999999999998 999999999999999999999999987543321110
Q ss_pred c----eeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 594 R----TFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 594 ~----~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .. .. ...+.....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~-----~~-~~~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-ML-----LE-KLNGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HH-----HH-HhcCCccccc
Confidence 0 0011346778999999876 458899999999999999999999986432111 00 00 0011111110
Q ss_pred cc---------------------------------------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 ED---------------------------------------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~---------------------------------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+. ..........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0011123456889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=285.16 Aligned_cols=240 Identities=25% Similarity=0.366 Sum_probs=190.0
Q ss_pred ccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||.|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++.+.+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3457899999999999986 468899999987654455677899999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC--cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 528 SLADVYSSPP--KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 528 sL~~~l~~~~--~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+|.+++.... +. .+.+++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .....+
T Consensus 102 ~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 177 (296)
T cd06655 102 SLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVG 177 (296)
T ss_pred cHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcCC
Confidence 9999885432 22 267899999999998 9999999999999999999999999998765433221 223457
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
+..|+|||.+.+..++.++||||||+++|+|++|+.||......... .. ........+..+. .....+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~-~~~~~~~~~~~~~----~~~~~~~ 246 (296)
T cd06655 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YL-IATNGTPELQNPE----KLSPIFR 246 (296)
T ss_pred CccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhcCCcccCCcc----cCCHHHH
Confidence 88999999999888999999999999999999999998764322111 11 1111111111111 2234577
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+++.+||+.+|.+||++.++++
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhh
Confidence 8999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=285.01 Aligned_cols=237 Identities=26% Similarity=0.380 Sum_probs=188.1
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++|+||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 467999999999999875 47789999886432 3344678999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCcc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 529 LADVYSSPPKN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 529 L~~~l~~~~~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
|.+++...... .+.++++|+.|||+. +++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 164 (277)
T cd06642 89 ALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGT 164 (277)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCc
Confidence 99988543222 268999999999998 999999999999999999999999999976543221 11224578
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (724)
..|+|||.+.+..++.++||||||++++||++|+.|+....+... ...+..+... .........+.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~ 231 (277)
T cd06642 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNSPP------TLEGQYSKPFKE 231 (277)
T ss_pred ccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCCCC------CCCcccCHHHHH
Confidence 899999999988899999999999999999999999864322111 0111111111 111223456889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 041285 683 VALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 683 l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
++.+|++.+|++||+|.++++.
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=278.99 Aligned_cols=240 Identities=31% Similarity=0.451 Sum_probs=190.0
Q ss_pred cccccCcCccceEEEEEeeC-----CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++.+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998864 378999999764333 567899999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 524 MSNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++++|.+++.... + ..+.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999885422 1 2267899999999998 9999999999999999999999999999876544222
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......++..|+|||.+....++.++||||+|++++||++ |..|+..... ... .+....+..... +
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~~~~--~---- 226 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEV-LEYLKKGYRLPK--P---- 226 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcCCCCCC--C----
Confidence 2212336789999999988889999999999999999998 6777654211 111 122222221111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
......+.+++.+|++.+|++|||+.|++++|
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=305.16 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=195.9
Q ss_pred cccccccCcCccceEEEEEeeCC-cEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeE-Eec------ccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGY-SFD------VSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~ 518 (724)
..+.+.|.+|||+.||.+....+ ..+|+|++-...+.+.+..++|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34567899999999999998776 999999987767788899999999999996 9999999993 321 24679
Q ss_pred EEEeeccCCChhhhcCC---------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 519 LVYEYMSNGSLADVYSS---------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~---------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
|.||||++|+|-+++.. ...+++.++++|+++||.. .++|||||||.+||||..++..||||||.+.-.-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999999842 1234478999999999985 6789999999999999999999999999986432
Q ss_pred CCC--cce------eeccccCccccCcccc---cCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH
Q 041285 590 PDQ--TRT------FTGIRGTRGYVAPEWH---WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 590 ~~~--~~~------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
... ... .....-|+.|.|||.+ .+.++++|+|||+|||+||-|+....||+...... +
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----------I 266 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----------I 266 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----------E
Confidence 211 100 0112358999999975 46789999999999999999999999998642211 1
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPI 713 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 713 (724)
.++.... ........++..|+..||+++|.+||++-+|+..+-.+...+.
T Consensus 267 lng~Y~~-----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 267 LNGNYSF-----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred EeccccC-----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1111111 1124678889999999999999999999999988876555443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=289.80 Aligned_cols=244 Identities=23% Similarity=0.238 Sum_probs=181.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45678999999999999875 4789999998642 1223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++++|.+++... . ...+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999988432 1 11267999999999998 999999999999999999999999999876544333222
Q ss_pred eccccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 597 TGIRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
....|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... +.............+ .+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-~~~- 232 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF-PPD- 232 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-CCc-
Confidence 23468999999999863 45788999999999999999999998653221 111111111111111 111
Q ss_pred cCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 041285 672 VDKKQLERMIKVALWCIL--DEPSLRPSMKKVLLM 704 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~--~~p~~RPs~~evl~~ 704 (724)
.......+.+++..|+. .++..||++.++++.
T Consensus 233 -~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 -VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11123345556666554 444558899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=285.13 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=190.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++..++|+||+++++++......++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 345578999999999999875 47889999876532 3345679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++... .+ ..+.+++.+|.|||+. .+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---~~ 161 (284)
T cd06620 87 CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DT 161 (284)
T ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---Cc
Confidence 99999887542 12 2267899999999963 2799999999999999999999999999865422211 12
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc-----hhcHHHHHHHHHHcCCccccccccccC
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED-----QVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+.......... .... ...
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~ 235 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPR-----LPS 235 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCC-----CCc
Confidence 467899999999988889999999999999999999999997543321 11111112121111 1110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
......+.+++.+|++.+|++||++.|++++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 12345688899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=284.08 Aligned_cols=240 Identities=26% Similarity=0.396 Sum_probs=185.9
Q ss_pred cccCcCccceEEEEEeeC-------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMIN-------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998743 2579999886532 23456799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC----------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-----CeEEccccC
Q 041285 524 MSNGSLADVYSSP----------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-----YAKISDFAL 584 (724)
Q Consensus 524 ~~~gsL~~~l~~~----------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-----~~kl~Dfgl 584 (724)
+++++|.+++... .+ ..+.+++.||.|||+. +++|+||+|+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999988421 11 1267999999999987 899999999999999877 899999999
Q ss_pred ccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCC
Q 041285 585 AKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGN 662 (724)
Q Consensus 585 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 662 (724)
+......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~----~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EV----LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HH----HHHHhcCC
Confidence 9765432221 1122345678999999999999999999999999999998 88887543211 11 11111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
... ........+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 231 ~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 111234568899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=288.58 Aligned_cols=244 Identities=26% Similarity=0.342 Sum_probs=199.9
Q ss_pred hhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccch---hHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAE---GEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 520 (724)
..+.+.++||+|.||.||+++.+. |+.+|+|.+.+.... +...+.+|+.+|+++. |||||.+.+.+.+....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 445666899999999999999876 899999999764332 3468999999999998 99999999999999999999
Q ss_pred EeeccCCChhhhcCCC--Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC----CCeEEccccCccccCC
Q 041285 521 YEYMSNGSLADVYSSP--PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN----RYAKISDFALAKLMKP 590 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~--~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~----~~~kl~Dfgl~~~~~~ 590 (724)
||++.+|.|.+.+... .. ..+.+|+.++.|||+. +|+||||||+|+|+... +.+|++|||++.....
T Consensus 115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999887543 22 2278999999999997 99999999999999543 4799999999998776
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
........||+.|+|||++....++..+||||+|+++|.|++|..||........ ...+..+... ++ .
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-------~~~i~~~~~~--f~-~ 259 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-------FLAILRGDFD--FT-S 259 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-------HHHHHcCCCC--CC-C
Confidence 3445567899999999999999999999999999999999999999987543221 1233444431 11 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..-......+.+++..++..||.+|+++.++++-
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2223346668888899999999999999999984
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=281.24 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=189.9
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||.|++|.||+++.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 4578999999999999875 47899999986532 334567899999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 528 SLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 528 sL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+|.+++..... ..+.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ......+
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 160 (274)
T cd06609 85 SCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTFVG 160 (274)
T ss_pred cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccccC
Confidence 99999865421 2278999999999998 999999999999999999999999999987654321 1223457
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
+..|+|||.+.+..++.++||||||+++|||++|+.|+....... .......+....+... .....+.
T Consensus 161 ~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~~ 228 (274)
T cd06609 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPSLEGN-----KFSKPFK 228 (274)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCCCCccc-----ccCHHHH
Confidence 889999999998889999999999999999999999986543211 1111111211111111 1344688
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+++..|++.+|++||+++++++
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhh
Confidence 8999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=280.70 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=186.9
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-----chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 3578999999999999864 57899999876421 12235688999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++... . ...+.+++.||.|||+. +++|+||+|+||++++++.++|+|||++...........
T Consensus 86 ~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 86 MPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred CCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence 9999999887432 1 22367899999999998 999999999999999999999999999976543221111
Q ss_pred --eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 597 --TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 597 --~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... . ........ ... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-~~~-----~~~~ 230 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-TNP-----QLPS 230 (263)
T ss_pred cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H-HHHHhccC-CCC-----CCCc
Confidence 23457889999999999889999999999999999999999986432111 0 11111111 111 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.....+.+++..||+.+|.+||++.|+++.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 233457889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=283.59 Aligned_cols=239 Identities=27% Similarity=0.304 Sum_probs=185.1
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.||+|+||.||++... .++.+|||.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3467999999999999875 57899999886532 2223457889999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++... .. ..+.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ .
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I 158 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence 99999887321 11 2267999999999987 999999999999999999999999999876543222 1
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ........... . ......
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~--~-----~~~~~~ 228 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ--E-----EYSEKF 228 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh--h-----hcCccC
Confidence 2346899999999999999999999999999999999999999754321110 00111111000 0 011112
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
...+.+++..||+.+|++||| +.|+++
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 345788999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=314.63 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=188.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.++||+|+||.||+|... .++.||||++.... ....++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999875 47899999987532 223457899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC------C------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 525 SNGSLADVYSSP------P------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 525 ~~gsL~~~l~~~------~------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
++++|.+++... . ...+.+|++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999887421 0 12267999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc-----------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc
Q 041285 587 LMKPDQT-----------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649 (724)
Q Consensus 587 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~ 649 (724)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-- 239 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-- 239 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh--
Confidence 6621110 001124689999999999999999999999999999999999999865322111
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEGT 708 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~ 708 (724)
... ......... ....+....+.+++.+|++.+|++|| +++++++.|+..
T Consensus 240 ----~~~----~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 240 ----SYR----DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhh----hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 000000000 00112334578899999999999995 677777777654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=286.33 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=189.9
Q ss_pred ccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 3457899999999999986 468999999987654455567889999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 528 SLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 528 sL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+|.+++..... ..+.+++.+|.|||+. +++|+||||+|||++.++.++|+|||++........ ......+
T Consensus 102 ~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~ 177 (297)
T cd06656 102 SLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVG 177 (297)
T ss_pred CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccC
Confidence 99998854321 2267899999999998 999999999999999999999999999876543322 1122457
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .....+ ...... .......+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~~~~~~----~~~~~~~~~ 246 (297)
T cd06656 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TPELQN----PERLSAVFR 246 (297)
T ss_pred CccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-CCCCCC----ccccCHHHH
Confidence 889999999998889999999999999999999999996543221110 000011 111111 112334578
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+++.+||+.+|++||++.++++
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=297.76 Aligned_cols=247 Identities=20% Similarity=0.205 Sum_probs=181.6
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 3445789999999999998864 68899996432 346789999999999999999999999999999999994
Q ss_pred CChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-eee
Q 041285 527 GSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFT 597 (724)
Q Consensus 527 gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~ 597 (724)
++|.+++... .+ .++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 6887776432 22 2378999999999998 9999999999999999999999999999876433221 222
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC-CcchhcHHHHHHHHHHcCCcc-----ccc----
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL-PEDQVILEEWVYQCFENGNLG-----QLI---- 667 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~-----~~~---- 667 (724)
...||+.|+|||++.+..++.++|||||||+||||++|..++.... ..........+.+.+...... ...
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 3568999999999999999999999999999999999876553221 111111111111222111110 000
Q ss_pred ------------ccc--ccC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 668 ------------EDE--DVD----KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 668 ------------~~~--~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+. ... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000 0112357889999999999999999999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=280.51 Aligned_cols=241 Identities=26% Similarity=0.401 Sum_probs=187.4
Q ss_pred cccccCcCccceEEEEEeeC--CcEEEEEEcccc----------cchhHHHHHHHHHhhcc-cCcCceeeeeeEEecccc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN--GKFVAVKRLQKM----------LAEGEREFQTEIKAIGR-THHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~ 516 (724)
+.+.||+|+||.||++.... ++.+|||.+... ......++.+|+.++.+ ++|+||+++++++.+.+.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45789999999999999865 678999987531 12233557788888875 699999999999999999
Q ss_pred eEEEEeeccCCChhhhcCC-------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCc
Q 041285 517 KILVYEYMSNGSLADVYSS-------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
.+++|||+++++|.+++.. .. +..+.+++.+|.|||+. .+++|+||+|+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999887621 11 22367999999999963 27999999999999999999999999999
Q ss_pred cccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc
Q 041285 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 665 (724)
....... ......++..|++||.+.+..++.++||||||+++|||++|+.|+...... ... .....+....
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~ 232 (269)
T cd08528 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLA-TKIVEAVYEP 232 (269)
T ss_pred eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHH-HHHhhccCCc
Confidence 8755433 233456889999999999888999999999999999999999998643211 111 1122222111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 666 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
.. .......+.+++.+|++.+|++||++.||..+|+
T Consensus 233 ~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 1122356888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=283.26 Aligned_cols=244 Identities=32% Similarity=0.476 Sum_probs=187.8
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhH--HHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGE--REFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||+||++.... ++.+|+|.+........ ....+|+.++.+++|+||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 356789999999999999865 56899999976433222 234569999999999999999999999999999999999
Q ss_pred CCChhhhcC-CCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYS-SPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~-~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++. ... ...+.++++||++||+. +++|+||||+||++++++.++|+|||.+... .........
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~ 157 (260)
T PF00069_consen 82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNP 157 (260)
T ss_dssp TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999886 222 22378999999999998 9999999999999999999999999999764 222233344
Q ss_pred cccCccccCccccc-CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHW-NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||.+. ....+.++||||+|+++++|++|..|+......... ....+... ........ ......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~-~~~~~~~~---~~~~~~ 230 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL---EIIEKILK-RPLPSSSQ---QSREKS 230 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH---HHHHHHHH-THHHHHTT---SHTTSH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhh---hhhhhccc-cccccccc---ccchhH
Confidence 66899999999998 788999999999999999999999998764111111 11111110 00000000 000012
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++..||+.+|++||++.++++
T Consensus 231 ~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 231 EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=292.15 Aligned_cols=251 Identities=26% Similarity=0.282 Sum_probs=182.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 518 (724)
+...+.||+|+||.||++... .++.||||++... ......++.+|+.+++.++||||+++++++.... ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 344578999999999999874 4789999998643 2234567889999999999999999999886543 479
Q ss_pred EEEeeccCCChhhhcCC-CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSS-PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||+++ +|...+.. ... ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 177 (359)
T cd07876 103 LVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF- 177 (359)
T ss_pred EEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc-
Confidence 99999975 45554432 222 2367999999999998 99999999999999999999999999997543221
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------------HHHHHHHH
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------------LEEWVYQC 657 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------------l~~~~~~~ 657 (724)
......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.......... +...+...
T Consensus 178 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 178 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred -cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 1223467999999999999999999999999999999999999997543211100 00000000
Q ss_pred HHcC-Ccc-----ccc----ccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 658 FENG-NLG-----QLI----EDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 658 ~~~~-~~~-----~~~----~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.... ... +.. .+. .........+.+++.+|++.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000 000 000 0111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=280.61 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=186.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||+|+||.||++... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||++++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 34578999999999999875 57899999987654444567889999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 528 SLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 528 sL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+|.+++.... ...+.+++.||.|||+. +++|+||||+||+++.++.+||+|||++....... .......
T Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 167 (267)
T cd06645 92 SLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFI 167 (267)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccccccc
Confidence 9999874322 12267899999999998 99999999999999999999999999987654221 1122346
Q ss_pred cCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 601 GTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 601 gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
|+..|+|||.+. ...++.++||||||+++|||++|..|+....+... ................ .....
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~ 238 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQPPKLKD---KMKWS 238 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCCCcccc---cCCCC
Confidence 889999999874 45588999999999999999999998864332111 0111111101000000 01123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++.+|++.+|++||++++|++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhc
Confidence 45788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=280.01 Aligned_cols=237 Identities=26% Similarity=0.382 Sum_probs=190.1
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.++||.|+||.||+|... .++.||||.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 467999999999999875 47899999886432 3445678999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 529 LADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 529 L~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
|.+++..... ..+.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 89 L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 164 (277)
T cd06640 89 ALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGT 164 (277)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCc
Confidence 9998865332 2267899999999988 999999999999999999999999999976543321 12224578
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (724)
..|+|||.+.+..++.++|+||||+++|||++|..|+........ ......+. +..........+.+
T Consensus 165 ~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~------~~~~~~~~~~~~~~ 231 (277)
T cd06640 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKNN------PPTLTGEFSKPFKE 231 (277)
T ss_pred ccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcCC------CCCCchhhhHHHHH
Confidence 899999999888899999999999999999999999865332110 01111111 11223345567889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 041285 683 VALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 683 l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
++..||+.+|++||++.++++.
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhC
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=284.60 Aligned_cols=238 Identities=25% Similarity=0.392 Sum_probs=187.7
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
..||+|+||.||++... +++.||||.+........+.+.+|+..+++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999874 57899999987644455667899999999999999999999999999999999999999999
Q ss_pred hhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 531 DVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 531 ~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+++..... ..+.+|+.||.|||+. +|+||||||+||++++++.+||+|||++........ ......++..
T Consensus 108 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~ 183 (292)
T cd06658 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPY 183 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCcc
Confidence 98744321 2277899999999998 999999999999999999999999999876543222 1122457899
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|+|||.+.+..++.++||||||+++|||++|+.|+........ ...+... ....+.. .......+..++
T Consensus 184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-~~~~~~~---~~~~~~~~~~li 252 (292)
T cd06658 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRDN-LPPRVKD---SHKVSSVLRGFL 252 (292)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-CCCcccc---ccccCHHHHHHH
Confidence 9999999888899999999999999999999999865322111 0111111 1111111 112234577888
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~~ 704 (724)
..|++.+|.+||+++|+++.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 253 DLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 89999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=289.28 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=182.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+...++||+|+||.||++... +++.||+|.++... ......+.+|++++++++|+||+++++++...+..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 344578999999999999875 47889999987432 2233467889999999999999999999999999999999997
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++.... . ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 162 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYS 162 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccc
Confidence 5 7777663321 1 1267999999999998 999999999999999999999999999876432221 122
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH--------HHHHHc------CC
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV--------YQCFEN------GN 662 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~--------~~~~~~------~~ 662 (724)
...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ +..+.. ..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3457889999998865 45789999999999999999999999754332211100000 000000 00
Q ss_pred cccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 LGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 ~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........ .........+.+++..|++.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 000112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=273.85 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=187.6
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCc-eeeeeeEEeccc------ceEEE
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVS------NKILV 520 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~~lv 520 (724)
.++||+|.||+||+|+.. +|+.||+|+++-... .-.....+|+.++++++|+| ||+|.+++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 367999999999999864 588999999875433 23345789999999999999 999999998877 78899
Q ss_pred EeeccCCChhhhcCCCCc-----------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSPPK-----------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~-----------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
+||+ .-+|..++..... ..+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.
T Consensus 96 fe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9998 5588888754332 2278999999999999 99999999999999999999999999999654
Q ss_pred CCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Cccc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQ 665 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~ 665 (724)
-. ....+..++|.-|.|||++.+. .|+...||||+||++.||++++..|......++. ..+.+.+... ..+.
T Consensus 172 ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 172 IP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGTPNEKDWPG 247 (323)
T ss_pred CC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCCCCccCCCC
Confidence 22 2224556789999999999887 6999999999999999999998888665432221 1122222111 1111
Q ss_pred cc---c----------ccccCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 666 LI---E----------DEDVDK---KQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 666 ~~---~----------~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.. + +..... .......+++.+|++.+|.+|.|++.++++
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10 0 000111 111468899999999999999999999876
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=280.75 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=190.5
Q ss_pred ccccccCcCccceEEEEEeeC-C----cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-G----KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||.||+|...+ + ..+|+|.+.... .....++.+|++++++++|+||+++++++.. ...++|+|
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 455789999999999998753 3 268999887543 2345678999999999999999999999987 78899999
Q ss_pred eccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+++++|.+++.... + ..+.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 89 LMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 999999999885422 1 2268999999999997 9999999999999999999999999999876533221
Q ss_pred e-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 595 T-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 595 ~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
. .....++..|+|||.+....++.++|+||||+++||+++ |+.|+...... + ....+..+... -.+..
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~--~~~~~- 235 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------E-IPDLLEKGERL--PQPPI- 235 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHhCCCCC--CCCCC-
Confidence 1 112234578999999988889999999999999999998 99988654321 1 11222222111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
....+.+++..||..+|.+||++.++++.|+....
T Consensus 236 ---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 236 ---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22457889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=288.53 Aligned_cols=232 Identities=24% Similarity=0.332 Sum_probs=180.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
++.+.||+|+||.||++... +++.||||.+.... ....+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 56688999999999999875 57899999987532 233456788889988885 57788899999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~ 158 (323)
T cd05615 83 VNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TT 158 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-cc
Confidence 9999999887432 22 2278999999999998 999999999999999999999999999875432221 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..+.+...... .....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~-------~p~~~ 224 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVS-------YPKSL 224 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------CCccC
Confidence 23458999999999999899999999999999999999999997543211 11222222211 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 041285 677 LERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
...+.+++.+|++.+|.+|++.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCC
Confidence 3457889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=277.28 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=190.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++++.+....+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 45678999999999999875 46789999987654556678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... . +..+.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ .....
T Consensus 86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 161 (262)
T cd06613 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSF 161 (262)
T ss_pred cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccc
Confidence 999987443 1 12377999999999998 999999999999999999999999999876543211 12234
Q ss_pred ccCccccCcccccCC---CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 600 RGTRGYVAPEWHWNL---PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
.++..|+|||.+... .++.++||||||+++|||++|+.|+........ ... .....+.... .......
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~~~~~~--~~~~~~~ 232 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSNFPPPK--LKDKEKW 232 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhccCCCcc--ccchhhh
Confidence 578899999998776 789999999999999999999999865432211 111 1111111000 0112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.+|.+||++.+|+.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 566899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=287.55 Aligned_cols=244 Identities=23% Similarity=0.215 Sum_probs=181.3
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.++||+|+||.||++.... ++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 355789999999999998764 6789999986421 223345888999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|+|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999998542 21 1267999999999998 999999999999999999999999999876543333333
Q ss_pred eccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 597 TGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...... +............ .+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-~~p~-- 231 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERF-QFPA-- 231 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccc-cCCC--
Confidence 3356899999999986 345788999999999999999999999754211 1111111111100 0111
Q ss_pred cCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILD--EPSLRPSMKKVLLM 704 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~ 704 (724)
........+.+++.+|+.. ++..||++.|+++.
T Consensus 232 ~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0111233456666666654 44447899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=277.25 Aligned_cols=239 Identities=22% Similarity=0.326 Sum_probs=189.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+....++++||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 35678999999999999875 5789999987542 233456788999999999999999999999999999999999999
Q ss_pred CChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... . ...+.+++.||.|||+. +++|+||||+||++++++.++|+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC 158 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence 9998887431 1 12278999999999998 999999999999999999999999999976543221 122
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ... .....+....+ .....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~------~~~~~ 225 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLI-LKVCQGSYKPL------PSHYS 225 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHH-HHHhcCCCCCC------CcccC
Confidence 346788999999999888999999999999999999999998753211 111 11222222111 11223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+.+++.+||+.+|++||++.|++..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=284.12 Aligned_cols=238 Identities=22% Similarity=0.333 Sum_probs=188.3
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
..||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999874 58899999986544445567889999999999999999999999999999999999999999
Q ss_pred hhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 531 DVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 531 ~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+++.... +..+.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.....+.. ......++..
T Consensus 107 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~ 182 (297)
T cd06659 107 DIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPY 182 (297)
T ss_pred HHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCcc
Confidence 8875422 12367999999999998 999999999999999999999999999876543321 1223457899
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|+|||.+.+..++.++||||||++++||++|+.|+........ ...+.......... .......+.+++
T Consensus 183 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~----~~~~~~~l~~~i 251 (297)
T cd06659 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPKLKN----AHKISPVLRDFL 251 (297)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCCccc----cCCCCHHHHHHH
Confidence 9999999988899999999999999999999999865332111 11111111111111 111234578899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~~ 704 (724)
..|++.+|++||+++++++.
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 252 ERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=280.62 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=188.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.+.||.|++|.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++.+.+....++||||++++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 34578999999999999875 57899999987655555678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++.... ...+.+++.+|.|||+. +|+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 88 ~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 163 (280)
T cd06611 88 ALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTF 163 (280)
T ss_pred cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-cccee
Confidence 9999875421 12278999999999998 999999999999999999999999999875432211 11234
Q ss_pred ccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 600 RGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 600 ~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.+++.|+|||.+. ...++.++||||||+++|||++|+.|+....... .. ..+..+....+..+ .
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~~----~ 232 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VL-LKILKSEPPTLDQP----S 232 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HH-HHHhcCCCCCcCCc----c
Confidence 5788999999875 3456789999999999999999999986542211 11 11222211111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.....+.+++..||+.+|++||++.++++-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 223457889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=287.96 Aligned_cols=186 Identities=26% Similarity=0.398 Sum_probs=149.2
Q ss_pred ccccCcCccceEEEEEee---CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 525 (724)
..+||+|+||.||++... .++.+|+|.+... .....+.+|++++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999865 3578999998753 223457889999999999999999998864 446789999985
Q ss_pred CCChhhhcCC------------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeee----CCCCCeEEccccCc
Q 041285 526 NGSLADVYSS------------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILM----DENRYAKISDFALA 585 (724)
Q Consensus 526 ~gsL~~~l~~------------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll----~~~~~~kl~Dfgl~ 585 (724)
+ +|.+++.. .. ...+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 77666521 11 12378999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCc--ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCC
Q 041285 586 KLMKPDQT--RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
+.+..... .......+|+.|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87653322 122335689999999998774 5889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=285.93 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=185.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|+||.||++... .+..+|+|.+.... .....++.+|++++.+++||||+++++++.+.+..++|+||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 34578999999999999875 47788999886432 22345688999999999999999999999999999999999999
Q ss_pred CChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++... .. ..+.++++||.|||+. .+++|+||||+|||++.++.+||+|||++....... ....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 158 (308)
T cd06615 84 GSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSF 158 (308)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---cccC
Confidence 9999998542 11 2267999999999973 279999999999999999999999999987543221 1234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc---------------
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG--------------- 664 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--------------- 664 (724)
.++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...............
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccc
Confidence 67899999999988889999999999999999999999985432111 000000000000000
Q ss_pred ---------ccc---cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 ---------QLI---EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ---------~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... .+..........+.+++.+|++.+|++||++.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000001123458899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=281.64 Aligned_cols=237 Identities=26% Similarity=0.405 Sum_probs=181.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecc------cceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV------SNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~lv~ 521 (724)
+.+.||+|+||.||+|... .++.||+|.+... .....++..|+.++.++ +|+||+++++++... ...+++|
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3467999999999999875 4788999998653 33456788999999998 799999999998753 3578999
Q ss_pred eeccCCChhhhcCCC-----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 522 EYMSNGSLADVYSSP-----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 522 e~~~~gsL~~~l~~~-----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||+++++|.+++... .+. .+.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 999999999987532 111 367999999999998 99999999999999999999999999987654322
Q ss_pred cceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
. ......|+..|+|||++. ...++.++||||||+++|||++|+.|+........ . ............
T Consensus 166 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~--~~~~~~~~~~~~ 237 (272)
T cd06637 166 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L--FLIPRNPAPRLK 237 (272)
T ss_pred c-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H--HHHhcCCCCCCC
Confidence 1 122356889999999986 33578899999999999999999999864321111 0 111111111111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+||+.+|.+||++.|+++
T Consensus 238 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 238 -----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1122345889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=275.35 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=190.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||.|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 35578999999999988764 4788999987643 23445678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++.... ...+.+++++|+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 999999885431 11267899999999988 999999999999999999999999999986644332 22
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+++.|+|||.+.+..++.++||||||++++||++|+.|+...... +.... +..+..... ....
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~~~------~~~~ 225 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVK-IVQGNYTPV------VSVY 225 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHcCCCCCC------cccc
Confidence 3346789999999998888899999999999999999999998653221 11112 222222211 1223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
...+.+++.+|++.+|++||++.++++.+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 44588899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=276.25 Aligned_cols=236 Identities=30% Similarity=0.435 Sum_probs=185.3
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.+.||+|+||.||++.. .++.+|+|.++.. .....+.+|+.++.+++|+|++++++++... ..+++|||++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 34568899999999999975 6788999998653 2345789999999999999999999998764 579999999999
Q ss_pred ChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... . ..+.++++||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence 9999885322 1 1267999999999988 99999999999999999999999999987543211 12
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.|+...... +. ......+..... .....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~~------~~~~~ 223 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEKGYRMEP------PEGCP 223 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhCCCCCCC------CCcCC
Confidence 234678999999988899999999999999999997 88887643221 11 122222211111 11234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=279.12 Aligned_cols=240 Identities=24% Similarity=0.376 Sum_probs=187.1
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEccccc------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
..+.||+|+||.||+|...+++.+|||.+.... ......+.+|++++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 346799999999999998888999999886421 12235688999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC-----
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD----- 591 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~----- 591 (724)
+++++|.+++... .. ..+.+++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 84 VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 9999999988442 22 2267999999999988 9999999999999999999999999998765321
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.........++..|+|||.+.+..++.++||||||++++||++|..|+........ ........+....
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~------ 229 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRGLMPR------ 229 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccCCCCC------
Confidence 11112234688999999999988899999999999999999999999864321110 0000000011111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=295.86 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=186.1
Q ss_pred HhhcccccccCcCccceEEEEEeeC---CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.+.||+|+||.||++...+ ++.||||.+... +.+.+|++++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3456667899999999999997543 568999988642 34568999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 522 EYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
|++. ++|.+++... .+ ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9985 6777777322 22 2267999999999998 999999999999999999999999999976543322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcch-hcHHHHHHHHHHcCCccc-------
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ-VILEEWVYQCFENGNLGQ------- 665 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~------- 665 (724)
.......||+.|+|||.+....++.++|||||||++|||++|+.||........ ..+.. +.+.........
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccchh
Confidence 222345789999999999999999999999999999999999999976443211 11111 111111000000
Q ss_pred ----------ccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 666 ----------LIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 666 ----------~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+. .........+.+++.+|++.+|++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0001123457788999999999999999999865
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=290.96 Aligned_cols=191 Identities=25% Similarity=0.319 Sum_probs=160.2
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||++... .++.||||.+.... ......+++|+.++.+++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4478999999999999875 47899999987532 2334568889999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-----
Q 041285 526 NGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT----- 593 (724)
Q Consensus 526 ~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 593 (724)
+|+|.+++.... . ..+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~ 161 (360)
T cd05627 85 GGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161 (360)
T ss_pred CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence 999999885321 1 1267999999999998 999999999999999999999999999875422110
Q ss_pred -----------------------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC
Q 041285 594 -----------------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL 643 (724)
Q Consensus 594 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~ 643 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00112468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=291.86 Aligned_cols=250 Identities=26% Similarity=0.302 Sum_probs=182.3
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKIL 519 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 519 (724)
...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999864 47899999987532 23345788899999999999999999988643 34699
Q ss_pred EEeeccCCChhhhcCC-CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 520 VYEYMSNGSLADVYSS-PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~-~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||||+++ +|.+.+.. ... ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 v~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 173 (355)
T cd07874 100 VMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_pred Ehhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--
Confidence 9999965 56555432 222 2378999999999998 99999999999999999999999999998653321
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------------HHHHHHHHH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------------LEEWVYQCF 658 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------------l~~~~~~~~ 658 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......+... +...+....
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_pred ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence 1223467999999999999899999999999999999999999997543111100 000000000
Q ss_pred HcC-Ccc-----cccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 659 ENG-NLG-----QLIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 659 ~~~-~~~-----~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... ... ...... .........+.+++.+|++.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 000 000000 0111224567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=275.18 Aligned_cols=237 Identities=29% Similarity=0.416 Sum_probs=187.4
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-----chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4578999999999999986 68899999886432 23456799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.... . ..+.++++||+|||+. +++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 158 (258)
T cd06632 84 VPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FA 158 (258)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--cc
Confidence 99999999885422 1 1267899999999998 99999999999999999999999999987654332 12
Q ss_pred eccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....++..|++||.+.... ++.++|+||||+++|+|++|+.|+...... .............. ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~------~~~~ 226 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP------IPDH 226 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC------cCCC
Confidence 3345788999999987766 899999999999999999999998654311 11111111111111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 227 LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2355788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=280.26 Aligned_cols=239 Identities=26% Similarity=0.288 Sum_probs=184.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++.+++|+|++++.+.+...+..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3467999999999999875 57899999986532 1223457889999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++... .+. .+.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence 99998877321 121 267999999999988 999999999999999999999999999876532211 1
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|+..|+|||.+.+..++.++|+||||+++|||++|..||........ ... .......... . .....
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~-~~~~~~~~~~--~-----~~~~~ 228 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REE-VDRRVLETEE--V-----YSAKF 228 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhhhcccc--c-----cCccC
Confidence 234689999999999988999999999999999999999999975322111 111 1111111111 0 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
...+.+++..|++.+|++||+ +.++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 345778899999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=262.99 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=189.2
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccc----h----hHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEE
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA----E----GEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 520 (724)
++.||+|..++|-+...+ .+++.|+|++..... + -.++-+.|+.+|+++ .||+|+.+.+++......++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999887664 578899998854211 1 123466799999998 699999999999999999999
Q ss_pred EeeccCCChhhhcCC-------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSS-------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~-------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+|.|+.|.|.++|.. ....++.|+.+|++|||.. .|+||||||+|||++++.++||+|||+++.+.+..
T Consensus 102 Fdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge- 177 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE- 177 (411)
T ss_pred hhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCch-
Confidence 999999999999953 2234488999999999998 99999999999999999999999999999876543
Q ss_pred ceeeccccCccccCcccccC------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWN------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
......||++|+|||.+.- ..|+...|+|+.||+||.|+.|.+||... .+ -.....+.+|.....
T Consensus 178 -kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQ----mlMLR~ImeGkyqF~- 248 (411)
T KOG0599|consen 178 -KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQ----MLMLRMIMEGKYQFR- 248 (411)
T ss_pred -hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HH----HHHHHHHHhcccccC-
Confidence 3445789999999998753 35788999999999999999999998642 11 112344555543221
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ....+....+.+++.+|++.||.+|.|.+|++.
T Consensus 249 s--peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 249 S--PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred C--cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 122344566889999999999999999999873
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=278.53 Aligned_cols=239 Identities=27% Similarity=0.380 Sum_probs=186.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccch---------hHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE---------GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 34578999999999999874 4789999988642211 1256889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+++||+++++|.+++... .. ..+.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++....+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999999999999988542 11 2368999999999998 9999999999999999999999999999876532
Q ss_pred Cc-----ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 592 QT-----RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 592 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . + .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~-~-~~~~~~~~~-- 230 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----A-I-FKIGENASP-- 230 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----H-H-HHHhccCCC--
Confidence 11 11112457889999999998889999999999999999999999987532111 0 1 111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++.+||+.+|.+||++.||++
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 ----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=273.99 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=189.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
...+.||+|+||.||++... +++.||+|.+..... ...+++.+|++++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999875 578999999875433 356789999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee--
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-- 596 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~-- 596 (724)
+++|.+++... .. ..+.++++||.|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 83 GGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999988543 11 2267999999999998 999999999999999999999999999987654333221
Q ss_pred -eccccCccccCcccccCCC---CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 597 -TGIRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 597 -~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
....++..|+|||.+.... .+.++||||||++++|+++|+.||........ .... ...+....+-.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~~~~~~---- 229 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFH-VGAGHKPPIPD---- 229 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHH-HhcCCCCCCCc----
Confidence 1345788999999988766 88999999999999999999999864321111 1111 11111111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1112345778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.99 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=187.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~~ 525 (724)
+.++||.|++|.||++... .++.+|+|.+.... .....++.+|++++++++|+||+++++++.+. ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4578999999999999985 47899999887432 23456799999999999999999999998654 36899999999
Q ss_pred CCChhhhcCC-------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS-------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|.+++.. .. ...+.++++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999887632 11 12378999999999998 999999999999999999999999999875432211
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... .+. ...........+.+......
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IEL-LSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHH-HHHHhcCCchhhccCCCCCC
Confidence 12346889999999998899999999999999999999999987653211111 111 11122211112211111112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++.+||+.+|++|||+.||++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 34567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=283.96 Aligned_cols=242 Identities=27% Similarity=0.413 Sum_probs=185.3
Q ss_pred ccccCcCccceEEEEEee-CCc----EEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGK----FVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.++++++|+||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 367999999999999864 343 578998875322 2334789999999999999999999998764 567999999
Q ss_pred cCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce-
Q 041285 525 SNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT- 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~- 595 (724)
++|+|.+++.... ...+.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.........
T Consensus 91 ~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 167 (303)
T cd05110 91 PHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167 (303)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccc
Confidence 9999999885422 12267999999999998 99999999999999999999999999998765332211
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ..+....+.... .+ .
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~~--~~----~ 234 (303)
T cd05110 168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---E----IPDLLEKGERLP--QP----P 234 (303)
T ss_pred cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHCCCCCC--CC----C
Confidence 112345678999999998899999999999999999997 88887543211 1 112222221111 11 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.....+.+++..||..+|++||++++++++|+...
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12345788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=290.00 Aligned_cols=238 Identities=26% Similarity=0.397 Sum_probs=191.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcc--c--ccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc--eEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQ--K--MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN--KILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~ 521 (724)
.|.++||+|+|-+||||... .|-+||--.++ + ......+.|..|+.+|+.|+|+|||+++.+..+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 46678999999999999874 36677644333 2 123344789999999999999999999999887665 78999
Q ss_pred eeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|.|..|+|..|+.+.. ..++.||++||.|||++ .++|+|||||.+||+|+. .|.+||+|+|||...+....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999985432 23378999999999997 789999999999999975 58899999999998764433
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
. ...|||.|||||... ..|.+.+||||||+.|+||+|+..|+....... -+++.+..|..+..+..-. +
T Consensus 202 k---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------QIYKKV~SGiKP~sl~kV~-d 270 (632)
T KOG0584|consen 202 K---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------QIYKKVTSGIKPAALSKVK-D 270 (632)
T ss_pred c---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------HHHHHHHcCCCHHHhhccC-C
Confidence 2 267999999999875 889999999999999999999999997654332 2456666676555444311 2
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++.+|+.. ..+|||+.|+|+
T Consensus 271 ----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3488999999999 999999999985
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=281.96 Aligned_cols=247 Identities=27% Similarity=0.367 Sum_probs=181.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.||+|++|.||+|+.. +++.||||.++... ....+.+.+|+.++.+++|+||+++++++.+....++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4578999999999999875 57899999886432 2234578899999999999999999999999999999999997
Q ss_pred CChhhhcCCCC------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPP------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|.+++.... . ..+.||++||+|||+. +++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY 158 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence 68877764321 1 1268999999999998 99999999999999999999999999997654322 112
Q ss_pred eccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHH-------HHc--------
Q 041285 597 TGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQC-------FEN-------- 660 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~-------~~~-------- 660 (724)
....+++.|+|||.+.+. .++.++||||||++++||++|+.|+......... ....... +..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhhHHHH
Confidence 223568899999988654 4788999999999999999999998754321110 0000000 000
Q ss_pred CCcccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 661 GNLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 661 ~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......... .........+.+++.+||+.||++|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=286.18 Aligned_cols=185 Identities=27% Similarity=0.402 Sum_probs=148.3
Q ss_pred cccCcCccceEEEEEeeC---CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 526 (724)
.+||+|+||.||+++..+ +..||+|.+... .....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998753 468999988753 223467899999999999999999998854 4567899999865
Q ss_pred CChhhhcCC------------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeee----CCCCCeEEccccCcc
Q 041285 527 GSLADVYSS------------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILM----DENRYAKISDFALAK 586 (724)
Q Consensus 527 gsL~~~l~~------------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll----~~~~~~kl~Dfgl~~ 586 (724)
+|.+++.. .. +..+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66655421 11 12367999999999998 99999999999999 566789999999998
Q ss_pred ccCCCCc--ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCC
Q 041285 587 LMKPDQT--RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 587 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
....... .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7653322 122335679999999998764 5789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=285.17 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=182.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||.||++... .++.||+|.++... ......+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 345578999999999999875 47899999986432 2233467889999999999999999999999999999999997
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... . ..+.+|++||+|||+. +++|+||||+|||+++++.+||+|||++....... ....
T Consensus 88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (301)
T cd07873 88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYS 162 (301)
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cccc
Confidence 58887764321 1 1267999999999998 99999999999999999999999999987543221 1122
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH------------HcCCcc
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF------------ENGNLG 664 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~------------~~~~~~ 664 (724)
...+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.. ..+.... ......
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhcccccc
Confidence 34568899999987654 4788999999999999999999998754322111 0000000 000000
Q ss_pred ccccccc-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIEDED-------VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~~~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..-.+.. ........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 01112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=287.63 Aligned_cols=233 Identities=25% Similarity=0.279 Sum_probs=175.5
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEcccccc---hhHHHHHHHHHhhccc---CcCceeeeeeEEecccceEEEEeeccC
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA---EGEREFQTEIKAIGRT---HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
||+|+||.||+++.. +++.||||++..... .....+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 478999999865321 2223455566666554 699999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++.... ...+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCc
Confidence 99988874321 12267999999999998 999999999999999999999999999875432221 12235
Q ss_pred ccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 600 RGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
.|++.|+|||.+.+. .++.++||||||+++|||++|+.||...... . ..+.+..+.... .. .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~~~--~~----~~~~~ 223 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKVRF--PK----NVLSD 223 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCCCC--CC----ccCCH
Confidence 689999999998765 4789999999999999999999998653211 1 112222222111 11 11234
Q ss_pred HHHHHHHHcccCCCCCCC----CHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRP----SMKKVLL 703 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RP----s~~evl~ 703 (724)
.+.+++.+||+.+|.+|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 577899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=277.72 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=185.0
Q ss_pred cccccCcCccceEEEEEee----CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ce
Q 041285 450 FKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NK 517 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 517 (724)
+.+.||+|+||.||+|.+. .++.||||.+.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4568999999999999864 25789999886532 334567899999999999999999999886542 24
Q ss_pred EEEEeeccCCChhhhcCC---------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 518 ILVYEYMSNGSLADVYSS---------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~---------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
++++||+++++|.+++.. .. ...+.+++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 788999999999877621 11 12378999999999988 999999999999999999999999999
Q ss_pred ccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCC
Q 041285 585 AKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGN 662 (724)
Q Consensus 585 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 662 (724)
++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+..... ..+ ...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEI----YNYLIKGN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHH----HHHHHcCC
Confidence 9865432211 1122345678999999988889999999999999999999 7777754321 111 11122221
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
... . .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~~--~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK--Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC--C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.30 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=191.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccch-----hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-----GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|++|.||+|... +++.||||.+...... ....+..|++++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34578999999999999875 5789999998754222 23457789999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+ +++|.+++.... ...+.||++||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 99 999999985433 12378999999999998 999999999999999999999999999986643321
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc---------CCcc
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN---------GNLG 664 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---------~~~~ 664 (724)
......+++.|+|||.+.+ ..++.++||||||++++||++|..++......+. +... ...... ..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKI-FEALGTPTEENWPGVTSLP 234 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHH-HHHcCCCchhhhhhccccc
Confidence 1222346788999998865 4578999999999999999999777654332111 1110 000000 0000
Q ss_pred cccc---cc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCCCC
Q 041285 665 QLIE---DE-----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDIPIPPN 716 (724)
Q Consensus 665 ~~~~---~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~~p~~ 716 (724)
.... .. .........+.+++..|++.+|++||++.|+++. +++......|.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~~ 296 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCCC
Confidence 0000 00 0112234678899999999999999999999986 555444443443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.80 Aligned_cols=237 Identities=22% Similarity=0.355 Sum_probs=188.6
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 58999999999999864 57899999886544445567899999999999999999999999999999999999999999
Q ss_pred hhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 531 DVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 531 ~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+++..... ..+.+++.||+|||+. +++||||+|+||+++.++.++|+|||++........ ......|++.
T Consensus 105 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~ 180 (285)
T cd06648 105 DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPY 180 (285)
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCcc
Confidence 98855321 2378999999999998 999999999999999999999999999876543322 1223457899
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|+|||.+.+..++.++||||||++++||++|+.|+...... ... .....+........ ......+.+++
T Consensus 181 y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~-~~~~~~~~~~~~~~----~~~~~~l~~li 249 (285)
T cd06648 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAM-KRIRDNLPPKLKNL----HKVSPRLRSFL 249 (285)
T ss_pred ccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHhcCCCCCccc----ccCCHHHHHHH
Confidence 99999998888999999999999999999999998653221 111 11222211111111 11335689999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~ 703 (724)
.+||+.+|++||++.++++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 250 DRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHcccChhhCcCHHHHcc
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=281.07 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=178.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhccc---CcCceeeeeeEEecc-----cce
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRT---HHRNLVRLLGYSFDV-----SNK 517 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~~~ 517 (724)
.+.+.||+|+||.||++... +++.||+|.++.... .....+.+|++++.++ +|+||+++++++... ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34578999999999999875 478999998865321 1223556777777665 699999999988642 357
Q ss_pred EEEEeeccCCChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 518 ILVYEYMSNGSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
++++||+++ +|.+++.... ...+.||+.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 999999974 7877774321 12267999999999998 9999999999999999999999999999866
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc---CCccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN---GNLGQ 665 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 665 (724)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+... ...... .....
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~-~~~~~~~~~~~~~~ 233 (288)
T cd07863 159 SCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKI-FDLIGLPPEDDWPR 233 (288)
T ss_pred cCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHH-HHHhCCCChhhCcc
Confidence 43221 223457899999999998899999999999999999999999886543211 11111 110000 00000
Q ss_pred -------ccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 -------LIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 -------~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+. .........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 011123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=282.21 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=189.2
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|++|.||++... +++.||||.++... ....+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999886 47899999886532 223467899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++.+..+.... . +..+.+|++||.|||+. +++|+||+|+||++++++.+||+|||++............
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 987777655332 1 22377999999999998 9999999999999999999999999999876544332333
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH--------HHH-HcC-----C
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY--------QCF-ENG-----N 662 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~--------~~~-~~~-----~ 662 (724)
...++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+......... ... ... .
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 45678899999999888 78999999999999999999999886543211100000000 000 000 0
Q ss_pred cccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 663 LGQLIEDE----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 663 ~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.....+.. .........+.+++..||+.+|++||+++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0111125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=290.42 Aligned_cols=181 Identities=25% Similarity=0.295 Sum_probs=150.2
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++.... ++.||+|..... ....|+.++++++|+||+++++++.+....++|+||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 4556789999999999998754 578999975432 23568999999999999999999999999999999994
Q ss_pred CChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++... .+ ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~ 215 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLG 215 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--ccccc
Confidence 6787777432 11 2267999999999998 9999999999999999999999999999753322 12233
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCC
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~ 640 (724)
..||+.|+|||.+.+..++.++||||||+++|||+++..++.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 568999999999999999999999999999999998766553
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=272.69 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=187.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc-cceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-SNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~ 524 (724)
.+.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 45688999999999999875 46889999986432 23445788999999999999999999987644 4578999999
Q ss_pred cCCChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++++|.+++... . ...+.+++.+++|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence 999999887432 1 22377999999999998 999999999999999999999999999986643222 2
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....+++.|+|||.+.+..++.++||||||++++||++|+.|+..... ...... ...+.+.. ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~~~------~~~~ 225 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKLPP------MPKD 225 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCCCC------Cccc
Confidence 2234578899999999999999999999999999999999998864321 111111 22222211 1123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 44568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=299.22 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=174.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc--------cceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--------SNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~ 518 (724)
+.+.+.||+|+||.||+|... .++.||||++.... ....+|+.++++++|+||+++++++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 445678999999999999875 47899999885421 2345799999999999999999876432 1356
Q ss_pred EEEeeccCCChhhhcCC-------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCcc
Q 041285 519 LVYEYMSNGSLADVYSS-------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAK 586 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~ 586 (724)
+||||+++ +|.+++.. .. +..+.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999975 66555421 11 12257999999999998 999999999999998664 79999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc-----
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN----- 660 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 660 (724)
.+..... .....|++.|+|||++.+. .++.++|||||||++|||++|..||......+. +... .+....
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p~~~~ 294 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTPTEDQ 294 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHH
Confidence 6643222 1234678999999988664 689999999999999999999999975432221 1110 000000
Q ss_pred -----CCcccccccc--------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 661 -----GNLGQLIEDE--------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 661 -----~~~~~~~~~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.-+. .........+.+++.+||+.+|.+|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000000 011112356889999999999999999999873
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.47 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=187.5
Q ss_pred cCHHHHHHhhcccc--cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec
Q 041285 438 FSYAELEKMTDGFK--EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD 513 (724)
Q Consensus 438 ~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 513 (724)
+...++..++.+|. +.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33445555555554 68999999999999874 5789999998653 22345678899999999 89999999999875
Q ss_pred c-----cceEEEEeeccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCe
Q 041285 514 V-----SNKILVYEYMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 514 ~-----~~~~lv~e~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
. ...++|+||+++++|.+++.. ..+ ..+.+++.||.|||+. +++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999987642 111 1267999999999988 99999999999999999999
Q ss_pred EEccccCccccCCCCcceeeccccCccccCcccccCCC-----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH
Q 041285 578 KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP-----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 578 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~ 652 (724)
||+|||++........ ......++..|+|||.+.... ++.++||||||+++|||++|+.|+........
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 9999999876543221 112245788999999876443 68899999999999999999999865322111
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.+ +..+....+.++. .....+.+++.+|++.+|++||++.|+++
T Consensus 242 -~~~-~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -LFK-IPRNPPPTLLHPE----KWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHH-HhcCCCCCCCccc----ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 1122222222221 22345889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=280.33 Aligned_cols=245 Identities=20% Similarity=0.217 Sum_probs=188.5
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|+++++.++|+||+++++.+......++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 345789999999999998754 6899999887532 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc----
Q 041285 525 SNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT---- 593 (724)
Q Consensus 525 ~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~---- 593 (724)
++++|.+++.... + ..+.++++||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 84 EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999984321 1 2267899999999998 999999999999999999999999999864211100
Q ss_pred ----------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 594 ----------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 594 ----------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
.......++..|+|||.+....++.++|+||||+++|||++|..|+...... +. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~-~~~~~~~~~ 233 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------EL-FGQVISDDI 233 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHhccc
Confidence 0111235788999999998888999999999999999999999998643211 11 122222222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...... ......+.+++.+|++.+|++||++.++.++|+.
T Consensus 234 ~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 EWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111 1233457899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=277.06 Aligned_cols=239 Identities=24% Similarity=0.318 Sum_probs=180.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEe-----cccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSF-----DVSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv~e 522 (724)
+.+.||+|+||.||++... .++.+|+|.+... .....++.+|+.++.++ +|+||+++++++. .+...++|||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 4478999999999999875 4789999987653 22345788999999999 6999999999884 3456899999
Q ss_pred eccCCChhhhcCC-------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 523 YMSNGSLADVYSS-------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 523 ~~~~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|+++++|.+++.. .. +..+.++++||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999887631 11 11367899999999998 9999999999999999999999999998765432
Q ss_pred CcceeeccccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.. ......|++.|+|||.+.. ..++.++||||||+++|||++|+.|+........ ... .........
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~ 249 (286)
T cd06638 178 RL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFK-IPRNPPPTL 249 (286)
T ss_pred CC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hhh-ccccCCCcc
Confidence 21 1223468899999998753 4478899999999999999999999865322111 001 111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.++.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 250 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 250 HQPEL----WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCC----cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111 23458889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.96 Aligned_cols=251 Identities=25% Similarity=0.267 Sum_probs=182.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 518 (724)
+.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 344578999999999999864 47899999987532 23345788999999999999999999987543 3579
Q ss_pred EEEeeccCCChhhhcCC-CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSS-PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||+++ +|.+.+.. ... ..+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 180 (364)
T cd07875 106 IVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 180 (364)
T ss_pred EEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-
Confidence 99999965 66665532 222 2378999999999998 99999999999999999999999999998654321
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------------HHHHHHHH
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------------LEEWVYQC 657 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------------l~~~~~~~ 657 (724)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+... +.......
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred -cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 1223468999999999999999999999999999999999999996543211100 00000000
Q ss_pred HHcCC-cc---------ccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 658 FENGN-LG---------QLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 658 ~~~~~-~~---------~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..... .. ....+ ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 00 00000 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=274.83 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=184.9
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccc----------hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA----------EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.||+|++|.||+|... +++.+|||.++.... ...+.+.+|+.++++++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 467999999999999864 588999998753111 112467889999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC---cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSSPP---KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~---~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|+||+++++|.+++.... .. .+.+|+.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 162 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162 (272)
T ss_pred EEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccc
Confidence 999999999999885421 11 267899999999998 99999999999999999999999999997654322
Q ss_pred c-ceeeccccCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 593 T-RTFTGIRGTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 593 ~-~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
. .......++..|+|||.+.... ++.++|+||||+++||+++|..|+...... .. ..+.. .......+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~-~~~~~-~~~~~~~~~- 234 (272)
T cd06629 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AA-MFKLG-NKRSAPPIP- 234 (272)
T ss_pred cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HH-HHHhh-ccccCCcCC-
Confidence 1 1122346789999999987654 789999999999999999999998532211 11 11111 111111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..........+.+++..|++.+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11222335678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.99 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=185.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34578999999999999886 47899999886432 2233568899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++.|..++... .+ ..+.|++++|+|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (286)
T cd07847 84 HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTD 159 (286)
T ss_pred ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccC
Confidence 99888876432 22 2278999999999998 999999999999999999999999999987643321 1122
Q ss_pred cccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH-HHHHH-------HHHHcCCc-ccccc
Q 041285 599 IRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL-EEWVY-------QCFENGNL-GQLIE 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l-~~~~~-------~~~~~~~~-~~~~~ 668 (724)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ..... ........ .....
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 346788999999876 4578999999999999999999999875433221100 00000 00000000 00000
Q ss_pred cc---cc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DE---DV-----DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~---~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+. .. .......+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.02 Aligned_cols=242 Identities=26% Similarity=0.420 Sum_probs=189.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++|+||+++++.+......++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4578999999999999886 47899999987643 344567899999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC--------cchHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPP--------KNNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~--------~~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... ...+.+++++|+|||+ . +++|+||+|+||++++++.++|+|||.+..........
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--- 158 (265)
T cd06605 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--- 158 (265)
T ss_pred cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc---
Confidence 9999885431 1236799999999998 6 99999999999999999999999999987653222111
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ........ ...+....+ .......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~-----~~~~~~~ 231 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY-IVNEPPPRL-----PSGKFSP 231 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH-HhcCCCCCC-----ChhhcCH
Confidence 5578899999999988999999999999999999999999865422111 11111111 111111111 0111345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+.+++..|++.+|++||++.++++.
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 58899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=275.95 Aligned_cols=236 Identities=22% Similarity=0.374 Sum_probs=195.1
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|.|..|-++++ -.|+.||||++.+. .......+..|++.|+.++|||||+|+.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 34557899999999988865 47999999999763 2334457899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC--------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSP--------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~--------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++|+|.+|+..+ ..+.+.||+.||.|+|+- .+|||||||+||.+- .-|-+||.|||++-.+.+.+.
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 999999998443 234488999999999998 999999999999775 567899999999977655433
Q ss_pred eeccccCccccCcccccCCCCC-cccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc-ccC
Q 041285 596 FTGIRGTRGYVAPEWHWNLPIT-AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE-DVD 673 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~ 673 (724)
.....|+..|-|||++.+..|+ ++.||||||||||.|++|+.||+.....+. +..++|-. .++
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKYtvP 239 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKYTVP 239 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccccCc
Confidence 3345789999999999999886 578999999999999999999987654332 22333433 245
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....++.+++..||+.||.+|.+.+||+.
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 566778999999999999999999999874
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=273.47 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=179.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-----chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 521 (724)
..+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3478999999999999875 47899999886321 12345688999999999999999999988753 5678999
Q ss_pred eeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 522 EYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
||+++++|.+++... . ...+.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 86 EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999887432 1 12378999999999988 999999999999999999999999999876532211
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ........... ...
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~~------~~~ 230 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPTN------PQL 230 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCCC------CCC
Confidence 11122457889999999998889999999999999999999999986532111 11111111110 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+..++ .|+..+|++||+++||++
T Consensus 231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112223344444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=272.96 Aligned_cols=238 Identities=27% Similarity=0.403 Sum_probs=188.1
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.++||+|+||.||+|... +++.+|||.+.... ....+.+.+|+.++.+++|+||+++++++.+....++||||++++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 4567999999999999864 57899999876422 233467899999999999999999999999999999999999999
Q ss_pred ChhhhcCCCC--cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 528 SLADVYSSPP--KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 528 sL~~~l~~~~--~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+|.+++.... +. .+.+++.++.|||+. +++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 88 ~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 163 (277)
T cd06641 88 SALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVG 163 (277)
T ss_pred cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccC
Confidence 9999886432 22 267899999999998 999999999999999999999999999876543221 1122457
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
+..|+|||.+.+..++.++|+||||+++|+|++|..|+...... . .......+.... ........+.
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~------~~~~~~~~~~ 230 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------K-VLFLIPKNNPPT------LEGNYSKPLK 230 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------H-HHHHHhcCCCCC------CCcccCHHHH
Confidence 88999999998888999999999999999999999998643211 1 111111121111 1122345578
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+++.+|++.+|++||++.++++.
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhC
Confidence 89999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=270.91 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=189.2
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.+|++... +++.+|+|.+... .....+++.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 35678999999999999875 5789999998642 22344678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++... . ...+.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 158 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LA 158 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hh
Confidence 99999887432 1 12367999999999998 999999999999999999999999999976543221 11
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+++.|+|||.+.+...+.++|+||||+++++|++|+.|+..... .+.+... ..+.... .....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~------~~~~~ 225 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSYPP------VSSHY 225 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCCCC------CcccC
Confidence 223578899999999988899999999999999999999999864321 1112222 2222111 11223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+|++.+|++||+|.+|++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 4568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=281.98 Aligned_cols=251 Identities=27% Similarity=0.376 Sum_probs=185.2
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.++||+|+||.||++... .++.+|+|++..... ...+.+.+|++++++++|+||+++++++......++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 45578999999999999986 478999998865322 234578899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.++.... .+ ..+.+|+++|+|||+. +++|+||+|+||++++++.++|+|||++....... .....
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 99998776432 22 2267999999999988 99999999999999999999999999988654332 22223
Q ss_pred cccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhc-HHHH-------HHHHHHcCCc-ccccc
Q 041285 599 IRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI-LEEW-------VYQCFENGNL-GQLIE 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~~-~~~~~ 668 (724)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+... +... .......... .....
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 457889999998875 347889999999999999999998886432211000 0000 0000000000 00000
Q ss_pred ccc--------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DED--------VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~--------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.. ........+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 01123466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=277.67 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=190.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 345578999999999999864 5789999998654444556789999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 527 GSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 527 gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
++|.+++.... . ..+.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++........ ......
T Consensus 101 ~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 176 (293)
T cd06647 101 GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 176 (293)
T ss_pred CcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccccc
Confidence 99999885432 1 2267899999999998 999999999999999999999999999876543322 122345
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
+++.|++||.+....++.++||||||+++||+++|+.||.......... .....+ ..... ........+
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~-~~~~~----~~~~~~~~l 245 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TPELQ----NPEKLSAIF 245 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC-CCCCC----CccccCHHH
Confidence 7889999999988889999999999999999999999996543221110 000111 11110 111223457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+++..||+.+|++||++.+++..
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=268.40 Aligned_cols=237 Identities=23% Similarity=0.277 Sum_probs=188.9
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||.|.-|+||++.+.+ +..+|+|++.+.. +....+...|-++|+.++||.|+.|++.+...+..+|+||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 679999999999999976 4789999997643 334456778999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCcch---------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC--------
Q 041285 528 SLADVYSSPPKNN---------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP-------- 590 (724)
Q Consensus 528 sL~~~l~~~~~~~---------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~-------- 590 (724)
+|..+.++++.+. +.+|+-||+|||-. +||.|||||+||||.++|++.|+||.|+.....
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 9999987655443 67899999999988 999999999999999999999999999754310
Q ss_pred C--------------------------Cc---------------------ceeeccccCccccCcccccCCCCCccccee
Q 041285 591 D--------------------------QT---------------------RTFTGIRGTRGYVAPEWHWNLPITAKADVY 623 (724)
Q Consensus 591 ~--------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 623 (724)
. .. ......+||-.|+|||++.+...+.++|.|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 0 00 000124699999999999999999999999
Q ss_pred ehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCC----HH
Q 041285 624 SFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS----MK 699 (724)
Q Consensus 624 S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~ 699 (724)
+|||+||||+.|..||.+....+. +. ..+. ..+.- + ..++....+.+|+...|..||.+|.. +.
T Consensus 320 tfGIflYEmLyG~TPFKG~~~~~T--l~----NIv~-~~l~F---p--~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSNNKET--LR----NIVG-QPLKF---P--EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCCchhh--HH----HHhc-CCCcC---C--CCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 999999999999999987654322 11 1111 11110 1 11244567889999999999999998 77
Q ss_pred HHHH
Q 041285 700 KVLL 703 (724)
Q Consensus 700 evl~ 703 (724)
||-+
T Consensus 388 eIK~ 391 (459)
T KOG0610|consen 388 EIKR 391 (459)
T ss_pred Hhhc
Confidence 7753
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=271.40 Aligned_cols=244 Identities=28% Similarity=0.430 Sum_probs=189.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||.|++|+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45678999999999999865 57899999986422 33557899999999999999999999999999999999999999
Q ss_pred CChhhhcCCC------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc--
Q 041285 527 GSLADVYSSP------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-- 594 (724)
Q Consensus 527 gsL~~~l~~~------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-- 594 (724)
++|.+++... .+ ..+.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999988432 11 2267999999999988 9999999999999999999999999998766543222
Q ss_pred -eeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 595 -TFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 595 -~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
......++..|+|||.+... .++.++|+||||++++||++|+.|+....... . ..+.... .. ........
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~----~~~~~~~-~~-~~~~~~~~ 232 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V----LMLTLQN-DP-PSLETGAD 232 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h----HHHHhcC-CC-CCcCCccc
Confidence 11234578999999998877 78999999999999999999999986543211 0 1111111 11 11111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++..|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1233466889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.92 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=187.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++... +++.||||++.... ......+.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999875 57899999987533 233467999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++|.+++.... +..+.+|+++|+|||+. +++|+||||+||+++.++.++|+|||++............
T Consensus 82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 999998874321 12367999999999998 9999999999999999999999999999876544322233
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC------------Ccc
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG------------NLG 664 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------------~~~ 664 (724)
...++..|+|||.+.+. .++.++||||+|++++||++|..++....... .+ .......... ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE--QL-AIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH--HH-HHHHHHcCCCChHHHhhccCcchhh
Confidence 45688999999988654 46899999999999999999977765432211 11 1111110000 000
Q ss_pred cccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDE-------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+. ....+....+.+++.+|++.+|.+||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=272.89 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=187.1
Q ss_pred ccccCcCccceEEEEEe-eCCcEEEEEEccccc------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 451 KEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+++|+.++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999986 457899999886432 11346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCc--
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQT-- 593 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~-- 593 (724)
+++++|.+++... . ...+.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 85 MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred cCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 9999999988432 1 22268999999999998 999999999999998775 599999999876643321
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......++..|+|||.+.+..++.++||||+|+++++|++|..|+......... ....+..... .....
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------~~~~~ 232 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASAT------TAPSI 232 (268)
T ss_pred CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccC------CCCCC
Confidence 1112245788999999998888999999999999999999999998643322111 1111111100 11122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2334566889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=302.37 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=194.1
Q ss_pred ccccccCcCccceEEEEEeeC--------CcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEecccceE
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 518 (724)
.+.+.||+|.||.|++|.+.. ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|......+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 456799999999999998641 34799999986433 3457899999999999 7999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC-----------------c------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC
Q 041285 519 LVYEYMSNGSLADVYSSPP-----------------K------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR 575 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~-----------------~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~ 575 (724)
+|.||+.+|+|.++|+... . ..+.|||.|++||++. +++||||.++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999996544 1 1168999999999998 899999999999999999
Q ss_pred CeEEccccCccccCCCCcceeeccc--cCccccCcccccCCCCCcccceeehhHHHHHhhccc-cCCCCCCCcchhcHHH
Q 041285 576 YAKISDFALAKLMKPDQTRTFTGIR--GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCR-RCFDQNLPEDQVILEE 652 (724)
Q Consensus 576 ~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~-~p~~~~~~~~~~~l~~ 652 (724)
.+||+|||+++.............. -+..|||||.+....|+.|+|||||||+||||+|.. .|+...... .+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-----~~ 530 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-----EE 530 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-----HH
Confidence 9999999999976554443322222 466799999999999999999999999999999854 454331111 11
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
+.+.+++|...+. +......+.++++.||+.+|++||++.++++.|+.
T Consensus 531 -l~~~l~~G~r~~~------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 -LLEFLKEGNRMEQ------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred -HHHHHhcCCCCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2334555532211 11224568899999999999999999999999987
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=273.63 Aligned_cols=239 Identities=24% Similarity=0.355 Sum_probs=186.4
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEcccc-cchhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEEEeec
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.||+|+||.||+|.. .+++.+|||.+... ......++.+|+.++++++ |+|++++++++.+....++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 456799999999999987 45789999988643 2334567889999999986 999999999999999999999999
Q ss_pred cCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 525 SNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 525 ~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++++|.+++..... ..+.+++++|.|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 85 ~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06917 85 EGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRST 160 (277)
T ss_pred CCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cccc
Confidence 99999998854322 1267899999999998 999999999999999999999999999987654332 2223
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..|+..|+|||.+.++ .++.++||||||+++|+|++|..|+....... .. ..........+ . .....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~-~~~~~~~~~~~-~----~~~~~ 228 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AM-MLIPKSKPPRL-E----DNGYS 228 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hh-hccccCCCCCC-C----cccCC
Confidence 4688899999988754 46899999999999999999999986532211 01 01111111111 1 11134
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+.+++..|++.+|++||++.|+++.
T Consensus 229 ~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 229 KLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 568889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.98 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=179.0
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv 520 (724)
..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 4468999999999999864 57899999986532 22345678899999999999999999987543 356899
Q ss_pred EeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+|++ +++|.+++..... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 171 (343)
T cd07878 99 TNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--- 171 (343)
T ss_pred eecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC---
Confidence 9987 7888887754222 2378999999999998 9999999999999999999999999999865432
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc-----------C-
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN-----------G- 661 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-----------~- 661 (724)
.....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +... .+.... .
T Consensus 172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRI-MEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HHHhCCCCHHHHHhcchhh
Confidence 223467999999999877 4688999999999999999999999865322111 1000 000000 0
Q ss_pred ------Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 662 ------NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 662 ------~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+...-... .........+.+++.+|++.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000112346789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=275.79 Aligned_cols=237 Identities=26% Similarity=0.403 Sum_probs=180.5
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec------ccceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD------VSNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~lv~ 521 (724)
+.+.||+|+||.||+|... .++.+|+|.+... .....++..|+.++.++ +|+||+++++++.. ....+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 3478999999999999874 4789999988653 23345788999999998 79999999999863 45679999
Q ss_pred eeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 522 EYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 522 e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||+++++|.+++... .. ..+.||++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 999999999988432 11 1256899999999998 99999999999999999999999999987553221
Q ss_pred cceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
. ......|++.|+|||.+. ...++.++||||||+++|||++|..|+....+.... .. ......
T Consensus 176 ~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~-~~~~~~---- 243 (282)
T cd06636 176 G-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPRNPP---- 243 (282)
T ss_pred c-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hh-HhhCCC----
Confidence 1 112245788999999875 345788999999999999999999998643221110 00 111111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...........+.+++..||+.+|.+||++.|+++
T Consensus 244 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 -PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.77 Aligned_cols=239 Identities=27% Similarity=0.413 Sum_probs=190.8
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3478999999999999986 578999999987544466789999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++... .+ ..+.+++++|.|||+. +++|+||+|+||++++++.++|+|||.+........ .....
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 99988543 11 1267999999999997 999999999999999999999999999987654332 22345
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
++..|++||.+.....+.++||||||+++++|++|+.|+........ . .............. ......+
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~~~----~~~~~~~ 227 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------L-FKIATNGPPGLRNP----EKWSDEF 227 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------H-HHHHhcCCCCcCcc----cccCHHH
Confidence 78899999999888899999999999999999999999865321111 1 11111111111111 1113568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+++..|++.+|++||++.|+++.
T Consensus 228 ~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 228 KDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.89 Aligned_cols=241 Identities=28% Similarity=0.393 Sum_probs=192.6
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||+|++|.||+++... ++.|+||++..... ...+++.+|+..+.+++|+||+++++++......++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 45789999999999999875 89999999876433 44578999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC---C----cchHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP---P----KNNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~---~----~~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... . +..+.+++++|.|||+ . +++|+||+|+||+++.++.++|+|||++.......... ...
T Consensus 85 ~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~ 160 (264)
T cd06623 85 SLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTF 160 (264)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cce
Confidence 999998532 1 2337899999999999 7 99999999999999999999999999998764332221 234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH-HHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK-QLE 678 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 678 (724)
.++..|+|||.+....++.++|+||||+++|||++|+.|+........ ...... +....... .... ...
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~-~~~~~~~~------~~~~~~~~ 230 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQA-ICDGPPPS------LPAEEFSP 230 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHH-HhcCCCCC------CCcccCCH
Confidence 578899999999988899999999999999999999999876542111 111111 11111111 1111 345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+.+++..|++.+|++||++.|+++.
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 78899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=268.72 Aligned_cols=238 Identities=23% Similarity=0.386 Sum_probs=186.6
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++... +++.+|||.+... .....+.+.+|++++++++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 45678999999999999874 5789999988643 23345679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCccccCCCCcce
Q 041285 526 NGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 526 ~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++|.+++... .. ..+.+++++|.|||+. +++|+||+|+||+++++ ..+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999988532 11 1267899999999998 99999999999999865 4589999999986643321
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....++..|+|||.+....++.++||||||+++|+|++|+.|+...... ..+... ..+......+ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~------~ 224 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKI-MSGTFAPISD------R 224 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHH-HhcCCCCCCC------C
Confidence 12245788999999999888999999999999999999999998654321 111111 1111111111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++..||+.+|++||++.|+++.
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 23458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=274.71 Aligned_cols=240 Identities=24% Similarity=0.396 Sum_probs=185.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|+||.||++... .++.+|+|.+.... ......+.+|++++.+++|+||+++++.+......++|+||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45578999999999999886 58899999886532 23346789999999999999999999999999999999999999
Q ss_pred CChhhhcCCC------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSP------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|..++... .. ..+.++++||.|||++ .+++|+||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 158 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--- 158 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---
Confidence 9999887542 11 1267899999999963 2899999999999999999999999999876532211
Q ss_pred eccccCccccCcccccCCC------CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 597 TGIRGTRGYVAPEWHWNLP------ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~------~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||........ . . .......+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~-~~~~~~~~~~~------ 228 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--F-A-QLSAIVDGDPP------ 228 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--H-H-HHHHHhhcCCC------
Confidence 2234788999999885543 47899999999999999999999864321110 0 0 01111112111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++.+|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112234566889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=276.71 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=185.4
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEeec
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~ 524 (724)
+.++||+|++|.||+++..+ ++.+|+|++.... ......+.+|++++++++|+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 45789999999999998764 7899999997642 23345688999999999999999999999988 7899999999
Q ss_pred cCCChhhhcCCC--C------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP--P------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~--~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++ +|.+++... . ...+.+|++||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 83 DH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 75 888877443 1 12268999999999998 999999999999999999999999999987654432223
Q ss_pred eccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---C---cccc---
Q 041285 597 TGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---N---LGQL--- 666 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~~--- 666 (724)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +. ...+..... . ...+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LE-KIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHHHhCCCchhhccccccchhh
Confidence 33456788999998765 4578999999999999999999999875432211 11 011110000 0 0000
Q ss_pred --cccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 --IEDE---------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 --~~~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... .........+.+++..|++.+|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 000112567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=306.09 Aligned_cols=243 Identities=20% Similarity=0.273 Sum_probs=182.5
Q ss_pred hhcccccccCcCccceEEEEEeeC-CcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILV 520 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 520 (724)
..+.+.++||+|+||+||++.... ++.+|+|.+... .......|..|+.++.+++|||||++++++.+ ....++|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 345567899999999999998754 678899987642 22334678999999999999999999998864 3468999
Q ss_pred EeeccCCChhhhcCC-------CC----cchHHHHHHHcccccccC----CCceEeCCCCCCCeeeCC------------
Q 041285 521 YEYMSNGSLADVYSS-------PP----KNNLIGIARGILYLHDEC----ESQIIHCDIKPQNILMDE------------ 573 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~----~~~i~H~dlk~~NIll~~------------ 573 (724)
|||+++++|.+++.. .. +.++.||+.||.|||+.. ..+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999988742 12 233679999999999852 136999999999999964
Q ss_pred -----CCCeEEccccCccccCCCCcceeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCCCCCcc
Q 041285 574 -----NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQNLPED 646 (724)
Q Consensus 574 -----~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~ 646 (724)
...+||+|||++..+..... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~- 249 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF- 249 (1021)
T ss_pred cccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-
Confidence 23489999999986543221 123468999999999864 45889999999999999999999999643221
Q ss_pred hhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 647 QVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 647 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... ...+..+.. + ........+.+|+..||+.+|.+||++.|++.
T Consensus 250 ----~ql-i~~lk~~p~--l-----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 ----SQL-ISELKRGPD--L-----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----HHH-HHHHhcCCC--C-----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 112222111 0 00112345888999999999999999999983
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.40 Aligned_cols=239 Identities=26% Similarity=0.404 Sum_probs=189.0
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 3467999999999999986 578999999876433 46678999999999999999999999999999999999999999
Q ss_pred hhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++.... . ..+.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 102 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 177 (286)
T cd06614 102 LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177 (286)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence 999985432 1 2278999999999997 999999999999999999999999999875543221 112234
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
++..|++||.+.+..++.++||||||+++|+|++|+.|+........ ... ..........+. ......+
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~~----~~~~~~l 246 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITTKGIPPLKNP----EKWSPEF 246 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCCCCcch----hhCCHHH
Confidence 67899999999888899999999999999999999999864322111 111 111112111111 1133568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+++.+|++.+|.+||++.++++.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhC
Confidence 899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=282.12 Aligned_cols=190 Identities=28% Similarity=0.419 Sum_probs=158.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cC-----ceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HR-----NLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~l 519 (724)
++.+.+.||+|.||.|-++... .++.||||+++.. ..-.++-..|+.+|..|+ |. |+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 5566789999999999999865 4899999999874 233456678999999996 43 89999999999999999
Q ss_pred EEeeccCCChhhhcCCCCc---------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC--CCeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSSPPK---------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN--RYAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~~---------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~--~~~kl~Dfgl~~~~ 588 (724)
|+|.+ ..+|.++++.... ..+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 6689999965332 2278999999999988 99999999999999653 36999999999875
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE 645 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~ 645 (724)
...-. ...-+.-|.|||++.+.+|+.+.||||||||+.||++|.+.|.+....
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 43322 233477899999999999999999999999999999998877655433
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=278.33 Aligned_cols=239 Identities=21% Similarity=0.269 Sum_probs=186.4
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+.+....++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 45789999999999998865 88999999875322 244678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc--
Q 041285 526 NGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-- 594 (724)
Q Consensus 526 ~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-- 594 (724)
+++|.+++.... . ..+.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999885421 1 1267999999999998 9999999999999999999999999998754321110
Q ss_pred --------------------------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchh
Q 041285 595 --------------------------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV 648 (724)
Q Consensus 595 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~ 648 (724)
......|+..|+|||.+.+..++.++||||||+++|+|++|..|+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~- 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET- 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-
Confidence 01123578899999999988899999999999999999999999865432211
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPS----MKKVLL 703 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~evl~ 703 (724)
..... ....... ........+.+++.+|++.+|++||+ +.|++.
T Consensus 241 -----~~~~~-~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 -----FSNIL-KKEVTFP-----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -----HHHHh-cCCccCC-----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 1111110 01114567899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=294.17 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=174.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC------cCceeeeeeEEecc-cceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH------HRNLVRLLGYSFDV-SNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~-~~~~l 519 (724)
+.+.++||+|+||+||++... .++.||||+++.. ....+++..|++++.+++ |.+++++++++... .+.++
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 345578999999999999875 4788999998653 222345566666666664 45688999988764 46889
Q ss_pred EEeeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----------------C
Q 041285 520 VYEYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----------------Y 576 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----------------~ 576 (724)
|||++ +++|.+++... . ..++.||+.||.|||++ .+|+||||||+|||++.++ .
T Consensus 210 v~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99988 67787776432 1 22378999999999963 2899999999999998765 4
Q ss_pred eEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHH-----
Q 041285 577 AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE----- 651 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~----- 651 (724)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...+.
T Consensus 287 vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 287 VRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred EEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 99999998764321 123357899999999999999999999999999999999999999764322211110
Q ss_pred ----HHHH--------HHHHc-CCcccccccc----------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 652 ----EWVY--------QCFEN-GNLGQLIEDE----------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 652 ----~~~~--------~~~~~-~~~~~~~~~~----------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.|.. ..+.. +.+....++. .........+++++..||+.||++|||++|+++
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 00000 0000000000 000112345789999999999999999999986
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=270.50 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=181.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-----chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 521 (724)
..+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+. ...++++
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4578999999999999875 47899999875321 12345788899999999999999999988764 4578999
Q ss_pred eeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 522 EYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
||+++++|.+++... . ...+.+++.+|+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 86 EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccccc
Confidence 999999999987432 1 12378999999999998 999999999999999999999999999886542211
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... . ..+..... . ....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-~-----~~~~ 230 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-T-----NPVL 230 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC-C-----CCCC
Confidence 11223457889999999988889999999999999999999999986432111 0 11111111 0 0112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++..|+. +|++||+++||++
T Consensus 231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 23344567778888885 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=273.70 Aligned_cols=237 Identities=22% Similarity=0.362 Sum_probs=187.0
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
.+||+|+||.||++... +++.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 58899999986544445567899999999999999999999999999999999999999999
Q ss_pred hhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCcc
Q 041285 531 DVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604 (724)
Q Consensus 531 ~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~ 604 (724)
+++..... ..+.+++.+|+|||+. +++|+||+|+||+++.++.++|+|||++........ ......+++.
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~ 181 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPY 181 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCcc
Confidence 88744321 2378999999999998 999999999999999999999999999876543221 2223457899
Q ss_pred ccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHH
Q 041285 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684 (724)
Q Consensus 605 y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 684 (724)
|+|||.+.+..++.++|+||||+++|||++|..|+........ ....... +...+. ........+.+++
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~-~~~~~~---~~~~~~~~l~~li 250 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDN-LPPKLK---NLHKVSPSLKGFL 250 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhh-CCcccC---CcccCCHHHHHHH
Confidence 9999999888899999999999999999999999865322111 0111111 111100 0111234577889
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 041285 685 LWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 685 ~~Cl~~~p~~RPs~~evl~ 703 (724)
.+||+.+|.+||++.++++
T Consensus 251 ~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 251 DRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHhCCcccCcCHHHHhc
Confidence 9999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=279.50 Aligned_cols=232 Identities=27% Similarity=0.389 Sum_probs=182.7
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhH---HHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||.|+||.||-+... +.+.||||++.-...++. .++..|+..|.+++|||+|.+-||+......+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 46999999999999864 467899999975333332 46889999999999999999999999999999999999 45
Q ss_pred ChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|-.|++.-+.. .+..+.+.||+|||+. +.||||||+.||||.+.+.+||+|||.+.+..+.+ .+
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-----sF 182 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-----SF 182 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----cc
Confidence 66666632211 1256889999999998 99999999999999999999999999998876543 36
Q ss_pred ccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 600 RGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 600 ~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
+|||.|||||++. .+.|+-|+||||+|+...||.-.++|...... . .-.+....+. .|-.-..+-
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---M---SALYHIAQNe------sPtLqs~eW 250 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQNE------SPTLQSNEW 250 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---H---HHHHHHHhcC------CCCCCCchh
Confidence 7999999999865 57899999999999999999998888643211 0 0011111111 111224455
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+..++..||+.-|.+|||.+++++-
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 6778899999999999999999998764
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.92 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=180.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|++|.||++... +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 34578999999999999875 578999999865322 2234577899999999999999999999999999999999985
Q ss_pred CChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.... ...+.|+++||.|||+. +++|+||||+||+++.++.+||+|||+++...... .....
T Consensus 88 -~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07844 88 -DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSN 162 (291)
T ss_pred -CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccc
Confidence 8988774321 11267999999999998 99999999999999999999999999987543211 11122
Q ss_pred cccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Cc---------cc
Q 041285 599 IRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NL---------GQ 665 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---------~~ 665 (724)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... + ....+..... .. ..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhhhhcccccc
Confidence 346788999998875 45789999999999999999999998654311110 0 0000100000 00 00
Q ss_pred ----cccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 ----LIEDED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ----~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...... ........+.+++.+|++.+|++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00111256788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=274.72 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=179.7
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++.+++.+.+..++|+||++ +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 4578999999999999874 578999999865332 223467899999999999999999999999999999999996 6
Q ss_pred ChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... . ...+.||++||+|||+. +++|+||||+|||++.++.+||+|||+++....... .....
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 163 (291)
T cd07870 88 DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSE 163 (291)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCCc
Confidence 666655321 1 12267999999999998 999999999999999999999999999875432211 11223
Q ss_pred ccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---------Ccc----c
Q 041285 600 RGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---------NLG----Q 665 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~----~ 665 (724)
.+++.|+|||.+.+. .++.++||||||+++|||++|+.||............ .+...... .+. .
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK--IWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH--HHHHcCCCChhhhhhhhhcccccch
Confidence 468899999998754 5788999999999999999999998754321111100 00000000 000 0
Q ss_pred cc---cccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 LI---EDED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ~~---~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. .+.. ........+.+++.+|++.+|.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000 00112356778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.10 Aligned_cols=236 Identities=26% Similarity=0.340 Sum_probs=181.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 344578999999999999875 57899999886422 23345788999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++ |+|.+++.. ..+. .+.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~--- 169 (307)
T cd06607 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--- 169 (307)
T ss_pred hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC---
Confidence 97 566665532 1222 267999999999988 99999999999999999999999999987653221
Q ss_pred eeccccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FTGIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
...++..|+|||.+. ...++.++||||||+++|||++|+.|+....... .... ........ ..
T Consensus 170 --~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~~~-----~~ 235 (307)
T cd06607 170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNDSPT-----LS 235 (307)
T ss_pred --CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCCCCC-----CC
Confidence 235688999999874 4568889999999999999999999986432111 0111 11111111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.......+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 12234568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=277.27 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=181.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||++... +|+.+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34578999999999999875 58899999986432 1223567889999999999999999999999999999999997
Q ss_pred CCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... . ...+.||++||.|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 83 -QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 4777766321 1 12268999999999998 99999999999999999999999999998654322 1122
Q ss_pred ccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---------Cccccc
Q 041285 598 GIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---------NLGQLI 667 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~~~~ 667 (724)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .+.. ........ ......
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR-IFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHH-HHHHhCCCChHHhHHhhhccccc
Confidence 345688999999887654 68999999999999999999988654322111 1100 00000000 000000
Q ss_pred ccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 EDE---------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... .........+.+++.+||+.+|.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=297.46 Aligned_cols=253 Identities=17% Similarity=0.216 Sum_probs=175.9
Q ss_pred hcccccccCcCccceEEEEEeeC--CcEEEEE------------------EcccccchhHHHHHHHHHhhcccCcCceee
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN--GKFVAVK------------------RLQKMLAEGEREFQTEIKAIGRTHHRNLVR 506 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~niv~ 506 (724)
.+.+.++||+|+||+||++.+.. +...++| .+.. .......+.+|++++++++|+||++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCc
Confidence 45566899999999999987643 1112211 1111 1223456889999999999999999
Q ss_pred eeeEEecccceEEEEeeccCCChhhhcCCC------------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC
Q 041285 507 LLGYSFDVSNKILVYEYMSNGSLADVYSSP------------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN 574 (724)
Q Consensus 507 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~ 574 (724)
+++++.+.+..++|+|++. ++|.+++... ....+.||+.||.|||+. +|+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 9999999999999999985 4666554221 112377999999999998 99999999999999999
Q ss_pred CCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCC-CCCcchhcHHHH
Q 041285 575 RYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ-NLPEDQVILEEW 653 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~-~~~~~~~~l~~~ 653 (724)
+.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|..++.. ........+.+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999987754433333345789999999999999999999999999999999998754432 211111111111
Q ss_pred HH-----------------HHHHcCCcccc---ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 654 VY-----------------QCFENGNLGQL---IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 654 ~~-----------------~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.. ..+........ +............+.+++.+||+.||.+|||+.|+++.
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00000000000 00000000112346677889999999999999999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=271.32 Aligned_cols=233 Identities=26% Similarity=0.346 Sum_probs=185.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 45678999999999999875 47899999986532 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++... .. ..+.++++||.|||+. +++|+||+|+|||++.++.+||+|||++...... ..
T Consensus 84 ~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 156 (290)
T cd05580 84 PGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156 (290)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CC
Confidence 999999987432 11 1267999999999998 9999999999999999999999999999876543 22
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...+++.|+|||.+.+...+.++||||||+++|+|++|+.|+...... ...+....+... ......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-------~~~~~~ 222 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKVR-------FPSFFS 222 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCcc-------CCccCC
Confidence 345789999999998888899999999999999999999998654311 111222222211 111124
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRP-----SMKKVL 702 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RP-----s~~evl 702 (724)
..+.+++.+||+.+|.+|| +++|++
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 5678899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=269.45 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=188.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~ 523 (724)
.+.+.||.|+||.||++... +++.+|+|.+... .....+++.+|++++++++|+||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 34578999999999999864 5788999988642 23334578899999999999999999998764 3457899999
Q ss_pred ccCCChhhhcCCC-------C----cchHHHHHHHcccccccC--CCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 524 MSNGSLADVYSSP-------P----KNNLIGIARGILYLHDEC--ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 524 ~~~gsL~~~l~~~-------~----~~~~~~ia~~l~yLH~~~--~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+++++|.+++... . +..+.++++||.|||... ..+++|+||+|+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999887431 1 123689999999999322 23999999999999999999999999999987654
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
... ......++..|+|||.+....++.++||||||+++++|++|+.|+..... .. ..+.+..+....
T Consensus 163 ~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~----- 229 (265)
T cd08217 163 DSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQ-LASKIKEGKFRR----- 229 (265)
T ss_pred Ccc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HH-HHHHHhcCCCCC-----
Confidence 332 12234678999999999988899999999999999999999999875431 11 112223332211
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
........+.+++.+|++.+|++||++.+|++.
T Consensus 230 -~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=269.85 Aligned_cols=238 Identities=26% Similarity=0.290 Sum_probs=188.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||.|+||.||++... .++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 35678999999999999886 47899999987532 234578999999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-Cc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP-PK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~-~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++... .. ..+.++++||.|||+. +++|+||+|+||++++++.++|+|||++....... ...
T Consensus 83 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 157 (258)
T cd05578 83 LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTT 157 (258)
T ss_pred CCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--ccc
Confidence 999999988543 22 2267999999999998 99999999999999999999999999988664332 122
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...++..|+|||.+....++.++|+||||+++|+|++|+.|+....... ........... . ........
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---~----~~~~~~~~ 226 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA---D----VLYPATWS 226 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc---c----ccCcccCc
Confidence 3457889999999988889999999999999999999999987654321 11111111110 0 11111233
Q ss_pred HHHHHHHHHcccCCCCCCCCH--HHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSM--KKVL 702 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~--~evl 702 (724)
..+.+++.+|++.+|.+||++ +|++
T Consensus 227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 227 TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.64 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=184.5
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++|+|++++++++.+....++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 4567999999999999875 57899999986432 2234578899999999999999999999999999999999997
Q ss_pred CCChhhhcCC--C--Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSS--P--PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~--~--~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++.. . .+. .+.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++...... .
T Consensus 109 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 109 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 4 77666532 1 111 267899999999998 9999999999999999999999999998754322 2
Q ss_pred ccccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 598 GIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
...+++.|+|||++. ...++.++||||||+++|||++|+.|+....... ........+ ... ....
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~-----~~~~ 247 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPT-----LQSN 247 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhcc-CCC-----CCCc
Confidence 235788999999874 4568899999999999999999999986532111 111111111 111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
.....+.+++.+|++.+|.+||++.+|++.+--....+
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 23345889999999999999999999998765444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=270.25 Aligned_cols=239 Identities=27% Similarity=0.364 Sum_probs=188.1
Q ss_pred cCcCccceEEEEEeeC-CcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||.||++.... ++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999865322 3456789999999999999999999999999999999999999999
Q ss_pred hhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-------ce
Q 041285 530 ADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-------RT 595 (724)
Q Consensus 530 ~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-------~~ 595 (724)
.+++.... ...+.||++||+|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 98885421 12378999999999998 999999999999999999999999999876433211 12
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....++..|++||.......+.++||||||++++||++|..|+...... ... .....+...... ...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~-----~~~ 225 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIF-QNILNGKIEWPE-----DVE 225 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhcCCcCCCc-----ccc
Confidence 22345788999999998888999999999999999999999998654321 111 112222211110 001
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
....+.+++..|++.+|++||++.++.+.|+-
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 24568899999999999999999777777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.54 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=187.3
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 355789999999999999864 7889999886531 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcce
Q 041285 526 NGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 526 ~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++|.+++... .+ ..+.++++||.|||+. +++|+||+|+||++++++ .+||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 99999987432 11 2267999999999998 999999999999998875 469999999886643221 1
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....|++.|+|||.+....++.++||||||++++||++|..|+..... ........ .+..... ...
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------~~~ 225 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAPI------SPN 225 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCCC------CCC
Confidence 2224578899999999888899999999999999999999999864321 12222221 1211111 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+|++.+|++||++.|+++.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 23468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=264.63 Aligned_cols=235 Identities=25% Similarity=0.320 Sum_probs=184.0
Q ss_pred cCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999854 7899999986532 23446799999999999999999999999999999999999999999
Q ss_pred hhhcCCCC---cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 530 ADVYSSPP---KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 530 ~~~l~~~~---~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
.+++.... .. .+.+|++||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 99885422 11 267899999999998 99999999999999999999999999998664332 11224578
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (724)
..|++||.+....++.++|+||||+++|||++|..|+........ ... .....+... . .........+.+
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~~~~-~----~~~~~~~~~~~~ 225 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIY-NDILKGNGK-L----EFPNYIDKAAKD 225 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHH-HHHhccCCC-C----CCCcccCHHHHH
Confidence 899999999888899999999999999999999999875432111 111 111111110 0 111112456899
Q ss_pred HHHHcccCCCCCCCC-----HHHHHH
Q 041285 683 VALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 683 l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
++..||+.+|++||+ ++|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=275.75 Aligned_cols=249 Identities=17% Similarity=0.192 Sum_probs=172.2
Q ss_pred hhcccccccCcCccceEEEEEeeCC----cEEEEEEcccccchh-----------HHHHHHHHHhhcccCcCceeeeeeE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMING----KFVAVKRLQKMLAEG-----------EREFQTEIKAIGRTHHRNLVRLLGY 510 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~ 510 (724)
..+.+.++||+|+||.||+|...++ ..+|+|......... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3455678999999999999987553 455666432211110 0112233445667789999999997
Q ss_pred Eeccc----ceEEEEeeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 511 SFDVS----NKILVYEYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 511 ~~~~~----~~~lv~e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
+.... ..++++|++.. ++.+.+... .. ..+.|+++||+|||+. +|+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 66543 33677776633 454444321 12 2378999999999998 9999999999999999999999
Q ss_pred ccccCccccCCCCcc------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH-
Q 041285 580 SDFALAKLMKPDQTR------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE- 652 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~- 652 (724)
+|||+++.+..+... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.............
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876432211 1122468999999999999999999999999999999999999997653222111000
Q ss_pred -HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 653 -WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 653 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
-....+..+.. .. ......+.+++..|++.+|++||++.++++.|+
T Consensus 248 ~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFIKRLHEGKI----KI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhhhhhh----cc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00111111111 01 112355888999999999999999999999874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=272.73 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=181.0
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..+.||.|++|.||+++.. +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3467999999999999875 57899999886432 2223578899999999999999999999999999999999995
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... .. ..+.++++||+|||+. +++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT 158 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence 6788876432 11 2267999999999988 999999999999999999999999999876543221 122
Q ss_pred ccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---------------
Q 041285 598 GIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG--------------- 661 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------------- 661 (724)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... .+..... .....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCChhhhhhhhHHHHHH
Confidence 234678899999887654 5889999999999999999999986543211 1111000 00000
Q ss_pred -Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 -NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 -~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......... .........+.+++.+|++.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=273.35 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=182.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.||.|++|.||+|... +|+.||||++.... ......+.+|++++++++|+|++++++++.+....+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999875 68999999986432 2223568899999999999999999999999999999999995
Q ss_pred CChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... + ..+.++++||.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 68988875432 1 2267899999999998 999999999999999999999999999976532211 112
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHH----------HHc-C----
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQC----------FEN-G---- 661 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~----------~~~-~---- 661 (724)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||........ +....... ... .
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 23468899999987664 578899999999999999999999865432111 11100000 000 0
Q ss_pred Cccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 NLGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 ~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........ ..........+.+++.+|++.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0011122356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=268.13 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=182.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEeccc------ceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVS------NKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~lv 520 (724)
.+.+.||+|++|.||++... +++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++.+.. ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34578999999999999985 46889999887543 3446799999999999 7999999999997644 48999
Q ss_pred EeeccCCChhhhcCCCC-------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSPP-------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~-------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
|||+++++|.+++.... . ..+.|+++||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999998874311 1 1267899999999998 99999999999999999999999999987653
Q ss_pred CCCcceeeccccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.... ......++..|+|||.+.. ..++.++||||||++++||++|..|+........ ..+ ...+...
T Consensus 165 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~ 236 (275)
T cd06608 165 STLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFK-IPRNPPP 236 (275)
T ss_pred cchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHH-hhccCCC
Confidence 3221 1223457889999998753 3467899999999999999999999864321110 111 1111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... .......+.+++.+||..||++|||+.++++
T Consensus 237 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 237 TLKS----PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCc----hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 1224456889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=275.71 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=182.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhccc-CcCceeeeeeEEecc--cceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV--SNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~lv~e 522 (724)
.+.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +|+||+++++++... ...++|+|
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 34578999999999999875 4789999988542 223345678899999999 999999999998654 36799999
Q ss_pred eccCCChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc---
Q 041285 523 YMSNGSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--- 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--- 593 (724)
|++ ++|..++.... + ..+.+|+.||+|||+. +|+|+||+|+||+++.++.+||+|||++........
T Consensus 90 ~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 90 YME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165 (337)
T ss_pred ccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccccccc
Confidence 997 58888775422 1 1378999999999998 999999999999999999999999999986643322
Q ss_pred -ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH----------HH---
Q 041285 594 -RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ----------CF--- 658 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~----------~~--- 658 (724)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......... ...... .+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL--EKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHHHhh
Confidence 12233467899999998765 45788999999999999999999998654322110 000000 00
Q ss_pred -HcCCcccccccc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 659 -ENGNLGQLIEDE-----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 659 -~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+....... .........+.+++.+|++.+|++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000 0011134568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=277.98 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=183.6
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~ 521 (724)
.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 34578999999999999864 57899999986422 23345688899999999999999999987654 3579999
Q ss_pred eeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-
Q 041285 522 EYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR- 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 594 (724)
||+++ +|.+++..... ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 88 e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 88 ELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred hhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 99964 77777654322 2367999999999998 9999999999999999999999999999765432211
Q ss_pred -eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-----------
Q 041285 595 -TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG----------- 661 (724)
Q Consensus 595 -~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 661 (724)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ + ..........
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--L-NLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHcCCCCHHHHHHhhch
Confidence 1123467899999998654 4688999999999999999999999865321110 0 0000000000
Q ss_pred C----ccccccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 041285 662 N----LGQLIEDED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGT 708 (724)
Q Consensus 662 ~----~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~ 708 (724)
. +...-.... ..+.....+.+++.+||+.+|++||++.|+++. |+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 000000000 011224568899999999999999999999976 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=266.72 Aligned_cols=237 Identities=23% Similarity=0.328 Sum_probs=180.4
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhh-cccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAI-GRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+|++|.||++... +++.||||.+.... ......+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 47899999986532 12223445555444 455899999999999999999999999999
Q ss_pred CChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
++|.+++... . ...+.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 9999988432 2 22368999999999998 999999999999999999999999999875432 1224
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.++..|+|||.+.+..++.++||||||+++|||++|..|+....... .......+.... +..........
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~ 223 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRINW---PEEVKEFCSPE 223 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccCC---CCcccccCCHH
Confidence 57889999999988888999999999999999999999986533211 111122221111 11111123456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
+.+++.+|++.+|++||++.++.+.|+
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 899999999999999998877766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.39 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=177.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHh-hcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKA-IGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||++... +++.||+|+++... .....++..|+.. ++.++|+||+++++++......++++||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34578999999999999875 58999999987532 2334456666665 556689999999999999999999999996
Q ss_pred CCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
++|.+++.. ..+ ..+.||+.||+|||++ .+++||||||+||+++.++.+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 677766532 111 2378999999999974 3799999999999999999999999999886532211
Q ss_pred eeeccccCccccCcccccC----CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 595 TFTGIRGTRGYVAPEWHWN----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... ... ..... .+..... .
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~-~~~~~~~-~-- 229 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQVV-EEPSPQL-P-- 229 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHHH-hcCCCCC-C--
Confidence 122457889999998865 44688999999999999999999998642211 111 11111 1111111 0
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++..||+.+|++||++.++++
T Consensus 230 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 --AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112356889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.85 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=182.3
Q ss_pred ccccccCcCccceEEEEEeeC---CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN---GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 520 (724)
.+.+.||+|++|.||+|+... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 455789999999999999854 6899999987632 23345678899999999999999999999988 789999
Q ss_pred EeeccCCChhhhcCCC--------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC----CCCeEEccccC
Q 041285 521 YEYMSNGSLADVYSSP--------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE----NRYAKISDFAL 584 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~--------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~----~~~~kl~Dfgl 584 (724)
|||+++ +|.+++... . +..+.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 565554211 1 12367999999999998 9999999999999999 89999999999
Q ss_pred ccccCCCCc--ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcch-------hcHHHHH
Q 041285 585 AKLMKPDQT--RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ-------VILEEWV 654 (724)
Q Consensus 585 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~-------~~l~~~~ 654 (724)
+........ .......+++.|+|||.+.+. .++.++||||||++++||++|+.|+........ ..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643322 112234578899999987664 578999999999999999999999976543220 0011100
Q ss_pred HHHHH------------cCCccc---cccccccC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 655 YQCFE------------NGNLGQ---LIEDEDVD---------K--KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 655 ~~~~~------------~~~~~~---~~~~~~~~---------~--~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+. ...... ........ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 239 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 -EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred -HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000000 00000000 0 23356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=262.14 Aligned_cols=239 Identities=28% Similarity=0.399 Sum_probs=190.7
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~~ 525 (724)
.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+..+++++|+||+++++.+.+. ...++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999986 588999999875432 4467899999999999999999999999988 88999999999
Q ss_pred CCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-eee
Q 041285 526 NGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~ 597 (724)
+++|.+++.... +..+.+++++|+|||+. +++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (260)
T cd06606 85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161 (260)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccccc
Confidence 999999885432 22378999999999997 9999999999999999999999999999876544321 122
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...++..|+|||.+.....+.++||||||+++++|++|..|+....... .........+... .......
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~ 230 (260)
T cd06606 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGEPP------EIPEHLS 230 (260)
T ss_pred CCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCCCc------CCCcccC
Confidence 3467889999999988889999999999999999999999987543111 1111111101111 1112225
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 231 EEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 67889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=272.59 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=181.2
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEeccc---------
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--------- 515 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------- 515 (724)
..+.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 344578999999999999985 47899999987532 223356788999999999999999999987655
Q ss_pred -ceEEEEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 516 -NKILVYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 516 -~~~lv~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..++|+||+++ +|..++... .+ ..+.+|+.||+|||+. +|+|+||+|+||++++++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 78999999986 666655432 11 2268999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN--- 662 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 662 (724)
..............++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ +.. +.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LEL-ISRLCGSPCPAV 241 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChhh
Confidence 765433222223345788999998765 3578899999999999999999998875432111 111 111110000
Q ss_pred ccccc--------cc------c--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 LGQLI--------ED------E--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 ~~~~~--------~~------~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+. +. . .........+.+++..||+.+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 00 0 000012456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.15 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=181.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEeec
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~ 524 (724)
+.+.||+|++|.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|+||+
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 4578999999999999986 478999999874322 2223567899999999999999999998877 7899999999
Q ss_pred cCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+ ++|.+++.... . ..+.||++||+|||+. +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 89 ~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 163 (293)
T cd07843 89 E-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PY 163 (293)
T ss_pred C-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-cc
Confidence 7 48888774321 1 2378999999999998 999999999999999999999999999986654321 11
Q ss_pred eccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH----------HHHHHc-----
Q 041285 597 TGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV----------YQCFEN----- 660 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~----------~~~~~~----- 660 (724)
....+++.|+|||.+.+. .++.++|+||||++++||++|..|+........ +.... +..+..
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchHHHHHhhccchhc
Confidence 223468899999988764 468999999999999999999999875432111 00000 000000
Q ss_pred -CCccccccc---cccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 661 -GNLGQLIED---EDVDKK-QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 661 -~~~~~~~~~---~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......... ...... ....+.+++..|++.+|++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000 000111 2456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.29 Aligned_cols=241 Identities=26% Similarity=0.405 Sum_probs=179.8
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.||+|+||.||++... .++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......++++||++.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 367999999999999875 47899999987532 234567899999999996 99999999999998999999999864
Q ss_pred ChhhhcC--------CCC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 528 SLADVYS--------SPP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 528 sL~~~l~--------~~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+|.++.. ... ...+.++++||+|||+. .+++||||||+||+++.++.+||+|||++........
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 163 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-- 163 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--
Confidence 5444321 111 12367899999999963 3899999999999999999999999999976543221
Q ss_pred eeccccCccccCcccccCC---CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FTGIRGTRGYVAPEWHWNL---PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.....++..|+|||.+... .++.++||||||+++|||++|+.||..... ......+. ..+....+. ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~~--~~~ 235 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV-VKGDPPILS--NSE 235 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh-cCCCCCcCC--CcC
Confidence 1223578899999998776 688999999999999999999999864320 11111111 111111111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.......+.+++.+|++.+|++||++.+|++.
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12345568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=276.40 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=182.7
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEEEE
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKILVY 521 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~ 521 (724)
.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 468999999999999864 58899999986531 22235688999999999999999999998754 2468999
Q ss_pred eeccCCChhhhcC-CCCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 522 EYMSNGSLADVYS-SPPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 522 e~~~~gsL~~~l~-~~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
||+.. +|..+.. .... ..+.++++||+|||+. +++||||||+||+++.++.+||+|||+++..... .
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~ 171 (342)
T cd07879 100 PYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----M 171 (342)
T ss_pred ccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----C
Confidence 99964 6766653 2222 2367999999999998 9999999999999999999999999998764322 1
Q ss_pred eccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH----------HHHHcCCccc
Q 041285 597 TGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY----------QCFENGNLGQ 665 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~----------~~~~~~~~~~ 665 (724)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..... +.+.......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHhcccchHH
Confidence 22356888999999876 4688999999999999999999999975432111 000000 0000000000
Q ss_pred ccc------ccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCC
Q 041285 666 LIE------DED---VDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDIPIP 714 (724)
Q Consensus 666 ~~~------~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~~p 714 (724)
.+. ... ..+.....+.+++..||+.+|++||++.|++.. +++..+.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 000 000 001123457899999999999999999999944 6665554433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=265.44 Aligned_cols=235 Identities=27% Similarity=0.318 Sum_probs=181.0
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 57899999886422 22344678899999999999999999999999999999999999999
Q ss_pred hhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 530 ADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 530 ~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
.+++.... . ..+.++++||.|||+. +++|+||+|+||+++.++.+||+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 98874322 1 1257999999999998 999999999999999999999999999876543211 12245
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
++..|+|||.+.+..++.++||||||+++++|++|+.||........ ... +.... ... +..........+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~----~~~---~~~~~~~~~~~~ 225 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKRRT----LEM---AVEYPDKFSPEA 225 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHhcc----ccc---cccCCccCCHHH
Confidence 78899999999888899999999999999999999999865432111 000 11111 110 111112234568
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 681 IKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
.+++..||+.+|++|| +..++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 8999999999999999 6666754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=267.09 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=176.3
Q ss_pred ccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhh---cccCcCceeeeeeEEecccceEEEEeecc
Q 041285 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAI---GRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.||+|+||.||++... +++.+|||.+.... ......+.+|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 47899999886432 12223344454433 34479999999999999999999999999
Q ss_pred CCChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++... .+. .+.|++.||.|||+. +++|+||||+|||+++++.++|+|||++........ ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cC
Confidence 99999887432 222 268999999999998 999999999999999999999999999875532221 22
Q ss_pred cccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..|+..|+|||.+.. ..++.++||||||++++||++|..||.......... ....... . .........
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~--~-----~~~~~~~~~ 223 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT--V-----NVELPDSFS 223 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc--C-----CcCCccccC
Confidence 458999999998864 568899999999999999999999997543222111 1111100 0 001122234
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
..+.+++..|++.+|++|| +++|+++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 5688899999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.59 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=180.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34578999999999999875 57899999886432 2234578899999999999999999999999999999999996
Q ss_pred CCChhhhcCCC-Cc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCcce
Q 041285 526 NGSLADVYSSP-PK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 526 ~gsL~~~l~~~-~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++|.+++... .. ..+.+|+.||+|||+. +++|+||+|+||+++. +..+||+|||++....... ..
T Consensus 85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (294)
T PLN00009 85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RT 159 (294)
T ss_pred -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cc
Confidence 5777666321 11 2367999999999998 9999999999999985 5679999999997654321 11
Q ss_pred eeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---------ccc
Q 041285 596 FTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---------LGQ 665 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~ 665 (724)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+......+. +... ........ +..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKI-FRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHhCCCChhhccccccchh
Confidence 2234568899999988664 578999999999999999999999865432111 1000 00000000 000
Q ss_pred c---c----cc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 L---I----ED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ~---~----~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. . .. ..........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00 0011123455889999999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=294.12 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=180.4
Q ss_pred hhccccc--ccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-------
Q 041285 446 MTDGFKE--EIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------- 514 (724)
Q Consensus 446 ~t~~f~~--~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 514 (724)
....|.+ .||+||||.|||++-+ ||+.+|||++.-. .........+|+.++++|+|||||+++....+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3344553 6999999999999864 8999999998754 233446788999999999999999987532100
Q ss_pred --------------------------------------------------------------------------------
Q 041285 515 -------------------------------------------------------------------------------- 514 (724)
Q Consensus 515 -------------------------------------------------------------------------------- 514 (724)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------cceEEEEeeccCCChhhhcCCC--------CcchHHHHHHHccccccc
Q 041285 515 --------------------------------SNKILVYEYMSNGSLADVYSSP--------PKNNLIGIARGILYLHDE 554 (724)
Q Consensus 515 --------------------------------~~~~lv~e~~~~gsL~~~l~~~--------~~~~~~~ia~~l~yLH~~ 554 (724)
..+|+-||||+...|.++++.. .|..+.+|++||+|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0135677788777777766432 234478999999999998
Q ss_pred CCCceEeCCCCCCCeeeCCCCCeEEccccCccccC-----------------CCCcceeeccccCccccCcccccCCC--
Q 041285 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMK-----------------PDQTRTFTGIRGTRGYVAPEWHWNLP-- 615 (724)
Q Consensus 555 ~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~-- 615 (724)
+||||||||.||+|+++..+||+|||++.... .......+..+||.-|+|||.+.+..
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 01112345578999999999987654
Q ss_pred -CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCC
Q 041285 616 -ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSL 694 (724)
Q Consensus 616 -~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~ 694 (724)
|+.|+|+||+|||++||+. ||...... ..+...++.+.++.. ..........-.+++.|+++.||.+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999999985 55543211 112334455555544 2222233444567889999999999
Q ss_pred CCCHHHHHH
Q 041285 695 RPSMKKVLL 703 (724)
Q Consensus 695 RPs~~evl~ 703 (724)
|||+.|+++
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999885
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.70 Aligned_cols=237 Identities=24% Similarity=0.332 Sum_probs=188.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+...||+|.|+.|.+++.. .+..||||.+.+..- .....+.+|+++|..++|||||+++.+......+|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345578999999999999875 488999999876432 22345899999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
.+|.+.+++.... ...+.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+... ....
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lq 212 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQ 212 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--cccc
Confidence 9999999994422 22378999999999998 9999999999999999999999999999877532 2234
Q ss_pred ccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...|++.|+|||++.+..+ .+++|+||+|++||.|++|..||++..-.+ ..+....+.. ..+.-.
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------Lr~rvl~gk~-------rIp~~m 278 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------LRPRVLRGKY-------RIPFYM 278 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------ccchheeeee-------ccccee
Confidence 4679999999999998876 579999999999999999999998643211 0011111110 011112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+-+++++++-.+|.+|+++.++.+
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhh
Confidence 234667888889999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=268.11 Aligned_cols=235 Identities=23% Similarity=0.377 Sum_probs=183.6
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEccc--ccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..++||+||-+.||++.-.+.+.+|+|++.. ...+...-|.+|+..|.+| .|.+||+|++|-..++.+|+||||= .
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d 443 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-D 443 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-c
Confidence 4468999999999999988888899887754 2345567899999999999 5999999999999999999999984 6
Q ss_pred CChhhhcCCCC-----cc---hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee-
Q 041285 527 GSLADVYSSPP-----KN---NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT- 597 (724)
Q Consensus 527 gsL~~~l~~~~-----~~---~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~- 597 (724)
.+|..+|.... |. ...|++.++.++|++ +|||.||||.|.|+- .|.+||+|||+|.-+..+.+....
T Consensus 444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeec
Confidence 68888885422 11 167999999999999 999999999999885 467999999999988776654433
Q ss_pred ccccCccccCcccccCC-----------CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 598 GIRGTRGYVAPEWHWNL-----------PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
...||+.||+||.+... +.++++||||+|||||+|+.|+.||+.... .| .. +..+
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~--aK-----l~aI 585 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI--AK-----LHAI 585 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH--HH-----HHhh
Confidence 46899999999987532 256899999999999999999999964210 11 11 1122
Q ss_pred ccccc---c-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 IEDED---V-DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ~~~~~---~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.++.- + ....-..++++++.||+.||.+||++.|+++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 22210 0 0001112999999999999999999999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=301.71 Aligned_cols=238 Identities=27% Similarity=0.393 Sum_probs=189.5
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
..||.|.||.||-+... .|+..|||-+... .....+...+|+.++..|+|||+|+++|+-.+.+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 46999999999999864 5788899977642 23344678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCcc-------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC---cceeec
Q 041285 529 LADVYSSPPKN-------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ---TRTFTG 598 (724)
Q Consensus 529 L~~~l~~~~~~-------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~ 598 (724)
|.+++...... ...|++.|++|||++ +||||||||.||+|+.++.+|++|||.|..+..+. ......
T Consensus 1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 99998654221 157999999999999 99999999999999999999999999998876542 122334
Q ss_pred cccCccccCcccccCCC---CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 599 IRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
..||+.|||||++.+.. ...++||||+|||++||+||++|+..-+.+-. +.-.+..|..+++ +..
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------IMy~V~~gh~Pq~------P~~ 1465 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------IMYHVAAGHKPQI------PER 1465 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------HHhHHhccCCCCC------chh
Confidence 68999999999997654 56789999999999999999999975432111 1112333433332 222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....-.+++..|++.||++|.++.|+++.
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 44556788999999999999988877654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=271.23 Aligned_cols=242 Identities=19% Similarity=0.223 Sum_probs=180.3
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.+|.|+++.|+++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455666666666655 6889999998653 334556899999999999999999999999999999999999999999
Q ss_pred hhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc------c
Q 041285 530 ADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT------R 594 (724)
Q Consensus 530 ~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~------~ 594 (724)
.+++... .. ..+.|+++||.|||+. +|+|+||||+||+++.++.+||+||+.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9988532 11 1267999999999998 999999999999999999999999999875432111 1
Q ss_pred eeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc-----
Q 041285 595 TFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI----- 667 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----- 667 (724)
......++..|+|||.+... .++.++||||||+++|||++|+.||........ +. +.. .+.....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~----~~~-~~~~~~~~~~~~~ 236 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LL----EKV-RGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH-hccCccccccCch
Confidence 11224567889999998763 578899999999999999999999975432111 00 111 00000000
Q ss_pred ---------------cc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 668 ---------------ED-------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 668 ---------------~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
++ ..........+.+++.+||+.+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 01122334578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=261.22 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=189.1
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.++||+|+||.||++.++ .|+.+|||++.- ..+.+++..|+.++++...+++|+++|.+.....+++|||||.-|++
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 478999999999999775 589999999875 45678899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCc----ch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 530 ADVYSSPPK----NN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 530 ~~~l~~~~~----~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
.+.++.... .. +...++||+|||.- .-+|||||+.||||+-+|.+||+|||.+..+-+.. .....+.|
T Consensus 116 SDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIG 191 (502)
T KOG0574|consen 116 SDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIG 191 (502)
T ss_pred HHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCcccc
Confidence 998843222 11 45678999999987 78999999999999999999999999997653221 22234679
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
|+-|||||++..-.|..++||||+|+...||..|++|+....+-.... .+.....+.+ ..+..-...+.
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIPT~PPPTF----~KPE~WS~~F~ 260 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIPTKPPPTF----KKPEEWSSEFN 260 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------eccCCCCCCC----CChHhhhhHHH
Confidence 999999999999999999999999999999999999987543321100 0000000000 11334456788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 041285 682 KVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
++++.||-.+|++|-++.++++
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhh
Confidence 9999999999999999988764
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=272.30 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=179.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccc--------
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN-------- 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------- 516 (724)
+.+.++||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 345578999999999999875 57899999886432 1223356789999999999999999999876543
Q ss_pred eEEEEeeccCCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 517 KILVYEYMSNGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
.++||||+.+ +|.+.+... . +..+.||++||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4999999964 777766432 1 12378999999999998 9999999999999999999999999999866
Q ss_pred CCCCc---ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 589 KPDQT---RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 589 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
..... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... ..... +...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~---~~~~~--~~~~ 244 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL---ISQLC--GSIT 244 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHh--CCCC
Confidence 43221 112234578899999988664 468899999999999999999998865432211111 11110 0000
Q ss_pred ccc--------------ccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLI--------------EDE---------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~--------------~~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+ .+. .........+.+++.+||+.+|++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000 000012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=265.90 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=179.5
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccC-cCceeeeeeEEecc--cceEEEEeec
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDV--SNKILVYEYM 524 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~~ 524 (724)
+.++||+|+||.||++... +++.+|+|+++... ........+|+..+.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4578999999999999875 57899999987532 222334567888899885 99999999999987 8899999999
Q ss_pred cCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+ ++|.+++... .+ ..+.++++||+|||+. +++|+||+|+||+++. +.+||+|||++........ .
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~ 155 (282)
T cd07831 83 D-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--Y 155 (282)
T ss_pred C-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--c
Confidence 7 5777766431 21 2278999999999998 9999999999999999 9999999999986643222 1
Q ss_pred eccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH-----------HHHcCCcc
Q 041285 597 TGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ-----------CFENGNLG 664 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~-----------~~~~~~~~ 664 (724)
....++..|+|||.+.. ..++.++||||||+++|||++|..|+......+. ...... ........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccc
Confidence 22356889999997654 5578899999999999999999999865432111 011100 11111111
Q ss_pred ccccccc-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIEDED-------VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~~~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.. ........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1101100 01233577999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=280.82 Aligned_cols=240 Identities=28% Similarity=0.419 Sum_probs=180.9
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv~ 521 (724)
..+.||+|+||.||+|+. ..|+.||||.++.... ...+...+|++++++++|+|||++++.-.+.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 347899999999999995 5699999999986432 23456789999999999999999999866543 568999
Q ss_pred eeccCCChhhhcCCCCc------ch----HHHHHHHcccccccCCCceEeCCCCCCCeeeC--CCC--CeEEccccCccc
Q 041285 522 EYMSNGSLADVYSSPPK------NN----LIGIARGILYLHDECESQIIHCDIKPQNILMD--ENR--YAKISDFALAKL 587 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~~------~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~--~~~--~~kl~Dfgl~~~ 587 (724)
|||.+|||...+..... .. +.+++.||.|||++ +|+||||||.||++- .++ ..||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999965322 21 55788999999998 999999999999983 334 379999999998
Q ss_pred cCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc------
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN------ 660 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------ 660 (724)
+..+. ......||..|++||.+.. +.++..+|.|||||++||++||..||.......... +..+.....
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--EIMWHIITKKPSGVA 249 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc--hhhhhhhccCCCcee
Confidence 76554 5667899999999999984 889999999999999999999999997644332111 111121111
Q ss_pred --------CCcccc--cc-ccccCHHHHHHHHHHHHHcccCCCCCCC
Q 041285 661 --------GNLGQL--IE-DEDVDKKQLERMIKVALWCILDEPSLRP 696 (724)
Q Consensus 661 --------~~~~~~--~~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 696 (724)
|.+..- +. +.-.......++.+....++..+|.+|-
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 110000 00 0012344556677777778888888888
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.65 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=186.1
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++......++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3467999999999999875 578999999865322 2356788999999999999999999999999999999999975
Q ss_pred CChhhhcCCC--C------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSP--P------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~--~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++... . ...+.+|++||.|||+. +++|+||+|+||+++.++.+||+|||.+....... .....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 887776442 1 12267999999999998 99999999999999999999999999998765443 12223
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccccccc------
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQLIE------ 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~------ 668 (724)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+.. ....+.+... ......+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhhh
Confidence 4578889999998776 7899999999999999999999888654321110 0000100000 0000000
Q ss_pred -----c-----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 -----D-----EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 -----~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ..........+.+++..||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=261.98 Aligned_cols=238 Identities=24% Similarity=0.404 Sum_probs=190.0
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.||+|++|.||++... +++.+|+|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4578999999999999885 478999999875432 4556789999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC-----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 527 GSLADVYSSPP-----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 527 gsL~~~l~~~~-----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++|.+++.... ...+.++++||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-L 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc-e
Confidence 99998885421 12267999999999998 999999999999999999999999999987654331 2
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....+++.|+|||.+....++.++||||+|+++++|++|+.|+..... ... ...........+ ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~~~------~~~ 226 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LEL-ALKILKGQYPPI------PSQ 226 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHH-HHHHhcCCCCCC------CCC
Confidence 2224578899999999888899999999999999999999999864321 111 112222222111 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+|++.+|++||++.|+++.
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 33568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=267.75 Aligned_cols=247 Identities=21% Similarity=0.221 Sum_probs=188.3
Q ss_pred ccccccCcCccceEEEEEee----CCcEEEEEEccccc----chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML----AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|++++.++ +|+||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34578999999999998753 46789999886421 22345688999999999 69999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC---cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSSPP---KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~---~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||||+++++|.+++.... .. .+.|++++|.|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999998875321 11 266999999999987 99999999999999999999999999988765433
Q ss_pred cceeeccccCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
........++..|+|||.+.+.. .+.++||||||++++||++|..|+...... ....+...... ....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~-~~~~------- 229 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRIL-KSKP------- 229 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHH-ccCC-------
Confidence 22222345789999999987665 788999999999999999999998643211 11111111111 1110
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.........+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11111234578899999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=268.38 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=183.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.++||+|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4578999999999999985 478999999875432 2345678899999999999999999999999999999999985
Q ss_pred ChhhhcCCCC------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 528 SLADVYSSPP------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 528 sL~~~l~~~~------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+|.+++.... + ..+.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ....
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFS 158 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccc
Confidence 7877764321 1 1268999999999988 99999999999999999999999999997553321 1122
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHH-HH-------HHHHHHcC-Cccccc
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE-EW-------VYQCFENG-NLGQLI 667 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~-~~-------~~~~~~~~-~~~~~~ 667 (724)
...++..|++||.+.+. .++.++||||||+++|||++|+.|+......+..... .. .++.+... ......
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 34568899999988664 4688999999999999999999998765432111000 00 00000000 000000
Q ss_pred cc------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 ED------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ....+.....+.+++..|++.+|.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0011123456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=267.55 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=179.6
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc-chhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML-AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++...+ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....+++|||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 356789999999999999865 8899999987532 233456677887777774 9999999999999999999999985
Q ss_pred CCChhhhcCC----CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSS----PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~----~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++.. .. ...+.+|++||+|||+. .+|+||||+|+||++++++.+||+|||++..+...... .
T Consensus 98 ~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--~ 172 (296)
T cd06618 98 T-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--T 172 (296)
T ss_pred c-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--c
Confidence 4 66655532 11 12478999999999973 28999999999999999999999999998765432221 2
Q ss_pred ccccCccccCcccccCCC----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 598 GIRGTRGYVAPEWHWNLP----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... +...... .+.....-..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~-~~~~~~~~~~---- 242 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKIL-QEEPPSLPPN---- 242 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHh-cCCCCCCCCC----
Confidence 234678999999987554 7889999999999999999999986432111 1111111 1111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
......+.+++.+||+.+|++||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=262.61 Aligned_cols=237 Identities=26% Similarity=0.409 Sum_probs=189.3
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 34578999999999999764 57899999987532 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhcCC-------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS-------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|.+++.. .. +..+.++++||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999988743 12 12367899999999998 99999999999999999999999999998765431
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....++..|++||.+.+..++.++|+||||++++||++|+.|+...... + .......+....+ ..
T Consensus 158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~------~~ 223 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQRGKYPPI------PP 223 (256)
T ss_pred -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCCCCC------ch
Confidence 11245788999999999989999999999999999999999998654321 1 1112222222211 12
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.....+.+++..|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 345668999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=270.83 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=179.5
Q ss_pred cccCcC--ccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRG--SSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.||+| +||+||++... .++.||||.+... .....+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 89999999874 6899999998642 223346788999999999999999999999999999999999999
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-e-
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-T- 595 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~- 595 (724)
++|.+++... .. ..+.|++.||+|||+. +++||||||+|||++.++.+|++||+.+......... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999987532 11 2367999999999988 9999999999999999999999999865433221110 0
Q ss_pred e----eccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH---------------
Q 041285 596 F----TGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV--------------- 654 (724)
Q Consensus 596 ~----~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~--------------- 654 (724)
. ....++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 0 012345679999998764 478999999999999999999999865432111 000000
Q ss_pred HHH-------HHcC---------Ccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 655 YQC-------FENG---------NLGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 655 ~~~-------~~~~---------~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... ...+ ....+.+.. .........+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0000 000000000 112234567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=264.28 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=183.1
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccc-hhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.||+|++|+||+|+..+ ++.||||++..... .......+|+..+.+++ |+||+++++++.+.+..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 56789999999999999864 78899999865322 22334567999999998 999999999999999999999999 8
Q ss_pred CChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++.... + ..+.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 156 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YT 156 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cC
Confidence 89988774422 1 1267999999999998 999999999999999999999999999976543221 12
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------HHHHHHHHHHcCCcccc
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------LEEWVYQCFENGNLGQL 666 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------l~~~~~~~~~~~~~~~~ 666 (724)
...++..|+|||.+.. ..++.++|+||||++++||++|+.|+......+... -..|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 2457889999998754 457899999999999999999998886543211100 00011110000111111
Q ss_pred cccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 667 IEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 667 ~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+... .........+.+++.+|++.+|++||+++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 0001124678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=264.91 Aligned_cols=242 Identities=22% Similarity=0.248 Sum_probs=184.0
Q ss_pred cccccCcCccceEEEEEe----eCCcEEEEEEccccc----chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEE
Q 041285 450 FKEEIGRGSSGTVYKGTM----INGKFVAVKRLQKML----AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 520 (724)
+.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|++++.++ +|+||+++++++......++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 457899999999999986 367899999987532 12345688899999999 699999999999998899999
Q ss_pred EeeccCCChhhhcCCC---Ccch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSSP---PKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~---~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||+++++|.+++... .... +.++++||.|||+. +++||||+|+|||++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999988432 2211 45899999999998 999999999999999999999999999987654333
Q ss_pred ceeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.......|+..|+|||.+... .++.++||||||+++|+|++|..|+...... ............ ... .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~-~~~-------~ 230 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK-SEP-------P 230 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc-cCC-------C
Confidence 322335678999999998753 4678999999999999999999998643221 111222221111 111 0
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
........+.+++..|++.+|++|| +..+++..
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1112334678999999999999997 66776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=273.56 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=182.4
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEec----ccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----VSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e 522 (724)
+.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4578999999999999875 58899999987532 2334567889999999999999999998763 346799999
Q ss_pred eccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc--
Q 041285 523 YMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-- 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 593 (724)
|+. ++|.+++.... +..+.||++||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 89 LME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred hhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 995 68888874321 12267999999999998 999999999999999999999999999976543221
Q ss_pred -ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHH-----------------HHH
Q 041285 594 -RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE-----------------EWV 654 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~-----------------~~~ 654 (724)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ..+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence 11123467889999998765 45889999999999999999999999654321110000 000
Q ss_pred HHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+.+..-..................+.+++..|++.+|++||++.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000000112235678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=257.94 Aligned_cols=238 Identities=26% Similarity=0.451 Sum_probs=188.6
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+....++++||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34578999999999999875 578999999876433 345679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++... .+ ..+.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 83 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 83 NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred CCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 99999988542 22 2377999999999988 9999999999999999999999999999876543221 223
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..++..|+|||...+...+.++||||+|+++++|++|+.|+....... . ..... ...... .......
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~-~~~~~~------~~~~~~~ 225 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----A-LFRIV-QDDHPP------LPEGISP 225 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----H-HHHHh-ccCCCC------CCCCCCH
Confidence 457889999999988888999999999999999999999986432111 0 11111 111111 1112245
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 6789999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=246.41 Aligned_cols=237 Identities=23% Similarity=0.405 Sum_probs=180.2
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc-chhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML-AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
..||.|.-|.|++..... |..+|||.+.+.. .+..++++..++++.+-+ +|.||+.+|||......++.||.|.- .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 569999999999998764 7899999998643 334467888888887775 89999999999999999999998843 3
Q ss_pred hhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
++.++.+ .+.. ....+.+||.||.++ .+|+|||+||+|||+|+.|++|++|||++..+-+. ...+...
T Consensus 177 ~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtrsA 252 (391)
T KOG0983|consen 177 AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTRSA 252 (391)
T ss_pred HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--ccccccc
Confidence 3344321 2222 246788999999886 58999999999999999999999999999765432 2334456
Q ss_pred cCccccCcccccCC---CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 601 GTRGYVAPEWHWNL---PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 601 gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
|-+.|||||-+... .|+.++||||||+.|+||.||+.|+.....+-. +...+.+.+ +..++... ...
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~e-PP~L~~~~---gFS 322 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEE-PPLLPGHM---GFS 322 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcC-CCCCCccc---CcC
Confidence 88999999988644 578899999999999999999999976542211 122222221 12222221 145
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++..||+.|+.+||...++++
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhc
Confidence 56889999999999999999998875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=272.77 Aligned_cols=250 Identities=26% Similarity=0.301 Sum_probs=182.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKIL 519 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 519 (724)
...+.||+|+||.||++... +++.||||.+... ......++.+|+.++++++|+||+++++++... ...++
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 34578999999999999875 5889999998642 223345678899999999999999999988643 35799
Q ss_pred EEeeccCCChhhhcCCC-Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 520 VYEYMSNGSLADVYSSP-PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~-~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+||+. ++|.+.+... .. ..+.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 v~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 173 (353)
T cd07850 99 VMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM- 173 (353)
T ss_pred EEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC-
Confidence 999996 4777766432 21 2378999999999998 999999999999999999999999999986543221
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------------HHHHHHHHH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------------LEEWVYQCF 658 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------------l~~~~~~~~ 658 (724)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... +........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T cd07850 174 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252 (353)
T ss_pred -CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence 223457889999999999999999999999999999999999986542111000 000000000
Q ss_pred HcCC------cccccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 659 ENGN------LGQLIEDE-------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 659 ~~~~------~~~~~~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.... +....... .........+.+++.+|++.||++||++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000000 0011235568899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=269.14 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=178.2
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhccc-CcCceeeeeeEEecccc-----eEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN-----KILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~lv 520 (724)
..+.||+|+||.||++... +++.||||.+..... .....+.+|+.+++++ +|+||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4578999999999999875 578999998765322 2235788899999999 56999999999887665 7999
Q ss_pred EeeccCCChhhhcCCC--------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccc
Q 041285 521 YEYMSNGSLADVYSSP--------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKL 587 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~--------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~ 587 (724)
|||+++ +|.+++... . +..+.||++||.|||+. +++||||+|+||+++. ++.+||+|||++..
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999985 787776321 1 11268999999999998 9999999999999998 88999999999876
Q ss_pred cCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc---
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL--- 663 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 663 (724)
...... ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ +.. +...+.....
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCChhhC
Confidence 532211 1122346788999998865 4578999999999999999999998865322111 000 0010000000
Q ss_pred ccc------c--------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQL------I--------EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~------~--------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... . +.....+.....+.+++..|++.+|.+||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=253.79 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=192.6
Q ss_pred cccccccCHHHHHHhhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeee
Q 041285 432 DIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLL 508 (724)
Q Consensus 432 ~~~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~ 508 (724)
+.....|+-++|+.. ..||.|+||+|+|-.+ +.|+..|||+++.... .+.++++.|.+...+- ++||||+++
T Consensus 55 ~~~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 334556766666654 4699999999999766 4589999999986443 5567889998877665 799999999
Q ss_pred eEEecccceEEEEeeccCCChhhhcC--------CCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC
Q 041285 509 GYSFDVSNKILVYEYMSNGSLADVYS--------SPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRY 576 (724)
Q Consensus 509 g~~~~~~~~~lv~e~~~~gsL~~~l~--------~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~ 576 (724)
|.+...+.-++.||.| ..||+.+.. ..+.++ .....+||.||.++ ..|+|||+||+||||+..|.
T Consensus 130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCC
Confidence 9999999999999999 567776552 222322 23467899999876 58999999999999999999
Q ss_pred eEEccccCccccCCCCcceeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH
Q 041285 577 AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV 654 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~ 654 (724)
+||+|||++..+... ...+.-.|-..|||||-+... .++.++||||||+.|+|+.||+.|+..... .+ +.+
T Consensus 207 vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vf-eql 279 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VF-EQL 279 (361)
T ss_pred EeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HH-HHH
Confidence 999999998765322 222334678899999988643 488999999999999999999999865321 11 111
Q ss_pred HHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+..|..+.++.+. ...+....+++++..|+..|..+||...++.++
T Consensus 280 -~~Vv~gdpp~l~~~~-~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 -CQVVIGDPPILLFDK-ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -HHHHcCCCCeecCcc-cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 233445555444332 233455668888889999999999999988653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=250.16 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=196.2
Q ss_pred CHHHHHHhhcccccccCcCccceEEEEE-eeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccc
Q 041285 439 SYAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 439 ~~~el~~~t~~f~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 516 (724)
.++++-+.|. +.||+|+++.|--.+ +..|.++|||++.+..........+|++++... .|+||+.|+.+++++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3556655553 789999999998775 467899999999988777788899999999999 59999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---CeEEccccCcc
Q 041285 517 KILVYEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---YAKISDFALAK 586 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfgl~~ 586 (724)
.|||||-|.||+|..++... ......+||.||.+||.+ +|.||||||+|||-.+.. -+||+||.+..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999999999998887432 223367899999999998 999999999999986544 38999999876
Q ss_pred ccC--CC----CcceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCc--------ch
Q 041285 587 LMK--PD----QTRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPE--------DQ 647 (724)
Q Consensus 587 ~~~--~~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~--------~~ 647 (724)
-+. .+ .+.....-.|+..|||||+.. ...|+.+.|.||||||||-||+|..||.+.-.. ..
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 432 11 122233457899999999753 234789999999999999999999999764322 22
Q ss_pred hcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 648 VILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 648 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........+.+.+|..... +...........+++...+..++.+|.++.+++.
T Consensus 308 r~CQ~~LFesIQEGkYeFP---dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFP---DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHHhccCCcCC---hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3344445566666644321 1112233445566667778899999999999876
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=274.61 Aligned_cols=238 Identities=22% Similarity=0.355 Sum_probs=186.5
Q ss_pred ccccCcCccceEEEEEeeCC-cEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 451 KEEIGRGSSGTVYKGTMING-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.-.||.|+||.||+++-++. -..|-|.+...+.....+|+-|+++|+...||+||+|++.+.-...++++.|||.||..
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 34689999999999987653 34567888777777788999999999999999999999999988999999999999999
Q ss_pred hhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 530 ADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 530 ~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
+.++-.+ ... ...+++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...... ......+.|
T Consensus 117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDsFIG 192 (1187)
T KOG0579|consen 117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDSFIG 192 (1187)
T ss_pred hHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-HhhhccccC
Confidence 8876322 211 167899999999999 9999999999999999999999999997543211 111223679
Q ss_pred CccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 602 TRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 602 t~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
|+.|||||+.. ..+|+.++||||||+.|.||.-+.+|-....+- + +.-.+.....+.++.+. .-
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-R------VllKiaKSePPTLlqPS----~W 261 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-R------VLLKIAKSEPPTLLQPS----HW 261 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-H------HHHHHhhcCCCcccCcc----hh
Confidence 99999999864 568999999999999999999998886543221 1 11222223333343332 33
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..||..||..||+++++++
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 455788899999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=263.05 Aligned_cols=246 Identities=28% Similarity=0.365 Sum_probs=180.3
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccc--hhHHHHHHHHHhhccc---CcCceeeeeeEEecccc-----eE
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA--EGEREFQTEIKAIGRT---HHRNLVRLLGYSFDVSN-----KI 518 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~~ 518 (724)
+.+.||+|+||.||+++... ++.+|||++..... .....+.+|+.++.++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45789999999999999864 88999999874322 1234566777776655 69999999999988776 89
Q ss_pred EEEeeccCCChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 519 LVYEYMSNGSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
++|||+++ +|.+++... . ...+.++++||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99999974 788776431 1 12378999999999998 99999999999999999999999999997764
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc-----
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG----- 664 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 664 (724)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|..|+......+ .+..............
T Consensus 159 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCCc
Confidence 3321 122346889999999999999999999999999999999988886543211 1111111000000000
Q ss_pred ----ccccc------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 ----QLIED------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ----~~~~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..... ..........+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0111233466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=272.01 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=189.4
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEeccc-----ceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-----NKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 520 (724)
.+.+.||+|++|.||+++... ++.+|||++.... ....+.+.+|+.++++++|+||+++++++.... ..+++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 456789999999999999764 7899999987643 334567999999999999999999999988775 78999
Q ss_pred EeeccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||++ ++|.+++.... . ..+.++++||+|||+. +|+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 83 TELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred ecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99997 47888775421 1 2368999999999998 999999999999999999999999999987654321
Q ss_pred --ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH-----------
Q 041285 594 --RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE----------- 659 (724)
Q Consensus 594 --~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~----------- 659 (724)
.......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+... .......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHhhhcc
Confidence 122334578899999999888 78999999999999999999999986543211100 0000000
Q ss_pred cCCcccccc---c------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccC
Q 041285 660 NGNLGQLIE---D------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGT 708 (724)
Q Consensus 660 ~~~~~~~~~---~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~ 708 (724)
.......+. . ..........+.+++..||+.+|++||++.++++. +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000 0 00011134568899999999999999999999974 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=267.01 Aligned_cols=234 Identities=26% Similarity=0.378 Sum_probs=179.9
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.||+|++|.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 467999999999999875 4688999988632 22334568899999999999999999999999999999999996
Q ss_pred CChhhhcCC--C--Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSS--P--PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~--~--~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++.. . .. ..+.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~ 170 (308)
T cd06634 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NX 170 (308)
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-----cc
Confidence 577766532 1 11 1267899999999988 9999999999999999999999999998765432 12
Q ss_pred cccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 599 IRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 599 ~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
..+++.|+|||.+. ....+.++||||||+++|||++|..|+....... .... ...+..... ....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~~~-----~~~~ 238 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNESPAL-----QSGH 238 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHH-HhhcCCCCc-----Cccc
Confidence 35788999999874 3567889999999999999999999875432111 1111 111111111 1122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
....+.+++.+||+.+|++||++.++++..
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 345578899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.68 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=182.6
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~ 521 (724)
..+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++.+++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 3468999999999999864 5789999998653 233345678899999999999999999988654 3479999
Q ss_pred eeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+. ++|.+++.... ...+.|+++||.|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 89 e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 163 (337)
T cd07858 89 ELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-D 163 (337)
T ss_pred eCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-c
Confidence 9996 67887774321 12267999999999998 99999999999999999999999999998654322 1
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH-----------cCC
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE-----------NGN 662 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~~~ 662 (724)
......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.......... ...+... .+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChHHhhhcCchh
Confidence 1223457889999998765 468899999999999999999999986542111000 0000000 000
Q ss_pred -------ccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcc
Q 041285 663 -------LGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEG 707 (724)
Q Consensus 663 -------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~ 707 (724)
.....+. ..........+.+++.+|++.+|++||+++|+++. ++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000 00111234568899999999999999999999866 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=269.66 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=180.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 523 (724)
.+.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.++.+++|+||+++++++.+. +..++|+||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34578999999999999875 488999999864321 1123567899999999999999999998765 468999999
Q ss_pred ccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+.+ +|.+++.... ...+.|+++||+|||+. +++|+||||+||+++.++.+||+|||++........ .
T Consensus 90 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~ 164 (309)
T cd07845 90 CEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-P 164 (309)
T ss_pred CCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-C
Confidence 964 7877764321 12378999999999998 999999999999999999999999999987653321 1
Q ss_pred eeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-----------Cc
Q 041285 596 FTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG-----------NL 663 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~~ 663 (724)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +.. +....... ..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDL-IIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhcCCCChhhchhhhcccc
Confidence 222345788999998865 4578999999999999999999999875432211 110 01100000 00
Q ss_pred ccc--cccccc------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 GQL--IEDEDV------DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 ~~~--~~~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... +..... .......+.+++.+|++.||++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000 01124557789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=264.47 Aligned_cols=232 Identities=26% Similarity=0.292 Sum_probs=185.0
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+||||.||-....+ |+.+|.|++.+. .++++...++|-.+|.+++.+.||.+-..+...+.++||+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 589999999999987754 889999988652 2455667889999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCc-----c----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSSPPK-----N----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~~~~-----~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.-++.+... + .+.+|+-||++||.. .||.|||||+|||||+.|+++|+|+|||..+...+.. ..
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~~ 345 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--RG 345 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--cc
Confidence 99988854331 1 178999999999998 9999999999999999999999999999987655443 33
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
.+||.+|||||++.+..|+...|.||+||+||||+.|+.||...-.... .+.+.+... -++..++....+
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~-------~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTL-------EDPEEYSDKFSE 415 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHh-------cchhhcccccCH
Confidence 4899999999999999999999999999999999999999964321110 001111111 122223344455
Q ss_pred HHHHHHHHcccCCCCCCCCH
Q 041285 679 RMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~ 698 (724)
.+..+....|+.||.+|.--
T Consensus 416 eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHHHccCHHHhccC
Confidence 56677777899999999744
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=272.43 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=182.6
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccchh--------------HHHHHHHHHhhcccCcCceeeeeeEEeccc
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEG--------------EREFQTEIKAIGRTHHRNLVRLLGYSFDVS 515 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 515 (724)
.+.||+|+||.||++... .++.||||.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999865 58899999886432211 125788999999999999999999999999
Q ss_pred ceEEEEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 516 NKILVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
..++||||++ ++|.+++.... ...+.|+++||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeec
Confidence 9999999996 68888874321 12278999999999988 9999999999999999999999999999765
Q ss_pred CCCC-------------cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH
Q 041285 589 KPDQ-------------TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV 654 (724)
Q Consensus 589 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~ 654 (724)
.... ........++..|+|||.+.+. .++.++||||||+++|||++|..|+......+. + ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~-~~i 246 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--L-GRI 246 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHH
Confidence 4110 1111223467889999998764 468899999999999999999999875432211 1 111
Q ss_pred HHHHHcCC---cccc--------ccc---c---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 655 YQCFENGN---LGQL--------IED---E---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 655 ~~~~~~~~---~~~~--------~~~---~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
........ .... ... . .........+.+++..|++.+|++||++.|++..-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 11111110 0000 000 0 00112245688999999999999999999999643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=259.46 Aligned_cols=239 Identities=23% Similarity=0.304 Sum_probs=182.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc-----cchhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-----LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 520 (724)
.+.+.||+|+||.||++... +++.+|+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 35678999999999999875 4789999987431 123345789999999999999999999998764 457899
Q ss_pred EeeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC-
Q 041285 521 YEYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ- 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~- 592 (724)
+||+++++|.+++... . ...+.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999887432 1 12267999999999988 99999999999999999999999999998653211
Q ss_pred -cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 593 -TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 593 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
........++..|+|||.+.+..++.++|+||||++++||++|+.|+....... . +.+..... ... .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~-~~~~~~~~-~~~-----~ 229 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----A-IFKIATQP-TKP-----M 229 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----H-HHHHHcCC-CCC-----C
Confidence 111123457899999999998889999999999999999999999986432111 0 11111111 111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+......+.+++..|++ +|.+||+..+++.
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 122334568889999999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=264.53 Aligned_cols=232 Identities=27% Similarity=0.378 Sum_probs=178.1
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
++||+|+||.||+|+.. .++.||+|.+.... ....+.+.+|++++++++|+|++++++++.+....++||||+. +
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 56999999999999874 57899999986422 2233568899999999999999999999999999999999996 5
Q ss_pred ChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... .+ ..+.+++.+|.|||+. +++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----~~~ 177 (313)
T cd06633 106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----NSF 177 (313)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----CCc
Confidence 676665321 11 1267899999999988 9999999999999999999999999998643221 234
Q ss_pred ccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 600 RGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 600 ~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
.++..|+|||.+. ...++.++||||||+++|||++|..|+........ ..... ........ ....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~-----~~~~ 245 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPTLQ-----SNEW 245 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHH-hcCCCCCC-----cccc
Confidence 5788999999974 45688899999999999999999999865422111 11111 11111111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+|++.+|.+||++.++++.
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=261.35 Aligned_cols=235 Identities=23% Similarity=0.262 Sum_probs=176.5
Q ss_pred ccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHH---hhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 453 EIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIK---AIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.||+|+||.||++... .++.||+|.+.... ......+..|.. .+....|+||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 47899999886431 122223444443 3444579999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|..++... .+ ..+.|+++||.|||+. +++|+||||+||+++.++.+||+|||++..+..... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cC
Confidence 99999888432 11 2267999999999998 999999999999999999999999999876543221 12
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..|+..|+|||.+.++ .++.++||||||+++|||++|+.|+.......... .......... .......
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~-------~~~~~~s 223 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAV-------ELPDSFS 223 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhccCC-------CCCCcCC
Confidence 4588999999998754 68899999999999999999999997543222111 1111111110 0111124
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRP-----SMKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 704 (724)
..+.+++.+|++.+|.+|| ++.++++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 5688899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=256.78 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=191.4
Q ss_pred cccccCcCccceEEEEEeeC------CcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-cceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-SNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~ 521 (724)
.+..+-+|.||.||+|.+.+ .+.|.||.++.. +.-+...+..|..++..+.|||+..+.+.+.+. +..+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 34568899999999997753 356778877653 334456788999999999999999999998764 5679999
Q ss_pred eeccCCChhhhcCC-----CCcc----------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 522 EYMSNGSLADVYSS-----PPKN----------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 522 e~~~~gsL~~~l~~-----~~~~----------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
.++.-|+|..||.. .... .+.|++.|++|||.. +++|.||.++|++||+...+||+|-.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999851 1110 167999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccee-eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC-Cc
Q 041285 587 LMKPDQTRTF-TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG-NL 663 (724)
Q Consensus 587 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~-~~ 663 (724)
.+-+.+.... .+...+..||+||.+....|+.++|||||||+||||+| |+.|+...++.+ .+..+++| ++
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkdGyRl 517 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKDGYRL 517 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhcccee
Confidence 6654444332 33556889999999999999999999999999999988 667776544332 34455554 33
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.+.+ +.+.++..++.-||...|++||++++++.-|..
T Consensus 518 aQP~-------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 518 AQPF-------NCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cCCC-------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 3322 345568899999999999999999999988864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=257.06 Aligned_cols=227 Identities=19% Similarity=0.255 Sum_probs=171.8
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCCChhh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD 531 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 531 (724)
||+|+||.||++... +++.+|+|.+...... +. |+.....+ +|+||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999874 5788999987643111 11 22222222 79999999999999999999999999999999
Q ss_pred hcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcceeeccccCc
Q 041285 532 VYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTFTGIRGTR 603 (724)
Q Consensus 532 ~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~~~~gt~ 603 (724)
++... .+ ..+.|+++||.|||+. +++||||||+||+++.++ .++|+|||++....... ...++.
T Consensus 99 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~ 170 (267)
T PHA03390 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGTL 170 (267)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCCC
Confidence 88543 22 1278999999999998 899999999999999988 99999999987654322 235788
Q ss_pred cccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHH
Q 041285 604 GYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683 (724)
Q Consensus 604 ~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 683 (724)
.|+|||.+.+..++.++||||||++++||++|+.|+...... ......+.... .... .........+.++
T Consensus 171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~l 240 (267)
T PHA03390 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QKKL-------PFIKNVSKNANDF 240 (267)
T ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cccC-------CcccccCHHHHHH
Confidence 999999999889999999999999999999999999744322 11122221111 1100 0111334568899
Q ss_pred HHHcccCCCCCCCC-HHHHHH
Q 041285 684 ALWCILDEPSLRPS-MKKVLL 703 (724)
Q Consensus 684 ~~~Cl~~~p~~RPs-~~evl~ 703 (724)
+..|++.+|.+||+ ++|+++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhccChhhCCchHHHHhc
Confidence 99999999999995 688874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=267.94 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=177.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEeccc--------ce
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--------NK 517 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~~ 517 (724)
.+.+.||+|++|.||++... +++.+|||++..... .....+.+|++++++++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34578999999999999875 578999998864322 12346788999999999999999999876543 46
Q ss_pred EEEEeeccCCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 518 ILVYEYMSNGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
++|+||+.+ +|...+... . ...+.|+++||.|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 999999865 566555322 1 12367999999999998 99999999999999999999999999997654
Q ss_pred CCCc----------ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH
Q 041285 590 PDQT----------RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 590 ~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
.... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+........ ... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~--~~~-~~~~~ 243 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ--LHL-IFKLC 243 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHh
Confidence 3221 111234568889999987654 578999999999999999999999865432211 110 01100
Q ss_pred Hc---------CCccccc----ccc-cc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 659 EN---------GNLGQLI----EDE-DV-----DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 659 ~~---------~~~~~~~----~~~-~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ..+.... ... .. .......+.+++.+|++.+|++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 0000000 000 00 0112256889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=264.54 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=184.8
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.||+|++|.||+|+... ++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 34679999999999999864 8899999987642 2334578899999999999999999999999999999999997
Q ss_pred CChhhhcCCC--C------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSP--P------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~--~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++... . ...+.++++||+|||+. +++|+||+|+||++++++.+||+|||++........ ....
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 5899888543 1 12268999999999998 999999999999999999999999999986643321 1222
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH-----------H-----cC
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF-----------E-----NG 661 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~-----------~-----~~ 661 (724)
..++..|+|||.+.+. .++.++||||||++++||++|+.|+......+. + ....... . ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--L-FKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H-HHHHHHhCCCcHHHHHhhcccccccc
Confidence 3457789999998776 789999999999999999999988865432111 0 0000000 0 00
Q ss_pred Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 ~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......... ...+.....+.+++..|++.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=263.41 Aligned_cols=234 Identities=26% Similarity=0.372 Sum_probs=186.2
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.||+|-||+||-|+.+ .|+.||||.+.+. ...++.++++|+.+|++++||.||.+--.|+..+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 57999999999999875 5899999998753 34556789999999999999999999999999999999999996655
Q ss_pred hhhhcCC----CCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCccccCCCCcceee
Q 041285 529 LADVYSS----PPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 529 L~~~l~~----~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|.-.|.. ++.+. +.||+.||.|||.+ +|+|+||||+||||.+. ..+||+|||+|++++.... ..
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--Rr 724 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RR 724 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hh
Confidence 5555533 22222 68999999999998 99999999999999654 4699999999998864322 23
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
.++||+.|+|||+++++.|...-|+||.||++|--++|-.||....+ +.+.+.+..+ +-+.....+..
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAaF---MyPp~PW~eis 792 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAAF---MYPPNPWSEIS 792 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhcccc---ccCCCchhhcC
Confidence 47899999999999999999999999999999999999999975421 1222332222 22333344555
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
...++++...+|..=.+|-|..+-+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 6678888888888888888876543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=270.89 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=179.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc------------
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------------ 514 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------------ 514 (724)
+.+.+.||.|+||.||+|... .++.||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 344578999999999999875 4789999998765455567789999999999999999999776543
Q ss_pred --cceEEEEeeccCCChhhhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCc
Q 041285 515 --SNKILVYEYMSNGSLADVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALA 585 (724)
Q Consensus 515 --~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~ 585 (724)
...++|+||++ ++|.+++.... +..+.||++||.|||+. +++||||||+||+++ ++..+||+|||++
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35789999997 58887774322 22278999999999998 999999999999997 4567899999999
Q ss_pred cccCCCCcc--eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH--------H
Q 041285 586 KLMKPDQTR--TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW--------V 654 (724)
Q Consensus 586 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~--------~ 654 (724)
......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.............. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 765322111 1122356889999997654 5678899999999999999999999965432111000000 0
Q ss_pred HHHHHcC---Ccc-cccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 655 YQCFENG---NLG-QLIEDE----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 655 ~~~~~~~---~~~-~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....... ... ...... .........+.+++.+|++.+|++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 000 000000 001122356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=260.90 Aligned_cols=238 Identities=25% Similarity=0.345 Sum_probs=187.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|++|.||++... +++.||+|.+... .....+.+.+|++++.+++ |+||+++++++.+.+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 35578999999999999875 5889999988652 2233467889999999998 99999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc---
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--- 593 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--- 593 (724)
+++++|.+++... . +..+.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 84 APNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999988543 1 12267999999999998 999999999999999999999999999886543221
Q ss_pred ----------------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHH
Q 041285 594 ----------------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQC 657 (724)
Q Consensus 594 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~ 657 (724)
.......++..|+|||.+....++.++||||||++++++++|+.|+....... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~ 233 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-------TFQK 233 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHH
Confidence 11223457889999999988889999999999999999999999987543110 0111
Q ss_pred HHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 041285 658 FENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSM----KKVLL 703 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~evl~ 703 (724)
...... .........+.+++..|++.+|++||++ +++++
T Consensus 234 ~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKLEY-------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCC-------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 0111224568899999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=265.23 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=180.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEec-ccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++.. ....++++||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 3478999999999999865 68899999875421 2234678899999999999999999998875 55789999998
Q ss_pred CCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 526 NGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 526 ~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+++|.+++..... ..+.|+++||.|||+. +++|+||+|+||++++++.+||+|||++...... ....
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~ 165 (328)
T cd07856 93 GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGY 165 (328)
T ss_pred ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----cCCC
Confidence 5688888754322 2267999999999998 9999999999999999999999999998754321 1223
Q ss_pred ccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhc-H--------HHHHHHHHHcCCcccc---
Q 041285 600 RGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI-L--------EEWVYQCFENGNLGQL--- 666 (724)
Q Consensus 600 ~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~-l--------~~~~~~~~~~~~~~~~--- 666 (724)
.++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... + .++... +..+.....
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT-ICSENTLRFVQS 244 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh-ccchhhHHHHhh
Confidence 56788999998766 568999999999999999999999886543211000 0 000000 000000000
Q ss_pred c-cccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 667 I-EDEDVD-----KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 667 ~-~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+ ...... ......+.+++.+|++.+|++||++.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 1123578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=253.37 Aligned_cols=229 Identities=26% Similarity=0.294 Sum_probs=181.7
Q ss_pred cCcCccceEEEEEee-CCcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 454 IGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 478999998875322 2445789999999999999999999999999999999999999999
Q ss_pred hhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 530 ADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 530 ~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
.+++... .+ ..+.++++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 9988543 22 2267999999999997 99999999999999999999999999998654332 122334578
Q ss_pred ccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHH
Q 041285 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682 (724)
Q Consensus 603 ~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (724)
..|++||...+...+.++|+||||+++||+++|+.|+..... ...... ...... .........+.+
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~-------~~~~~~~~~l~~ 222 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEK-ILKDPL-------RFPEFLSPEARD 222 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-HhcCCC-------CCCCCCCHHHHH
Confidence 899999999888889999999999999999999999865432 111111 111111 111112456789
Q ss_pred HHHHcccCCCCCCCCHHH
Q 041285 683 VALWCILDEPSLRPSMKK 700 (724)
Q Consensus 683 l~~~Cl~~~p~~RPs~~e 700 (724)
++..|++.+|++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=264.97 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=177.6
Q ss_pred ccccccCcCccceEEEEEeeC---CcEEEEEEccccc--chhHHHHHHHHHhhccc-CcCceeeeeeEEecc----cceE
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN---GKFVAVKRLQKML--AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV----SNKI 518 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~ 518 (724)
.+.+.||+|+||.||++.... +..+|||++.... ....+.+.+|++++.++ +|+||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 356789999999999998753 6789999886532 22345688899999999 599999999976432 4568
Q ss_pred EEEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+++||+. ++|.+++.... ...+.||+.||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8888885 68888774321 12278999999999998 9999999999999999999999999999865432
Q ss_pred Ccc---eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH---------HHHHHHH-
Q 041285 592 QTR---TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL---------EEWVYQC- 657 (724)
Q Consensus 592 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l---------~~~~~~~- 657 (724)
... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..|+........... .......
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 211 1123468899999998765 4688999999999999999999998865432110000 0000000
Q ss_pred -------HHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 658 -------FENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 658 -------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......................+.+++.+|++.+|.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000001112356889999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=265.66 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=181.8
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv 520 (724)
..+.||+|+||.||++... +++.||||++... .......+.+|++++++++|+||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 4468999999999999864 5889999998542 1223456889999999999999999999887543 35899
Q ss_pred EeeccCCChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|||+ +++|.+++.... . ..+.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 172 (343)
T cd07880 99 MPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-- 172 (343)
T ss_pred EecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc--
Confidence 9998 778888775322 2 2267999999999998 99999999999999999999999999998654321
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH----------HHHHHHcCC-
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW----------VYQCFENGN- 662 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~----------~~~~~~~~~- 662 (724)
....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||........ +... ....+....
T Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 173 --TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred --cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHhhcchhH
Confidence 22356889999998876 4578999999999999999999999875432110 0000 000000000
Q ss_pred ------ccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHhccCCCC
Q 041285 663 ------LGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVL--LMLEGTMDI 711 (724)
Q Consensus 663 ------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl--~~L~~~~~~ 711 (724)
+...... ..........+.+++.+|++.+|++||++.+++ .-++...+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0000000 000112234578999999999999999999998 334443333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=264.80 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=181.9
Q ss_pred HHHHHhhcccc--cccCcCccceEEEEEe-eCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc-
Q 041285 441 AELEKMTDGFK--EEIGRGSSGTVYKGTM-INGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV- 514 (724)
Q Consensus 441 ~el~~~t~~f~--~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~- 514 (724)
.++...+++|. +.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44555555554 6799999999999986 458899999986532 22345688899999999999999999988643
Q ss_pred -----cceEEEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 515 -----SNKILVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 515 -----~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
...+++++++ +++|.+++..... ..+.|+++||+|||+. +++||||||+||++++++.+||+|||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccc
Confidence 3467888876 7889887754322 2367999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH-------
Q 041285 584 LAKLMKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY------- 655 (724)
Q Consensus 584 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~------- 655 (724)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ +.....
T Consensus 166 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 239 (345)
T cd07877 166 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGA 239 (345)
T ss_pred cccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 98764322 123457889999998866 4678899999999999999999999854322111 000000
Q ss_pred ---HHHHcC-------Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 656 ---QCFENG-------NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 656 ---~~~~~~-------~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+... .+....... .........+.+++..|++.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 000000000 0000123457899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=257.91 Aligned_cols=237 Identities=22% Similarity=0.347 Sum_probs=179.6
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEcccc-----cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM-----LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 456889999999999998754 344555555431 12233457789999999999999999999999999999999
Q ss_pred eccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 523 YMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 523 ~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|+++++|.+++.. ..+ ..+.++++||.|||+. +++|+||+|+||++++ +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999887632 111 2267999999999998 9999999999999975 56999999998765432
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. ......++..|+|||.+....++.++|+||||+++|+|++|..|+..... .... .....+....
T Consensus 159 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~-~~~~~~~~~~------ 224 (260)
T cd08222 159 CD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV-LRIVEGPTPS------ 224 (260)
T ss_pred cc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH-HHHHcCCCCC------
Confidence 22 12234578899999999888889999999999999999999999853221 1111 1111221111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........+.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12234456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=247.58 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=184.4
Q ss_pred cccccCcCccceEEEEEeeC-----CcEEEEEEcccccch-h-HHHHHHHHHhhcccCcCceeeeeeEEec-ccceEEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAE-G-EREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKILVY 521 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 521 (724)
....||+|.+|.||+++-.+ ...+|+|+++..... + .....+|+.+++.++||||+.|..++.+ +...+|++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 34679999999999996543 237899999754211 1 2346789999999999999999998887 67889999
Q ss_pred eeccCCChhhhcCCCC------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC----CCeEEccccCc
Q 041285 522 EYMSNGSLADVYSSPP------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN----RYAKISDFALA 585 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~----~~~kl~Dfgl~ 585 (724)
||.++ +|-..++.+. +.++.||+.|+.|||++ .|+||||||.|||+..+ |.+||+|+|++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99966 5555552211 12267999999999999 99999999999999877 89999999999
Q ss_pred cccCCCCcc--eeeccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcch------hcHHHHHHH
Q 041285 586 KLMKPDQTR--TFTGIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ------VILEEWVYQ 656 (724)
Q Consensus 586 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~------~~l~~~~~~ 656 (724)
+++...-.. ....++-|+-|.|||.+.+.. |+.+.|||+.|||..||++-.+.|........ ......+.+
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 988643221 223356799999999998865 89999999999999999998887764321100 000011111
Q ss_pred HHHc---CCcccccccc------------ccCH-----------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 657 CFEN---GNLGQLIEDE------------DVDK-----------KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 657 ~~~~---~~~~~~~~~~------------~~~~-----------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.+.. ...+.+..-. ..+. .......++...+|+.||.+|.|.++.++-. -..+
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF~~ 342 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YFTE 342 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cccc
Confidence 1100 0000000000 0000 0112267888889999999999999877543 3456
Q ss_pred CCCCCCCC
Q 041285 711 IPIPPNPT 718 (724)
Q Consensus 711 ~~~p~~p~ 718 (724)
.+.||+|.
T Consensus 343 d~lpp~pt 350 (438)
T KOG0666|consen 343 DPLPPLPT 350 (438)
T ss_pred CCCCCCcc
Confidence 66677774
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=244.27 Aligned_cols=229 Identities=25% Similarity=0.286 Sum_probs=179.3
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
|.+.||+|.||.|-+.+-+ .++.+|+|++++... .....-..|-++|+..+||.+..|-..+...+++++||||..
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 5578999999999998765 488999999987432 233446678899999999999999999999999999999999
Q ss_pred CCChhhhcCCCCc-----ch--HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSPPK-----NN--LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~~~-----~~--~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
||.|.-+|.+... .. -..|..||.|||+. +||.||||.+|.|||.+|++||+|||+++.--.. ......
T Consensus 252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~kT 327 (516)
T KOG0690|consen 252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTTKT 327 (516)
T ss_pred CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc-cceecc
Confidence 9999888855321 11 45799999999998 9999999999999999999999999999853221 233445
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
..||+.|+|||++....|....|.|.+||+||||++|+.||.....+. + .+.+..+ ++-.+....+
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---L----FeLIl~e---d~kFPr~ls~---- 393 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---L----FELILME---DLKFPRTLSP---- 393 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---H----HHHHHhh---hccCCccCCH----
Confidence 789999999999999999999999999999999999999997643221 1 1222111 1112222222
Q ss_pred HHHHHHHHcccCCCCCCC
Q 041285 679 RMIKVALWCILDEPSLRP 696 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RP 696 (724)
....++.-.+..+|.+|.
T Consensus 394 eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHHHHhhcChHhhc
Confidence 345556667889999996
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=266.18 Aligned_cols=230 Identities=23% Similarity=0.260 Sum_probs=183.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.|...+|.|+|+.|-.+... .++..+||++.+. ..+-.+|+.++.+. +|+||+++.+.+.+..+.++|||.+.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 445667999999999988764 4788999999764 23345677666666 79999999999999999999999999
Q ss_pred CCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeee-CCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILM-DENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll-~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++-|.+.+..... .++.+|+.++.|||++ +++||||||+|||+ ++.++++|+|||.++...++ ...
T Consensus 400 g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred ccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 9877766643222 2478999999999998 99999999999999 58999999999999987655 111
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
-.-|..|.|||++....+++++|+||||++||+||+|+.|+....... .+...+..+... ...+.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~~~s---------~~vS~ 537 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMPKFS---------ECVSD 537 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCCccc---------cccCH
Confidence 234789999999999999999999999999999999999997654331 122333333332 33345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+.+++.+||+.+|.+||+|.++..
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhcc
Confidence 6788999999999999999999863
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=265.62 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=180.1
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccc------eEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN------KILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~lv 520 (724)
+.+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|+|++++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4578999999999999885 4789999998642 12234567889999999999999999998776554 8999
Q ss_pred EeeccCCChhhhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+||+ +++|.+++.... +..+.++++||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--- 171 (343)
T cd07851 99 THLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--- 171 (343)
T ss_pred EecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc---
Confidence 9998 668988875432 22377999999999998 9999999999999999999999999999865432
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHH-----------HHcCC
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQC-----------FENGN 662 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~-----------~~~~~ 662 (724)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +.. ..+. +....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKR-IMNLVGTPDEELLQKISSES 247 (343)
T ss_pred -ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHhcCCCCHHHHhhccchh
Confidence 222356888999998865 3678999999999999999999999865432111 000 0000 00000
Q ss_pred cccccc------ccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 LGQLIE------DED---VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 ~~~~~~------~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+. ... ........+.+++.+|++.+|++|||+.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 000 00112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=275.44 Aligned_cols=190 Identities=27% Similarity=0.299 Sum_probs=166.5
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.|..++.+. ++.+|+|++.+. .+....-|+.|-.+|..-+.+=|+.++-.|.+...+|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 34789999999999998864 788999999872 23445679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---cch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSPP---KNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~~---~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
||+|-.++.... ... +..|.-||.-||+- ++|||||||+|||||..|++||+|||.+..+..+..-....
T Consensus 159 GGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~ 235 (1317)
T KOG0612|consen 159 GGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV 235 (1317)
T ss_pred CchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence 999999986644 222 56899999999988 99999999999999999999999999999888777766667
Q ss_pred cccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 599 IRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
.+|||.|++||++.. +.|++.+|.||+||++|||+.|..||...
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 899999999999863 56889999999999999999999999753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=247.83 Aligned_cols=236 Identities=24% Similarity=0.321 Sum_probs=182.7
Q ss_pred HHHhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccc---hhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 443 LEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA---EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 443 l~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
+.....+|...||+|+||.|.++.-+. .+.+|||+|++... .+.+--+.|-++|+.. +-|.++.+..++...+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 334455788999999999999997654 57899999987432 2223356677888877 567899999999999999
Q ss_pred EEEEeeccCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 518 ILVYEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
|+||||+.+|+|--++... ..-.+.+||-||.+||++ +|+.||||..|||||.++.+||+|||+++.---
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998776432 122278999999999998 999999999999999999999999999985321
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
+. .......||+.|+|||++...+|+..+|.|||||+||||+.|+.||+....++ +.+.+.+...
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~ehnv------- 567 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIMEHNV------- 567 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHHccC-------
Confidence 11 22234689999999999999999999999999999999999999998764322 2222322222
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRP 696 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RP 696 (724)
.++...+.+...+....+...|.+|.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12333445566777777888999885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=243.86 Aligned_cols=231 Identities=28% Similarity=0.376 Sum_probs=184.0
Q ss_pred ccceEEEEEeeC-CcEEEEEEcccccchh-HHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChhhhcCC
Q 041285 458 SSGTVYKGTMIN-GKFVAVKRLQKMLAEG-EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS 535 (724)
Q Consensus 458 ~~g~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 535 (724)
+||.||+++..+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999997654433 67899999999999999999999999999999999999999999998854
Q ss_pred CC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCc
Q 041285 536 PP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608 (724)
Q Consensus 536 ~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 608 (724)
.. +..+.++++++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 32 22377899999999998 99999999999999999999999999998765432 22334578899999
Q ss_pred ccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcc
Q 041285 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCI 688 (724)
Q Consensus 609 E~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 688 (724)
|.+....++.++||||||+++++|++|..|+....... . ..+....+....... .......+.+++.+|+
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l 225 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPPFPPP----EWKISPEAKDLIRKLL 225 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCCCccc----cccCCHHHHHHHHHHc
Confidence 99988889999999999999999999999886532111 1 112222221111100 0003456889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 041285 689 LDEPSLRPSMKKVLL 703 (724)
Q Consensus 689 ~~~p~~RPs~~evl~ 703 (724)
..+|++||++.++++
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=278.07 Aligned_cols=135 Identities=30% Similarity=0.413 Sum_probs=116.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.++||+|+||.||++... .++.||||+++... ......+.+|+.++..++|+||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 35578999999999999886 57899999987532 222367889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 525 SNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 525 ~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
++++|.+++... .+.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999988432 123378999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=267.93 Aligned_cols=228 Identities=33% Similarity=0.428 Sum_probs=179.9
Q ss_pred cccCcCccce-EEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGT-VYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.+|.|..|+ ||+|.. +|++||||++-. +-..-..+|+..|+.- +||||||+++.-.+...+|+..|.| ..+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 5689998875 799998 688999999864 2334567899999888 7999999999989999999999999 6699
Q ss_pred hhhcCCC--C---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---C--CCeEEccccCccccCCCCc
Q 041285 530 ADVYSSP--P---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---N--RYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 530 ~~~l~~~--~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~--~~~kl~Dfgl~~~~~~~~~ 593 (724)
.++++.. . +..+.|+++||++||+- +||||||||+||||.. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9988652 1 22267999999999997 9999999999999965 2 4699999999998876654
Q ss_pred ce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHHcC--Ccccccc
Q 041285 594 RT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENG--NLGQLIE 668 (724)
Q Consensus 594 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~ 668 (724)
.. .....||-+|+|||.+....-+.++||||+|||+|+.++| .+||+.....+.- +..+ .+..+..
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---------Il~~~~~L~~L~~ 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---------ILTGNYTLVHLEP 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---------hhcCccceeeecc
Confidence 32 3346899999999999999888999999999999999997 7888764322111 1111 1211111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
. .+. ...+++..|+..+|..||++.+|+
T Consensus 738 ~----~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 L----PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred C----chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 111 677889999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=263.77 Aligned_cols=244 Identities=20% Similarity=0.218 Sum_probs=164.2
Q ss_pred cccccCcCccceEEEEEe-----------------eCCcEEEEEEcccccchhHHH--------------HHHHHHhhcc
Q 041285 450 FKEEIGRGSSGTVYKGTM-----------------INGKFVAVKRLQKMLAEGERE--------------FQTEIKAIGR 498 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E~~~l~~ 498 (724)
+.++||+|+||+||+|.+ .+++.||||++........++ +..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 347899999999999964 235689999986532222222 3446777777
Q ss_pred cCcCce-----eeeeeEEec--------ccceEEEEeeccCCChhhhcCCCC----------------------------
Q 041285 499 THHRNL-----VRLLGYSFD--------VSNKILVYEYMSNGSLADVYSSPP---------------------------- 537 (724)
Q Consensus 499 l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------------- 537 (724)
++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766654 678888753 356899999999999998874210
Q ss_pred ---cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCC
Q 041285 538 ---KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614 (724)
Q Consensus 538 ---~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 614 (724)
...+.+++++|.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 01256899999999998 999999999999999999999999999976543322111223357899999987543
Q ss_pred C----------------------CCcccceeehhHHHHHhhcccc-CCCCCCCcc------hhcHHHHHHHHHHcCCccc
Q 041285 615 P----------------------ITAKADVYSFGVVLLEIICCRR-CFDQNLPED------QVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 615 ~----------------------~~~k~Dv~S~Gvll~elltg~~-p~~~~~~~~------~~~l~~~~~~~~~~~~~~~ 665 (724)
. ...+.||||+||+++||+++.. |+....... ...+..| +.+.......
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~~~ 463 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKYDF 463 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCCCc
Confidence 2 1235799999999999999875 553211000 0111111 1111111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 041285 666 LIEDEDVDKKQLERMIKVALWCILDEP---SLRPSMKKVLL 703 (724)
Q Consensus 666 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~evl~ 703 (724)
. . .........+++..++..+| .+|+|++|+++
T Consensus 464 ~----~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 464 S----L-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c----c-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 0 11123456777888888765 78999999885
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=246.97 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=180.7
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEccc--ccchh-----HHHHHHHHHhhcccCcCceeeeeeEEe-cccceEEE
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQK--MLAEG-----EREFQTEIKAIGRTHHRNLVRLLGYSF-DVSNKILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv 520 (724)
+...||+|||+.||++.. ...+.||||+-.- ..+.. .+...+|.++-+.|.||.||++++++. +.+..+-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 345699999999999974 4578999997542 21111 134678999999999999999999886 55678999
Q ss_pred EeeccCCChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeC---CCCCeEEccccCccccCC
Q 041285 521 YEYMSNGSLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKP 590 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~---~~~~~kl~Dfgl~~~~~~ 590 (724)
+||++|.+|+-+|+.. ...+++||+.||.||.+. +++|+|-||||.||||- .-|.+||+|||+++++.+
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 9999999999998542 234488999999999986 67999999999999995 457899999999999875
Q ss_pred CCcc------eeeccccCccccCcccccCC----CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 591 DQTR------TFTGIRGTRGYVAPEWHWNL----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 591 ~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
+... ......||..|++||++.-+ +++.|.||||.|||+|+.+.|+.||........ ++.+ ...+..
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-ILqe--NTIlkA 702 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-ILQE--NTILKA 702 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HHhh--hchhcc
Confidence 5432 12235799999999987644 478899999999999999999999987543221 1111 011111
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
.+.... ..+........++.+||+..-++|....++.
T Consensus 703 tEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 703 TEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred eeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111 1112233466778889999888888777764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=235.70 Aligned_cols=236 Identities=22% Similarity=0.246 Sum_probs=183.8
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec----ccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD----VSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~~ 525 (724)
++||-|-.|.|-....+ .++.+|+|.|.+. ...++|+++--+. .|+|||.+++++.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999988764 5788999998753 3457888877666 69999999998765 456789999999
Q ss_pred CCChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||.|...+.... .+++.+|+.|+.|||+. +|.||||||+|+|... |..+||+|||+|+......
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 999998874322 23377899999999998 9999999999999964 5679999999999765322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....-.-|+.|.|||++...+++...|+||+||++|-|++|.+||....... +..-....+..|... .+....
T Consensus 219 -~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~---FP~pEW 291 (400)
T KOG0604|consen 219 -DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYE---FPEPEW 291 (400)
T ss_pred -cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCcc---CCChhH
Confidence 2223346899999999999999999999999999999999999998654321 111123334444322 233334
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...++...++++..|..+|.+|.++.+++.
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 455677888999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=271.89 Aligned_cols=248 Identities=23% Similarity=0.216 Sum_probs=156.6
Q ss_pred ccccccCcCccceEEEEEeeC-----CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeE------Eecccce
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY------SFDVSNK 517 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~~~ 517 (724)
.+.++||+|+||.||+|.+.+ +..||||++..... .+.+..| .+....+.+++.++.. +.+....
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 345789999999999999854 58999998864321 1111111 1112222222222211 2456678
Q ss_pred EEEEeeccCCChhhhcCCCC---------------------------cchHHHHHHHcccccccCCCceEeCCCCCCCee
Q 041285 518 ILVYEYMSNGSLADVYSSPP---------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNIL 570 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~---------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIl 570 (724)
++||||+++++|.+++.... ...+.||++||.|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 99999999999988874321 12367899999999998 9999999999999
Q ss_pred eCC-CCCeEEccccCccccCCCCcceeeccccCccccCcccccCC----------------------CCCcccceeehhH
Q 041285 571 MDE-NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL----------------------PITAKADVYSFGV 627 (724)
Q Consensus 571 l~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~Dv~S~Gv 627 (724)
++. ++.+||+|||+++.+............+++.|+|||.+... .+..++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 986 57899999999986644333333345689999999965322 2345679999999
Q ss_pred HHHHhhccccCCCCCCCcc-------hhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 041285 628 VLLEIICCRRCFDQNLPED-------QVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 628 ll~elltg~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
+||||+++..+.......- ...+..|... .......++...............+++.+|++.||++|||+.|
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 9999998765543210000 0001111000 0000000000000000001123458999999999999999999
Q ss_pred HHHH
Q 041285 701 VLLM 704 (724)
Q Consensus 701 vl~~ 704 (724)
+++.
T Consensus 447 ~L~H 450 (566)
T PLN03225 447 ALAH 450 (566)
T ss_pred HhCC
Confidence 9864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=216.78 Aligned_cols=184 Identities=27% Similarity=0.406 Sum_probs=153.0
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
|+||+|.+|+||+++..+ ++.||+|+++-. .+.-.....+|+-+++.++|+|||++++....+..+-+|+||+. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 679999999999998754 688999988643 22223567899999999999999999999999999999999994 46
Q ss_pred hhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|..++..... ..+.|+++||.++|++ ++.||||||+|.|++.+++.|++|||+++-++.. .......+
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vrcysaev 162 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSAEV 162 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEeeecee
Confidence 7776644332 2278999999999998 9999999999999999999999999999977643 23344456
Q ss_pred cCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCC
Q 041285 601 GTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFD 640 (724)
Q Consensus 601 gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~ 640 (724)
-|.-|.+|+++.+.+ ++...|+||-|+++.|+....+|.-
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 689999999988765 7899999999999999987655543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=243.26 Aligned_cols=213 Identities=21% Similarity=0.201 Sum_probs=164.6
Q ss_pred CccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChhhhcCC
Q 041285 457 GSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS 535 (724)
Q Consensus 457 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 535 (724)
|.+|.||++... +++.+|+|++.... ++..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 57899999987532 334455555566799999999999999999999999999999988743
Q ss_pred C---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCc
Q 041285 536 P---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608 (724)
Q Consensus 536 ~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 608 (724)
. .. ..+.++++||.|||+. +++||||||+||+++.++.++++|||.+...... .....++..|+||
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP 151 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP 151 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence 2 11 2267999999999998 9999999999999999999999999987655432 1223456789999
Q ss_pred ccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcc
Q 041285 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCI 688 (724)
Q Consensus 609 E~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 688 (724)
|.+....++.++||||+|+++|||++|+.++...... .... ..+ + .+......+.+++.+|+
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~--~~~-~---~~~~~~~~~~~li~~~l 213 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH--TTL-N---IPEWVSEEARSLLQQLL 213 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc--ccc-C---CcccCCHHHHHHHHHHc
Confidence 9998888999999999999999999999876432110 0000 000 0 11112345788999999
Q ss_pred cCCCCCCCCHH
Q 041285 689 LDEPSLRPSMK 699 (724)
Q Consensus 689 ~~~p~~RPs~~ 699 (724)
+.||++||++.
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-29 Score=233.99 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=178.2
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccc-ccchh-HHHHHHHHHhhcccCcCceeeeeeEEecc--------cceEEE
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQK-MLAEG-EREFQTEIKAIGRTHHRNLVRLLGYSFDV--------SNKILV 520 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~-~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~lv 520 (724)
.+||+|.||.||+++..+ ++.||+|++-- ....+ ...-.+|+++|..++|+|++.++..|... ...+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 469999999999998754 67788886532 11111 23467899999999999999999988642 347999
Q ss_pred EeeccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
++++++ +|..+|..... +.+.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSK 178 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence 999965 67766654321 2267899999999998 99999999999999999999999999998775432
Q ss_pred c---ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHH--------Hc
Q 041285 593 T---RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF--------EN 660 (724)
Q Consensus 593 ~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~--------~~ 660 (724)
. ...++.+-|..|.+||.+.+. .++++.|||.-||++.||.++.+.++......+..+.....-.+ .+
T Consensus 179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~ 258 (376)
T KOG0669|consen 179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDN 258 (376)
T ss_pred ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCccc
Confidence 2 223445669999999998875 58999999999999999999999888765544433222111000 00
Q ss_pred CCccccccccc-------cCHHHH------HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 661 GNLGQLIEDED-------VDKKQL------ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 661 ~~~~~~~~~~~-------~~~~~~------~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
-.+-+.++.+. .-++.. ...++++..++..||.+||...+++.
T Consensus 259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00111110000 011111 25678888899999999999988864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=237.76 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=195.3
Q ss_pred cccccCHHHHHHhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccC-cC-----ceee
Q 041285 434 ALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HR-----NLVR 506 (724)
Q Consensus 434 ~~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~ 506 (724)
+-..|...+.....+.+...+|+|.||.|-...... +..||||+++... .-.+.-+-|+++++++. +. -+|.
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 335566667767777777899999999999886643 6899999998642 23345678999999993 32 3677
Q ss_pred eeeEEecccceEEEEeeccCCChhhhcCCCCc---------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC----
Q 041285 507 LLGYSFDVSNKILVYEYMSNGSLADVYSSPPK---------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---- 573 (724)
Q Consensus 507 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---- 573 (724)
+.+++.-.++.++|+|.+ |-|+.+++..... ....|++++++|||+. +++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 788899999999999998 6699999965322 2267999999999998 9999999999999832
Q ss_pred ----------------CCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhcccc
Q 041285 574 ----------------NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRR 637 (724)
Q Consensus 574 ----------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~ 637 (724)
+..+||+|||.|....... ..++.|..|.|||++.+-.++.++||||+||||.|+.+|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 2348999999998654333 34566999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhcHHH--------------HHHHHHHcCCcc-----------cccccc-------ccCHHHHHHHHHHHH
Q 041285 638 CFDQNLPEDQVILEE--------------WVYQCFENGNLG-----------QLIEDE-------DVDKKQLERMIKVAL 685 (724)
Q Consensus 638 p~~~~~~~~~~~l~~--------------~~~~~~~~~~~~-----------~~~~~~-------~~~~~~~~~l~~l~~ 685 (724)
.|+.....+..-+-+ .+.+....+.+. ...+.. .....+...|++|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 998765433221111 122222223222 111111 113345677999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 041285 686 WCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 686 ~Cl~~~p~~RPs~~evl~ 703 (724)
.+|..||.+|+|+.|+++
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=252.08 Aligned_cols=240 Identities=26% Similarity=0.369 Sum_probs=186.7
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec-----ccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD-----VSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~l 519 (724)
+..|.+.||.|.+|.||+++.. +++.+|||++... ....++...|.++++.. +|||++.++|++.. ++.++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3456689999999999999864 5788899988764 34446788899999988 79999999999863 568999
Q ss_pred EEeeccCCChhhhcCCCCc-----ch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 520 VYEYMSNGSLADVYSSPPK-----NN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~~-----~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
|||||.+||..|+++.... .. +..+++|+.+||.+ .++|||||-.||||+.++.+|+.|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999854321 11 56899999999998 999999999999999999999999999976543
Q ss_pred CCcceeeccccCccccCcccccCC-----CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNL-----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 665 (724)
.... .....||+.|||||++... .|+.++|+||||++..||--|.+|+....+-. .++...+.+
T Consensus 176 T~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~IpRNP- 244 (953)
T KOG0587|consen 176 TVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFLIPRNP- 244 (953)
T ss_pred cccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhccCCCCC-
Confidence 2211 1225799999999998643 47789999999999999999999987544321 111111000
Q ss_pred cccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 LIEDED-VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+.. -+..-...+.+++..|+..|-++||++.++++
T Consensus 245 --PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 --PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111 13455678999999999999999999998874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-28 Score=228.69 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=186.6
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~ 523 (724)
+-||-|+||.||..+.+ +|+.||+|++... .-.+.+.+.+|+.+|...+|.|++..++...-. ++.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 56999999999999875 6899999998753 234457889999999999999999998876533 356888888
Q ss_pred ccCCChhhhcCC-------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS-------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~-------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
| ..+|...+-. ..+-.+.||++||+|||+. +|.||||||.|.|++.|-..||+|||+++.-..++...+
T Consensus 139 m-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 M-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred H-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 8 4577776632 1222378999999999998 999999999999999999999999999998877777777
Q ss_pred eccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH--------HHHHHHcCCccccc
Q 041285 597 TGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW--------VYQCFENGNLGQLI 667 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~~~~ 667 (724)
+..+-|-.|.|||.+++. .|+.+.||||.||++.||+..+-.|+...+.++..+..- ..+..-+|....++
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 777778999999999886 489999999999999999998888876555444332211 00111111111111
Q ss_pred c----cc----c----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 668 E----DE----D----VDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 668 ~----~~----~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
. .. . .....-...+.+...++..+|++|.+..+.+.-+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1 00 0 0112223455666778999999999998887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=213.01 Aligned_cols=186 Identities=27% Similarity=0.425 Sum_probs=151.4
Q ss_pred cccCcCccceEEEEEe-eCCcEEEEEEcccc-cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTM-INGKFVAVKRLQKM-LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.||+|++|.|=+-++ ..|...|||++... ..+..++..+|+.+..+. .+|.+|.++|........++.||.| ..|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 5799999999977765 46899999999753 245557788899887766 7999999999988889999999999 557
Q ss_pred hhhhcCC-------C----CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 529 LADVYSS-------P----PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 529 L~~~l~~-------~----~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+.+... - ..+++..|.+||.|||++ ..++|||+||+|||++.+|.+|++|||.+..+.+.-. .+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--kt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--KT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--HH
Confidence 7776521 1 123378899999999987 5899999999999999999999999999987643221 12
Q ss_pred ccccCccccCcccccC----CCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 598 GIRGTRGYVAPEWHWN----LPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
-..|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++..
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 2346788999998753 46899999999999999999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=240.22 Aligned_cols=191 Identities=26% Similarity=0.378 Sum_probs=159.1
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||-|+||+|.++..-| ...+|+|.|++.. +......++|-.+|+.-..+=||+|+..|.+.+.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 459999999999997654 5678999997632 334456889999999999999999999999999999999999999
Q ss_pred ChhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC---------C-
Q 041285 528 SLADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK---------P- 590 (724)
Q Consensus 528 sL~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~---------~- 590 (724)
++-.+|.+. ..-.+.+++.|+++.|.- ++|||||||+|||||.+|.+||+||||+.-++ .
T Consensus 715 DmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g 791 (1034)
T KOG0608|consen 715 DMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG 791 (1034)
T ss_pred cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCC
Confidence 999887432 222377899999999987 99999999999999999999999999986441 0
Q ss_pred CC---------------cc----------------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCC
Q 041285 591 DQ---------------TR----------------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF 639 (724)
Q Consensus 591 ~~---------------~~----------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~ 639 (724)
+. .. .....+||+.|+|||++....++..+|.||.|||||||+.|+.||
T Consensus 792 dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf 871 (1034)
T KOG0608|consen 792 DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPF 871 (1034)
T ss_pred CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCc
Confidence 00 00 001135999999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 041285 640 DQNLPE 645 (724)
Q Consensus 640 ~~~~~~ 645 (724)
....+.
T Consensus 872 ~~~tp~ 877 (1034)
T KOG0608|consen 872 LADTPG 877 (1034)
T ss_pred cCCCCC
Confidence 876544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=221.87 Aligned_cols=235 Identities=23% Similarity=0.286 Sum_probs=183.1
Q ss_pred ccccCcCccceEEEEEeeC-CcEEEEEEcccc---cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKM---LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.||+|++..|..+.+.. .+.+|+|++++. ..++.+-.+.|-.+..+- +||.+|-|..++.....+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 4689999999999998854 678999998763 234445567777777766 79999999999999999999999999
Q ss_pred CCChhhhcCCC---Ccch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|+|--++.+. +... ...|.-||.|||+. +|+.||||..|||||..+.+||+|+|+++.--.+.. ....
T Consensus 335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd-~tst 410 (593)
T KOG0695|consen 335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD-TTST 410 (593)
T ss_pred CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc-cccc
Confidence 99997776432 2222 45789999999998 999999999999999999999999999985432222 2334
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC-CcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL-PEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..||+.|+|||++++..|....|.|++||+|+||+.|+.||+... .........+..+.+.+.++.- +....
T Consensus 411 fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri-------prsls 483 (593)
T KOG0695|consen 411 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI-------PRSLS 483 (593)
T ss_pred ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc-------cceee
Confidence 789999999999999999999999999999999999999998543 2223344556666655443321 11223
Q ss_pred HHHHHHHHHcccCCCCCCC
Q 041285 678 ERMIKVALWCILDEPSLRP 696 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RP 696 (724)
.+...+++.-+..||.+|.
T Consensus 484 vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhHHHHHHhhcCCcHHhc
Confidence 3456677778899999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=217.32 Aligned_cols=203 Identities=36% Similarity=0.563 Sum_probs=173.3
Q ss_pred cCcCccceEEEEEeeC-CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChhh
Q 041285 454 IGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD 531 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 531 (724)
||+|.+|.||++...+ ++.++||.+...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998764322 34679999999999999999999999999999999999999999999
Q ss_pred hcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCcceeeccccC
Q 041285 532 VYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 532 ~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
++... .. ..+.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98543 11 2267999999999998 9999999999999999 89999999999986654321 12224568
Q ss_pred ccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 603 RGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 603 ~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
..|++||..... ..+.+.|+|++|+++++| ..+.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------~~~~ 191 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------PELK 191 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------HHHH
Confidence 899999998877 788999999999999999 3478
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHh
Q 041285 682 KVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
+++..|++.+|++||++.++++.|
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-26 Score=237.96 Aligned_cols=234 Identities=23% Similarity=0.306 Sum_probs=184.1
Q ss_pred ccCcCccceEEEEEeeCCc-EEEEEEccc---ccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 453 EIGRGSSGTVYKGTMINGK-FVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.||-|+||.|=++.....+ .+|+|.+++ .....++....|-.+|...+.|.||+++-.+.+.+..|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 5999999999998875443 378887765 233445568889999999999999999999999999999999999999
Q ss_pred hhhhcCCC-------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 529 LADVYSSP-------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 529 L~~~l~~~-------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
|-..|+.. ..-.+..+++|++|||.+ +||.|||||+|.||+.+|-+||.|||+|+.+..... .-...|
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwTFcG 581 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWTFCG 581 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc--eeeecC
Confidence 98877432 122256799999999998 999999999999999999999999999998764432 223679
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHH
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (724)
|+.|.|||++.++..+..+|.||||+++|||++|.+||....+-.. +..+..| +|.-..+........
T Consensus 582 TpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkG-----id~i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 582 TPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKG-----IDKIEFPRRITKTAT 649 (732)
T ss_pred CcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhh-----hhhhhcccccchhHH
Confidence 9999999999999999999999999999999999999987653221 1222222 111112233345577
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHH
Q 041285 682 KVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 682 ~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
++++..+..+|.+|.- +.+|-+
T Consensus 650 ~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHHHHHhcCcHhhhccccCChHHHHh
Confidence 7888888999999986 556653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=212.15 Aligned_cols=189 Identities=33% Similarity=0.499 Sum_probs=161.3
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999876 789999999765433 5678999999999999999999999999999999999999999
Q ss_pred ChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++..... ..+.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+..............
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999854321 2367899999999998 999999999999999999999999999987654421122234
Q ss_pred ccCccccCcccc-cCCCCCcccceeehhHHHHHhhccccCCCC
Q 041285 600 RGTRGYVAPEWH-WNLPITAKADVYSFGVVLLEIICCRRCFDQ 641 (724)
Q Consensus 600 ~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvll~elltg~~p~~~ 641 (724)
.++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 567889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=224.86 Aligned_cols=183 Identities=26% Similarity=0.363 Sum_probs=152.3
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccc--------hhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEE
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA--------EGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 519 (724)
+.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-..-.|+++|..++ |+||++++.+|++.+..||
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 569999999999998865 56899998875311 11123557999999997 9999999999999999999
Q ss_pred EEeec-cCCChhhhcCCCCc-------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 520 VYEYM-SNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~-~~gsL~~~l~~~~~-------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
++|-. ++.+|.++++..+. -++.||+-|+++||+. +|+|||||-+||.++.+|-+||+|||.+......
T Consensus 647 ~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksg 723 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG 723 (772)
T ss_pred EecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCC
Confidence 99975 45688888854332 2378999999999999 9999999999999999999999999999876433
Q ss_pred CcceeeccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCC
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFD 640 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~ 640 (724)
.+...+||.+|.|||++.+.+| ...-|||++|++||.++....|+.
T Consensus 724 ---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 724 ---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 2334679999999999999887 456799999999999999888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-24 Score=203.31 Aligned_cols=242 Identities=15% Similarity=0.239 Sum_probs=173.1
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeE-EecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGY-SFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~e~~ 524 (724)
+++.+.||+|.||.+-++.++. ...+++|.+... ....++|.+|...--.| .|.||+.-+.. +...+.+++++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 4456789999999999998865 578999998764 34457899998765556 68999988765 55667788999999
Q ss_pred cCCChhhhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC--CCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD--ENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~--~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|.|+|.+-+.... ...+.|++.||.|+|++ ++||||||.+|||+- +...+||+|||+.+..+..-.
T Consensus 105 P~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--- 178 (378)
T KOG1345|consen 105 PRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--- 178 (378)
T ss_pred ccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh---
Confidence 9999998885432 33478999999999998 999999999999993 334799999999876542211
Q ss_pred eccccCccccCcccccCC-----CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 597 TGIRGTRGYVAPEWHWNL-----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
....+..|.+||..... ...+.+|+|.||++++.+++|..|++.....+... |-+..+..+....+-+ .
T Consensus 179 -~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y---~~~~~w~~rk~~~~P~--~ 252 (378)
T KOG1345|consen 179 -YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY---WEWEQWLKRKNPALPK--K 252 (378)
T ss_pred -hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH---HHHHHHhcccCccCch--h
Confidence 12346678999975432 24678999999999999999999998544333322 2233333332221111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ....+++.++.++-+..+|++|=-..++.+
T Consensus 253 F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 253 F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred h-cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1 112345667777788889998844444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=199.49 Aligned_cols=245 Identities=20% Similarity=0.368 Sum_probs=179.5
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEeccc--ceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVS--NKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lv~e~~~ 525 (724)
+.+++|+|.++.||.|.. .+.+.++||.++.. ..+...+|+.+|..|. ||||++|++...+.. ...||+||+.
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 446899999999999974 46788999999853 3467899999999996 999999999988754 5689999999
Q ss_pred CCChhhhcCCCCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCcceeeccc
Q 041285 526 NGSLADVYSSPPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 526 ~gsL~~~l~~~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
+.+...+...+... .+.++++||.|+|+. +|.|||+||.|+++|. ....+|+|+|+|.+..+...... .+
T Consensus 119 n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--RV 193 (338)
T KOG0668|consen 119 NTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RV 193 (338)
T ss_pred cccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee--ee
Confidence 98887776544322 278999999999998 9999999999999986 45699999999988755433221 23
Q ss_pred cCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCc-chhc----------HHHHHHHHH--HcCCcccc
Q 041285 601 GTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPE-DQVI----------LEEWVYQCF--ENGNLGQL 666 (724)
Q Consensus 601 gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~-~~~~----------l~~~~~~~~--~~~~~~~~ 666 (724)
.+.-|--||.+...+ ++..-|+|||||++.+|+..+.||-..... ++.. +..++.+.- .+.+...+
T Consensus 194 ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i 273 (338)
T KOG0668|consen 194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI 273 (338)
T ss_pred ehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH
Confidence 466788999887654 788899999999999999999998654322 2211 111111110 00111111
Q ss_pred ccccc----------cCHH-HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 667 IEDED----------VDKK-QLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 667 ~~~~~----------~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
+.... .... ....+++++...+..|-.+|||++|..
T Consensus 274 ~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 274 LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 11100 0001 124577888888999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=211.08 Aligned_cols=258 Identities=27% Similarity=0.326 Sum_probs=182.3
Q ss_pred ccCcCccceEEEEEe-eCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEEEEee
Q 041285 453 EIGRGSSGTVYKGTM-INGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKILVYEY 523 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~e~ 523 (724)
.+|.|.- .|-.+.. -.+++||+|++... .....+...+|..++..++|+|+++++.++.-. .+.|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3566665 3333322 24789999988643 234446678899999999999999999998643 356999999
Q ss_pred ccCCChhhhcCC-----CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 524 MSNGSLADVYSS-----PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 524 ~~~gsL~~~l~~-----~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
| ..+|+..+.. ....+..|+..|++|||+. +|+||||||+||++..+..+||.|||+++.-..+ ..++.
T Consensus 103 m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtp 176 (369)
T KOG0665|consen 103 M-DANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTP 176 (369)
T ss_pred h-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cccCc
Confidence 9 5577776531 2233478999999999998 9999999999999999999999999999865433 34455
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchh----------------cHHHHHHHHHHcC-
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV----------------ILEEWVYQCFENG- 661 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~----------------~l~~~~~~~~~~~- 661 (724)
.+.+.-|.|||++.+-.+.+.+||||.||++.||++|.-.|.+...-++. .+...++......
T Consensus 177 yVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~ 256 (369)
T KOG0665|consen 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP 256 (369)
T ss_pred hhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh
Confidence 67889999999999988999999999999999999999887643211110 0111111111110
Q ss_pred -----Ccccccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hc---cCCCCCCCCCC
Q 041285 662 -----NLGQLIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LE---GTMDIPIPPNP 717 (724)
Q Consensus 662 -----~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~---~~~~~~~p~~p 717 (724)
.....+.+. +.+......+.+++..||-.+|++|.|.+++++- ++ ...+++.|++|
T Consensus 257 ~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 257 QYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 111111111 1122345667889999999999999999999864 33 34455555555
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=212.51 Aligned_cols=123 Identities=26% Similarity=0.369 Sum_probs=97.9
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-----c---CceeeeeeEEec---
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-----H---RNLVRLLGYSFD--- 513 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~--- 513 (724)
..+...++||-|.|++||++-.. ..+.||+|+.+.. ..-.+....|+++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 45556689999999999999764 4689999998763 333455678999999883 2 379999999874
Q ss_pred -ccceEEEEeeccCCChhhhcCC-----C----CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 514 -VSNKILVYEYMSNGSLADVYSS-----P----PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 514 -~~~~~lv~e~~~~gsL~~~l~~-----~----~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
+.+.++|+|++ |.+|..++.. . .++++.||+.||.|||.+| +|||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56899999998 6678777732 1 2344789999999999985 899999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-24 Score=217.85 Aligned_cols=261 Identities=20% Similarity=0.245 Sum_probs=194.6
Q ss_pred ccccCHHHHHHhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccC------cCceeee
Q 041285 435 LLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTH------HRNLVRL 507 (724)
Q Consensus 435 ~~~~~~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 507 (724)
-....+.|+....+...-..|+|-|++|-++.... |..||||++.... .-.+.=+.|+++|.+|+ --|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 44566677777777777789999999999998753 7799999998642 22344568999999995 3389999
Q ss_pred eeEEecccceEEEEeeccCCChhhhcCCCCcch----------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CC
Q 041285 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN----------LIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RY 576 (724)
Q Consensus 508 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~ 576 (724)
+-.|....+++||+|-+ ..+|.++|+...... +.|+.-||..|..- +|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999987 568888885433322 67999999999987 99999999999999875 56
Q ss_pred eEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH---
Q 041285 577 AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW--- 653 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~--- 653 (724)
+||||||.|.....++... ..-+..|.|||++.+.+|+...|+||.||.||||.||+-.|-+........+..-
T Consensus 576 LKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 8999999998776554322 2235679999999999999999999999999999999998876543322111100
Q ss_pred --HHHHHHcCCccc-c--------------------------ccc--------------cccCHHHHHHHHHHHHHcccC
Q 041285 654 --VYQCFENGNLGQ-L--------------------------IED--------------EDVDKKQLERMIKVALWCILD 690 (724)
Q Consensus 654 --~~~~~~~~~~~~-~--------------------------~~~--------------~~~~~~~~~~l~~l~~~Cl~~ 690 (724)
...++..|.+.+ . +.| .......+..+.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 011122221111 0 001 011334567788999999999
Q ss_pred CCCCCCCHHHHHH
Q 041285 691 EPSLRPSMKKVLL 703 (724)
Q Consensus 691 ~p~~RPs~~evl~ 703 (724)
||++|.+..+.|+
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=208.69 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=182.8
Q ss_pred ccccCcCccceEEEEEeeC----CcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.++||+|.|++||++.+.. .+.||+|.+... .......+|+++|..+ -+.||+++.+++...+...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 3689999999999998754 578999998763 3445689999999999 59999999999999999999999999
Q ss_pred CCChhhhcCCCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCC----------
Q 041285 526 NGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKP---------- 590 (724)
Q Consensus 526 ~gsL~~~l~~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~---------- 590 (724)
+....+++....... +..+.+||+++|.+ +|+||||||+|+|.+. .+.-.|.|||++.....
T Consensus 119 H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~ 195 (418)
T KOG1167|consen 119 HDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSY 195 (418)
T ss_pred ccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhh
Confidence 999999987765433 67899999999999 9999999999999975 46678999999972100
Q ss_pred ---CCc------------------------------ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccc
Q 041285 591 ---DQT------------------------------RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCR 636 (724)
Q Consensus 591 ---~~~------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~ 636 (724)
... .......||++|.|||++..- .-+.+.||||-|||++.+++++
T Consensus 196 ~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~ 275 (418)
T KOG1167|consen 196 SGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRR 275 (418)
T ss_pred hcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccc
Confidence 000 001123599999999998654 4688999999999999999999
Q ss_pred cCCCCCCCcchhcHHHHH--------HHH-HHcCC--ccc----------------c----ccc--------cccCHHHH
Q 041285 637 RCFDQNLPEDQVILEEWV--------YQC-FENGN--LGQ----------------L----IED--------EDVDKKQL 677 (724)
Q Consensus 637 ~p~~~~~~~~~~~l~~~~--------~~~-~~~~~--~~~----------------~----~~~--------~~~~~~~~ 677 (724)
.||-....+.... .+.+ ++. ...|. +-+ + +-+ ........
T Consensus 276 ~PFf~a~dd~~al-~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~ 354 (418)
T KOG1167|consen 276 YPFFKAKDDADAL-AEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFP 354 (418)
T ss_pred cccccCccccchH-HHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccccc
Confidence 9997554332211 1110 000 00111 000 0 000 00011123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..++++..+|++.||.+|.|++|.|+
T Consensus 355 ~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 355 ALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred HHHHHHHHHHccCChhhcccHHHHhc
Confidence 47889999999999999999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=220.48 Aligned_cols=237 Identities=23% Similarity=0.312 Sum_probs=180.5
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
..++|.|.+|.|||++.. .++..|||.++-......+-...|+-+++..+|+|||.++|.+...+.+++.|||+.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 467999999999999874 5788999999876666667788999999999999999999999999999999999999999
Q ss_pred hhhcCCCC----cch---HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccC
Q 041285 530 ADVYSSPP----KNN---LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602 (724)
Q Consensus 530 ~~~l~~~~----~~~---~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt 602 (724)
.+..+... .++ .....+|++|||+. +-+|||||-.|||+.+.+.+|++|||.+..+..- ........||
T Consensus 100 Qdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~KrksfiGt 175 (829)
T KOG0576|consen 100 QDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFIGT 175 (829)
T ss_pred cceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhhhhcccCC
Confidence 99875321 111 45678899999998 8899999999999999999999999998754321 1122346799
Q ss_pred ccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc-c-cCHHHH
Q 041285 603 RGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE-D-VDKKQL 677 (724)
Q Consensus 603 ~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~-~~~~~~ 677 (724)
+.|||||+.. .+.+..++|||+.|+...|+---+.|.....+.. + -.+.... ..++. . ....-.
T Consensus 176 pywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~-l~LmTkS---~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------A-LFLMTKS---GFQPPTLKDKTKWS 244 (829)
T ss_pred ccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------H-HHHhhcc---CCCCCcccCCccch
Confidence 9999999753 4568999999999999999976665543322111 1 1111111 11111 1 112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
+.+.++++.|+..+|++||+++.++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhe
Confidence 5577888889999999999998765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-23 Score=244.31 Aligned_cols=188 Identities=20% Similarity=0.270 Sum_probs=129.5
Q ss_pred cccCc-CceeeeeeEE-------ecccceEEEEeeccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceE
Q 041285 497 GRTHH-RNLVRLLGYS-------FDVSNKILVYEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQII 560 (724)
Q Consensus 497 ~~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~ 560 (724)
+.++| +||++++++| .+.+..++++||+ +++|.+++..... ..+.||++||.|||+. +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 34556 6888888887 2334567888987 6699999954221 1267999999999998 999
Q ss_pred eCCCCCCCeeeCC-------------------CCCeEEccccCccccCCCCc---------------ceeeccccCcccc
Q 041285 561 HCDIKPQNILMDE-------------------NRYAKISDFALAKLMKPDQT---------------RTFTGIRGTRGYV 606 (724)
Q Consensus 561 H~dlk~~NIll~~-------------------~~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~y~ 606 (724)
||||||+||||+. ++.+||+|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566777777654221000 0011135788899
Q ss_pred CcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHH
Q 041285 607 APEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALW 686 (724)
Q Consensus 607 aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 686 (724)
|||++.+..++.++|||||||+||||++|..|+.... ..+.. +....+ .+. .......+..++.+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~-----~~~~~~----~~~--~~~~~~~~~~~~~~ 247 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSS-----LRHRVL----PPQ--ILLNWPKEASFCLW 247 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHH-----HHHhhc----Chh--hhhcCHHHHHHHHH
Confidence 9999999999999999999999999999887654211 01111 111111 110 01122345678889
Q ss_pred cccCCCCCCCCHHHHHH
Q 041285 687 CILDEPSLRPSMKKVLL 703 (724)
Q Consensus 687 Cl~~~p~~RPs~~evl~ 703 (724)
||+.+|.+||+|.|+++
T Consensus 248 ~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hCCCChhhCcChHHHhh
Confidence 99999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-22 Score=207.69 Aligned_cols=162 Identities=22% Similarity=0.165 Sum_probs=125.4
Q ss_pred hcccccccCcCccceEEEEEee--CCcEEEEEEcccc-----cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI--NGKFVAVKRLQKM-----LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||+||++... +++.||||++... .....+.|.+|++++.+++|+|+++.+.. ....++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence 3455688999999999999875 4677899986532 11234569999999999999999853322 246799
Q ss_pred EEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCC-CCCCeeeCCCCCeEEccccCccccCCCCc-----
Q 041285 520 VYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDI-KPQNILMDENRYAKISDFALAKLMKPDQT----- 593 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dl-k~~NIll~~~~~~kl~Dfgl~~~~~~~~~----- 593 (724)
||||+++++|...........+.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+++.+.....
T Consensus 96 VmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~ 172 (365)
T PRK09188 96 VRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA 172 (365)
T ss_pred EEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh
Confidence 99999999997432222234578899999999998 9999999 99999999999999999999997754322
Q ss_pred --ceeeccccCccccCcccccCC
Q 041285 594 --RTFTGIRGTRGYVAPEWHWNL 614 (724)
Q Consensus 594 --~~~~~~~gt~~y~aPE~~~~~ 614 (724)
.......+++.|+|||.+...
T Consensus 173 ~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 173 AYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhhccCccCCcccCChh
Confidence 112345688899999998654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=191.09 Aligned_cols=238 Identities=25% Similarity=0.373 Sum_probs=177.0
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEccc--ccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+|..+|.+...|+.|+|++. |..+++|++.- ......++|..|.-.|+...||||+.++|.|....++.++..|||.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457888999999999995 44566676642 2233446899999999999999999999999999999999999999
Q ss_pred CChhhhcCCC---------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEc--cccCccccCCCCcce
Q 041285 527 GSLADVYSSP---------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS--DFALAKLMKPDQTRT 595 (724)
Q Consensus 527 gsL~~~l~~~---------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~--Dfgl~~~~~~~~~~~ 595 (724)
|+|..+|+.. ..+.++++|+|++|||+- .+-|.---|....|++|++.+++|+ |--++. .
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------q 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q 342 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence 9999998643 234488999999999986 3344455788999999999998875 222211 1
Q ss_pred eeccccCccccCcccccCCCCC---cccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FTGIRGTRGYVAPEWHWNLPIT---AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~---~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.....-.+.||+||.+...+-+ ..+|+|||+++||||.|...||....+-+... +...+| +..-+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialeg-lrv~i----- 410 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEG-LRVHI----- 410 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhcc-ccccC-----
Confidence 1112236789999999877643 57999999999999999999998655433211 111111 11112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
++.....+.+++.-|+.+||.+||.+..|+-+||+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 223344577788889999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=186.76 Aligned_cols=158 Identities=23% Similarity=0.242 Sum_probs=113.4
Q ss_pred CChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
|+|.+++.. ..+ ..+.||++||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 567777743 122 2378999999999987 3 999999999999999 99988654322
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH-
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL- 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~- 677 (724)
..|++.|+|||++.+..++.++||||||+++|||++|+.|+........ .+. .... +................
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~----~~~~-~~~~~~~~~~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILE----ILLN-GMPADDPRDRSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHH----HHHH-HhccCCccccccHHHHHh
Confidence 2578999999999999999999999999999999999999865332111 111 1111 11111000001111222
Q ss_pred -HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 -ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 -~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++..|++.+|++||++.|+++.+..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 258999999999999999999999988753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=160.72 Aligned_cols=69 Identities=36% Similarity=0.904 Sum_probs=62.3
Q ss_pred CCcceEEEEEccCCcEEEEEEecCCCCCceeEEecccCCCCCCcccCCCCCccccCCCCCCccCCCCCcccc
Q 041285 203 TEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPII 274 (724)
Q Consensus 203 ~~~~~~~~~l~~dG~l~~~~~~~~~~~~~W~~~~~~p~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~~ 274 (724)
+.+.++|++||.+|++++|.|.. ..+.|.+.|++|.|+||+|+.||+||+|+.+ ..|.|+||+||+|++
T Consensus 42 ~~s~~~r~~ld~~G~l~~~~w~~--~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 42 NSSVLSRLVLDSDGQLQRYIWNE--STQSWSVFWSAPKDQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred CCceEEEEEEeeeeEEEEEEEec--CCCcEEEEEEecccCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence 45788999999999999999985 4668999999999999999999999999865 578999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=191.91 Aligned_cols=208 Identities=26% Similarity=0.420 Sum_probs=155.2
Q ss_pred hcccCcCceeeeeeEEecccceEEEEeeccCCChhhhcCCCCcch--------HHHHHHHcccccccCCCce-EeCCCCC
Q 041285 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQI-IHCDIKP 566 (724)
Q Consensus 496 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~ia~~l~yLH~~~~~~i-~H~dlk~ 566 (724)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.....+. +.+|++||.|||+. +| .|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 467899999999999999999999999999999999996533222 67899999999987 44 8999999
Q ss_pred CCeeeCCCCCeEEccccCccccCC-CCcceeeccccCccccCcccccCCC-------CCcccceeehhHHHHHhhccccC
Q 041285 567 QNILMDENRYAKISDFALAKLMKP-DQTRTFTGIRGTRGYVAPEWHWNLP-------ITAKADVYSFGVVLLEIICCRRC 638 (724)
Q Consensus 567 ~NIll~~~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~Dv~S~Gvll~elltg~~p 638 (724)
+|++++....+||+|||+...... ..........-...|.|||.+.... .+.++||||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999887642 1111112223466899999987641 46789999999999999999999
Q ss_pred CCCCCCcchhcHHHHHHHHHHcCCccccccccccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 639 FDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK-KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 639 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
|......... .+.+.. +..+ ....+-+..... +....+..++..||.++|++||++.+|-..++....
T Consensus 158 ~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCCh--HHHHHH-HHhc-CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9875433221 122222 2221 111112221111 333469999999999999999999999998876544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=175.60 Aligned_cols=170 Identities=15% Similarity=0.142 Sum_probs=131.0
Q ss_pred HhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHH---------HHHHHHHhhcccCcCceeeeeeEEecc-
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGER---------EFQTEIKAIGRTHHRNLVRLLGYSFDV- 514 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~g~~~~~- 514 (724)
+-.....+.||.|+||.||.... ++..+|||.+........+ .+.+|++.+.+++|++|..+..+....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 34445567899999999999655 5778999999754322222 268999999999999999998885533
Q ss_pred -------cceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 515 -------SNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 515 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
...+++|||++|.+|.++... ......+++.+|..||+. +++|||+||+||+++.++ ++|+|||....
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~-~~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPEI-SEDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhhc-cHHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 357899999999999887432 234467999999999998 999999999999999888 99999999875
Q ss_pred cCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhh
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ell 633 (724)
...+... ..++....+..++|+|+||+.+.-+.
T Consensus 184 ~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 5322111 11334445667999999999987664
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=182.89 Aligned_cols=249 Identities=22% Similarity=0.227 Sum_probs=176.7
Q ss_pred hcccccccCcCccceEEEEEeeCC--cEEEEEEcccccchhHHHHHHHHHhhcccCc----CceeeeeeEE-ecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMING--KFVAVKRLQKMLAEGEREFQTEIKAIGRTHH----RNLVRLLGYS-FDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 519 (724)
.+.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 344568899999999999987653 4788887765433333378889999988863 5888888888 46677899
Q ss_pred EEeeccCCChhhhcCCCC-c--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-----CCeEEccccCc
Q 041285 520 VYEYMSNGSLADVYSSPP-K--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-----RYAKISDFALA 585 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-----~~~kl~Dfgl~ 585 (724)
||+.+ +.+|.++..... . .++.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 889998874333 1 1267999999999998 99999999999999754 46999999999
Q ss_pred c--ccCCCCc------ce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH
Q 041285 586 K--LMKPDQT------RT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656 (724)
Q Consensus 586 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~ 656 (724)
+ .+..... .. ....+||..|++++...+...+.+.|+||++.++.|++.|..|+........ ... +.+
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~-~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK-FEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH-HHH
Confidence 8 3322211 11 1235699999999999999999999999999999999999988855332211 111 111
Q ss_pred HHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......... .....+ ..+.++...+-..+..++|....+...|+..
T Consensus 252 ~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 DPRKLLTDR---FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred Hhhhhcccc---ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111110 111122 2344444445557999999999998887653
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-19 Score=155.05 Aligned_cols=89 Identities=28% Similarity=0.586 Sum_probs=75.4
Q ss_pred CCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCce---------------------eEEEEeecCCCCeeEecCC
Q 041285 16 NGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV---------------------GRIVLRSTEQGQDSIIADD 74 (724)
Q Consensus 16 ~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~---------------------g~l~l~~~~~~~~~~~~~~ 74 (724)
.++++|+|++|.|++|||++......+.+|||++++ .++ |+|+|. +.++.++|++++
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~S~~ 82 (116)
T cd00028 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIY-DGSGTVVWSSNT 82 (116)
T ss_pred CCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEE-cCCCcEEEEecc
Confidence 447799999999999999997654599999998875 222 889998 567789999987
Q ss_pred CC--cceEEEecCCccEEEEeCCCceEEeecCCC
Q 041285 75 SQ--SASSASMLDSGSFVLYDSDGKVIWQTFDHP 106 (724)
Q Consensus 75 ~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~P 106 (724)
+. ...+|+|+|+|||||++.++++||||||||
T Consensus 83 ~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 83 TRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred cCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 65 334899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=204.11 Aligned_cols=245 Identities=20% Similarity=0.224 Sum_probs=178.7
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEcc----c-ccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQ----K-MLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~----~-~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+|.|++|.|+...... .+..+.|... . ... .....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34679999999877766432 2333333221 1 111 111226668888888999999988888887777777799
Q ss_pred eccCCChhhhcCCC-C------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc--
Q 041285 523 YMSNGSLADVYSSP-P------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-- 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~-~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 593 (724)
|++. +|..++... . ...+.|+..|+.|||+. +|.|||||++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 998887553 1 11278999999999998 999999999999999999999999999987754433
Q ss_pred -ceeeccccCccccCcccccCCCCCc-ccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITA-KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~-k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.......|+..|+|||.+.+..+.+ ..||||.|+++..|++|+.||......+.... .....+.......+..
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhccccccccccChHH
Confidence 3445678999999999999999876 58999999999999999999976654433210 0000111111111112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+...++..+|+.+|.+|.+|++|++
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 33445667788999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=172.00 Aligned_cols=187 Identities=21% Similarity=0.342 Sum_probs=156.1
Q ss_pred cccccCcCccceEEEEE-eeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCC
Q 041285 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..++||+|.||.++.|+ +.++++||||.-.. .....+++.|.+..+.| ..+.|...+.|-.++.+-.||+|.+ |.
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 45789999999999997 45789999997554 23345788899888888 5789999998889999999999998 88
Q ss_pred ChhhhcCCCCcc--------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-----CCeEEccccCccccCCCCcc
Q 041285 528 SLADVYSSPPKN--------NLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-----RYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 528 sL~~~l~~~~~~--------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-----~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||.|++.-.... ++.|++.-++|+|++ .+|.|||||+|.||... ..+.|+|||+|+...+..+.
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 999988433222 267888899999998 99999999999999643 35899999999988765442
Q ss_pred e------eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 595 T------FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 595 ~------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
. .....||.+||+-....+++-+.+.|+-|+|-++...|-|..|+++.
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 2 23357999999999999999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-17 Score=176.09 Aligned_cols=246 Identities=28% Similarity=0.367 Sum_probs=184.6
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEcccccch---hHHHHHHHHHhhcccCcC-ceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHR-NLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++..++......++++|++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4567999999999999886 78899998764332 367899999999999888 79999999977777899999999
Q ss_pred CCChhhhcCCCC----c------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSSPP----K------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~~~----~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~ 594 (724)
++++.+++.... . ..+.+++.++.|+|.. +++|||+||+||+++... .++++|||++..+......
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999997765332 1 1267899999999998 899999999999999988 7999999999865443321
Q ss_pred -----eeeccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc--
Q 041285 595 -----TFTGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG-- 664 (724)
Q Consensus 595 -----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 664 (724)
......|+..|++||.+.. .......|+||+|++++++++|..|+...... .........+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCccc
Confidence 2345678999999999987 57889999999999999999999996544321 0001111222221111
Q ss_pred -ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 -QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 -~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....... .......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc-cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111100 02223567788888999999999999887753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-18 Score=162.89 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=178.4
Q ss_pred hhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCc-CceeeeeeEEecccceEEEEee
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH-RNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 523 (724)
-.+...++||.|+||.+|.|.. .+|++||||.-+... ...++.-|..+...|+| ..|..+..|..+...-.+||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 3455668999999999999975 569999999766532 33467889999999975 6888888889999999999999
Q ss_pred ccCCChhhhcCCCCcc----h----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCccccCCCC
Q 041285 524 MSNGSLADVYSSPPKN----N----LIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~----~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~~~~~~~ 592 (724)
+ +.||.+++.-.... . +-|++.-++|+|.. +++||||||+|.|..-+ ..+.++|||+++.+.+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 88999987432222 1 55888899999998 99999999999999643 458899999999875443
Q ss_pred cc------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 593 TR------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 593 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
+. ......||.+|.+-....+...+.+.|+-|+|.+|....-|..|++......... ..+.+.+..+...
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----KyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----KYEKISEKKMSTP 244 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH----HHHHHHHhhcCCC
Confidence 32 2234679999999988888888999999999999999999999998754433222 1222322222211
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+.. .....+.++...+..|-...-++-|...-+.++
T Consensus 245 ie~--LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 245 IEV--LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred HHH--HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 111 111123345555556666666666766544443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-19 Score=153.88 Aligned_cols=77 Identities=43% Similarity=0.641 Sum_probs=58.9
Q ss_pred eeEEEEeecCCCCeeEec-CCCCc---ceEEEecCCccEEEEeCCCceEEeecCCCcccccccCcccc----C--Ceecc
Q 041285 55 VGRIVLRSTEQGQDSIIA-DDSQS---ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLA----G--MELFP 124 (724)
Q Consensus 55 ~g~l~l~~~~~~~~~~~~-~~~~~---~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~----~--~~L~s 124 (724)
.|+|+|. +..+..+|++ ++... ...|+|+|+|||||+|..+++|||||||||||+||+|+|+. + ..|+|
T Consensus 28 dGnLvl~-~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~s 106 (114)
T PF01453_consen 28 DGNLVLY-DSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTS 106 (114)
T ss_dssp TSEEEEE-ETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSSS-EEEEEET--TSEEEEESTSSEE
T ss_pred CCeEEEE-cCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCCccEEEeccCcccCCCccccceEEe
Confidence 3899998 5567789999 54432 45999999999999999999999999999999999999976 3 45999
Q ss_pred CCCCCCCC
Q 041285 125 GISKTDPS 132 (724)
Q Consensus 125 ~~s~~dps 132 (724)
|++.+|||
T Consensus 107 w~s~~dps 114 (114)
T PF01453_consen 107 WSSNTDPS 114 (114)
T ss_dssp EESS----
T ss_pred ECCCCCCC
Confidence 99999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=159.28 Aligned_cols=183 Identities=15% Similarity=0.105 Sum_probs=137.3
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccch----hHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE----GEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
...|++|+||+||.+.- ++..++.+.+.....- ....|.+|+++|++|+ |+++++++++ ...+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997665 6777887777653221 1125889999999995 5889999886 45799999999
Q ss_pred CCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCC-CCCCeeeCCCCCeEEccccCccccCCCCcc----e---e-
Q 041285 526 NGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDI-KPQNILMDENRYAKISDFALAKLMKPDQTR----T---F- 596 (724)
Q Consensus 526 ~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dl-k~~NIll~~~~~~kl~Dfgl~~~~~~~~~~----~---~- 596 (724)
+.+|...+.......+.+++++|.++|+. +|+|||| ||.|||++.++.++|+|||++......... . .
T Consensus 82 G~~L~~~~~~~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 82 GAAMYQRPPRGDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred CccHHhhhhhhhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 99997665433334577899999999998 9999999 799999999999999999999865433210 0 0
Q ss_pred ----eccccCccccCcccccCC-CCC-cccceeehhHHHHHhhccccCCCC
Q 041285 597 ----TGIRGTRGYVAPEWHWNL-PIT-AKADVYSFGVVLLEIICCRRCFDQ 641 (724)
Q Consensus 597 ----~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~S~Gvll~elltg~~p~~~ 641 (724)
.-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+...
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 012356777777643221 233 567899999999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-17 Score=161.66 Aligned_cols=132 Identities=19% Similarity=0.273 Sum_probs=97.8
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccch--h-------HHHH-----------------HHHHHhhcccCcCcee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE--G-------EREF-----------------QTEIKAIGRTHHRNLV 505 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~h~niv 505 (724)
..||+|+||.||+|...+|+.||||.++..... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999998753211 0 1122 3499999999877764
Q ss_pred eeeeEEecccceEEEEeeccCCChhhh-cCCC--Cc----chHHHHHHHcccc-cccCCCceEeCCCCCCCeeeCCCCCe
Q 041285 506 RLLGYSFDVSNKILVYEYMSNGSLADV-YSSP--PK----NNLIGIARGILYL-HDECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 506 ~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~--~~----~~~~~ia~~l~yL-H~~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
....+. ....++||||++++++... +... .. ..+.+++.+|.|| |+. +|+||||||+|||++ ++.+
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcE
Confidence 333222 2234899999998877544 2221 11 2267899999999 676 999999999999998 4789
Q ss_pred EEccccCccccC
Q 041285 578 KISDFALAKLMK 589 (724)
Q Consensus 578 kl~Dfgl~~~~~ 589 (724)
+|+|||++....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-17 Score=145.12 Aligned_cols=87 Identities=25% Similarity=0.536 Sum_probs=73.2
Q ss_pred CCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCce---------------------eEEEEeecCCCCeeEecCC
Q 041285 16 NGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNV---------------------GRIVLRSTEQGQDSIIADD 74 (724)
Q Consensus 16 ~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~---------------------g~l~l~~~~~~~~~~~~~~ 74 (724)
.++++|+|+++.|++|||.+... ..+.+|||++.+ +++ |+|+|. +..|.++|++++
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~S~t 81 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLY-DGDGRVVWSSNT 81 (114)
T ss_pred CCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEE-eCCCCEEEEecc
Confidence 44779999999999999998765 589999998765 222 889998 566789999987
Q ss_pred C--CcceEEEecCCccEEEEeCCCceEEeecCC
Q 041285 75 S--QSASSASMLDSGSFVLYDSDGKVIWQTFDH 105 (724)
Q Consensus 75 ~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 105 (724)
. ....+|+|+|+|||||++..+++|||||||
T Consensus 82 ~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 82 TGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred cCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 6 333489999999999999999999999997
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.1e-17 Score=156.50 Aligned_cols=134 Identities=17% Similarity=0.198 Sum_probs=101.8
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccch---------------------h-----HHHHHHHHHhhcccCcCce
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE---------------------G-----EREFQTEIKAIGRTHHRNL 504 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 504 (724)
...||+|++|.||+|...+|+.||||.++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998753210 0 1124578999999999887
Q ss_pred eeeeeEEecccceEEEEeeccCCChhhh-cCCCC------cchHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCC
Q 041285 505 VRLLGYSFDVSNKILVYEYMSNGSLADV-YSSPP------KNNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRY 576 (724)
Q Consensus 505 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~------~~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~ 576 (724)
.....+... ..++||||++++++... +.... ...+.+++.++.+||+ . +|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence 544433332 34899999998855332 32221 1236899999999998 7 999999999999998 889
Q ss_pred eEEccccCccccCC
Q 041285 577 AKISDFALAKLMKP 590 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~ 590 (724)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-18 Score=189.40 Aligned_cols=240 Identities=25% Similarity=0.310 Sum_probs=168.9
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEccccc-chhHHHHHHHHHh--hcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML-AEGEREFQTEIKA--IGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
..+.+.||++.|=.|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-......|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345678999999999999998877 8889875432 3344555554443 44558999999887766666778888887
Q ss_pred cCCChhhhcCCCCc------c-hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc--CCCCcce
Q 041285 525 SNGSLADVYSSPPK------N-NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM--KPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~~------~-~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~--~~~~~~~ 595 (724)
. .+|.|.+...+. + ++.|++.||..+|.. +|+|||||.+|||++.-..+.|+||.--+.. ..++...
T Consensus 104 k-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 104 K-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred h-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 4 477777765432 1 278999999999998 9999999999999999999999999887643 2222221
Q ss_pred ----eeccccCccccCcccccCC----------C-CCcccceeehhHHHHHhhcc-ccCCCCCCCcchhcHHHHHHHHHH
Q 041285 596 ----FTGIRGTRGYVAPEWHWNL----------P-ITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 596 ----~~~~~gt~~y~aPE~~~~~----------~-~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
+...+.-..|+|||-+... . .+++-||||+||++.||++- +++|... .+-. ++
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a-----Yr 248 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA-----YR 248 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh-----Hh
Confidence 2223345589999976541 2 57789999999999999885 5555421 0111 11
Q ss_pred cCC---ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 660 NGN---LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 660 ~~~---~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+. ...++. .-+...+.++++.|++.||++|.|+++.++.-.|.
T Consensus 249 ~~~~~~~e~~Le-----~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGNADDPEQLLE-----KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCccCHHHHHH-----hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111 000110 01112578899999999999999999999885553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=154.71 Aligned_cols=129 Identities=18% Similarity=0.246 Sum_probs=100.4
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-----CcCceeeeeeEEeccc---c-eEEEEe
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-----HHRNLVRLLGYSFDVS---N-KILVYE 522 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lv~e 522 (724)
+.||+|+||.||. .++....+||++........+++.+|++++.++ .||||++++|++.+.. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 433333478887654344567899999999999 5799999999998864 3 237899
Q ss_pred e--ccCCChhhhcCCCCcc----hHHHHHHHc-ccccccCCCceEeCCCCCCCeeeCC----CCCeEEccccCc
Q 041285 523 Y--MSNGSLADVYSSPPKN----NLIGIARGI-LYLHDECESQIIHCDIKPQNILMDE----NRYAKISDFALA 585 (724)
Q Consensus 523 ~--~~~gsL~~~l~~~~~~----~~~~ia~~l-~yLH~~~~~~i~H~dlk~~NIll~~----~~~~kl~Dfgl~ 585 (724)
| +++++|.+++...... .+.+++.++ +|||++ +|+||||||+|||++. +..++|+||+-+
T Consensus 86 ~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5689999999643211 256778777 899998 9999999999999974 347999995443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.7e-17 Score=172.23 Aligned_cols=178 Identities=26% Similarity=0.283 Sum_probs=145.8
Q ss_pred cCcCccceEEEEEe----eCCcEEEEEEcccccchh--HHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccC
Q 041285 454 IGRGSSGTVYKGTM----INGKFVAVKRLQKMLAEG--EREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 454 lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+|+|.||.|+.... ..+..+|+|.+.+..... ......|..++..++ ||.+|++...+......+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999987643 246678888776532111 114566788888886 99999999999999999999999999
Q ss_pred CChhhhcCCCCcch-------HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPPKNN-------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~~~~-------~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
|.|...+....... ...+|-++.++|+. +|+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 99988876543322 56788899999998 9999999999999999999999999999875433222
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCC
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ 641 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~ 641 (724)
.||..|||||++. .....+|.||||++++||++|-.||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 6899999999998 667899999999999999999999976
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=149.72 Aligned_cols=136 Identities=23% Similarity=0.248 Sum_probs=107.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccc----------------------hhHHHHHHHHHhhcccCcCc--
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA----------------------EGEREFQTEIKAIGRTHHRN-- 503 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-- 503 (724)
..+.+.||+|+||.||++...+|+.||||++..... .....+..|...+.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 445688999999999999988899999998653210 01123667888898888774
Q ss_pred eeeeeeEEecccceEEEEeeccCCChhhhcC-CCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYS-SPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 504 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
++..++ ....++||||+++++|..... ......+.++++++.++|+. +++|+||||+||++++++.++|+||
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDf 169 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDW 169 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEEC
Confidence 444443 235589999999999988765 44445578999999999997 9999999999999999999999999
Q ss_pred cCccccCC
Q 041285 583 ALAKLMKP 590 (724)
Q Consensus 583 gl~~~~~~ 590 (724)
|++.....
T Consensus 170 g~~~~~~~ 177 (198)
T cd05144 170 PQMVSTDH 177 (198)
T ss_pred CccccCCC
Confidence 99975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-15 Score=150.69 Aligned_cols=131 Identities=24% Similarity=0.306 Sum_probs=109.8
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccc--------hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA--------EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.||+|++|.||+|.. .+..++||+...... .....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 677899997653211 1124578899999999999998888887777888999999
Q ss_pred ccCCChhhhcCCCCc---chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 524 MSNGSLADVYSSPPK---NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~---~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+++++|.+++..... ..+.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998865443 4477899999999998 999999999999999 78899999999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.61 E-value=1e-15 Score=154.64 Aligned_cols=219 Identities=21% Similarity=0.245 Sum_probs=138.1
Q ss_pred ccccCcCccceEEEEEeeC-CcEEEEEEccc---ccchhHHHHHHHHHhhcccCc----------CceeeeeeEEe----
Q 041285 451 KEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHH----------RNLVRLLGYSF---- 512 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~---- 512 (724)
.+.||.|+++.||.++..+ ++++|||.... ......+++++|.-.+..+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4679999999999999865 89999998753 223445678888766666432 22222222211
Q ss_pred -----ccc--------ceEEEEeeccCCChhhhcCC-----CC-cch--------HHHHHHHcccccccCCCceEeCCCC
Q 041285 513 -----DVS--------NKILVYEYMSNGSLADVYSS-----PP-KNN--------LIGIARGILYLHDECESQIIHCDIK 565 (724)
Q Consensus 513 -----~~~--------~~~lv~e~~~~gsL~~~l~~-----~~-~~~--------~~~ia~~l~yLH~~~~~~i~H~dlk 565 (724)
... ..+++|+-+ .++|.+++.. .. ... ..|+++.+++||.. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 235667766 6688776521 11 111 36788999999998 99999999
Q ss_pred CCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCC--------CCCcccceeehhHHHHHhhcccc
Q 041285 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL--------PITAKADVYSFGVVLLEIICCRR 637 (724)
Q Consensus 566 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~k~Dv~S~Gvll~elltg~~ 637 (724)
|+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.+++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999887654321111 2345789999976432 46889999999999999999999
Q ss_pred CCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCC
Q 041285 638 CFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLR 695 (724)
Q Consensus 638 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 695 (724)
|++.......... +-.... +..+.+..++..+|+.+|.+|
T Consensus 249 Pf~~~~~~~~~~~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986532211100 111223 566778889999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-15 Score=149.23 Aligned_cols=130 Identities=25% Similarity=0.355 Sum_probs=107.1
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEccccc--------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.||+|++|.||+|.. ++..+++|...... .....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 67889999854321 112356788999999999887666666666667789999999
Q ss_pred cCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 525 SNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
++++|.+++.......+.+++++|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987554335688999999999998 999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.9e-15 Score=152.29 Aligned_cols=190 Identities=21% Similarity=0.245 Sum_probs=129.2
Q ss_pred CcCceeeeeeEEec---------------------------ccceEEEEeeccCCChhhhcCCCCcc------hHHHHHH
Q 041285 500 HHRNLVRLLGYSFD---------------------------VSNKILVYEYMSNGSLADVYSSPPKN------NLIGIAR 546 (724)
Q Consensus 500 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~ia~ 546 (724)
+|||||+++++|.+ ...+|+||... ..+|..++...... ++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 69999999887643 23468888877 45888888443222 2679999
Q ss_pred HcccccccCCCceEeCCCCCCCeee--CCCC--CeEEccccCccccCCC-----CcceeeccccCccccCcccccCCCC-
Q 041285 547 GILYLHDECESQIIHCDIKPQNILM--DENR--YAKISDFALAKLMKPD-----QTRTFTGIRGTRGYVAPEWHWNLPI- 616 (724)
Q Consensus 547 ~l~yLH~~~~~~i~H~dlk~~NIll--~~~~--~~kl~Dfgl~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~- 616 (724)
|+.|||.+ +|.|||||.+|||+ ++|. ...|+|||++.-.... .....-...|....||||+....+-
T Consensus 353 av~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 353 AVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999998 99999999999999 4443 4789999997533211 0111112346778899998765431
Q ss_pred -----CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCC
Q 041285 617 -----TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDE 691 (724)
Q Consensus 617 -----~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~ 691 (724)
-.|+|.|+.|.+.||+++...||.... +....... +.+.+++.+-+ .....+.+++...++.|
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~-----Yqe~qLPalp~------~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRT-----YQESQLPALPS------RVPPVARQLVFDLLKRD 497 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhh-----hhhhhCCCCcc------cCChHHHHHHHHHhcCC
Confidence 248999999999999999999997622 11111111 22333333322 12334677888889999
Q ss_pred CCCCCCHHHHHHHh
Q 041285 692 PSLRPSMKKVLLML 705 (724)
Q Consensus 692 p~~RPs~~evl~~L 705 (724)
|.+||+..-....|
T Consensus 498 pskRvsp~iAANvl 511 (598)
T KOG4158|consen 498 PSKRVSPNIAANVL 511 (598)
T ss_pred ccccCCccHHHhHH
Confidence 99999976554444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-15 Score=169.23 Aligned_cols=132 Identities=21% Similarity=0.341 Sum_probs=107.1
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEccccc-------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKML-------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.||+|+||+||+|.+.+...++.+++.+.. ....+.+.+|++++.+++|++++....++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 57899999999999987554433322222211 11235688999999999999999888888887788999999
Q ss_pred ccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 524 MSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+++++|.+++. .....+.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~-~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE-GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH-HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999886 2334578999999999998 99999999999999 678899999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.6e-15 Score=146.67 Aligned_cols=132 Identities=20% Similarity=0.206 Sum_probs=101.0
Q ss_pred cccccCcCccceEEEEE--eeCCcEEEEEEcccccch------------------------hHHHHHHHHHhhcccCcC-
Q 041285 450 FKEEIGRGSSGTVYKGT--MINGKFVAVKRLQKMLAE------------------------GEREFQTEIKAIGRTHHR- 502 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h~- 502 (724)
+.+.||+|++|.||+|. ..+|+.||||.++..... ....+..|++.+.++.+.
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 567999999988642110 012356899999999753
Q ss_pred -ceeeeeeEEecccceEEEEeeccCCChhhhc-CCCC------cchHHHHHHHcccccccCCCc-eEeCCCCCCCeeeCC
Q 041285 503 -NLVRLLGYSFDVSNKILVYEYMSNGSLADVY-SSPP------KNNLIGIARGILYLHDECESQ-IIHCDIKPQNILMDE 573 (724)
Q Consensus 503 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l-~~~~------~~~~~~ia~~l~yLH~~~~~~-i~H~dlk~~NIll~~ 573 (724)
.+.+++++ ...++||||+++.+|.... .... ...+.+++.++.+||+. + ++||||||+||+++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~- 183 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH- 183 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-
Confidence 34444443 2358999999998887654 2211 13478999999999998 8 99999999999999
Q ss_pred CCCeEEccccCccccC
Q 041285 574 NRYAKISDFALAKLMK 589 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~ 589 (724)
++.++|+|||++....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.5e-15 Score=168.91 Aligned_cols=191 Identities=25% Similarity=0.296 Sum_probs=143.3
Q ss_pred HHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC---cCceeeeeeEEecccceE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 518 (724)
++...+..+...||+|+||+||+|...+|+.||+|.-+.... -+|.--.+++.||+ -+-|+.+.....-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344445556788999999999999998899999998664322 22333333444444 122333333344456778
Q ss_pred EEEeeccCCChhhhcCCC---Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeC-------CCCCeEEccccC
Q 041285 519 LVYEYMSNGSLADVYSSP---PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMD-------ENRYAKISDFAL 584 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~---~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-------~~~~~kl~Dfgl 584 (724)
||+||.+.|+|.+++... .+. .+.++++.+..||.. +|||+||||+|.||. +...++|+|||.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999999632 122 268999999999998 999999999999994 244699999999
Q ss_pred ccccCCC-CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccC
Q 041285 585 AKLMKPD-QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC 638 (724)
Q Consensus 585 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p 638 (724)
+..+.-- +...+....+|-.+-.+|...+++.+...|.|.++.+++-||.|+..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9754321 12345567788999999999999999999999999999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-15 Score=157.06 Aligned_cols=162 Identities=23% Similarity=0.348 Sum_probs=119.0
Q ss_pred ceEEEEeeccCCChhhhcCCCC----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCc
Q 041285 516 NKILVYEYMSNGSLADVYSSPP----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
.+++.|+++...+|.+++.... ..++.|++.++.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 4688999999999999995321 1226788889989 4 8899999999999999999999999998
Q ss_pred cccCCCC-----cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 586 KLMKPDQ-----TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 586 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
....... ....+...||..||+||.+.+..++.|+||||||+||+||+. -...++. ......+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8765444 233455689999999999999999999999999999999987 1211110 11223344
Q ss_pred cCCccc-cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 041285 660 NGNLGQ-LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 660 ~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
++.++. .+.. .+ .-..+.++++...|.+||+..+
T Consensus 474 ~g~ip~~~~~d---~p----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIPPEFLQD---YP----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCChHHhhc---Cc----HHHHHHHHhcCCCcccCchHHH
Confidence 454441 1111 11 2345777889999999994443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.7e-14 Score=136.62 Aligned_cols=131 Identities=23% Similarity=0.303 Sum_probs=94.0
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccch--hHHHH----------------------HHHHHhhcccCcC--ce
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE--GEREF----------------------QTEIKAIGRTHHR--NL 504 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~h~--ni 504 (724)
.+.||+|+||.||++...+++.||||++...... ....+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 11111 3455555555433 23
Q ss_pred eeeeeEEecccceEEEEeeccCC-----ChhhhcC-CCCcchHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCe
Q 041285 505 VRLLGYSFDVSNKILVYEYMSNG-----SLADVYS-SPPKNNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYA 577 (724)
Q Consensus 505 v~l~g~~~~~~~~~lv~e~~~~g-----sL~~~l~-~~~~~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~ 577 (724)
.+.+++ ...++||||++++ .|.+... ......+.+++.++.++|. . +|+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcE
Confidence 444432 3468999999994 4444333 2233447889999999998 6 999999999999999 8899
Q ss_pred EEccccCccccC
Q 041285 578 KISDFALAKLMK 589 (724)
Q Consensus 578 kl~Dfgl~~~~~ 589 (724)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=137.62 Aligned_cols=132 Identities=17% Similarity=0.216 Sum_probs=104.3
Q ss_pred cccC-cCccceEEEEEeeCCcEEEEEEccccc-------------chhHHHHHHHHHhhcccCcCce--eeeeeEEeccc
Q 041285 452 EEIG-RGSSGTVYKGTMINGKFVAVKRLQKML-------------AEGEREFQTEIKAIGRTHHRNL--VRLLGYSFDVS 515 (724)
Q Consensus 452 ~~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~ 515 (724)
..|| .||.|+||+.... +..++||+..... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999874 6788998775310 1223467889999999998775 67777654432
Q ss_pred ----ceEEEEeeccC-CChhhhcCCC--CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 516 ----NKILVYEYMSN-GSLADVYSSP--PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 516 ----~~~lv~e~~~~-gsL~~~l~~~--~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
..++|+|++++ .+|.+++... ....+.+|+++|.+||+. +|+|+||||.|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 23599999997 6898887543 333478999999999998 999999999999999988999999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-13 Score=127.35 Aligned_cols=133 Identities=17% Similarity=0.174 Sum_probs=109.5
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCc--CceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH--RNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.||+|.++.||++...+ ..++||....... ...+.+|+..+..++| .++++++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 579999999999999854 7899998865432 4678999999999976 5899999988888889999999999887
Q ss_pred hhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 530 ADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 530 ~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
..+-.......+.++++++++||.....+++|+|++|+||++++.+.+++.||+.+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7651111122367899999999986555799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.3e-13 Score=153.21 Aligned_cols=203 Identities=23% Similarity=0.286 Sum_probs=132.3
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
+.|..|++|.||..+++. .+.+|+| +.+.. --+++ ++.....|.+| |+=.
T Consensus 89 klisngAygavylvrh~~trqrfa~k-iNkq~----lilRn---ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN---ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc---cccccCCccee---------------------chhh
Confidence 578999999999998764 4567774 33210 00111 22222333333 2222
Q ss_pred hhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC------------Cccee--
Q 041285 531 DVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD------------QTRTF-- 596 (724)
Q Consensus 531 ~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~------------~~~~~-- 596 (724)
..++... ..-.+.+.+++|||+. +|+|||+||+|.+|+.=+.+|+.|||+.+..... +.+.+
T Consensus 140 tllk~~g-~lPvdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 140 TLLKNIG-PLPVDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred hhcccCC-CCcchhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 2222111 1112347899999998 9999999999999999999999999998753211 11111
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
..+.||+.|.|||++....|...+|.|++|+|+||.+-|..||....+++- +...+.+ .+.-.+.+...
T Consensus 216 KqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd-----~i~wpE~dea~ 284 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISD-----DIEWPEEDEAL 284 (1205)
T ss_pred ccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhh-----hccccccCcCC
Confidence 225799999999999999999999999999999999999999987654321 1111111 00001112222
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 041285 677 LERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
..++.+++.+.++.+|..|---
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhccc
Confidence 3446677777899999999643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.6e-13 Score=154.77 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=174.4
Q ss_pred ccccccCcCccceEEEEEeeC--CcEEEEEEccccc--chhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN--GKFVAVKRLQKML--AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 345669999999998776543 3456777665432 122233444676666775 99999999999999999999999
Q ss_pred ccCCChhhhc-CCCC--------cchHHHHHHHccccc-ccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCC-C
Q 041285 524 MSNGSLADVY-SSPP--------KNNLIGIARGILYLH-DECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKP-D 591 (724)
Q Consensus 524 ~~~gsL~~~l-~~~~--------~~~~~~ia~~l~yLH-~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~-~ 591 (724)
..++++.+.+ .... ...+.++..++.|+| +. ++.|+|+||+|.+++..+ ..|++|||+|..+.. +
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999998887 3221 112779999999999 76 999999999999999999 999999999988766 3
Q ss_pred Cc-ceeecccc-CccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 592 QT-RTFTGIRG-TRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 592 ~~-~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
.. .......| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++........ ...|.... +....
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~~~~--- 252 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GRFTQ--- 252 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---ccccc---
Confidence 32 33334567 9999999998885 4467899999999999999999998765543321 11111110 00000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
...........++...++..+|..|.+.+++.
T Consensus 253 --~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 253 --LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --CccccCChhhhhcccccccCCchhcccccccc
Confidence 01112223466677778889999999988774
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.4e-13 Score=104.57 Aligned_cols=58 Identities=26% Similarity=0.496 Sum_probs=50.2
Q ss_pred CCCceeeeccccccCcchhhc-ccchHHhHHHHhhcCCccccccccC----cccccccccccc
Q 041285 292 SNKAIEELKNTVWEDVSYSVL-SKTTEQNCQEACLKDCNCEAALYKD----EECKMQRLPLRF 349 (724)
Q Consensus 292 ~~~~f~~l~~~~~~~~~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~~----~~C~~~~~~l~~ 349 (724)
++++|+++++|++|++..... ...++++|++.||+||||+||+|.+ ++|++|.+.|.+
T Consensus 3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 467999999999999866553 5689999999999999999999974 579999988865
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.2e-12 Score=136.32 Aligned_cols=135 Identities=21% Similarity=0.283 Sum_probs=95.1
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchh----------------------------------------HHHHHH
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG----------------------------------------EREFQT 491 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~ 491 (724)
+.||.|++|.||+|++.+|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 3699999999999999999999999876431110 112455
Q ss_pred HHHhhcccC----cCceeeeeeEEec-ccceEEEEeeccCCChhhhcCCC----C-cchHHHHHH-HcccccccCCCceE
Q 041285 492 EIKAIGRTH----HRNLVRLLGYSFD-VSNKILVYEYMSNGSLADVYSSP----P-KNNLIGIAR-GILYLHDECESQII 560 (724)
Q Consensus 492 E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~----~-~~~~~~ia~-~l~yLH~~~~~~i~ 560 (724)
|.+.+.++. |.+-+.+-..+.+ ....+|||||++|++|.++.... . ...+..+++ .+..+|.. +++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~---g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD---GFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---Cce
Confidence 655555542 3333333333332 34579999999999998876321 1 122344444 35667876 999
Q ss_pred eCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 561 HCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 561 H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
|+|+||.||+++.++.++++|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.8e-11 Score=121.34 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=128.7
Q ss_pred HHhhcccCcCceeeeeeEEecc-----cceEEEEeeccCCChhhhcCCC----------Ccc-hHHHHHHHcccccccCC
Q 041285 493 IKAIGRTHHRNLVRLLGYSFDV-----SNKILVYEYMSNGSLADVYSSP----------PKN-NLIGIARGILYLHDECE 556 (724)
Q Consensus 493 ~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----------~~~-~~~~ia~~l~yLH~~~~ 556 (724)
...|-++-|.|||+++.|..+. .+..++.|||.-|+|..+|++. .|+ +..||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 4455566799999999987653 3568999999999999999542 222 26799999999998 47
Q ss_pred CceEeCCCCCCCeeeCCCCCeEEccccCcccc---CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhh
Q 041285 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLM---KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633 (724)
Q Consensus 557 ~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ell 633 (724)
+.|+|+++..+.|++..++-+||.--.-.... ..-.........+-++|.+||+=.....+..+|||+||+-.+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999998887532111110 000011112235678999999877777888999999999999997
Q ss_pred ccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 634 CCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 634 tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+.-..... +......+-....+. .+..-+ =...+..|++.+|..||+|++++.
T Consensus 277 ilEiq~tns--eS~~~~ee~ia~~i~--~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNS--ESKVEVEENIANVII--GLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCC--cceeehhhhhhhhee--eccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 766432111 010000000000000 000111 124566799999999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-11 Score=111.86 Aligned_cols=130 Identities=18% Similarity=0.191 Sum_probs=97.0
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCcee-eeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLV-RLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
+.|+.|.++.||++... ++.+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999874 77899998765321 233567899999988655544 444443 23458999999999887
Q ss_pred hhcCCCCcchHHHHHHHcccccccC--CCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 531 DVYSSPPKNNLIGIARGILYLHDEC--ESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 531 ~~l~~~~~~~~~~ia~~l~yLH~~~--~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
.. .......+.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~-~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 54 2222334778999999999873 23469999999999999 66899999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-11 Score=99.98 Aligned_cols=71 Identities=21% Similarity=0.437 Sum_probs=59.4
Q ss_pred CceeeeccccccCcchhhcccchHHhHHHHhhcCCccccccccC--cccccccccccccccccCCCcceeeecc
Q 041285 294 KAIEELKNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAALYKD--EECKMQRLPLRFGRRKLSDSDIAFIKVD 365 (724)
Q Consensus 294 ~~f~~l~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~~l~~~~~~~~~~~~~~lkv~ 365 (724)
..|..++++++|+..+.. ...++++|++.||+||+|+||+|.+ ++|++|..++.+.+.....+...|||++
T Consensus 12 ~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 489999999999887665 6778999999999999999999974 7899999888876654444578888873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.7e-11 Score=127.50 Aligned_cols=244 Identities=21% Similarity=0.195 Sum_probs=173.6
Q ss_pred HHHHHhhcccccccCc--CccceEEEEEe---eCCcEEEEEEcccccc--hhHHHHHHHHHhhccc-CcCceeeeeeEEe
Q 041285 441 AELEKMTDGFKEEIGR--GSSGTVYKGTM---INGKFVAVKRLQKMLA--EGEREFQTEIKAIGRT-HHRNLVRLLGYSF 512 (724)
Q Consensus 441 ~el~~~t~~f~~~lg~--G~~g~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 512 (724)
.+..+...++.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....++ .|+|.++......
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 4555666677788999 99999999987 3567899997443222 3333445677777777 5999999888888
Q ss_pred cccceEEEEeeccCCChhhhcCC--------CCcchHHHHHH----HcccccccCCCceEeCCCCCCCeeeCCC-CCeEE
Q 041285 513 DVSNKILVYEYMSNGSLADVYSS--------PPKNNLIGIAR----GILYLHDECESQIIHCDIKPQNILMDEN-RYAKI 579 (724)
Q Consensus 513 ~~~~~~lv~e~~~~gsL~~~l~~--------~~~~~~~~ia~----~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl 579 (724)
..+..++-+|++. .+|..+-.. ..|....+..+ |+.++|.. .++|-|+||.||++..+ ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 9999999999985 677666532 23334556666 99999998 99999999999999999 88999
Q ss_pred ccccCccccCCCCc----ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH
Q 041285 580 SDFALAKLMKPDQT----RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY 655 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~ 655 (724)
+|||+...+..... .......|...|++||... +.++.++|+|++|.++++..++.......... .|
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W-- 335 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW-- 335 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--
Confidence 99999988765442 1122235788899999774 55688999999999999999988765433111 11
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
.. +.....+.++......++.....++++++|..|++.+.+.
T Consensus 336 ~~-----~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 SQ-----LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc-----cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 1111122222212223344477789999999999887665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-10 Score=126.52 Aligned_cols=136 Identities=17% Similarity=0.197 Sum_probs=89.4
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccchh----------------------------------------HHHHH
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEG----------------------------------------EREFQ 490 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------------~~~~~ 490 (724)
+.||+|++|.||++++++ |+.||||+++....+. +-+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 369999999999999988 9999999987432110 11244
Q ss_pred HHHHhhcccC----cCceeeeeeEEec-ccceEEEEeeccCCChhhhc--CCCCc---chHHHHHHH-cccccccCCCce
Q 041285 491 TEIKAIGRTH----HRNLVRLLGYSFD-VSNKILVYEYMSNGSLADVY--SSPPK---NNLIGIARG-ILYLHDECESQI 559 (724)
Q Consensus 491 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~---~~~~~ia~~-l~yLH~~~~~~i 559 (724)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++- ..... ..+...++. +..++.. ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~---Gf 281 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRD---GF 281 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4554444442 3333443333333 44678999999999998752 22111 111111111 2223333 99
Q ss_pred EeCCCCCCCeeeCCCC----CeEEccccCccccCC
Q 041285 560 IHCDIKPQNILMDENR----YAKISDFALAKLMKP 590 (724)
Q Consensus 560 ~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~~~ 590 (724)
+|+|+||.||+++.++ .+++.|||+...+..
T Consensus 282 fHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 282 FHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred eeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 9999999999999887 899999999987643
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-10 Score=93.18 Aligned_cols=66 Identities=14% Similarity=0.183 Sum_probs=55.6
Q ss_pred CCceeeeccccccCcchhhcccchHHhHHHHhhc---CCccccccccC--cccccccccc-cccccccCCCcceeee
Q 041285 293 NKAIEELKNTVWEDVSYSVLSKTTEQNCQEACLK---DCNCEAALYKD--EECKMQRLPL-RFGRRKLSDSDIAFIK 363 (724)
Q Consensus 293 ~~~f~~l~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~--~~C~~~~~~l-~~~~~~~~~~~~~~lk 363 (724)
+++|+.+.++++|++.. .++++|+++|++ ||||+||+|.+ .+|.+|...+ .+.+.....+..+|+|
T Consensus 8 ~g~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 8 AGTTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred CCeEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 46799999999998765 578999999999 99999999964 5799999999 7777665556777876
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.2e-09 Score=99.43 Aligned_cols=130 Identities=22% Similarity=0.362 Sum_probs=102.1
Q ss_pred ccCcCccceEEEEEeeCCcEEEEE-Ecccccc-------hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVK-RLQKMLA-------EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+++|+-+.+|.+.+.+ ..+++| ++++..+ -......+|+.++.+++--.|.-..-+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57889999999997743 345555 3433211 11235678999999987666666666778888899999999
Q ss_pred cCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 525 SNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 525 ~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
++..|.+.+.......+..|-+-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhcchHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999777555677788888899998 999999999999998775 99999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-09 Score=115.39 Aligned_cols=161 Identities=17% Similarity=0.209 Sum_probs=119.6
Q ss_pred eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChhhhcCCCCcch----HHH
Q 041285 468 INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN----LIG 543 (724)
Q Consensus 468 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~ 543 (724)
.++.+|.|...+...........+.++.++.++||||++++.........|||+|-+ ..|..+++...... +.|
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELGKEEVCLGLFQ 112 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhHHHHHHHHHHH
Confidence 457888888877644433455778899999999999999999999999999999987 34566665444322 789
Q ss_pred HHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCccccee
Q 041285 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623 (724)
Q Consensus 544 ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 623 (724)
|+.||.|||+. .+++|++|...-|+++..|.-||++|-+......-.. .......--.|..|+.+.... ...|.|
T Consensus 113 Il~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 113 ILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhh
Confidence 99999999976 3899999999999999999999999988764432211 000011123455665443222 346999
Q ss_pred ehhHHHHHhhcc
Q 041285 624 SFGVVLLEIICC 635 (724)
Q Consensus 624 S~Gvll~elltg 635 (724)
-||++++|++.|
T Consensus 188 ~Lg~li~el~ng 199 (690)
T KOG1243|consen 188 GLGCLIEELFNG 199 (690)
T ss_pred hHHHHHHHHhCc
Confidence 999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-08 Score=102.14 Aligned_cols=136 Identities=19% Similarity=0.234 Sum_probs=100.1
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccc-hhHHHHHHHHHhhcccCc--CceeeeeeEEeccc---ceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHH--RNLVRLLGYSFDVS---NKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~~~ 525 (724)
+.|+.|..+.||++...+|+.+++|....... ....++..|++++..+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999887668899998765322 134578999999999965 44677777776543 5689999999
Q ss_pred CCChhhhcC--CCCc----chHHHHHHHccccccc---------------------------------------------
Q 041285 526 NGSLADVYS--SPPK----NNLIGIARGILYLHDE--------------------------------------------- 554 (724)
Q Consensus 526 ~gsL~~~l~--~~~~----~~~~~ia~~l~yLH~~--------------------------------------------- 554 (724)
+.++.+.+. .... ..+.++++.|..||+.
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 998877653 1111 2245666666666632
Q ss_pred --------CCCceEeCCCCCCCeeeCC--CCCeEEccccCccc
Q 041285 555 --------CESQIIHCDIKPQNILMDE--NRYAKISDFALAKL 587 (724)
Q Consensus 555 --------~~~~i~H~dlk~~NIll~~--~~~~kl~Dfgl~~~ 587 (724)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246899999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-08 Score=96.20 Aligned_cols=130 Identities=14% Similarity=0.194 Sum_probs=91.0
Q ss_pred cccCcCccceEEEEEeeC-------CcEEEEEEccccc------------c----------hhHHHHH----HHHHhhcc
Q 041285 452 EEIGRGSSGTVYKGTMIN-------GKFVAVKRLQKML------------A----------EGEREFQ----TEIKAIGR 498 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~~----~E~~~l~~ 498 (724)
-.||.|--+.||.|.-.+ +..+|||..+... + ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998653 4799999764210 0 0012233 78999988
Q ss_pred cCc--CceeeeeeEEecccceEEEEeeccCCChhh-hcCCCC------cchHHHHHHHcccc-cccCCCceEeCCCCCCC
Q 041285 499 THH--RNLVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSSPP------KNNLIGIARGILYL-HDECESQIIHCDIKPQN 568 (724)
Q Consensus 499 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~------~~~~~~ia~~l~yL-H~~~~~~i~H~dlk~~N 568 (724)
+.. -++.+++++ ...++||||+.+..+.. .+.... .....+++.+|..| |.. +++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 843 466666654 56789999997653321 122111 12256888999988 777 99999999999
Q ss_pred eeeCCCCCeEEccccCccccC
Q 041285 569 ILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 569 Ill~~~~~~kl~Dfgl~~~~~ 589 (724)
||+. ++.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 4679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-08 Score=92.12 Aligned_cols=132 Identities=22% Similarity=0.312 Sum_probs=96.9
Q ss_pred cccCcCccceEEEEEeeCCcEEEEE-Ecccccc-------hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVK-RLQKMLA-------EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.|-+|+-+.|+++.. .|+...|| +..+..+ -..+..++|++.+.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999988 45665555 3332211 2235678899999998765666556667777888899999
Q ss_pred ccC-CChhhhcCC----CC-----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCccc
Q 041285 524 MSN-GSLADVYSS----PP-----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALAKL 587 (724)
Q Consensus 524 ~~~-gsL~~~l~~----~~-----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~~~ 587 (724)
+++ .++.+++.. .. ...+..|-+.+.-||.+ .|+|+||..+||+|..++. +.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 366676621 11 12256788889999999 9999999999999976543 58999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.7e-08 Score=109.14 Aligned_cols=233 Identities=20% Similarity=0.172 Sum_probs=157.7
Q ss_pred ccccCcCccceEEEEEee--CCcEEEEEEcccccchhHH--HHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMI--NGKFVAVKRLQKMLAEGER--EFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
...||.|.|+.|++.... ++..+++|.+.+....... .-..|+.+...+ .|.+++++..........++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 357999999999998754 4678899987653322222 123455555555 68899998887777788889999999
Q ss_pred CCChhhhc-------CCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVY-------SSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l-------~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++.... ....+....+++.++-++|+. .++|+|++|+||++..+ +..++.|||++..+.-.. ..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---~~ 423 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---GV 423 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec---cc
Confidence 99876554 123344478999999999987 99999999999999886 888999999986421111 11
Q ss_pred ccccCccc-cCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGY-VAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y-~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+..| .+++......+..+.|++|||+-+.|.+++......... +..+..+.+... ...
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~~-------~~~ 486 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPNL-------PGL 486 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccCC-------Cch
Confidence 11123333 355556667789999999999999999998754322110 011112211111 111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
...+..+++-+...++..||++.+...+.+
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 134555666688899999999988776554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.2e-08 Score=101.17 Aligned_cols=159 Identities=19% Similarity=0.288 Sum_probs=120.1
Q ss_pred cceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEe----cccceEEEEeeccC-CChhhh
Q 041285 459 SGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF----DVSNKILVYEYMSN-GSLADV 532 (724)
Q Consensus 459 ~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~~ 532 (724)
-.+.||+.- .||..+++|+++....+....-..-++.++++.|.|+|++...+. .+..+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788764 479999999996544444444456688999999999999998876 34568999999986 466554
Q ss_pred cCC----------------------CCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 533 YSS----------------------PPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 533 l~~----------------------~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
... ..|..+.|++.||.++|+. ++..+-|.+++||++.+..++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 310 1233378999999999998 999999999999999999999998888766544
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccC
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC 638 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p 638 (724)
+.... + .-..+-|.=.||.+++.|.||...
T Consensus 446 d~~~~---------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP---------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc---------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 43111 1 112467888999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-07 Score=90.70 Aligned_cols=121 Identities=26% Similarity=0.321 Sum_probs=79.1
Q ss_pred eEEEEEeeCCcEEEEEEccccc--------------c------------hhHHHHHHHHHhhcccCcC--ceeeeeeEEe
Q 041285 461 TVYKGTMINGKFVAVKRLQKML--------------A------------EGEREFQTEIKAIGRTHHR--NLVRLLGYSF 512 (724)
Q Consensus 461 ~Vy~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 512 (724)
.||.|..++|..+|||..+... + ......++|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999764210 0 0123467899999999655 56666644
Q ss_pred cccceEEEEeecc--CCChhhhcCCC-----CcchHHHHHHHccc-ccccCCCceEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 513 DVSNKILVYEYMS--NGSLADVYSSP-----PKNNLIGIARGILY-LHDECESQIIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 513 ~~~~~~lv~e~~~--~gsL~~~l~~~-----~~~~~~~ia~~l~y-LH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
....+||||++ +..+..+.... ....+.+++..+.. +|.. +|+|+||.+.|||++++ .+.|+|||.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --eCCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCc
Confidence 34579999998 65554433222 22335667775555 4676 99999999999999988 999999999
Q ss_pred ccccC
Q 041285 585 AKLMK 589 (724)
Q Consensus 585 ~~~~~ 589 (724)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.3e-08 Score=112.39 Aligned_cols=186 Identities=21% Similarity=0.267 Sum_probs=130.8
Q ss_pred CcCceeeeeeEEecccceEEEEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 500 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
+||-+++....+......+|+++|..+++|...|+... ...+..+.+++.|||.. .+.|+|++|.|+|..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhc
Confidence 45666655555556678899999999999988875433 22267788999999987 689999999999999
Q ss_pred CCCCeEEccccCccccC---------------------CC----C-----cceeeccccCccccCcccccCCCCCcccce
Q 041285 573 ENRYAKISDFALAKLMK---------------------PD----Q-----TRTFTGIRGTRGYVAPEWHWNLPITAKADV 622 (724)
Q Consensus 573 ~~~~~kl~Dfgl~~~~~---------------------~~----~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 622 (724)
.++..+++||+...... .. . ........+|+.|.+||.+.+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 99999999998433211 00 0 011122468999999999999999999999
Q ss_pred eehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 041285 623 YSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMK 699 (724)
Q Consensus 623 ~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 699 (724)
|+.|+.++|.++|..|+....+... .+.+..+..... ....+....+..++...+..+|.+|-.|.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~-------f~ni~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQI-------FENILNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhh-------hhccccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999987654322 122222222111 11222233345555556788999987776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.4e-07 Score=89.45 Aligned_cols=134 Identities=22% Similarity=0.254 Sum_probs=94.6
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEccccc----------------------chhHHHHHHHHHhhcccCcC--c
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML----------------------AEGEREFQTEIKAIGRTHHR--N 503 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 503 (724)
+.+.++||.|--+.||.|..++|.++|||.-+... ..+....++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34668899999999999999999999999543210 01122356788888888544 5
Q ss_pred eeeeeeEEecccceEEEEeeccCCChhhhc--CCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVY--SSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 504 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
+.+.+++ +...+||||+++--|...- .......+-.|++-+.-+-.. +++|+|+++-||++++++.+.++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEe
Confidence 5555543 5568999999987665543 222222344455544433344 999999999999999999999999
Q ss_pred ccCcccc
Q 041285 582 FALAKLM 588 (724)
Q Consensus 582 fgl~~~~ 588 (724)
|--+...
T Consensus 246 wPQ~v~~ 252 (304)
T COG0478 246 WPQAVPI 252 (304)
T ss_pred CcccccC
Confidence 9776543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.1e-07 Score=90.55 Aligned_cols=125 Identities=17% Similarity=0.140 Sum_probs=88.5
Q ss_pred cceEEEEEeeCCcEEEEEEcccccc-----------hhHHHHHHHHHhhcccCcC--ceeeeeeEEec-----ccceEEE
Q 041285 459 SGTVYKGTMINGKFVAVKRLQKMLA-----------EGEREFQTEIKAIGRTHHR--NLVRLLGYSFD-----VSNKILV 520 (724)
Q Consensus 459 ~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~-----~~~~~lv 520 (724)
...|.+..+ +|+.+.||+...... .....+.+|.+.+.++... ..+.++++... ....+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 344667665 678899997643211 1112477899988888433 34455666543 2346899
Q ss_pred EeeccCC-ChhhhcCC---CC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-------CCCeEEcccc
Q 041285 521 YEYMSNG-SLADVYSS---PP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-------NRYAKISDFA 583 (724)
Q Consensus 521 ~e~~~~g-sL~~~l~~---~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-------~~~~kl~Dfg 583 (724)
+|++++. +|.+++.. .. ...+.++++.+.-||+. +|+|+|++++|||++. +..+.++||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 88888742 11 12356899999999999 9999999999999975 4678999999
Q ss_pred Cccc
Q 041285 584 LAKL 587 (724)
Q Consensus 584 l~~~ 587 (724)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.6e-07 Score=99.26 Aligned_cols=140 Identities=21% Similarity=0.318 Sum_probs=91.4
Q ss_pred ccc-cccCcCccceEEEEEeeCCcEEEEEEcccccchh----------------------------------------HH
Q 041285 449 GFK-EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG----------------------------------------ER 487 (724)
Q Consensus 449 ~f~-~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~ 487 (724)
.|. +-|+.++-|.||+|++++|+.||||+.+....+. +-
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 455 4699999999999999999999999886432211 11
Q ss_pred HHHHHHHhhccc----CcCceeeeeeEEec-ccceEEEEeeccCCChhhhc--CCCCcc---hHHHHHHHcccccccCCC
Q 041285 488 EFQTEIKAIGRT----HHRNLVRLLGYSFD-VSNKILVYEYMSNGSLADVY--SSPPKN---NLIGIARGILYLHDECES 557 (724)
Q Consensus 488 ~~~~E~~~l~~l----~h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~---~~~~ia~~l~yLH~~~~~ 557 (724)
++..|..-+.++ ++..-+++=..+.+ .....|+|||++|-.+.+.. +..... .+..++++ |+.+-...
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhc
Confidence 234444444443 22222333333433 45779999999999998874 332222 12222222 11111122
Q ss_pred ceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 558 ~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
++.|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-07 Score=100.06 Aligned_cols=150 Identities=19% Similarity=0.303 Sum_probs=100.2
Q ss_pred HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee--------eccccCccccCccccc
Q 041285 541 LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF--------TGIRGTRGYVAPEWHW 612 (724)
Q Consensus 541 ~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 612 (724)
+.+++.|+.|+|.. ..+||++|.|++|.++.++..||+.|+.+........... .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 55677999999986 5899999999999999999999999998865433111100 1123467899999999
Q ss_pred CCCCCcccceeehhHHHHHhhccccC-CCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCC
Q 041285 613 NLPITAKADVYSFGVVLLEIICCRRC-FDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDE 691 (724)
Q Consensus 613 ~~~~~~k~Dv~S~Gvll~elltg~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~ 691 (724)
....+.++|+||+|+++|.+..|+.+ +........ +. ......+..... +..+...++.+=+.+.+..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~-~~~~~~~~~~~~----~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YS-FSRNLLNAGAFG----YSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hh-hhhccccccccc----ccccCcHHHHHHHHHHhcCC
Confidence 98889999999999999999955444 332211110 00 000111111111 12233344555566678899
Q ss_pred CCCCCCHHHHH
Q 041285 692 PSLRPSMKKVL 702 (724)
Q Consensus 692 p~~RPs~~evl 702 (724)
+..||++.++.
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999887764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.2e-06 Score=73.26 Aligned_cols=93 Identities=27% Similarity=0.575 Sum_probs=65.6
Q ss_pred eEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc---ceEEEecCCccEEEEeCCCceEEeecCCCcccccccCccc
Q 041285 41 YYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS---ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLL 117 (724)
Q Consensus 41 ~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~---~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~ 117 (724)
+-+|.. +...+..|++|+.....+.++|++++... +..+.|.++|||||++.++.++|+|= |-
T Consensus 17 f~~G~~--~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~-----t~------- 82 (114)
T smart00108 17 FELGFF--TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSN-----TT------- 82 (114)
T ss_pred Eeeecc--ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEec-----cc-------
Confidence 445653 23345679999984433578999987532 24789999999999999999999971 10
Q ss_pred cCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccc
Q 041285 118 AGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSF 165 (724)
Q Consensus 118 ~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 165 (724)
...|.+.+.|+++|+++++...+ ...|.++
T Consensus 83 -------------~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf 112 (114)
T smart00108 83 -------------GANGNYVLVLLDDGNLVIYDSDG-----NFLWQSF 112 (114)
T ss_pred -------------CCCCceEEEEeCCCCEEEECCCC-----CEEeCCC
Confidence 12567899999999999874332 3467654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.9e-06 Score=73.16 Aligned_cols=93 Identities=24% Similarity=0.522 Sum_probs=66.4
Q ss_pred eEEEeecCCcCCCc-eeEEEEeecCCCCeeEecCCCC---cceEEEecCCccEEEEeCCCceEEeecCCCcccccccCcc
Q 041285 41 YYVGVFLAGIPEKN-VGRIVLRSTEQGQDSIIADDSQ---SASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRL 116 (724)
Q Consensus 41 ~ylgiW~~~~~~~t-~g~l~l~~~~~~~~~~~~~~~~---~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l 116 (724)
+-+|.. +...+. .|++|+.....+.++|++++.. ....+.|.++|||||.|.++.++|||=-.
T Consensus 17 f~~G~~--~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~----------- 83 (116)
T cd00028 17 FELGFF--KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT----------- 83 (116)
T ss_pred EEEecc--cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc-----------
Confidence 335652 234455 7999997443357899998754 23478999999999999999999997311
Q ss_pred ccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccc
Q 041285 117 LAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSF 165 (724)
Q Consensus 117 ~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 165 (724)
.+.+.+.+.|+++|+++++..+. ...|.++
T Consensus 84 --------------~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf 113 (116)
T cd00028 84 --------------RVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSF 113 (116)
T ss_pred --------------CCCCceEEEEeCCCCEEEECCCC-----CEEEcCC
Confidence 02567899999999999875442 3467764
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.1e-06 Score=78.87 Aligned_cols=129 Identities=20% Similarity=0.171 Sum_probs=95.3
Q ss_pred cCcCccceEEEEEeeCCcEEEEEEccccc------chhHHHHHHHHHhhcccCc--CceeeeeeEEec-----ccceEEE
Q 041285 454 IGRGSSGTVYKGTMINGKFVAVKRLQKML------AEGEREFQTEIKAIGRTHH--RNLVRLLGYSFD-----VSNKILV 520 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~-----~~~~~lv 520 (724)
-|+||.+.|++..+. |+.+-+|+-.... ..+...|.+|+..|.++.. -.+.+.+ ++.. ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 577999999998774 4468888765211 3356789999999999853 3355555 3331 1235899
Q ss_pred EeeccC-CChhhhcCCCCc---------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC--eEEccccCccc
Q 041285 521 YEYMSN-GSLADVYSSPPK---------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY--AKISDFALAKL 587 (724)
Q Consensus 521 ~e~~~~-gsL~~~l~~~~~---------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~--~kl~Dfgl~~~ 587 (724)
+|-+++ .+|.+++..... ..+.+|++.++-||+. ++.|+|+.+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 588888754322 3477899999999998 9999999999999986666 89999977653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.2e-06 Score=80.77 Aligned_cols=100 Identities=23% Similarity=0.305 Sum_probs=77.0
Q ss_pred HHHHHHHHHhhcccC--cCceeeeeeEEeccc----ceEEEEeeccCC-ChhhhcCC-------CCcchHHHHHHHcccc
Q 041285 486 EREFQTEIKAIGRTH--HRNLVRLLGYSFDVS----NKILVYEYMSNG-SLADVYSS-------PPKNNLIGIARGILYL 551 (724)
Q Consensus 486 ~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~-------~~~~~~~~ia~~l~yL 551 (724)
.....+|...+.++. .-.+.+.+++..... ..++|+|++++. +|.+++.. .....+.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888887774 334566677765532 358999999884 89888864 1123377899999999
Q ss_pred cccCCCceEeCCCCCCCeeeCCCC---CeEEccccCcccc
Q 041285 552 HDECESQIIHCDIKPQNILMDENR---YAKISDFALAKLM 588 (724)
Q Consensus 552 H~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfgl~~~~ 588 (724)
|+. +|+|+|++++|||++.+. .+.++||+.++..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999 999999999999998887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.5e-06 Score=68.03 Aligned_cols=58 Identities=26% Similarity=0.497 Sum_probs=46.1
Q ss_pred CceeeeccccccCcchhhcccchHHhHHHHhhc-CCcccccccc--Cccccccc-ccccccc
Q 041285 294 KAIEELKNTVWEDVSYSVLSKTTEQNCQEACLK-DCNCEAALYK--DEECKMQR-LPLRFGR 351 (724)
Q Consensus 294 ~~f~~l~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~ 351 (724)
..|..++++.+++.........++++|++.|+. +|+|.|+.|. ++.|.+|. ..+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 468889999998665544456689999999999 9999999997 56799998 5555444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.5e-05 Score=87.86 Aligned_cols=141 Identities=25% Similarity=0.320 Sum_probs=89.8
Q ss_pred cccc-cccCcCccceEEEEEeeCCcEEEEEEcccccchh-------------------------------------HHHH
Q 041285 448 DGFK-EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG-------------------------------------EREF 489 (724)
Q Consensus 448 ~~f~-~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~ 489 (724)
..|. +.|+.-+.|.||++++++|+.||||+-+...+.. +-+|
T Consensus 162 ~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 162 SEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred HhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3455 4699999999999999999999999765422111 1134
Q ss_pred HHHHHhhccc----CcCce---eeeeeEEec-ccceEEEEeeccCCChhhhc--CCCCc---chHHHHHHHcccccccCC
Q 041285 490 QTEIKAIGRT----HHRNL---VRLLGYSFD-VSNKILVYEYMSNGSLADVY--SSPPK---NNLIGIARGILYLHDECE 556 (724)
Q Consensus 490 ~~E~~~l~~l----~h~ni---v~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~---~~~~~ia~~l~yLH~~~~ 556 (724)
..|.+-..+. .|-++ |++=.++.+ ...+.|+||||+|..+.+.. ..... ..+..+.++ |++.-..
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA--YLEQIFK 319 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH--HHHHHHh
Confidence 4555444333 35451 122223333 34789999999999887764 22111 112222222 3332223
Q ss_pred CceEeCCCCCCCeeeCC----CCCeEEccccCccccCC
Q 041285 557 SQIIHCDIKPQNILMDE----NRYAKISDFALAKLMKP 590 (724)
Q Consensus 557 ~~i~H~dlk~~NIll~~----~~~~kl~Dfgl~~~~~~ 590 (724)
.+++|+|-+|.||+++. +..+.+.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 48999999999999984 66799999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.6e-05 Score=80.89 Aligned_cols=243 Identities=13% Similarity=0.144 Sum_probs=138.8
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEe-------cccceEEEEe
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSF-------DVSNKILVYE 522 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-------~~~~~~lv~e 522 (724)
++.||+|+-+.+|-.-- -+..| -|+.......... ..+..|.+. .||-+-.-+.+=. .+...-++|.
T Consensus 16 gr~LgqGgea~ly~l~e-~~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE-VRDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch-hhchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 46799999999985321 11223 3544432221111 223334444 4554332122111 1122445666
Q ss_pred eccCC-ChhhhcCC---------CCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 523 YMSNG-SLADVYSS---------PPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 523 ~~~~g-sL~~~l~~---------~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
.+++. -+..+++. ..|.. +..+|.+.+-||+. +.+-+|++++|+|+.++..+.|.|-......
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 55543 23333321 23333 45788888999998 9999999999999999999999875443322
Q ss_pred CCCCcceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhcc-ccCCCCCCCc--chhcHHHHHHHHHHc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICC-RRCFDQNLPE--DQVILEEWVYQCFEN 660 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg-~~p~~~~~~~--~~~~l~~~~~~~~~~ 660 (724)
........-+|...|++||.-. +-.-+...|-|.+|+++++++.| ++|+.+.... ....++ ..+..
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia~ 241 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIAH 241 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhhc
Confidence 2223344567899999999754 33456789999999999999887 8898764311 111111 11112
Q ss_pred CCcccccc--------ccccCH-HHHHHHHHHHHHcccCC--CCCCCCHHHHHHHhcc
Q 041285 661 GNLGQLIE--------DEDVDK-KQLERMIKVALWCILDE--PSLRPSMKKVLLMLEG 707 (724)
Q Consensus 661 ~~~~~~~~--------~~~~~~-~~~~~l~~l~~~Cl~~~--p~~RPs~~evl~~L~~ 707 (724)
|.+.+.-+ +...+. -....+..+..+|+.+. +.-||+.+-.+..|..
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 21111111 111111 12234566677788763 5689999998887754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.8e-05 Score=76.66 Aligned_cols=129 Identities=13% Similarity=0.127 Sum_probs=83.3
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCc--eeeeeeEEecccceEEEEeeccCCC-
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN--LVRLLGYSFDVSNKILVYEYMSNGS- 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 528 (724)
+.||+|..+.||+. .+..+++|..... .......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999983 2456778877642 23345788999998886433 4677888877777889999999863
Q ss_pred hhhhc---------------------CCCCc---ch------HH-----------HHHHH-ccccccc-CCCceEeCCCC
Q 041285 529 LADVY---------------------SSPPK---NN------LI-----------GIARG-ILYLHDE-CESQIIHCDIK 565 (724)
Q Consensus 529 L~~~l---------------------~~~~~---~~------~~-----------~ia~~-l~yLH~~-~~~~i~H~dlk 565 (724)
+...+ +.... .. .. .+.+. ..+|... ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 11100 00 00 00011 1122111 12357899999
Q ss_pred CCCeeeCCCCCeEEccccCcc
Q 041285 566 PQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 566 ~~NIll~~~~~~kl~Dfgl~~ 586 (724)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.2e-05 Score=73.09 Aligned_cols=130 Identities=20% Similarity=0.201 Sum_probs=82.7
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHH---------HHHHHhhcccCc---CceeeeeeEEe-----cc
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREF---------QTEIKAIGRTHH---RNLVRLLGYSF-----DV 514 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~g~~~-----~~ 514 (724)
+.+-......|.+-.. +++.+++|..+......++.| .+++..+.+++. .....++.... -.
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 4455555555665555 567888897765333222222 233444444432 22333222222 22
Q ss_pred cceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 515 SNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
...+|+|||++|..|.++..-. ......+++++.-||+. ++.|+|.+|.|+++.+++ +++.||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~i~-e~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIEDID-EDLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchhcC-HHHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 3457999999999988765322 22345688889999998 999999999999998654 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-05 Score=77.06 Aligned_cols=129 Identities=17% Similarity=0.199 Sum_probs=83.0
Q ss_pred cCcCcc-ceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCChhh
Q 041285 454 IGRGSS-GTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGSLAD 531 (724)
Q Consensus 454 lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 531 (724)
|-.|.. ..||+.... +..+.||+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 788998764 4678888876532 345678888888873 4456677887776667899999999987764
Q ss_pred hcCC-CCcchHHHHHHHc---------------------------------------------------ccccc----cC
Q 041285 532 VYSS-PPKNNLIGIARGI---------------------------------------------------LYLHD----EC 555 (724)
Q Consensus 532 ~l~~-~~~~~~~~ia~~l---------------------------------------------------~yLH~----~~ 555 (724)
.... .....+.++++.+ ..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 3210 0000000011100 11100 11
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2458999999999999998778899998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=9.3e-05 Score=68.59 Aligned_cols=126 Identities=21% Similarity=0.294 Sum_probs=90.0
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceee-eeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVR-LLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
+.|++|.+|.||+|.+. +..+|+|.-+.+ .....+..|++++..+.-.++-+ ++.|-.+ .+.|||+.|-.|.
T Consensus 28 ~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~ 100 (201)
T COG2112 28 KELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG 100 (201)
T ss_pred hhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence 57999999999999984 558888876653 33467889999999887665543 3333222 3449999998998
Q ss_pred hhcCCCCcchHHHHHHHcccccccCCCceEeCCCCC-CCeeeCCCCCeEEccccCccc
Q 041285 531 DVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKP-QNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 531 ~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~-~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+.......+.+..+++.-.-|... +|-|+.|+- ...+|..+..+.|+||..|..
T Consensus 101 ~~~~~~~rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGGDRKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcccHHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 877665566677777773334444 888888864 444444444899999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=1.7e-05 Score=86.54 Aligned_cols=174 Identities=20% Similarity=0.117 Sum_probs=123.7
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCc-eeeeeeEEecccceEEEEeeccCC-Ch
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVSNKILVYEYMSNG-SL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~g-sL 529 (724)
+.+++++.+.++|.+-...+.+.++.+.. ....+-++++|.+++||| .++.++-+......++.++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 45788888888887654444444554433 245567899999999999 777777777777889999999877 22
Q ss_pred hhhcCCC--------CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecccc
Q 041285 530 ADVYSSP--------PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG 601 (724)
Q Consensus 530 ~~~l~~~--------~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g 601 (724)
....... .......-+++++|||+. .-+|+| ||+..+ ...|..||+....+.+.. ......+
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~ 392 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIG 392 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCCC
Confidence 2211110 001123456788999976 457888 776655 578999999987654432 2233568
Q ss_pred CccccCcccccCCCCCcccceeehhHHHHHhhccccCCC
Q 041285 602 TRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640 (724)
Q Consensus 602 t~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~ 640 (724)
++.++|||......+..+.|+|+.|+-..++--|..|-.
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999999999999999999999999998777777766644
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00019 Score=72.34 Aligned_cols=74 Identities=15% Similarity=0.176 Sum_probs=45.6
Q ss_pred cccCcCccc-eEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC---ceeeeeeEEeccc---ceEEEEeec
Q 041285 452 EEIGRGSSG-TVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR---NLVRLLGYSFDVS---NKILVYEYM 524 (724)
Q Consensus 452 ~~lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lv~e~~ 524 (724)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+.+..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346766665 58874 23567776543 22345788999988877432 3444444433322 348899999
Q ss_pred cCCChhh
Q 041285 525 SNGSLAD 531 (724)
Q Consensus 525 ~~gsL~~ 531 (724)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9977743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00062 Score=66.03 Aligned_cols=125 Identities=18% Similarity=0.250 Sum_probs=86.6
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEccccc----------------chhHHHHHHHHHhhcccC------cCceeeeee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKML----------------AEGEREFQTEIKAIGRTH------HRNLVRLLG 509 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~g 509 (724)
..||+|+.-.||. +++.....||++.... ....++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4699999999996 4556667788776543 123456777766655555 889999999
Q ss_pred EEecccceEEEEeeccC------CChhhhcCCCCcch-HHH-HHHHcccccccCCCceEeCCCCCCCeeeCCCC----Ce
Q 041285 510 YSFDVSNKILVYEYMSN------GSLADVYSSPPKNN-LIG-IARGILYLHDECESQIIHCDIKPQNILMDENR----YA 577 (724)
Q Consensus 510 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~-~~~-ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~ 577 (724)
+.......-+|+|.+.+ .+|.+++....... +.+ +-+-..||-+. .|+.+||+|.||++.... .+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~l 161 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRL 161 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEE
Confidence 99999999999998753 25667774332222 222 22334567666 899999999999995432 36
Q ss_pred EEcc
Q 041285 578 KISD 581 (724)
Q Consensus 578 kl~D 581 (724)
.|+|
T Consensus 162 vlID 165 (199)
T PF10707_consen 162 VLID 165 (199)
T ss_pred EEEe
Confidence 6665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00044 Score=67.96 Aligned_cols=130 Identities=22% Similarity=0.346 Sum_probs=82.3
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccc---------hhHH---------------HHHHHHHhhcccC--cCceee
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLA---------EGER---------------EFQTEIKAIGRTH--HRNLVR 506 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------~~~~---------------~~~~E~~~l~~l~--h~niv~ 506 (724)
.|..|.-..||+|.-.++..+|||+.+.... ++.. -.++|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4677888899999887889999998764211 0101 1234555555552 333344
Q ss_pred eeeEEecccceEEEEeeccCCCh-hhhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 507 LLGYSFDVSNKILVYEYMSNGSL-ADVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 507 l~g~~~~~~~~~lv~e~~~~gsL-~~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
-+++. +-.|||||+....+ .-.|+... .....++++.+.-|-.. .++||+||+.-|||+. ++.+.|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEE
Confidence 44332 34799999865421 12222211 11244566666655542 2899999999999999 889999
Q ss_pred ccccCccccC
Q 041285 580 SDFALAKLMK 589 (724)
Q Consensus 580 ~Dfgl~~~~~ 589 (724)
+|++-+....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0011 Score=63.64 Aligned_cols=125 Identities=26% Similarity=0.418 Sum_probs=90.6
Q ss_pred hhcccccccCcCcc-ceEEEEEeeCCcEEEEEEcccc-----------cc----------hhHHHHHHHHHhhcccC---
Q 041285 446 MTDGFKEEIGRGSS-GTVYKGTMINGKFVAVKRLQKM-----------LA----------EGEREFQTEIKAIGRTH--- 500 (724)
Q Consensus 446 ~t~~f~~~lg~G~~-g~Vy~~~~~~~~~vavK~l~~~-----------~~----------~~~~~~~~E~~~l~~l~--- 500 (724)
..-.|.+.||.|.- |.||+..+ +|+.+|+|..+.. .. .-..-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 44556789999999 99999998 6779999983210 00 11234889999999884
Q ss_pred cCce--eeeeeEEecc------------------cceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceE
Q 041285 501 HRNL--VRLLGYSFDV------------------SNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQII 560 (724)
Q Consensus 501 h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~ 560 (724)
+.++ |+.+||..-. ..+.+|.||++... ...-..+.++.+-|..+|.. +|+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~~~~~~~~dl~~~~k~---gI~ 186 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIRDIPQMLRDLKILHKL---GIV 186 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchhHHHHHHHHHHHHHHC---Cee
Confidence 4466 9999987422 12367888876644 22223367788888899988 999
Q ss_pred eCCCCCCCeeeCCCCCeEEccccCc
Q 041285 561 HCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 561 H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
-+|+++.|.. .-||+|||.+
T Consensus 187 ~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 187 PRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred eccCcccccc-----CCEEEecccC
Confidence 9999999985 5689999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00077 Score=67.53 Aligned_cols=132 Identities=22% Similarity=0.296 Sum_probs=81.4
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC--ceeeeeeEEecc---cceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR--NLVRLLGYSFDV---SNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lv~e~~~~ 526 (724)
+.|+.|..+.||+....+ +.+++|..... .....+.+|..++..+... .+.+++.++... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 458889999999999866 68999987653 4456788898888888433 356777655332 246899999999
Q ss_pred CChhh----------------hc---CCC--Cc---ch---------------------------HHHHHH-Hcccccc-
Q 041285 527 GSLAD----------------VY---SSP--PK---NN---------------------------LIGIAR-GILYLHD- 553 (724)
Q Consensus 527 gsL~~----------------~l---~~~--~~---~~---------------------------~~~ia~-~l~yLH~- 553 (724)
..+.. .+ +.. .. .. ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 000 00 00 001122 2233332
Q ss_pred ---cCCCceEeCCCCCCCeeeC-CCCCeEEccccCcc
Q 041285 554 ---ECESQIIHCDIKPQNILMD-ENRYAKISDFALAK 586 (724)
Q Consensus 554 ---~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~ 586 (724)
.....++|+|+++.|||++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 55556799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0017 Score=66.31 Aligned_cols=128 Identities=13% Similarity=0.092 Sum_probs=74.3
Q ss_pred cCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCce-eeeeeEEecccceEEEEeeccCCChhhh
Q 041285 454 IGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL-VRLLGYSFDVSNKILVYEYMSNGSLADV 532 (724)
Q Consensus 454 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~~~ 532 (724)
+..|-...+|+... +++.+++|........-.-...+|.++++.+....+ .++++.+. ..+|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998873 566788887553221111235778888888854333 34444432 3689999998766431
Q ss_pred -----------------cCCCC---cc--h---HHH-------------HHHHcccccc-----cCCCceEeCCCCCCCe
Q 041285 533 -----------------YSSPP---KN--N---LIG-------------IARGILYLHD-----ECESQIIHCDIKPQNI 569 (724)
Q Consensus 533 -----------------l~~~~---~~--~---~~~-------------ia~~l~yLH~-----~~~~~i~H~dlk~~NI 569 (724)
++... .. . +.. +.+.+..+.. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 01110 00 0 000 0011111111 1123589999999999
Q ss_pred eeCCCCCeEEccccCccc
Q 041285 570 LMDENRYAKISDFALAKL 587 (724)
Q Consensus 570 ll~~~~~~kl~Dfgl~~~ 587 (724)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0018 Score=67.69 Aligned_cols=75 Identities=12% Similarity=0.031 Sum_probs=55.6
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-c--CceeeeeeEEecc---cceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-H--RNLVRLLGYSFDV---SNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~---~~~~lv~e~~~ 525 (724)
+.||.|..+.||+....+++ ++||..+. ......|.+|.+.++.+. + -.+.+++++|... +..++|||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46999999999998775564 66676432 112357899999998884 2 3688888887643 56899999999
Q ss_pred CCCh
Q 041285 526 NGSL 529 (724)
Q Consensus 526 ~gsL 529 (724)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0012 Score=69.09 Aligned_cols=131 Identities=19% Similarity=0.189 Sum_probs=80.7
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC--ceeeeeeE------EecccceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR--NLVRLLGY------SFDVSNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lv~e~ 523 (724)
+.|..|....+|+.... +..+++|+... ....+...|++++..+.+. .+.+++.. ....+..++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 35777777899988764 44688888764 2334566788877777433 24454432 1223456899999
Q ss_pred ccCCChhhh----c----------C----CCCc--------ch----------------HHHHHHHcccccc----cCCC
Q 041285 524 MSNGSLADV----Y----------S----SPPK--------NN----------------LIGIARGILYLHD----ECES 557 (724)
Q Consensus 524 ~~~gsL~~~----l----------~----~~~~--------~~----------------~~~ia~~l~yLH~----~~~~ 557 (724)
++|..+... . + .... .. ...+.+++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 998775320 0 0 0000 00 0012233333332 1234
Q ss_pred ceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 558 QIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 558 ~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
.++|+|++|.|||++++..+.|.||..+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 69999999999999998778899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0028 Score=63.73 Aligned_cols=73 Identities=14% Similarity=0.119 Sum_probs=46.5
Q ss_pred cccCcCccceEEEEEeeC--CcEEEEEEcccccchhHHHHHHHHHhhcccCcCc-eeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMIN--GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.|..|-...+|+....+ ++.+++|....... ..-...+|+.++..+.... .+++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 356777788999988764 57888887654211 1123347888888874333 344444432 247999999876
Q ss_pred h
Q 041285 529 L 529 (724)
Q Consensus 529 L 529 (724)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 6
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0017 Score=77.73 Aligned_cols=78 Identities=14% Similarity=0.262 Sum_probs=57.1
Q ss_pred cccCcCccceEEEEEeeCC---cEEEEEEccccc-chhHHHHHHHHHhhcccC-cCce--eeeeeEEecc---cceEEEE
Q 041285 452 EEIGRGSSGTVYKGTMING---KFVAVKRLQKML-AEGEREFQTEIKAIGRTH-HRNL--VRLLGYSFDV---SNKILVY 521 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv~ 521 (724)
+.++.|....+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688899999999877554 367777764321 123457889999999995 6654 7888888764 4578999
Q ss_pred eeccCCCh
Q 041285 522 EYMSNGSL 529 (724)
Q Consensus 522 e~~~~gsL 529 (724)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00091 Score=64.54 Aligned_cols=94 Identities=19% Similarity=0.227 Sum_probs=74.2
Q ss_pred HHHHHhhcccCc-CceeeeeeEEecccceEEEEeeccCCChh-------hhcCCCCcc----hHHHHHHHcccccccCCC
Q 041285 490 QTEIKAIGRTHH-RNLVRLLGYSFDVSNKILVYEYMSNGSLA-------DVYSSPPKN----NLIGIARGILYLHDECES 557 (724)
Q Consensus 490 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~-------~~l~~~~~~----~~~~ia~~l~yLH~~~~~ 557 (724)
..|.-++..+++ +++++++|+|-. ++|.||.+.+++. .++ ..+|. ++.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~-~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFL-QSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccccc-ccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 457788888876 699999999944 6899999877553 333 23443 377888888999886655
Q ss_pred ceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 558 QIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 558 ~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
.+.-+|++++|+-+++++.+|+.|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7889999999999999999999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00039 Score=55.75 Aligned_cols=46 Identities=24% Similarity=0.476 Sum_probs=35.5
Q ss_pred ccccccCcchhhcccchHHhHHHHhhcCCccccccccC--cccccccc
Q 041285 300 KNTVWEDVSYSVLSKTTEQNCQEACLKDCNCEAALYKD--EECKMQRL 345 (724)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~ 345 (724)
+++.+++.++......+.++|++.|+.||+|.||.|.. +.|+++..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 45666666555544568899999999999999999964 56988765
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0024 Score=56.14 Aligned_cols=59 Identities=36% Similarity=0.688 Sum_probs=41.8
Q ss_pred eEEEecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCC
Q 041285 79 SSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAP 158 (724)
Q Consensus 79 ~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~ 158 (724)
..+.|.++|||||.+..+.++|+| ..| .........+.|+.+|+++++-.. .
T Consensus 21 ~~L~l~~dGnLvl~~~~~~~iWss--~~t---------------------~~~~~~~~~~~L~~~GNlvl~d~~-----~ 72 (114)
T PF01453_consen 21 YTLILQSDGNLVLYDSNGSVIWSS--NNT---------------------SGRGNSGCYLVLQDDGNLVLYDSS-----G 72 (114)
T ss_dssp EEEEEETTSEEEEEETTTEEEEE----S----------------------TTSS-SSEEEEEETTSEEEEEETT-----S
T ss_pred ccceECCCCeEEEEcCCCCEEEEe--ccc---------------------CCccccCeEEEEeCCCCEEEEeec-----c
Confidence 478999999999999999999998 000 001113678999999999987521 2
Q ss_pred Ccccccc
Q 041285 159 YSYWTSF 165 (724)
Q Consensus 159 ~~yw~~~ 165 (724)
...|.+.
T Consensus 73 ~~lW~Sf 79 (114)
T PF01453_consen 73 NVLWQSF 79 (114)
T ss_dssp EEEEEST
T ss_pred eEEEeec
Confidence 5678773
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0082 Score=64.69 Aligned_cols=75 Identities=23% Similarity=0.252 Sum_probs=53.3
Q ss_pred cccCcCccceEEEEEeeCC-cEEEEEEccccc-------chhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEE
Q 041285 452 EEIGRGSSGTVYKGTMING-KFVAVKRLQKML-------AEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 520 (724)
+.||.|.+..||++...+| +.|+||.-.... ....+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5699999999999999877 589999854211 123456677888777762 2356667766 44567899
Q ss_pred EeeccCCC
Q 041285 521 YEYMSNGS 528 (724)
Q Consensus 521 ~e~~~~gs 528 (724)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0051 Score=64.54 Aligned_cols=73 Identities=21% Similarity=0.261 Sum_probs=45.9
Q ss_pred ccCcCccceEEEEEeeC-------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCc-eeeeeeEEecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMIN-------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~ 524 (724)
.|..|-...+|+....+ ++.+++|...... .......+|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 35556666888887654 4788888865432 22235577887777774322 3455555542 3589999
Q ss_pred cCCChh
Q 041285 525 SNGSLA 530 (724)
Q Consensus 525 ~~gsL~ 530 (724)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0063 Score=62.83 Aligned_cols=72 Identities=17% Similarity=0.283 Sum_probs=47.2
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999987 567889999766 233457888888887773 446778888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.012 Score=62.29 Aligned_cols=130 Identities=12% Similarity=0.138 Sum_probs=72.7
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC--ceeeeeeE------EecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR--NLVRLLGY------SFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lv~e~~ 524 (724)
.|..|....+|+....+| .+++|+.+. ...+....|+.++..|... .+.+.+.. ....+..++++||+
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 466677778999876555 688887752 1223334455555554211 23333321 12244578999999
Q ss_pred cCCChhh-----------hc---C----CC--------C--cc-h-H---------------HH-HHHHcccccc----c
Q 041285 525 SNGSLAD-----------VY---S----SP--------P--KN-N-L---------------IG-IARGILYLHD----E 554 (724)
Q Consensus 525 ~~gsL~~-----------~l---~----~~--------~--~~-~-~---------------~~-ia~~l~yLH~----~ 554 (724)
+|..+.. .+ + .. . +. . + .+ +...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9875421 00 0 00 0 00 0 0 00 1111122221 1
Q ss_pred CCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 555 ~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
...+++|+|+++.||+++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 34589999999999999977666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.011 Score=62.11 Aligned_cols=131 Identities=17% Similarity=0.178 Sum_probs=76.9
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC--ceeeeeeEE------ecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR--NLVRLLGYS------FDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~------~~~~~~~lv~e~~ 524 (724)
.++.|-...+|+....++ .+++|..... ....+...|++++..|... .+.+++... ...+..++++||+
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 466777788998875444 5677876542 1234455667777666322 244444321 1234568999999
Q ss_pred cCCChhhh-----------c---C----C--C---------Ccch----------------HHHHHHHcccccc----cC
Q 041285 525 SNGSLADV-----------Y---S----S--P---------PKNN----------------LIGIARGILYLHD----EC 555 (724)
Q Consensus 525 ~~gsL~~~-----------l---~----~--~---------~~~~----------------~~~ia~~l~yLH~----~~ 555 (724)
+|..+... + + . . .|.. ...+.+.+.++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 88554210 0 0 0 0 0000 0012223333322 23
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..+++|+|+++.||+++.++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4589999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.03 Score=58.30 Aligned_cols=118 Identities=18% Similarity=0.245 Sum_probs=73.8
Q ss_pred CcEEEEEEccc--ccchhHHHHHHHHHhhcccC--cCceeeeeeEEeccc--ceEEEEeeccCCChhhhcCCCCc--chH
Q 041285 470 GKFVAVKRLQK--MLAEGEREFQTEIKAIGRTH--HRNLVRLLGYSFDVS--NKILVYEYMSNGSLADVYSSPPK--NNL 541 (724)
Q Consensus 470 ~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~--~~~ 541 (724)
++..+|. ... ..........+|.++|+.+. -.-+.+.++.|.++. ..+.||+|.++..+.+.+..... ..+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6677777 331 22334456677888888773 334566778888776 67999999988433222211000 000
Q ss_pred H-H--------------------------------------------------HHHHccccccc-----CCCceEeCCCC
Q 041285 542 I-G--------------------------------------------------IARGILYLHDE-----CESQIIHCDIK 565 (724)
Q Consensus 542 ~-~--------------------------------------------------ia~~l~yLH~~-----~~~~i~H~dlk 565 (724)
. . ...-..||++. ..+.++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 0 1 12223344332 23579999999
Q ss_pred CCCeeeCCCCCeEEccccCcccc
Q 041285 566 PQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 566 ~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
+.||+++...-+-|.||+++..-
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999998888999999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0042 Score=63.26 Aligned_cols=133 Identities=17% Similarity=0.175 Sum_probs=89.6
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--c------------------c--hhHHHHHHHHHhhcccC-cC-c
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--L------------------A--EGEREFQTEIKAIGRTH-HR-N 503 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~------------------~--~~~~~~~~E~~~l~~l~-h~-n 503 (724)
..+.+.||-|.-+.||.+...+|++.++|.-+-. + . .+.-...+|...|+.|. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 3466889999999999999999999998843210 0 0 01112446777777773 22 2
Q ss_pred eeeeeeEEecccceEEEEeeccCCChhhhcCCCCcchHHH-HHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG-IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 504 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
+.+.+ +....++|||++.+-.|...-+......+.+ +..-+.-|-.+ ++||+|.+-=||+++++..++++||
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDF 246 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDF 246 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeec
Confidence 33333 3356689999999988877654333333322 22223345444 9999999999999999999999999
Q ss_pred cCccc
Q 041285 583 ALAKL 587 (724)
Q Consensus 583 gl~~~ 587 (724)
--...
T Consensus 247 PQmvS 251 (465)
T KOG2268|consen 247 PQMVS 251 (465)
T ss_pred hHhhc
Confidence 76543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.054 Score=55.84 Aligned_cols=31 Identities=32% Similarity=0.628 Sum_probs=25.7
Q ss_pred CceEeCCCCCCCeeeCCCCC-eEEccccCccc
Q 041285 557 SQIIHCDIKPQNILMDENRY-AKISDFALAKL 587 (724)
Q Consensus 557 ~~i~H~dlk~~NIll~~~~~-~kl~Dfgl~~~ 587 (724)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.048 Score=58.25 Aligned_cols=130 Identities=22% Similarity=0.273 Sum_probs=74.9
Q ss_pred ccCcCccceEEEEEeeC-----CcEEEEEEcccccchhHHHHHHHHHhhcccCcCce-eeeeeEEecccceEEEEeeccC
Q 041285 453 EIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL-VRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.|-.|-.-.+|+....+ ++.+++|........- -...+|..++..+...++ .++++++..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34456677888877543 3578888776532221 123678888887754333 3555665433 58999987
Q ss_pred CChhhh-----------------cCCCC----c-----chH---H------------------HHHHHccc----ccc-c
Q 041285 527 GSLADV-----------------YSSPP----K-----NNL---I------------------GIARGILY----LHD-E 554 (724)
Q Consensus 527 gsL~~~-----------------l~~~~----~-----~~~---~------------------~ia~~l~y----LH~-~ 554 (724)
.+|... ++... . ..+ . .+...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 01110 0 000 0 01111111 111 1
Q ss_pred CCCceEeCCCCCCCeeeCC-CCCeEEccccCccc
Q 041285 555 CESQIIHCDIKPQNILMDE-NRYAKISDFALAKL 587 (724)
Q Consensus 555 ~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~ 587 (724)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2336899999999999986 46899999988764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.01 Score=63.97 Aligned_cols=158 Identities=23% Similarity=0.304 Sum_probs=87.4
Q ss_pred HHHHHHHHhhcccCcCceeeeeeEEeccc-ceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCC
Q 041285 487 REFQTEIKAIGRTHHRNLVRLLGYSFDVS-NKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIK 565 (724)
Q Consensus 487 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk 565 (724)
.+.....+.++.++|+|+..++.+..... ...+|+|++ +.||.+.+...........+ | ++.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~~------~-----~~~~---- 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLLA------H-----GVLH---- 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhcc------c-----ccce----
Confidence 35566678888999999999998877654 457888988 77888887554321111111 1 1211
Q ss_pred CCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCc
Q 041285 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE 645 (724)
Q Consensus 566 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~ 645 (724)
.|| .+++| .+.. . | | .+..+|+||||+|.++.|+.-|...+....
T Consensus 91 -~~~-------~~~td-~~~t----------------~-~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~-- 135 (725)
T KOG1093|consen 91 -LNI-------IYITD-HFLT----------------K-Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELT-- 135 (725)
T ss_pred -ehh-------hhccc-cccc----------------c-C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHH--
Confidence 122 12222 0000 0 0 0 111259999999999999998876443211
Q ss_pred chhcHHHHHHHHHHc----CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 041285 646 DQVILEEWVYQCFEN----GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMK 699 (724)
Q Consensus 646 ~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 699 (724)
..++......- +.+..+.-......+....++++.+.|+-..|..||...
T Consensus 136 ----~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 136 ----ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred ----HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 11111111110 111111111122334456788999999999999888543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.078 Score=55.80 Aligned_cols=30 Identities=23% Similarity=0.313 Sum_probs=25.8
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357899999999999987 568899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.068 Score=56.22 Aligned_cols=126 Identities=17% Similarity=0.208 Sum_probs=76.0
Q ss_pred ccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-c--Cc---eeeeee----EEecccceEEEEeeccCC
Q 041285 458 SSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-H--RN---LVRLLG----YSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 458 ~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~n---iv~l~g----~~~~~~~~~lv~e~~~~g 527 (724)
.-..+|+....+|+. ++|..+.. ....+...|+..+..|. + += |..+=| ........+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789988877776 77877653 34456677777777663 1 11 111212 111223678899999998
Q ss_pred Chhh-hc------------------C-----------CCCcch-----------------HHHHHHHcccccccC----C
Q 041285 528 SLAD-VY------------------S-----------SPPKNN-----------------LIGIARGILYLHDEC----E 556 (724)
Q Consensus 528 sL~~-~l------------------~-----------~~~~~~-----------------~~~ia~~l~yLH~~~----~ 556 (724)
.+.. .- + ...|.. ..++...+..+++.. .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8772 10 0 112220 122333333332211 1
Q ss_pred C-c--eEeCCCCCCCeeeCCCCC-eEEccccCcc
Q 041285 557 S-Q--IIHCDIKPQNILMDENRY-AKISDFALAK 586 (724)
Q Consensus 557 ~-~--i~H~dlk~~NIll~~~~~-~kl~Dfgl~~ 586 (724)
. + ++|+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 2 999999999999998875 8899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.016 Score=68.34 Aligned_cols=190 Identities=16% Similarity=0.159 Sum_probs=119.5
Q ss_pred HHHHHHHhhcccCcCceeeeeeEEecccce----EEEEeeccCCChhhhcCCCC---cc----hHHHHHHHcccccccCC
Q 041285 488 EFQTEIKAIGRTHHRNLVRLLGYSFDVSNK----ILVYEYMSNGSLADVYSSPP---KN----NLIGIARGILYLHDECE 556 (724)
Q Consensus 488 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~---~~----~~~~ia~~l~yLH~~~~ 556 (724)
...-|...+.++.|+|++++++|-.+.... .+..|++..-++...+.... .. ...++.+|++|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 344577788888999999999987765433 24456676666666654321 11 145788999999987
Q ss_pred CceEeCCCCCC---CeeeCCCCCeEEc--cccCccccCCCCcceeeccccCccccCcccccCCCCC--cccceeehhHHH
Q 041285 557 SQIIHCDIKPQ---NILMDENRYAKIS--DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT--AKADVYSFGVVL 629 (724)
Q Consensus 557 ~~i~H~dlk~~---NIll~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~k~Dv~S~Gvll 629 (724)
...|.-|..+ +...+.++...++ ||+............. ..-+..+.+||......+. .+.|+|.+|.+.
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4444434433 4444556666666 8888876654332211 1234456777776655544 457999999999
Q ss_pred HHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 041285 630 LEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLML 705 (724)
Q Consensus 630 ~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 705 (724)
..+..|..+....... ..+++. .. ...+......|+..++++|++..+++...
T Consensus 383 ~~~~~~~~i~~~~~~~------------------~~~l~~-~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP------------------VSLLDV-LS----TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccch------------------hhhhcc-cc----chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999887654321100 000000 00 00355666779999999999999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.15 Score=54.93 Aligned_cols=72 Identities=13% Similarity=0.182 Sum_probs=47.8
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccc-------hhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEEE
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA-------EGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.||.|....||+... +++.++||+-..... .....-..|.+.|..+. ..++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 5689999999999876 455789997652111 12233344455555442 347788888887 4467889
Q ss_pred eeccC
Q 041285 522 EYMSN 526 (724)
Q Consensus 522 e~~~~ 526 (724)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.35 Score=47.36 Aligned_cols=74 Identities=19% Similarity=0.229 Sum_probs=51.8
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
++.-|..-..|.... +..++.||.-. .+....|.+|+.-|..|. --++.+++..-.+..+.++|+||++-+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 355555555555443 34678888654 334467888887776663 45677888888888999999999998776
Q ss_pred h
Q 041285 530 A 530 (724)
Q Consensus 530 ~ 530 (724)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.22 Score=52.34 Aligned_cols=32 Identities=22% Similarity=0.379 Sum_probs=28.5
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 724 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-04 | ||
| 2d04_A | 113 | Crystal Structure Of Neoculin, A Sweet Protein With | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2D04|A Chain A, Crystal Structure Of Neoculin, A Sweet Protein With Taste-Modifying Activity. Length = 113 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 724 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-116 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-108 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-99 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-69 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-58 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-56 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-53 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-52 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-51 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-50 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-50 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-50 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-49 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-48 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-48 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-47 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-47 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-38 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-36 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-34 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-34 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-34 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-31 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-31 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-31 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-30 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-30 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-30 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-30 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-30 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-30 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-30 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-30 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-29 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-29 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-29 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-29 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-29 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-29 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-29 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-29 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-29 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-29 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-28 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-27 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-27 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-27 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-27 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-27 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-27 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-27 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-27 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-27 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-27 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-27 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-27 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-27 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-27 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-27 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 9e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-26 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-26 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-26 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-26 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-26 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-26 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-26 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-26 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-26 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-26 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-26 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-26 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 9e-26 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-25 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-25 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-25 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-25 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-25 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-25 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 9e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-24 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-24 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 7e-24 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-23 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-23 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-23 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-23 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-22 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-22 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-22 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-22 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-21 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-21 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-21 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-21 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-21 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-20 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-20 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-20 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 8e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-18 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 8e-18 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 1e-17 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-17 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-17 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-16 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-16 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 5e-16 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-16 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-16 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 9e-16 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 3e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-15 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 1e-15 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 3e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-15 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 2e-15 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 2e-05 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 4e-05 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-15 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-15 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 8e-15 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 1e-14 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 6e-07 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 1e-06 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 4e-14 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 2e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-14 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 6e-14 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 1e-06 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 7e-14 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 2e-07 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 8e-14 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 3e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-14 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 8e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-11 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 4e-11 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 4e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 9e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-06 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 4e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 9e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-116
Identities = 117/290 (40%), Positives = 169/290 (58%), Gaps = 19/290 (6%)
Query: 437 SFSYAELEKMTDGFKEE--IGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG-EREFQTEI 493
FS EL+ +D F + +GRG G VYKG + +G VAVKRL++ +G E +FQTE+
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 494 KAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-----VYSSPP------KNNLI 542
+ I HRNL+RL G+ + ++LVY YM+NGS+A S PP + +
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 543 GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGT 602
G ARG+ YLHD C+ +IIH D+K NIL+DE A + DF LAKLM T T +RGT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 603 RGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLP--EDQVILEEWVYQCFEN 660
G++APE+ + K DV+ +GV+LLE+I +R FD +D V+L +WV +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 661 GNLGQLIE---DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707
L L++ + +++E++I+VAL C P RP M +V+ MLEG
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-108
Identities = 112/313 (35%), Positives = 167/313 (53%), Gaps = 20/313 (6%)
Query: 416 RSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEE--IGRGSSGTVYKGTMINGKFV 473
++ I S+ Y +LE+ T+ F + IG G G VYKG + +G V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 474 AVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-V 532
A+KR ++G EF+TEI+ + H +LV L+G+ + + IL+Y+YM NG+L +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 533 Y-SSPPKNNL---------IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582
Y S P ++ IG ARG+ YLH IIH D+K NIL+DEN KI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 583 ALAKLM-KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQ 641
++K + DQT T ++GT GY+ PE+ +T K+DVYSFGVVL E++C R Q
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 642 NLPEDQVILEEWVYQCFENGNLGQLIE---DEDVDKKQLERMIKVALWCILDEPSLRPSM 698
+LP + V L EW + NG L Q+++ + + + L + A+ C+ RPSM
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 699 KKVLLMLEGTMDI 711
VL LE + +
Sbjct: 304 GDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 2e-99
Identities = 114/300 (38%), Positives = 152/300 (50%), Gaps = 35/300 (11%)
Query: 435 LLSFSYAELEKMTDGFKEE--------IGRGSSGTVYKGTMINGKFVAVKRLQKMLA--- 483
SFS+ EL+ +T+ F E +G G G VYKG +N VAVK+L M+
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGY-VNNTTVAVKKLAAMVDITT 70
Query: 484 -EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD-VYSSPPKNNL 541
E +++F EIK + + H NLV LLG+S D + LVY YM NGSL D + L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 542 ---------IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM-KPD 591
G A GI +LH+ IH DIK NIL+DE AKISDF LA+ K
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE 651
QT + I GT Y+APE IT K+D+YSFGVVLLEII D++ +L
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL 244
Query: 652 EWVYQCF-ENGNLGQLIED---EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707
+ + E + I D D D +E M VA C+ ++ + RP +KKV +L+
Sbjct: 245 DIKEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 36/305 (11%)
Query: 436 LSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEI 493
+ L + + E RG G V+K + ++VAVK + + + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF-PIQDKQSWQNEYEV 69
Query: 494 KAIGRTHHRNLVRLLGYSFDVSN----KILVYEYMSNGSLADVYSSPP------KNNLIG 543
++ H N+++ +G ++ L+ + GSL+D + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAET 129
Query: 544 IARGILYLHDECESQ-------IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596
+ARG+ YLH++ I H DIK +N+L+ N A I+DF LA + ++
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 597 T-GIRGTRGYVAPE-----WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650
T G GTR Y+APE ++ + D+Y+ G+VL E+ D + E +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 651 EEWVYQ--CFE-------NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKV 701
EE + Q E + ++ D + + + C + R S V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 702 LLMLE 706
+
Sbjct: 310 GERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-58
Identities = 85/288 (29%), Positives = 136/288 (47%), Gaps = 32/288 (11%)
Query: 440 YAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRL--QKMLAEGEREFQTEIKAIG 497
+ +L KE+IG GS GTV++ +G VAVK L Q AE EF E+ +
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 498 RTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADV-YSSPPKNNL---------IGIARG 547
R H N+V +G N +V EY+S GSL + + S + L +A+G
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
+ YLH I+H ++K N+L+D+ K+ DF L++L K + GT ++A
Sbjct: 150 MNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMA 207
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667
PE + P K+DVYSFGV+L E+ ++ + NL QV+ ++
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVV-----AAVGFKCKRLEIP 261
Query: 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPP 715
+ + Q+ +I+ C +EP RPS ++ +L + +PP
Sbjct: 262 RNLN---PQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 69/319 (21%), Positives = 114/319 (35%), Gaps = 53/319 (16%)
Query: 436 LSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTE- 492
+ + +E D K E IGRG G VYKG++ + + VAVK + F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56
Query: 493 -IKAIGRTHHRNLVRLLGYSFDVS-----NKILVYEYMSNGSLADVYSSPPKNN------ 540
I + H N+ R + V+ +LV EY NGSL S +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116
Query: 541 LIGIARGILYLHDECES------QIIHCDIKPQNILMDENRYAKISDFALAKLMKPD--- 591
+ RG+ YLH E I H D+ +N+L+ + ISDF L+ + +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 592 ----QTRTFTGIRGTRGYVAPE-------WHWNLPITAKADVYSFGVVLLEII--CCRRC 638
+ GT Y+APE + D+Y+ G++ EI C
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 639 FDQNLPEDQVILEEWVYQ-----------CFENGNLGQLIEDEDVDKKQLERMIKVALWC 687
+++PE Q+ + V E + E + + + + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP-KFPEAWKENSLAVRSLKETIEDC 295
Query: 688 ILDEPSLRPSMKKVLLMLE 706
+ R + + +
Sbjct: 296 WDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-56
Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 36/278 (12%)
Query: 440 YAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT 499
Y E+E +E +GRG+ G V K K VA+K+++ + F E++ + R
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRV 58
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADV-YSSPPKNNL---------IGIARGIL 549
+H N+V+L G + LV EY GSL +V + + P + ++G+
Sbjct: 59 NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 550 YLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
YLH +IH D+KP N+L+ KI DF A D T +G+ ++AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAP 172
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668
E + K DV+S+G++L E+I R+ FD+ I ++ LI+
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRP-PLIK 227
Query: 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ K +E ++ C +PS RPSM++++ ++
Sbjct: 228 NLP---KPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-53
Identities = 77/286 (26%), Positives = 111/286 (38%), Gaps = 56/286 (19%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRL----QKMLAEGEREFQTEIKAIGRTHHRNLV 505
+E IG G G VY+ G VAVK + +++ + E K H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSS---PPKNNL---IGIARGILYLHDECESQI 559
L G N LV E+ G L V S PP + + IARG+ YLHDE I
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 560 IHCDIKPQNILMDE--------NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
IH D+K NIL+ + N+ KI+DF LA+ + G ++APE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEVI 186
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---------- 661
+ +DV+S+GV+L E++ F + V Y N
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVA-----YGVAMNKLALPIPSTCP 240
Query: 662 -NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+L+ED C +P RPS +L L
Sbjct: 241 EPFAKLMED-----------------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-52
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 45/290 (15%)
Query: 440 YAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRL-------QKMLAEGEREFQT 491
E+E ++++IG+G G V+KG + + VA+K L + + E +EFQ
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 492 EIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK--------NNLIG 543
E+ + +H N+V+L G + +V E++ G L ++
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDE-----NRYAKISDFALAKLMKPDQTRTFTG 598
IA GI Y+ + I+H D++ NI + AK++DF L++ + +G
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 599 IRGTRGYVAPE--WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656
+ G ++APE T KAD YSF ++L I+ FD ++ +
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMIR- 243
Query: 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
E G + ED +L +I+ C +P RP ++ L
Sbjct: 244 --EEGLRPTIPEDCP---PRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 43/281 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
E IG+G G VY G +G+ VA++ + ++ + + F+ E+ A +T H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQ 558
+G + ++ +L V K L I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMK----PDQTRTFTGIRGTRGYVAPE----- 609
I+H D+K +N+ D + I+DF L + + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 610 ----WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
LP + +DV++ G + E+ F + P + +I W +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAII---WQMGT----GMKP 261
Query: 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + K++ ++ +C E RP+ K++ MLE
Sbjct: 262 NLSQIGMG-KEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 63/294 (21%)
Query: 440 YAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRL--QKMLAEGEREFQTEIKAIG 497
+ +L F ++ SG ++KG G + VK L + R+F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 498 RTHHRNLVRLLGYSFD--VSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIAR 546
H N++ +LG + L+ +M GSL +V + + +AR
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYV 606
G+ +LH E I + +++++DE+ A+IS + + G +V
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWV 175
Query: 607 APEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG-- 661
APE P AD++SF V+L E++ F +L ++ + G
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIG-----MKVALEGLR 229
Query: 662 ---------NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
++ +L++ C+ ++P+ RP ++ +LE
Sbjct: 230 PTIPPGISPHVSKLMKI-----------------CMNEDPAKRPKFDMIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+ IG GS GTVYKG +G VAVK L + + F+ E+ + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSP----PKNNLIG----IARGILYLHDECESQI 559
+GYS +V ++ SL + LI ARG+ YLH I
Sbjct: 86 MGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTFTGIRGTRGYVAPE---WHWNLP 615
IH D+K NI + E+ KI DF LA + F + G+ ++APE + P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 616 ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED--EDVD 673
+ ++DVY+FG+VL E++ + + DQ+I + G+L + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---EM---VGRGSLSPDLSKVRSNCP 255
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
K+ M ++ C+ + RPS ++L +E
Sbjct: 256 KR----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 72/299 (24%), Positives = 111/299 (37%), Gaps = 43/299 (14%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E +G+G G K T G+ + +K L + E +R F E+K + H N+++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQI 559
G + + EY+ G+L + IA G+ YLH I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLM-------------KPDQTRTFTGIRGTRGYV 606
IH D+ N L+ EN+ ++DF LA+LM K + + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 607 APEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666
APE K DV+SFG+VL EII LP G L +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------VRGFLDRY 243
Query: 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG-----TMDIPIPPNPTSL 720
+ + + C +P RPS K+ LE +P+ P L
Sbjct: 244 CP-PNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 68/291 (23%), Positives = 108/291 (37%), Gaps = 38/291 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
++IG+G G V+ G G+ VAVK E +TEI H N++ +
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 510 YSFDVSNKI----LVYEYMSNGSLADV---YSSPPKNNL---IGIARGILYLHDECESQ- 558
+ L+ +Y NGSL D + K+ L G+ +LH E S
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 559 ----IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF---TGIRGTRGYVAPE-- 609
I H D+K +NIL+ +N I+D LA D GT+ Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 610 ----WHWNLPITAKADVYSFGVVLLEIICC----------RRCFDQNLPEDQVILEEWVY 655
+ AD+YSFG++L E+ + + +P D +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
C + + + L +M K+ C P+ R + +V L
Sbjct: 279 VCIKKLRPS--FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 67/293 (22%), Positives = 110/293 (37%), Gaps = 42/293 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTE--IKAIGRTHHRNLVRL 507
+E IG+G G V++G G+ VAVK + ER + E I H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 508 LGYSFDVSNKI----LVYEYMSNGSLADV---YSSPPKNNL---IGIARGILYLHDECES 557
+ + LV +Y +GSL D Y+ + + + A G+ +LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 558 Q-----IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF---TGIRGTRGYVAPE 609
I H D+K +NIL+ +N I+D LA GT+ Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 610 ------WHWNLPITAKADVYSFGVVLLEIICC----------RRCFDQNLPEDQVILEEW 653
+ +AD+Y+ G+V EI + + +P D + E
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
C + I + + L M K+ C + R + ++ L
Sbjct: 282 KVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 66/292 (22%), Positives = 113/292 (38%), Gaps = 40/292 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQ--TEIKAIGRTHHRNLVRL 507
E +G+G G V++G+ G+ VAVK + E+ + TE+ H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 508 LGYSFDVSNKI----LVYEYMSNGSLADV---YSSPPKNNL---IGIARGILYLHDECES 557
+ + L+ Y GSL D + + L + IA G+ +LH E
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 558 Q-----IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR---TFTGIRGTRGYVAPE 609
I H D+K +NIL+ +N I+D LA + + GT+ Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 610 ------WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ--CFEN- 660
+ D+++FG+VL E + R + + + + + V FE+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 661 ----GNLGQ--LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
Q I + L + K+ C PS R + ++ L
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 70/276 (25%), Positives = 111/276 (40%), Gaps = 44/276 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLL 508
K+ +G G+ GT+ M + + VAVKR+ E E++ + H N++R
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYF 84
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSP--------PKNNLIGIARGILYLHDECESQII 560
D + + E + +L + P L G+ +LH I+
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 561 HCDIKPQNILMDE-----NRYAKISDFALAKLMKPDQ--TRTFTGIRGTRGYVAPE---W 610
H D+KP NIL+ A ISDF L K + + +G+ GT G++APE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 611 HWNLPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669
T D++S G V +I F ++L IL +L L +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-------GACSLDCLHPE 253
Query: 670 EDVDK--KQL-ERMIKVALWCILDEPSLRPSMKKVL 702
+ D ++L E+MI + +P RPS K VL
Sbjct: 254 KHEDVIARELIEKMIAM-------DPQKRPSAKHVL 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 33/269 (12%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
F EIGRGS TVYKG VA + +K+ + F+ E + + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 507 LLGYSFDVSNK----ILVYEYMSNGSLADVYSSPPKNNLIGIAR-------GILYLHDEC 555
+LV E M++G+L + + G+ +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 556 ESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
IIH D+K NI + KI D LA L + + GT ++APE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMYEE- 204
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED-EDVD 673
DVY+FG+ +LE+ + + + Q + G + V
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSE---------CQNAAQIYRRVTSGVKPASFDKVA 255
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVL 702
+++ +I+ CI R S+K +L
Sbjct: 256 IPEVKEIIE---GCIRQNKDERYSIKDLL 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 39/274 (14%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGE--REFQTEIKAIG--RTHHRNLVRL 507
++IG G S V++ + A+K + A+ + ++ EI + + H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 508 LGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIAR----GILYLHDECESQII 560
Y +V E N L S + + +H I+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 130
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGYVAPE---------- 609
H D+KP N L+ + K+ DF +A M+PD T GT Y+ PE
Sbjct: 131 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 610 -WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668
I+ K+DV+S G +L + + F Q + + + + IE
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQISKLHAIIDPNHEIE 241
Query: 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
D+ +K L+ ++K C+ +P R S+ ++L
Sbjct: 242 FPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-34
Identities = 75/297 (25%), Positives = 109/297 (36%), Gaps = 65/297 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLL 508
++ +G GSSGTV G+ VAVKR+ + EIK + + H N++R
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSP--------------PKNNLIGIARGILYLHDE 554
+ E N +L D+ S P + L IA G+ +LH
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 555 CESQIIHCDIKPQNILMD-------------ENRYAKISDFALAKLMKPDQ---TRTFTG 598
+IIH D+KPQNIL+ EN ISDF L K + Q
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 599 IRGTRGYVAPE-------WHWNLPITAKADVYSFGVVLLEIICC-RRCFDQNLPEDQVIL 650
GT G+ APE +T D++S G V I+ + F + I+
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 651 EEWVYQCFENGNLGQLIEDEDVDK----KQL-ERMIKVALWCILDEPSLRPSMKKVL 702
+L ++ D L +MI +P RP+ KVL
Sbjct: 252 R-------GIFSLDEMKCLHDRSLIAEATDLISQMIDH-------DPLKRPTAMKVL 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 39/274 (14%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKR--LQKMLAEGEREFQTEIKAIG--RTHHRNLVRL 507
++IG G S V++ + A+K L++ + ++ EI + + H ++RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 508 LGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIAR----GILYLHDECESQII 560
Y +V E N L S + + +H I+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 149
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGYVAPE---------- 609
H D+KP N L+ + K+ DF +A M+PD T GT Y+ PE
Sbjct: 150 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 610 -WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668
I+ K+DV+S G +L + + F Q + + + + IE
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQISKLHAIIDPNHEIE 260
Query: 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
D+ +K L+ ++K C+ +P R S+ ++L
Sbjct: 261 FPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 61/276 (22%), Positives = 106/276 (38%), Gaps = 46/276 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
IG GS G K +GK + K M ++ +E+ + H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 509 GYSFDVSNKIL--VYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHDEC 555
D +N L V EY G LA V + K + + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 556 ES--QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ ++H D+KP N+ +D + K+ DF LA+++ D + T + GT Y++PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFD-QNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672
+ K+D++S G +L E+ F + E L I +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------------LAGKIREGKF 233
Query: 673 DK------KQLERMIKVALWCILDEPSLRPSMKKVL 702
+ +L +I + + RPS++++L
Sbjct: 234 RRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 39/274 (14%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKR--LQKMLAEGEREFQTEIKAIG--RTHHRNLVRL 507
++IG G S V++ + A+K L++ + ++ EI + + H ++RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 508 LGYSFDVSNKILVYEYMSNGSLADV---YSSPPKNNLIGIAR----GILYLHDECESQII 560
Y +V E N L S + + +H I+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIV 177
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGYVAPE---------- 609
H D+KP N L+ + K+ DF +A M+PD T G Y+ PE
Sbjct: 178 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 610 -WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668
I+ K+DV+S G +L + + F Q + + + + IE
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQISKLHAIIDPNHEIE 288
Query: 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
D+ +K L+ ++K C+ +P R S+ ++L
Sbjct: 289 FPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 319
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 35/284 (12%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
+ +G+G++ V++G G A+K + + E + + + +H+N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 508 LGYSFDVSNK--ILVYEYMSNGSLADVYSSPPKNNLIG----------IARGILYLHDEC 555
+ + + +L+ E+ GSL V P + + G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-- 609
E+ I+H +IKP NI+ D K++DF A+ ++ D+ F + GT Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMY 187
Query: 610 ------WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663
A D++S GV F + +E +Y+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245
Query: 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL-LMLE 706
G + + + ++ + + C L L+ + VL +LE
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVLANILE 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 59/292 (20%), Positives = 114/292 (39%), Gaps = 47/292 (16%)
Query: 431 EDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVK--RLQKMLAEGER 487
D+ + + +EK ++IG GS G +G+ +K + +M ++
Sbjct: 11 VDLGTENLYFQSMEKYV--RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 488 EFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL----- 541
E + E+ + H N+V+ SF+ + + +V +Y G L ++
Sbjct: 69 ESRREVAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 542 ----IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597
+ I + ++HD +I+H DIK QNI + ++ ++ DF +A+++
Sbjct: 128 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD-QNLPEDQVILEEWVYQ 656
I GT Y++PE N P K+D+++ G VL E+ + F+ ++
Sbjct: 185 CI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----------- 232
Query: 657 CFENGNLGQLIEDEDVDK------KQLERMIKVALWCILDEPSLRPSMKKVL 702
L I L ++ P RPS+ +L
Sbjct: 233 ------LVLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSIL 275
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 35/284 (12%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
+ +G+G++ V++G G A+K + + E + + + +H+N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 508 LGYSFDVSNK--ILVYEYMSNGSLADVYSSPPKNNLIG----------IARGILYLHDEC 555
+ + + +L+ E+ GSL V P + + G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-- 609
E+ I+H +IKP NI+ D K++DF A+ ++ D+ F + GT Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMY 187
Query: 610 ------WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663
A D++S GV F + +E +Y+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245
Query: 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL-LMLE 706
G + + + ++ + + C L L+ + VL +LE
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVLANILE 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 51/277 (18%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVK--RLQKMLAEGEREF-QTEIKAIGRTHHRNLVRL 507
++IGRG VY+ + +G VA+K ++ ++ R EI + + +H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 508 LGYSFDVSNKILVY-EYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHDEC 555
SF N++ + E G L+ + K + + + ++H
Sbjct: 98 YA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
+++H DIKP N+ + K+ D L + T + + GT Y++PE
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212
Query: 616 ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL---IEDEDV 672
K+D++S G +L E+ + F + NL L IE D
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYG-----------------DKMNLYSLCKKIEQCDY 255
Query: 673 DK-------KQLERMIKVALWCILDEPSLRPSMKKVL 702
++L +++ CI +P RP + V
Sbjct: 256 PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVY 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 59/287 (20%), Positives = 104/287 (36%), Gaps = 61/287 (21%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKR--LQKMLAEGEREFQTEIKAIGR-THHRNLVRL 507
E+IG G G+V+K ++G A+KR + E+ E+ A H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 508 LGYSFDVSNKILVY-EYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHDEC 555
++ + +L+ EY + GSLAD S + L+ + RG+ Y+H
Sbjct: 77 FS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM- 134
Query: 556 ESQIIHCDIKPQNILMDEN-------------------RYAKISDFALAKLMKPDQTRTF 596
++H DIKP NI + KI D + Q
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE- 191
Query: 597 TGIRGTRGYVAPE-WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY 655
G ++A E N KAD+++ + ++ ++W
Sbjct: 192 ----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--------DQW-- 237
Query: 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
G L ++ V ++ ++K I +P RPS ++
Sbjct: 238 HEIRQGRLPRI---PQVLSQEFTELLK---VMIHPDPERRPSAMALV 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 437 SFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF-QTEIK 494
+ EK+ E+G G+ G V+K + +G +A K + + R E++
Sbjct: 29 ELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 495 AIGRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNLIGIARGIL- 549
+ + +V G +F +I + E+M GSL V P+ L ++ ++
Sbjct: 84 VLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142
Query: 550 ---YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYV 606
YL ++ +I+H D+KP NIL++ K+ DF ++ + +F GTR Y+
Sbjct: 143 GLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYM 197
Query: 607 APEWHWNLPITAKADVYSFGVVLLEI 632
+PE + ++D++S G+ L+E+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/286 (20%), Positives = 102/286 (35%), Gaps = 53/286 (18%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+ +GRG G V++ ++ A+KR++ E RE E+KA+ + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 510 YSFD---------VSNKILVY---EYMSNGSLADV-----YSSPPKNNLIG-----IARG 547
+ S K+ +Y + +L D + ++ IA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-----------TF 596
+ +LH + ++H D+KP NI + K+ DF L M D+
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656
TG GT+ Y++PE + K D++S G++L E+ Q
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVR-------TLT 238
Query: 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
N L M++ + P RP ++
Sbjct: 239 DVRNLKFPPLFTQ---KYPCEYVMVQ---DMLSPSPMERPEAINII 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRL 507
+++G G TVY I VA+K + E E + F+ E+ + H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNL---IGIARGILYLHDECESQII 560
+ + LV EY+ +L++ S + I GI + H + +I+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPITAK 619
H DIKPQNIL+D N+ KI DF +AK + + + T T + GT Y +PE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 620 ADVYSFGVVLLEIICCRRCFD 640
D+YS G+VL E++ F+
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFN 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 59/280 (21%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E IG G G V+K I+GK +KR++ + + E+KA+ + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 511 SFDVSNKI----------------LVYEYMSNGSLADVYSSPPKNNL---------IGIA 545
+ E+ G+L L I
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGY 605
+G+ Y+H + ++I+ D+KP NI + + + KI DF L +K D R T +GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 187
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
++PE + + D+Y+ G++L E++ FE
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTA------------------FETSKFFT 229
Query: 666 LIEDEDVDK---KQLERMIKVALWCILDEPSLRPSMKKVL 702
+ D + K+ + +++ + +P RP+ ++L
Sbjct: 230 DLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEIL 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 46/197 (23%), Positives = 72/197 (36%), Gaps = 23/197 (11%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQK--MLAEGEREFQTEIKAIGR-THHRNLVRL 507
+G GS G V+K +G+ AVKR + E+ + + H VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQ 558
+++ + L E SL + L + +LH
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QG 177
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLM-KPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
++H D+KP NI + K+ DF L + G Y+APE
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQGSYG 233
Query: 618 AKADVYSFGVVLLEIIC 634
ADV+S G+ +LE+ C
Sbjct: 234 TAADVFSLGLTILEVAC 250
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 13/190 (6%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTVY + G+ VA++++ + EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPP-KNNLIG-IARGIL----YLHDECESQIIHCD 563
S+ V +++ +V EY++ GSL DV + I + R L +LH Q+IH D
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
IK NIL+ + K++DF + P+Q++ T + GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 624 SFGVVLLEII 633
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 15/191 (7%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+IG GS+G V +G+ VAVK + + E+ + H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK- 109
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIA-------RGILYLHDECESQIIHC 562
S+ V ++ ++ E++ G+L D+ S N IA + + YLH + +IH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-IATVCEAVLQALAYLHAQ---GVIHR 165
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
DIK +IL+ + K+SDF + D + + + GT ++APE + D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDI 224
Query: 623 YSFGVVLLEII 633
+S G++++E++
Sbjct: 225 WSLGIMVIEMV 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 62/304 (20%), Positives = 108/304 (35%), Gaps = 56/304 (18%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
F +++G G V + +G F A+KR+ + E Q E +H N++RL+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 509 GYSFDVSNK----ILVYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHD 553
Y L+ + G+L + L+GI RG+ +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTGI------RGTRGY 605
+ H D+KP NIL+ + + D + +R + R T Y
Sbjct: 153 K---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 606 VAPE-WHW--NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN 662
APE + + I + DV+S G VL ++ +D F+ G+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV---------------FQKGD 254
Query: 663 LGQLIEDEDVDK-------KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPP 715
L + L +++ + +P RP + +L LE + P P
Sbjct: 255 SVALAVQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLE-ALQPPAPG 310
Query: 716 NPTS 719
T+
Sbjct: 311 QHTT 314
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 432 DIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQT 491
A L + E++ F +E+G G G V G VA+K + K + E EF
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIE 68
Query: 492 EIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIAR 546
E K + H LV+L G ++ EYM+NG L + Y L+ + +
Sbjct: 69 EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCK 127
Query: 547 GI----LYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG--- 598
+ YL ES+ +H D+ +N L+++ K+SDF L++ + D+ + G
Sbjct: 128 DVCEAMEYL----ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 183
Query: 599 -IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
+R + PE ++K+D+++FGV++ EI
Sbjct: 184 PVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 26/206 (12%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
KE +G G G V + G+ VA+K+ ++ L+ RE + EI+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 508 L------GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIG----------IARGILYL 551
+L EY G L + + I+ + YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 552 HDECESQIIHCDIKPQNILMDENRYA---KISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
H E++IIH D+KP+NI++ KI D AK + + T GT Y+AP
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAP 192
Query: 609 EWHWNLPITAKADVYSFGVVLLEIIC 634
E T D +SFG + E I
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 18/192 (9%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
+G+G+ G VY G + N +A+K + + + + EI H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 513 DVSNKILVYEYMSNGSLADVYSS-----PPKNNLIG-----IARGILYLHDECESQIIHC 562
+ + E + GSL+ + S IG I G+ YLHD QI+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 563 DIKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE--WHWNLPITAK 619
DIK N+L++ + KISDF +K + T T GT Y+APE
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKA 205
Query: 620 ADVYSFGVVLLE 631
AD++S G ++E
Sbjct: 206 ADIWSLGCTIIE 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ ++G+G G V+ GT VA+K L K F E + + + H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 510 YSFDVSNK--ILVYEYMSNGSLADVY------SSPPKNNLIGIARGI----LYLHDECES 557
VS + +V EYMS GSL D + L+ +A I Y+
Sbjct: 247 V---VSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 299
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+H D++ NIL+ EN K++DF LA+L++ ++ G + + APE T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 618 AKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649
K+DV+SFG++L E+ R + +V+
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
F +EIG G G V+ G +N VA+K + + A E +F E + + + H LV+L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 510 YSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDECESQ-I 559
+ + LV E+M +G L+D Y L+G+ + YL E +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACV 125
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHWNLP 615
IH D+ +N L+ EN+ K+SDF + + + DQ + TG ++ +PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181
Query: 616 ITAKADVYSFGVVLLEII 633
++K+DV+SFGV++ E+
Sbjct: 182 YSSKSDVWSFGVLMWEVF 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 35/215 (16%), Positives = 69/215 (32%), Gaps = 33/215 (15%)
Query: 450 FKEEIGRGSSGTVYKGT------MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
+G G+ VY+ T N + +K + ++ + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------------LIGIARGILYL 551
++ + +LV E S G+L + + + + I +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 552 HDECESQIIHCDIKPQNILM-----------DENRYAKISDFALAKLMKP-DQTRTFTGI 599
H + +IIH DIKP N ++ D + + D + MK + FT
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC 634
T G+ E N P + D + + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
+G+G+ G V K ++ ++ A+K+++ E + +E+ + +H+ +VR
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 508 LGYSFDVSNKI-------------LVYEYMSNGSLADV----YSSPPKNNLIGIAR---- 546
+ N + + EY NG+L D+ + ++ + R
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR------ 600
+ Y+H + IIH D+KP NI +DE+R KI DF LAK + +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 601 -------GTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652
GT YVA E K D+YS G++ E+I E IL+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGM--ERVNILK- 239
Query: 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+ + ++ + +D K +++I+ I +P+ RP + +L
Sbjct: 240 ---KLR-SVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLL 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 27/197 (13%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+ +GRGS G V++ G AVK RL+ E E+ A +V L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPL 115
Query: 508 LGYSFDVSNKILVY-EYMSNGSLADVYSS--PPKNNLIG-----IARGILYLHDECESQI 559
G + + ++ E + GSL + + G+ YLH +I
Sbjct: 116 YG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 560 IHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHWNL 614
+H D+K N+L+ + A + DF A ++PD I GT ++APE
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 615 PITAKADVYSFGVVLLE 631
P AK D++S ++L
Sbjct: 232 PCDAKVDIWSSCCMMLH 248
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 26/201 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-VAVKRL-QKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
E+IGRG+ G V+ G + VAVK + + + + +F E + + + H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLI----GIARGILYLHDECESQ 558
+G +V E + G + + L+ A G+ YL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVAPE-WHW 612
IH D+ +N L+ E KISDF +++ G ++ T APE ++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 613 NLPITAKADVYSFGVVLLEII 633
++++DV+SFG++L E
Sbjct: 290 GR-YSSESDVWSFGILLWETF 309
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-30
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ ++G+G G V+ GT VA+K L K F E + + + H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 510 YSFDVSNK--ILVYEYMSNGSLADVY------SSPPKNNLIGIARGI----LYLHDECES 557
VS + +V EYMS GSL D + L+ +A I Y+ E
Sbjct: 330 V---VSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV----ER 381
Query: 558 Q-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H D++ NIL+ EN K++DF LA+L++ ++ G + + APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649
T K+DV+SFG++L E+ R + +V+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 14/194 (7%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-VAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
K ++G G G VY+G VAVK L K EF E + H NLV+LL
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQI 559
G ++ E+M+ G+L D + + I+ + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
IH ++ +N L+ EN K++DF L++LM D G + + APE + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 620 ADVYSFGVVLLEII 633
+DV++FGV+L EI
Sbjct: 400 SDVWAFGVLLWEIA 413
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 24/198 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+E+G G G V G VAVK + K + E EF E + + + H LV+ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 510 YSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDECESQ-I 559
+V EY+SNG L + Y + L+ + + +L ES
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQF 125
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHWNLP 615
IH D+ +N L+D + K+SDF + + + DQ + G ++ + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 616 ITAKADVYSFGVVLLEII 633
++K+DV++FG+++ E+
Sbjct: 182 YSSKSDVWAFGILMWEVF 199
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 436 LSFSYAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEI 493
+ +LE + E+GRG+ G V K + +G+ +AVKR++ + E++ ++
Sbjct: 2 MEVKADDLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 494 KAIGRT-HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN-------LIGI 544
RT V G + + + E M + SL Y L I
Sbjct: 57 DISMRTVDCPFTVTFYG-ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 545 ARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGI 599
A I+ +LH + +IH D+KP N+L++ K+ DF + L+
Sbjct: 115 AVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-- 170
Query: 600 RGTRGYVAPE----WHWNLPITAKADVYSFGVVLLEI 632
G + Y+APE + K+D++S G+ ++E+
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 42/212 (19%)
Query: 450 FKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL 504
+ ++G+G+ G+V G VAVK+LQ + +R+FQ EI+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 505 VRLLGYSFDVSNK--ILVYEYMSNGSLAD-VYSSPPK---NNLIG----IARGILYLHDE 554
V+ G S+ + LV EY+ +G L D + + + L+ I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
+ +H D+ +NIL++ + KI+DF LAKL+ D+ YV E
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----------YYVVRE-PGQS 192
Query: 615 PI-------------TAKADVYSFGVVLLEII 633
PI + ++DV+SFGVVL E+
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRL 507
E +G G V+ + + + VAVK L+ LA F+ E + +H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 508 LGYSFDVSNKI----LVYEYMSNGSLADVYSS----PPKNNL---IGIARGILYLHDECE 556
+ +V EY+ +L D+ + PK + + + + H +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTG-IRGTRGYVAPEWHWNL 614
+ IIH D+KP NI++ K+ DF +A+ + + T T + GT Y++PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 615 PITAKADVYSFGVVLLEIICCRRCFD 640
+ A++DVYS G VL E++ F
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 436 LSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-FQTEI 493
F+ +L+ + EIGRG+ G+V K +G+ +AVKR++ + E E++ ++
Sbjct: 17 WDFTAEDLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 494 KAIGRT-HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKN-------NLIG- 543
+ R+ +V+ G + + E M + S Y ++G
Sbjct: 72 DVVMRSSDCPYIVQFYG-ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 544 IARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599
I + +L + +IIH DIKP NIL+D + K+ DF ++ + +T
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA- 186
Query: 600 RGTRGYVAPE----WHWNLPITAKADVYSFGVVLLEI 632
G R Y+APE ++DV+S G+ L E+
Sbjct: 187 -GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 63/297 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL 504
F +++G+G+ G+V G+ VAVK+LQ E R+F+ EI+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 505 VRLLG--YSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHD 553
V+ G YS N L+ EY+ GSL D Y K + I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ IH D+ +NIL++ KI DF L K++ D+ + E
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----------FFKVKE-PGE 178
Query: 614 LPI-------------TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660
PI + +DV+SFGVVL E+ E ++
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 661 GNLGQLIEDEDVDKKQLER-----------MIKVALWCILDEPSLRPSMKKVLLMLE 706
+L +L++ + +L R M + C + + RPS + + L ++
Sbjct: 239 FHLIELLK----NNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 34/201 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG--EREFQTEIKAIGRTHHRNLVRL 507
+ IG+G G V G G VAVK + + F E + + H NLV+L
Sbjct: 197 LLQTIGKGEFGDVMLG-DYRGNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECES 557
LG + + +V EYM+ GSL D S ++ L + + + YL E
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EG 307
Query: 558 Q-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHW 612
+H D+ +N+L+ E+ AK+SDF L K + + T ++ T APE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEALR 359
Query: 613 NLPITAKADVYSFGVVLLEII 633
+ K+DV+SFG++L EI
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 63/297 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL 504
F +++G+G+ G+V G+ VAVK+LQ E R+F+ EI+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 505 VRLLG--YSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHD 553
V+ G YS N L+ EY+ GSL D Y L+ I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYLG- 162
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ IH D+ +NIL++ KI DF L K++ D+ Y E
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----------YYKVKE-PGE 209
Query: 614 LPI-------------TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660
PI + +DV+SFGVVL E+ E ++
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 661 GNLGQLIEDEDVDKKQLER-----------MIKVALWCILDEPSLRPSMKKVLLMLE 706
+L +L++ + +L R M + C + + RPS + + L ++
Sbjct: 270 FHLIELLK----NNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 16/191 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EE+G G+ G V++ G+ K + + + EI + + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 509 GYSFDVSNKILVYEYMSNGSLAD-------VYSSPPKNNLIG-IARGILYLHDECESQII 560
D +L+ E++S G L D S N + G+ ++H E I+
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 171
Query: 561 HCDIKPQNILM--DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H DIKP+NI+ + KI DF LA + PD+ T + APE P+
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 229
Query: 619 KADVYSFGVVL 629
D+++ GV+
Sbjct: 230 YTDMWAIGVLG 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 28/200 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
++++G G G V+ T VAVK + K + F E + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 510 YSFDVSNK--ILVYEYMSNGSLAD-----VYSSPPKNNLIGIARGI----LYLHDECESQ 558
V+ + ++ E+M+ GSL D S P LI + I ++ E +
Sbjct: 251 V---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI----EQR 303
Query: 559 -IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHWN 613
IH D++ NIL+ + KI+DF LA++++ ++ G I+ T APE
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINF 359
Query: 614 LPITAKADVYSFGVVLLEII 633
T K+DV+SFG++L+EI+
Sbjct: 360 GSFTIKSDVWSFGILLMEIV 379
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 70/297 (23%), Positives = 111/297 (37%), Gaps = 65/297 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
++G G G V G+ VAVK L+ R ++ EI + +H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 504 LVRLLG--YSFDVSNKILVYEYMSNGSLADVY---SSPPKNNLIG----IARGILYLHDE 554
+++ G ++ LV EY+ GSL D Y S L+ I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLH-- 151
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
IH D+ +N+L+D +R KI DF LAK + Y E +
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----------YYRVRE-DGDS 199
Query: 615 PI-------------TAKADVYSFGVVLLEII-CCRRCFDQNLPEDQVILEEWVYQCFEN 660
P+ +DV+SFGV L E++ C ++I
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTV 257
Query: 661 GNLGQLIEDEDVDKKQLER-----------MIKVALWCILDEPSLRPSMKKVLLMLE 706
L +L+E ++L R M C E S RP+ + ++ +L+
Sbjct: 258 LRLTELLE----RGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILK 306
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 65/298 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
++G G G V G+ VAVK L+ + + EI+ + +H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 504 LVRLLG--YSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLH 552
+V+ G + L+ E++ +GSL + Y KN + + I +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
Q +H D+ +N+L++ KI DF L K ++ D+ Y +
Sbjct: 144 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE----------YYTVKD-DR 189
Query: 613 NLPI-------------TAKADVYSFGVVLLEII-CCRRCFDQNLPEDQVILEEWVYQCF 658
+ P+ +DV+SFGV L E++ C ++I +
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT--HGQM 247
Query: 659 ENGNLGQLIEDEDVDKKQLERMIK----------VALWCILDEPSLRPSMKKVLLMLE 706
L ++ + +R+ + C +PS R S + ++ E
Sbjct: 248 TVTRLVNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 50/226 (22%), Positives = 84/226 (37%), Gaps = 29/226 (12%)
Query: 452 EEIGRGSSGTVYKG--TMINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLL 508
I G G +Y +NG+ V +K L + E + + H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 509 GYSFDVSNKI-----LVYEYMSNGSLADVYSSP-PKNNLIGIARGIL----YLHDECESQ 558
+ +V EY+ SL P I IL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIG 202
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
+++ D+KP+NI++ E + K+ D + + + GT G+ APE P T
Sbjct: 203 LVYNDLKPENIMLTEEQ-LKLIDLGAVSRI--NSFGY---LYGTPGFQAPEIVRTGP-TV 255
Query: 619 KADVYSFGVVLLEIICCRRCFD----QNLPEDQVILEEWVYQCFEN 660
D+Y+ G L + + LPED +L+ Y +
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK--TYDSYGR 299
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 31/205 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK---------MLAEGEREFQTEIKAIGR- 498
KE +GRG S V + K AVK + + E E+ + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 499 THHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILY 550
+ H N+++L ++ + LV++ M G L D S ++ + I
Sbjct: 81 SGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE- 609
LH I+H D+KP+NIL+D++ K++DF + + P + + GT Y+APE
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEI 194
Query: 610 -----WHWNLPITAKADVYSFGVVL 629
+ + D++S GV++
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 28/244 (11%), Positives = 59/244 (24%), Gaps = 54/244 (22%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE---FQTEIKAIGRTHHRNLV 505
E + G V+ + + A+K E A R +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 506 RLLGY--------------------------SFDVSNKILVYEYMSNGSLADVYSSPPKN 539
+ V+N +L+ S L ++S+
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 540 NLIG--------------IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585
+ + R L + ++H P N+ + + + D +
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 586 KLMKPDQTRTFTGIRGTRGYVAPEW--HWNLPITAKADVYSFGVVLLEIICCRRCFDQNL 643
K + Y E+ T + + G+ + + C F
Sbjct: 242 W--KVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 644 PEDQ 647
P +
Sbjct: 298 PGIK 301
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
E +G G G V+ G VAVK L K + F E + + H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 510 YSFDVSNK--ILVYEYMSNGSLADVY------SSPPKNNLIG----IARGILYLHDECES 557
V+ + ++ EYM NGSL D + N L+ IA G+ ++ E
Sbjct: 76 V---VTQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFI----EE 127
Query: 558 Q-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHW 612
+ IH D++ NIL+ + KI+DF LA+L++ ++ G I+ T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 613 NLPITAKADVYSFGVVLLEII 633
T K+DV+SFG++L EI+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIV 204
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 40/191 (20%), Positives = 82/191 (42%), Gaps = 17/191 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E++GRG G V++ + K K ++ + + EI + HRN++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLH 67
Query: 509 GYSFDVSNKILVYEYMSNGSLAD-------VYSSPPKNNLIG-IARGILYLHDECESQII 560
+ ++++E++S + + + + + + + +LH I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 561 HCDIKPQNILM--DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H DI+P+NI+ + KI +F A+ +KP F + Y APE H + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 619 KADVYSFGVVL 629
D++S G ++
Sbjct: 183 ATDMWSLGTLV 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 19/192 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
F E +G G+ V+ GK A+K ++K A + + EI + + H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 509 GYSFDVSNKI-LVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQII 560
++ + LV + +S G L D VY+ + +I + + YLH+ I+
Sbjct: 73 DI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIV 128
Query: 561 HCDIKPQNIL---MDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
H D+KP+N+L +EN I+DF L+K+ + T GT GYVAPE P +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---GTPGYVAPEVLAQKPYS 185
Query: 618 AKADVYSFGVVL 629
D +S GV+
Sbjct: 186 KAVDCWSIGVIT 197
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRL 507
+GRG G VY+ + + VA+K + + L+ Q E + GR ++V +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 508 LGYSFDVSNKI--LVYEYMSNGSLADVYSS----PPKNNL---IGIARGILYLHDECESQ 558
+ F + + ++ LA + P + I + H +
Sbjct: 100 --HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPIT 617
H D+KP+NIL+ + +A + DF +A D+ T G GT Y+APE T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 618 AKADVYSFGVVLLEIICCRRCFD 640
+AD+Y+ VL E + +
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQ 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
+ +G G+ GTVYKG I VA+K L++ + E E + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDE 554
+ RLLG + ++ + + M G L D Y K+N+ + IA+G+ YL
Sbjct: 79 VCRLLGICLTSTVQL-ITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKP-DQTRTFTG----IRGTRGYVAP 608
E + ++H D+ +N+L+ ++ KI+DF LAKL+ ++ G I+ A
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----AL 188
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E + T ++DV+S+GV + E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 36/202 (17%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG--EREFQTEIKAIGRTHHRNLVRL 507
+ IG+G G V G G VAVK + + F E + + H NLV+L
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVY------SSPPKNNLI----GIARGILYLHDECE 556
LG + + +V EYM+ GSL D Y S + L+ + + YL E
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL----E 134
Query: 557 SQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWH 611
+H D+ +N+L+ E+ AK+SDF L K + + T ++ T APE
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEAL 186
Query: 612 WNLPITAKADVYSFGVVLLEII 633
+ K+DV+SFG++L EI
Sbjct: 187 REKKFSTKSDVWSFGILLWEIY 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGER------EFQTEIKAIGRTHHR 502
EE+G G V K G A K ++K + R E + E+ + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDEC 555
N++ L + ++ +L+ E +S G L D S + I I G+ YLH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+I H D+KP+NI++ + K+ DF LA ++ F I GT +VAPE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIV 190
Query: 612 WNLPITAKADVYSFGVVL 629
P+ +AD++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G+G ++ + + A K + K +L +RE EI H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQIIHC 562
+ D +V E SL +++ L I G YLH ++IH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 139
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D+K N+ ++E+ KI DF LA ++ D R + GT Y+APE + + DV
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 623 YSFGVVLLEIICCRRCF-DQNLPE 645
+S G ++ ++ + F L E
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
E +G G G V+K G +A K ++ + + E + EI + + H NL++L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 508 LGYSFDVSNKILVYEYMSNGSLAD-------VYSSPPKNNLIG-IARGILYLHDECESQI 559
++ +LV EY+ G L D + + I GI ++H + I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYI 208
Query: 560 IHCDIKPQNILMDENRYA--KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+H D+KP+NIL KI DF LA+ KP + GT ++APE ++
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVS 266
Query: 618 AKADVYSFGVVL 629
D++S GV+
Sbjct: 267 FPTDMWSVGVIA 278
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 63/191 (32%), Positives = 96/191 (50%), Gaps = 14/191 (7%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
E+IG+GS G V+KG K VA+K + AE E E Q EI + + + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 510 YSFDVSNKI-LVYEYMSNGSLADVYSSPP-KNNLIG-IARGIL----YLHDECESQIIHC 562
S+ K+ ++ EY+ GS D+ P I I R IL YLH E + IH
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHR 143
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
DIK N+L+ E+ K++DF +A + Q + T + GT ++APE +KAD+
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADI 202
Query: 623 YSFGVVLLEII 633
+S G+ +E+
Sbjct: 203 WSLGITAIELA 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+G G+ G VYK G A K ++ E ++ EI+ + H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG- 83
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKN---NLIG-IARGIL----YLHDECESQIIH 561
++ K+ ++ E+ G++ + + I + R +L +LH + +IIH
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-----WHWNLPI 616
D+K N+LM +++DF ++ + + I GT ++APE + P
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 617 TAKADVYSFGVVLLEII 633
KAD++S G+ L+E+
Sbjct: 200 DYKADIWSLGITLIEMA 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGER------EFQTEIKAIGRTHHR 502
EE+G G V K GK A K ++K R E + E+ + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDEC 555
N++ L + ++ +L+ E +S G L D + + I G+ YLH
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+I H D+KP+NI++ N K+ DF +A ++ F I GT +VAPE
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIV 183
Query: 612 WNLPITAKADVYSFGVVL 629
P+ +AD++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVIT 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E++G GS G+VYK G+ VA+K++ + +E EI + + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG- 91
Query: 511 SFDVSNKI-LVYEYMSNGSLADVYSSPPKN---NLIG-IARGIL----YLHDECESQIIH 561
S+ + + +V EY GS++D+ K + I I + L YLH + IH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
DIK NIL++ +AK++DF +A + + T I GT ++APE + AD
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVAD 207
Query: 622 VYSFGVVLLEII 633
++S G+ +E+
Sbjct: 208 IWSLGITAIEMA 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 46/211 (21%), Positives = 75/211 (35%), Gaps = 37/211 (17%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF--------VAVKRLQKMLAEGEREFQTEIKAIGRTHH 501
F E +G+G+ ++KG V +K L K F + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLH 552
++LV G ILV E++ GSL Y + + +A+ + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDT-YLKKNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 553 DECESQ-IIHCDIKPQNILMD--------ENRYAKISDFALAKLMKPDQTRTFTGIRGTR 603
E +IH ++ +NIL+ + K+SD ++ + P I
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER-IPWV- 184
Query: 604 GYVAPEWHWNLPI-TAKADVYSFGVVLLEII 633
PE N D +SFG L EI
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 63/200 (31%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-VAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
K ++G G G VY+G VAVK L K EF E + H NLV+LL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 509 GYSFDVSNKILVYEYMSNGSLADVY------SSPPKNNLI----GIARGILYLHDECESQ 558
G ++ E+M+ G+L D Y L+ I+ + YL E +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYL----EKK 130
Query: 559 -IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAPEWHWN 613
IH D+ +N L+ EN K++DF L++LM D G I+ T APE
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 186
Query: 614 LPITAKADVYSFGVVLLEII 633
+ K+DV++FGV+L EI
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G+G ++ + + A K + K +L +RE EI H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQIIHC 562
+ D +V E SL +++ L I G YLH ++IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 165
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D+K N+ ++E+ KI DF LA ++ D R + GT Y+APE + + DV
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 623 YSFGVVLLEIICCRRCF-DQNLPE 645
+S G ++ ++ + F L E
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKE 248
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 16/191 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EE+G G+ G V++ T G A K + + + EI+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 509 GYSFDVSNKILVYEYMSNGSLAD-------VYSSPPKNNLIG-IARGILYLHDECESQII 560
D + +++YE+MS G L + S + + +G+ ++H E+ +
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYV 277
Query: 561 HCDIKPQNILMDENRYA--KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H D+KP+NI+ R K+ DF L + P Q + GT + APE P+
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 619 KADVYSFGVVL 629
D++S GV+
Sbjct: 336 YTDMWSVGVLS 346
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 44/213 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
F E IGRG G VY GT+++ AVK L ++ GE +F TE + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 505 VRLLGYSFDVSNKIL-VYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHDE 554
+ LLG L V YM +G L + + +P +LIG +A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
S+ +H D+ +N ++DE K++DF LA+ M + + G +
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK---------- 193
Query: 614 LPI-------------TAKADVYSFGVVLLEII 633
LP+ T K+DV+SFGV+L E++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 45/213 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
++ IG G G VYKG + VA+K L+ E +R +F E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDE 554
++RL G +++ EYM NG+L + L+G+ RGI YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
+ +H D+ +NIL++ N K+SDF L+++++ D T+T G +
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SGGK---------- 211
Query: 614 LPI-------------TAKADVYSFGVVLLEII 633
+PI T+ +DV+SFG+V+ E++
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 46/205 (22%), Positives = 79/205 (38%), Gaps = 27/205 (13%)
Query: 452 EEIGRGSS--GTVYKGTMI-NGKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVR 506
IG+G TV G++V V+R L+ E Q E+ +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL----IG-IARGIL----YLHDECE 556
+F N++ +V +M+ GS D+ + + + I I +G+L Y+H
Sbjct: 91 YRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-- 147
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYV------APE- 609
+H +K +IL+ + +S M R + V +PE
Sbjct: 148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 610 -WHWNLPITAKADVYSFGVVLLEII 633
AK+D+YS G+ E+
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELA 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 53/195 (27%), Positives = 83/195 (42%), Gaps = 21/195 (10%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGR-THHRNLVR 506
+E+GRG V + G+ A K L+K + E EI + ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD--------VYSSPPKNNLIG-IARGILYLHDECES 557
L + S IL+ EY + G + + S LI I G+ YLH ++
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QN 150
Query: 558 QIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
I+H D+KPQNIL+ KI DF +++ + I GT Y+APE
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYD 208
Query: 615 PITAKADVYSFGVVL 629
PIT D+++ G++
Sbjct: 209 PITTATDMWNIGIIA 223
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 436 LSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-FQTEI 493
+LE + E+G G+ G V+K G +AVK++++ + E + ++
Sbjct: 20 YQAEINDLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74
Query: 494 KAIGRTH-HRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSP---PKNNLIGIARGI 548
+ ++H +V+ G +F + + + E M + P+ L + I
Sbjct: 75 DVVLKSHDCPYIVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 549 L----YLHDECESQIIHCDIKPQNILMDENRYAKISDFAL-AKLMKPDQTRTFTGIRGTR 603
+ YL ++ +IH D+KP NIL+DE K+ DF + +L+ G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCA 188
Query: 604 GYVAPE-----WHWNLPITAKADVYSFGVVLLEI 632
Y+APE +ADV+S G+ L+E+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGER------EFQTEIKAIGRTHHR 502
EE+G G V K G A K ++K + R E + E+ + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDEC 555
N++ L + ++ +L+ E +S G L D S + I I G+ YLH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+I H D+KP+NI++ + K+ DF LA ++ F I GT +VAPE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIV 190
Query: 612 WNLPITAKADVYSFGVVL 629
P+ +AD++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
KEE+G+G+ V + G A K + + A ++ + E + + H N+VR
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L + S LV++ ++ G L + YS ++ I I I Y H + I
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGI 126
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H ++KP+N+L+ + K++DF LA + + + G GT GY++PE P
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPY 184
Query: 617 TAKADVYSFGVVL 629
+ D+++ GV+L
Sbjct: 185 SKPVDIWACGVIL 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/307 (18%), Positives = 106/307 (34%), Gaps = 62/307 (20%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLL 508
+ + G VY+ + +G+ A+KRL E R E+ + + + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 509 GYSFDVSNK-------ILVYEYMSNGSLADVYSSPPKNNLI----------GIARGILYL 551
+ + L+ + G L + + R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTGI---------R 600
H + IIH D+K +N+L+ K+ DF A + PD + +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 601 GTRGYVAPE---WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQC 657
T Y PE + N PI K D+++ G +L +C R+ P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCFRQ-----HP------------- 252
Query: 658 FENGNLGQLIE------DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711
FE+G +++ D +I+ + P R S+ +V+ L+
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAA 309
Query: 712 PIPPNPT 718
+
Sbjct: 310 RNVNPKS 316
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--------MLAEGEREFQTEIKAIGR-T 499
K+ IGRG S V + G AVK ++ L E + E + +
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 500 HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYL 551
H +++ L+ ++ S+ + LV++ M G L D S +++ + + +L
Sbjct: 158 GHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-- 609
H I+H D+KP+NIL+D+N ++SDF + ++P + + GT GY+APE
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEIL 271
Query: 610 ----WHWNLPITAKADVYSFGVVL 629
+ + D+++ GV+L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
+G G G VY+G N K VAVK +K + +F +E + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 505 VRLLGYSFDVSNK--ILVYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHD 553
V+L+G + + ++ E G L Y +S L+ I + + YL
Sbjct: 76 VKLIGI---IEEEPTWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYL-- 129
Query: 554 ECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAP 608
ES +H DI +NIL+ K+ DF L++ ++ + + I+ +P
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SP 183
Query: 609 EWHWNLPI-----TAKADVYSFGVVLLEII 633
E I T +DV+ F V + EI+
Sbjct: 184 E-----SINFRRFTTASDVWMFAVCMWEIL 208
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 17/192 (8%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK-MLAEGEREFQT--EIKAIGRTHHRNLVRLLG 509
+G+G G VY + +A+K L K L + E Q E++ H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPK-NNLIG------IARGILYLHDECESQIIHC 562
Y D + L+ EY G++ K + +A + Y H ++IH
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 133
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
DIKP+N+L+ KI+DF + + GT Y+ PE K D+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKVDL 190
Query: 623 YSFGVVLLEIIC 634
+S GV+ E +
Sbjct: 191 WSLGVLCYEFLV 202
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
++ IG G SG V G + VA+K L+ E +R +F +E +G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDEC 555
+RL G ++V EYM NGSL + L+G+ RG+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYL---- 167
Query: 556 ESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
+H D+ +N+L+D N K+SDF L+++++ D +T G +
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG-----------KI 216
Query: 615 PI-------------TAKADVYSFGVVLLEII 633
PI ++ +DV+SFGVV+ E++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
+++G G+ G V A+K ++K + + E+ + H N+++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L + D N LV E G L D ++ +I + G+ YLH + I
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNI 157
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H D+KP+N+L+ +++ KI DF L+ + + + GT Y+APE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEV-LRKKY 214
Query: 617 TAKADVYSFGVVLLEIIC 634
K DV+S GV+L ++
Sbjct: 215 DEKCDVWSIGVILFILLA 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 27/196 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+ IGRGS G V A K++ K E F+ EI+ + H N++RL
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 509 GYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQIIH 561
D ++ LV E + G L + V+ ++ + + Y H + H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAH 129
Query: 562 CDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI-- 616
D+KP+N L + K+ DF LA KP + GT YV+P+ +
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQ------VLE 181
Query: 617 ---TAKADVYSFGVVL 629
+ D +S GV++
Sbjct: 182 GLYGPECDEWSAGVMM 197
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 453 EIGRGSSGTVYKGTMINGKF---VAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
E+G G+ GTV KG K VAVK L+ + E E + + + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 508 LGYSFDVSNK---ILVYEYMSNGSLADVY----SSPPKNNLIGIARGI----LYLHDECE 556
+G + +LV E G L Y N+I + + YL E
Sbjct: 84 IG----ICEAESWMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVHQVSMGMKYL----E 134
Query: 557 SQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
+H D+ +N+L+ YAKISDF L+K ++ D+ + + P
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGK----------WP 183
Query: 616 I-------------TAKADVYSFGVVLLEII 633
+ ++K+DV+SFGV++ E
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK--------MLAEGEREFQTEIKAIGRTH 500
+ +G G+ G V K VA+K + K A+ +TEI+ + + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHD 553
H ++++ + FD + +V E M G L D + + YLH+
Sbjct: 74 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 554 ECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE- 609
+ IIH D+KP+N+L+ +E+ KI+DF +K++ + GT Y+APE
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEV 187
Query: 610 --WHWNLPITAKADVYSFGVVL 629
D +S GV+L
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVIL 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 44/213 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
F E IGRG G VY GT+++ AVK L ++ GE +F TE + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 505 VRLLGYSFDVSNKIL-VYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHDE 554
+ LLG L V YM +G L + + +P +LIG +A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
S+ +H D+ +N ++DE K++DF LA+ M + + G +
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK---------- 257
Query: 614 LPI-------------TAKADVYSFGVVLLEII 633
LP+ T K+DV+SFGV+L E++
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 22/196 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRL 507
FK ++G G+ G V+ +G +K + K ++ E + EI+ + H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 508 LGYSFDVSNKILVYEYMSNGSLAD--VYSSPPKNNL---------IGIARGILYLHDECE 556
D N +V E G L + V + L + + Y H +
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 557 SQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
++H D+KP+NIL + KI DF LA+L K D+ T GT Y+APE +
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEV-FK 199
Query: 614 LPITAKADVYSFGVVL 629
+T K D++S GVV+
Sbjct: 200 RDVTFKCDIWSAGVVM 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 31/207 (14%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF---QTEIKAIGRTHHRNLVRL 507
E IG G++ V + VA+KR+ L + + EI+A+ + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IA-------RGILYL 551
SF V +++ LV + +S GS+ D+ IA G+ YL
Sbjct: 79 YT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR----GTRGYVA 607
H IH D+K NIL+ E+ +I+DF ++ + T +R GT ++A
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 608 PE-WHWNLPITAKADVYSFGVVLLEII 633
PE KAD++SFG+ +E+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 23/198 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGER------EFQTEIKAIGRTHHR 502
EE+G G V K G A K ++K + R + + E+ + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDEC 555
N++ L + ++ IL+ E ++ G L D + + I G+ YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 556 ESQIIHCDIKPQNILM----DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
QI H D+KP+NI++ KI DF LA + F I GT +VAPE
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 612 WNLPITAKADVYSFGVVL 629
P+ +AD++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVIT 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 30/205 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
+ +G G G V G + VA+K L+ E +R +F E +G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDEC 555
+RL G ++V EYM NGSL + + L+G+ RGI YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYL---- 163
Query: 556 ESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTG----IRGTRGYVAP 608
+H D+ +NIL++ N K+SDF L ++++ P+ T G IR T +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E T+ +DV+S+G+VL E++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
+ +G G GTV+KG I V +K ++ + AIG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLI----GIARGILYLHDE 554
+VRLLG S ++ V +Y+ GSL D + + L+ IA+G+ YL
Sbjct: 77 IVRLLGLCPGSSLQL-VTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-----IRGTRGYVAP 608
E ++H ++ +N+L+ +++DF +A L+ PD + I+ A
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E T ++DV+S+GV + E++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 422 PGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK 480
G+A D + + L + + E+GRG++ VY+ K A+K L+K
Sbjct: 30 AAPGTASLVPDYWIDGSNRDALSDFFE-VESELGRGATSIVYRCKQKGTQKPYALKVLKK 88
Query: 481 MLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLAD------VY 533
++ +TEI + R H N+++L F+ +I LV E ++ G L D Y
Sbjct: 89 --TVDKKIVRTEIGVLLRLSHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYY 145
Query: 534 SSPPKNNLIG-IARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMK 589
S + + I + YLH E+ I+H D+KP+N+L + KI+DF L+K+++
Sbjct: 146 SERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVL 629
+ GT GY APE + D++S G++
Sbjct: 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLV 505
+ +G+GS G V G+ AVK + K + E++ + + H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQ 558
+L + D LV E + G L D +S +I + GI Y+H +++
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNK 146
Query: 559 IIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
I+H D+KP+N+L+ ++ +I DF L+ + + GT Y+APE +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEV-LHGT 203
Query: 616 ITAKADVYSFGVVLLEIIC 634
K DV+S GV+L ++
Sbjct: 204 YDEKCDVWSTGVILYILLS 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 28/202 (13%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQK--------MLAEGEREFQTEIKAIGRTH 500
+ +G G+ G V K VA++ + K A+ +TEI+ + + +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHD 553
H ++++ + FD + +V E M G L D + + YLH+
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 554 ECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE- 609
IIH D+KP+N+L+ +E+ KI+DF +K++ + GT Y+APE
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEV 312
Query: 610 --WHWNLPITAKADVYSFGVVL 629
D +S GV+L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G+GS VY+ + G VA+K + K M G + Q E+K + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIH 561
Y D + LV E NG + + K + + I G+LYLH I+H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+ N+L+ N KI+DF LA +K + +T + GT Y++PE ++D
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESD 194
Query: 622 VYSFGVVLLEIICCRRCF-DQNLPE 645
V+S G + ++ R F +
Sbjct: 195 VWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 18/204 (8%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVKRLQK-MLAEGEREFQT--EIKAIGRTHHRNLVRLLG 509
+G+G G VY N +A+K L K L + E Q EI+ H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPK-NNLIG------IARGILYLHDECESQIIHC 562
Y D L+ E+ G L + + +A + Y H E ++IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHR 138
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
DIKP+N+LM KI+DF + + RT GT Y+ PE K D+
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDL 195
Query: 623 YSFGVVLLEIICCRRCF-DQNLPE 645
+ GV+ E + F + E
Sbjct: 196 WCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
+G+GS G V K + AVK + K + E++ + + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L D S+ +V E + G L D +S +I + GI Y+H + I
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNI 142
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H D+KP+NIL+ +++ KI DF L+ + + GT Y+APE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEV-LRGTY 199
Query: 617 TAKADVYSFGVVLLEIIC 634
K DV+S GV+L ++
Sbjct: 200 DEKCDVWSAGVILYILLS 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
IG+G G VY G I+ A+K L ++ + F E + +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 505 VRLLGYSFDVSNKIL-VYEYMSNGSLADVY-----SSPPKNNLIG----IARGILYLHDE 554
+ L+G + YM +G L + +P +LI +ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
Q +H D+ +N ++DE+ K++DF LA+ + + + R R
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR---------- 189
Query: 614 LPI-------------TAKADVYSFGVVLLEII 633
LP+ T K+DV+SFGV+L E++
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
KEE+G+G+ V + G A K + + A ++ + E + + H N+VR
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L + S LV++ ++ G L + YS ++ I I I Y H + I
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGI 149
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H ++KP+N+L+ + K++DF LA + + + G GT GY++PE P
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPY 207
Query: 617 TAKADVYSFGVVL 629
+ D+++ GV+L
Sbjct: 208 SKPVDIWACGVIL 220
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
+G+GS G V K + AVK + K + E++ + + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L D S+ +V E + G L D +S +I + GI Y+H I
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H D+KP+NIL+ +++ KI DF L+ + + GT Y+APE +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPE------V 194
Query: 617 -----TAKADVYSFGVVL 629
K DV+S GV+L
Sbjct: 195 LRGTYDEKCDVWSAGVIL 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 43/210 (20%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
IG G G V++G ++ + VA+K + ++ R +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 505 VRLLGYSFDVSNK--ILVYEYMSNGSLADVY-----SSPPKNNLI----GIARGILYLHD 553
V+L+G ++ ++ E + G L + S +LI ++ + YL
Sbjct: 79 VKLIGV---ITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYL-- 132
Query: 554 ECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVAP 608
ES+ +H DI +N+L+ N K+ DF L++ M+ + I+ AP
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----AP 186
Query: 609 EWHWNLPI-----TAKADVYSFGVVLLEII 633
E I T+ +DV+ FGV + EI+
Sbjct: 187 E-----SINFRRFTSASDVWMFGVCMWEIL 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 52/221 (23%)
Query: 454 IGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREF-----------------QTEIKAI 496
+ +G + + KF A+K+ +K L E +R+F + E++ I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 497 GRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG------------ 543
+ + G +++ ++YEYM N S+ +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 544 ---IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
+ Y+H+E I H D+KP NILMD+N K+SDF ++ M + + R
Sbjct: 157 IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 601 GTRGYVAPE-------WHWNLPITAKADVYSFGVVLLEIIC 634
GT ++ PE ++ AK D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFY 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 50/213 (23%)
Query: 451 KEEIGRGSSGTVYKGTMINGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVR 506
E+G G+ G+V +G K VA+K L++ + + E E + + + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 507 LLGYSFDVSNK---ILVYEYMSNGSLADVY-----SSPPKNNLIGIARGI----LYLHDE 554
L+G V +LV E G L + P +N+ + + YL
Sbjct: 75 LIG----VCQAEALMLVMEMAGGGPLHK-FLVGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
E + +H D+ +N+L+ YAKISDF L+K + D + +T +
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGK---------- 174
Query: 614 LPI-------------TAKADVYSFGVVLLEII 633
P+ ++++DV+S+GV + E +
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLG 509
E +G G+ G VYKG + G+ A+K + + + E E + EI + + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 510 -----YSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL----IG-IARGIL----YLHDE 554
+ +++ LV E+ GS+ D+ + N L I I R IL +LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE----- 609
++IH DIK QN+L+ EN K+ DF ++ + R T I GT ++APE
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 204
Query: 610 WHWNLPITAKADVYSFGVVLLEII 633
+ + K+D++S G+ +E+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMA 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 40/215 (18%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF------VAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
+G G+ G VY+G + VAVK L ++ +E + +F E I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNNLIG----IARGI 548
N+VR +G S + ++ E M+ G L SS +L+ IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 549 LYLHDECESQ-IIHCDIKPQNILMD---ENRYAKISDFALAK-LMKPDQTRTFTGIRGTR 603
YL E IH DI +N L+ R AKI DF +A+ + + R +G
Sbjct: 154 QYL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-----KGGC 204
Query: 604 GYV-----APEWHWNLPITAKADVYSFGVVLLEII 633
+ PE T+K D +SFGV+L EI
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF-----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRN 503
+ +G G+ GTVYKG I VA+K L++ + E E + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDE 554
+ RLLG + ++ + + M G L D Y K+N+ + IA+G+ YL
Sbjct: 79 VCRLLGICLTSTVQL-ITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 555 CESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTFTG----IRGTRGYVAP 608
E + ++H D+ +N+L+ ++ KI+DF LAKL+ ++ G I+ A
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----AL 188
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E + T ++DV+S+GV + E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 46/200 (23%), Positives = 75/200 (37%), Gaps = 24/200 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVK-----RLQKMLAEGEREFQTEIKAIGRTHHRN 503
E IG+G V + G+ AVK + + + E H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLAD----------VYSSPPKNNLIG-IARGILYLH 552
+V LL +V+E+M L VYS ++ + I + Y H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 553 DECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
++ IIH D+KP +L+ + + K+ F +A + G GT ++APE
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRVGTPHFMAPE 203
Query: 610 WHWNLPITAKADVYSFGVVL 629
P DV+ GV+L
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/228 (26%), Positives = 88/228 (38%), Gaps = 61/228 (26%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
K E+G G+ G V+ N VAVK L+ ++FQ E + + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSL--------------ADVYSSPPKNNL-------- 541
+V+ G D I+V+EYM +G L D K L
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 542 -IGIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTG 598
IA G++YL SQ +H D+ +N L+ N KI DF +++ + D R
Sbjct: 139 ASQIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 599 IRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
LPI T ++DV+SFGV+L EI
Sbjct: 195 TM-------------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF----VAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNL 504
IG G G V++G ++ + VA+K + ++ R +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 505 VRLLGYSFDVSNK---ILVYEYMSNGSLADVY-----SSPPKNNLI----GIARGILYLH 552
V+L+G V + ++ E + G L + S +LI ++ + YL
Sbjct: 454 VKLIG----VITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYL- 507
Query: 553 DECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----IRGTRGYVA 607
ES+ +H DI +N+L+ N K+ DF L++ M+ + I+ A
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----A 560
Query: 608 PEWHWNLPITAKADVYSFGVVLLEII 633
PE T+ +DV+ FGV + EI+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/207 (28%), Positives = 82/207 (39%), Gaps = 33/207 (15%)
Query: 450 FKEEIGRGSSGTVYKGT--MINGKF--VAVKRLQK---MLAEGEREFQTEIKAIGRTHHR 502
E++G GS G V +G +GK VAVK L+ E +F E+ A+ HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVY-----SSPPKNNLI----GIARGILYLHD 553
NL+RL G K+ V E GSL D L +A G+ YL
Sbjct: 82 NLIRLYGVVLTPPMKM-VTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 554 ECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMK--PDQTRTFTG----IRGTRGYV 606
ES+ IH D+ +N+L+ KI DF L + + D
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC---- 191
Query: 607 APEWHWNLPITAKADVYSFGVVLLEII 633
APE + +D + FGV L E+
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 451 KEEIGRGSSGTVYKGTMINGK---FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHRNLVR 506
E+G G+ G+V +G K VA+K L++ + + E E + + + + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 507 LLGYSFDVSNK---ILVYEYMSNGSLADVYSSP----PKNNLI----GIARGILYLHDEC 555
L+G V +LV E G L P +N+ ++ G+ YL
Sbjct: 401 LIG----VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---- 452
Query: 556 ESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTG----IRGTRGYVAP 608
E + +H ++ +N+L+ YAKISDF L+K + D + + ++ AP
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----AP 508
Query: 609 EWHWNLPITAKADVYSFGVVLLEII 633
E ++++DV+S+GV + E +
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 46/193 (23%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQK-MLAEGERE-FQTEIKAIGRTHHRNLVR 506
EE+G+G+ V + + G+ A + L+ + + + E + H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 507 LLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQI 559
L + + L+++ ++ G L + YS ++ I I +L+ H + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGV 131
Query: 560 IHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
+H ++KP+N+L+ + K++DF LA ++ +Q + + G GT GY++PE P
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPY 190
Query: 617 TAKADVYSFGVVL 629
D+++ GV+L
Sbjct: 191 GKPVDLWACGVIL 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 60/227 (26%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN 503
K E+G G+ G V+ N VAVK L++ ++FQ E + + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNN------------L 541
+VR G + ++V+EYM +G L A + +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 542 IGIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGI 599
+A G++YL +H D+ +N L+ + KI DF +++ + D R
Sbjct: 165 SQVAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----- 215
Query: 600 RGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
G R LPI T ++DV+SFGVVL EI
Sbjct: 216 VGGRTM--------LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 40/215 (18%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
+G G+ G VY+G + VAVK L ++ +E + +F E I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNNLIG----IARGI 548
N+VR +G S + ++ E M+ G L SS +L+ IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 549 LYLHDECESQ-IIHCDIKPQNILMD---ENRYAKISDFALAK-LMKPDQTRTFTGIRGTR 603
YL E IH DI +N L+ R AKI DF +A+ + + R +G
Sbjct: 195 QYL----EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGC 245
Query: 604 GYV-----APEWHWNLPITAKADVYSFGVVLLEII 633
+ PE T+K D +SFGV+L EI
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 30/209 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK-------------MLAEGEREFQTEIKA 495
++G G+ G V A+K ++K + + E EI
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGI 548
+ H N+++L D LV E+ G L + + N++ I GI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 549 LYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGY 605
YLH + I+H DIKP+NIL+ + KI DF L+ D GT Y
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYY 214
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEIIC 634
+APE K DV+S GV++ ++C
Sbjct: 215 IAPEV-LKKKYNEKCDVWSCGVIMYILLC 242
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 54/222 (24%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF------VAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
E+G+GS G VY+G VA+K + + + ER EF E + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSL-------------ADVYSSPPKNNLIG----IA 545
++VRLLG +++ E M+ G L V + P + +I IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFTGIRGTRG 604
G+ YL+ ++ +H D+ +N ++ E+ KI DF + + + D R +G +G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKG 200
Query: 605 YVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
LP+ T +DV+SFGVVL EI
Sbjct: 201 L--------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 59/225 (26%), Positives = 88/225 (39%), Gaps = 54/225 (24%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF------VAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
F EE+G G VYKG + VA+K L+ R EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD--------------VYSSPPKNNL------- 541
N+V LLG +++ Y S+G L + K+ L
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 542 --IGIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALA-KLMKPDQTRTFT 597
IA G+ YL S ++H D+ +N+L+ + KISD L ++ D +
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 598 G----IRGTRGYVAPEWHWNLPI-----TAKADVYSFGVVLLEII 633
IR APE I + +D++S+GVVL E+
Sbjct: 189 NSLLPIRWM----APE-----AIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 21/193 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
KE+IG GS + AVK + K + E + ++ H N++ L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ---HPNIITLK 82
Query: 509 GYSFDVSNKI-LVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQII 560
+D + +V E M G L D +S + ++ I + + YLH + ++
Sbjct: 83 DV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVV 138
Query: 561 HCDIKPQNILM---DENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI 616
H D+KP NIL N + +I DF AK ++ + T +VAPE
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGY 197
Query: 617 TAKADVYSFGVVL 629
A D++S GV+L
Sbjct: 198 DAACDIWSLGVLL 210
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 56/223 (25%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLA-EGER-EFQTEIKAIGRTHHRN 503
+ +G G G+V +G + VAVK ++ + + E EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 504 LVRLLGYSFD-----VSNKILVYEYMSNGSL---------ADVYSSPPKNNLIG----IA 545
++RLLG + + +++ +M G L P L+ IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 546 RGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAK-LMKPDQTRTFTGIRGTR 603
G+ YL ++ +H D+ +N ++ ++ ++DF L+K + D R +G
Sbjct: 158 LGMEYL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRI 208
Query: 604 GYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
+P+ T+K+DV++FGV + EI
Sbjct: 209 A--------KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 63/227 (27%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF---VAVKRLQKMLAEGER-EFQTEI---KAIGRTHHR 502
F++ IG G+ G V K + A+KR+++ ++ + +F E+ +G HH
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHP 86
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD--------------VYSSPPKNNL------- 541
N++ LLG L EY +G+L D ++ + L
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 542 --IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599
+ARG+ YL + Q IH D+ +NIL+ EN AKI+DF L++ + T
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201
Query: 600 RGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
R LP+ T +DV+S+GV+L EI+
Sbjct: 202 R-------------LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 29/238 (12%), Positives = 75/238 (31%), Gaps = 63/238 (26%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVK---RLQKMLAEGEREFQTEIKAIGR--------- 498
+G+ + T G+ V ++ + ++ + E+ +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 499 ----------------THHRNLVRLLGYSFD--VSNKILVYEYMSN---------GSLAD 531
+ ++R+ D V ++ +Y M + S +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 532 VYSSPPKNNLIGIARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587
+ S + + + ++ LH ++H ++P +I++D+ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 588 MKPDQTRTFTGIRGTRGYVAPEW-----------HWNLPITAKADVYSFGVVLLEIIC 634
+ + +RG+ PE +T D ++ G+V+ I C
Sbjct: 255 -RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 26/198 (13%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREF---QTEIKAIGRTHHRNLVRL 507
EIG GS G VY + N + VA+K++ + ++ E++ + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 508 LGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKN---NLIG-IARGIL----YLHDECESQ 558
G + + LV EY GS +D+ K I + G L YLH
Sbjct: 120 RG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE---WHWNLP 615
+IH D+K NIL+ E K+ DF A +M +F GT ++APE
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSFV---GTPYWMAPEVILAMDEGQ 229
Query: 616 ITAKADVYSFGVVLLEII 633
K DV+S G+ +E+
Sbjct: 230 YDGKVDVWSLGITCIELA 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 51/225 (22%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF------VAVKRLQKMLAEGER-EFQTEI---KAIGRT 499
F + +G G+ G V + T VAVK L+ ER +E+ +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSL---------------------ADVYSSPPK 538
H N+V LLG +++ EY G L D +
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 539 NNLIG----IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
+L+ +A+G+ +L S+ IH D+ +NIL+ R KI DF LA+ +K D
Sbjct: 145 EDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 594 RTFTG-----IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
G ++ APE +N T ++DV+S+G+ L E+
Sbjct: 201 YVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 45/215 (20%), Positives = 87/215 (40%), Gaps = 39/215 (18%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK----FVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRN 503
+G+G G+V + + VAVK L+ + + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 504 LVRLLGYSFD------VSNKILVYEYMSNGSL---------ADVYSSPPKNNLIG----I 544
+ +L+G S + +++ +M +G L + + P L+ I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 545 ARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG----- 598
A G+ YL S+ IH D+ +N ++ E+ ++DF L++ +
Sbjct: 147 ACGMEYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
++ A E + T +DV++FGV + EI+
Sbjct: 203 VKWL----ALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+ IG+G+ V ++ G+ VA+K + ++ ++ E++ + +H N+V+L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 509 GYSFDV---SNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDEC 555
F+V + L+ EY S G + D + + I + Y H +
Sbjct: 80 ---FEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNL 614
I+H D+K +N+L+D + KI+DF + F G Y APE
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGK 188
Query: 615 PIT-AKADVYSFGVVLLEIICCRRCFD-QNLPE 645
+ DV+S GV+L ++ FD QNL E
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 19/194 (9%)
Query: 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLV 505
D + +G GS K + + AVK + K + ++ EI A+ H N+V
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIV 69
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQ 558
+L D + LV E ++ G L + +S + ++ + + ++HD
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126
Query: 559 IIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP 615
++H D+KP+N+L ++N KI DF A+L PD + T Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNG 185
Query: 616 ITAKADVYSFGVVL 629
D++S GV+L
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 46/202 (22%), Positives = 87/202 (43%), Gaps = 26/202 (12%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLL 508
++ +G G+ V +I + AVK ++K E++ + + HRN++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 509 GYSFDVSNKILVYEYMSNGSLAD------VYSSPPKNNLIG-IARGILYLHDECESQIIH 561
+ + LV+E M GS+ ++ + ++ +A + +LH+ I H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAH 134
Query: 562 CDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIR------GTRGYVAPE--- 609
D+KP+NIL ++ KI DF L +K + + G+ Y+APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 610 --WHWNLPITAKADVYSFGVVL 629
+ D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 58/233 (24%), Positives = 91/233 (39%), Gaps = 67/233 (28%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK--------FVAVKRLQKMLAEGER-EFQTEI---KAIG 497
+ +G G+ G V + VAVK L+ E + + +E+ K IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 498 RTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL-------------------ADVYSSPPK 538
+ H+N++ LLG ++ EY S G+L
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 539 NNLIG----IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
+L+ +ARG+ YL SQ IH D+ +N+L+ EN KI+DF LA+ +
Sbjct: 157 KDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 594 RTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
T R LP+ T ++DV+SFGV++ EI
Sbjct: 213 YKKTT--NGR----------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 66/232 (28%)
Query: 450 FKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEGER-EFQTEI---KAIGRT 499
+ +GRG+ G V + + VAVK L++ E +E+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 500 HHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLAD-------------------VYSSPPKN 539
H N+V LLG + ++ E+ G+L+
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 540 NLIG----IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594
+LI +A+G+ +L S+ IH D+ +NIL+ E KI DF LA+ + D
Sbjct: 149 HLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 595 TFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
G R LP+ T ++DV+SFGV+L EI
Sbjct: 205 VRKG--DAR----------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-23
Identities = 25/233 (10%), Positives = 65/233 (27%), Gaps = 54/233 (23%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRL---QKMLAEGEREFQTEIKAIGR--------- 498
+G+ + T G+ V ++ + ++ + E+ +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 499 ----------------THHRNLVRLLGYSFD--VSNKILVYEYMSNGSLADVYSS----- 535
+ ++R+ D V ++ +Y M +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 202
Query: 536 -----PPKNNLIGIARGIL----YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586
+ + + ++ LH ++H ++P +I++D+ ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 587 LMKPDQTRTFTGIRGTRGYVAPEW-----HWNLPITAKADVYSFGVVLLEIIC 634
A H +T D ++ G+ + I C
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 47/221 (21%)
Query: 450 FKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGER-EFQTEI---KAIGRT 499
F + +G G+ G V + T VAVK L+ E+ +E+ +G
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-- 107
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSL-----------------ADVYSSPPKNNLI 542
H N+V LLG +++ EY G L A S+ +L+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 543 ----GIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597
+A+G+ +L S+ IH D+ +N+L+ AKI DF LA+ + D
Sbjct: 168 HFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 598 G-----IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEII 633
G ++ APE ++ T ++DV+S+G++L EI
Sbjct: 224 GNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 27/196 (13%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
K+ +G G +G V + G+ A+K L + +E +A G ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASG---GPHIVCILD 89
Query: 510 YSFDVSNKI----LVYEYMSNGSLAD--------VYSSPPKNNLIG-IARGILYLHDECE 556
++ + ++ E M G L ++ ++ I I +LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-- 147
Query: 557 SQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
I H D+KP+N+L +++ K++DF AK + +T T YVAPE
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC---YTPYYVAPEVLGP 203
Query: 614 LPITAKADVYSFGVVL 629
D++S GV++
Sbjct: 204 EKYDKSCDMWSLGVIM 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 55/238 (23%), Positives = 89/238 (37%), Gaps = 72/238 (30%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGER-EFQTEI---KAIGRT 499
F + +G G+ G V T VAVK L++ ER +E+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSL--------------------------ADVY 533
H N+V LLG L++EY G L +
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 534 SSPPKNNLIG----IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLM 588
+ +L+ +A+G+ +L E + +H D+ +N+L+ + KI DF LA+ +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
D G R LP+ T K+DV+S+G++L EI
Sbjct: 223 MSDSNYVVRG--NAR----------LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 69/317 (21%), Positives = 119/317 (37%), Gaps = 93/317 (29%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK--------FVAVKRLQKMLAEGER-EFQTEI---KAIG 497
+ +G G G V + VAVK L+ E + + +E+ K IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 498 RTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL--------------ADVYSSPPKNNL-- 541
+ H+N++ LLG ++ EY S G+L + + P+ +
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 542 -------IGIARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
+ARG+ YL SQ IH D+ +N+L+ EN KI+DF LA+ +
Sbjct: 203 KDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 594 RTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEIICCRRCFD 640
T R LP+ T ++DV+SFGV++ EI
Sbjct: 259 YKKTT--NGR----------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------ 300
Query: 641 QNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER-------MIKVALWCILDEPS 693
L Y L +L++ + ++++ + + C PS
Sbjct: 301 ---------LGGSPYPGIPVEELFKLLK----EGHRMDKPANCTNELYMMMRDCWHAVPS 347
Query: 694 LRPSMKKVLLMLEGTMD 710
RP+ K+++ L+ +
Sbjct: 348 QRPTFKQLVEDLDRILT 364
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 67/233 (28%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKF--------VAVKRLQKMLAEGER-EFQTEI---KAIG 497
+ +G G+ G V I VAVK L+ E + + +E+ K IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 498 RTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL----------ADVYSSPPKNNLIG---- 543
+ H+N++ LLG ++ EY S G+L YS P +N
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 544 ---------IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
+ARG+ YL S+ IH D+ +N+L+ E+ KI+DF LA+ +
Sbjct: 191 KDLVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 594 RTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
T R LP+ T ++DV+SFGV+L EI
Sbjct: 247 YKKTT--NGR----------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 70/237 (29%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
+ +IG G+ G V++ VAVK L++ + + +FQ E + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSL---------------------------ADVYSS 535
N+V+LLG L++EYM+ G L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 536 PPKNNLIG----IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALA-KLMK 589
+ +A G+ YL + +H D+ +N L+ EN KI+DF L+ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 590 PDQTRTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
D + +PI T ++DV+++GVVL EI
Sbjct: 227 ADYYK-----ADGNDA--------IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVK-----RLQKMLAEGEREFQT------------- 491
K+EIG+GS G V + + A+K +L + R
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 492 --------EIKAIGRTHHRNLVRLLGYSFDV-----SNKI-LVYEYMSNGSLADVYSSPP 537
EI + + H N+V+L +V + + +V+E ++ G + +V + P
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 538 KNNLIGIAR--------GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589
+ AR GI YLH +IIH DIKP N+L+ E+ + KI+DF ++ K
Sbjct: 134 LS--EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 590 PDQTRTFTGIRGTRGYVAPEWHWNLPIT---AKADVYSFGVVLLEIICCRRCF-DQNLPE 645
GT ++APE DV++ GV L + + F D+ +
Sbjct: 189 GSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 56/291 (19%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQK----------MLAEGEREFQTEIKAIGRTH 500
+G+G GTV+ G + + VA+K + + E K
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 501 HRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG----------IARGIL 549
H ++RLL + F+ LV E D++ + +G + I
Sbjct: 97 HPGVIRLLDW-FETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 550 YLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
+ H ++H DIK +NIL+D R AK+ DF L+ + F GTR Y P
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPP 207
Query: 609 EWHWNLPIT-AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667
EW A V+S G++L +++C F++ + +++ E + + + LI
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEILEAELHFPAHVSPDCCALI 264
Query: 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL---MLEGTMDIPIPP 715
C+ +PS RPS++++LL M D+P+ P
Sbjct: 265 R-----------------RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRL--QKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G G+ G V G + G VAVK L QK+ + + EI+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 510 YSFDV---SNKI-LVYEYMSNGSLADVYSSPPKNNL-IGIAR--------GILYLHDECE 556
+ V +V EY+S G L D + AR + Y H
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLP 615
++H D+KP+N+L+D + AKI+DF L+ +M + RT G+ Y APE
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186
Query: 616 IT-AKADVYSFGVVLLEIICCRRCFD-QNLPE 645
+ D++S GV+L ++C FD +++P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 57/357 (15%), Positives = 109/357 (30%), Gaps = 113/357 (31%)
Query: 426 SARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGT-MINGKFVAVKR------- 477
++RY D + ++ +GRG G V++ ++ A+KR
Sbjct: 1 ASRYLTD-------FEPIQC--------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE 45
Query: 478 --LQKMLAEGEREFQTEIKAIGRTHHR--------------------------------- 502
+K++ E + + E I R +
Sbjct: 46 LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM 105
Query: 503 -------------NLVRLLGYSFDVSNKILVY---EYMSNGSLADV-----YSSPPKNNL 541
+ +G S K+ +Y + +L D ++ +
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 542 I-----GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK------- 589
IA + +LH + ++H D+KP NI + K+ DF L M
Sbjct: 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 590 ----PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE 645
T TG GT+ Y++PE + K D++S G++L E+ Q
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL--LYSFSTQM--- 277
Query: 646 DQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+ + + Q M++ + P+ RP ++
Sbjct: 278 -------ERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDII 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 26/197 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+ +G G +G V + + A+K LQ + RE + +A ++VR++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQ---CPHIVRIV 121
Query: 509 GY---SFDVSNKI-LVYEYMSNGSLAD--------VYSSPPKNNLIG-IARGILYLHDEC 555
+ + +V E + G L ++ + ++ I I YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 180
Query: 556 ESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
I H D+KP+N+L N K++DF AK + T T YVAPE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLG 236
Query: 613 NLPITAKADVYSFGVVL 629
D++S GV++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 38/209 (18%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKR--LQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
G+G+ GTV G G VA+K+ RE Q ++ + HH N+V+L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN--RELQ-IMQDLAVLHHPNIVQLQ 85
Query: 509 GYSFDVSNK-------ILVYEYMSNGSLADVYSSPPKNNLIG-----------IARGILY 550
Y + + + +V EY+ + +L + + + + R I
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 551 LHDECESQIIHCDIKPQNILMDENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
LH + H DIKP N+L++E K+ DF AK + P + +R Y APE
Sbjct: 145 LHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPE 201
Query: 610 WHWNLPI-----TAKADVYSFGVVLLEII 633
L T D++S G + E++
Sbjct: 202 ----LIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 52/226 (23%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK----MLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+G GS G V + AVK L+K + GE + EI+ + R H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 509 GYSFDV-----SNKI-LVYEYMSNGSLADVYSSPPKNNL-IGIAR--------GILYLHD 553
DV K+ +V EY G + ++ S P+ + A G+ YLH
Sbjct: 72 ---VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT----RTFTG---------IR 600
+ I+H DIKP N+L+ KIS +A+ + P RT G
Sbjct: 128 QG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCF-DQNLPE 645
G + K D++S GV L I F N+ +
Sbjct: 185 GLDTFSGF----------KVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+ IG GS G V++ ++ VA+K K+L + + + E++ + H N+V L +
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIK---KVLQDKRFKNR-ELQIMRIVKHPNVVDLKAFF 101
Query: 512 FDVSNKI------LVYEYMSNGSLADVYSSPPKNNLIG-----------IARGILYLHDE 554
+ +K LV EY+ ++ K + R + Y+H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-- 158
Query: 555 CESQIIHCDIKPQNILMDENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYVAPE---- 609
I H DIKPQN+L+D K+ DF AK++ +R Y APE
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPELIFG 215
Query: 610 -WHWNLPITAKADVYSFGVVLLEIICCR 636
++ I D++S G V+ E++ +
Sbjct: 216 ATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 51/245 (20%), Positives = 82/245 (33%), Gaps = 63/245 (25%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVK-----RLQKMLAEGEREFQTEIKAIGRTHHRN 503
K IG+GS G V A+K +++++ + +TE++ + + HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 504 LVRLLGYSFDVSNKILVYEYM----------SNGSLADVYSSPPKNNLIG---------- 543
+ RL D LV E + +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 544 ---------------------------IARGILYLHDECESQIIHCDIKPQNILM--DEN 574
I + YLH++ I H DIKP+N L +++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206
Query: 575 RYAKISDFALAKLM---KPDQTRTFTGIRGTRGYVAPE--WHWNLPITAKADVYSFGVVL 629
K+ DF L+K + T GT +VAPE N K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 630 LEIIC 634
++
Sbjct: 267 HLLLM 271
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 41/210 (19%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRN 503
E+IG G+ GTV+K + VA+KR+ ++ + E RE I + H+N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALRE----ICLLKELKHKN 62
Query: 504 LVRLLGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPPKNNLIG-----IARGILYLH 552
+VRL DV K+ LV+E+ D + ++ + +G+ + H
Sbjct: 63 IVRLH----DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE--- 609
++H D+KPQN+L++ N K+++F LA+ R ++ T Y P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 610 --WHWNLPITAKADVYSFGVVLLEIICCRR 637
++ I D++S G + E+ R
Sbjct: 175 GAKLYSTSI----DMWSAGCIFAELANAGR 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRL--QKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G G+ G V G + G VAVK L QK+ + + EI+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 510 YSFDV---SNKI-LVYEYMSNGSLADVYSSPPKNNL-IGIAR--------GILYLHDECE 556
+ V + I +V EY+S G L D L +R G+ Y H
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLP 615
++H D+KP+N+L+D + AKI+DF L+ +M + RT G+ Y APE
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 191
Query: 616 IT-AKADVYSFGVVLLEIICCRRCFD-QNLPE 645
+ D++S GV+L ++C FD ++P
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 68/236 (28%)
Query: 450 FKEEIGRGSSGTVYKGTMINGK------FVAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
+ +G G G V K T + K VAVK L++ + E + +E + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADV--YSSPPKNNLIG----------------- 543
++++L G +L+ EY GSL S +G
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 544 ------------IARGILYLHDECESQ-IIHCDIKPQNILMDENRYAKISDFALAKLMKP 590
I++G+ YL ++H D+ +NIL+ E R KISDF L++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 591 DQTRTFTGIRGTRGYVAPEWHWNLPI-------------TAKADVYSFGVVLLEII 633
+ + R +P+ T ++DV+SFGV+L EI+
Sbjct: 203 EDSYVKRS--QGR----------IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREF-QTEIKAIGRTHHRNLV 505
F + +G GS TV + + A+K L+K ++ E + + E + R H V
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILY 550
+L ++F K+ Y NG L Y++ I + Y
Sbjct: 94 KLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALEY 145
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP--DQTRTFTGIRGTRGYVAP 608
LH + IIH D+KP+NIL++E+ + +I+DF AK++ P Q R + GT YV+P
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 201
Query: 609 EWHWNLPITAKADVYSFGVVLLEIIC 634
E +D+++ G ++ +++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 45/228 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK---MLAEGEREFQTEIKAIGRTHHRNLVR 506
+G+G G V + T GK A K+L+K +GE E + + + + R +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSL----------------ADVYSSPPKNNLIGIARGIL 549
L Y+++ + + LV M+ G L A Y++ I G+
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTFTGIRGTRGYVAP 608
LH E +I++ D+KP+NIL+D++ + +ISD LA + Q + GT GY+AP
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAP 354
Query: 609 EWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656
E N T D ++ G +L E+I + F Q + I E V +
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ---RKKKIKREEVER 399
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK---MLAEGEREFQTE---IKAIGRTHHRN 503
IGRG G VY T GK A+K L K + +GE E + +
Sbjct: 197 IGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 504 LVRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGI 548
+V + Y+F +K+ + + M+ G L Y++ I G+
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-------IILGL 305
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
++H+ +++ D+KP NIL+DE+ + +ISD LA + GT GY+AP
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 359
Query: 609 E-WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652
E + + AD +S G +L +++ F Q+ +D+ ++
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQK-------MLAEGEREFQTEIKAIGRTHHR- 502
+G G G+VY G + + VA+K ++K L G R E+ + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGF 107
Query: 503 -NLVRLLGYSFDVSNKI-LVYEYMSN-GSLADVYSSPPKNNLI-GIAR--------GILY 550
++RLL + F+ + L+ E L D + + L +AR + +
Sbjct: 108 SGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRH 164
Query: 551 LHDECESQIIHCDIKPQNILMDENRY-AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
H+ ++H DIK +NIL+D NR K+ DF L+K F GTR Y PE
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE 218
Query: 610 WHWNLPITA-KADVYSFGVVLLEIICCRRCFD 640
W A V+S G++L +++C F+
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 31/176 (17%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRNL 504
E++G G+ G VYK G+ VA+KR+ ++ AE E RE I + HH N+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIRE----ISLLKELHHPNI 81
Query: 505 VRLLGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPPKNNLIG-----IARGILYLHD 553
V L+ DV + LV+E+M + D + +++ I + RG+ + H
Sbjct: 82 VSLI----DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
+I+H D+KPQN+L++ + K++DF LA+ R++T T Y AP+
Sbjct: 138 ---HRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAPD 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-21
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 33/178 (18%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRN 503
E+IG G+ G VYK + G+ VA+K++ ++ E E RE I + +H N
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIRE----ISLLKELNHPN 63
Query: 504 LVRLLGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPP------KNNLIGIARGILYL 551
+V+LL DV NK+ LV+E++ D + K+ L + +G+ +
Sbjct: 64 IVKLL----DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
H +++H D+KPQN+L++ K++DF LA+ RT+T T Y APE
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 173
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 435 LLSFSYAELEKMT-DGFKEE--IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEG 485
L + + E + M D F + +GRG G V+ K T GK A K+L K +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRK 227
Query: 486 EREF-QTEIKAIGRTHHRNLVRLLGYSFDVSNKI-LVYEYMSNGSL-ADVYSSPPKNNLI 542
+ E K + + H R +V L Y+F+ + LV M+ G + +Y+ N
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 543 GIAR----------GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592
R G+ +LH II+ D+KP+N+L+D++ +ISD LA +K Q
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCR---RCFDQNLPEDQV- 648
T+T GT G++APE D ++ GV L E+I R R + + ++
Sbjct: 344 TKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 649 --ILEE 652
+LE+
Sbjct: 403 QRVLEQ 408
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRNL 504
E+IG G+ G VYK G+ A+K++ ++ E E RE I + H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHSNI 62
Query: 505 VRLLGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPPKNNLIG-----IARGILYLHD 553
V+L DV ++ LV+E++ L DV ++ + GI Y HD
Sbjct: 63 VKLY----DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
+++H D+KPQN+L++ KI+DF LA+ R +T T Y AP+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPD 170
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 38/209 (18%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+ IG GS G VY+ + +G+ VA+K K+L + + + E++ + + H N+VRL +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFKNR-ELQIMRKLDHCNIVRLRYF 115
Query: 511 SFDVSNKI------LVYEYMSNGSLADVYSSPPKNNLIG-----------IARGILYLHD 553
+ K LV +Y+ ++ V + + R + Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 554 ECESQIIHCDIKPQNILMDENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYVAPE--- 609
I H DIKPQN+L+D + K+ DF AK + + +R Y APE
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIF 229
Query: 610 --WHWNLPITAKADVYSFGVVLLEIICCR 636
+ I DV+S G VL E++ +
Sbjct: 230 GATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 32/278 (11%), Positives = 78/278 (28%), Gaps = 49/278 (17%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRL 507
G ++ + VA+ + + +E + + R + R+
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPK-----NNLIGIARGILYLHDECESQIIHC 562
L + ++V E++ GSL +V + P + +A H + +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALS 153
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
P + + + ++ + + D+
Sbjct: 154 IDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NPQDDI 185
Query: 623 YSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682
G L ++ R + + + GQ IE D+D+ ++
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAP---AER----DTAGQPIEPADIDRDIPFQISA 238
Query: 683 VALWCILDEPSLRPS--MKKVLLMLEGTMDIPIPPNPT 718
VA + + +R + + ++ D P
Sbjct: 239 VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPI 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRL--QKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
+G GS G V T + VA+K + Q + + EI + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 510 YSFDV---SNKI-LVYEYMSNGSLADVYSSPPKNNL-IGIAR--------GILYLHDECE 556
+DV I +V EY + G L D K + R I Y H
Sbjct: 75 --YDVITTPTDIVMVIEY-AGGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK- 128
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLP 615
I+H D+KP+N+L+D+N KI+DF L+ +M +T G+ Y APE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKL 183
Query: 616 IT-AKADVYSFGVVLLEIICCRRCFD-QNLPE 645
+ DV+S G+VL ++ R FD + +P
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 59/204 (28%), Positives = 84/204 (41%), Gaps = 24/204 (11%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQK-MLAEGEREFQTEIKAIGRTHHRNLVRLLGYS 511
+G G+ G V + + VAVK + + + EI +H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 512 FDV---SNKI-LVYEYMSNGSLADVYSSPPKNNLIGIAR--------GILYLHDECESQI 559
+ N L EY S G L D P A+ G++YLH I
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR-GTRGYVAPEWHWNLPIT- 617
H DIKP+N+L+DE KISDF LA + + + GT YVAPE
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 618 AKADVYSFGVVLLEIICCRRCFDQ 641
DV+S G+VL ++ +DQ
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 29/180 (16%)
Query: 452 EEIGRGSSGTVYKG--TMINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHR 502
EIG G+ G V+K G+FVA+KR+ ++ E RE ++ + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 503 NLVRLL----GYSFDVSNKI-LVYEYMSN--GSLADVYSSPP------KNNLIGIARGIL 549
N+VRL D K+ LV+E++ + D P K+ + + RG+
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
+LH ++H D+KPQNIL+ + K++DF LA++ T + T Y APE
Sbjct: 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPE 189
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 24/173 (13%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---EIKAIGRTHHRNLVRL 507
+IG GS G V+K G+ VA+K+ + + EI+ + + H NLV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 508 LGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPPKNNLIG-----IARGILYLHDECE 556
L +V ++ LV+EY + D Y +L+ + + + H +
Sbjct: 68 L----EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---K 120
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
IH D+KP+NIL+ ++ K+ DF A+ + + + TR Y +PE
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVATRWYRSPE 172
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 26/174 (14%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---EIKAIGRTHHRNLVRL 507
+G GS G V K G+ VA+K+ + + + EIK + + H NLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 508 LGYSFDV---SNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDEC 555
L +V + LV+E++ + ++ D P + L I GI + H
Sbjct: 90 L----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-- 142
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
IIH DIKP+NIL+ ++ K+ DF A+ + TR Y APE
Sbjct: 143 -HNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVATRWYRAPE 194
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 29/181 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT------EI---KAIGRTHH 501
EIG G+ GTVYK +G FVA+K + ++ G E+ + + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 502 RNLVRLL----GYSFDVSNKI-LVYEYMSN--GSLADVYSSPP------KNNLIGIARGI 548
N+VRL+ D K+ LV+E++ + D P K+ + RG+
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAP 608
+LH + I+H D+KP+NIL+ K++DF LA++ T + T Y AP
Sbjct: 134 DFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTLWYRAP 188
Query: 609 E 609
E
Sbjct: 189 E 189
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 57/211 (27%), Positives = 82/211 (38%), Gaps = 32/211 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF 512
IG G+ G + + VAVK +++ A E Q EI H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF----K 82
Query: 513 DV---SNKI-LVYEYMSNGSLADVYSSPPKNNLI-GIAR--------GILYLHDECESQI 559
+V + ++ EY S G L + + AR G+ Y H QI
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM---QI 137
Query: 560 IHCDIKPQNILMDENRYA--KISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPI 616
H D+K +N L+D + KI DF +K ++ GT Y+APE
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEY 194
Query: 617 T-AKADVYSFGVVLLEIICCRRCF-DQNLPE 645
ADV+S GV L ++ F D P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQK--MLAEGEREFQT------EIKAIGRTHHR 502
+G G+ G V+ K V VK ++K +L + E EI + R H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 503 NLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG----------IARGILYL 551
N++++L F+ LV E +G D+++ ++ + + + YL
Sbjct: 90 NIIKVLDI-FENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEW 610
+ IIH DIK +NI++ E+ K+ DF A ++ + TF GT Y APE
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEV 200
Query: 611 HWNLP-ITAKADVYSFGVVLLEIICCRRCFD 640
P + +++S GV L ++ F
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 60/208 (28%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVK-----RLQKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+G G+ G V + + VAVK R ++E I +H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 508 LGYSFDV---SNKI-LVYEYMSNGSLADVYSSPPKNNLIGIAR--------GILYLHDEC 555
+ N L EY S G L D P A+ G++YLH
Sbjct: 71 ----YGHRREGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR-GTRGYVAPEWHWNL 614
I H DIKP+N+L+DE KISDF LA + + + GT YVAPE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 615 PIT-AKADVYSFGVVLLEIICCRRCFDQ 641
DV+S G+VL ++ +DQ
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-----REFQTEIKAIGRTHHRNLV 505
+++G G+ TVYKG + VA+K ++ EG RE + + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 506 RLLGYSFDV---SNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHD 553
L D+ + LV+EY+ L K L + RG+ Y H
Sbjct: 64 TLH----DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
+++H D+KPQN+L++E K++DF LA+ K T+T+ T Y P+
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLWYRPPD 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRN 503
++G G+ G VYK + + VA+KR+ ++ E E RE + + HRN
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHRN 94
Query: 504 LVRLLGYSFDV---SNKI-LVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLH 552
++ L V ++++ L++EY N L P K+ L + G+ + H
Sbjct: 95 IIELK----SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 553 DECESQIIHCDIKPQNILMDENRYA-----KISDFALAKLMKPDQTRTFTGIRGTRGYVA 607
+ +H D+KPQN+L+ + + KI DF LA+ R FT T Y
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRP 205
Query: 608 PE 609
PE
Sbjct: 206 PE 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 32/179 (17%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREF-QT---EIKAIGRTHHRNLVR 506
E++G G+ TVYKG G +VA+K + K+ + E T EI + H N+VR
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV-KL--DSEEGTPSTAIREISLMKELKHENIVR 67
Query: 507 LLGYSFDV---SNKI-LVYEYMSN--GSLADVYSSPPKNNLIGIA----------RGILY 550
L DV NK+ LV+E+M N D + + + +G+ +
Sbjct: 68 LY----DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
H+ ++I+H D+KPQN+L+++ K+ DF LA+ TF+ T Y AP+
Sbjct: 124 CHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFSSEVVTLWYRAPD 178
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREF---QT---EIKAIGRTHHRNL 504
+ +G G TVYK + VA+K++ K+ E + +T EIK + H N+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 505 VRLLGYSFDV---SNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLH 552
+ LL D + I LV+++M L + K ++ +G+ YLH
Sbjct: 75 IGLL----DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
I+H D+KP N+L+DEN K++DF LAK R +T TR Y APE
Sbjct: 130 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPE 182
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
IG+GS G V T K A+K + K E + E++ + H LV
Sbjct: 23 IGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 507 LLGYSF-DVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYL 551
L YSF D + +V + + G L ++ + + YL
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVMALDYL 131
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ-TRTFTGIRGTRGYVAPE- 609
+IIH D+KP NIL+DE+ + I+DF +A ++ + T GT+ Y+APE
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEM 185
Query: 610 --WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED 646
+ D +S GV E++ RR +
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 41/207 (19%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAIGRTHHRNLVR 506
+G+G+ G V K T G++ A+K L+K ++A+ E TE + + T H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYL 551
L Y+F +++ V EY + G L A Y + I + YL
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-------IVSALEYL 121
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVAPE 609
H +++ DIK +N+++D++ + KI+DF L K + +TF GT Y+APE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPE 175
Query: 610 WHWNLPITAKADVYSFGVVLLEIICCR 636
+ D + GVV+ E++C R
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 36/185 (19%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE-------REFQTEIKAIGRTHHRN 503
+IG+G+ G V+K G+ VA+K++ M E E RE IK + H N
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALRE----IKILQLLKHEN 77
Query: 504 LVRLLG-------YSFDVSNKI-LVYEYMSNGSLADVYSSPP--------KNNLIGIARG 547
+V L+ I LV+++ + LA + S+ K + + G
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM---KPDQTRTFTGIRGTRG 604
+ Y+H ++I+H D+K N+L+ + K++DF LA+ K Q +T T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 605 YVAPE 609
Y PE
Sbjct: 194 YRPPE 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 454 IGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHHRN 503
IG G+ G V I + VA+K+L R FQ E+ + +H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 504 LVRLL-----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN-----LIGIARGILYLH 552
++ LL S + + +V E M +L V + L + GI +LH
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612
+ IIH D+KP NI++ + KI DF LA+ T TR Y APE
Sbjct: 145 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 199
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILE 651
+ D++S G ++ E+I F DQ ++E
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 40/207 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAIGRTHHRNLVR 506
+G+G+ G V K T G++ A+K L+K ++A+ E TE + + + H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYL 551
L YSF +++ V EY + G L A Y + I + YL
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVSALDYL 264
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAK--LMKPDQTRTFTGIRGTRGYVAPE 609
H E +++ D+K +N+++D++ + KI+DF L K + +TF GT Y+APE
Sbjct: 265 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPE 319
Query: 610 WHWNLPITAKADVYSFGVVLLEIICCR 636
+ D + GVV+ E++C R
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 48/212 (22%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVR 506
IGRG+ G V K K A+K L K ML E F+ E + + +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSL---------------ADVYSSPPKNNLIGIARGILY 550
L Y+F N + LV +Y G L A Y + + I
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-------MVIAIDS 190
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD---QTRTFTGIRGTRGYVA 607
+H + +H DIKP NILMD N + +++DF + D Q+ GT Y++
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV---GTPDYIS 244
Query: 608 PE-----WHWNLPITAKADVYSFGVVLLEIIC 634
PE + D +S GV + E++
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 45/223 (20%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRL---QKML--AEGEREFQTEIKAIGRTHH---- 501
++G G TV+ M+N VA+K + + AE E + + T
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 502 -RNLVRLLGYSFDVSNKI-----LVYEYMSNGSLADVYSSPPKNNLIG--------IARG 547
++++LL F+ +V+E + +L + K G I++
Sbjct: 85 ANHILKLLD-HFNHKGPNGVHVVMVFEVLGE-NLLALIK---KYEHRGIPLIYVKQISKQ 139
Query: 548 IL----YLHDECESQIIHCDIKPQNILMDENRYA------KISDFALAKLMKPDQTRTFT 597
+L Y+H C IIH DIKP+N+LM+ KI+D A +T
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYT 193
Query: 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFD 640
TR Y +PE P AD++S ++ E+I F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-17
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 27/135 (20%)
Query: 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
+D + +L G L + G + +QND NL+ Y N W S T
Sbjct: 1 SDRLNSGHQLDTGGSL---------AEGGYLFIIQNDCNLVLYDNNRA------VWASGT 45
Query: 167 DGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLR 226
+GK L + +G+L + + + + T +N Y + + D +Y
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGN----YYLILQRDRNVVIY----- 96
Query: 227 RQNSTWQVLWES-TN 240
+++ +W + TN
Sbjct: 97 --DNSNNAIWATHTN 109
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 18/107 (16%), Positives = 28/107 (26%), Gaps = 15/107 (14%)
Query: 7 INIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIV-LRSTEQ 65
+N G L G+ + G Y F N Y + L+
Sbjct: 4 LNSGHQLDTGGSLA----EGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQND 59
Query: 66 GQDSIIADD----------SQSASSASMLDSGSFVLYDSDGKVIWQT 102
G I + + + V+YD+ IW T
Sbjct: 60 GNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 45/196 (22%), Positives = 91/196 (46%), Gaps = 26/196 (13%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLLG 509
++GRG V++ + N + V VK L+ + + + + EIK + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 98
Query: 510 YSFDVSNK--ILVYEYMSNGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCD 563
D ++ LV+E+++N +Y + + + I + + Y H I+H D
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRD 155
Query: 564 IKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-----WHWNLPIT 617
+KP N+++D E+R ++ D+ LA+ P Q + +R + PE ++ +
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSL- 212
Query: 618 AKADVYSFGVVLLEII 633
D++S G +L +I
Sbjct: 213 ---DMWSLGCMLASMI 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVR 506
IGRG+ G V K T K A+K L K M+ + F E + + +V+
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 507 LLGYSF-DVSNKILVYEYMSNGSL-------------ADVYSSPPKNNLIGIARGILYLH 552
L Y+F D +V EYM G L A Y++ + + +H
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-------VVLALDAIH 185
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGIRGTRGYVAPE-- 609
IH D+KP N+L+D++ + K++DF M + R T + GT Y++PE
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 610 --WHWNLPITAKADVYSFGVVLLEIIC 634
+ + D +S GV L E++
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 54/224 (24%), Positives = 84/224 (37%), Gaps = 53/224 (23%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGE--REFQT---------EIKAIGRTH 500
I GS G V G G VA+KR+ +++G EI+ + H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 501 HRNLVRLLG----YSFDVSNKI-LVYEYM----------SNGSLAD------VYSSPPKN 539
H N++ L + +K+ LV E M ++ +Y
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH----- 142
Query: 540 NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599
I G+ LH+ + ++H D+ P NIL+ +N I DF LA+ D T
Sbjct: 143 ----ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHY 193
Query: 600 RGTRGYVAPE----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
R Y APE + T D++S G V+ E+ + F
Sbjct: 194 VTHRWYRAPELVMQFKGF---TKLVDMWSAGCVMAEMFNRKALF 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 37/206 (17%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVRL 507
+G+GS G V+ + A+K L+K + + E + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 508 LGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYLH 552
Y+F K+ L+ +++ G L Y + +A + +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHLH 143
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQ-TRTFTGIRGTRGYVAPEW 610
II+ D+KP+NIL+DE + K++DF L+K + ++ +F GT Y+APE
Sbjct: 144 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEV 197
Query: 611 HWNLPITAKADVYSFGVVLLEIICCR 636
T AD +SFGV++ E++
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVR 506
IGRG+ V K T G+ A+K + K ML GE F+ E + R + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 507 LLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIAR--------GILYLHDECES 557
L ++F N + LV EY G L + S + +AR I +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RL 181
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGIRGTRGYVAPE------- 609
+H DIKP NIL+D + +++DF ++ D R+ + GT Y++PE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGG 240
Query: 610 WHWNLPITAKADVYSFGVVLLEIIC 634
+ D ++ GV E+
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHH 501
+G G+ G+V +G+ VA+K+L R FQ+ E+ + H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQH 82
Query: 502 RNLVRLL-----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN-----LIGIARGILY 550
N++ LL S LV +M L + + + +G+ Y
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE- 609
+H + ++H D+KP N+ ++E+ KI DF LA+ + TG TR Y APE
Sbjct: 142 IHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 194
Query: 610 ---WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILE 651
W D++S G ++ E++ + F DQ+ IL+
Sbjct: 195 ILSWMHY---NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 36/223 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHH 501
+ IG G+ G V + + VA+K+L + FQ E+ + +H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNH 120
Query: 502 RNLVRLL-----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN-----LIGIARGILY 550
+N++ LL + + + LV E M + +L V + L + GI +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW 610
LH + IIH D+KP NI++ + KI DF LA+ T TR Y APE
Sbjct: 180 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEV 234
Query: 611 HWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILE 651
+ D++S G ++ E++ + F DQ ++E
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 40/203 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQKMLAEGEREFQ---TEIKAIGRTHHRNLVR 506
+G GS G V K + G A+K L K ++ + E + + + LV+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 507 LLGYSF-DVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYL 551
L +SF D SN +V EY++ G + A Y++ I YL
Sbjct: 106 LE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-------IVLTFEYL 157
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
H +I+ D+KP+N+L+D+ Y +++DF AK + +T T GT +APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTL---CGTPEALAPEII 210
Query: 612 WNLPITAKADVYSFGVVLLEIIC 634
+ D ++ GV++ E+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAA 233
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 44/209 (21%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
IG+GS G V K F AVK LQK +L + E + +E + + H L
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSE-RNVLLKNVKHPFL 101
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
V L +SF ++K+ V +Y++ G L A Y++ IA +
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------IASALG 153
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQ-TRTFTGIRGTRGYVA 607
YLH I++ D+KP+NIL+D + ++DF L K ++ + T TF GT Y+A
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLA 207
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCR 636
PE P D + G VL E++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 40/203 (19%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAIGRTHHRNLVR 506
+G GS G V+ + G++ A+K L+K ++ + E E + H ++R
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 507 LLGYSF-DVSNKILVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGILYL 551
+ +F D ++ +Y+ G L A Y++ + + YL
Sbjct: 71 MW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------VCLALEYL 122
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
H + II+ D+KP+NIL+D+N + KI+DF AK + PD T T GT Y+APE
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTL---CGTPDYIAPEVV 175
Query: 612 WNLPITAKADVYSFGVVLLEIIC 634
P D +SFG+++ E++
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLA 198
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 46/227 (20%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGERE-FQTEIKAI--GRTHHRNL 504
+G+GS G V +K T +F A+K L+K +L + + E E K + H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVE-KRVLSLAWEHPFL 80
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
+ +F + V EY++ G L A Y++ I G+
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-------IILGLQ 132
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQ-TRTFTGIRGTRGYVA 607
+LH I++ D+K NIL+D++ + KI+DF + K M D T TF GT Y+A
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---GTPDYIA 186
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEE 652
PE D +SFGV+L E++ + F E+ I +
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHH 501
+ +G G+ G V G VA+K+L + FQ+ E++ + H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRH 83
Query: 502 RNLVRLL-----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGIL 549
N++ LL + D LV +M L + + + +G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
Y+H + IIH D+KP N+ ++E+ KI DF LA+ + TG TR Y APE
Sbjct: 143 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPE 195
Query: 610 ----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
W T D++S G ++ E+I + F
Sbjct: 196 VILNWMRY---TQTVDIWSVGCIMAEMITGKTLF 226
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.2 bits (191), Expect = 5e-16
Identities = 46/278 (16%), Positives = 87/278 (31%), Gaps = 42/278 (15%)
Query: 3 GHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVG--VFLAGIPEKNVGRIVL 60
G S + +LS LSP+ + N G V++A + I L
Sbjct: 13 GTSVLPAYQTLSAG--QYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 61 RSTEQGQ-----------------------DSIIADDSQSASSASMLDSGSFVLYDSDGK 97
R+ + + ++D + + + D G+ VL DS
Sbjct: 71 RNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLAL 130
Query: 98 VIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTA 157
+ + L G EL G+ G +L Q DGNL+ Y
Sbjct: 131 WNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGNLVAY-----GPN 182
Query: 158 PYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDG 216
+ W + T GKG V +G+L + + + + T G ++++ ++G
Sbjct: 183 GAATWNAGTQGKG-AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS-----AVLRLQANG 236
Query: 217 IFRLYSYNLRRQNSTWQVLWESTNEKCDPLGLCGFNSF 254
+ +Q + + ++
Sbjct: 237 SIAILDEKPVWARFGFQPTYRHIRKINPDQKPIDIWTW 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 45/211 (21%)
Query: 454 IGRGSSGTVY-------KGTMINGKFVAVKRLQK-MLAEGEREF---QTEIKAIGRTHHR 502
+G+G G V+ T GK A+K L+K M+ ++ + E + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 503 NLVRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARG 547
+V L+ Y+F K+ L+ EY+S G L A Y + I+
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE-------ISMA 133
Query: 548 ILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQ-TRTFTGIRGTRGY 605
+ +LH + II+ D+KP+NI+++ + K++DF L K + T TF GT Y
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEY 187
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEIICCR 636
+APE D +S G ++ +++
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
+G+GS G V KGT + AVK L+K ++ + + E E K + L
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVE-KRVLALPGKPPFL 83
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
+L F +++ V EY++ G L A Y++ IA G+
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IAIGLF 135
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVA 607
+L + II+ D+K N+++D + KI+DF + K + T+TF GT Y+A
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIA 189
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEE 652
PE P D ++FGV+L E++ + F+ ++ Q I+E
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 44/209 (21%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
IGRGS V K T + A+K ++K + + + ++ QTE K + ++H L
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQASNHPFL 72
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
V L F +++ V EY++ G L A YS+ I+ +
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISLALN 124
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVA 607
YLH E II+ D+K N+L+D + K++D+ + K ++P D T TF GT Y+A
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIA 178
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCR 636
PE D ++ GV++ E++ R
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 42/215 (19%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHH 501
IG G+ G V +N VA+K++ F+ EIK + R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 502 RNLVRLLG----YSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGILY 550
N++ + + + + +V + M L + + +N L I RG+ Y
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 551 LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF--TGIRGTRGYVAP 608
+H + ++H D+KP N+L++ KI DF LA++ PD T T TR Y AP
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 609 E----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
E T D++S G +L E++ R F
Sbjct: 201 EIMLNSKG---YTKSIDIWSVGCILAEMLSNRPIF 232
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 9e-16
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 31/138 (22%)
Query: 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+ +L Q L A L G + L +QN NL++Y W S TD
Sbjct: 3 NVLLSGQTLHADHSL---------QAGAYTLTIQNKCNLVKYQNGRQ------IWASNTD 47
Query: 168 GKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLR 226
+G L L +G+L + + ++ + G+N Y + + DG F +Y
Sbjct: 48 RRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGK----YALVLQKDGRFVIYG---- 99
Query: 227 RQNSTWQVLWES-TNEKC 243
VLW N
Sbjct: 100 ------PVLWSLGPNGCR 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 26/160 (16%), Positives = 44/160 (27%), Gaps = 57/160 (35%)
Query: 10 GSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDS 69
G +L + + +G Y + N Y GR + S + S
Sbjct: 8 GQTLHADHSLQ----AGAYTLTIQNKCNLVKY------------QNGRQIWASNTDRRGS 51
Query: 70 IIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKT 129
++L G+ V+YD + +W S
Sbjct: 52 --------GCRLTLLSDGNLVIYDHNNNDVWG-------------------------SAC 78
Query: 130 DPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGK 169
GK+ L +Q DG + Y W+ +G
Sbjct: 79 WGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGC 110
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 1e-15
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 454 IGRGSSGTV----YKGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
+G+GS G V KGT + AVK L+K ++ + + E E K + L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVE-KRVLALPGKPPFL 404
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL------ADVYSSPPKNNLIG-IARGILYLHDECE 556
+L F +++ V EY++ G L + P IA G+ +L +
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVAPEWHWNL 614
II+ D+K N+++D + KI+DF + K + T+TF GT Y+APE
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQ 517
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEE 652
P D ++FGV+L E++ + F+ ++ Q I+E
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-15
Identities = 22/107 (20%), Positives = 36/107 (33%), Gaps = 10/107 (9%)
Query: 116 LLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSL 175
LL G + S MQ D NL+ Y + + S T G+G + +L
Sbjct: 5 LLTGDVIHTDNQ---LSYESAAFVMQGDCNLVLYNEAGG-------FQSNTHGRGVDCTL 54
Query: 176 NLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222
L+ G L + ++ + T Y + D +Y
Sbjct: 55 RLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG 101
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 15/106 (14%), Positives = 28/106 (26%), Gaps = 29/106 (27%)
Query: 83 MLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQN 142
M + VLY+ +Q S T L++ N
Sbjct: 26 MQGDCNLVLYN--EAGGFQ-------------------------SNTHGRGVDCTLRLNN 58
Query: 143 DGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNS 188
G L + + P + + N + L + H+ +
Sbjct: 59 RGQLEIH--SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP 102
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 70/238 (29%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
+ +G GS G V + I +GK A+K K+L + + + E+ + H N+++L+ Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYKNR-ELDIMKVLDHVNIIKLVDY 68
Query: 511 SFDVSNKI--------------------------------------LVYEYMSNGSLADV 532
+ ++ ++ EY+ + +L V
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 533 YSSPPKNNLI-----------GIARGILYLHDECESQIIHCDIKPQNILMDENRYA-KIS 580
S ++ + R + ++H I H DIKPQN+L++ K+
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 581 DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPI-----TAKADVYSFGVVLLEII 633
DF AK + P + +R Y APE L + T D++S G V E+I
Sbjct: 185 DFGSAKKLIPSE--PSVAYICSRFYRAPE----LMLGATEYTPSIDLWSIGCVFGELI 236
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-15
Identities = 22/122 (18%), Positives = 49/122 (40%), Gaps = 20/122 (16%)
Query: 104 DHP--TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSY 161
+ P + + +Q + +L +T + L M++D NL+ + +
Sbjct: 1 NIPRVRNVLFSSQVMYDNAQL---------ATRDYSLVMRDDCNLVLTKGSKTNI----V 47
Query: 162 WTSFTDGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRL 220
W S T G+G + + L +G L + + + + T G+ Y++ + +G +
Sbjct: 48 WESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGD----YVLILQINGQAVV 103
Query: 221 YS 222
Y
Sbjct: 104 YG 105
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 10/69 (14%), Positives = 18/69 (26%), Gaps = 25/69 (36%)
Query: 81 ASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKM 140
+ SG + D ++ S T G + L +
Sbjct: 61 MRLGHSGELDITDDRLNTVFV-------------------------SNTVGQEGDYVLIL 95
Query: 141 QNDGNLIQY 149
Q +G + Y
Sbjct: 96 QINGQAVVY 104
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 16/107 (14%), Positives = 30/107 (28%), Gaps = 31/107 (28%)
Query: 83 MLDSGSFVLYDSD-GKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQ 141
M D + VL ++W++ T +++
Sbjct: 30 MRDDCNLVLTKGSKTNIVWES-------------------------GTSGRGQHCFMRLG 64
Query: 142 NDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNS 188
+ G L D + + S T G+ + L L NG +
Sbjct: 65 HSGELDIT-----DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP 106
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
+G+GS G V K T G AVK L+K +L + + E TE K I +H L
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTE-KRILSLARNHPFL 86
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
+L F +++ V E+++ G L A Y++ I ++
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------IISALM 138
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQ-TRTFTGIRGTRGYVA 607
+LH + II+ D+K N+L+D + K++DF + K + T TF GT Y+A
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIA 192
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--QVILEE 652
PE + D ++ GV+L E++C F+ +D + IL +
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 44/209 (21%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREF-QTEIKAI--GRTHHRNL 504
IGRGS V K T + A++ ++K + + + ++ QTE K + ++H L
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTE-KHVFEQASNHPFL 115
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
V L F +++ V EY++ G L A YS+ I+ +
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISLALN 167
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKP-DQTRTFTGIRGTRGYVA 607
YLH E II+ D+K N+L+D + K++D+ + K ++P D T TF GT Y+A
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIA 221
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCR 636
PE D ++ GV++ E++ R
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 37/159 (23%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTH 500
+ IG GS G V + + + VA+K++ R F+ EI + R +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLN 110
Query: 501 HRNLVRLL----GYSFDVSNKI-LVYEYM---------SNGSLADVYSSPPKNNLIGIAR 546
H ++V++L + +++ +V E + L +++ K L +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI---KTLLYNLLV 167
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585
G+ Y+H + I+H D+KP N L++++ K+ DF LA
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTHH 501
+G G+ G+V G VAVK+L + FQ+ E++ + H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKH 87
Query: 502 RNLVRLL-----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGIL 549
N++ LL S + N + LV M L ++ + + I RG+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE 609
Y+H + IIH D+KP N+ ++E+ KI DF LA+ + TG TR Y APE
Sbjct: 147 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPE 199
Query: 610 ----WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILE 651
W D++S G ++ E++ R F DQ+ IL
Sbjct: 200 IMLNWMHY---NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 441 AELEKMTDGFK---EEIGRGSSGTVYKG---TMINGKFVAVKRLQKMLAEG-EREFQTEI 493
+E E++ D F+ ++GRG+ G VYK + K A+K+++ G EI
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREI 69
Query: 494 KAIGRTHHRNLVRLLG-YSFDVSNKI-LVYEYMSN--GSLADVYSSPPKNNLIG------ 543
+ H N++ L + K+ L+++Y + + + + N
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 544 -------IARGILYLHDECESQIIHCDIKPQNILMDENRYA----KISDFALAKLMKPDQ 592
I GI YLH + ++H D+KP NIL+ KI+D A+L
Sbjct: 130 VKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SP 185
Query: 593 TRTFTGIRG---TRGYVAPEW-----HWNLPITAKADVYSFGVVLLEII 633
+ + T Y APE H+ I D+++ G + E++
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 47/222 (21%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRL---QKMLAEGEREFQTEIKAIGRTHHRNLVRL 507
+ +G G +G V+ K VA+K++ + + EIK I R H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALR-EIKIIRRLDHDNIVKV 73
Query: 508 L-------------GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG---------I 544
S N + +V EYM D+ + + L+ +
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARLFMYQL 129
Query: 545 ARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRT--FTGIRG 601
RG+ Y+H + ++H D+KP N+ ++ E+ KI DF LA++M P + +
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 602 TRGYVAPE----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
T+ Y +P + T D+++ G + E++ + F
Sbjct: 187 TKWYRSPRLLLSPNN---YTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-14
Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 31/135 (22%)
Query: 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+ + + L G L + G++ MQ D NL+ Y + P W + T
Sbjct: 2 NILYSGETLSPGEFL---------NNGRYVFIMQEDCNLVLYDVDKP------IWATNTG 46
Query: 168 GKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLR 226
G L++ +G+L + + I + T GEN Y+ + D +Y
Sbjct: 47 GLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGN----YVCVLQKDRNVVIYG---- 98
Query: 227 RQNSTWQVLWES-TN 240
W + TN
Sbjct: 99 ------TARWATGTN 107
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-07
Identities = 18/113 (15%), Positives = 31/113 (27%), Gaps = 33/113 (29%)
Query: 56 GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQR 115
+VL ++ + SM G+ V+Y IW
Sbjct: 29 CNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWA-------------- 74
Query: 116 LLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDG 168
S T G + +Q D N++ Y + W + T+
Sbjct: 75 -----------SNTGGENGNYVCVLQKDRNVVIYGT--------ARWATGTNI 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 39/210 (18%)
Query: 454 IGRGSSGTVY----KGTMINGKFVAVKRLQK--MLAEGEREFQTEI-KAI--GRTHHRNL 504
+G G+ G V+ GK A+K L+K ++ + + T + + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSL--------------ADVYSSPPKNNLIGIARGIL 549
V L Y+F K+ L+ +Y++ G L +Y I +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE-------IVLALE 173
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL-MKPDQTRTFTGIRGTRGYVAP 608
+LH + II+ DIK +NIL+D N + ++DF L+K + + R + GT Y+AP
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 609 E--WHWNLPITAKADVYSFGVVLLEIICCR 636
+ + D +S GV++ E++
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 34/155 (21%), Positives = 63/155 (40%), Gaps = 26/155 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRL 507
+ +G G +G V + + A+K LQ + + E++ R + ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 508 LGY---SFDVSNKI-LVYEYMSNGSLAD--------VYSSPPKNNLIG-IARGILYLHDE 554
+ + + +V E + G L ++ + ++ I I YLH
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 555 CESQIIHCDIKPQNILM---DENRYAKISDFALAK 586
I H D+KP+N+L N K++DF AK
Sbjct: 137 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRL---QKMLAEGEREFQ--TEIKAIGRTHHRNLV 505
+ IG+GS G V K + VA+K + ++ + E + ++ + + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IARGIL----YLH 552
+L F N I + +E +S +L ++ KN G A IL LH
Sbjct: 163 HMLEN-FTFRNHICMTFELLSM-NLYELIK---KNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 553 DECESQIIHCDIKPQNILMDENRYA--KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW 610
++IIHCD+KP+NIL+ + + K+ DF + + + +R Y APE
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQSRFYRAPEV 270
Query: 611 HWNLPITAKADVYSFGVVLLEI 632
D++S G +L E+
Sbjct: 271 ILGARYGMPIDMWSLGCILAEL 292
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-14
Identities = 29/128 (22%), Positives = 45/128 (35%), Gaps = 29/128 (22%)
Query: 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
T+ +L Q L L G F L MQ+D NL+ Y N W S T
Sbjct: 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYNGN---------WQSNT 44
Query: 167 DGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNL 225
G + L L + G L + N G + ++ + Y + DG ++
Sbjct: 45 ANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGN----YAAVVHPDGRLVVFG--- 97
Query: 226 RRQNSTWQ 233
S ++
Sbjct: 98 ---PSVFK 102
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 13/90 (14%), Positives = 25/90 (27%), Gaps = 33/90 (36%)
Query: 81 ASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKM 140
++ D G V+ + DG +W+ S G + +
Sbjct: 53 LTLTDYGELVIKNGDGSTVWK-------------------------SGAQSVKGNYAAVV 87
Query: 141 QNDGNLIQYPKNTPDTAPYSYWTSFTDGKG 170
DG L+ + S + +G
Sbjct: 88 HPDGRLVVFGP--------SVFKIDPWVRG 109
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-14
Identities = 25/123 (20%), Positives = 42/123 (34%), Gaps = 22/123 (17%)
Query: 118 AGMELFPGISKTDPS-TGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLN 176
L S T +R MQ D NL+ Y N P W + T G G+
Sbjct: 13 HPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNP------IWATNTGGLGNGCRAV 66
Query: 177 LDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVL 235
L +G L ++ + + ++ G+ Y++ + D +Y L
Sbjct: 67 LQPDGVLVVITNENVTVWQSPVAGKAGH----YVLVLQPDRNVVIYG----------DAL 112
Query: 236 WES 238
W +
Sbjct: 113 WAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 22/165 (13%), Positives = 42/165 (25%), Gaps = 53/165 (32%)
Query: 3 GHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRS 62
+ N L + L + +Y F Q++ +VL
Sbjct: 7 KQPDDNHPQILHATESLEILFGTHVYRFIM--QTDC------------------NLVLYD 46
Query: 63 TEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMEL 122
+ + A + G V+ ++ +WQ
Sbjct: 47 NNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQ--------------------- 85
Query: 123 FPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
S G + L +Q D N++ Y + W + T
Sbjct: 86 ----SPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQTV 118
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRT 499
K +G G+ G V T G+ VA+K++ F EIK +
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHF 66
Query: 500 HHRNLVRLL----GYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNN------LIGIARGI 548
H N++ + SF+ N++ ++ E M L V S+ ++ + R +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 549 LYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG------- 601
LH S +IH D+KP N+L++ N K+ DF LA+++
Sbjct: 126 KVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 602 --TRGYVAPE----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
TR Y APE + DV+S G +L E+ R F
Sbjct: 183 VATRWYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRRPIF 223
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-14
Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 21/118 (17%)
Query: 106 PTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSF 165
+ + Q L L + +L MQ D NL+ Y W S
Sbjct: 5 TNNLLFSGQVLYGDGRL---------TAKNHQLVMQGDCNLVLYGGKY-------GWQSN 48
Query: 166 TDGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYS 222
T G G++ L L+ G L + + I + + + Y++ + DG +Y
Sbjct: 49 THGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGE----YVLILQDDGFGVIYG 102
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-06
Identities = 13/69 (18%), Positives = 23/69 (33%), Gaps = 25/69 (36%)
Query: 81 ASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKM 140
+ G ++ D D K IW S++ G++ L +
Sbjct: 58 LRLNHKGELIIKDDDFKTIWS-------------------------SRSSSKQGEYVLIL 92
Query: 141 QNDGNLIQY 149
Q+DG + Y
Sbjct: 93 QDDGFGVIY 101
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 7e-14
Identities = 30/132 (22%), Positives = 47/132 (35%), Gaps = 29/132 (21%)
Query: 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+++ L G L G +RL MQ D N + Y P W S T
Sbjct: 2 NSLSSPNSLFTGHSLEVG--------PSYRLIMQGDCNFVLYDSGKP------VWASNTG 47
Query: 168 GKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLR 226
G G L L NG+L + + + I + T G+ Y++ + D +Y
Sbjct: 48 GLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDH----YVLVLQQDRNVVIYG---- 99
Query: 227 RQNSTWQVLWES 238
V+W +
Sbjct: 100 ------PVVWAT 105
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-07
Identities = 17/92 (18%), Positives = 32/92 (34%), Gaps = 33/92 (35%)
Query: 77 SASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKF 136
S ++ ++G+ V+YD +VIWQ +KT+ +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQ-------------------------TKTNGKEDHY 85
Query: 137 RLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDG 168
L +Q D N++ Y W + +
Sbjct: 86 VLVLQQDRNVVIYGP--------VVWATGSGP 109
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 8e-14
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 27/128 (21%)
Query: 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+ + + L AG L + MQ D NL+ Y +T W S T
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLYDHSTS------VWASNTG 46
Query: 168 GKG-DNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYNL 225
G L +G+ + ++ G ++ + + N Y++ + DG +Y
Sbjct: 47 ILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGN----YVLVLQEDGNVVIYG--- 99
Query: 226 RRQNSTWQ 233
+ W
Sbjct: 100 ---SDIWS 104
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 34/112 (30%)
Query: 56 GRIVL-RSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQ 114
+VL + S + A + G+FV+YD++G+ +W
Sbjct: 29 CNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWA------------- 75
Query: 115 RLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
S + G + L +Q DGN++ Y + W++ T
Sbjct: 76 ------------SHSVRGNGNYVLVLQEDGNVVIY-----GSD---IWSTGT 107
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 54/288 (18%), Positives = 98/288 (34%), Gaps = 78/288 (27%)
Query: 451 KEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQT---------EIKAIGRTH 500
K IGRGS G VY K VA+K++ +M F+ EI + R
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLK 83
Query: 501 HRNLVRLLG----YSFDVSNKI-LVYEYM---------SNGSLAD------VYSSPPKNN 540
++RL +++ +V E + L + +Y+
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN------ 137
Query: 541 LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600
+ G ++H ES IIH D+KP N L++++ K+ DF LA+ + ++
Sbjct: 138 ---LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 601 G---------------------TRGYVAPE----WHWNLPITAKADVYSFGVVLLEIICC 635
TR Y APE T D++S G + E++
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN---YTKSIDIWSTGCIFAELLNM 248
Query: 636 RRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
+ + + + + ++ + QL + +
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN-RDQLNIIFNI 295
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 64/353 (18%), Positives = 109/353 (30%), Gaps = 111/353 (31%)
Query: 454 IGRGSSGTVYKG-TMINGKFVAVK---RLQKML--AEGEREFQTEIKAIGRTHH-RNLVR 506
+G G TV+ + KFVA+K + A E ++ R +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 507 LLGYSFDVSNKI-----LVYEYMSNGSLAD-VYSSP----PKNNLIGIARGIL----YLH 552
L F +S +V+E + + L + S P + I + +L YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 553 DECESQIIHCDIKPQNILM----------------------------------------- 571
+C +IIH DIKP+NIL+
Sbjct: 164 TKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 572 --------DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
E KI+D A + + FT TR Y + E AD++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVH----KHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQV-------------------ILEEWVY--QCF-ENG 661
S + E+ F+ + E+ ++ Y + F + G
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337
Query: 662 NL------------GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+L L+E + +++ L + P R + + L
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 31/201 (15%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVK---RLQKMLAEGEREFQ--TEIKAIGRTHHRNLV 505
IG+GS G V K + ++VA+K + L + + E + + +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 506 RLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IARGIL----YLH 552
L + F N + LV+E +S +L D+ N G A+ + +L
Sbjct: 120 HLKRH-FMFRNHLCLVFEMLSY-NLYDLLR---NTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 553 DECESQIIHCDIKPQNILM-DENRYA-KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW 610
E IIHCD+KP+NIL+ + R A KI DF + + +R Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC----QLGQRIYQYIQSRFYRSPEV 229
Query: 611 HWNLPITAKADVYSFGVVLLE 631
+P D++S G +L+E
Sbjct: 230 LLGMPYDLAIDMWSLGCILVE 250
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 57/222 (25%)
Query: 452 EEIGRGSSGTVYKG--TMINGKFVAVK---RLQKMLAEGEREFQ--TEIKAIGRTHHRNL 504
+ +G G+ G V + G+ VAVK + + E Q +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IARGIL----YL 551
V++L + F+ I +V+E + S D +N + +A I +L
Sbjct: 80 VQMLEW-FEHHGHICIVFELLGL-STYDFIK---ENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR----G------ 601
H ++ H D+KP+NIL ++ Y + + K+ + ++T I+ G
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYN---PKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 602 --------TRGYVAPE----WHWNLPITAKADVYSFGVVLLE 631
TR Y APE W+ P DV+S G +L+E
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC----DVWSIGCILIE 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 67/238 (28%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT--------- 499
+++G+G+ G V+K G+ VAVK++ FQ A RT
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQ-RTFREIMILTE 64
Query: 500 --HHRNLVRLLGYSFDVS-----NKI-LVYEYMSNGSLADVYSSPPKNN------LIGIA 545
H N+V LL +V + LV++YM L V + + +
Sbjct: 65 LSGHENIVNLL----NVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI 119
Query: 546 RGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRG---- 601
+ I YLH ++H D+KP NIL++ + K++DF L++ + T
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 602 ----------------TRGYVAPE----WHWNLPITAKADVYSFGVVLLEIICCRRCF 639
TR Y APE T D++S G +L EI+C + F
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILCGKPIF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 63/227 (27%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVK---RLQKMLAEGEREFQTEIKAIGR-----THHR 502
++G G+ G V + N K+ AVK ++K + E + + ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96
Query: 503 NLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IARGIL---- 549
N+V+ G F + + L++E + SL ++ + +NN G IL
Sbjct: 97 NIVKYHGK-FMYYDHMCLIFEPLGP-SLYEIIT---RNNYNGFHIEDIKLYCIEILKALN 151
Query: 550 YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF---TGIR----G- 601
YL + H D+KP+NIL+D+ + K TGI+ G
Sbjct: 152 YLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 602 -------------TRGYVAPE----WHWNLPITAKADVYSFGVVLLE 631
TR Y APE W++ D++SFG VL E
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSS----DMWSFGCVLAE 251
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 4e-11
Identities = 28/186 (15%), Positives = 58/186 (31%), Gaps = 21/186 (11%)
Query: 54 NVGRIVLRSTEQGQ-DSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILP 112
+ G +V+ + + S S + + +Y +
Sbjct: 64 SDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANN 123
Query: 113 TQRLLAGMELFPGISKT-----DPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+L + +T +RL M+ D NL+ + ++ W++ T
Sbjct: 124 GNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDR------VWSTNTA 177
Query: 168 GKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRR 227
GKG L NG + +L + + T G + + G + + D +Y
Sbjct: 178 GKGTGCRAVLQPNGRMDVLTNQNIAV--WTSGNSRSAGRYVFV-LQPDRNLAIYG----- 229
Query: 228 QNSTWQ 233
+ W
Sbjct: 230 -GALWT 234
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 4e-07
Identities = 29/173 (16%), Positives = 51/173 (29%), Gaps = 21/173 (12%)
Query: 106 PTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSF 165
+ Q L A L FR MQ+D NL+ + + W S
Sbjct: 7 LSHEGSHPQTLHAAQSL---------ELSSFRFTMQSDCNLVLFDSDVR------VWASN 51
Query: 166 TDGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIFRLYSYN 224
T G L +G L +L + + T+G Y++ + D +Y
Sbjct: 52 TAGAT-GCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGN----YVLVLQPDRTVTIYGPG 106
Query: 225 LRRQNSTWQVLWESTNEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPIIQGN 277
L ++ + N L N + L + ++ +
Sbjct: 107 LWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETD 159
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 45/222 (20%), Positives = 79/222 (35%), Gaps = 57/222 (25%)
Query: 452 EEIGRGSSGTVYKG--TMINGKFVAVK---RLQKMLAEGEREFQ--TEIKAIGRTHHRNL 504
+G G+ G V + VA+K + K E +IK + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 505 VRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIG--------IARGIL----YL 551
V + + F+ + + +E + + + +NN +A + +L
Sbjct: 85 VLMSDW-FNFHGHMCIAFELLGK-NTFEFLK---ENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR----G------ 601
H+ +Q+ H D+KP+NIL + + + + + K + T IR G
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN---TSIRVADFGSATFDH 193
Query: 602 --------TRGYVAPE----WHWNLPITAKADVYSFGVVLLE 631
TR Y PE W P DV+S G +L E
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPC----DVWSIGCILFE 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 544 IARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTR 603
+A+G+ +L + IH D+ +NIL+ E KI DF LA+ + D R
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----RKGD 254
Query: 604 GYV-----APEWHWNLPITAKADVYSFGVVLLEII 633
+ APE ++ T ++DV+SFGV+L EI
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 9/148 (6%)
Query: 450 FKEEIGRGSSGTVYKGTM--INGKFVAVKRLQKMLAEG-----EREFQTEIK-AIGRTHH 501
+ +GRG+ G V + I+ KML EG R +E+K I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 502 RNLVRLLGYSFDVSNKILV-YEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQII 560
N+V LLG ++V E+ G+L+ S + +G + + I
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLM 588
D+K + + ++ + S F K +
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 31/203 (15%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVRL 507
++IG G+ G + G + ++VA+K L+ M + E++ + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKN----NLIGIARGIL----YLHDECESQI 559
+ +V E + SL D++ + ++ IA ++ Y+H + +
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---L 126
Query: 560 IHCDIKPQNILM-----DENRYAKISDFALAKLMKPDQT------RTFTGIRGTRGYVAP 608
I+ D+KP+N L+ + I DFALAK +T R + GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 609 EWHWNLPITAKADVYSFGVVLLE 631
H + + D+ + G + +
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMY 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 2e-08
Identities = 27/219 (12%), Positives = 51/219 (23%), Gaps = 66/219 (30%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVKRL------------QKMLAEGEREFQ-----TEIK 494
E+IG G G V++ + VA+K + QK E E + +
Sbjct: 26 EKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 495 AIGRTHHRNLVRLLG------------------------------YSFDVSNKILVYEYM 524
+ L F +V E+
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 525 SNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAK 578
G + + + L + + + H D+ N+L+ + K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKK 202
Query: 579 ISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
+ K + G + L
Sbjct: 203 LHYTLNGKSST----------IPSCGLQVSIIDYTLSRL 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVRL 507
+IG GS G +Y GT + G+ VA+K + + + E + K + + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKI-YKMMQGGVG--IPTI 70
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPK----NNLIGIARGIL----YLHDECESQI 559
+ ++V E + SL D+++ + ++ +A ++ Y+H
Sbjct: 71 RWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNF 126
Query: 560 IHCDIKPQNILMDENRYAK---ISDFALAKLMKPDQT------RTFTGIRGTRGYVAPEW 610
IH D+KP N LM + I DF LAK + +T R + GT Y +
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186
Query: 611 HWNLPITAKADVYSFGVVLLE 631
H + + + D+ S G VL+
Sbjct: 187 HLGIEQSRRDDLESLGYVLMY 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 33/204 (16%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVRL 507
IG GS G +++GT ++N + VA+K + ++ E++T G T + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTG---IPNV 71
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKN------NLIG---IARGILYLHDECESQ 558
+ + + +LV + + SL D+ + + +AR + +H++
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLAR-VQSIHEKS--- 126
Query: 559 IIHCDIKPQNILMDENRYAK-----ISDFALAKLMKPDQT------RTFTGIRGTRGYVA 607
+++ DIKP N L+ + DF + K + T R + GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 608 PEWHWNLPITAKADVYSFGVVLLE 631
H + + D+ + G V +
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMY 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 31/202 (15%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLVRL 507
+IG GS G +Y GT + + VA+K + + + E + + + + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKI-YRILQGGTG--IPNV 68
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKN------NLIG---IARGILYLHDECESQ 558
+ + +LV + + SL D+++ + ++ I R + ++H +
Sbjct: 69 RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINR-VEFVHSKS--- 123
Query: 559 IIHCDIKPQNILMDENRYAK---ISDFALAKLMKPDQT------RTFTGIRGTRGYVAPE 609
+H DIKP N LM R A I DF LAK + T R + GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 610 WHWNLPITAKADVYSFGVVLLE 631
H + + + D+ S G VL+
Sbjct: 184 THLGIEQSRRDDLESLGYVLMY 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 38/245 (15%), Positives = 80/245 (32%), Gaps = 56/245 (22%)
Query: 436 LSFSYAELEKMTDGFKEE------IGRGSSGTVYKGT-MINGKFVAV------------- 475
S + E + + D + IG G G +Y + A
Sbjct: 21 QSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL 80
Query: 476 -------KRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK----ILVYEYM 524
+R+ K + + ++ +G + G +V E +
Sbjct: 81 FSELKFYQRVAKKDCIKKWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERL 134
Query: 525 SNGSLADVYSSPPKNNL---IGIARGIL----YLHDECESQIIHCDIKPQNILMDENRYA 577
L + + + +L Y+H E++ +H DIK N+L+
Sbjct: 135 GI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190
Query: 578 KI--SDFALAKLMKPDQT------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVL 629
++ +D+ L+ P+ G GT + + + H + ++ ++DV G +
Sbjct: 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250
Query: 630 LEIIC 634
L +C
Sbjct: 251 LRWLC 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 35/221 (15%), Positives = 77/221 (34%), Gaps = 47/221 (21%)
Query: 454 IGRGSSGTVYKGTMINGKFVAVK-------------------RLQKMLAEGEREFQTEIK 494
IG+G G +Y M + + V + + A+ E+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI--QKWI 100
Query: 495 AIGRTHHRNLVRLLGYSFDVSNK----ILVYEYMSNGSLADVYSS-----PPKNNLIGIA 545
+ + + + G N ++ + + L +Y + K L ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQ-LS 158
Query: 546 RGIL----YLHDECESQIIHCDIKPQNILMDENRYAKI--SDFALAKLMKPDQT------ 593
IL Y+H E + +H DIK N+L++ ++ D+ LA P+
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC 634
GT + + + H + + + D+ G +++ +
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 27/146 (18%), Positives = 43/146 (29%), Gaps = 18/146 (12%)
Query: 454 IGRGSSGTVYKGTMINGKFVAVKRLQKMLAE----------GEREFQTEIKAIGRTHHRN 503
+G G V+ VK + G+ F R R
Sbjct: 98 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157
Query: 504 LVRLLGYS----FDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQI 559
L +L G + + ++ E + L V P L I + I
Sbjct: 158 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF---YHRGI 214
Query: 560 IHCDIKPQNILMDENRYAKISDFALA 585
+H D+ N+L+ E I DF +
Sbjct: 215 VHGDLSQYNVLVSEE-GIWIIDFPQS 239
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 13/150 (8%)
Query: 444 EKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM-----LAEGEREFQT--EIKAI 496
K + IG+G+ + + + ++ + +R++K L E R+ +T E + +
Sbjct: 334 GKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYL 393
Query: 497 GRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECE 556
+ + D+ NK ++ Y++ DV I + LH +
Sbjct: 394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDI-AYKIGEIVGKLH---K 449
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAK 586
+ +IH D+ N + D++ Y I DF L K
Sbjct: 450 NDVIHNDLTTSNFIFDKDLY--IIDFGLGK 477
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 28/185 (15%), Positives = 59/185 (31%), Gaps = 44/185 (23%)
Query: 454 IGRGSSGTVYKGTMINGKF---------VAVK------RLQKMLAEGEREFQTE----IK 494
R + G +Y+ + ++K RL +R + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 495 AIGRTHHRNLVRLLGY-SFDVSNKILVYEYMSNGSLADVYSSPPKNNL-----IGIARGI 548
+ T + +G+ + LV + SL PK+ L + +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 549 L----YLHDECESQIIHCDIKPQNILMDENRYAKI--SDFALAKL---------MKPDQT 593
L +LH E++ +H ++ +NI +D +++ + + A
Sbjct: 169 LDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 594 RTFTG 598
G
Sbjct: 226 SPHEG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 52/370 (14%), Positives = 109/370 (29%), Gaps = 101/370 (27%)
Query: 416 RSYRII------PGNGSARYCEDIALLSFSYAEL-EKMTDGFKEEIGRGSSGTVYKGTMI 468
+ R+ ++ E+ +L +Y L + ++ + +
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEE--VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 469 NG--KFVA--VKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524
N F V RLQ L +++ + L+ L + +L+ +
Sbjct: 121 NDNQVFAKYNVSRLQPYL---------KLR-------QALLEL-----RPAKNVLIDG-V 158
Query: 525 SNGS----LA-DVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579
GS +A DV S + I +L+ + +C+ + M + +I
Sbjct: 159 L-GSGKTWVALDVCLSYKV--QCKMDFKIFWLN------LKNCNSPETVLEMLQKLLYQI 209
Query: 580 --SDFALAKLMKPDQTRT------FTGIRGTRGY---------VAPEWHWN--------L 614
+ + + + R + ++ Y V WN L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL 269
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILEEWVYQCFE-------NGN--- 662
T V F L D+V +L +++ + N
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 663 ---LGQLIED--------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711
+ + I D + V+ +L +I+ +L L+ R ++ +
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPP---SA 385
Query: 712 PIPPNPTSLL 721
IP SL+
Sbjct: 386 HIPTILLSLI 395
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.66 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.26 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.23 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.22 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.14 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.11 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.99 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.92 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.84 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 98.82 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.75 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.75 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.73 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 98.71 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.67 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.65 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.5 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.23 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.01 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 98.0 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.77 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.72 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 80.32 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.19 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=420.66 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=204.1
Q ss_pred HHHHhhcccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecc
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDV 514 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 514 (724)
|+...+..|.++||+|+||+||+|.+. +++.||||+++.... ...++|++|+.++++++|||||+++|+|.+.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 444556678899999999999999873 467899999975432 3356899999999999999999999999999
Q ss_pred cceEEEEeeccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 515 SNKILVYEYMSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
+..++|||||++|+|.++|... .+ .++.|||+||+|||+. +|+||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 9999999999999999998321 11 2378999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
++++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---- 254 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---- 254 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH----
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987643332 22334679999999999999999999999999999999998 88898654321
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
+ +...+..+..... +...+..+.+++.+||+.||++||||+||++.|+...++
T Consensus 255 --~-~~~~i~~~~~~~~------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 255 --D-VVEMIRNRQVLPC------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp --H-HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred --H-HHHHHHcCCCCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 1 2233444432221 112345688999999999999999999999999875543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=420.14 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=194.5
Q ss_pred ccccccCcCccceEEEEEee------CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.++||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45688999999999999864 367899999987666667889999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCC------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEc
Q 041285 523 YMSNGSLADVYSSP------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS 580 (724)
Q Consensus 523 ~~~~gsL~~~l~~~------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~ 580 (724)
||++|+|.+++... .+ .++.|||+||+|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999998432 11 2378999999999998 99999999999999999999999
Q ss_pred cccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHH
Q 041285 581 DFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 581 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||...... + +...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------E-AIDCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------H-HHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------H-HHHHH
Confidence 9999987654333 23334679999999999999999999999999999999999 89998754321 1 12233
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
..+.... .+. .....+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ~~g~~~~--~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELE--RPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCC--CCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCC--Ccc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 3332111 111 2234588999999999999999999999999986543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=412.65 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=200.1
Q ss_pred cccccccCcCccceEEEEEee------CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
..+.++||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++|+|.+.+..++||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 346689999999999999874 36789999998766666788999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCC----------------CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 522 EYMSNGSLADVYSS----------------PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 522 e~~~~gsL~~~l~~----------------~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
|||++|+|.+++.. ..+. .+.|||+||+|||++ +|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 99999999999842 2222 278999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 582 FALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 582 fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
||+++......... .....||+.|||||++.+..++.|+|||||||+||||+| |+.||...... + +...+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~i~ 244 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIECIT 244 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHH
Confidence 99998765443322 223568999999999999999999999999999999999 89998754321 1 223333
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.+..... + ...+..+.+++.+||+.||++||||+||++.|++..
T Consensus 245 ~~~~~~~--p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 245 QGRVLQR--P----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HTCCCCC--C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCC--C----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3432211 1 122346889999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=409.07 Aligned_cols=248 Identities=28% Similarity=0.372 Sum_probs=190.4
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
...|.++||+|+||+||+|++. ..||||+++.. ..+..++|.+|++++++++|||||+++|+|.+ +..++|||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 3356789999999999999874 36999998642 23445789999999999999999999999865 5689999999
Q ss_pred cCCChhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ce
Q 041285 525 SNGSLADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~ 595 (724)
++|+|.+++... .+. ++.|||+||+|||+. +|+||||||+||||++++.+||+|||+|+....... ..
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999998432 222 278999999999998 999999999999999999999999999987654322 23
Q ss_pred eeccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FTGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.....||+.|||||++.. .+++.|+|||||||+||||+||+.||........ +...+..+.....+ ...
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~~p~~--~~~ 262 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYASPDL--SKL 262 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCCCCCS--TTS
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCCc--ccc
Confidence 344679999999999864 4689999999999999999999999975432211 22223333211111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.......+.+++.+||+.+|++||||.||+++|+.+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223345688999999999999999999999998743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.89 Aligned_cols=258 Identities=24% Similarity=0.258 Sum_probs=194.0
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc----ceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----NKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~~ 524 (724)
.+.++||+|+||+||+|++ .|+.||||++.... .....+.+|+..+.+++|||||+++|+|.+.+ .++||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 4568999999999999998 68999999997532 22233456777888999999999999998754 579999999
Q ss_pred cCCChhhhcCCCC--c----chHHHHHHHcccccccC-----CCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 525 SNGSLADVYSSPP--K----NNLIGIARGILYLHDEC-----ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 525 ~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~-----~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
++|+|.++++... + ..+.|+|+||+|||+++ .++|+||||||+||||+.++.+||+|||+++.......
T Consensus 84 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 9999999995432 2 23789999999999863 45899999999999999999999999999987654332
Q ss_pred c---eeeccccCccccCcccccCC------CCCcccceeehhHHHHHhhccccCCCCCCCcc---------hhcHHHHHH
Q 041285 594 R---TFTGIRGTRGYVAPEWHWNL------PITAKADVYSFGVVLLEIICCRRCFDQNLPED---------QVILEEWVY 655 (724)
Q Consensus 594 ~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~---------~~~l~~~~~ 655 (724)
. ......||+.|||||++.+. .++.|+|||||||+||||+||+.|+....... ..... ...
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~-~~~ 242 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE-EMR 242 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH-HHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH-HHH
Confidence 2 12235799999999998764 36779999999999999999988764322110 11111 122
Q ss_pred HHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+..+.+...+.......+....+.+++.+||+.||++||||.||+++|+.+.
T Consensus 243 ~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 333333332222222334456778999999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=394.11 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=196.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.++||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 344578999999999999875 5899999999765555567799999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 527 GSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 527 gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|+|.+++.... . ..+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+..... ......
T Consensus 156 g~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 231 (346)
T 4fih_A 156 GALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 231 (346)
T ss_dssp EEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCC
T ss_pred CcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccc
Confidence 99999885322 2 2278999999999998 999999999999999999999999999987754332 233467
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
||+.|||||++.+..++.++|||||||++|||++|+.||......+ +...+..+....+-... .....+
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~~~~~~----~~s~~~ 300 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPRLKNLH----KVSPSL 300 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSSCCCCSCGG----GSCHHH
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCCCCccc----cCCHHH
Confidence 9999999999999999999999999999999999999997542211 11222222211111111 223457
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+++.+||+.||++|||+.|+++
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 88999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=378.29 Aligned_cols=239 Identities=27% Similarity=0.363 Sum_probs=186.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec----ccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----VSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 521 (724)
.|.++||+|+||+||+|... .++.||||++... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999875 4789999998653 23344679999999999999999999999865 34579999
Q ss_pred eeccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||++|+|.+++.. .... .+.||++||+|||++ .++|+||||||+||||+. ++.+||+|||+|+......
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~- 186 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 186 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc-
Confidence 99999999999843 2222 267999999999987 123999999999999984 7899999999998654322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.....||+.|||||++.+ .++.++|||||||+||||++|+.||....... .+...+..+......+. .
T Consensus 187 --~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~~~~-~-- 254 (290)
T 3fpq_A 187 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFDK-V-- 254 (290)
T ss_dssp --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGGG-C--
T ss_pred --cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCCCCc-c--
Confidence 234679999999998864 69999999999999999999999996533211 12233333322222211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++|||++|+++
T Consensus 255 --~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 --AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1235788999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=398.84 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=200.4
Q ss_pred HHHhhcccccccCcCccceEEEEEeeC------CcEEEEEEcccccc-hhHHHHHHHHHhhcccCc-CceeeeeeEEecc
Q 041285 443 LEKMTDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHH-RNLVRLLGYSFDV 514 (724)
Q Consensus 443 l~~~t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~ 514 (724)
+......+.++||+|+||+||+|.... ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 334455667899999999999998753 35899999976433 335679999999999965 8999999999764
Q ss_pred -cceEEEEeeccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCee
Q 041285 515 -SNKILVYEYMSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNIL 570 (724)
Q Consensus 515 -~~~~lv~e~~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIl 570 (724)
...++|||||++|+|.++|+.. .+ ..+.|||+||+|||+. +|+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999998421 11 1267999999999998 9999999999999
Q ss_pred eCCCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchh
Q 041285 571 MDENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQV 648 (724)
Q Consensus 571 l~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~ 648 (724)
|++++.+||+|||+|+.+..+.... .....||+.|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999999775544332 334678999999999999999999999999999999998 899997543222
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.+...+..+..... +.. ....+.+++..||+.||++||||.||++.|+.+++
T Consensus 296 ----~~~~~i~~g~~~~~--p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 296 ----EFCRRLKEGTRMRA--PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ----HHHHHHHHTCCCCC--CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCC--Ccc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 12233333322111 111 23458889999999999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=395.59 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=196.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.++||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 345578999999999999875 5899999999765555567799999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 527 GSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 527 gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|+|.+++.... . ..+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+..... ......
T Consensus 233 G~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 308 (423)
T 4fie_A 233 GALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 308 (423)
T ss_dssp EEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCE
T ss_pred CcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccc
Confidence 99999884322 2 2278999999999998 999999999999999999999999999987654332 223467
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
||+.|||||++.+..++.++|||||||++|||++|+.||......+ +...+..+....+-.... ....+
T Consensus 309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~~~~~~~----~s~~~ 377 (423)
T 4fie_A 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPRLKNLHK----VSPSL 377 (423)
T ss_dssp ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCCSCTTS----SCHHH
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCCCccccc----CCHHH
Confidence 9999999999999999999999999999999999999997542211 112222222211111111 23458
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+++.+||+.||++|||+.|+++
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 88999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=383.95 Aligned_cols=240 Identities=23% Similarity=0.256 Sum_probs=189.9
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
.+.++||+|+||.||+++.. .|+.||||+++... .+.+|+.++++++|||||++++++.+.+..++||||+++|
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 34578999999999999875 58999999997531 2357999999999999999999999999999999999999
Q ss_pred ChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcc----e
Q 041285 528 SLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTR----T 595 (724)
Q Consensus 528 sL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~----~ 595 (724)
+|.+++.. .... .+.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++.+..+... .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 99999843 2222 278999999999998 999999999999999987 5999999999987543321 1
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|||||++.+..++.++|||||||+||||++|+.||........ + ..+..+.... ......
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-----~~i~~~~~~~----~~~~~~ 281 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C-----LKIASEPPPI----REIPPS 281 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-----HHHHHSCCGG----GGSCTT
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-----HHHHcCCCCc----hhcCcc
Confidence 2235799999999999999999999999999999999999999976543221 1 1111221111 011223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
....+.+++.+||+.||++|||+.|+++.|..
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 34568889999999999999999999887754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=392.42 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=187.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.++||+|+||+||+++.. +|+.||||++... .....+.|++|++++++++|||||++++++.+.+..++||||+
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 455688999999999999874 5899999998653 2334567999999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++|+|.+++... .. ..+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 181 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-EL 181 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-cc
Confidence 999999998321 11 2268999999999998 99999999999999999999999999998764321 11
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... .+.. ..+..+..... ...
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~-~~i~~~~~~~~------~~~ 248 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLV-LKIISGSFPPV------SLH 248 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHTCCCCC------CTT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHH-HHHHcCCCCCC------Ccc
Confidence 2335799999999999999999999999999999999999999975421 1112 22333332211 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345889999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.43 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=194.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||+||+++.. +++.||||.+.+. .....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 556789999999999999874 5899999999753 233456799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ce
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~ 595 (724)
+++|+|.+++.. ... ..+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 114 ~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 114 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999999843 222 2278999999999998 999999999999999999999999999998764433 22
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|||||++.+..++.++||||+||++|||++|+.||...... + ....+..+.... +..
T Consensus 191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~-~~~~i~~~~~~~---p~~---- 256 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------L-IFAKIIKLEYDF---PEK---- 256 (311)
T ss_dssp BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCC---CTT----
T ss_pred ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCC---Ccc----
Confidence 34568999999999999999999999999999999999999999754211 1 122233333211 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKV 701 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~ev 701 (724)
....+.+++.+||+.||++|||++|+
T Consensus 257 ~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 257 FFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp CCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred cCHHHHHHHHHHccCCHhHCcChHHH
Confidence 23457889999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=365.65 Aligned_cols=236 Identities=25% Similarity=0.361 Sum_probs=178.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||+||++... +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456689999999999999874 58999999986532 23345799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+ +|+|.+++.. ... ..+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 95 ~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~ 168 (275)
T 3hyh_A 95 A-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FL 168 (275)
T ss_dssp C-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred C-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--cc
Confidence 9 6799888742 222 2278999999999998 99999999999999999999999999998654322 22
Q ss_pred eccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....||+.|||||.+.+..+ +.++||||+||++|||++|+.||..... .. ..+.+..+.... +..
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-~~~~i~~~~~~~---p~~---- 234 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-LFKNISNGVYTL---PKF---- 234 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCCCC---CTT----
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHcCCCCC---CCC----
Confidence 34679999999999998876 5799999999999999999999975321 11 122333332211 111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++|||++|+++
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2345788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=371.49 Aligned_cols=238 Identities=24% Similarity=0.270 Sum_probs=183.4
Q ss_pred cccccccCcCccceEEEEEee----CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.+.+.||+|+||+||+++.. .++.||||.++... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456789999999999999863 36799999987532 223346889999999999999999999999999999999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+++|+|.+++.. ... ..+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-
Confidence 99999999999843 222 2277999999999998 999999999999999999999999999986543322
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
......||+.|||||.+.+..++.++|||||||++|||++|+.||...... + ....+..+.... +..
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~-~~~~i~~~~~~~---p~~--- 248 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------E-TMTMILKAKLGM---PQF--- 248 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CTT---
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------H-HHHHHHcCCCCC---CCc---
Confidence 223467999999999999999999999999999999999999999754321 1 112222332211 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
....+.+++.+||+.||++||| ++|+++
T Consensus 249 -~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 -LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 2345788999999999999998 467763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=366.49 Aligned_cols=237 Identities=22% Similarity=0.338 Sum_probs=176.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEeccc-----------
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----------- 515 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----------- 515 (724)
.+.+.||+|+||+||+++.. +++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 45578999999999999874 589999999875332 33467999999999999999999999987544
Q ss_pred -ceEEEEeeccCCChhhhcCCCC----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 516 -NKILVYEYMSNGSLADVYSSPP----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 516 -~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
..++||||+++|+|.+++.... ...+.||++||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999985321 12367999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcc-----------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH
Q 041285 585 AKLMKPDQTR-----------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW 653 (724)
Q Consensus 585 ~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~ 653 (724)
|+.+..+... ..+...||+.|||||.+.+..++.++|||||||++|||++ ||.... ... .
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~-~- 235 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV-R- 235 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH-H-
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH-H-
Confidence 9877543221 1223579999999999999999999999999999999996 654211 000 0
Q ss_pred HHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.....+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~p~~------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRNLKFPPL------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHTTCCCHH------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCCCC------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122222222211 1223345678999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.36 Aligned_cols=271 Identities=38% Similarity=0.622 Sum_probs=226.2
Q ss_pred CHHHHHHhhcccc--cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 439 SYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 439 ~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
.+.+++..+.+|. +.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3344445555554 68999999999999988899999999887656667789999999999999999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCC-------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCc
Q 041285 517 KILVYEYMSNGSLADVYSSPP-------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~-------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
.++||||+++++|.+++.... + ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999985432 1 2278999999999998 9999999999999999999999999999
Q ss_pred cccCCCC-cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 586 KLMKPDQ-TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 586 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.|+....+........|.......+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654322 222233568999999999998999999999999999999999999998766655556666666666666666
Q ss_pred cccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 665 QLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 665 ~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
..+++. ....+....+.+++.+||+.||++|||+.||++.|+.+..+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 666654 346778889999999999999999999999999999766543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=355.09 Aligned_cols=275 Identities=42% Similarity=0.722 Sum_probs=226.4
Q ss_pred cccccCHHHHHHhhcccc--cccCcCccceEEEEEeeCCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeE
Q 041285 434 ALLSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGY 510 (724)
Q Consensus 434 ~~~~~~~~el~~~t~~f~--~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~ 510 (724)
....|++.+++..+.+|. +.||+|+||.||++...+++.||||++..... .....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788999999888876 68999999999999988899999999976432 233478999999999999999999999
Q ss_pred EecccceEEEEeeccCCChhhhcCCCC-----------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 511 SFDVSNKILVYEYMSNGSLADVYSSPP-----------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 511 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
+.+....++||||+++++|.+++.... ...+.+++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999884321 123789999999999987779999999999999999999999
Q ss_pred ccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC--CcchhcHHHHHHHH
Q 041285 580 SDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL--PEDQVILEEWVYQC 657 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~--~~~~~~l~~~~~~~ 657 (724)
+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998876555544555679999999999988889999999999999999999999996311 12233444555444
Q ss_pred HHcCCcccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 658 FENGNLGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 658 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.....+..+.+.. .........+.+++.+||+.+|.+|||+.||+++|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4444555554443 34677888999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.85 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=186.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEec------ccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD------VSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 518 (724)
+.+.+.||+|+||+||++... +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ....+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 455689999999999999874 58999999997532 2334678899999999999999999998764 35789
Q ss_pred EEEeeccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+|||||+ |+|.+++.... . ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 136 ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9999995 67988885422 1 2278999999999998 9999999999999999999999999999876433
Q ss_pred C---cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc--
Q 041285 592 Q---TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ-- 665 (724)
Q Consensus 592 ~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 665 (724)
. ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+. +. .+...........
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~-~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQ-LIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HH-HHHHHHCCCCGGGTC
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHhcCCCChHHhh
Confidence 2 1223446899999999998875 468999999999999999999999976432211 11 1111110000000
Q ss_pred -------------cccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 -------------LIEDEDVD-----KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 -------------~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+-...... ......+.+++.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000001 112346789999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=353.23 Aligned_cols=191 Identities=21% Similarity=0.331 Sum_probs=160.8
Q ss_pred cccccccCcCccceEEEEEee----CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.++||+|+||+||+++.. .++.||||++... ....++.+|++++.++ +|||||++++++.+.++.++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 456689999999999999764 3678999998753 3345788999999998 69999999999999999999999
Q ss_pred eccCCChhhhcCCCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCccccCCCCc----
Q 041285 523 YMSNGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLMKPDQT---- 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~~~~~~---- 593 (724)
|+++|+|.+++....... +.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 101 YLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp CCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred CCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999997765443 78999999999998 99999999999999876 7999999999986543211
Q ss_pred -----------------------ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCC
Q 041285 594 -----------------------RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNL 643 (724)
Q Consensus 594 -----------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~ 643 (724)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 112234699999999999876 48999999999999999999999996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=369.62 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=195.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +|+.||||.+........+.+++|+++|++++|||||++++++.+....++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 456789999999999999875 5899999999765555567899999999999999999999999999999999999999
Q ss_pred CChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC--CCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN--RYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~--~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+|.+++..... ..+.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+..... .
T Consensus 239 g~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~--~ 313 (573)
T 3uto_A 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--V 313 (573)
T ss_dssp CBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--E
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--e
Confidence 999998854321 2278999999999998 99999999999999854 7899999999998764432 3
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|||||++.+..++.++||||+||++|||++|+.||......+ ....+..+.... .. ......
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~~--~~-~~~~~~ 383 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNM--DD-SAFSGI 383 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCCC--CS-GGGTTS
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCCC--Cc-ccccCC
Confidence 34579999999999999999999999999999999999999997543211 112233322211 00 011112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.||.+|||+.|+++
T Consensus 384 s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 384 SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345788999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.92 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=204.4
Q ss_pred cccCHHHHHHhhcc------------cccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcC
Q 041285 436 LSFSYAELEKMTDG------------FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR 502 (724)
Q Consensus 436 ~~~~~~el~~~t~~------------f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ 502 (724)
..++++++.+++.. +.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45888998888754 2357999999999999986 6899999999765556667899999999999999
Q ss_pred ceeeeeeEEecccceEEEEeeccCCChhhhcCCCCcc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC
Q 041285 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY 576 (724)
Q Consensus 503 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~ 576 (724)
||+++++++...+..++||||+++++|.+++...... .+.|+++||.|||+. +|+||||||+|||++.++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCc
Confidence 9999999999999999999999999999998654322 278999999999998 9999999999999999999
Q ss_pred eEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH
Q 041285 577 AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~ 656 (724)
+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...
T Consensus 180 ~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-------~~~ 251 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMK 251 (321)
T ss_dssp EEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHH
T ss_pred EEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 99999999987654322 2234578999999999999999999999999999999999999997542111 112
Q ss_pred HHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+............ .....+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDSPPPKLKNSH----KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHSSCCCCTTGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcCCCCCcCccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222221111111 123457889999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=359.83 Aligned_cols=237 Identities=23% Similarity=0.281 Sum_probs=185.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHH---HHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQT---EIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
.+.+.||+|+||.||+++.. +|+.||||++.+.. ......+.+ ++.++..++|||||++++++.+.+.+|+||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45578999999999999875 48999999996521 222233333 467778889999999999999999999999
Q ss_pred eeccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||++||+|.+++.. .... .+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 272 Ey~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~- 347 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 347 (689)
T ss_dssp CCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC-
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCCC-
Confidence 99999999999843 2222 278999999999998 999999999999999999999999999987754332
Q ss_pred eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|||||++.. ..++.++|+|||||+||||++|+.||......... . +........... +.
T Consensus 348 --~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~-i~~~i~~~~~~~---p~--- 415 (689)
T 3v5w_A 348 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLTMAVEL---PD--- 415 (689)
T ss_dssp --CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---H-HHHHHHHCCCCC---CT---
T ss_pred --CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---H-HHHhhcCCCCCC---Cc---
Confidence 33579999999999975 57999999999999999999999999754322211 1 112222222111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPS-----MKKVL 702 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl 702 (724)
.....+.+++..||+.||.+|++ +.||+
T Consensus 416 -~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 416 -SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp -TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred -cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 22345889999999999999998 67775
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.26 Aligned_cols=254 Identities=30% Similarity=0.433 Sum_probs=189.4
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
...+.+.||+|+||.||++.. .++.||||++.... ....+++.+|++++++++||||+++++++.+....++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 344568899999999999987 68899999986532 333467999999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCCc----------chHHHHHHHcccccccCCCc--eEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 525 SNGSLADVYSSPPK----------NNLIGIARGILYLHDECESQ--IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 525 ~~gsL~~~l~~~~~----------~~~~~ia~~l~yLH~~~~~~--i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
++++|.+++..... ..+.||++||+|||+. + |+||||||+|||++.++.+||+|||+++......
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999854321 2267999999999998 7 9999999999999999999999999997543322
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ............. .
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~------~ 260 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKRLE------I 260 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCCCC------C
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCCCC------C
Confidence 12233568999999999999999999999999999999999999997543211 1111111111111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNP 717 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p 717 (724)
.......+.+++.+||+.+|++|||+.|++++|+....-..||.+
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 112234588999999999999999999999999987665554444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.74 Aligned_cols=260 Identities=24% Similarity=0.314 Sum_probs=198.4
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc----ceEEEEe
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----NKILVYE 522 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 522 (724)
.+.+.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++.+.. ..++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 3445688999999999999874 789999999754 233456677999999999999999999998754 3699999
Q ss_pred eccCCChhhhcCCCCc------chHHHHHHHcccccccC-------CCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 523 YMSNGSLADVYSSPPK------NNLIGIARGILYLHDEC-------ESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~-------~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
|+++|+|.+++..... ..+.|+++||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~ 182 (322)
T 3soc_A 103 FHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182 (322)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence 9999999999854322 23789999999999862 3389999999999999999999999999998765
Q ss_pred CCCcc-eeeccccCccccCcccccCC-----CCCcccceeehhHHHHHhhccccCCCCCCCcchhc----------HHHH
Q 041285 590 PDQTR-TFTGIRGTRGYVAPEWHWNL-----PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI----------LEEW 653 (724)
Q Consensus 590 ~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~----------l~~~ 653 (724)
..... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......... ...+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T 3soc_A 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262 (322)
T ss_dssp TTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred cccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence 44332 22335789999999998863 45568899999999999999999997654322211 1111
Q ss_pred HHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
............+............+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 263 -QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp -HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122222222222222223445677999999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.20 Aligned_cols=269 Identities=41% Similarity=0.587 Sum_probs=213.6
Q ss_pred cccccCHHHHHHhhccccc--------ccCcCccceEEEEEeeCCcEEEEEEccccc----chhHHHHHHHHHhhcccCc
Q 041285 434 ALLSFSYAELEKMTDGFKE--------EIGRGSSGTVYKGTMINGKFVAVKRLQKML----AEGEREFQTEIKAIGRTHH 501 (724)
Q Consensus 434 ~~~~~~~~el~~~t~~f~~--------~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h 501 (724)
....|++.++.+++.+|.+ .||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4567999999999999974 499999999999987 68899999986422 2335679999999999999
Q ss_pred CceeeeeeEEecccceEEEEeeccCCChhhhcCC------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 502 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
|||+++++++.+.+..++||||+++++|.+++.. ..+ ..+.++++||.|||+. +|+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998842 122 2267999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH
Q 041285 572 DENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l 650 (724)
+.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.|+........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 99999999999999876543322 2233578999999998765 578999999999999999999999976433221 1
Q ss_pred HHHHHHHHH-cCCcccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 651 EEWVYQCFE-NGNLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 651 ~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+...... ...+...++.. .........+.+++..||+.+|.+||++.+|+++|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111111 11122222222 235667788999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.24 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=195.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
..+.+.||+|+||.||++... +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 345678999999999999875 4889999998766566678899999999999999999999999999999999999999
Q ss_pred CChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce---
Q 041285 527 GSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT--- 595 (724)
Q Consensus 527 gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--- 595 (724)
++|.+++... .+ ..+.|+++||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9999998532 21 2278999999999998 99999999999999999999999999998764332211
Q ss_pred ----------eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcch---hcHHHHHHHHHHcCC
Q 041285 596 ----------FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ---VILEEWVYQCFENGN 662 (724)
Q Consensus 596 ----------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~---~~l~~~~~~~~~~~~ 662 (724)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ ........ ..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~- 243 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RY- 243 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HT-
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----cc-
Confidence 1135689999999999999999999999999999999999998865432221 11111110 00
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
. .......+.+++..||+.||++|||+.|+++.|+.+
T Consensus 244 ~---------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 244 C---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp C---------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 111123478899999999999999999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=338.56 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=196.5
Q ss_pred hcccccccCcCccceEEEEEee----CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
.+.+.+.||+|+||.||+|... .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+....++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 4445678999999999999984 3456999999764 2344567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++++|.+++.... . ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 9999999999984321 1 2277999999999998 999999999999999999999999999987754432
Q ss_pred c--eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 594 R--TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 594 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+..+....
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~-~~~~~~~~~~~~----- 274 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------D-VISSVEEGYRLP----- 274 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCCCC-----
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------H-HHHHHHcCCCCC-----
Confidence 2 2223456788999999998899999999999999999999 99998653221 1 112222221111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPI 713 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 713 (724)
........+.+++..||+.+|++||++.||+++|+.+...+.
T Consensus 275 -~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 275 -APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111233468899999999999999999999999998655443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.87 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=191.0
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcc--cCcCceeeeeeEEecc----cceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGR--THHRNLVRLLGYSFDV----SNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~lv~ 521 (724)
+.+.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 44568899999999999987 7899999998753 33455666666655 7999999999997653 4579999
Q ss_pred eeccCCChhhhcCCCCcc------hHHHHHHHccccc--------ccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 522 EYMSNGSLADVYSSPPKN------NLIGIARGILYLH--------DECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~~~------~~~~ia~~l~yLH--------~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
||+++|+|.+++...... .+.||++||+||| +. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp CCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred hhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999999999654322 2789999999999 65 999999999999999999999999999986
Q ss_pred cCCCCcce---eeccccCccccCcccccCC------CCCcccceeehhHHHHHhhcc----------ccCCCCCCCcchh
Q 041285 588 MKPDQTRT---FTGIRGTRGYVAPEWHWNL------PITAKADVYSFGVVLLEIICC----------RRCFDQNLPEDQV 648 (724)
Q Consensus 588 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvll~elltg----------~~p~~~~~~~~~~ 648 (724)
........ .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 65433322 2234789999999999876 445799999999999999999 7777554322211
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
... .............+............+.+++..||+.||++|||+.||+++|+++
T Consensus 243 -~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 -FED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -HHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhh-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 1122222211112222223345677899999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=328.13 Aligned_cols=241 Identities=27% Similarity=0.363 Sum_probs=194.9
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 34557899999999999986 45889999999765555667899999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 527 GSLADVYSSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 527 gsL~~~l~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
++|.+++.... +..+.+++.||.|||+. +|+||||||+|||++.++.+||+|||++........ ......
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 177 (297)
T 3fxz_A 102 GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (297)
T ss_dssp CBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCcc
Confidence 99999985432 22378999999999998 999999999999999999999999999987654332 223457
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........+. .....+. .....+
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~-~~~~~~~----~~~~~~ 246 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PELQNPE----KLSAIF 246 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-CCCSCGG----GSCHHH
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-CCCCCcc----ccCHHH
Confidence 8999999999999999999999999999999999999996543211 1111112111 1111111 223458
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+++..||+.||++|||+.|+++
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhh
Confidence 88999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.33 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred hcccccccCcCccceEEEEEee--------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 516 (724)
...+.+.||+|+||.||++... ++..||||.++... ....+++.+|+++++++ +||||+++++++.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 3445688999999999999863 24579999997642 33456799999999999 89999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCC-------------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC
Q 041285 517 KILVYEYMSNGSLADVYSSPP-------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE 573 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~-------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~ 573 (724)
.++||||+++|+|.+++.... + ..+.||++||.|||+. +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 999999999999999884321 1 1267999999999998 9999999999999999
Q ss_pred CCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHH
Q 041285 574 NRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILE 651 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~ 651 (724)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----- 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999999987654332 22233467889999999999999999999999999999999 888886543221
Q ss_pred HHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 652 EWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
....+..+.... ........+.+++..||+.+|++||++.|+++.|+.++.
T Consensus 314 --~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 --LFKLLKEGHRMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --HHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112233332111 111223468899999999999999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.52 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=201.5
Q ss_pred hhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
....+.+.||+|+||.||++...++..||||.+.... ...+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 3455668899999999999999888899999997642 345679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++|.+++... .. ..+.|+++||+|||+. +|+||||||+|||++.++.+||+|||++............
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999988432 21 2378999999999998 9999999999999999999999999999877655444444
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .......+.. ...+...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~~~~---- 230 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------E-VVLKVSQGHR--LYRPHLA---- 230 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHHTTCC--CCCCTTS----
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------H-HHHHHHcCCC--CCCCCcC----
Confidence 4567888999999998889999999999999999999 89888653321 1 1112222211 1111112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
...+.+++..||+.+|++|||+.|+++.|+...+-
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 34588999999999999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.99 Aligned_cols=246 Identities=27% Similarity=0.435 Sum_probs=199.1
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.+.||+|+||.||++...+++.||||++... ....+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 34456889999999999999988899999999764 33456799999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++.... . ..+.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.............
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 99999984422 1 2267999999999998 99999999999999999999999999998765443333334
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ....+..+.. ...+.. ..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~~~----~~ 233 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFR--LYKPRL----AS 233 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC--CCCCTT----SC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHhcCcc--CCCCCc----CC
Confidence 567889999999999999999999999999999999 88888653221 1 1122222211 111111 23
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+.+++..||+.+|++||++.|+++.|+.+.
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 45889999999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.07 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=198.6
Q ss_pred hhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
....+.+.||+|+||.||+|...++..||||.++.. ....++|.+|++++++++||||+++++++. .+..++||||++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 344566899999999999999988889999999864 345678999999999999999999999986 567899999999
Q ss_pred CCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 9999999853 222 2368999999999998 999999999999999999999999999987654322222
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....+++.|+|||.+....++.++||||||++||||++ |+.||...... + +...+..+.. +..+ ..
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~--~~~~----~~ 409 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------E-VIRALERGYR--MPRP----EN 409 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHHHHTCC--CCCC----TT
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC--CCCC----CC
Confidence 33456789999999999999999999999999999999 99998653211 1 1122222211 1111 12
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
....+.+++.+||+.+|++|||+.+|+++|+....
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 23568899999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=353.44 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=201.3
Q ss_pred HhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.....+.++||+|+||.||+|.... +..||||.++.. ....++|.+|++++++++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3445567899999999999999865 789999999764 33467899999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 524 MSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 524 ~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|+|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999998431 11 1267999999999998 9999999999999999999999999999877544333
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......+++.|+|||.+....++.++||||||++||||++ |+.|+....... +.+.+..+.... . .
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~----~ 441 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRME--R----P 441 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC--C----C
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--C----C
Confidence 3334556789999999998999999999999999999999 888886543221 112222221110 1 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
......+.+++.+||+.+|++|||+.+|+++|+....
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1223468889999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.35 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=184.5
Q ss_pred hcccccccCcCccceEEEEEee----CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||+|... ++..||||.++... ....++|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3445678999999999999875 46789999997542 334567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++++|.+++.... + ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999985432 1 2278999999999998 999999999999999999999999999987654332
Q ss_pred ce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 594 RT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 594 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . +...+..+...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~-~~~~i~~~~~~------ 269 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------D-VIKAVDEGYRL------ 269 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------H-HHHHHHTTEEC------
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC------
Confidence 21 122345778999999999999999999999999999998 99998654211 1 11222222110
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.........+.+++..||+.+|++||++.||+++|+.+.
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 011123456889999999999999999999999997653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=348.67 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=195.0
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.++||+|+||.||+|...++..||||.++... ...++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 345668899999999999999888889999998643 345689999999999999999999999876 678999999999
Q ss_pred CChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 999999863 222 2278999999999998 9999999999999999999999999999876544333333
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...++..|+|||.+....++.++||||||+++|||++ |+.|+...... + +...+..+.... .....
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~------~~~~~ 406 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRMP------CPPEC 406 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCC------CCTTS
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC------CCCCC
Confidence 4557889999999999999999999999999999999 88888653211 1 122222221111 11123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC-CCCCCCC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD-IPIPPNP 717 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~-~~~p~~p 717 (724)
...+.+++.+||+.+|++|||+.+|+++|+.... .+...+|
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 4568899999999999999999999999998654 3333444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.12 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=193.5
Q ss_pred HhhcccccccCcCccceEEEEEe-----eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc--cce
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNK 517 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 517 (724)
.....+.+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 34455678999999999999984 25789999999876556667899999999999999999999999754 458
Q ss_pred EEEEeeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 518 ILVYEYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
++||||+++++|.+++.... . ..+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999985422 1 2267999999999998 99999999999999999999999999998765
Q ss_pred CCCc--ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCc---------chhcHHHHHHHHH
Q 041285 590 PDQT--RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPE---------DQVILEEWVYQCF 658 (724)
Q Consensus 590 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~---------~~~~l~~~~~~~~ 658 (724)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4332 1222345778899999999999999999999999999999999887542100 0001111122222
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
..+.... ........+.+++..||+.+|++|||+.|++++|+.+
T Consensus 246 ~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 246 KNNGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HTTCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCcCC------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2221111 1112335688999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.49 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=196.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... .++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 445688999999999999864 5789999998542 223346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.++++||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 93 ~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 93 IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 999999998843 222 2367999999999998 999999999999999999999999999987654433333
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... ...... .......
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~~~--~~~~~~~ 240 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPNVT--TDVRKDI 240 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCCHH--HHSCTTS
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCCcc--hhcccCC
Confidence 4456899999999999999999999999999999999999999754321 111122211 111110 0111223
Q ss_pred HHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCCCCCCCC
Q 041285 677 LERMIKVALWCILDEPSLRP-SMKKVLLMLEGTMDIPIPPN 716 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~~~p~~ 716 (724)
...+.+++.+|++.+|++|| +++++.+.|+....-.....
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 45688999999999999998 99999999998765554443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.23 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=194.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.+.||+|+||.||+|... +++.||||.++... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345688999999999999986 68899999987542 2334578999999999999999999999999999999999999
Q ss_pred CCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee-
Q 041285 526 NGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF- 596 (724)
Q Consensus 526 ~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~- 596 (724)
+|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 9999998843 222 2267999999999998 999999999999999999999999999986543221111
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....+++.|+|||.+....++.++||||||+++|||++ |..|+....... +.+.+..+.... .+. .
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~~----~ 339 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLP--CPE----L 339 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCC--CCT----T
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--CCC----C
Confidence 11235778999999998899999999999999999998 888886532111 122232221111 111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....+.+++..||+.+|++|||+.+|++.|+.+
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 234588899999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.63 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=191.8
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 34567899999999999987 46899999998753 2334567889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++.. .. +..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 97 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~ 171 (328)
T 3fe3_A 97 SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LD 171 (328)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--GG
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--cc
Confidence 99999998832 22 22378999999999998 999999999999999999999999999986653322 23
Q ss_pred ccccCccccCcccccCCCCC-cccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPIT-AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...||+.|+|||.+.+..+. .++||||||+++|||++|+.||..... .. ....+..+.... + ...
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-~~~~i~~~~~~~---p----~~~ 237 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KE-LRERVLRGKYRI---P----FYM 237 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCCC---C----TTS
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCCCCC---C----CCC
Confidence 45789999999999888765 799999999999999999999975431 11 122233332211 1 112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++..||+.||.+|||++|+++.
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3457889999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.07 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=196.0
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.+.||+|+||.||++...++..||||++... ....+++.+|++++.+++|+||+++++++.+....++||||+++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 44556889999999999999988889999999764 23456799999999999999999999999999999999999999
Q ss_pred CChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++... .. ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.............
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9999998541 11 2278999999999998 99999999999999999999999999998765433333334
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+..+.. ...+... .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~~~~----~ 247 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLR--LYRPHLA----S 247 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHHTTCC--CCCCTTC----C
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------H-HHHHHhcccC--CCCCCcC----C
Confidence 557888999999998999999999999999999998 99998654321 1 1122222211 1111111 3
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 45889999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.91 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=201.7
Q ss_pred HhhcccccccCcCccceEEEEEee--------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV 514 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 514 (724)
.....+.+.||+|+||.||++... .+..||||++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 344556789999999999999863 23579999997643 33446799999999999 999999999999999
Q ss_pred cceEEEEeeccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 515 SNKILVYEYMSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
+..++||||+++|+|.+++... .+ ..+.||++||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999999999988421 11 2278999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhc
Q 041285 572 DENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVI 649 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~ 649 (724)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987654332 22233567889999999999999999999999999999999 88888653211
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNP 717 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~p 717 (724)
. +.+.+..+..... +. .....+.+++..||+.+|++|||+.||++.|+.+.........
T Consensus 301 --~-~~~~~~~~~~~~~--~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 301 --E-LFKLLKEGHRMDK--PS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp --H-HHHHHHTTCCCCC--CS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred --H-HHHHHHcCCCCCC--Cc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 1 2233333321111 11 1234588999999999999999999999999887655444433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.51 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=187.4
Q ss_pred hcccccccCcCccceEEEEEee-CCc----EEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGK----FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
.+.+.+.||+|+||.||+|... +++ .||+|.+... .....++|.+|+.++++++||||++++++|.+.. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 3445678999999999999864 333 4688888643 2345578999999999999999999999998754 7899
Q ss_pred EeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+||+++|+|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999988432 11 2378999999999998 99999999999999999999999999998775443
Q ss_pred cc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 593 TR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 593 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+.... .
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~~--~-- 240 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERLP--Q-- 240 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCCC--C--
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHHHHcCCCCC--C--
Confidence 32 2233567889999999999999999999999999999999 999987543222 1 12222221111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 241 --~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 241 --PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 112234588999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.42 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=198.3
Q ss_pred cCHHHHHHh--hcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeee
Q 041285 438 FSYAELEKM--TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRL 507 (724)
Q Consensus 438 ~~~~el~~~--t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 507 (724)
+...+.+-. .+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344444433 3445688999999999999743 35789999997643 33346799999999999 89999999
Q ss_pred eeEEecccc-eEEEEeeccCCChhhhcCCCCc------------------------------------------------
Q 041285 508 LGYSFDVSN-KILVYEYMSNGSLADVYSSPPK------------------------------------------------ 538 (724)
Q Consensus 508 ~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 538 (724)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999998843211
Q ss_pred -------------------------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 539 -------------------------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 539 -------------------------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1267999999999998 999999999999999999999999999987644332
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ....+..+..... +..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~~--~~~ 320 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA--PDY 320 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCC--CTT
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCCC--CCC
Confidence 22334568999999999999999999999999999999998 9999876443221 1222222221111 111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....+.+++..||+.+|++|||+.||++.|+.++
T Consensus 321 ----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 321 ----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2345888999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.44 Aligned_cols=247 Identities=16% Similarity=0.178 Sum_probs=192.2
Q ss_pred ccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|+||.||+|.. .+++.||||.+... ...+.+.+|+++++++ +|+||+++++++.+.+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 4567899999999999986 46889999998753 2335789999999999 9999999999999999999999999 9
Q ss_pred CChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC-----eEEccccCccccCCCCc
Q 041285 527 GSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY-----AKISDFALAKLMKPDQT 593 (724)
Q Consensus 527 gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~-----~kl~Dfgl~~~~~~~~~ 593 (724)
++|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 89 PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9999988532 21 2278999999999998 9999999999999998887 99999999987643322
Q ss_pred c------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 594 R------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 594 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--- 242 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE--- 242 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH---
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH---
Confidence 1 1234679999999999999999999999999999999999999998654332211111111110000000
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....... .+.+++..|++.+|.+||++.+|++.|+..
T Consensus 243 ---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 243 ---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp ---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000112 688999999999999999999999998643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=338.62 Aligned_cols=238 Identities=28% Similarity=0.385 Sum_probs=191.5
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc-ceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS-NKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~~~ 526 (724)
..+.+.||+|+||.||+|.. .++.||||.++.. ...+.|.+|++++++++||||+++++++.+.+ ..++||||+++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 34567899999999999988 4789999999864 34578999999999999999999999988765 78999999999
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----c
Confidence 9999998431 21 2378999999999998 99999999999999999999999999998543221 1
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+ +...+..+.... .+ ...
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~--~p----~~~ 411 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMD--AP----DGC 411 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCCCC--CC----TTC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--CC----CcC
Confidence 2356889999999999999999999999999999998 999987543322 112233331111 11 122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+.+++..||+.+|++|||+.++++.|+.+
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 35688999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.32 Aligned_cols=250 Identities=16% Similarity=0.207 Sum_probs=196.3
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++.. .+++.||||.+... ...+.+.+|+.++.++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 44568899999999999986 46889999998653 3345789999999999 8999999999999999999999999
Q ss_pred CCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC-----eEEccccCccccCCCC
Q 041285 526 NGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY-----AKISDFALAKLMKPDQ 592 (724)
Q Consensus 526 ~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~-----~kl~Dfgl~~~~~~~~ 592 (724)
+++|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++. +||+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99999998532 21 2278999999999998 9999999999999987766 9999999998765432
Q ss_pred cc------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 593 TR------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 593 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 21 123457899999999999999999999999999999999999999865433222111111111111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 246 ------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 246 ------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp ------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1122356889999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.49 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=191.5
Q ss_pred HhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhc--ccCcCceeeeeeEEecc----cceE
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIG--RTHHRNLVRLLGYSFDV----SNKI 518 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~~~----~~~~ 518 (724)
...+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++. .++||||+++++++.+. ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 345566789999999999999874 899999998643 2234444555444 45999999999999877 6789
Q ss_pred EEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccC-----CCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 519 LVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDEC-----ESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~-----~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+||||+++|+|.+++..... ..+.+++.||+|||+.. ..+|+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 99999999999999854322 23789999999999752 34899999999999999999999999999987
Q ss_pred cCCCCcce---eeccccCccccCcccccCCCCCcc------cceeehhHHHHHhhcc----------ccCCCCCCCcchh
Q 041285 588 MKPDQTRT---FTGIRGTRGYVAPEWHWNLPITAK------ADVYSFGVVLLEIICC----------RRCFDQNLPEDQV 648 (724)
Q Consensus 588 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~S~Gvll~elltg----------~~p~~~~~~~~~~ 648 (724)
+....... .....||+.|+|||.+.+.....+ +||||||+++|||++| +.|+........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~- 270 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP- 270 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-
Confidence 65433221 123568999999999987776665 9999999999999999 455543322221
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
.... ..........................+.+++.+||+.||++|||+.||++.|+.+.+-
T Consensus 271 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 271 SYED-MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CHHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chhh-hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 1111 1222222222222222222335677899999999999999999999999999875543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.42 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=201.2
Q ss_pred HHHhhcccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 443 LEKMTDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 443 l~~~t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+......+.+.||+|+||.||++.... ++.||||.+... ....+++.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 344455667899999999999999865 789999998753 345578999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 522 EYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 522 e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||+++++|.+++... .. ..+.+++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999998432 11 2267999999999998 99999999999999999999999999998776555
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
........+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... . .+.+...... ..+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~----~~~~~~~~~~--~~~-- 234 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYRM--ERP-- 234 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCCC--CCC--
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhccCCC--CCC--
Confidence 444445567889999999999999999999999999999999 888886543221 1 1222221111 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++..|++.+|.+|||+.|++++|+..
T Consensus 235 --~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 235 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 12234688999999999999999999999999764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.17 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=198.7
Q ss_pred hhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
....+.++||+|+||.||+|...++..||||+++... ...++|.+|++++++++|+||+++++++.+ +..++||||++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 3445668899999999999999888889999997643 345689999999999999999999999876 67899999999
Q ss_pred CCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 9999999863 222 2378999999999998 999999999999999999999999999987653322222
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....++..|+|||.+....++.++||||||++||||++ |+.||...... + +...+..+.... ....
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~------~~~~ 488 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRMP------CPPE 488 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------H-HHHHHHTTCCCC------CCTT
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC------CCCC
Confidence 33456789999999999999999999999999999999 88888653211 1 122233321111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
....+.+++..||+.+|++|||+.+|+++|+....-
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 234688999999999999999999999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.30 Aligned_cols=244 Identities=29% Similarity=0.434 Sum_probs=196.2
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.+.||+|+||.||++...+++.||||.+... ....+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 44566899999999999999888889999998754 3345789999999999999999999999864 568999999999
Q ss_pred CChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... .. ..+.|+++||.|||+. +|+||||||+|||+++++.+||+|||++............
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9999998642 22 2278999999999998 9999999999999999999999999999877554333333
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... + ....+..+.. ...+. ..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~--~~~~~----~~ 235 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------E-VIQNLERGYR--MVRPD----NC 235 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC--CCCCT----TC
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------H-HHHHHhcccC--CCCcc----cc
Confidence 4557889999999988889999999999999999999 88888653211 1 1122222211 11111 22
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+.+++..|++.+|++|||+.+++++|+..
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 34688999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.47 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=191.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccch------hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE------GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
+.+.+.||+|+||.||++... +|+.||||.+...... ..+.+.+|+.++.+++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456689999999999999875 5889999998753221 246799999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----CeEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----YAKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~~ 589 (724)
|||+++|+|.+++.... ...+.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999985432 12278999999999998 999999999999998876 79999999998765
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
... ......||+.|+|||.+.+..++.++||||||+++|||++|..||...... + ....+..+.... ++
T Consensus 171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~-~~~~i~~~~~~~--~~ 239 (361)
T 2yab_A 171 DGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------E-TLANITAVSYDF--DE 239 (361)
T ss_dssp TTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------H-HHHHHHTTCCCC--CH
T ss_pred CCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhcCCCC--Cc
Confidence 432 223456899999999999999999999999999999999999999754211 1 112222222111 00
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++..||+.||.+|||+.|+++
T Consensus 240 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 240 -EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000112345788999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.78 Aligned_cols=244 Identities=31% Similarity=0.388 Sum_probs=183.2
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccc----hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA----EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
..+.+.||+|+||.||++.. .++.||||.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 44568899999999999997 488999999875322 2346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC--------CCCeEEccccCccccC
Q 041285 524 MSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE--------NRYAKISDFALAKLMK 589 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~--------~~~~kl~Dfgl~~~~~ 589 (724)
+++++|.+++..... ..+.|+++||+|||+....+|+||||||+|||++. ++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 167 (271)
T 3dtc_A 88 ARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167 (271)
T ss_dssp CTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred CCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence 999999999864432 22789999999999982223999999999999986 6789999999998654
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .... ..........
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~-- 235 (271)
T 3dtc_A 168 RTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYG-VAMNKLALPI-- 235 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHH-HHTSCCCCCC--
T ss_pred cccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHh-hhcCCCCCCC--
Confidence 3322 23468999999999999999999999999999999999999997532111 1111 1112111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.......+.+++..||+.+|++|||+.|+++.|+.
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 236 ---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11223468899999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.80 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=190.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45578999999999999875 5889999999753 2334567899999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|+|..++.. ... ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 88 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~~~ 163 (337)
T 1o6l_A 88 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 163 (337)
T ss_dssp TTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CBC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-ccc
Confidence 99999988742 222 2267999999999998 999999999999999999999999999986432221 223
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+... -+. ...
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~---~p~----~~s 229 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEIR---FPR----TLS 229 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---CCT----TSC
T ss_pred ccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC---CCC----CCC
Confidence 457899999999999999999999999999999999999999753211 1 11222222211 111 123
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
..+.+++..||+.||++|| ++.|+++
T Consensus 230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 4578899999999999999 8999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.54 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=193.6
Q ss_pred hhcccccccCcCccceEEEEEee------CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
....+.+.||+|+||.||+|... .++.||||++... ......++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 34456788999999999999853 3568999999653 3344567999999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCCC----------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---CeEEcc
Q 041285 519 LVYEYMSNGSLADVYSSP----------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---YAKISD 581 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~----------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---~~kl~D 581 (724)
+||||+++|+|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999988421 11 2378999999999998 999999999999999554 599999
Q ss_pred ccCccccCCCC-cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHH
Q 041285 582 FALAKLMKPDQ-TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 582 fgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~-~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHH
Confidence 99997543211 122233567899999999999999999999999999999998 88888654321 1 122233
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
.+..... .......+.+++..||+.+|++||++.||++.|+..
T Consensus 301 ~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCC------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2221111 112234588999999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.29 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=196.8
Q ss_pred cccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.+.||+|+||.||++...+ ++.||||.++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 3455789999999999999853 3789999997643 33356799999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCC---------------------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCe
Q 041285 521 YEYMSNGSLADVYSSP---------------------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNI 569 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~---------------------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NI 569 (724)
|||+++++|.+++... . +..+.||++||.|||+. +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999988431 1 11368999999999998 999999999999
Q ss_pred eeCCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcch
Q 041285 570 LMDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQ 647 (724)
Q Consensus 570 ll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~ 647 (724)
|++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 283 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 283 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH--
Confidence 999999999999999986643322 22233567899999999999999999999999999999999 88888653211
Q ss_pred hcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 648 VILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 648 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+ ....+..+..... + ......+.+++..||+.+|++||++.+|+++|+.+.+
T Consensus 284 ----~-~~~~~~~~~~~~~--~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 284 ----E-VIYYVRDGNILAC--P----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ----H-HHHHHHTTCCCCC--C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----H-HHHHHhCCCcCCC--C----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 1223333332211 1 1223468899999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.88 Aligned_cols=240 Identities=19% Similarity=0.299 Sum_probs=192.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 445688999999999999875 4789999998753 34456789999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC--CCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE--NRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|.+++.... . ..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||++........ .
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 160 (321)
T 1tki_A 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--F 160 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--E
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--c
Confidence 99999986432 1 2278999999999998 9999999999999987 78999999999987754332 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|..||...... ... ..+..+..... . ......
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~-~~i~~~~~~~~--~-~~~~~~ 230 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QII-ENIMNAEYTFD--E-EAFKEI 230 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHTCCCCC--H-HHHTTS
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHcCCCCCC--h-hhhccC
Confidence 3456899999999999888999999999999999999999999754321 111 22222221110 0 000112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.||++|||+.|+++
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 346889999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.05 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=197.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.+.||+|+||.||++...+++.||||.+.... ...+++.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 44568899999999999999888899999997643 34468999999999999999999999999999999999999999
Q ss_pred ChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 528 SLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 528 sL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|.+++... .. ..+.++++||.|||+. +++|+||||+||+++.++.+||+|||++..............
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 999988432 22 2267999999999998 999999999999999999999999999987654322223334
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (724)
.++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ....+..+.. ...+.. ...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~i~~~~~--~~~~~~----~~~ 232 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFR--LYKPRL----AST 232 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC--CCCCTT----SCH
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------H-HHHHHhcCCc--CCCCcc----CcH
Confidence 57889999999998899999999999999999999 88888653211 1 1122222211 111111 234
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 679 RMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 679 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.+.+++.+||+.+|++||++.|++++|+.+.
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5888999999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.66 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=184.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--------------------------hhHHHHHHHHHhhcccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--------------------------EGEREFQTEIKAIGRTH 500 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~l~ 500 (724)
+.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 445688999999999999874 578999999864321 11356899999999999
Q ss_pred cCceeeeeeEEec--ccceEEEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 501 HRNLVRLLGYSFD--VSNKILVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 501 h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
||||+++++++.+ ....++||||+++++|.+++..... ..+.||++||+|||+. +|+||||||+|||++
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVG 171 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEC
Confidence 9999999999987 5678999999999999988754322 2277999999999998 999999999999999
Q ss_pred CCCCeEEccccCccccCCCCcceeeccccCccccCcccccCCC---CCcccceeehhHHHHHhhccccCCCCCCCcchhc
Q 041285 573 ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649 (724)
Q Consensus 573 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~ 649 (724)
.++.+||+|||++........ ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----- 245 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI----- 245 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-----
Confidence 999999999999987654322 223457899999999997765 37789999999999999999999965321
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ....+........ ... .....+.+++.+||+.||++||++.|+++
T Consensus 246 -~~-~~~~~~~~~~~~~-~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -MC-LHSKIKSQALEFP-DQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -HH-HHHHHHHCCCCCC-SSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -HH-HHHHHhcccCCCC-Ccc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 1122222222111 111 12345889999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.58 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=197.4
Q ss_pred hcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 3445688999999999999863 34789999997532 3345679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC-------------------------------cchHHHHHHHcccccccCCCceEeCCCCCCC
Q 041285 520 VYEYMSNGSLADVYSSPP-------------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQN 568 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-------------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~N 568 (724)
||||+++++|.+++.... +..+.||++||.|||+. +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 999999999999884321 12267999999999998 99999999999
Q ss_pred eeeCCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcc
Q 041285 569 ILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPED 646 (724)
Q Consensus 569 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~ 646 (724)
||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876544332 2223457889999999998889999999999999999999 999987543221
Q ss_pred hhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 647 QVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 647 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....+..+..... .......+.+++..||+.||++||++.|+++.|+.++
T Consensus 261 -------~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 261 -------LFNLLKTGHRMER------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -------HHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHhhcCCcCCC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122333221111 1122346889999999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.98 Aligned_cols=261 Identities=25% Similarity=0.302 Sum_probs=200.3
Q ss_pred HHHHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcc--cCcCceeeeeeEEeccc--
Q 041285 440 YAELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGR--THHRNLVRLLGYSFDVS-- 515 (724)
Q Consensus 440 ~~el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~-- 515 (724)
..+.....+.+.+.||+|+||.||+++. +++.||||.+... ..+.+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3444555667789999999999999988 5899999998643 34567888888877 79999999999998876
Q ss_pred --ceEEEEeeccCCChhhhcCCCCc------chHHHHHHHccccc--------ccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 516 --NKILVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLH--------DECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 516 --~~~lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH--------~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
..++||||+++++|.+++..... ..+.++++||+||| +. +|+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEE
Confidence 78999999999999999854322 23789999999999 55 9999999999999999999999
Q ss_pred ccccCccccCCCCcc---eeeccccCccccCcccccCCC------CCcccceeehhHHHHHhhcc----------ccCCC
Q 041285 580 SDFALAKLMKPDQTR---TFTGIRGTRGYVAPEWHWNLP------ITAKADVYSFGVVLLEIICC----------RRCFD 640 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~S~Gvll~elltg----------~~p~~ 640 (724)
+|||++......... ......|++.|+|||.+.+.. ++.++||||||+++|||++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999999876543322 123357899999999987763 33689999999999999999 56665
Q ss_pred CCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 641 QNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 641 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....... ....+ ...+....+...+.......+....+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 269 ~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 269 DLVPSDP-SVEEM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTSCSSC-CHHHH-HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcCcc-cHHHH-HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 4332211 12222 2222222222222222234466778999999999999999999999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=321.14 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=185.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccc---------
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN--------- 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------- 516 (724)
+.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 345678999999999999986 68999999987432 3345789999999999999999999999865432
Q ss_pred ------------------------------------------------eEEEEeeccCCChhhhcCCCC----------c
Q 041285 517 ------------------------------------------------KILVYEYMSNGSLADVYSSPP----------K 538 (724)
Q Consensus 517 ------------------------------------------------~~lv~e~~~~gsL~~~l~~~~----------~ 538 (724)
.++||||+++++|.+++.... +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 799999999999999985421 2
Q ss_pred chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-----------ceeeccccCccccC
Q 041285 539 NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-----------RTFTGIRGTRGYVA 607 (724)
Q Consensus 539 ~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~y~a 607 (724)
..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 3478999999999998 999999999999999999999999999987754421 11233568999999
Q ss_pred cccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHc
Q 041285 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWC 687 (724)
Q Consensus 608 PE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 687 (724)
||.+.+..++.++||||||+++|||++|..|+.. . .............. ........+.+++..|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~----~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----R----VRIITDVRNLKFPL------LFTQKYPQEHMMVQDM 309 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----H----HHHHHHHHTTCCCH------HHHHHCHHHHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----H----HHHHHHhhccCCCc------ccccCChhHHHHHHHH
Confidence 9999999999999999999999999998665321 0 01112222222211 1123345678899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 041285 688 ILDEPSLRPSMKKVLL 703 (724)
Q Consensus 688 l~~~p~~RPs~~evl~ 703 (724)
|+.||++||++.|+++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.88 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=193.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +++.||+|.+..........+.+|++++.+++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 455688999999999999875 5789999998765445566899999999999999999999999999999999999999
Q ss_pred CChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC--CCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE--NRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|.+++..... ..+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++........ .
T Consensus 133 g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 207 (387)
T 1kob_A 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 207 (387)
T ss_dssp CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--e
Confidence 999999864321 1278999999999998 9999999999999974 46799999999987754432 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+....... +. ......
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~i~~~~~~~--~~-~~~~~~ 277 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETL-QNVKRCDWEF--DE-DAFSSV 277 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHHCCCCC--CS-STTTTS
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCCC--Cc-cccccC
Confidence 2346899999999999999999999999999999999999999754211 111 1122221111 11 111122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++..||+.||++|||+.|+++.
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 3468899999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=326.04 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=196.8
Q ss_pred hhcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
....+.+.||+|+||.||++... .++.||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 34456689999999999999862 35689999987532 33446799999999999 899999999999999999
Q ss_pred EEEEeeccCCChhhhcCCCC------------------------------cchHHHHHHHcccccccCCCceEeCCCCCC
Q 041285 518 ILVYEYMSNGSLADVYSSPP------------------------------KNNLIGIARGILYLHDECESQIIHCDIKPQ 567 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~------------------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~ 567 (724)
++||||+++|+|.+++.... +..+.||++||.|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 99999999999999984422 11367999999999998 9999999999
Q ss_pred CeeeCCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCc
Q 041285 568 NILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPE 645 (724)
Q Consensus 568 NIll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~ 645 (724)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999876543332 2233567889999999999999999999999999999998 99998765332
Q ss_pred chhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 646 DQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 646 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.. ....+..+.... .+ ......+.+++..||+.+|.+|||+.|+++.|+....
T Consensus 282 ~~------~~~~~~~~~~~~--~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 282 AN------FYKLIQNGFKMD--QP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp HH------HHHHHHTTCCCC--CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HH------HHHHHhcCCCCC--CC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 21 122222221111 11 1123468889999999999999999999999987544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.00 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=188.2
Q ss_pred HHHHhhcccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
|+......+.++||+|+||.||+++.. ..||||.++.. .....+.|.+|++++++++|+||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 444455667789999999999999863 46999998643 234456799999999999999999999965 4567899
Q ss_pred EEeeccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 520 VYEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
||||+++++|.+++..... ..+.+++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999853221 2378999999999998 9999999999999999999999999999865432
Q ss_pred C-cceeeccccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 592 Q-TRTFTGIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 592 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
. ........|++.|+|||.+. ...++.++||||||+++|||++|+.||........ ..+....+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCcch
Confidence 2 22233456899999999986 56788899999999999999999999976433221 22333333222211
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
. .........+.+++..||+.+|++|||+.|++++|+.+.
T Consensus 248 ~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 S--KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp T--SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h--hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 112223456889999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.91 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=183.1
Q ss_pred hhcccccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.+.+.||+|+||.||+|.... +..||||.+.... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 345567899999999999998743 4579999987532 333467999999999999999999999984 4678999
Q ss_pred EeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|||+++++|.+++... .. ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999988432 22 1267999999999998 99999999999999999999999999998765443
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
........+++.|+|||.+....++.++||||||+++|||++ |..||......+ . ...+..+....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~----~~~i~~~~~~~------ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGERLP------ 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCCC------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---H----HHHHHcCCCCC------
Confidence 333333456889999999998999999999999999999996 888887543221 1 12222222111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
........+.+++..||+.+|++||++.|+++.|+.+.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122356889999999999999999999999998643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.74 Aligned_cols=242 Identities=30% Similarity=0.482 Sum_probs=184.9
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
..+.+.||+|+||.||++.. .++.||||++.. ....+.|.+|++++++++||||+++++++.+ ..++||||++++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 34567899999999999987 478899999975 3345689999999999999999999998874 589999999999
Q ss_pred ChhhhcCCCC------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC-eEEccccCccccCCCCccee
Q 041285 528 SLADVYSSPP------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY-AKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 528 sL~~~l~~~~------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~-~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|.+++.... . ..+.|+++||+|||+....+|+||||||+|||++.++. +||+|||++...... .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~ 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----M 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----c
Confidence 9999985432 1 12579999999999943348999999999999988876 799999999765432 1
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .......+...... ...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~~~------~~~ 229 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----R-IMWAVHNGTRPPLI------KNL 229 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----H-HHHHHHTTCCCCCB------TTC
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----H-HHHHHhcCCCCCcc------ccc
Confidence 234589999999999999999999999999999999999999975432211 1 11112222221111 112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
...+.+++.+||+.+|++|||+.|++++|+.+.
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 345888999999999999999999999998643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=320.13 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=192.5
Q ss_pred hhcccccccCcCccceEEEEEeeC-C-------cEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccce
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN-G-------KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 517 (724)
..+.+.+.||+|+||.||++.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345567899999999999998753 2 47999999876666677899999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC--------eEEcc
Q 041285 518 ILVYEYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY--------AKISD 581 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~--------~kl~D 581 (724)
++||||+++++|.+++.... . ..+.||++||.|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999999999985422 1 2378999999999998 9999999999999998877 99999
Q ss_pred ccCccccCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 582 FALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 582 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........ .......
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~~~~ 233 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYED 233 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHT
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHHhhc
Confidence 9998754322 22457889999999987 6789999999999999999997665543322111 1111111
Q ss_pred -CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 661 -GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 661 -~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
..+.... ...+.+++..||+.||++|||+.|+++.|+.+..-.
T Consensus 234 ~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 234 RHQLPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TCCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred cCCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111 234788999999999999999999999999876643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=334.74 Aligned_cols=251 Identities=23% Similarity=0.251 Sum_probs=193.5
Q ss_pred HHHHHhhccc--ccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecc
Q 041285 441 AELEKMTDGF--KEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV 514 (724)
Q Consensus 441 ~el~~~t~~f--~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 514 (724)
.++...+.+| .++||+|+||.||+++... ++.||||++.... ......+++|+.++.+++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444444444 4789999999999999865 7899999997532 22234589999999999999999999999999
Q ss_pred cceEEEEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 515 SNKILVYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
+..++||||+++|+|.+++... .. ..+.+|+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999998542 11 1268999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .... +......-
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~~-i~~~~~~~ 300 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGK-IMNHKERF 300 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-HHTHHHHC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHHh-hhhccccc
Confidence 77655544444567999999999987 5568999999999999999999999997543211 1111 11000111
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSL--RPSMKKVLL 703 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~ 703 (724)
.+.... ......+.+++.+|++.+|++ ||+++|+++
T Consensus 301 ~~p~~~------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 QFPTQV------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCSSC------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cCCccc------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111110 112345778888999888888 999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.42 Aligned_cols=243 Identities=26% Similarity=0.340 Sum_probs=189.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345678999999999999876 68899999986432 2334678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ceee
Q 041285 526 NGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~ 597 (724)
+++|.+++.... +..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++..+..... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 999999986432 12378999999999998 999999999999999999999999999986643322 2223
Q ss_pred ccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... . ..+..... ...+ ....
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~~~~--~~~~---~~~~ 234 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKT--YLNP---WKKI 234 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHTTCT--TSTT---GGGS
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhcccc--cCCc---cccC
Confidence 4678999999999987775 77999999999999999999999765432221 1 11111111 0111 0112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 235 DSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 3457789999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.22 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=191.8
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccch------hHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE------GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3556789999999999999875 4889999998753221 35679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----CeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----YAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~ 588 (724)
||||+++++|.+++.... +..+.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999985432 12278999999999998 999999999999998877 7999999999876
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+........
T Consensus 169 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~-~~~~~~~~~~~-- 237 (326)
T 2y0a_A 169 DFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVNYEFE-- 237 (326)
T ss_dssp CTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHTCCCCC--
T ss_pred CCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHHhcCCCcC--
Confidence 53322 233568999999999999999999999999999999999999996532111 11 11111111100
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. .........+.+++..||+.||++|||+.|+++
T Consensus 238 ~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 D-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H-HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c-cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000112345788999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.76 Aligned_cols=238 Identities=26% Similarity=0.313 Sum_probs=185.1
Q ss_pred ccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.+.||+|+||.||++... +++.||||+++.......+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999874 5889999999865555667899999999999999999999999999999999999999999
Q ss_pred hhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee--CCCCCeEEccccCccccCCCCcceeecc
Q 041285 530 ADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM--DENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 530 ~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll--~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
.+++... .. ..+.||++||.|||+. +|+||||||+|||+ +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 8877322 11 2267999999999998 99999999999999 6678899999999987654332 2234
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.||+.|+|||.+....++.++||||||+++|||++|+.||...... ........ ..... .. .........
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~-~~~~~--~~-~~~~~~~~~ 318 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILA-CRWDL--ED-EEFQDISEE 318 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCCS--CS-GGGTTSCHH
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-ccCCC--Ch-hhhccCCHH
Confidence 6899999999999889999999999999999999999999754321 11112221 11110 00 001112346
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.+++.+||+.+|.+||++.|+++
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=332.76 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=190.2
Q ss_pred cccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 44789999999999998864 7899999987521 2233468899999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 526 NGSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 526 ~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+|+|.+++.... . ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++.............
T Consensus 153 gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~ 229 (410)
T 3v8s_A 153 GGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229 (410)
T ss_dssp TEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSC
T ss_pred CCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCC
Confidence 999999885422 1 2268999999999998 999999999999999999999999999987765544334456
Q ss_pred ccCccccCcccccCCC----CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-CccccccccccCH
Q 041285 600 RGTRGYVAPEWHWNLP----ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG-NLGQLIEDEDVDK 674 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~ 674 (724)
.||+.|+|||++.... ++.++||||||+++|||++|+.||....... . ........ .+. .-+...
T Consensus 230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~----~~~i~~~~~~~~-~p~~~~--- 299 (410)
T 3v8s_A 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T----YSKIMNHKNSLT-FPDDND--- 299 (410)
T ss_dssp CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H----HHHHHTHHHHCC-CCTTCC---
T ss_pred cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--H----HHHHHhcccccc-CCCccc---
Confidence 7999999999998765 7889999999999999999999997543211 1 11111100 010 000111
Q ss_pred HHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSL--RPSMKKVLLM 704 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 704 (724)
....+.+++..||+.+|.+ ||+++||++.
T Consensus 300 -~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 300 -ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 2345788899999999988 9999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=320.19 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=194.8
Q ss_pred HhhcccccccCcCccceEEEEEe-----eCCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SN 516 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 516 (724)
.....+.+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34455668899999999999984 357899999987532 33456799999999999999999999999876 56
Q ss_pred eEEEEeeccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcccc
Q 041285 517 KILVYEYMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLM 588 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~ 588 (724)
.++||||+++++|.+++.. ... ..+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 8999999999999999832 221 2377999999999998 9999999999999999999999999999877
Q ss_pred CCCCcc--eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC--------CcchhcHHHHHHHHH
Q 041285 589 KPDQTR--TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL--------PEDQVILEEWVYQCF 658 (724)
Q Consensus 589 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~--------~~~~~~l~~~~~~~~ 658 (724)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... +..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 654332 2233568888999999999899999999999999999999998764321 000011111112222
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+.... ........+.+++.+||+.+|.+|||+.|++++|+.++
T Consensus 257 ~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRLP------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCC------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2221111 11123356889999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=318.52 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=187.1
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||+||++...+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 34557899999999999999889999999987532 2224678899999999999999999999999999999999998
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++.... . ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 103 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 177 (311)
T 3niz_A 103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT 177 (311)
T ss_dssp E-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred C-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-ccc
Confidence 5 7777663321 1 2278999999999998 999999999999999999999999999987643222 223
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc-----------
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ----------- 665 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----------- 665 (724)
...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .. ............
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PK-IFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HH-HHHHHCCCCTTTSGGGTTSHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHHCCCChHHhhhhhccchhh
Confidence 3568999999999876 56899999999999999999999999765433321 11 111111110000
Q ss_pred -----cccccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 -----LIEDED---VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 -----~~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+... ........+.+++..||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 01112346789999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.13 Aligned_cols=253 Identities=20% Similarity=0.325 Sum_probs=197.4
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEeccc--ceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--NKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 4456889999999999998864 8899999997533 334567889999999999999999999998765 67999999
Q ss_pred ccCCChhhhcCCC------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeee----CCCCCeEEccccCccccC
Q 041285 524 MSNGSLADVYSSP------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM----DENRYAKISDFALAKLMK 589 (724)
Q Consensus 524 ~~~gsL~~~l~~~------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll----~~~~~~kl~Dfgl~~~~~ 589 (724)
+++++|.+++... .. ..+.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999998542 22 2278999999999998 99999999999999 778889999999998765
Q ss_pred CCCcceeeccccCccccCccccc--------CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHW--------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
.... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||......... .+.........
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGK 243 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHC
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCC
Confidence 4332 22356899999999876 567899999999999999999999999754322211 11122222211
Q ss_pred C---ccc--------------cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 662 N---LGQ--------------LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 662 ~---~~~--------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
. ... +-............+.+++..||+.||++|||++|+++....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1 000 001112356677889999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.88 Aligned_cols=243 Identities=28% Similarity=0.433 Sum_probs=188.0
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchh-------HHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEG-------EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
.+.+.+.||+|+||.||++... +++.||||++....... .+.+.+|++++++++||||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 3455688999999999999874 68899999986432211 167899999999999999999999987654 7
Q ss_pred EEEeeccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCc--eEeCCCCCCCeeeCCCCC-----eEEcccc
Q 041285 519 LVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQ--IIHCDIKPQNILMDENRY-----AKISDFA 583 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~--i~H~dlk~~NIll~~~~~-----~kl~Dfg 583 (724)
+||||+++++|.+++.... +..+.|++.||+|||+. + |+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 9999999999988773321 12378999999999998 7 999999999999988776 9999999
Q ss_pred CccccCCCCcceeeccccCccccCccccc--CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQTRTFTGIRGTRGYVAPEWHW--NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
+++.... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||......... ........+
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~ 246 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMIREEG 246 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHHHHSC
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHHhccC
Confidence 9975432 233456899999999984 455789999999999999999999999764432211 111111111
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....+ .......+.+++..||+.||++|||+.|+++.|+.+
T Consensus 247 -~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 -LRPTI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CCCCC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 112235688999999999999999999999999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.80 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=187.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccch---hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE---GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++.+++||||+++++++.+.+..++|+||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 445688999999999999875 5789999998754222 236789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.++++||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 116 INGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp CCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 999999998843 222 2378999999999998 999999999999999999999999999987654433333
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+... .... .......
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~-~~~~---~~~~~~~ 261 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQA-IPRP---STVRPGI 261 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSC-CCCG---GGTSTTC
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccC-CCCc---cccCCCC
Confidence 445689999999999999999999999999999999999999865321 1112222221 1111 1111222
Q ss_pred HHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCCCCCCCCCC
Q 041285 677 LERMIKVALWCILDEPSLRP-SMKKVLLMLEGTMDIPIPPNPT 718 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~~~p~~p~ 718 (724)
...+.+++.+||+.+|++|| +++++++.|+....-..+....
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~ 304 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence 34588899999999999999 9999999999877666554443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.65 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=181.7
Q ss_pred ccccccCcCccceEEEEEeeC--C--cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEec-ccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN--G--KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 522 (724)
.+.+.||+|+||.||+|...+ + ..||||.++... ....++|.+|+.++++++||||+++++++.+ .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 456789999999999998743 2 368999987532 3445789999999999999999999999865 457899999
Q ss_pred eccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-
Q 041285 523 YMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
|+++++|.+++..... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 9999999999854221 2267999999999998 999999999999999999999999999986643322
Q ss_pred --ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 594 --RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 594 --~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+ .. ..+..+.. ...+.
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~----~~~~~~~~--~~~p~ 319 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT----VYLLQGRR--LLQPE 319 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HH----HHHHTTCC--CCCCT
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HH----HHHHcCCC--CCCCC
Confidence 11233457889999999999999999999999999999999 555665433222 11 12222221 11121
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
. ....+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 320 ~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 320 Y----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2 2345889999999999999999999999998643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=325.96 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=199.2
Q ss_pred HHhhcccccccCcCccceEEEEEee--------CCcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEec
Q 041285 444 EKMTDGFKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD 513 (724)
Q Consensus 444 ~~~t~~f~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 513 (724)
....+.+.+.||+|+||.||++... ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3445556789999999999999863 46789999997542 33456799999999999 89999999999999
Q ss_pred ccceEEEEeeccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCee
Q 041285 514 VSNKILVYEYMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNIL 570 (724)
Q Consensus 514 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIl 570 (724)
.+..++||||+++++|.+++.... +..+.||++||+|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 999999999999999999984321 11267999999999998 9999999999999
Q ss_pred eCCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchh
Q 041285 571 MDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQV 648 (724)
Q Consensus 571 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~ 648 (724)
++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 999999999999999876544322 2223457889999999988889999999999999999999 88888653211
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
+ ....+..+..... .......+.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus 267 ---~-~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 267 ---E-LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ---H-HHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---H-HHHHHhcCCCCCC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 1122222221111 1122345889999999999999999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.11 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=189.3
Q ss_pred cccccccCcCccceEEEEEeeC-Cc----EEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GK----FVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
..+.+.||+|+||.||+|.... ++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++|+
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 3455789999999999998743 43 38888875432 333457889999999999999999999886 56789999
Q ss_pred eeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++|+|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999988442 11 2267999999999998 999999999999999999999999999998754433
Q ss_pred c-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 R-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+.... .+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~~~ 241 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA--QPQI 241 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCC--CCTT
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC--CCCc
Confidence 2 2334567889999999999999999999999999999999 999997643222 112222221111 1111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....+.+++..||+.+|.+||++.|+++.|+...
T Consensus 242 ----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 ----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1224778999999999999999999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.46 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=189.0
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccce----EE
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK----IL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~l 519 (724)
+.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|++++.+++||||+++++++...... ++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 44568899999999999986 4688999999975322 2345789999999999999999999998866543 99
Q ss_pred EEeeccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||||+++++|.+++.. .. +..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 94 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 9999999999998842 22 22378999999999998 99999999999999999999999999998765432
Q ss_pred c--ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 593 T--RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 593 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .................
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~-- 242 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPSAR-- 242 (311)
T ss_dssp -----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCHHHH--
T ss_pred cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCcccc--
Confidence 2 1222356899999999999999999999999999999999999999654321 11222222222111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhccCCCCCCCCCCCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKK-VLLMLEGTMDIPIPPNPTS 719 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e-vl~~L~~~~~~~~p~~p~~ 719 (724)
.......+.+++.+||+.||++||+..+ +.+.|.....-..|+.|..
T Consensus 243 --~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 243 --HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp --STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred --cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 1112345889999999999999996554 5556655444444444443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.84 Aligned_cols=256 Identities=15% Similarity=0.190 Sum_probs=189.2
Q ss_pred hcccccccCcCccceEEEEEeeC------CcEEEEEEcccccchh-----------HHHHHHHHHhhcccCcCceeeeee
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKMLAEG-----------EREFQTEIKAIGRTHHRNLVRLLG 509 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g 509 (724)
.+.+.+.||+|+||.||+|.... ++.||||.+....... ...+..|+..+.+++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 44566899999999999998865 4789999986532111 122445666778889999999999
Q ss_pred EEecc----cceEEEEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC--CCC
Q 041285 510 YSFDV----SNKILVYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD--ENR 575 (724)
Q Consensus 510 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~--~~~ 575 (724)
++... ...++||||+ +++|.+++... .+ ..+.||+.||+|||+. +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98875 4579999999 99999998432 22 2278999999999998 999999999999998 889
Q ss_pred CeEEccccCccccCCCCcc------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhc
Q 041285 576 YAKISDFALAKLMKPDQTR------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649 (724)
Q Consensus 576 ~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~ 649 (724)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~- 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY- 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH-
Confidence 9999999999876433211 112345999999999999999999999999999999999999999754322211
Q ss_pred HHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 650 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
........ ...+..+++...........+.+++..||+.+|++||++.+|+++|+...
T Consensus 271 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 271 -VRDSKIRY-RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -HHHHHHHH-HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHHHHh-hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 11111111 11122222221111122456888999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.09 Aligned_cols=244 Identities=25% Similarity=0.237 Sum_probs=187.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc-----cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-----LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
.+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 3556789999999999999874 5789999998653 234456899999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCCC-----------------------------------------------CcchHHHHHHHcccccc
Q 041285 521 YEYMSNGSLADVYSSP-----------------------------------------------PKNNLIGIARGILYLHD 553 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-----------------------------------------------~~~~~~~ia~~l~yLH~ 553 (724)
|||+++|+|.+++... .+..+.||++||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999988410 01236799999999999
Q ss_pred cCCCceEeCCCCCCCeeeCCCC--CeEEccccCccccCCCC---cceeeccccCccccCcccccC--CCCCcccceeehh
Q 041285 554 ECESQIIHCDIKPQNILMDENR--YAKISDFALAKLMKPDQ---TRTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFG 626 (724)
Q Consensus 554 ~~~~~i~H~dlk~~NIll~~~~--~~kl~Dfgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~G 626 (724)
. +|+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||.+.+ ..++.++||||||
T Consensus 187 ~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 187 Q---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp T---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred C---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 8 999999999999998776 89999999998653321 122334578999999999875 6789999999999
Q ss_pred HHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 627 VVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 627 vll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+++|||++|+.||...... .......... .... . .........+.+++..||+.+|.+||++.|+++
T Consensus 264 ~il~el~~g~~pf~~~~~~------~~~~~~~~~~-~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDA------DTISQVLNKK-LCFE-N--PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-CCTT-S--GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChH------HHHHHHHhcc-cccC-C--cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999654321 1112222221 1110 0 011112345889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=345.38 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=188.7
Q ss_pred ccCcCccceEEEEEee---CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 453 EIGRGSSGTVYKGTMI---NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++++|.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 35679999997643 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--eec
Q 041285 529 LADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT--FTG 598 (724)
Q Consensus 529 L~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~~ 598 (724)
|.+++..... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999854321 2278999999999998 99999999999999999999999999998765433211 122
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..+++.|+|||++....++.++||||||++||||++ |+.||......+ +...+..+..... .....
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------p~~~~ 565 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC------PPECP 565 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCCC------CTTCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCC------CCcCC
Confidence 346789999999999999999999999999999998 999987643321 1233333321111 11233
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
..+.+++..||+.+|++||++.+|+++|+..
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 5688999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.62 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred hhcccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
....+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 34556789999999999999852 357899999975432 3446799999999999 999999999999999999
Q ss_pred EEEEeeccCCChhhhcCCC---------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 518 ILVYEYMSNGSLADVYSSP---------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~---------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
++||||+++++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 9999999999999988432 11 1267999999999998 999999999999999
Q ss_pred CCCCeEEccccCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcH
Q 041285 573 ENRYAKISDFALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVIL 650 (724)
Q Consensus 573 ~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l 650 (724)
.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--- 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---
Confidence 99999999999998775543322 223457889999999999999999999999999999999 8988865432221
Q ss_pred HHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 651 EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.......+.. . ..+ ......+.+++.+||+.+|.+|||+.|++++|++..
T Consensus 257 ---~~~~~~~~~~-~-~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 ---FYKMIKEGFR-M-LSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---HHHHHHHTCC-C-CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHhccCCC-C-CCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1122222211 1 111 122346889999999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.92 Aligned_cols=255 Identities=26% Similarity=0.326 Sum_probs=197.5
Q ss_pred hhcccccccCcCccceEEEEEe-----eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEe--cccceE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF--DVSNKI 518 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 518 (724)
..+.+.+.||+|+||.||++.+ ..++.||||++........+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 3445668999999999999984 357899999998765566678999999999999999999999987 445689
Q ss_pred EEEeeccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 519 LVYEYMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+||||+++++|.+++.. ... ..+.+|++||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999998853 222 2267999999999998 999999999999999999999999999987754
Q ss_pred CCcce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc--------hhcHHHHHHHHHHc
Q 041285 591 DQTRT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--------QVILEEWVYQCFEN 660 (724)
Q Consensus 591 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~--------~~~l~~~~~~~~~~ 660 (724)
..... .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 43322 223467888999999998889999999999999999999999886421100 00000111122222
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+.... ........+.+++..||+.+|++|||+.|+++.|+.+.
T Consensus 260 ~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 260 GQRLP------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp TCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred ccCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21111 11223456889999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=314.88 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=185.2
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++....++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 34567899999999999998779999999986432 2224678899999999999999999999999999999999997
Q ss_pred CCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+ +|.+++... . ...+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 5 888877432 1 12278999999999998 999999999999999999999999999987643221 223
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---cccc-----cc
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQL-----IE 668 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-----~~ 668 (724)
...+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+.. ......... .... .+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcccccc
Confidence 34679999999998764 58999999999999999999999997543211 1111 111111100 0000 00
Q ss_pred c----------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 D----------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0001122456789999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.52 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=192.7
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34556789999999999999875 5889999998653 22344678999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCccccCCCC
Q 041285 523 YMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~~~~~~~ 592 (724)
|+++++|.+++.... +..+.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999998885432 12278999999999998 99999999999999865 459999999998765332
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..||...... . ....+..+....... .
T Consensus 186 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~-~~~~i~~~~~~~~~~---~ 253 (362)
T 2bdw_A 186 A--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAYDYPSP---E 253 (362)
T ss_dssp S--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCCCTT---G
T ss_pred c--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCCCCcc---c
Confidence 2 23457899999999999999999999999999999999999999653211 1 122233332221110 0
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.......+.+++..||+.||++||++.|+++.
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223457889999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.78 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=190.8
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEccccc-----chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
..+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45667789999999999999875 58999999986421 1235679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCc
Q 041285 520 VYEYMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALA 585 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~ 585 (724)
||||+++++|.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999877631 122 2367999999999998 9999999999999986654 999999999
Q ss_pred cccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc
Q 041285 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 665 (724)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . . ....+..+....
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~----~-~~~~i~~~~~~~ 251 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---E----R-LFEGIIKGKYKM 251 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---H----H-HHHHHHHTCCCC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---H----H-HHHHHHcCCCCC
Confidence 87654322 2233568999999999999999999999999999999999999997531 1 1 112222222211
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. +. ........+.+++.+||+.||++|||+.|+++
T Consensus 252 ~--~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 N--PR-QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--HH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00 00112346889999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.01 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=182.7
Q ss_pred cccccccCcCccceEEEEEeeCCc----EEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccce----
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK---- 517 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 517 (724)
+.+.+.||+|+||.||++...... .||||.+... .....+++.+|++++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 445688999999999999875432 7999998753 334567899999999999999999999999887655
Q ss_pred --EEEEeeccCCChhhhcCC---------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 518 --ILVYEYMSNGSLADVYSS---------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 518 --~lv~e~~~~gsL~~~l~~---------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
++|+||+++++|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 999999999999988731 221 2378999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 583 ALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 583 gl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
|+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+..
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~ 254 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLIG 254 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHT
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HHHHHhc
Confidence 99987644332 22233456889999999999999999999999999999999 888887543221 1122222
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
+..... .......+.+++.+||+.||++|||+.++++.|+.++.-
T Consensus 255 ~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 GNRLKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCC------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 211111 112234688999999999999999999999999876544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=319.56 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=196.0
Q ss_pred ccccccCcCccceEEEEEee-----CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-----NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 520 (724)
.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45688999999999998753 57899999997643 23456799999999999999999999999874 567999
Q ss_pred EeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|||+++++|.+++..... ..+.+|+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp ECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999999999865332 2278999999999998 9999999999999999999999999999877544322
Q ss_pred --eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcc--------hhcHHHHHHHHHHcCCcc
Q 041285 595 --TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPED--------QVILEEWVYQCFENGNLG 664 (724)
Q Consensus 595 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~--------~~~l~~~~~~~~~~~~~~ 664 (724)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .........+....+...
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC
T ss_pred cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC
Confidence 2233567888999999998889999999999999999999999986431100 000000111222222111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
. ........+.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus 271 ~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 271 P------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 1 1122345688999999999999999999999999876443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.31 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=191.1
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 3556789999999999999864 58899999986532 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC---CCCCeEEccccCccccCCCCc
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~---~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+++|+|.+++... . ...+.||++||.|||+. +|+||||||+|||++ .++.+||+|||++........
T Consensus 92 ~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 92 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999998887322 1 22378999999999998 999999999999998 467899999999987654322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||...... . ....+..+....... ..
T Consensus 169 -~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~~~~~---~~ 237 (444)
T 3soa_A 169 -AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------R-LYQQIKAGAYDFPSP---EW 237 (444)
T ss_dssp -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCCCCTT---TT
T ss_pred -eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------H-HHHHHHhCCCCCCcc---cc
Confidence 223457999999999999999999999999999999999999999653211 1 122333332221111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++..||+.||++|||+.|+++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122345888999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.63 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=186.5
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec-----ccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-----VSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~e 522 (724)
+.+.+.||+|+||.||+|+. +++.||||++..... .......|+..+..++|+||+++++.+.. ....++|||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 34567899999999999977 789999999875322 11222344555666899999999986542 235689999
Q ss_pred eccCCChhhhcCCCCc------chHHHHHHHcccccccC------CCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 523 YMSNGSLADVYSSPPK------NNLIGIARGILYLHDEC------ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~------~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
|+++|+|.+++..... ..+.||++||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 93 YYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172 (336)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence 9999999999853322 23789999999999863 33899999999999999999999999999987653
Q ss_pred CCc-------ceeeccccCccccCcccccC-------CCCCcccceeehhHHHHHhhccccCCCCCCCcch--h------
Q 041285 591 DQT-------RTFTGIRGTRGYVAPEWHWN-------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ--V------ 648 (724)
Q Consensus 591 ~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~--~------ 648 (724)
... .......||+.|+|||.+.+ ..++.++||||||+++|||++|..|+........ .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 252 (336)
T 3g2f_A 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252 (336)
T ss_dssp SSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred ccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence 221 11223568999999999876 3456789999999999999999877654322111 0
Q ss_pred ----cHHHHHHHHHHcCC-ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 649 ----ILEEWVYQCFENGN-LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 649 ----~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..... ........ ...+-+...........+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 253 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 253 GNHPTFEDM-QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CSSCCHHHH-HHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCchHHHH-HhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 01111 11111111 11111111223445677999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=322.63 Aligned_cols=240 Identities=24% Similarity=0.293 Sum_probs=185.9
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||+++... ++.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 3456789999999999999764 7899999997642 22334688999999887 89999999999999999999999
Q ss_pred eccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
|+++|+|..++.. ... ..+.+|+.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 209 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 209 (396)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-Cc
Confidence 9999999988743 222 2278999999999998 99999999999999999999999999998533221 12
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcch--hcHHHHHHHHHHcCCccccccccccC
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ--VILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........+.+..+.+.. +
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p---- 282 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P---- 282 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC---C----
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC---C----
Confidence 3346799999999999999999999999999999999999999965322111 111122233333332211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
......+.+++..||+.||.+||++
T Consensus 283 ~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1123457899999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.71 Aligned_cols=250 Identities=24% Similarity=0.259 Sum_probs=191.2
Q ss_pred HHHHHhhccc--ccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecc
Q 041285 441 AELEKMTDGF--KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV 514 (724)
Q Consensus 441 ~el~~~t~~f--~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 514 (724)
.++.....+| .+.||+|+||.||+++.. +++.||||++.+.. ....+.+++|..++.+++|+||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3333334444 478999999999999985 58999999997532 22334689999999999999999999999999
Q ss_pred cceEEEEeeccCCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 515 SNKILVYEYMSNGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
+..++||||+++|+|.+++.. .... .+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999999843 2222 267999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCccccc-------CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHW-------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .... +.....
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~-i~~~~~ 287 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TYGK-IVHYKE 287 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-HHTHHH
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HHHH-HHhccc
Confidence 77655443334467999999999987 3568999999999999999999999997543211 1111 100000
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLR---PSMKKVLL 703 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~ 703 (724)
...+.. ........+.+++.+||+ +|.+| |+++|+++
T Consensus 288 ~~~~p~------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 288 HLSLPL------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HCCCC----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CcCCCc------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 011110 011223468889999999 99998 58999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.05 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.... ++.||||.+.... ....+.+.+|++++.+++|||||++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 4456889999999999998754 7899999986532 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|..++... .. ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 97 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~ 171 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QI 171 (384)
T ss_dssp CTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ce
Confidence 9999999988542 11 2277999999999998 99999999999999999999999999998765332 22
Q ss_pred eccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 597 TGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|+|||++.. ..++.++||||||+++|||++|+.||......... .. ...+...... ..
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~-~~~~~~~~~~-------~p 240 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---EI-VHTFETTVVT-------YP 240 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---HH-HHHHHHCCCC-------CC
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---HH-HHHHhhcccC-------CC
Confidence 34579999999999874 45889999999999999999999999754433221 11 1122222111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPS-MKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~ 703 (724)
......+.+++..||+.+|.+||+ +.+|++
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122346889999999999999998 777663
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.56 Aligned_cols=247 Identities=20% Similarity=0.249 Sum_probs=188.5
Q ss_pred cccccccCcC--ccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRG--SSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.+.||+| +||.||++... +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4566899999 99999999986 58999999997532 3334678899999999999999999999999999999999
Q ss_pred eccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 523 YMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 523 ~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|+++++|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999988432 11 2267999999999998 999999999999999999999999999865422111
Q ss_pred ------ceeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccc
Q 041285 594 ------RTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665 (724)
Q Consensus 594 ------~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 665 (724)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ... .+....
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~-----~~~~~~ 256 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKL-----NGTVPC 256 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHh-----cCCCCc
Confidence 11112468999999999987 578999999999999999999999997643322110 000 000000
Q ss_pred cccc---------------------------------------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 666 LIED---------------------------------------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 666 ~~~~---------------------------------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+.+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 00112234568899999999999999999999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=320.38 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=186.6
Q ss_pred ccccccCcCccceEEEEEeeC-----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||.||+|.... +..||||.++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345789999999999998753 2369999987542 2344579999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+++++|.+++... .. ..+.+|++||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999998432 21 2278999999999998 9999999999999999999999999999876543221
Q ss_pred --eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 595 --TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 595 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . +...+..+....
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~~~~~~~~~~~------ 270 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------E-VMKAINDGFRLP------ 270 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCCC------
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------H-HHHHHHCCCcCC------
Confidence 1222356789999999999999999999999999999999 99998653211 1 122233221111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112234688999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.79 Aligned_cols=240 Identities=23% Similarity=0.339 Sum_probs=192.4
Q ss_pred cccCcCccceEEEEEee---CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMI---NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
+.||+|+||.||+|... .+..||||.++... ....+++.+|++++.+++||||+++++++ +.+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999864 57789999997642 34456799999999999999999999999 556789999999999
Q ss_pred ChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--ee
Q 041285 528 SLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT--FT 597 (724)
Q Consensus 528 sL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~ 597 (724)
+|.+++..... ..+.++++||.|||+. +|+||||||+|||++.++.+||+|||++.......... ..
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 99999853221 2278999999999998 99999999999999999999999999998775443322 22
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.... .....
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~~------~~~~~ 238 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME------CPPEC 238 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC------CCTTC
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcCC------CCCCc
Confidence 2456889999999988889999999999999999998 999987543221 112222222111 11123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
...+.+++..||+.+|++||++.++++.|+.+
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 45688999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.17 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=194.9
Q ss_pred hhcccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
....+.+.||+|+||.||++.... ...||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 344556889999999999998643 2479999987643 23456799999999999 899999999999999999
Q ss_pred EEEEeeccCCChhhhcCCC-----------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC
Q 041285 518 ILVYEYMSNGSLADVYSSP-----------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY 576 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~-----------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~ 576 (724)
++||||+++|+|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence 9999999999999987421 11 2267999999999998 9999999999999999999
Q ss_pred eEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHH
Q 041285 577 AKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWV 654 (724)
Q Consensus 577 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~ 654 (724)
+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+........ .
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~ 276 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------F 276 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------H
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------H
Confidence 999999999866433322 2233457889999999999999999999999999999998 8888865432221 1
Q ss_pred HHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+... ..+.. ....+.+++..||+.+|.+|||+.||++.|+..
T Consensus 277 ~~~~~~~~~~--~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 YKLVKDGYQM--AQPAF----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHTCCC--CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCC--CCCCC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1222222111 11111 234588899999999999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.31 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=171.0
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.||+|+||.||++... +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999885 5789999998652 3467789999999996 99999999999999999999999999999
Q ss_pred hhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---CeEEccccCccccCCCCcceeecc
Q 041285 530 ADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---YAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 530 ~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++....... .....
T Consensus 94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 169 (325)
T 3kn6_A 94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTP 169 (325)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccccc
Confidence 9988432 21 2378999999999998 999999999999997665 799999999986543322 22335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+..+..... ..........
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~ 246 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE---GEAWKNVSQE 246 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC---SHHHHTSCHH
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC---cccccCCCHH
Confidence 6799999999999999999999999999999999999999764322111111122233333322111 0111123456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+.+++..||+.||++|||++|+++.
T Consensus 247 ~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHCCCChhHCCCHHHHhcC
Confidence 8899999999999999999998743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=314.04 Aligned_cols=235 Identities=25% Similarity=0.321 Sum_probs=189.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345678999999999999875 58899999997532 23446788999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++... .. ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~ 160 (318)
T 1fot_A 88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 160 (318)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence 9999999998432 22 2268999999999998 9999999999999999999999999999875432 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+..+... .+. ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~-~~i~~~~~~---~p~----~~ 226 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY-EKILNAELR---FPP----FF 226 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHCCCC---CCT----TS
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCC---CCC----CC
Confidence 2356899999999999999999999999999999999999999753211 111 222222211 111 12
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
...+.+++..|++.+|++|| +++|+++
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 34588899999999999999 8888873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.88 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=190.1
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc--cceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--SNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 523 (724)
..+.+.||+|+||.||+|+. +++.||||.+... .....++|.+|+.++++++||||+++++++.+. ...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 44568899999999999998 4889999998753 234456799999999999999999999999887 778999999
Q ss_pred ccCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCc--eEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 524 MSNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQ--IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 524 ~~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~--i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+++++|.+++.... . ..+.||++||+|||+. + ++||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 99999999985432 1 1278999999999987 7 99999999999999999999999988764322
Q ss_pred cceeeccccCccccCcccccCCCCCc---ccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITA---KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
....||+.|+|||.+.+...+. ++||||||+++|||++|+.||...... .........+.....
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--- 232 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPTI--- 232 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCCCC---
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCCCC---
Confidence 2245789999999998765444 899999999999999999999754211 111222222211111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.......+.+++..||+.+|++|||+.|+++.|+.+.
T Consensus 233 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 ---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122345889999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.51 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=195.8
Q ss_pred hcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||+|... .++.||||.+.... .....++.+|++++++++|+||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 4455689999999999999865 36789999997532 2334578999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCC-------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 520 VYEYMSNGSLADVYSSP-------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~-------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
||||+++++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999988421 11 2267999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 583 ALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 583 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
|++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ....+..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~ 255 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVME 255 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHHT
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-HHHHHHc
Confidence 999865432221 1122456889999999999999999999999999999999 78887643211 1 1222333
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+..... .......+.+++..||+.+|.+|||+.|+++.|+..+.
T Consensus 256 ~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 322111 11223458889999999999999999999999987644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.48 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=189.2
Q ss_pred cccccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||+|.... +..||||.+.... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 4456889999999999998754 2369999987642 3345679999999999999999999999865 45689999
Q ss_pred eccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+++++|.+++.. ... ..+.++++||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 9999999998843 222 2267999999999998 9999999999999999999999999999876544333
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..+..+.... .+.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~----~~~~~~~~~~--~~~--- 237 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI----GVLEKGDRLP--KPD--- 237 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH----HHHHHTCCCC--CCT---
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH----HHHhcCCCCC--CCC---
Confidence 3334567889999999998999999999999999999998 999986543222 11 1222221111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.....+.+++..||+.+|++||++.|+++.|+.+.
T Consensus 238 -~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 238 -LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 12345889999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.59 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=187.4
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 520 (724)
....+.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|.+++.++ +||||+++++++.+.+..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 34456689999999999999875 4789999999753 223445688999999988 799999999999999999999
Q ss_pred EeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||+++|+|..++.. ... ..+.+|+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~- 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG- 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence 999999999988842 222 2378999999999998 99999999999999999999999999998543222
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... + ..+.+..+.... +..
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~~---p~~-- 246 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEVVY---PTW-- 246 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CTT--
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCC---CCC--
Confidence 2223457899999999999888999999999999999999999999754321 1 122222232211 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSM------KKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~ 703 (724)
....+.+++..||+.+|.+||++ .|+++
T Consensus 247 --~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 --LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 23457889999999999999998 66653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=320.88 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=177.3
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++.... ++.||||++... ...+.+.+|++++.+++||||+++++++.+....++||||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 3456789999999999999864 789999999763 2446788999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|.+++.... +..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 133 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 207 (349)
T 2w4o_A 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM 207 (349)
T ss_dssp CBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--cc
Confidence 99999885432 12278999999999998 9999999999999975 8899999999998654322 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....+........ . ......
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~~~-~--~~~~~~ 278 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYYFI-S--PWWDEV 278 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCCCC-T--TTTTTS
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCccC-C--chhhhC
Confidence 335689999999999999999999999999999999999999965432211 1222222222111 1 111123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.||++|||+.|+++.
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4468899999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.39 Aligned_cols=256 Identities=16% Similarity=0.207 Sum_probs=186.7
Q ss_pred hcccccccCcCccceEEEEEee----CCcEEEEEEcccccch-----------hHHHHHHHHHhhcccCcCceeeeeeEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKMLAE-----------GEREFQTEIKAIGRTHHRNLVRLLGYS 511 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~ 511 (724)
.+.+.+.||+|+||.||++... .+..+|||.+...... ..+.+.+|+..+..++|+||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 4556689999999999999985 4678999988653211 123467788899999999999999999
Q ss_pred ec----ccceEEEEeeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC--CeE
Q 041285 512 FD----VSNKILVYEYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR--YAK 578 (724)
Q Consensus 512 ~~----~~~~~lv~e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~--~~k 578 (724)
.+ ....++||||+ +++|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++ .+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 87 67889999999 99999998642 22 2378999999999998 999999999999998877 999
Q ss_pred EccccCccccCCCCc------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH
Q 041285 579 ISDFALAKLMKPDQT------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 579 l~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~ 652 (724)
|+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-VQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-HHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-HHH
Confidence 999999987643221 1113357899999999999999999999999999999999999999643222111 111
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....... .+...+............+.+++..||+.+|++||++.+|+++|+...
T Consensus 273 -~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 -AKTNLLD-ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHH-TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHhhcc-cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111 111111100000123346889999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.16 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=182.3
Q ss_pred HHHhhcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceE
Q 041285 443 LEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 443 l~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 518 (724)
+....+.+.++||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +|+||+++++++.+....+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34445566689999999999999986 68999999886432 22334555666666655 8999999999999999999
Q ss_pred EEEeeccCCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 519 LVYEYMSNGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+||||+ +++|.+++.. ..+. .+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999 6788887632 2222 378999999999998 999999999999999999999999999987643
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
... .....||+.|+|||++.+ .++.++||||||+++|||++|..++.... ....+..+.....+
T Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~~~--- 273 (311)
T 3p1a_A 210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPPEF--- 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCHHH---
T ss_pred CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCccc---
Confidence 322 233468999999998875 78999999999999999999987664311 11222222221111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+||+.||++|||+.|+++
T Consensus 274 --~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 --TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112356889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.80 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=186.2
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.||+|+||.||++... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999864 6889999999765555567899999999985 799999999999999999999999999999
Q ss_pred hhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCccccCCCCc------
Q 041285 530 ADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALAKLMKPDQT------ 593 (724)
Q Consensus 530 ~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~~~~~~~~~------ 593 (724)
.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 175 (316)
T 2ac3_A 99 LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175 (316)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccc
Confidence 998842 222 2378999999999998 9999999999999988766 99999999976542211
Q ss_pred ceeeccccCccccCcccccC-----CCCCcccceeehhHHHHHhhccccCCCCCCCcchh--------cHHHHHHHHHHc
Q 041285 594 RTFTGIRGTRGYVAPEWHWN-----LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--------ILEEWVYQCFEN 660 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~--------~l~~~~~~~~~~ 660 (724)
.......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+.. .......+.+..
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 255 (316)
T 2ac3_A 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255 (316)
T ss_dssp ------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH
T ss_pred cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc
Confidence 11223458999999999875 45789999999999999999999999765432100 001112222333
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCCCCCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDIPIPPNPT 718 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~~p~~p~ 718 (724)
+...... .........+.+++.+||+.||++|||+.|+++. +.+.......|.|.
T Consensus 256 ~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~ 312 (316)
T 2ac3_A 256 GKYEFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPM 312 (316)
T ss_dssp CCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC------------
T ss_pred cCcccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCcc
Confidence 3221110 0000123468899999999999999999999973 44444344444443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.47 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=191.2
Q ss_pred cccccCcCccceEEEEEeeCC----cEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccce-EEEEee
Q 041285 450 FKEEIGRGSSGTVYKGTMING----KFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK-ILVYEY 523 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e~ 523 (724)
..+.||+|+||.||+|...+. ..||||.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 447899999999999986432 3799999875332 3456799999999999999999999999877665 999999
Q ss_pred ccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc--
Q 041285 524 MSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-- 593 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-- 593 (724)
+.+++|.+++..... ..+.++++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999999854221 2267999999999998 999999999999999999999999999986643321
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......+++.|+|||.+.+..++.++||||||+++|||++|..|+........ + ......+.... .+
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~----~~~~~~~~~~~--~~--- 250 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--L----THFLAQGRRLP--QP--- 250 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--H----HHHHHTTCCCC--CC---
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--H----HHHhhcCCCCC--CC---
Confidence 122235678999999999999999999999999999999997766544332221 1 12222221111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
......+.+++..||+.+|.+|||+.+++++|+.+.
T Consensus 251 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 251 -EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112345889999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=344.56 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=187.7
Q ss_pred cccCcCccceEEEEEee---CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
++||+|+||.||+|.+. .++.||||+++.... ...++|.+|++++.+++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 357899999976432 335789999999999999999999999964 568999999999
Q ss_pred CChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc--ceee
Q 041285 527 GSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFT 597 (724)
Q Consensus 527 gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~--~~~~ 597 (724)
|+|.+++... .+ ..+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 9999998432 22 2378999999999998 999999999999999999999999999987754432 2223
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...+|+.|+|||++....++.++||||||++||||++ |+.||......+ +...+..+..... ....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------p~~~ 597 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC------PAGC 597 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC------CTTC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC------CCCC
Confidence 3456889999999999999999999999999999998 999987543211 2233333322111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...+.+++..||+.+|++||++.+|+++|+.
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 3568899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.51 Aligned_cols=249 Identities=20% Similarity=0.223 Sum_probs=189.9
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEE-ecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS-FDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++.. .+++.||||.+... ...+++.+|++++.+++|++++..++.+ .+....++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 44568899999999999986 46889999987643 2335689999999999988877777666 5566789999999
Q ss_pred CCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 9999998852 122 2278999999999998 99999999999999 78899999999999876543321
Q ss_pred ------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 595 ------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 595 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........................
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV--- 241 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH---
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh---
Confidence 12245789999999999999999999999999999999999999986543322222111111111110000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
........+.+++..||+.+|++||++.+|+++|+..
T Consensus 242 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 242 ---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp ---HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ---hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0011234688999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.14 Aligned_cols=240 Identities=25% Similarity=0.293 Sum_probs=186.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|..++.++ +||||+++++++.+....++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 345678999999999999985 47899999997532 23345688999999988 89999999999999999999999
Q ss_pred eccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
|+++|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~ 166 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 166 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence 9999999988843 222 2268999999999998 99999999999999999999999999998643222 12
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchh--cHHHHHHHHHHcCCccccccccccC
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......+.+..+.... +
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p---- 239 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P---- 239 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC---C----
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC---C----
Confidence 23457899999999999999999999999999999999999999653211100 11112223333332211 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSM 698 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 698 (724)
......+.+++..||+.||.+||++
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1223458889999999999999995
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.34 Aligned_cols=234 Identities=22% Similarity=0.258 Sum_probs=190.3
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999875 58899999986532 234567889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 124 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~----~ 196 (350)
T 1rdq_E 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----W 196 (350)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----C
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc----c
Confidence 99999998843 222 2278999999999998 99999999999999999999999999998764322 2
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+.... +. ...
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~~---p~----~~~ 262 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------Q-IYEKIVSGKVRF---PS----HFS 262 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CT----TCC
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------H-HHHHHHcCCCCC---CC----CCC
Confidence 346899999999999999999999999999999999999999754211 1 122233332211 11 123
Q ss_pred HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
..+.+++..||+.||.+||+ ++||++
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 45889999999999999998 888864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=322.46 Aligned_cols=237 Identities=25% Similarity=0.380 Sum_probs=191.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445688999999999999875 68999999997532 12345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~--~ 172 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--L 172 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--B
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc--c
Confidence 99999999986432 1 2278999999999998 999999999999999999999999999987654322 2
Q ss_pred eccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....+..+.... +...
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~---p~~~--- 239 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIFYT---PQYL--- 239 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCCCC---CTTC---
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCcCC---CccC---
Confidence 33568999999999988765 689999999999999999999997543211 122233332211 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..||+.||++|||+.|+++
T Consensus 240 -s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 -NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 235788999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.58 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=188.5
Q ss_pred cccccccCcCccceEEEEEeeCC----cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEec-ccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMING----KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD-VSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 521 (724)
..+.+.||+|+||.||+|...+. ..+|||.+.... ....+.+.+|+.++++++||||+++++++.+ ....++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 44568899999999999986432 368999987533 2344679999999999999999999999764 45789999
Q ss_pred eeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++++|.+++.... . ..+.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999985422 1 1267999999999998 999999999999999999999999999987654322
Q ss_pred ---ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 594 ---RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 594 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
.......+|+.|+|||.+.+..++.++||||||+++|||++|..|+........ .. .....+.. ...+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~----~~~~~~~~--~~~~~ 255 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT----VYLLQGRR--LLQPE 255 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HH----HHHHTTCC--CCCCT
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HH----HHHhcCCC--CCCCc
Confidence 122335678899999999999999999999999999999995554433222111 11 11222211 11111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
. ....+.+++..||+.+|++|||+.|++++|+.+..
T Consensus 256 ~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 256 Y----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 23458899999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.41 Aligned_cols=236 Identities=24% Similarity=0.339 Sum_probs=186.8
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 34568899999999999997 468899999987532 22235789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+ +|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 91 ~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~--~ 164 (336)
T 3h4j_B 91 A-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--L 164 (336)
T ss_dssp C-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--T
T ss_pred C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--c
Confidence 9 7888887732 222 2378999999999998 999999999999999999999999999987654322 2
Q ss_pred eccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ..+..+ .. ..+..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~---~~----~~p~~ 230 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------KKVNSC---VY----VMPDF 230 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------CCCCSS---CC----CCCTT
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHcC---CC----CCccc
Confidence 33568999999999988776 78999999999999999999999754321110 000000 00 01112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2345789999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.68 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=185.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.++||+|+||+||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 345678999999999999875 47899999987532 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhc-C---CCC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 525 SNGSLADVY-S---SPP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 525 ~~gsL~~~l-~---~~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++ +|.+++ . ... +..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 76 444443 2 111 12378999999999998 99999999999999999999999999998764322 222
Q ss_pred eccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---ccccc---cc
Q 041285 597 TGIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQLI---ED 669 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~---~~ 669 (724)
....||+.|+|||.+.+.. ++.++||||||+++|||++|..|+........ .+.. +.+...... ..... +.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~-i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR-IFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHH-HHHHHCCCCTTTCTTGGGSTTC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH-HHHHhCCCChhhhhhhcccccc
Confidence 3356899999999988766 79999999999999999999988654332211 1111 111111100 00000 00
Q ss_pred ------------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 ------------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..........+.+++..||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0011223456789999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.81 Aligned_cols=240 Identities=26% Similarity=0.334 Sum_probs=184.2
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.+.||+|+||.||++... +++.+|||.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 3556789999999999999875 47899999987643 334578999999999999999999999999999999999999
Q ss_pred cCCChhhhcC-------CCCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCC
Q 041285 525 SNGSLADVYS-------SPPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKP 590 (724)
Q Consensus 525 ~~gsL~~~l~-------~~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~ 590 (724)
++++|.+++. .... ..+.++++||+|||+. +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999998872 2222 2378999999999998 99999999999999 4567899999999986643
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
... .....|++.|+|||.+. ..++.++||||||+++|||++|+.||...... .. ................
T Consensus 180 ~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~-~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 180 DEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EV-QQKATYKEPNYAVECR 249 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCCCCCC--C
T ss_pred ccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HH-HhhhccCCcccccccC
Confidence 322 23356899999999875 56899999999999999999999999754311 11 1111111111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ...+.+++..||+.||++|||+.|+++
T Consensus 250 ~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 250 PL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12 345778999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.98 Aligned_cols=238 Identities=25% Similarity=0.336 Sum_probs=169.3
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 34557899999999999987 468899999986532 12246789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++++|.+++... .. ..+.|+++||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 168 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-K 168 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-c
Confidence 9999999988542 11 2278999999999998 999999999999999999999999999987643222 1
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+......... ... ...... ....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~---~~~~~~----~~~~ 234 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKV---VLADYE----MPSF 234 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C---CSSCCC----CCTT
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHH---hhcccC----Cccc
Confidence 22346899999999999888999999999999999999999999754322110 000 011111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2345789999999999999999999886
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.92 Aligned_cols=238 Identities=24% Similarity=0.309 Sum_probs=189.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||+++.. +++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3445688999999999999985 47899999997632 23445688899999887 9999999999999999999999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+++|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 99999999998843 222 2278999999999998 999999999999999999999999999986432221
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+... .+.
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~---~p~---- 239 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------E-LFHSIRMDNPF---YPR---- 239 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---CCT----
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHhCCCC---CCc----
Confidence 223457899999999999999999999999999999999999999754211 1 11222222211 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMK-KVL 702 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 702 (724)
.....+.+++..||+.+|++||++. +++
T Consensus 240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1234588899999999999999997 664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.14 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=190.7
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEE-ecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYS-FDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++.. .+++.||||.+... ...+++.+|+.++.+++|++++..+.++ .+....++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34567899999999999986 56899999998653 2335789999999999988877666665 4566779999999
Q ss_pred CCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|.+++.. ... ..+.||++||+|||+. +|+||||||+|||+ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9999998852 121 2278999999999998 99999999999999 47889999999999876543321
Q ss_pred ------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 595 ------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 595 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..............+...........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV--- 241 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH---
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH---
Confidence 12345789999999999999999999999999999999999999986443222211111111111110000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
........+.+++..||+.+|++||++.+|++.|+...
T Consensus 242 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 242 ---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 01112345889999999999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.82 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=191.2
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec-----------
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----------- 513 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 513 (724)
..+.+.+.||+|+||.||++... +++.||||.+.... +.+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 34455688999999999999986 68999999987532 467899999999999999999998864
Q ss_pred -----ccceEEEEeeccCCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 514 -----VSNKILVYEYMSNGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 514 -----~~~~~lv~e~~~~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
....++||||+++++|.+++.. ... ..+.||++||.|||+. +|+|+||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEE
Confidence 4457999999999999998842 222 2367999999999998 9999999999999999999999
Q ss_pred ccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH
Q 041285 580 SDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... .. ......
T Consensus 164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~~~~~~ 232 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-FFTDLR 232 (284)
T ss_dssp CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-HHHHHH
T ss_pred Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-HHHHhh
Confidence 99999987654322 22346899999999999999999999999999999999998876321 01 122223
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPI 713 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 713 (724)
.+.+... ....+.+++.+||+.||++||++.|+++.|+....-+.
T Consensus 233 ~~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 233 DGIISDI---------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TTCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccc---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 3322221 12347789999999999999999999999987654443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.54 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=195.1
Q ss_pred hcccccccCcCccceEEEEEe-----eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc--ceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM-----INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--NKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~l 519 (724)
...+.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 345668899999999999984 357899999998765566678999999999999999999999987654 6899
Q ss_pred EEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 520 VYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
||||+++++|.+++... .. ..+.+|++||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999998432 21 2267999999999998 9999999999999999999999999999877544
Q ss_pred Ccce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC---------CcchhcHHHHHHHHHHc
Q 041285 592 QTRT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL---------PEDQVILEEWVYQCFEN 660 (724)
Q Consensus 592 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~---------~~~~~~l~~~~~~~~~~ 660 (724)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.... ............+.+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 3321 122456788999999998889999999999999999999998875321 00000111111122222
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
+.... ........+.+++.+||+.+|++||++.||+++|+.+
T Consensus 279 ~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 279 NGRLP------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp TCCCC------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21111 1112235688999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=301.38 Aligned_cols=240 Identities=24% Similarity=0.295 Sum_probs=191.2
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++.... +..+|+|++........+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 4556889999999999998754 678999999876566678899999999999999999999999999999999999999
Q ss_pred CChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++|.+++.. .. +..+.++++||.|||+. +|+||||||+|||+ +.++.+||+|||++........ .
T Consensus 91 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--~ 165 (277)
T 3f3z_A 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 165 (277)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--B
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--h
Confidence 999887732 22 22378999999999998 99999999999999 7888999999999987654332 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... . ....+..+...... ......
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~---~~~~~~ 234 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------E-VMLKIREGTFTFPE---KDWLNV 234 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCH---HHHTTS
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCCCCc---hhhhcC
Confidence 334689999999988654 899999999999999999999999754321 1 11222222221110 000012
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..|++.+|++||++.|+++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 356889999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.32 Aligned_cols=238 Identities=23% Similarity=0.269 Sum_probs=180.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 345678999999999999874 5889999999753 223345688999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++++|.+++.. ... ..+.||++||+|||+ . +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 230 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 305 (446)
T 4ejn_A 230 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 305 (446)
T ss_dssp CSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cc
Confidence 999999988842 222 226799999999997 6 89999999999999999999999999998643322 22
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+...... .+. .
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~---~p~----~ 371 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K-LFELILMEEIR---FPR----T 371 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---CCT----T
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHHhCCCC---CCc----c
Confidence 33467999999999999999999999999999999999999999654211 1 11222222211 111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
....+.+++..||+.||.+|| +++|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 234588999999999999999 9999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.32 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=177.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34578999999999999875 48899999987533 2234678999999999999999999999999999999999998
Q ss_pred CChhhhcCC---------CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 527 GSLADVYSS---------PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 527 gsL~~~l~~---------~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
++|.+++.. .... .+.||++||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 589887732 1111 256999999999998 999999999999999999999999999987643221
Q ss_pred ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---cccc---
Q 041285 594 RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQL--- 666 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~--- 666 (724)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. + ..+.+...... ....
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 164 -TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--L-KLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp -CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCSCCTTTCGGGGGC
T ss_pred -cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCChhHhhhhhhh
Confidence 22335689999999998764 689999999999999999999999975432211 1 11111111000 0000
Q ss_pred ------ccc-----------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 ------IED-----------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ------~~~-----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.. ..........+.+++..||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 0000112346889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.42 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=192.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccch------hHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE------GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||++... +++.||||.+...... ..+++.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3556789999999999999875 5889999998753221 35679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----CeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----YAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~ 588 (724)
||||+++++|.+++.... +..+.|+++||.|||+. +|+||||||+|||++.++ .+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999985422 12378999999999998 999999999999999887 7999999999876
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+...... .+
T Consensus 170 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~i~~~~~~--~~ 238 (321)
T 2a2a_A 170 EDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANITSVSYD--FD 238 (321)
T ss_dssp CTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHTTCCC--CC
T ss_pred Ccccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhcccc--cC
Confidence 54322 23356899999999999999999999999999999999999999653211 111 122222111 00
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+ .........+.+++..||+.||++|||+.|+++
T Consensus 239 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 E-EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp H-HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred h-hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000112345889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.58 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=183.5
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccC--cCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTH--HRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4456889999999999999888999999998643 2344568999999999996 5999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-e
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-T 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 595 (724)
+.+++|.+++... . ...+.||++||.|||+. +|+||||||+|||++ ++.+||+|||+++.+...... .
T Consensus 137 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 5688999988432 1 12378999999999998 999999999999995 578999999999876543322 2
Q ss_pred eeccccCccccCcccccC-----------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 596 FTGIRGTRGYVAPEWHWN-----------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..... +......
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~-~~~~~~~ 286 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA-IIDPNHE 286 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH-HHCTTSC
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH-HhCcccc
Confidence 234579999999999865 368899999999999999999999997543211 11111 1121111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... +... ...+.+++..||+.||.+||++.|+++.
T Consensus 287 ~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IEF-PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCC-CCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-Cccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 1111 3457889999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.95 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=195.1
Q ss_pred hcccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEeccc-ce
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVS-NK 517 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 517 (724)
.+.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 3445688999999999999852 457999999976432 3346799999999999 7999999999988755 48
Q ss_pred EEEEeeccCCChhhhcCCCCc-----------------------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC
Q 041285 518 ILVYEYMSNGSLADVYSSPPK-----------------------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN 574 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~~-----------------------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~ 574 (724)
++||||+++++|.+++..... ..+.||++||.|||+. +|+||||||+|||++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 999999999999999854321 1267999999999998 99999999999999999
Q ss_pred CCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHH
Q 041285 575 RYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~ 652 (724)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----- 259 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 259 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-----
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-----
Confidence 99999999999876544332 2233567899999999999999999999999999999998 9999865432221
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
....+..+..... +. .....+.+++..||+.+|.+|||+.|+++.|+.++
T Consensus 260 -~~~~~~~~~~~~~--~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 260 -FCRRLKEGTRMRA--PD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp -HHHHHHHTCCCCC--CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHhccCccCCC--CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122222221111 11 12345888999999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.98 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=181.5
Q ss_pred cccccccCcCccceEEEEEeeC----CcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccc-----
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN----- 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 516 (724)
+.+.+.||+|+||.||+|.... ++.||||.+... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 3455789999999999998753 358999998753 23344679999999999999999999999987653
Q ss_pred eEEEEeeccCCChhhhcCC---------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcccc
Q 041285 517 KILVYEYMSNGSLADVYSS---------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFA 583 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~---------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfg 583 (724)
.++|+||+++++|.+++.. ... ..+.+|++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 4999999999999998721 111 2278999999999998 99999999999999999999999999
Q ss_pred CccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 584 LAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 584 l~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... . ......+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 265 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M----YDYLLHG 265 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H----HHHHHcC
Confidence 9987643322 22223457889999999999999999999999999999999 788876543221 1 1222222
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..... + ......+.+++..||+.+|++||++.++++.|+...
T Consensus 266 ~~~~~--~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 266 HRLKQ--P----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CCCCC--B----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC--C----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1 122346889999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.30 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=190.6
Q ss_pred ccccc-ccCcCccceEEEEEee---CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKE-EIGRGSSGTVYKGTMI---NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.+.+ .||+|+||.||++... .++.||||.+.... ....+++.+|++++++++||||+++++++ +.+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 34445 8999999999999653 35789999987532 22356799999999999999999999999 567789999
Q ss_pred eeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+++++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999999988432 21 2378999999999998 9999999999999999999999999999877544332
Q ss_pred e--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 595 T--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 595 ~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ....+..+....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------ 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG------ 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence 2 122456789999999988889999999999999999999 999987543211 122233332111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
........+.+++..||+.+|++||++.+++++|+..
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112345688999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.53 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=186.4
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.. .+++.||||++... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 45668899999999999987 46899999998742 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 524 MSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 524 ~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+++++|.+++.. ... ..+.+|++||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999988742 111 2378999999999998 99999999999999999999999999998654332
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ....+..+.......
T Consensus 191 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~~~~~~---- 260 (310)
T 2wqm_A 191 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCDYPPLPS---- 260 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH-HHHHHHTTCSCCCCT----
T ss_pred c-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH-HHHHhhcccCCCCcc----
Confidence 2 1223468999999999999999999999999999999999999986532211 11 112233332222111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 712 (724)
......+.+++.+||+.||++||++.+|+++|+.+....
T Consensus 261 -~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 261 -DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 122345889999999999999999999999998764433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.67 Aligned_cols=239 Identities=22% Similarity=0.254 Sum_probs=180.5
Q ss_pred hcccccccCcCccceEEEEEe----eCCcEEEEEEccccc----chhHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM----INGKFVAVKRLQKML----AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
.+.+.+.||+|+||.||++.. .+++.||||+++... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 345668899999999999987 368899999987532 223456889999999999999999999999999999
Q ss_pred EEEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+||||+++++|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999988843 122 2367999999999998 9999999999999999999999999999754322
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+......
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-~~i~~~~~~------- 239 (327)
T 3a62_A 175 GT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTI-DKILKCKLN------- 239 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHHTCCC-------
T ss_pred Cc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhCCCC-------
Confidence 21 223356899999999999999999999999999999999999999754211 111 122222111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
........+.+++.+||+.+|++|| ++.|+++
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0111234588899999999999999 7778765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.71 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=185.7
Q ss_pred cccccccCcCccceEEEEEee-CCc----EEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGK----FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.+.+.||+|+||.||++... +++ .||+|.+... .....+++.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 345678999999999999864 344 4678877543 2345678999999999999999999999998754 88999
Q ss_pred eeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++|+|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999988432 11 2378999999999998 999999999999999999999999999987654332
Q ss_pred -ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+.... .+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~~--~~-- 241 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERLP--QP-- 241 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCCC--CC--
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCC--CC--
Confidence 22233457889999999999999999999999999999999 999987643322 1 12222221111 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
......+.+++..||+.+|.+||++.|+++.|+....
T Consensus 242 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 242 --PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1123458889999999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.80 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=190.1
Q ss_pred hcccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEe----cccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF----DVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~ 521 (724)
.+.+.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++. .....++|+
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 345668899999999999987 468999999987655566678999999999999999999999987 345789999
Q ss_pred eeccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 522 EYMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 522 e~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
||+++++|.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999988743 121 2378999999999998 999999999999999999999999999876532
Q ss_pred CCcc--------eeeccccCccccCcccccCCC---CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH
Q 041285 591 DQTR--------TFTGIRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659 (724)
Q Consensus 591 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 659 (724)
.... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||........ .. .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~ 261 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV----ALAVQ 261 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH----HHHHH
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh----hHHhh
Confidence 1110 011245799999999987654 68899999999999999999999853111000 11 11111
Q ss_pred cCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 660 NGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.. .. ... .......+.+++..||+.||.+||++.|+++.|+....
T Consensus 262 ~~-~~-~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQ-LS-IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cc-CC-CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11 10 000 11223468899999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.35 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=189.6
Q ss_pred hcccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||++.... ++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 34456889999999999999864 7899999997532 23446788999999988 8999999999999999999999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+++|+|.+++.. ... ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc-
Confidence 99999999998843 222 2378999999999998 999999999999999999999999999986432221
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+.+..+.... +.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~~---p~---- 242 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHNVAY---PK---- 242 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CT----
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCCCCC---CC----
Confidence 223457899999999999999999999999999999999999999753211 1 112222222211 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
.....+.+++..||+.+|.+||+ ++|+++
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 22345888999999999999995 466653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.92 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=181.1
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 3456689999999999999886 58899999997542 334678999999999999999999999999999999999999
Q ss_pred CCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC--eEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY--AKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~--~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++. +||+|||+++...... ..
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence 9999988732 222 2378999999999998 9999999999999987765 9999999997433221 12
Q ss_pred eccccCccccCcccccCCCCCcc-cceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAK-ADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....||+.|+|||.+.+..+..+ +||||||+++|||++|+.||........ ....... +........ ... .
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~-~~~~~~~~~-~~~----~ 246 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQR-ILSVKYSIP-DDI----R 246 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHH-HHTTCCCCC-TTS----C
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHH-HhcCCCCCC-CcC----C
Confidence 23468999999999988887665 8999999999999999999976433221 1121222 111111110 000 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+||+.+|++|||+.|+++.
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 23457899999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=300.71 Aligned_cols=242 Identities=27% Similarity=0.339 Sum_probs=191.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 455688999999999999875 58899999986532 2345679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ceee
Q 041285 526 NGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~ 597 (724)
+++|.+++.... +..+.++++||.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 999999986431 12278999999999998 999999999999999999999999999986543222 1223
Q ss_pred ccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. ..+..... ..... ...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~-~~~~~----~~~ 234 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKT-YLNPW----KKI 234 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCT-TSTTG----GGS
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhccc-ccCch----hhc
Confidence 4568999999999987765 7799999999999999999999976543221 11 11111111 00001 112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..||+.||++|||+.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 345788999999999999999999886
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=296.90 Aligned_cols=210 Identities=20% Similarity=0.339 Sum_probs=162.1
Q ss_pred CCcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEE-----EeecCCcC----------CCc-----eeEEEE--
Q 041285 3 GHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYV-----GVFLAGIP----------EKN-----VGRIVL-- 60 (724)
Q Consensus 3 ~~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~yl-----giW~~~~~----------~~t-----~g~l~l-- 60 (724)
+.++|++|++|+. +++|||++|+|+||||+++ ++|| -||..+-. ..+ .|+|+|
T Consensus 13 ~~~~l~~g~~l~~--~~~l~S~~g~F~lgf~~~~---~~~ly~~~~vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~ 87 (276)
T 3m7h_A 13 GTSVLPAYQTLSA--GQYLLSPNQRFKLLLQGDG---NLVIQDNGATVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFL 87 (276)
T ss_dssp TSSEECTTEEBCT--TCEEECTTSSEEEEECTTS---CEEEEETTEEEEECSTTSTTEEEEECCCTTCCSEEEESSSEEE
T ss_pred cCCEecCCCEecC--CCEEEcCCCcEEEEEECCC---CeEEECCCCeEEECCCCCCcCCcccccceEEEEeCCCcEEEEE
Confidence 4689999999976 6799999999999999433 4555 37776532 112 188988
Q ss_pred eecCCCCeeEecCCCC-------cceEEEecCCccEEEEeCCCceEEeecCCCcccccccCc----cccCCeeccCCCCC
Q 041285 61 RSTEQGQDSIIADDSQ-------SASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQR----LLAGMELFPGISKT 129 (724)
Q Consensus 61 ~~~~~~~~~~~~~~~~-------~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~----l~~~~~L~s~~s~~ 129 (724)
. ++++.++|+++++. ++.+|+|+|+|||||+| +.+|||| ||||||||||| |..|.+| ++.+
T Consensus 88 ~-~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L---~S~~ 159 (276)
T 3m7h_A 88 D-DYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL---VQGV 159 (276)
T ss_dssp E-EGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE---CTTC
T ss_pred e-CCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc---ccCC
Confidence 5 56788999998754 23489999999999998 7899999 99999999999 7778888 4578
Q ss_pred CCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEEcCCcceeeccccCCCCCCcceEE
Q 041285 130 DPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYL 209 (724)
Q Consensus 130 dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (724)
||++|.|++++|++|+++++. .. ...||++++++... ..+.++.+|.+++++.++..+...... ....+|
T Consensus 160 dps~G~fsl~l~~dGnlvLy~-~~----~~~yW~Sgt~~~~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~----~~~~~r 229 (276)
T 3m7h_A 160 VYGAGASKLVFQGDGNLVAYG-PN----GAATWNAGTQGKGA-VRAVFQGDGNLVVYGAGNAVLWHSHTG----GHASAV 229 (276)
T ss_dssp EEEETTEEEEECTTSCEEEEC-TT----SSEEEECCCTTTTC-CEEEECTTSCEEEECTTSCEEEECSCT----TCTTCE
T ss_pred CCCCceEEEeecCCceEEEEe-CC----CeEEEECCCCCCcc-EEEEEcCCCeEEEEeCCCcEEEEecCC----CCCCEE
Confidence 999999999999999877652 21 36799998887654 678889999999887655333322221 122479
Q ss_pred EEEccCCcEEEEEEecCCCCCceeEEecccC
Q 041285 210 MKIDSDGIFRLYSYNLRRQNSTWQVLWESTN 240 (724)
Q Consensus 210 ~~l~~dG~l~~~~~~~~~~~~~W~~~~~~p~ 240 (724)
++|+.||+|++|.|. ..|..++.+|+
T Consensus 230 l~Ld~dGnLvly~~~-----~~Wqsf~~~P~ 255 (276)
T 3m7h_A 230 LRLQANGSIAILDEK-----PVWARFGFQPT 255 (276)
T ss_dssp EEECTTSCEEEEEEE-----EEEESSSCCTT
T ss_pred EEEcCCccEEEEcCC-----CeEEccCccCC
Confidence 999999999999982 25777776665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=317.97 Aligned_cols=241 Identities=22% Similarity=0.326 Sum_probs=181.8
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCc--CceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHH--RNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+....++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 4456889999999999999888999999998643 23344679999999999976 999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-e
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-T 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 595 (724)
+.+++|.+++... . ...+.||++||.|||+. +|+||||||+|||++ ++.+||+|||+++........ .
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 90 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 5688999988432 1 12378999999999998 999999999999997 578999999999876544332 2
Q ss_pred eeccccCccccCcccccC-----------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 596 FTGIRGTRGYVAPEWHWN-----------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....... .....
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~-~~~~~ 239 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-DPNHE 239 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH-CTTSC
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHHHh-cCCcc
Confidence 234579999999999864 678899999999999999999999997533211 1111111 11111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... +.. ....+.+++..||+.||.+|||+.|+++.
T Consensus 240 ~~~-~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 IEF-PDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCC-CCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC-ccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111 111 12457889999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.22 Aligned_cols=235 Identities=26% Similarity=0.288 Sum_probs=177.9
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHh-hcccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKA-IGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||+++... ++.||||+++... ....+.+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 4456899999999999998864 7899999997642 2233456777776 577899999999999999999999999
Q ss_pred eccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
|+++|+|.+++.. ... ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 120 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~ 195 (373)
T 2r5t_A 120 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-ST 195 (373)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-Cc
Confidence 9999999988843 221 2378999999999998 99999999999999999999999999998643221 12
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... + ..+.+..+.+.. +. .
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~~---~~----~ 261 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------E-MYDNILNKPLQL---KP----N 261 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------H-HHHHHHHSCCCC---CS----S
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhcccCC---CC----C
Confidence 23457899999999999999999999999999999999999999753211 1 112222222111 11 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
....+.+++..||+.||.+||++.+
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 2345788999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.49 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=198.9
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEeccc--ceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS--NKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 4456889999999999998864 8899999997533 334567889999999999999999999998765 67999999
Q ss_pred ccCCChhhhcCCCC------c----chHHHHHHHcccccccCCCceEeCCCCCCCeee----CCCCCeEEccccCccccC
Q 041285 524 MSNGSLADVYSSPP------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILM----DENRYAKISDFALAKLMK 589 (724)
Q Consensus 524 ~~~gsL~~~l~~~~------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll----~~~~~~kl~Dfgl~~~~~ 589 (724)
+++++|.+++.... . ..+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999986532 1 1277999999999998 99999999999999 777889999999998765
Q ss_pred CCCcceeeccccCccccCcccccC--------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWN--------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
.... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+....... +
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~-~ 242 (396)
T 4eut_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT-G 242 (396)
T ss_dssp CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH-S
T ss_pred CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc-C
Confidence 4322 233568999999998865 45678999999999999999999999754322111 111222222 2
Q ss_pred Cccccc------------------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 662 NLGQLI------------------EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 662 ~~~~~~------------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
.....+ ............+.+++..||+.||++||++.|+++.|+.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111100 01123466778899999999999999999999999998876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.89 Aligned_cols=249 Identities=25% Similarity=0.299 Sum_probs=181.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 518 (724)
+.+.+.||+|+||.||++... .++.||||++... .....+++.+|+.++++++||||+++++++... .+.+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 345578999999999999864 5889999999753 233456788999999999999999999999654 3569
Q ss_pred EEEeeccCCChhhhcC-CCCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYS-SPPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~-~~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||++++ |.+.+. ..... .+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 144 lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 218 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 218 (464)
T ss_dssp EEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC-
T ss_pred EEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc-
Confidence 999999765 555443 33322 378999999999998 99999999999999999999999999998764322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH------------------H
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV------------------Y 655 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~------------------~ 655 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. +...+ .
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 219 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred -ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHcchhhh
Confidence 23345789999999999999999999999999999999999999976432111 11100 0
Q ss_pred HHHHcC-Ccc-----cccccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 656 QCFENG-NLG-----QLIEDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 656 ~~~~~~-~~~-----~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...... ... ...... .........+.+++.+||+.||++|||++|+++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 000000 0111225678999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.95 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=185.8
Q ss_pred HhhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccc-----hhHHHHHHHHHhhcccC---cCceeeeeeEEeccc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLA-----EGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVS 515 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 515 (724)
...+.+.++||+|+||+||++.. .+++.||||++..... .....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 34455678999999999999986 4588999999874321 11346777888777764 999999999998754
Q ss_pred -----ceEEEEeeccCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEcc
Q 041285 516 -----NKILVYEYMSNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISD 581 (724)
Q Consensus 516 -----~~~lv~e~~~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~D 581 (724)
..++||||+. ++|.+++.... . ..+.||++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4799999997 59998885432 1 2278999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 582 FALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 582 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+.. +.+.....
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-i~~~~~~~ 238 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK-IFDLIGLP 238 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHH-HHHHHCCC
T ss_pred CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCC
Confidence 999986643322 234578999999999999999999999999999999999999997543221 1111 11111110
Q ss_pred C---ccccc-------ccc------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 N---LGQLI-------EDE------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 ~---~~~~~-------~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ..... .+. ....+....+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 00000 000 001123456889999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.53 Aligned_cols=236 Identities=27% Similarity=0.351 Sum_probs=185.1
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
....+.||+|+||.||++.. .+++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 34457899999999999986 468899999986432 23345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 524 MSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++ |+|.+++.. ..+ ..+.++++||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 97 677776631 222 2367999999999998 9999999999999999999999999999865432
Q ss_pred eeccccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 596 FTGIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
....||+.|+|||.+. ...++.++||||||+++|||++|+.|+...... .......... ..... .
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~~~~~-~--- 275 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPALQ-S--- 275 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCC-C---
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCCC-C---
Confidence 2346899999999884 567899999999999999999999998653211 1112222221 11111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
......+.+++..||+.+|++|||+.++++.
T Consensus 276 -~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 -GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1123457889999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.37 Aligned_cols=187 Identities=28% Similarity=0.392 Sum_probs=159.6
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-----cCceeeeeeEEecccceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-----HRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lv 520 (724)
.+.+.++||+|+||.||++... +++.||||++... ....+.+..|++++.+++ |+||+++++++...+..++|
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 3445589999999999999874 5789999999753 344466788999998886 99999999999999999999
Q ss_pred EeeccCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC------------------
Q 041285 521 YEYMSNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE------------------ 573 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~------------------ 573 (724)
|||+ +++|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 999999884322 1 2278999999999998 9999999999999975
Q ss_pred -------CCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCC
Q 041285 574 -------NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQN 642 (724)
Q Consensus 574 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~ 642 (724)
++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7889999999998654322 2356899999999999999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.75 Aligned_cols=232 Identities=22% Similarity=0.280 Sum_probs=186.9
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 518 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 445578999999999999864 57899999987532 123346888999999999999999999999999999
Q ss_pred EEEeeccCC-ChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 519 LVYEYMSNG-SLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 519 lv~e~~~~g-sL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
+||||+.+| +|.+++.... . ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999777 9998885431 1 2378999999999998 999999999999999999999999999987654
Q ss_pred CCcceeeccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... . ... ...+
T Consensus 183 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~-~~~---~~~~ 244 (335)
T 3dls_A 183 GKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V-EAA---IHPP 244 (335)
T ss_dssp TCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T-TTC---CCCS
T ss_pred CCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H-hhc---cCCC
Confidence 332 223568999999999988876 78999999999999999999998642110 0 000 0011
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.. ....+.+++..||+.+|++|||+.|+++.
T Consensus 245 ~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 245 YL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 23458889999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=320.04 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=179.8
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEccccc--------chhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
..+.+.+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 44566789999999999999875 47899999986531 1122358899999999999999999999754 45
Q ss_pred eEEEEeeccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCcc
Q 041285 517 KILVYEYMSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAK 586 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~ 586 (724)
.++||||+++++|.+++.... . ..+.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 799999999999999885422 1 2268999999999998 99999999999999754 459999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ + ...+..+..
T Consensus 291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~i~~~~~ 362 (419)
T 3i6u_A 291 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQITSGKY 362 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHHHHTTCC
T ss_pred ecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHHHhcCCC
Confidence 765322 2234568999999999864 5678899999999999999999999975432221 1 122233322
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..... ........+.+++.+||+.||++||++.|+++
T Consensus 363 ~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NFIPE---VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCch---hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11100 00112356889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=328.75 Aligned_cols=240 Identities=27% Similarity=0.302 Sum_probs=191.8
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++... +|+.||||++... .......+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999875 5899999999753 2234567889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCCC-----cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 525 SNGSLADVYSSPP-----KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 525 ~~gsL~~~l~~~~-----~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
++|+|.+++.... .. .+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~-- 341 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc--
Confidence 9999998884321 11 267999999999998 999999999999999999999999999987654332
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ... +...+...... ....
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~-i~~~i~~~~~~-------~p~~ 411 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE-VERLVKEVPEE-------YSER 411 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHH-HHHHHHHCCCC-------CCTT
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHH-HHHHhhccccc-------CCcc
Confidence 2335799999999999998999999999999999999999999976532211 111 12222222111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
....+.+++..||+.||.+|| ++.||++
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 234688899999999999999 7888874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.52 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=189.3
Q ss_pred cccccccCcCccceEEEEEee-CCcE--EEEEEcccc-cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKF--VAVKRLQKM-LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.||+|+||.||++... ++.. +|||.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 446688999999999999875 4554 599988753 233456799999999999 99999999999999999999999
Q ss_pred eccCCChhhhcCCCC-----------------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEE
Q 041285 523 YMSNGSLADVYSSPP-----------------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKI 579 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~-----------------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl 579 (724)
|+++++|.+++.... +..+.||++||.|||+. +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999985432 12278999999999998 9999999999999999999999
Q ss_pred ccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHH
Q 041285 580 SDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 580 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~~~~ 254 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKL 254 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHG
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------H-HHHHh
Confidence 999998743211 11122356889999999988889999999999999999998 99998654211 1 12222
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
..+.... ........+.+++.+||+.+|++||++.|+++.|+...+
T Consensus 255 ~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 255 PQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GGTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2221111 111223458899999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.76 Aligned_cols=237 Identities=28% Similarity=0.374 Sum_probs=185.4
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec----ccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----VSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 521 (724)
.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45568999999999999875 4679999998753 23345679999999999999999999999875 35689999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCc--eEeCCCCCCCeeeC-CCCCeEEccccCccccCCC
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQ--IIHCDIKPQNILMD-ENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~--i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~ 591 (724)
||+++++|.+++.. ... ..+.+|+.||.|||+. + |+||||||+|||++ .++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999999843 222 2378999999999998 6 99999999999997 7899999999999765433
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. ....|++.|+|||.+. ..++.++||||||+++|||++|+.||........ .......+......+.
T Consensus 186 ~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~-- 253 (290)
T 1t4h_A 186 FA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDK-- 253 (290)
T ss_dssp SB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGGGG--
T ss_pred cc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCccccCC--
Confidence 22 2346899999999876 4589999999999999999999999975432211 1222222222211111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++..||+.+|.+|||+.|+++
T Consensus 254 ---~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 254 ---VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11245889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=321.33 Aligned_cols=251 Identities=15% Similarity=0.192 Sum_probs=191.0
Q ss_pred hcccccccCcCccceEEEEEeeC---------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceee-----------
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN---------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVR----------- 506 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 506 (724)
.+.+.+.||+|+||.||++.... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34456889999999999998864 789999998753 46889999999999999988
Q ss_pred ----eeeEEec-ccceEEEEeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 507 ----LLGYSFD-VSNKILVYEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 507 ----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
+++++.. ....++||||+ +++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 6677765 67889999999 99999998532 21 2278999999999998 999999999999999
Q ss_pred CCC--CeEEccccCccccCCCCcc------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCC
Q 041285 573 ENR--YAKISDFALAKLMKPDQTR------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLP 644 (724)
Q Consensus 573 ~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~ 644 (724)
.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 8999999999876432211 11234789999999999999999999999999999999999999976542
Q ss_pred cchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 645 EDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 645 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.... +...... +. .....+.+...........+.+++..||+.||++||++.+|+++|+.+.
T Consensus 274 ~~~~-~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 274 NTED-IMKQKQK-FV-DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CHHH-HHHHHHH-HH-HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHH-HHHHHHh-cc-CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 2211 1111111 11 1112222211111112355889999999999999999999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.27 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=191.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchh-----------------HHHHHHHHHhhcccCcCceeeeeeE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEG-----------------EREFQTEIKAIGRTHHRNLVRLLGY 510 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~g~ 510 (724)
+.+.+.||+|+||.||++.. +++.||||.+....... .+.+.+|++++.+++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34567899999999999998 89999999987532211 1789999999999999999999999
Q ss_pred EecccceEEEEeeccCCChhhh------cCCC-----Cc----chHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCC
Q 041285 511 SFDVSNKILVYEYMSNGSLADV------YSSP-----PK----NNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDEN 574 (724)
Q Consensus 511 ~~~~~~~~lv~e~~~~gsL~~~------l~~~-----~~----~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~ 574 (724)
+.+.+..++||||+++++|.++ +... .. ..+.||+.||.|||+ . +|+||||||+|||++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence 9999999999999999999998 5431 11 226899999999998 7 99999999999999999
Q ss_pred CCeEEccccCccccCCCCcceeeccccCccccCcccccCC-CCCc-ccceeehhHHHHHhhccccCCCCCCCcchhcHHH
Q 041285 575 RYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL-PITA-KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~ 652 (724)
+.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----- 260 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE----- 260 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-----
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----
Confidence 99999999999876433 23345689999999999887 5666 99999999999999999999976443211
Q ss_pred HHHHHHHcCCcccccccc------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 653 WVYQCFENGNLGQLIEDE------------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+..+......+.. .........+.+++.+||+.||.+||++.|+++
T Consensus 261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12223333222111100 000223456889999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=302.39 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=190.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 345678999999999999875 47899999986532 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCccccCCCCcc
Q 041285 525 SNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALAKLMKPDQTR 594 (724)
Q Consensus 525 ~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~~~~~~~~~~ 594 (724)
++++|.+++.. .. +..+.+++.||.|||+. +|+||||||+||+++.++. +||+|||++........
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~- 163 (284)
T 3kk8_A 88 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163 (284)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB-
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc-
Confidence 99999887632 22 22378999999999998 9999999999999986655 99999999987653322
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+..+........ ..
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~-~~~~~~~~~~~~~~~~---~~ 232 (284)
T 3kk8_A 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAYDYPSPE---WD 232 (284)
T ss_dssp -CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCCCTTT---TT
T ss_pred -ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------H-HHHHHHhccccCCchh---hc
Confidence 23356899999999999999999999999999999999999999653211 1 1122222322211111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++..||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22345889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.79 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=190.6
Q ss_pred HhhcccccccCcCccceEEEEEee------CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccce
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 517 (724)
...+.+.+.||+|+||.||++... +++.||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 344556789999999999999842 4678999999643 234556799999999999999999999999999999
Q ss_pred EEEEeeccCCChhhhcCCCC--------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEc
Q 041285 518 ILVYEYMSNGSLADVYSSPP--------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKIS 580 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~ 580 (724)
++||||+++++|.+++.... +..+.+|++||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999984321 12267999999999998 9999999999999984 4569999
Q ss_pred cccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHH
Q 041285 581 DFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCF 658 (724)
Q Consensus 581 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 658 (724)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ....+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~-~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------H-HHHHH
Confidence 9999976533222 22233567899999999999999999999999999999998 88888653211 1 12222
Q ss_pred HcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
..+..... .......+.+++..||+.+|.+||++.++++.|+..
T Consensus 259 ~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22221111 112234588899999999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.72 Aligned_cols=227 Identities=13% Similarity=0.141 Sum_probs=175.6
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEcccc---cchhHHHHHHHH---HhhcccCcCceeeee-------eEEeccc
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKM---LAEGEREFQTEI---KAIGRTHHRNLVRLL-------GYSFDVS 515 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~~~ 515 (724)
+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+ +.+++++|||||+++ +++.+.+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 457899999999999997 45899999998742 234457899999 666667899999998 5555443
Q ss_pred -----------------ceEEEEeeccCCChhhhcCC---CC-----------cchHHHHHHHcccccccCCCceEeCCC
Q 041285 516 -----------------NKILVYEYMSNGSLADVYSS---PP-----------KNNLIGIARGILYLHDECESQIIHCDI 564 (724)
Q Consensus 516 -----------------~~~lv~e~~~~gsL~~~l~~---~~-----------~~~~~~ia~~l~yLH~~~~~~i~H~dl 564 (724)
..++||||+ +|+|.+++.. .. +..+.||++||+|||+. +|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 278999999 6899998842 11 12378999999999998 9999999
Q ss_pred CCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCC-----------CCCcccceeehhHHHHHhh
Q 041285 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL-----------PITAKADVYSFGVVLLEII 633 (724)
Q Consensus 565 k~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvll~ell 633 (724)
||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++||||||+++|||+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999986432 2334567 999999999887 8999999999999999999
Q ss_pred ccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 634 CCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 634 tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+|+.||........ ...+.... ......+.+++.+||+.||++||++.|+++
T Consensus 308 tg~~Pf~~~~~~~~---------------~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 308 CADLPITKDAALGG---------------SEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HSSCCC------CC---------------SGGGGSSC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HCCCCCcccccccc---------------hhhhhhhc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999865332111 11111100 111345888999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=315.43 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=177.6
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccC-cCceeeeeeEEeccc--ceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVS--NKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lv 520 (724)
.+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 4456689999999999999874 5889999998643 2344567889999999997 999999999997544 68999
Q ss_pred EeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC---
Q 041285 521 YEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD--- 591 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~--- 591 (724)
|||++ ++|..++..... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 90 FDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred ecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99997 588888753221 2267999999999998 9999999999999999999999999999865321
Q ss_pred -----------------CcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH
Q 041285 592 -----------------QTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW 653 (724)
Q Consensus 592 -----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~ 653 (724)
.........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i 243 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ--LERI 243 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence 1112233579999999999876 6789999999999999999999999975432111 1110
Q ss_pred HHHHHHcCC-----------------------------ccccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCC
Q 041285 654 VYQCFENGN-----------------------------LGQLIED-------EDVDKKQLERMIKVALWCILDEPSLRPS 697 (724)
Q Consensus 654 ~~~~~~~~~-----------------------------~~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 697 (724)
........ ....... ..........+.+++.+||+.||++|||
T Consensus 244 -~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 244 -IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp -HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred -HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 01000000 0000000 0000012346889999999999999999
Q ss_pred HHHHHHH
Q 041285 698 MKKVLLM 704 (724)
Q Consensus 698 ~~evl~~ 704 (724)
+.|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.15 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=189.8
Q ss_pred HHHHhhcccc-cccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhccc-CcCceeeeeeEEecccc
Q 041285 442 ELEKMTDGFK-EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 442 el~~~t~~f~-~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 516 (724)
+.....+.+. +.||+|+||.||++... +++.||||.+.... .....++.+|+.++.++ +||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3333344444 78999999999999875 48899999987532 23356889999999999 57999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccC
Q 041285 517 KILVYEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFAL 584 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl 584 (724)
.++||||+++++|.+++... .. ..+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999998432 11 2278999999999998 9999999999999987 78999999999
Q ss_pred ccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 585 AKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
+........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+......
T Consensus 181 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~ 251 (327)
T 3lm5_A 181 SRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-------TYLNISQVNVD 251 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC
T ss_pred ccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHHHhcccc
Confidence 987643322 233568999999999999999999999999999999999999996543211 11111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... .........+.+++..||+.+|++|||++|+++.
T Consensus 252 ~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 YSE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111 1111233458889999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=306.60 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=184.9
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|+||.||++.... ++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 3456789999999999999854 88999998865322 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++... .. ..+.++++||+|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 160 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence 999998887432 22 2367999999999998 999999999999999999999999999987653322 123
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH--------HHHHHcCCc---cc
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV--------YQCFENGNL---GQ 665 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~---~~ 665 (724)
...|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ......... ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 3468999999999876 56899999999999999999999999764322211110000 000000000 00
Q ss_pred ccccccc------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 666 LIEDEDV------DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 666 ~~~~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..++... .......+.+++..||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0011000 1123455889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.92 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=180.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccch-hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++... +++.||||++...... ....+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 345678999999999999875 5889999998753222 22356689999999999999999999999999999999997
Q ss_pred CCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++|.+++... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYD 158 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccc
Confidence 5888877422 11 2267999999999998 99999999999999999999999999998654322 2223
Q ss_pred ccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccccccccc---
Q 041285 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQLIEDE--- 670 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~~~--- 670 (724)
...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+....... .........
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchhhc
Confidence 3467999999999876 5689999999999999999999999976432211 11111111110 011110000
Q ss_pred -------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 671 -------------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 671 -------------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++..||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 001112356789999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.13 Aligned_cols=245 Identities=22% Similarity=0.246 Sum_probs=191.0
Q ss_pred cccccccCcCccceEEEEEe----eCCcEEEEEEccccc----chhHHHHHHHHHhhccc-CcCceeeeeeEEecccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTM----INGKFVAVKRLQKML----AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 518 (724)
+.+.+.||+|+||.||++.. ..++.||||+++... ....+.+.+|++++.++ +|+||+++++++.+....+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 44568899999999999987 368899999987532 23345678899999999 6999999999999999999
Q ss_pred EEEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+||||+++++|.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999998842 222 2267999999999998 9999999999999999999999999999876544
Q ss_pred CcceeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.........||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ .......... ...
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~-~~~------ 283 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-SEP------ 283 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH-CCC------
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc-cCC------
Confidence 44334446799999999999863 478999999999999999999999975432221 1121222211 111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRP-----SMKKVLLML 705 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~L 705 (724)
.........+.+++.+||+.||.+|| ++.|+++..
T Consensus 284 -~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11112234578899999999999999 999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.67 Aligned_cols=236 Identities=26% Similarity=0.383 Sum_probs=185.8
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.||+|+||.||++.... ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 345789999999999998754 6799999986532 223467899999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++.. ... ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 165 (279)
T 3fdn_A 92 PLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RT 165 (279)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---------
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc---cc
Confidence 99999988742 222 2378999999999998 99999999999999999999999999986543322 22
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+....... + ....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~---~----~~~~ 231 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVEFTF---P----DFVT 231 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCCCC---C----TTSC
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------H-HHHHHHhCCCCC---C----CcCC
Confidence 346899999999999999999999999999999999999998753211 1 111222211110 1 1123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+.+++..||+.+|++||++.|+++.
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 457889999999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.59 Aligned_cols=237 Identities=22% Similarity=0.250 Sum_probs=178.4
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcc-cCcCceeeeeeEEec----ccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRLLGYSFD----VSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e~~~ 525 (724)
+.||+|+||.||++... +++.||||++... ..+.+|++++.+ .+|+||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 67999999999999875 4789999998642 456788888754 489999999998875 567899999999
Q ss_pred CCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+|+|.+++.... . ..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 999999985422 1 2278999999999998 9999999999999987 7889999999998654322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ....+..+...... ...
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~~~~---~~~ 291 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFPN---PEW 291 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCCCCT---TTT
T ss_pred -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcccCCC---ccc
Confidence 22345689999999999999999999999999999999999999976543221000 11122222221110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
......+.+++..||+.||++|||+.|+++.
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1223458899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=305.67 Aligned_cols=239 Identities=28% Similarity=0.390 Sum_probs=184.8
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc-cceEEEEeecc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-SNKILVYEYMS 525 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~~ 525 (724)
...+.+.||+|+||.||++.. .++.||||.++.. ...+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 345568899999999999987 5889999999753 3456799999999999999999999997655 47899999999
Q ss_pred CCChhhhcCCC-----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYSSP-----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~-----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|.+++... . +..+.++++||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 99999988532 2 22378999999999998 99999999999999999999999999987654321
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ....+..+.... ....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~ 238 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMD------APDG 238 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCCC------CCTT
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCC------Cccc
Confidence 12356889999999999999999999999999999998 998886543221 112222221111 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....+.+++..||+.+|++||++.|+++.|+.+
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 235688999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.44 Aligned_cols=241 Identities=26% Similarity=0.363 Sum_probs=189.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.+.||+|+||.||++... +++.||||.+........+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 4556689999999999999875 588999999986544455678999999999999999999999999999999999999
Q ss_pred CCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCCCcce
Q 041285 526 NGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 526 ~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+++|.+++.. ... ..+.+++.||.|||+. +|+||||||+||++ +.++.+||+|||++.......
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--- 163 (304)
T 2jam_A 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--- 163 (304)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT---
T ss_pred CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc---
Confidence 9999988732 222 2378999999999998 99999999999999 788899999999987543221
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..+..... ......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~~~~---~~~~~~ 233 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------K-LFEKIKEGYYEFE---SPFWDD 233 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHCCCCCC---TTTTTT
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCCCCC---cccccc
Confidence 12345899999999999999999999999999999999999998654211 1 1122223322110 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2356889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=301.66 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=188.8
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccc------hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA------EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3556789999999999999986 588999999865321 135679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----CeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----YAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~ 588 (724)
||||+++++|.+++.. ... ..+.+|++||.|||+. +++||||||+||+++.++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999998842 222 2378999999999998 999999999999998877 7999999999876
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+....... .
T Consensus 163 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--~ 231 (283)
T 3bhy_A 163 EAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNYDF--D 231 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCCC--C
T ss_pred cCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhcccCC--c
Confidence 43322 233468999999999999999999999999999999999999986542111 111222221110 0
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. .........+.+++.+||+.+|++||++.|+++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 232 E-EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp H-HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000112345889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.92 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=183.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 518 (724)
+.+.+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 445578999999999999874 58999999986432 233467899999999999999999999998653 459
Q ss_pred EEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 519 LVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+||||+ +++|.+++..... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp EEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 999999 8899988853221 2277999999999998 9999999999999999999999999999875432
Q ss_pred cceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC----------
Q 041285 593 TRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---------- 661 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 661 (724)
.....+|+.|+|||.+.+ ..++.++||||+|++++||++|+.||......+. +.. +.+.....
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKE-IMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHHHHTCSC
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhcCCCCHHHHHHhhh
Confidence 233568999999999877 6799999999999999999999999975432111 110 00000000
Q ss_pred --------Cccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCC
Q 041285 662 --------NLGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTM 709 (724)
Q Consensus 662 --------~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~L~~~~ 709 (724)
.+...... ..........+.+++.+||+.||++|||+.|+++ -++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000000 0011122456889999999999999999999987 355443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.23 Aligned_cols=240 Identities=28% Similarity=0.393 Sum_probs=192.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 344578999999999999864 58899999986532 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCCcc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 526 NGSLADVYSSPPKN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 526 ~gsL~~~l~~~~~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+++|.+++...... .+.+++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .....
T Consensus 104 ~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 179 (303)
T 3a7i_A 104 GGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTF 179 (303)
T ss_dssp TEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCC
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCcc
Confidence 99999998654322 278999999999998 999999999999999999999999999987643322 12335
Q ss_pred ccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 600 RGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
.|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+..+..... .......
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~ 246 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNPPTL------EGNYSKP 246 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCC------CSSCCHH
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCCCCC------ccccCHH
Confidence 68999999999999999999999999999999999999986532111 1111222211111 1112345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+.+++..||+.+|++|||+.|+++.
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 8899999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=312.98 Aligned_cols=239 Identities=19% Similarity=0.184 Sum_probs=186.8
Q ss_pred hcccccccCcCccceEEEEE------eeCCcEEEEEEcccccchhHHHHHHHHHhhcccC---cCceeeeeeEEecccce
Q 041285 447 TDGFKEEIGRGSSGTVYKGT------MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 517 (724)
.+.+.+.||+|+||.||+|. ...++.||||++... ...++..|++++.+++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34456789999999999994 446789999999753 3456777777777775 99999999999999999
Q ss_pred EEEEeeccCCChhhhcCC--------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-----------C
Q 041285 518 ILVYEYMSNGSLADVYSS--------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-----------N 574 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~--------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-----------~ 574 (724)
++||||+++|+|.+++.. .. ...+.||++||+|||+. +|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999842 11 12378999999999998 9999999999999998 8
Q ss_pred CCeEEccccCccccCC-CCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH
Q 041285 575 RYAKISDFALAKLMKP-DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW 653 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~ 653 (724)
+.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 9999999999976532 222334456799999999999999999999999999999999999999854322110
Q ss_pred HHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhccCC
Q 041285 654 VYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLR-PSMKKVLLMLEGTM 709 (724)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~evl~~L~~~~ 709 (724)
.+...+.. .. ..+.+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 294 --------~~~~~~~~-~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 --------KPEGLFRR-LP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------EECSCCTT-CS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------eechhccc-cC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 01111111 11 13346677888999999998 68888888887644
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.86 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=186.2
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.+.||+|+||.||+|...+ .+|||.+.... ....+.+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3456889999999999998743 49999986532 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc----
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT---- 593 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~---- 593 (724)
+++|.+++.... . ..+.+|++||+|||+. +|+||||||+|||++ ++.+||+|||++........
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 999999996532 1 2278999999999998 999999999999998 67999999999876532111
Q ss_pred ceeeccccCccccCcccccC---------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 594 RTFTGIRGTRGYVAPEWHWN---------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.......|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... . .......+...
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~ 261 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A-IIWQMGTGMKP 261 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H-HHHHHHTTCCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHhccCCCC
Confidence 11223458999999999864 45788999999999999999999999754321 1 11222233222
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC-CCCCCCCCCc
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI-PIPPNPTSLL 721 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~-~~p~~p~~~~ 721 (724)
..... .....+.+++..||+.+|++||++.+++++|+.+... .....|..+.
T Consensus 262 ~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 262 NLSQI-----GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp CCCCS-----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CCCcC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 22111 1123488999999999999999999999999986544 3345555443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.38 Aligned_cols=249 Identities=19% Similarity=0.219 Sum_probs=190.9
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCc-CceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH-RNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||.||++.. .+++.||||++... ....++..|++++..++| +++..+..++.+.+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 34568899999999999986 45889999987653 233468999999999976 56666666777788889999999
Q ss_pred CCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+++|.+++.. ..+ .++.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.+......
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9999999852 222 2278999999999998 99999999999999 58899999999999876543321
Q ss_pred ------eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 595 ------TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 595 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
......||+.|+|||.+.+..++.++||||||++||||++|+.||..............+........+..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC- 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH-
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh-
Confidence 1224679999999999999999999999999999999999999998654333222111111111111111110
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++..||+.+|++||++.+|+++|+.+
T Consensus 242 -----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 242 -----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11234688999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.07 Aligned_cols=242 Identities=25% Similarity=0.294 Sum_probs=187.2
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.+.||+|+||.||++... +++.||||.+.... ..+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 3455688999999999999875 47899999997532 2346788888888 7999999999999999999999999
Q ss_pred cCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC----CCeEEccccCccccCCCCc
Q 041285 525 SNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN----RYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 525 ~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~----~~~kl~Dfgl~~~~~~~~~ 593 (724)
++|+|.+++.... . ..+.+|+.||.|||+. +|+||||||+|||+.++ +.+||+|||+++.......
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9999999884321 1 2378999999999998 99999999999998543 3499999999987644322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......||+.|+|||.+.+..++.++||||||+++|||++|..||........ .+ ....+..+...... ...
T Consensus 176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~-~~~~i~~~~~~~~~---~~~ 247 (342)
T 2qr7_A 176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EE-ILARIGSGKFSLSG---GYW 247 (342)
T ss_dssp -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HH-HHHHHHHCCCCCCS---TTT
T ss_pred -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HH-HHHHHccCCcccCc---ccc
Confidence 22335689999999999888889999999999999999999999975432221 11 22333333322111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++..||+.||++||++.|+++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 123345888999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.88 Aligned_cols=237 Identities=25% Similarity=0.352 Sum_probs=184.0
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCChh
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLA 530 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 530 (724)
..||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 37999999999999864 57899999997655555678999999999999999999999999999999999999999999
Q ss_pred hhcCCC----C--cc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccCCCCcceeecc
Q 041285 531 DVYSSP----P--KN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 531 ~~l~~~----~--~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+++... . .. .+.++++||.|||+. +++|+||||+|||++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 988432 1 11 267999999999998 9999999999999987 89999999999987643221 12235
Q ss_pred ccCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 600 RGTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
.|++.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ........... .......
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~ 252 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVGMFKVHP------EIPESMS 252 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-----HHHHHHHCCCC------CCCTTSC
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-----HHhhccccccc------cccccCC
Confidence 6899999999987654 789999999999999999999998643221110 11111111111 1111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++.+||+.+|++||++.|+++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 46888999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.04 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=184.3
Q ss_pred hcccccccCcCccceEEEEEeeC--Cc--EEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN--GK--FVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~--~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||.||++.... ++ .||||.++.. .....+.+.+|++++.+++||||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 34556889999999999998643 33 6899988753 2334568999999999999999999999998764 889
Q ss_pred EEeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 520 VYEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|+||+++++|.+++... .. ..+.++++||.|||+. +++|+||||+|||++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999988432 11 2378999999999998 9999999999999999999999999999877544
Q ss_pred Ccce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 592 QTRT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 592 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .........+... ..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~ 246 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL--PR 246 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC--CC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC--CC
Confidence 3321 223457889999999988889999999999999999999 99998654211 1112222211111 11
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.......+.+++..||+.+|++||++.++++.|+....
T Consensus 247 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 247 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11233568899999999999999999999999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.23 Aligned_cols=237 Identities=29% Similarity=0.333 Sum_probs=180.6
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.+.||+|+||+||.....+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4679999999998776668999999998653 235678999999886 89999999999999999999999995 699
Q ss_pred hhhcCCCC--------------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-------------CCeEEccc
Q 041285 530 ADVYSSPP--------------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-------------RYAKISDF 582 (724)
Q Consensus 530 ~~~l~~~~--------------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-------------~~~kl~Df 582 (724)
.+++.... +..+.||+.||+|||+. +|+||||||+|||++.+ ..+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99884321 12478999999999998 99999999999999654 47999999
Q ss_pred cCccccCCCCcc---eeeccccCccccCcccccC-------CCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHH
Q 041285 583 ALAKLMKPDQTR---TFTGIRGTRGYVAPEWHWN-------LPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILE 651 (724)
Q Consensus 583 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~ 651 (724)
|+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||........
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---- 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---- 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH----
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH----
Confidence 999977544322 1223579999999999875 568999999999999999999 8889865432211
Q ss_pred HHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 652 EWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. +..+..................+.+++.+||+.||.+|||+.||++
T Consensus 249 ----~-i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ----N-IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----H-HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H-HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1111111100111234456678999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=323.12 Aligned_cols=184 Identities=27% Similarity=0.436 Sum_probs=140.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 519 (724)
+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++|+||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 455688999999999999875 5889999998653 233456789999999999999999999998543 56899
Q ss_pred EEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||||+ +++|.+++.... ...+.||++||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 99998 578888874421 12378999999999998 99999999999999999999999999998764221
Q ss_pred c--------------------------ceeeccccCccccCcccc-cCCCCCcccceeehhHHHHHhhcc
Q 041285 593 T--------------------------RTFTGIRGTRGYVAPEWH-WNLPITAKADVYSFGVVLLEIICC 635 (724)
Q Consensus 593 ~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvll~elltg 635 (724)
. .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1 122345789999999976 566799999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.46 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=187.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 345578999999999999885 57899999987542 3334679999999999999999999999999999999999999
Q ss_pred CCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|.+++.. ... ..+.+++.||+|||+. .+|+||||||+|||++.++.+||+|||++...... ....
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 189 (360)
T 3eqc_A 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189 (360)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence 9999998843 222 2378999999999973 17999999999999999999999999998754221 1223
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH----------------------------
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL---------------------------- 650 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l---------------------------- 650 (724)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 4689999999999999999999999999999999999999975432111000
Q ss_pred --------HHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 651 --------EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 651 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... .....+.... .........+.+++..||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 270 DSRPPMAIFELL-DYIVNEPPPK-----LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----CCCHHHHH-HHHHHSCCCC-----CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccchhhh-hHHhccCCCC-----CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 0000000000 001112346889999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=311.71 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=185.0
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc--------c
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV--------S 515 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~ 515 (724)
.+.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++... .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 3445688999999999999884 68899999986432 22345788999999999999999999998873 4
Q ss_pred ceEEEEeeccCCChhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 516 NKILVYEYMSNGSLADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
..++||||+++ +|.+.+... . +..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999975 666655322 1 12378999999999998 999999999999999999999999999987
Q ss_pred cCCCCc---ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC-
Q 041285 588 MKPDQT---RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN- 662 (724)
Q Consensus 588 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~- 662 (724)
+..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+........
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSITP 250 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCh
Confidence 653222 22234578999999998876 4579999999999999999999999876432211 111111111000
Q ss_pred --cccc-----------ccccccC-HH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 663 --LGQL-----------IEDEDVD-KK------QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 663 --~~~~-----------~~~~~~~-~~------~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.... ....... .+ ....+.+++.+||+.||++|||+.|+++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0000000 01 12457899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.70 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=187.0
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.+.||+|+||.||++... +++.||||.+... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 3445678999999999999875 4889999998753 345678999999999999999999999999999999999999
Q ss_pred CCChhhhcC--C--CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 526 NGSLADVYS--S--PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 526 ~gsL~~~l~--~--~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
+++|.+++. . ... ..+.+|+.||.|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 183 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN 183 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence 999999874 1 222 2378999999999998 999999999999999999999999999986643322 223
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... ............+.. ..
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~~~~~~----~~ 252 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIF-MIPTNPPPTFRKPEL----WS 252 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCCCCSSGGG----SC
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHhcCCCcccCCccc----CC
Confidence 3568999999999999999999999999999999999999987532111 111 111111111111111 23
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.+++..||+.+|.+||++.++++
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 45889999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.43 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=189.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 522 (724)
+.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345678999999999999875 5889999998643 23345679999999999999999999998854 567899999
Q ss_pred eccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCc-----eEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 523 YMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQ-----IIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 523 ~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~-----i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
|+++++|.+++.. ... ..+.++++||+|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999998842 222 2378999999999998 6 9999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... . . ....+..+....+
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~-~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K---E-LAGKIREGKFRRI 236 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-HHHHHHHTCCCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---H---H-HHHHHhhcccccC
Confidence 7654322 11234689999999999998999999999999999999999999875421 1 1 1223333333221
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.......+.+++.+||+.+|++||++.||++.+..
T Consensus 237 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 ------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11223468899999999999999999999987753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=309.41 Aligned_cols=246 Identities=20% Similarity=0.320 Sum_probs=188.9
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEec--ccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFD--VSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++.. .+++.||||.+.. ...+.+.+|++++.+++ |+||+++++++.+ ....++||||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 44567899999999999986 4688999999874 33467899999999997 9999999999987 5678999999
Q ss_pred ccCCChhhhcCCCCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcceeec
Q 041285 524 MSNGSLADVYSSPPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++++|.+++...... .+.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 115 ~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 189 (330)
T 3nsz_A 115 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNV 189 (330)
T ss_dssp CCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCS
T ss_pred cCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--ccc
Confidence 9999999998665433 378999999999998 999999999999999776 899999999987654332 223
Q ss_pred cccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH--------HHHHHcCCc------
Q 041285 599 IRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV--------YQCFENGNL------ 663 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~------ 663 (724)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... +.... ...+.....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccch
Confidence 468999999999877 67899999999999999999999999654322111 11100 011111100
Q ss_pred ------------cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 ------------GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...... .........+.+++..||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 001113456889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.20 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=184.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 445678999999999999986 4789999999766556667899999999999999999999999999999999999999
Q ss_pred CChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++|.+++.. ... ..+.+|++||.|||+. +++||||||+|||++.++.+||+|||++...... ......
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 176 (302)
T 2j7t_A 101 GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDS 176 (302)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC---
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cccccc
Confidence 999988732 222 2278999999999998 9999999999999999999999999997542111 011122
Q ss_pred cccCccccCcccc-----cCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 599 IRGTRGYVAPEWH-----WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 599 ~~gt~~y~aPE~~-----~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
..|++.|+|||.+ ....++.++||||||+++|||++|+.|+...... ...... ..+.......+..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~~~~-- 247 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSDPPTLLTPSK-- 247 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCCCCCSSGGG--
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHH-hccCCcccCCccc--
Confidence 4689999999998 4667899999999999999999999998754321 111122 2222222222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++..||+.+|++|||+.++++
T Consensus 248 --~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 248 --WSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2345889999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.87 Aligned_cols=232 Identities=24% Similarity=0.325 Sum_probs=184.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.||||.+... ......++.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 445678999999999999886 6899999998753 234456788999999999 999999999999999999999999
Q ss_pred ccCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-------------------
Q 041285 524 MSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE------------------- 573 (724)
Q Consensus 524 ~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~------------------- 573 (724)
+++++|.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999998843 122 2378999999999998 9999999999999984
Q ss_pred CCCeEEccccCccccCCCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH
Q 041285 574 NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~ 652 (724)
...+||+|||++........ ..|++.|+|||.+.+. .++.++||||||+++|||++|..++....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------- 235 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------- 235 (289)
T ss_dssp CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred ceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence 44799999999987654322 3489999999998766 56689999999999999999987654321
Q ss_pred HHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 653 WVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+..+....+- ......+.+++..||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -QWHEIRQGRLPRIP------QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HHHHHHTTCCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHcCCCCCCC------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11223333332221 112345889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.90 Aligned_cols=243 Identities=21% Similarity=0.281 Sum_probs=173.3
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEe--------cccc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSF--------DVSN 516 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~~~ 516 (724)
.+.+.+.||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4456689999999999999874 58899999987655556678999999999995 999999999984 3345
Q ss_pred eEEEEeeccCCChhhhcCC------CCc----chHHHHHHHcccccccCCCc--eEeCCCCCCCeeeCCCCCeEEccccC
Q 041285 517 KILVYEYMSNGSLADVYSS------PPK----NNLIGIARGILYLHDECESQ--IIHCDIKPQNILMDENRYAKISDFAL 584 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~------~~~----~~~~~ia~~l~yLH~~~~~~--i~H~dlk~~NIll~~~~~~kl~Dfgl 584 (724)
.++|+||+. |+|.+++.. ..+ ..+.+|+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 799999995 788887732 222 2378999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCcce-----------eeccccCccccCcccc---cCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH
Q 041285 585 AKLMKPDQTRT-----------FTGIRGTRGYVAPEWH---WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 585 ~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l 650 (724)
+.......... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1134589999999998 56678999999999999999999999986432110
Q ss_pred HHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 651 EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
...+...... .. .....+.+++..||+.+|++||++.|+++.|+...
T Consensus 261 -------~~~~~~~~~~-~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 -------IVNGKYSIPP-HD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------------CCCCT-TC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------hhcCcccCCc-cc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011111000 00 11123778999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.37 Aligned_cols=239 Identities=26% Similarity=0.316 Sum_probs=189.2
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3467999999999999985 58999999997532 2334678999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC-------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 526 NGSLADVYSSPP-------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 526 ~gsL~~~l~~~~-------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+|+|.+++.... . ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999998874321 1 1267999999999998 9999999999999999999999999999876543322
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... .+.+...... .+.
T Consensus 346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~-~~~i~~~~~~-------~p~ 414 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKEL-KQRVLEQAVT-------YPD 414 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHH-HHHHHHCCCC-------CCT
T ss_pred -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHH-HHHHhhcccC-------CCc
Confidence 223579999999999999999999999999999999999999997643221 11111 1222222211 111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSM-----KKVL 702 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl 702 (724)
.....+.+++..||+.||++||++ .+++
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 223457889999999999999975 5565
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=310.64 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=185.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccch-----hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-----GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.+.+.||+|+||.||++... +++.||||++...... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 445578999999999999975 4889999998743211 1246889999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++ +|.+++.... . ..+.++++||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 92 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 99986 7887775422 1 2278999999999998 99999999999999999999999999998764332
Q ss_pred ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccccc---
Q 041285 594 RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLGQL--- 666 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--- 666 (724)
.......+|+.|+|||.+.+. .++.++||||||+++|||++|..|+......+ .+.. +.+..... .....
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTR-IFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTSSSTTSS
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHcCCCChhhhhhhccC
Confidence 222345689999999998764 48899999999999999999998886543211 1111 11111110 00000
Q ss_pred ---cccc---ccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 667 ---IEDE---DVD-----KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 667 ---~~~~---~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+... ... ......+.+++..||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 001 1223568999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.98 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=172.1
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
.+.+.+.||+|+||.||++... +++.||||++.... ....+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 3445688999999999999864 57899999886532 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhcCC-----------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 525 SNGSLADVYSS-----------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 525 ~~gsL~~~l~~-----------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
++++|.+++.. ... ..+.||++||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999998742 111 2267999999999998 99999999999999999999999999998764
Q ss_pred CCCc----ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC--C
Q 041285 590 PDQT----RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG--N 662 (724)
Q Consensus 590 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~ 662 (724)
.... .......|++.|+|||.+.. ..++.++||||||+++|||++|+.||......... ....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~ 246 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQNDPPS 246 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHTSSCCC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhccCCCc
Confidence 3321 11223568999999999875 56899999999999999999999999764322211 1111111 0
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 LGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.................+.+++..||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11101111111122346888999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.15 Aligned_cols=189 Identities=27% Similarity=0.408 Sum_probs=152.9
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 518 (724)
.+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 3455688999999999999875 4789999999753 233456789999999999999999999999766 5689
Q ss_pred EEEeeccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+||||++ ++|.+++... .. ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999986 5999888542 21 2278999999999998 9999999999999999999999999999876533
Q ss_pred Cc---------------------ceeeccccCccccCcccc-cCCCCCcccceeehhHHHHHhhccccCC
Q 041285 592 QT---------------------RTFTGIRGTRGYVAPEWH-WNLPITAKADVYSFGVVLLEIICCRRCF 639 (724)
Q Consensus 592 ~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvll~elltg~~p~ 639 (724)
.. .......||+.|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 21 122446789999999985 5667999999999999999999865544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.73 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=190.7
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++...+ ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 3456789999999999999864 7899999986532 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.|+++||+|||+. +++||||||+|||++.++.+||+|||++........ ..
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 172 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-cc
Confidence 999999988742 222 2378999999999998 999999999999999999999999999987643222 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... +. ...+..+... .+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~---~~~----~~ 238 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEYS---IPK----HI 238 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHTTCCC---CCT----TS
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhhccCC---Ccc----cc
Confidence 2356899999999999888999999999999999999999998754311 11 1122222111 111 12
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.+|++||++.|+++.
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2457889999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.69 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=178.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.++||+|+||.||++... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 445678999999999999864 588999999975322 22456789999999999999999999999999999999999
Q ss_pred cCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-----CCCCeEEccccCccccCCCC
Q 041285 525 SNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-----ENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 525 ~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-----~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+ ++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++ .++.+||+|||++.......
T Consensus 116 ~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 116 E-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp S-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred C-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 7 4898887432 21 2378999999999998 999999999999994 45569999999998764332
Q ss_pred cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---cccc--
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQL-- 666 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-- 666 (724)
. ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+.. ..+...... ....
T Consensus 192 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 192 R-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK-IFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGG
T ss_pred c-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH-HHHHhCCCchhhhhhhhh
Confidence 2 22334679999999998875 48999999999999999999999997543211 1111 111110000 0000
Q ss_pred -------ccc-ccc------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 -------IED-EDV------DKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 -------~~~-~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... ... .......+.+++..||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000 0112356789999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.62 Aligned_cols=236 Identities=24% Similarity=0.300 Sum_probs=189.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 445678999999999999875 46789999986532 22346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.+|++||.|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 96 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 169 (284)
T 2vgo_A 96 APRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---R 169 (284)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---B
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---c
Confidence 999999988742 222 2378999999999998 99999999999999999999999999987654322 1
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+...... .....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~~~~-------~~~~~ 235 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------E-THRRIVNVDLK-------FPPFL 235 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCCC-------CCTTS
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------H-HHHHHhccccC-------CCCcC
Confidence 2346899999999999999999999999999999999999998754211 1 11222222211 11112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 345788999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.93 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++...+ ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 3456789999999999998864 6899999986532 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 123 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (335)
T 2owb_A 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 198 (335)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cc
Confidence 999999988742 222 2378999999999998 999999999999999999999999999987643322 12
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+..+... .+.. .
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~~~~~~~~---~~~~----~ 264 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETY-LRIKKNEYS---IPKH----I 264 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHTCCC---CCTT----S
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHH-HHHhcCCCC---CCcc----C
Confidence 3356899999999999988999999999999999999999998653211 111 112222111 0111 2
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.||++||++.|+++
T Consensus 265 ~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 235788999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=305.59 Aligned_cols=241 Identities=22% Similarity=0.346 Sum_probs=188.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--------hhHHHHHHHHHhhccc-CcCceeeeeeEEecccce
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--------EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 517 (724)
+.+.+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.++.++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 444578999999999999985 689999998864321 1135688999999999 799999999999999999
Q ss_pred EEEEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 518 ILVYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 518 ~lv~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
++||||+++++|.+++.. ... ..+.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+..
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999999998842 222 2378999999999998 999999999999999999999999999987654
Q ss_pred CCcceeeccccCccccCcccccC------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWN------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... . ....+..+...
T Consensus 253 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~----~~~~i~~~~~~ 323 (365)
T 2y7j_A 253 GEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L----MLRMIMEGQYQ 323 (365)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCCC
T ss_pred Ccc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhCCCC
Confidence 322 233578999999998863 35788999999999999999999999653211 1 11222222221
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..... .......+.+++..||+.||++||++.|+++
T Consensus 324 ~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 324 FSSPE---WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCHHH---HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11000 0012345888999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=333.31 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=191.1
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||++... +++.||||+++.. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3445678999999999999875 4789999999753 233456788999999988 7999999999999999999999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
||+++|+|.+++.. ... ..+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 99999999998843 222 2378999999999998 999999999999999999999999999986433222
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
......||+.|+|||++.+..++.++||||||++||||++|+.||...... + ..+.+..+.... + .
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~~~---p----~ 563 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHNVAY---P----K 563 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHSSCCCC---C----T
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCCCCC---C----c
Confidence 233467999999999999999999999999999999999999999754221 1 222333332211 1 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSM-----KKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 703 (724)
.....+.+++..||+.||++||++ +||++
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 223458899999999999999997 67753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=335.47 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=190.2
Q ss_pred hhcccccccCcCccceEEEEEeeC----CcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
....+.+.||+|+||.||+|.... +..||||.+.... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 445567889999999999998743 4579999987532 2334679999999999999999999999854 568999
Q ss_pred EeeccCCChhhhcCCC----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSP----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|||+++|+|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999998532 22 2267999999999998 99999999999999999999999999998775443
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+..+....
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~-~~~~i~~~~~~~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------D-VIGRIENGERLP------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHHTCCCC------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------H-HHHHHHcCCCCC------
Confidence 333334557889999999998999999999999999999997 88888653221 1 112222222111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
........+.+++.+||+.||++||++.|++++|+.+
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112235688999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=316.72 Aligned_cols=243 Identities=25% Similarity=0.310 Sum_probs=190.6
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
..+.+.+.||+|+||+||++... +++.||||++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 34667789999999999999875 58899999986432 3345679999999999999999999999999999999999
Q ss_pred eccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeC---CCCCeEEccccCccccCCCC
Q 041285 523 YMSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 523 ~~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~---~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|+++++|.+++.. .. ...+.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999887732 22 22378999999999998 999999999999995 45679999999998765432
Q ss_pred cceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+..+........
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~--- 245 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDLPQ--- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSCSGG---
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCCCcc---
Confidence 2233568999999999875 58999999999999999999999997543211 1222333322211111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.......+.+++..||+.+|.+|||+.|+++.
T Consensus 246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223458899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.05 Aligned_cols=243 Identities=12% Similarity=0.014 Sum_probs=169.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhccc--CcCceeeee-------eEEecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRT--HHRNLVRLL-------GYSFDV 514 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~ 514 (724)
+.+.+.||+|+||.||++... +++.||||++.... ....+.+++|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 345678999999999999975 68899999997632 23345678885544444 699988755 333322
Q ss_pred -----------------cceEEEEeeccCCChhhhcCC----CCc----------chHHHHHHHcccccccCCCceEeCC
Q 041285 515 -----------------SNKILVYEYMSNGSLADVYSS----PPK----------NNLIGIARGILYLHDECESQIIHCD 563 (724)
Q Consensus 515 -----------------~~~~lv~e~~~~gsL~~~l~~----~~~----------~~~~~ia~~l~yLH~~~~~~i~H~d 563 (724)
...++||||++ ++|.+++.. ... ..+.||++||+|||+. +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999998 899998842 111 2248999999999998 999999
Q ss_pred CCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCCCC
Q 041285 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCFDQ 641 (724)
Q Consensus 564 lk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~~~ 641 (724)
|||+|||++.++.+||+|||+++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999866422 113456799999999987 6799999999999999999999999976
Q ss_pred CCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 642 NLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 642 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
............ ........ ....+ ........+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~~~~~--~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGSWKRP--SLRVPGTD-SLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTCCCBC--CTTSCCCC-SCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccchhhh--hhhhcccc-ccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 533211100000 00000000 00000 01123456889999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=295.82 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=182.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 445688999999999999986 68999999986532 22345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++++|.+++.. ... ..+.|+++||.|||+. +++|+||||+||+++.++.+||+|||++........ .
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~ 167 (276)
T 2h6d_A 93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--L 167 (276)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--e
Confidence 999999998842 222 2378999999999998 999999999999999999999999999987654322 2
Q ss_pred eccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
....+++.|+|||.+.+..+ +.++||||||+++|||++|+.|+...... . ..+.+..+... .+..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~---~~~~---- 233 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------T-LFKKIRGGVFY---IPEY---- 233 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---CCTT----
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H-HHHHhhcCccc---Cchh----
Confidence 23468999999999987765 68999999999999999999998653211 1 12222222211 1111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++.+|++.+|++|||+.|+++.
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 23457889999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.66 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=185.4
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.+.+.||+|+||.||++... .+..||||.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3556789999999999999875 57899999987532 33356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCc
Q 041285 524 MSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+++|+|.+++.. .. +..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||++.......
T Consensus 118 ~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 999999887732 22 22378999999999998 9999999999999976 4559999999998765432
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
......||+.|+|||.+. ..++.++||||||+++|+|++|..||...... + ....+..+....... ..
T Consensus 194 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~~~~~~---~~ 261 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------E-ILRKVEKGKYTFDSP---EW 261 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCCCSG---GG
T ss_pred -cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCCCch---hc
Confidence 223356899999999886 56899999999999999999999999754321 1 122233332211110 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++..||+.+|.+|||+.|+++
T Consensus 262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 122345888999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.10 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=183.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc----chhHHHHHHHHHhhcccCcCceeeeeeEEe--cccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML----AEGEREFQTEIKAIGRTHHRNLVRLLGYSF--DVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv 520 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++|+||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 445688999999999999875 57899999987532 234567999999999999999999999984 45578999
Q ss_pred EeeccCCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 521 YEYMSNGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|||++++ |.+++.. ... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999877 6555522 111 2267999999999998 9999999999999999999999999999876532
Q ss_pred C-cceeeccccCccccCcccccCCC--CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 592 Q-TRTFTGIRGTRGYVAPEWHWNLP--ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 592 ~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
. ........|++.|+|||.+.+.. .+.++||||||+++|||++|+.|+..... .. ..+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~~~--- 232 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGSYAI--- 232 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCCCCC---
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCCCCC---
Confidence 2 22233456899999999987654 37799999999999999999999875321 11 112222222211
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 123457889999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=320.54 Aligned_cols=242 Identities=26% Similarity=0.328 Sum_probs=192.1
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
..+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34556789999999999999875 68899999986432 334567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeee---CCCCCeEEccccCccccCCC
Q 041285 522 EYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILM---DENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 522 e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll---~~~~~~kl~Dfgl~~~~~~~ 591 (724)
||+++++|.+++.... +..+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999998874321 12378999999999998 99999999999999 56789999999999876543
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+ ....+..+........
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~-- 250 (484)
T 3nyv_A 183 KK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFELPQ-- 250 (484)
T ss_dssp CS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCSGG--
T ss_pred cc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCCCcc--
Confidence 32 233568999999999865 68999999999999999999999997543211 1223333332211111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++..||+.+|.+|||+.|+++
T Consensus 251 -~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 -WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1122345889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.92 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=169.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 518 (724)
+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 345578999999999999864 5889999998653 223456788999999999999999999998754 5579
Q ss_pred EEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 519 LVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+|+|++ +++|.+++..... ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 111 lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp EEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 999999 7899888864322 2278999999999998 9999999999999999999999999999865432
Q ss_pred cceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC------c--
Q 041285 593 TRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN------L-- 663 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~-- 663 (724)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +.. +.+...... +
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL-ILRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCSCCHHHHTTCCC
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHHHHhhh
Confidence 233568999999999877 6789999999999999999999999975432111 111 111110000 0
Q ss_pred -------cccccccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 -------GQLIEDEDVD-----KKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 -------~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+....... ......+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 1123458899999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.48 Aligned_cols=250 Identities=28% Similarity=0.358 Sum_probs=184.7
Q ss_pred cccccccCcCccceEEEEEeeC-CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
+.+.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 3445789999999999998864 8899999886432 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 525 SNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 525 ~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
++++|.+++.. ... ..+.+|+.||.|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 182 (331)
T 4aaa_A 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYD 182 (331)
T ss_dssp SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccC
Confidence 99999887532 222 2378999999999998 999999999999999999999999999986543221 222
Q ss_pred ccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH----------HHHHHcC-----
Q 041285 598 GIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV----------YQCFENG----- 661 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~----------~~~~~~~----- 661 (724)
...|++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +.... ...+...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcccccc
Confidence 34689999999998875 689999999999999999999999876432211 11100 0000000
Q ss_pred -Cccccccccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 -NLGQLIEDED---VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 -~~~~~~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+........ ........+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111100 01123466899999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=302.20 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=184.1
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEccccc--------chhHHHHHHHHHhhcccCcCceeeeeeEEecccc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 516 (724)
..+.+.+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 34566789999999999999875 47899999986421 122346889999999999999999999987654
Q ss_pred eEEEEeeccCCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCcc
Q 041285 517 KILVYEYMSNGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALAK 586 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~~ 586 (724)
.++||||+++++|.+++.... . ..+.||++||.|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999885422 1 2267999999999998 9999999999999987654 9999999998
Q ss_pred ccCCCCcceeeccccCccccCccccc---CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
...... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||........ +. ..+..+..
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~~~~ 237 (322)
T 2ycf_A 166 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQITSGKY 237 (322)
T ss_dssp ECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHHHTCC
T ss_pred eccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHHhCcc
Confidence 764322 122346899999999874 56788999999999999999999999975433221 11 22222222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...- .........+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFIP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCc---hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1110 000112356889999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.56 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=186.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 520 (724)
+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 445678999999999999875 57899999987532 23346789999999999999999999999764 368999
Q ss_pred EeeccCCChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+||++ ++|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99997 58888874322 2 2378999999999998 9999999999999999999999999999876533221
Q ss_pred e--eeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc--------
Q 041285 595 T--FTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL-------- 663 (724)
Q Consensus 595 ~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 663 (724)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .. +.........
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NH-ILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH--HH-HHHHHCSCCHHHHHTCCC
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH--HH-HHHHhCCCCHHHHHHhhh
Confidence 1 233578999999998654 45899999999999999999999999765432221 11 1111000000
Q ss_pred -------cccccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 -------GQLIEDED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 -------~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........ ........+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 01122356889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.43 Aligned_cols=241 Identities=27% Similarity=0.397 Sum_probs=180.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec-------------
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD------------- 513 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------- 513 (724)
+.+.+.||+|+||.||++... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 345678999999999999874 6889999999653 3445789999999999999999999998865
Q ss_pred ccceEEEEeeccCCChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCc
Q 041285 514 VSNKILVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALA 585 (724)
Q Consensus 514 ~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~ 585 (724)
....++||||+++++|.+++.... +..+.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 456799999999999999985322 12378999999999998 9999999999999999999999999999
Q ss_pred cccCCCC-------------cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHH
Q 041285 586 KLMKPDQ-------------TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE 651 (724)
Q Consensus 586 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~ 651 (724)
....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+.... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~ 235 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERV 235 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hHH
Confidence 8664321 1112335689999999998765 68999999999999999998 432210 011
Q ss_pred HHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 652 EWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
. ....+...... .+..........+.+++..||+.||.+|||+.|+++.
T Consensus 236 ~-~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 N-ILKKLRSVSIE---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H-HHHHHHSTTCC---CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H-HHHhccccccc---cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 11222222111 1111223334567899999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.00 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=169.7
Q ss_pred ccccCcCccceEEEEEee---CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEeecc
Q 041285 451 KEEIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYEYMS 525 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 525 (724)
.++||+|+||.||++... +++.||||++... .....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 357999999999999975 4689999999753 233578899999999999999999999954 667899999996
Q ss_pred CCChhhhcCC------------CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeee----CCCCCeEEccccCc
Q 041285 526 NGSLADVYSS------------PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILM----DENRYAKISDFALA 585 (724)
Q Consensus 526 ~gsL~~~l~~------------~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll----~~~~~~kl~Dfgl~ 585 (724)
++|.+++.. .. +..+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 477666521 11 22377999999999998 99999999999999 67789999999999
Q ss_pred cccCCCCc--ceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcc-------hhcHHHHHH
Q 041285 586 KLMKPDQT--RTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPED-------QVILEEWVY 655 (724)
Q Consensus 586 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~-------~~~l~~~~~ 655 (724)
+.+..... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... ...+.. +.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~-i~ 258 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR-IF 258 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH-HH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH-HH
Confidence 87653322 222346789999999998874 58999999999999999999999997543210 111111 11
Q ss_pred HHHHcCC---cccccc------------cc---ccC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 656 QCFENGN---LGQLIE------------DE---DVD---------KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 656 ~~~~~~~---~~~~~~------------~~---~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..+.... ...+.. .. ... ......+.+++..||+.||.+|||++|+++
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110000 000000 00 000 001345789999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.03 Aligned_cols=250 Identities=24% Similarity=0.289 Sum_probs=187.6
Q ss_pred hhcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC--------cCceeeeeeEEe----
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH--------HRNLVRLLGYSF---- 512 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~---- 512 (724)
..+.+.++||+|+||.||++... +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 34556688999999999999864 5789999999753 344567899999999985 788999999988
Q ss_pred cccceEEEEeeccCCChhhhc-CC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC--------
Q 041285 513 DVSNKILVYEYMSNGSLADVY-SS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-------- 575 (724)
Q Consensus 513 ~~~~~~lv~e~~~~gsL~~~l-~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-------- 575 (724)
+....++||||+ +++|.+.+ .. ... ..+.||++||.|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 566889999999 55555554 22 121 23789999999999842 799999999999998775
Q ss_pred -----------------------------------------CeEEccccCccccCCCCcceeeccccCccccCcccccCC
Q 041285 576 -----------------------------------------YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614 (724)
Q Consensus 576 -----------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 614 (724)
.+||+|||++...... .....||+.|+|||.+.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 2234689999999999999
Q ss_pred CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH---HHHHH--------HcCCc-----------cccc-----
Q 041285 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW---VYQCF--------ENGNL-----------GQLI----- 667 (724)
Q Consensus 615 ~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~---~~~~~--------~~~~~-----------~~~~----- 667 (724)
.++.++||||||+++|||++|+.||..........-... ..+.. ..+.. ..+.
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 999999999999999999999999976543221111111 11110 00000 0000
Q ss_pred -------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 -------EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 -------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
............+.+++.+||+.||++|||+.|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001224566788999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.34 Aligned_cols=256 Identities=26% Similarity=0.309 Sum_probs=182.8
Q ss_pred HHHHHHhhccc--ccccCcCccceEEEEEeeCCcEEEEEEcccccch-----------hHHHHHHHHHhhcccCcCceee
Q 041285 440 YAELEKMTDGF--KEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE-----------GEREFQTEIKAIGRTHHRNLVR 506 (724)
Q Consensus 440 ~~el~~~t~~f--~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 506 (724)
..++......| .+.||+|+||.||++...+++.||||++...... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45666655555 4789999999999999888999999998643221 1367999999999999999999
Q ss_pred eeeEEec-----ccceEEEEeeccCCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC
Q 041285 507 LLGYSFD-----VSNKILVYEYMSNGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE 573 (724)
Q Consensus 507 l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~ 573 (724)
+++++.. ....++||||++ |+|.+++.... . ..+.||+.||.|||+. +|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 9999854 335799999997 67777764321 1 2278999999999998 9999999999999999
Q ss_pred CCCeEEccccCccccCCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH
Q 041285 574 NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE 652 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~ 652 (724)
++.+||+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~ 245 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ--LNK 245 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH
T ss_pred CCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 99999999999975433222 223468899999999877 6789999999999999999999999976432111 111
Q ss_pred HHHHHHHcCC-------------------cccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 653 WVYQCFENGN-------------------LGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 653 ~~~~~~~~~~-------------------~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+...... ........ .........+.+++..||+.||++|||+.|+++.
T Consensus 246 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 -IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111110000 00000000 0111224568899999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.88 Aligned_cols=248 Identities=25% Similarity=0.265 Sum_probs=178.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 518 (724)
+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 345578999999999999864 5789999998753 2233467889999999999999999999998654 679
Q ss_pred EEEeeccCCChhhhcCC-CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSS-PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||+++ +|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 107 lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 181 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181 (371)
T ss_dssp EEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred EEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc-
Confidence 99999975 67776642 222 2378999999999998 99999999999999999999999999998654322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHH------------------HH
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEW------------------VY 655 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~------------------~~ 655 (724)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +... ..
T Consensus 182 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 182 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ---------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred -ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHHhhhHHH
Confidence 22335689999999999999999999999999999999999999975432111 0000 00
Q ss_pred HHHHcCC-c---------ccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 656 QCFENGN-L---------GQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 656 ~~~~~~~-~---------~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....... . .....+. .........+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000 0 0000000 011223567899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.09 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=180.0
Q ss_pred ccccccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEe--------------c
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSF--------------D 513 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------~ 513 (724)
...+.||+|+||.||++.... ++.||||++........+++.+|++++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 445789999999999999864 8899999987655566678999999999999999999999874 3
Q ss_pred ccceEEEEeeccCCChhhhcCCCCc------chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCcc
Q 041285 514 VSNKILVYEYMSNGSLADVYSSPPK------NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAK 586 (724)
Q Consensus 514 ~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~ 586 (724)
....++||||++ ++|.+++..... ..+.||++||+|||+. +|+||||||+|||++ +++.+||+|||++.
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred cCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 467899999997 699999865332 2278999999999998 999999999999997 56799999999998
Q ss_pred ccCCCCc--ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH--------
Q 041285 587 LMKPDQT--RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY-------- 655 (724)
Q Consensus 587 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~-------- 655 (724)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ +.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILESIPVVHEE 247 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHSCCCCHH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCchh
Confidence 7643222 12233457899999998765 6789999999999999999999999975432111 110000
Q ss_pred --HHHHcCCccccc-----ccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 656 --QCFENGNLGQLI-----EDE----DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 656 --~~~~~~~~~~~~-----~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... ..+...+ .+. .........+.+++..||+.||++|||+.|+++
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 248 DRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 0000000 000 001122456889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=313.02 Aligned_cols=187 Identities=24% Similarity=0.288 Sum_probs=156.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc------CcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT------HHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~lv 520 (724)
+.+.+.||+|+||.||++... .++.||||++... ....+++.+|++++..+ +|+||+++++++......++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 445688999999999999875 4789999999753 23345677788877776 577999999999999999999
Q ss_pred EeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC--eEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY--AKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~--~kl~Dfgl~~~~~ 589 (724)
|||+. ++|.+++... .+ ..+.||++||+|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 6888887432 21 2378999999999998 9999999999999999887 9999999997654
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL 643 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~ 643 (724)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 254 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 254 QR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 32 223468999999999999999999999999999999999999987643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.25 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=186.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc-------------hhHHHHHHHHHhhcccCcCceeeeeeEEec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-------------EGEREFQTEIKAIGRTHHRNLVRLLGYSFD 513 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 513 (724)
+.+.++||+|+||+||++... .++.||||.+..... ...+++.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445688999999999999875 478999999875321 234678999999999999999999999999
Q ss_pred ccceEEEEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---CeEEcccc
Q 041285 514 VSNKILVYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR---YAKISDFA 583 (724)
Q Consensus 514 ~~~~~lv~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~---~~kl~Dfg 583 (724)
....++||||+++|+|.+++.. ... ..+.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 9999999999999999888732 222 2378999999999998 999999999999998775 69999999
Q ss_pred CccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 584 LAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 584 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
++........ .....||+.|+|||.+. ..++.++||||||+++|+|++|..||...... . ....+..+..
T Consensus 195 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~i~~~~~ 264 (504)
T 3q5i_A 195 LSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------D-IIKKVEKGKY 264 (504)
T ss_dssp TCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC
T ss_pred CCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCC
Confidence 9987654322 23356899999999986 56899999999999999999999999754321 1 1222333322
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...... .......+.+++..||+.+|.+|||+.|+++
T Consensus 265 ~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 YFDFND---WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccc---cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111100 0112345889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.97 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=188.4
Q ss_pred hcccccccCcCccceEEEEEe--eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCc------eeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM--INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN------LVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 518 (724)
.+.+.+.||+|+||.||++.. .+++.||||.++.. ....+.+.+|++++++++|++ ++++++++.+.+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 455678899999999999986 35789999999753 334567889999999987765 999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC----------------
Q 041285 519 LVYEYMSNGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---------------- 573 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---------------- 573 (724)
+||||+ +++|.+++.... . ..+.||++||+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889998874321 1 2378999999999998 9999999999999987
Q ss_pred ---CCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH
Q 041285 574 ---NRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 574 ---~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l 650 (724)
++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-- 243 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL-- 243 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH--
T ss_pred cccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH--
Confidence 6689999999998654321 2346899999999999999999999999999999999999999754322111
Q ss_pred HHHHHHHHH--------cCCccc-------------------------cccccccCHHHHHHHHHHHHHcccCCCCCCCC
Q 041285 651 EEWVYQCFE--------NGNLGQ-------------------------LIEDEDVDKKQLERMIKVALWCILDEPSLRPS 697 (724)
Q Consensus 651 ~~~~~~~~~--------~~~~~~-------------------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 697 (724)
. ....... ...... +.............+.+++..||+.||.+|||
T Consensus 244 ~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 244 A-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp H-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred H-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1 1111100 000000 00001112345677899999999999999999
Q ss_pred HHHHHH
Q 041285 698 MKKVLL 703 (724)
Q Consensus 698 ~~evl~ 703 (724)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=306.09 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=182.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccce------E
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK------I 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------~ 518 (724)
+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...... +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 345578999999999999875 58899999987532 23346788999999999999999999999877655 9
Q ss_pred EEEeeccCCChhhhcCCC-Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSSP-PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~-~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||+. ++|.+++... .. ..+.+|+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-- 197 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 197 (371)
T ss_dssp EEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred EEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence 9999997 6888877542 22 2377999999999998 9999999999999999999999999999865432
Q ss_pred ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC------Cc---
Q 041285 594 RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG------NL--- 663 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------~~--- 663 (724)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +... ....... .+
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i-~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 198 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQI-LKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH-HHHHCCCCHHHHTTCSCH
T ss_pred --cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCcHHHHHHhhhh
Confidence 233567999999999887 6789999999999999999999999975432111 1110 0000000 00
Q ss_pred ------cccccccc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 ------GQLIEDED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 ------~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
..+..... ........+.+++..||+.||++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 011224568899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=303.34 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=184.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 520 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345578999999999999875 58899999986432 23345788999999999999999999988764 678999
Q ss_pred EeeccCCChhhhcCCC--Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 521 YEYMSNGSLADVYSSP--PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~--~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
+||++ ++|.+++... .. ..+.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 93 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp ECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 99997 6888887432 22 2378999999999998 9999999999999999999999999999876532211
Q ss_pred ---------eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC--
Q 041285 595 ---------TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN-- 662 (724)
Q Consensus 595 ---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 662 (724)
......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ +. ..........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~ 245 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LL-LIFGIIGTPHSD 245 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCCST
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HH-HHHHHhCCCchh
Confidence 1123468999999998764 6789999999999999999999999975432111 10 0111110000
Q ss_pred -----------------ccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 663 -----------------LGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 663 -----------------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0001122456789999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=311.36 Aligned_cols=237 Identities=26% Similarity=0.340 Sum_probs=175.8
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 527 (724)
...+.||+|+||+|+.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+....++||||++ |
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 3457899999999665555678999999986532 23467899999999 89999999999999999999999996 6
Q ss_pred ChhhhcCCCC--------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-----CCCeEEccccCccccCCCCc-
Q 041285 528 SLADVYSSPP--------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-----NRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 528 sL~~~l~~~~--------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-----~~~~kl~Dfgl~~~~~~~~~- 593 (724)
+|.+++.... ...+.||++||.|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9998884321 23478999999999998 9999999999999953 33588999999987653322
Q ss_pred -ceeeccccCccccCccccc---CCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 594 -RTFTGIRGTRGYVAPEWHW---NLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 594 -~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
.......||+.|+|||.+. ...++.++||||||+++|||++ |..|+....... ........... ...
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~-~~~ 251 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLD-CLH 251 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCCCT-TSC
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCCcc-ccC
Confidence 2223467999999999987 4567889999999999999999 888885432211 11111111111 111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
........+.+++.+||+.||++|||+.||++
T Consensus 252 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 ---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 12234456789999999999999999999983
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=296.68 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=188.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---------chhHHHHHHHHHhhcccC-cCceeeeeeEEecccc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---------AEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSN 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 516 (724)
+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++.++. ||||+++++++.+...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 344578999999999999885 57899999986432 122356889999999995 9999999999999999
Q ss_pred eEEEEeeccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 517 KILVYEYMSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
.++||||+++++|.+++.. .. +..+.+|+.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 9999999999999998843 22 22378999999999998 99999999999999999999999999998765
Q ss_pred CCCcceeeccccCccccCccccc------CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHW------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
.... .....+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... . ....+..+..
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~ 246 (298)
T 1phk_A 176 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L-MLRMIMSGNY 246 (298)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCC
T ss_pred CCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------H-HHHHHhcCCc
Confidence 4322 23356899999999875 456789999999999999999999998653211 1 1122222222
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..... ........+.+++..||+.+|++||++.|+++
T Consensus 247 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 QFGSP---EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCTT---TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCcc---cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110 11123456889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=300.62 Aligned_cols=238 Identities=26% Similarity=0.406 Sum_probs=180.0
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec------ccceEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD------VSNKILV 520 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~lv 520 (724)
.+.+.||+|+||.||++... +++.||||.+... ....+++.+|+.++.++ +||||+++++++.. ....++|
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 34578999999999999874 6889999998753 33456899999999999 89999999999986 4578999
Q ss_pred EeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 521 YEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|||+++++|.+++... .. ..+.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999988432 11 2267999999999998 9999999999999999999999999999865432
Q ss_pred CcceeeccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.|+....... .... +........
T Consensus 183 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~ 254 (326)
T 2x7f_A 183 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFL-IPRNPAPRL 254 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSCCCCC
T ss_pred cc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHH-hhcCccccC
Confidence 21 122346899999999987 5678899999999999999999999986532111 1111 112211111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. ......+.+++..||+.+|.+||++.++++
T Consensus 255 ~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 255 KS-----KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SC-----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cc-----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 112345888999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=296.80 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=171.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc--hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeec
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYM 524 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 524 (724)
..+.+.||+|+||.||++... +++.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 445688999999999999874 688999999875322 22234555556688889999999999999999999999999
Q ss_pred cCCChhhhcCC-------CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 525 SNGSLADVYSS-------PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 525 ~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+ ++|.+++.. ..+ ..+.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++........
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 7 588776521 222 2378999999999984 3899999999999999999999999999986644322
Q ss_pred ceeeccccCccccCcccc----cCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWH----WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.....|++.|+|||.+ ....++.++||||||+++|||++|+.|+........ ........... ...
T Consensus 166 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~-~~~-- 235 (290)
T 3fme_A 166 --KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEPSP-QLP-- 235 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSCCC-CCC--
T ss_pred --ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccCCC-Ccc--
Confidence 1224689999999996 556789999999999999999999999975322111 11222222211 111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1122345889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.06 Aligned_cols=241 Identities=22% Similarity=0.323 Sum_probs=181.0
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccC--cCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTH--HRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||++...+++.||||.+... .....+.+.+|++++.+++ |+||+++++++.+....++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4456789999999999999888999999998642 2334567999999999997 5999999999999999999999
Q ss_pred ccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-e
Q 041285 524 MSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-T 595 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~-~ 595 (724)
+.+++|.+++... . +..+.++++||.|||+. +|+||||||+|||+++ +.+||+|||++......... .
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence 5688999988432 1 12378999999999998 9999999999999964 78999999999876543322 1
Q ss_pred eeccccCccccCcccccC-----------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc
Q 041285 596 FTGIRGTRGYVAPEWHWN-----------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 664 (724)
.....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....... .....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~-~~~~~ 258 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-DPNHE 258 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH-CTTSC
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHH-hcccc
Confidence 223568999999999875 468889999999999999999999997543211 1111111 11111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
... +... ...+.+++..||+.+|++||++.|+++.
T Consensus 259 ~~~-~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEF-PDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCC-CCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC-cccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 1111 3457889999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=299.83 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=182.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccc------eE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN------KI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 518 (724)
+.+.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 345578999999999999875 58899999986532 2334678999999999999999999999987654 49
Q ss_pred EEEeeccCCChhhhcCCC-Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSSP-PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~-~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||++ ++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 106 lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp EEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred EEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 9999997 6888887532 22 2378999999999998 9999999999999999999999999999865432
Q ss_pred ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-----------
Q 041285 594 RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG----------- 661 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 661 (724)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +.. +.......
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHH-HHHHHCBCCHHHHTTCSCH
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHHHHHhhH
Confidence 223467999999999877 6789999999999999999999999976432111 111 00100000
Q ss_pred -------Cccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 662 -------NLGQLIED--EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 662 -------~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0111223456889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.75 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=170.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc-------eEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN-------KIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~l 519 (724)
+.+.+.||+|+||.||++... +++.||||++... ......+.+|++.+..++||||+++++++..... .++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 344578999999999999885 5889999998653 2333456788888999999999999999976443 789
Q ss_pred EEeeccCCChhhhc----CCC---C----cchHHHHHHHccccc--ccCCCceEeCCCCCCCeeeCC-CCCeEEccccCc
Q 041285 520 VYEYMSNGSLADVY----SSP---P----KNNLIGIARGILYLH--DECESQIIHCDIKPQNILMDE-NRYAKISDFALA 585 (724)
Q Consensus 520 v~e~~~~gsL~~~l----~~~---~----~~~~~~ia~~l~yLH--~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~ 585 (724)
||||++++ |...+ ... . +..+.+++.||.||| +. +|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 104 VMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred Eeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 99999875 33322 221 1 123779999999999 66 9999999999999996 899999999999
Q ss_pred cccCCCCcceeeccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH--------
Q 041285 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ-------- 656 (724)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~-------- 656 (724)
........ .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... .+......
T Consensus 180 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 180 KKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGCPSREV 255 (360)
T ss_dssp BCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred eecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCCCCHHH
Confidence 87654332 22356899999999987654 8999999999999999999999997643221 11111110
Q ss_pred --HHHc-CCccccccccc---------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 657 --CFEN-GNLGQLIEDED---------VDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 657 --~~~~-~~~~~~~~~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+.. .......+... ........+.+++..||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00000000000 111235678999999999999999999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.10 Aligned_cols=247 Identities=25% Similarity=0.352 Sum_probs=184.5
Q ss_pred cccccccCcCccceEEEEEe--eCCcEEEEEEcccccc--hhHHHHHHHHHhhccc---CcCceeeeeeEEe-----ccc
Q 041285 448 DGFKEEIGRGSSGTVYKGTM--INGKFVAVKRLQKMLA--EGEREFQTEIKAIGRT---HHRNLVRLLGYSF-----DVS 515 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 515 (724)
+.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34567899999999999997 3578999999875322 1234577888877766 8999999999987 556
Q ss_pred ceEEEEeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 516 NKILVYEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..++||||++ ++|.+++... .. ..+.||++||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999997 6999887432 11 2277999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---c
Q 041285 587 LMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---L 663 (724)
Q Consensus 587 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~ 663 (724)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .+.. +........ .
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~ 243 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGK-ILDVIGLPGEEDW 243 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCGGGS
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHcCCCCcccC
Confidence 654322 2233568999999999999999999999999999999999999997543211 1111 111111000 0
Q ss_pred ccc-------ccc------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQL-------IED------EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~-------~~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... ... ..........+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000 0011223456789999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=287.10 Aligned_cols=243 Identities=24% Similarity=0.305 Sum_probs=189.8
Q ss_pred HhhcccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 345566789999999999999885 58899999986532 234567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC---CCeEEccccCccccCCC
Q 041285 522 EYMSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN---RYAKISDFALAKLMKPD 591 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~---~~~kl~Dfgl~~~~~~~ 591 (724)
||+++++|.+++.. .. +..+.+|++||.|||+. +++|+||||+||+++.+ ..+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999887732 22 22378999999999998 99999999999999754 46999999999876543
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.|+...... . ....+..+........
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~~~-- 245 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAFDLPQ-- 245 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCCCSGG--
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCCCchh--
Confidence 22 122457899999998865 4899999999999999999999998754211 1 1222333322211111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 246 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 -WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0112345889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.50 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=190.1
Q ss_pred hhcccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccC-----------cCceeeeeeEEec
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-----------HRNLVRLLGYSFD 513 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 513 (724)
..+.+.+.||+|+||.||++.. .+++.||||.+... ....+.+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 3456678999999999999987 45889999999753 334567889999998886 8999999999886
Q ss_pred cc----ceEEEEeeccCCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC------CC
Q 041285 514 VS----NKILVYEYMSNGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD------EN 574 (724)
Q Consensus 514 ~~----~~~lv~e~~~~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~------~~ 574 (724)
.. ..++||||+ +++|.+++.. ... ..+.||+.||+|||+. .+|+||||||+|||++ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCc
Confidence 54 789999999 8999998743 111 2378999999999984 2899999999999994 44
Q ss_pred CCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH
Q 041285 575 RYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV 654 (724)
Q Consensus 575 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~ 654 (724)
+.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...............
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 57999999999876432 22346899999999999999999999999999999999999999754322111001111
Q ss_pred HHHHH-cCCccc--------------------cc-------------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 041285 655 YQCFE-NGNLGQ--------------------LI-------------EDEDVDKKQLERMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 655 ~~~~~-~~~~~~--------------------~~-------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
..... .+.+.. .+ ............+.+++..||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 11110 011000 00 001234566788999999999999999999999
Q ss_pred HHH--HhccCCCCCC
Q 041285 701 VLL--MLEGTMDIPI 713 (724)
Q Consensus 701 vl~--~L~~~~~~~~ 713 (724)
+++ -+.+......
T Consensus 331 ll~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 331 LVNHPWLKDTLGMEE 345 (373)
T ss_dssp HHTCGGGTTCTTCTT
T ss_pred HhhChhhhcccCccc
Confidence 997 4555444433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.83 Aligned_cols=244 Identities=26% Similarity=0.341 Sum_probs=177.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv 520 (724)
+.+.+.||+|+||.||+++.. +++.||||++.... +.+.+|++++++++|+|||++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 445678999999999999985 48999999986532 2345799999999999999999998542 236799
Q ss_pred EeeccCCChhhhcC-------CCC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC-CCeEEccccCcccc
Q 041285 521 YEYMSNGSLADVYS-------SPP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN-RYAKISDFALAKLM 588 (724)
Q Consensus 521 ~e~~~~gsL~~~l~-------~~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~-~~~kl~Dfgl~~~~ 588 (724)
|||+++ +|.+.+. ... +..+.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 5554432 112 12378999999999998 99999999999999965 56899999999876
Q ss_pred CCCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH-------HHH-
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ-------CFE- 659 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~-------~~~- 659 (724)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+...+.. .+.
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh
Confidence 43322 2235689999999998765 78999999999999999999999997643221 11111110 000
Q ss_pred -cCCcccccccc--------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 660 -NGNLGQLIEDE--------DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 660 -~~~~~~~~~~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+. .........+.+++.+||+.||++||++.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 01111110000 011122456889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.68 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=178.9
Q ss_pred hcccccccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc-----------
Q 041285 447 TDGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV----------- 514 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 514 (724)
.+.+.+.||+|+||.||++.. .+++.||||++.... +...+|++++++++|+||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 345568999999999999987 468999999986532 2335799999999999999999998543
Q ss_pred ---------------------------cceEEEEeeccCCChhhhcCC-------CCc----chHHHHHHHcccccccCC
Q 041285 515 ---------------------------SNKILVYEYMSNGSLADVYSS-------PPK----NNLIGIARGILYLHDECE 556 (724)
Q Consensus 515 ---------------------------~~~~lv~e~~~~gsL~~~l~~-------~~~----~~~~~ia~~l~yLH~~~~ 556 (724)
...++||||++ ++|.+.+.. ... ..+.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 23789999998 577666531 121 2277999999999998
Q ss_pred CceEeCCCCCCCeeeC-CCCCeEEccccCccccCCCCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhc
Q 041285 557 SQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIIC 634 (724)
Q Consensus 557 ~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~ellt 634 (724)
+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999997 688999999999987654332 2234679999999998775 48999999999999999999
Q ss_pred cccCCCCCCCcchhcHHHHHHHHHHc----------C-----Ccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCC
Q 041285 635 CRRCFDQNLPEDQVILEEWVYQCFEN----------G-----NLGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRP 696 (724)
Q Consensus 635 g~~p~~~~~~~~~~~l~~~~~~~~~~----------~-----~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RP 696 (724)
|+.||......+. +...+ +.... . ......... .........+.+++..||+.+|.+||
T Consensus 238 g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 238 GKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp SSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999976432211 11111 10000 0 000000000 01122345688999999999999999
Q ss_pred CHHHHHH
Q 041285 697 SMKKVLL 703 (724)
Q Consensus 697 s~~evl~ 703 (724)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.66 Aligned_cols=236 Identities=21% Similarity=0.248 Sum_probs=156.1
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEec----ccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----VSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~~~~ 526 (724)
+.||+|+||.||++... +++.||||++.... ....+....+..++|+||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999886 58999999986531 122222334556699999999999876 4458999999999
Q ss_pred CChhhhcCCCC---------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCcc
Q 041285 527 GSLADVYSSPP---------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 527 gsL~~~l~~~~---------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+|.+++.... +..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||++.......
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-- 185 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence 99999985432 12278999999999998 9999999999999976 4559999999998654322
Q ss_pred eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 595 TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 595 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....+|+.|+|||.+....++.++||||||+++|||++|+.||......... .........+... .+.....
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~ 258 (336)
T 3fhr_A 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQYG---FPNPEWS 258 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C---CCTTTST
T ss_pred -cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhccccc---cCchhhc
Confidence 22346799999999998888999999999999999999999999654322110 0000111111110 0101111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++..||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23456889999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=300.31 Aligned_cols=189 Identities=26% Similarity=0.349 Sum_probs=155.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cC-----ceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HR-----NLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~lv 520 (724)
+.+.+.||+|+||.||+|... +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++...+..++|
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 445678999999999999875 5789999999753 233467788888888874 44 499999999999999999
Q ss_pred EeeccCCChhhhcCCC-----Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC--CCCCeEEccccCccccC
Q 041285 521 YEYMSNGSLADVYSSP-----PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD--ENRYAKISDFALAKLMK 589 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~-----~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~--~~~~~kl~Dfgl~~~~~ 589 (724)
|||++ ++|.+++... .. ..+.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++...
T Consensus 135 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 99996 5998887432 11 2278999999999953 23899999999999995 47789999999998764
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCC
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNL 643 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~ 643 (724)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 213 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 213 QR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 223568999999999999999999999999999999999999997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-34 Score=309.68 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=180.0
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccc------eEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN------KILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~lv~ 521 (724)
+.+.+.||+|+||.||+++...+..||+|++.... +...+|++++++++||||+++++++..... .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 45568899999999999999877779999886432 223479999999999999999999865433 78999
Q ss_pred eeccCCChhhhc------CCCCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCccccCC
Q 041285 522 EYMSNGSLADVY------SSPPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKP 590 (724)
Q Consensus 522 e~~~~gsL~~~l------~~~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~ 590 (724)
||++++.+.... ..... ..+.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999876444332 11221 2367999999999998 999999999999998 799999999999987643
Q ss_pred CCcceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHH----------
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE---------- 659 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~---------- 659 (724)
... .....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +.... +...
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~-~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEII-KVLGTPSREQIKTM 269 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHH
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCHHHHHhh
Confidence 322 2234679999999998765 589999999999999999999999976432211 11111 1000
Q ss_pred -----cCCcccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 660 -----NGNLGQLIEDE---DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 660 -----~~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+....... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000 0111234568999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=297.27 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=184.8
Q ss_pred hcccccccCcCccceEEEEEeeC-C-cEEEEEEcccccchhHHHHHHHHHhhcccCcCc------eeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN-G-KFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN------LVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 518 (724)
.+.+.+.||+|+||.||++.... + +.||||.++.. ....+.+.+|+.++++++|++ ++.+++++......+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 45566889999999999998743 3 68999999753 344567889999999998776 899999999999999
Q ss_pred EEEeeccCCChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeee------------------
Q 041285 519 LVYEYMSNGSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILM------------------ 571 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll------------------ 571 (724)
+||||+ +++|.+++.. ... ..+.||++||+|||+. +|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 5666665522 111 2278999999999998 99999999999999
Q ss_pred -CCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH
Q 041285 572 -DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 572 -~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l 650 (724)
+.++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-- 248 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL-- 248 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--
T ss_pred ccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 567889999999998654322 2356899999999999999999999999999999999999999754322111
Q ss_pred HHHHHHHHH--------cCCcccc-------------------------ccccccCHHHHHHHHHHHHHcccCCCCCCCC
Q 041285 651 EEWVYQCFE--------NGNLGQL-------------------------IEDEDVDKKQLERMIKVALWCILDEPSLRPS 697 (724)
Q Consensus 651 ~~~~~~~~~--------~~~~~~~-------------------------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 697 (724)
. ....... ....... .............+.+++..||+.||++|||
T Consensus 249 ~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 249 V-MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp H-HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred H-HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 1 1111100 0000000 0000112234567899999999999999999
Q ss_pred HHHHHH
Q 041285 698 MKKVLL 703 (724)
Q Consensus 698 ~~evl~ 703 (724)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=291.50 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=164.5
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccccc-hh-HHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-EG-EREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||++... +++.||||.+..... .. .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34578999999999999985 588999999875322 22 234455556778889999999999999999999999999
Q ss_pred CCChhhhcC----CCCc----chHHHHHHHcccccc-cCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 526 NGSLADVYS----SPPK----NNLIGIARGILYLHD-ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 526 ~gsL~~~l~----~~~~----~~~~~ia~~l~yLH~-~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
++.+..+.. .... ..+.+|++||.|||+ . +|+|+||||+|||++.++.+||+|||++........ .
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 181 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--K 181 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--c
Confidence 455554442 1222 237899999999998 4 899999999999999999999999999976543322 2
Q ss_pred eccccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 597 TGIRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||....... ........ +..........
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~~~~~~~ 255 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQ-EEPPLLPGHMG 255 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHH-SCCCCCCSSSC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhc-cCCCCCCccCC
Confidence 2346899999999984 4568889999999999999999999987532211 11112222 21111111111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||.+||++.|+++
T Consensus 256 ----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 256 ----FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2345888999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-33 Score=295.92 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=162.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHH-hhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIK-AIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+.+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34578999999999999985 58899999997532 233345666665 7777899999999999999999999999998
Q ss_pred CCChhhhcC------CC--Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYS------SP--PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~------~~--~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+ +|.+++. .. .. ..+.++++||.|||+. .+|+||||||+|||++.++.+||+|||++........
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 5 7776653 11 11 2378999999999984 3899999999999999999999999999986643322
Q ss_pred ceeeccccCccccCcccc----cCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWH----WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.....|++.|+|||.+ .+..++.++||||||+++|||++|+.||........ .. .....+....+..
T Consensus 182 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~~~~~~- 252 (327)
T 3aln_A 182 --KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDPPQLSN- 252 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCCCC-
T ss_pred --cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCCCCCCC-
Confidence 2223689999999998 456789999999999999999999999875321100 00 0001111111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++.+||+.||++||++.|+++
T Consensus 253 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 -SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001122346889999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=318.97 Aligned_cols=231 Identities=23% Similarity=0.310 Sum_probs=180.5
Q ss_pred hcccccccCcCccceEEEEEee--CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccc-----eE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI--NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSN-----KI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~ 518 (724)
.+.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++.+++||||+++++++.+.+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 3456688999999999999975 58999999986432 3344678999999999999999999999987665 69
Q ss_pred EEEeeccCCChhhhcCC-CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 519 LVYEYMSNGSLADVYSS-PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~-~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+||||+++++|.+++.. ..+ ..+.||++||.|||+. +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 161 lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp EEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred EEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence 99999999999988754 222 2278999999999998 99999999999999986 8999999999876543
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|+|||.+.+.. +.++||||||+++|||++|..|+....... +. .....
T Consensus 235 ---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~----~~~~~ 290 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP----EDDPV 290 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC----TTCHH
T ss_pred ---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc----ccccc
Confidence 3356899999999987654 889999999999999999988875421110 00 00011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcc
Q 041285 674 KKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEG 707 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~ 707 (724)
......+.+++.+||+.||++|| +++++.+.|.+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 12235688999999999999999 56666666654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=290.99 Aligned_cols=232 Identities=23% Similarity=0.390 Sum_probs=184.2
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccch------hHHHHHHHHHhhcccC--cCceeeeeeEEecccce
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE------GEREFQTEIKAIGRTH--HRNLVRLLGYSFDVSNK 517 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 517 (724)
.+.+.+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++.+++ |+||+++++++.+.+..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 3456689999999999999864 5789999998754221 2356788999999996 59999999999999999
Q ss_pred EEEEeeccC-CChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCcccc
Q 041285 518 ILVYEYMSN-GSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLM 588 (724)
Q Consensus 518 ~lv~e~~~~-gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~ 588 (724)
++|+|++.+ ++|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++ +++.+||+|||++...
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999976 899988742 222 2367999999999998 999999999999998 7889999999999876
Q ss_pred CCCCcceeeccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 667 (724)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... .+...
T Consensus 201 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~-~~~~~--- 261 (320)
T 3a99_A 201 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-RGQVF--- 261 (320)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-HCCCC---
T ss_pred cccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh-ccccc---
Confidence 5332 223568999999999887765 678999999999999999999985420 111 11111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 668 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.+.. ....+.+++.+||+.+|++||++.|+++.
T Consensus 262 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 23458899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=289.74 Aligned_cols=233 Identities=25% Similarity=0.410 Sum_probs=178.5
Q ss_pred HhhcccccccCcCccceEEEEEee-CCcEEEEEEcccccc------hhHHHHHHHHHhhccc----CcCceeeeeeEEec
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA------EGEREFQTEIKAIGRT----HHRNLVRLLGYSFD 513 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~g~~~~ 513 (724)
...+.+.+.||+|+||.||++... +++.||||.+..... .....+.+|+.++.++ +|+||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 344556789999999999999874 578999999965322 1234567799999888 89999999999999
Q ss_pred ccceEEEEee-ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccC
Q 041285 514 VSNKILVYEY-MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFAL 584 (724)
Q Consensus 514 ~~~~~lv~e~-~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl 584 (724)
.+..++|+|| +.+++|.+++.. ... ..+.+|++||.|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 789999998843 222 2378999999999998 999999999999998 889999999999
Q ss_pred ccccCCCCcceeeccccCccccCcccccCCCCC-cccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 585 AKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT-AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 585 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
+....... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.... + ......
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~-~~~~~~ 250 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------E-ILEAEL 250 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H-HHHTCC
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------H-Hhhhcc
Confidence 98765432 2335689999999998877664 58999999999999999999986320 1 111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ........+.+++.+||+.+|++||++.|+++
T Consensus 251 ~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 H-------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp C-------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 01112345788999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=285.51 Aligned_cols=224 Identities=14% Similarity=0.152 Sum_probs=173.9
Q ss_pred hcccccccCcCccceEEEEEeeC-CcEEEEEEcccccc---hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.+.||+|+||.||++.... ++.||||.+..... ...+.+.+|+..+.+++|+||+++++++.+.+..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 34566899999999999999854 88999999976422 234679999999999999999999999999999999999
Q ss_pred eccCCChhhhcCCCCc-----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 523 YMSNGSLADVYSSPPK-----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~-----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+++++|.+++..... ..+.||++||.|||+. +|+||||||+|||++.++.+||++++
T Consensus 112 ~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp CCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred ecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 9999999999865331 2378999999999998 99999999999999999999998443
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
|++ +++.++||||||+++|||++|+.||............ .... .+. ............
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~---~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQ---PIEPADIDRDIP 233 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSC---BCCHHHHCTTSC
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccC---CCChhhcccCCC
Confidence 333 3688999999999999999999999765432110000 0000 000 000001112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
..+.+++.+||+.||++| |+.|+++.|+...
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 558899999999999999 9999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=312.34 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=184.0
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEec------ccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD------VSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 518 (724)
.+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 3456689999999999999874 5889999998753 23445679999999999999999999998765 66789
Q ss_pred EEEeeccCCChhhhcCCC------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC---eEEccccCc
Q 041285 519 LVYEYMSNGSLADVYSSP------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY---AKISDFALA 585 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~---~kl~Dfgl~ 585 (724)
+||||+++++|.+++... .. ..+.+++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 999999999999988532 11 2378999999999998 9999999999999987665 999999999
Q ss_pred cccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchh---cHHHHHHHHHH---
Q 041285 586 KLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV---ILEEWVYQCFE--- 659 (724)
Q Consensus 586 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~---~l~~~~~~~~~--- 659 (724)
........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 172 KELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 87654322 23357899999999999999999999999999999999999998653210000 00000000000
Q ss_pred -cCCc--ccc-ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 041285 660 -NGNL--GQL-IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKK 700 (724)
Q Consensus 660 -~~~~--~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 700 (724)
.+.. ... -.+..........+.+++..||+.||++|||+.|
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 000 0011233446678999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=277.14 Aligned_cols=210 Identities=21% Similarity=0.303 Sum_probs=161.8
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhh-cccCcCceeeeeeEEec----ccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAI-GRTHHRNLVRLLGYSFD----VSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~e~~~ 525 (724)
+.||+|+||.||++... +++.||||.++.. ..+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 67999999999999874 5789999998642 4567888888 55599999999999876 677899999999
Q ss_pred CCChhhhcCCCC-----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYSSPP-----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~~~~-----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+++|.+++.... . ..+.+++.||.|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999884321 1 2278999999999998 9999999999999998 7889999999986532
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc-cc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE-DV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~ 672 (724)
+..++.++||||||+++|||++|+.||........ ............ ..
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQYEF 221 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCCSS
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccccC
Confidence 23457799999999999999999999965322110 000000000000 01
Q ss_pred C----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 673 D----KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 673 ~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
. ......+.+++..||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 122456889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=282.51 Aligned_cols=234 Identities=13% Similarity=0.060 Sum_probs=170.9
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEccccc--------chhHHHHHHHHHhhcccC---------cCceeeeee
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTH---------HRNLVRLLG 509 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~g 509 (724)
.+.+.+.||+|+||.||+++. +++.||||++.... ....+.+.+|+.++++++ |+|||++.+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 345568899999999999987 78999999997532 122367889999888885 777777666
Q ss_pred EEe-----------------c-------------ccceEEEEeeccCCChhhhcCCCC--c----chHHHHHHHccccc-
Q 041285 510 YSF-----------------D-------------VSNKILVYEYMSNGSLADVYSSPP--K----NNLIGIARGILYLH- 552 (724)
Q Consensus 510 ~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH- 552 (724)
.+. + ....++||||+++|++.+.+.... . ..+.||+.||.|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 179 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA 179 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 542 2 678999999999997666663322 1 22789999999999
Q ss_pred ccCCCceEeCCCCCCCeeeCCCC--------------------CeEEccccCccccCCCCcceeeccccCccccCccccc
Q 041285 553 DECESQIIHCDIKPQNILMDENR--------------------YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW 612 (724)
Q Consensus 553 ~~~~~~i~H~dlk~~NIll~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 612 (724)
+. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||.+.
T Consensus 180 ~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 180 SL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGC
T ss_pred hC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhc
Confidence 88 999999999999999887 8999999999866432 236899999999998
Q ss_pred CCCCCcccceeehhHH-HHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCC
Q 041285 613 NLPITAKADVYSFGVV-LLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDE 691 (724)
Q Consensus 613 ~~~~~~k~Dv~S~Gvl-l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~ 691 (724)
+.. +.++||||++.. .+++++|..|+.. ........+.+.....................+.+++.+||+.+
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 766 889999998766 7888888887732 11101111111111111111111223456778999999999966
Q ss_pred CCCCCCHHHHH
Q 041285 692 PSLRPSMKKVL 702 (724)
Q Consensus 692 p~~RPs~~evl 702 (724)
|++|++
T Consensus 324 -----sa~e~l 329 (336)
T 2vuw_A 324 -----SATDLL 329 (336)
T ss_dssp -----SHHHHH
T ss_pred -----CHHHHH
Confidence 899887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=289.22 Aligned_cols=225 Identities=14% Similarity=0.144 Sum_probs=162.5
Q ss_pred ccccCcCccceEEEEEe-eCCcEEEEEEccccc---chhHHHHHHHHHhhcccCc-Ccee---------------eee--
Q 041285 451 KEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHH-RNLV---------------RLL-- 508 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv---------------~l~-- 508 (724)
.+.||+|+||.||++.. .+|+.||||++.... ....+.|++|+.++..++| +|.. .+.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46899999999999995 458999999987322 2335779999999999977 2211 111
Q ss_pred ----eEEec-----ccceEEEEeeccCCChhhhcC------CCCc--------chHHHHHHHcccccccCCCceEeCCCC
Q 041285 509 ----GYSFD-----VSNKILVYEYMSNGSLADVYS------SPPK--------NNLIGIARGILYLHDECESQIIHCDIK 565 (724)
Q Consensus 509 ----g~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk 565 (724)
.+... ....+++|+++ +++|.+++. .... ..+.||++||+|||+. +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 11111 12346666654 789988883 1111 1258999999999998 99999999
Q ss_pred CCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccc----------cCCCCCcccceeehhHHHHHhhcc
Q 041285 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH----------WNLPITAKADVYSFGVVLLEIICC 635 (724)
Q Consensus 566 ~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~Dv~S~Gvll~elltg 635 (724)
|+|||++.++.+||+|||+++..... .....| +.|+|||.+ ....++.++||||||+++|||++|
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999998865422 333567 999999998 555688899999999999999999
Q ss_pred ccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 636 RRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 636 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
+.||........ ....+.... .....+.+++..||+.+|++||++.|++
T Consensus 314 ~~Pf~~~~~~~~---------------~~~~~~~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 314 DLPNTDDAALGG---------------SEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SCCCCTTGGGSC---------------SGGGGSSCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCcchhhh---------------HHHHHhhcc---cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999975432111 111111100 1124588999999999999999976653
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=236.94 Aligned_cols=200 Identities=17% Similarity=0.239 Sum_probs=143.8
Q ss_pred CCCcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEE---eecCCcCCCc--------eeEEEEeecCCCCeeE
Q 041285 2 QGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVG---VFLAGIPEKN--------VGRIVLRSTEQGQDSI 70 (724)
Q Consensus 2 ~~~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylg---iW~~~~~~~t--------~g~l~l~~~~~~~~~~ 70 (724)
+..++|++|++|++ +++| ++|.|+|||+.+++.. .|.+ ||-.+-.... .|+|||. +.+|.++|
T Consensus 6 ~~~~~i~~g~~L~~--g~~l--~~g~f~l~f~~~gnl~-ly~~~~~vW~an~~~~~~~~l~l~~dGnLvl~-d~~~~~vW 79 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA--AQSL--ELSSFRFTMQSDCNLV-LFDSDVRVWASNTAGATGCRAVLQSDGLLVIL-TAQNTIRW 79 (236)
T ss_dssp CSSSSSCSCSCCCT--TCEE--CSTTEEEEECTTSCEE-EEESSSEEECCCCCSCSCCBCCBCSSSCBCCB-CTTTCCSC
T ss_pred eccceeCCCCEECC--CCEE--EcCCEEEEECCCCcEE-EEECCEEEEECCCCCCCCeEEEEcCCCcEEEE-cCCCcEEE
Confidence 35689999999977 5588 5999999998766542 4544 7876532111 2999998 56788999
Q ss_pred ecCCCCc--ceEEEecCCccEEEEeCCCceEEeecCCCcccc----------cccCccccC-CeeccCCCCCCCCCCceE
Q 041285 71 IADDSQS--ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTI----------LPTQRLLAG-MELFPGISKTDPSTGKFR 137 (724)
Q Consensus 71 ~~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtl----------Lpg~~l~~~-~~L~s~~s~~dps~G~f~ 137 (724)
++++... ...|+|+|+|||||++. ++||||||||||+ +|||+++.+ +.|++ .+||++|.|+
T Consensus 80 ~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~ 153 (236)
T 1dlp_A 80 SSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---TQSLQLSPYR 153 (236)
T ss_dssp CCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---SCCCBCSSCE
T ss_pred eCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---CcEeecCcEE
Confidence 9987543 23899999999999954 8999999998655 777766543 46764 7899999999
Q ss_pred EEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEEcCCcceeeccccCCCCCCcceEEEEEccCCc
Q 041285 138 LKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGI 217 (724)
Q Consensus 138 ~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~ 217 (724)
++++++|++.++. .. ..||++++++........++.+|.+++++.++.......... ....+|++||+||+
T Consensus 154 l~l~~dG~LvL~~--~~----~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~---~~~~~rl~Ld~dG~ 224 (236)
T 1dlp_A 154 LSMETDCNLVLFD--RD----DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSR---SAGRYVFVLQPDRN 224 (236)
T ss_dssp EEEETTTEEEEEB--TT----BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCC---SSSCCEEEECSSSC
T ss_pred EEECCCCcEEEEc--CC----EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCC---CCCCEEEEEcCCCc
Confidence 9999999776652 21 469998887544344566788898777654443333222211 12357999999999
Q ss_pred EEEEE
Q 041285 218 FRLYS 222 (724)
Q Consensus 218 l~~~~ 222 (724)
+++|.
T Consensus 225 l~ly~ 229 (236)
T 1dlp_A 225 LAIYG 229 (236)
T ss_dssp EEEEC
T ss_pred EEEeC
Confidence 99984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=262.75 Aligned_cols=182 Identities=16% Similarity=0.093 Sum_probs=126.6
Q ss_pred cccCcCccceEEEEE-eeCCcEEEEEEcccc----------cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEE
Q 041285 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKM----------LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 519 (724)
...+.|++|.+..+. ..-|+.+|||.+... .....++|.+|+++|+++ +|+||+++++++.+....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346667777665543 234788999998642 122345799999999999 79999999999999999999
Q ss_pred EEeeccCCChhhhcCCCC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 520 VYEYMSNGSLADVYSSPP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
||||++|++|.+++.... .+++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....+.. .
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-W 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-C
T ss_pred EEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-c
Confidence 999999999999985421 23488999999999999 999999999999999999999999999987654332 2
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccC
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRC 638 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p 638 (724)
.....||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 234679999999999865 456789999999999999776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-24 Score=241.77 Aligned_cols=182 Identities=18% Similarity=0.190 Sum_probs=144.8
Q ss_pred ccccCcCccceEEEEEeeCCcEEEEEEccccc--------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 451 KEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 451 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.||+|+||.||++.. .++.+++|+..... ....+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 57788888753211 1123458999999999999999987777778888899999
Q ss_pred eccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce------e
Q 041285 523 YMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT------F 596 (724)
Q Consensus 523 ~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~------~ 596 (724)
|+++++|.+++.. ....+.|++++|.|||+. +|+||||||+|||++. .+||+|||+++......... .
T Consensus 420 ~~~ggsL~~~l~~-~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 420 YINGKLAKDVIED-NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp CCCSEEHHHHSTT-CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHH-HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhh
Confidence 9999999999987 556689999999999998 9999999999999999 99999999999875432211 1
Q ss_pred eccccCccccCcccccC--CCCCcccceeehhHHHHHhhccccCC
Q 041285 597 TGIRGTRGYVAPEWHWN--LPITAKADVYSFGVVLLEIICCRRCF 639 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvll~elltg~~p~ 639 (724)
....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24579999999999876 56788899999988888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-21 Score=200.58 Aligned_cols=141 Identities=16% Similarity=0.100 Sum_probs=114.7
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEcccccc------------------hhHHHHHHHHHhhcccCcCceeeeeeEE
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA------------------EGEREFQTEIKAIGRTHHRNLVRLLGYS 511 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 511 (724)
+.+.||+|+||.||++...+|+.||||.++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4578999999999999997789999999864211 13456899999999998 5 6666654
Q ss_pred ecccceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 512 FDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 512 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
. .+..++||||+++++|.++........+.||++||.|||+. +|+||||||+|||++ ++.+||+|||+++.
T Consensus 171 ~-~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~---- 241 (282)
T 1zar_A 171 A-WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---- 241 (282)
T ss_dssp E-EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEE----
T ss_pred e-ccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeE----
Confidence 3 46679999999999999932333445588999999999988 999999999999999 99999999999874
Q ss_pred CcceeeccccCccccCccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHW 612 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~ 612 (724)
+..++|||++.
T Consensus 242 ----------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----------VGEEGWREILE 252 (282)
T ss_dssp ----------TTSTTHHHHHH
T ss_pred ----------CCCCCHHHHHH
Confidence 34578888764
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=5.3e-18 Score=149.24 Aligned_cols=106 Identities=19% Similarity=0.312 Sum_probs=83.4
Q ss_pred CcccCCCCceecCCCCeee--cCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ce
Q 041285 4 HSNINIGSSLSPNGNSSWL--SPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--AS 79 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lv--S~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~ 79 (724)
.++|.+|++|.+ +++|+ |++|.|+|+|+.+++ . +||++ +.++|+++.... +.
T Consensus 8 ~~~l~~g~~L~~--g~~l~~~S~~g~~~L~~~~dgn---l---vly~~----------------~~~vW~sn~~~~~~~~ 63 (119)
T 1b2p_A 8 QPDDNHPQILHA--TESLEILFGTHVYRFIMQTDCN---L---VLYDN----------------NNPIWATNTGGLGNGC 63 (119)
T ss_dssp CSSSCCCCEEET--TCEEEEEETTEEEEEEECTTSC---E---EEEET----------------TEEEEECCCTTSCSSC
T ss_pred CcccCCCCEEcC--CCEEEEeCCCCCEEEEEecCCC---E---EEEEC----------------CEEEEeCCCccCCCce
Confidence 568999999977 56999 999999999997654 1 34432 445666665432 34
Q ss_pred EEEecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCC
Q 041285 80 SASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPY 159 (724)
Q Consensus 80 ~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~ 159 (724)
.|+|+|+|||||+|.+++++|||| +||++|.|++.++++|+++++. .
T Consensus 64 ~l~l~~dGNLVl~d~~~~~lW~S~-------------------------~~~~~g~~~l~l~~~Gnlvl~~--------~ 110 (119)
T 1b2p_A 64 RAVLQPDGVLVVITNENVTVWQSP-------------------------VAGKAGHYVLVLQPDRNVVIYG--------D 110 (119)
T ss_dssp EEEECTTSCEEEECTTCCEEEECS-------------------------CCCCSSCEEEEECTTSCEEEEE--------S
T ss_pred EEEEccCCEEEEEeCCCcEEEcCC-------------------------CCCCCCCEEEEEECCCcEEEEC--------c
Confidence 899999999999999999999999 4567899999999999987763 1
Q ss_pred ccccccc
Q 041285 160 SYWTSFT 166 (724)
Q Consensus 160 ~yw~~~~ 166 (724)
.||++++
T Consensus 111 ~~W~Sg~ 117 (119)
T 1b2p_A 111 ALWATQT 117 (119)
T ss_dssp EEEECCC
T ss_pred cEeCCCC
Confidence 5898764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.2e-17 Score=166.72 Aligned_cols=131 Identities=16% Similarity=0.250 Sum_probs=101.4
Q ss_pred ccccccCcCccceEEEEEe-eCCcE--EEEEEcccccc------------------------hhHHHHHHHHHhhcccCc
Q 041285 449 GFKEEIGRGSSGTVYKGTM-INGKF--VAVKRLQKMLA------------------------EGEREFQTEIKAIGRTHH 501 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~h 501 (724)
.+.+.||+|+||.||+|.. .+|+. ||||.++.... .....+.+|++.+.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999998 68888 99998653210 111368899999999988
Q ss_pred Cce--eeeeeEEecccceEEEEeeccC-C----ChhhhcCC----CCcchHHHHHHHccccc-ccCCCceEeCCCCCCCe
Q 041285 502 RNL--VRLLGYSFDVSNKILVYEYMSN-G----SLADVYSS----PPKNNLIGIARGILYLH-DECESQIIHCDIKPQNI 569 (724)
Q Consensus 502 ~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~----~~~~~~~~ia~~l~yLH-~~~~~~i~H~dlk~~NI 569 (724)
+++ +.++.+ ...+|||||+.+ | +|.++... .....+.+++.+|.||| +. +|+||||||+||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NI 202 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNI 202 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSE
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHE
Confidence 764 344432 467899999942 4 66665433 22334789999999999 87 999999999999
Q ss_pred eeCCCCCeEEccccCcccc
Q 041285 570 LMDENRYAKISDFALAKLM 588 (724)
Q Consensus 570 ll~~~~~~kl~Dfgl~~~~ 588 (724)
|++. .++|+|||++...
T Consensus 203 Ll~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EESS--SEEECCCTTCEET
T ss_pred EEcC--cEEEEECcccccC
Confidence 9998 9999999999754
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=136.14 Aligned_cols=105 Identities=22% Similarity=0.370 Sum_probs=84.3
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ceEE
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--ASSA 81 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~~a 81 (724)
.++|.+|+.|.. +++|+ ++|.|+|+|+.. |+|||.+ .+.++|++++... +..|
T Consensus 1 ~d~l~~g~~L~~--g~~l~-~~~~~~l~~~~d--------------------Gnlvl~~--~~~~vW~sn~~~~~~~~~l 55 (110)
T 3a0c_A 1 VNSLSSPNSLFT--GHSLE-VGPSYRLIMQGD--------------------CNFVLYD--SGKPVWASNTGGLGSGCRL 55 (110)
T ss_dssp CCEEETTCEECT--TCEEE-ETTTEEEEECTT--------------------SCEEEEE--TTEEEEECCCTTSCSSCEE
T ss_pred CCEeCCCCEECC--CCEEE-ECCCEEEEEcCC--------------------CcEEEEE--CCEEEEECCCCCCCCcEEE
Confidence 368999999976 66999 999999999743 4567763 3678888876533 3489
Q ss_pred EecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcc
Q 041285 82 SMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSY 161 (724)
Q Consensus 82 ~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~y 161 (724)
+|+|+|||||+|.+++++|||| +++++|.|++.++++|+++++. . .|
T Consensus 56 ~l~~dGNLVl~~~~~~~~W~S~-------------------------t~~~~g~~~l~l~~dGnlvl~~--~------~~ 102 (110)
T 3a0c_A 56 TLHNNGNLVIYDQSNRVIWQTK-------------------------TNGKEDHYVLVLQQDRNVVIYG--P------VV 102 (110)
T ss_dssp EECTTSCEEEECTTCCEEEECC-------------------------CCCSSSCCEEEECTTSCEEEEC--S------EE
T ss_pred EEeCCCCEEEECCCCcEEEecC-------------------------CCCCCCCEEEEEeCCccEEEEC--C------CE
Confidence 9999999999999899999999 3566899999999999987753 1 58
Q ss_pred ccccc
Q 041285 162 WTSFT 166 (724)
Q Consensus 162 w~~~~ 166 (724)
|++++
T Consensus 103 W~S~~ 107 (110)
T 3a0c_A 103 WATGS 107 (110)
T ss_dssp EECSC
T ss_pred ecCCC
Confidence 98765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-16 Score=137.11 Aligned_cols=109 Identities=23% Similarity=0.455 Sum_probs=83.7
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCC--cceEE
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQ--SASSA 81 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~--~~~~a 81 (724)
+|+|.+|++|+. +++| ++|.|+|+|+.+++ |+|.+ . +.++|++++.. .+..|
T Consensus 1 tdtl~~gq~L~~--g~~L--~~~~~~L~~~~dgn--------------------lvl~~-~-~~~vW~sn~~~~~~~~~l 54 (112)
T 1xd5_A 1 SDRLNSGHQLDT--GGSL--AEGGYLFIIQNDCN--------------------LVLYD-N-NRAVWASGTNGKASGCVL 54 (112)
T ss_dssp CCEEETTEEECT--TCEE--EETTEEEEECTTSC--------------------EEEEE-T-TEEEEECCCTTSCSSEEE
T ss_pred CCCCCCCCEECC--CCEE--eCCCEEEEEcCCCc--------------------EEEEE-C-CEEEEeCCCcCCCCCEEE
Confidence 478999999976 5688 58999999986543 44542 2 56778777643 23489
Q ss_pred EecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcc
Q 041285 82 SMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSY 161 (724)
Q Consensus 82 ~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~y 161 (724)
+|+++|||||+| ++.++||||+ ||++|.|++.++++|+++++... ...|
T Consensus 55 ~l~~~GNLvl~d-~~~~~W~S~~-------------------------~~~~g~~~l~l~~dGnlvl~~~~-----~~~~ 103 (112)
T 1xd5_A 55 KMQNDGNLVIYS-GSRAIWASNT-------------------------NRQNGNYYLILQRDRNVVIYDNS-----NNAI 103 (112)
T ss_dssp EECTTSCEEEEE-TTEEEEECCC-------------------------CCSCCCCEEEECTTSCEEEECTT-----SCEE
T ss_pred EEeCCCCEEEEc-CCEEEEECCc-------------------------cCCCCCEEEEEeCCCcEEEECCC-----CceE
Confidence 999999999999 8889999994 45678999999999998876421 2579
Q ss_pred cccccCCC
Q 041285 162 WTSFTDGK 169 (724)
Q Consensus 162 w~~~~~~~ 169 (724)
|+++++.+
T Consensus 104 W~S~~~~g 111 (112)
T 1xd5_A 104 WATHTNVG 111 (112)
T ss_dssp EECCCCCC
T ss_pred EECCCccC
Confidence 99887653
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6e-16 Score=135.70 Aligned_cols=107 Identities=21% Similarity=0.461 Sum_probs=84.2
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ceEE
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--ASSA 81 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~~a 81 (724)
.|+|.+|++|.. +++|+ +|.|+|+|+..+ +|+|.+ .+.++|++++... +..+
T Consensus 2 ~dtl~~gq~L~~--g~~L~--~g~~~L~~~~dg--------------------nlvly~--~~~~vW~sn~~~~~~~~~l 55 (115)
T 2dpf_A 2 DNVLLSGQTLHA--DHSLQ--AGAYTLTIQNKC--------------------NLVKYQ--NGRQIWASNTDRRGSGCRL 55 (115)
T ss_dssp CCEEETTCEEET--TEEEE--ETTEEEEECTTS--------------------CEEEEE--TTEEEEECSCTTSCSSCEE
T ss_pred CCEeCCCCEECC--CCEEE--CCCEEEEEcCCC--------------------cEEEEe--CCEEEEeCCCCCCCCceEE
Confidence 578999999977 56898 899999997543 345542 3567787775432 3489
Q ss_pred EecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcc
Q 041285 82 SMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSY 161 (724)
Q Consensus 82 ~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~y 161 (724)
+|+++|||||+|.+++++||||++ +++|.|++.++++|+++++. . .|
T Consensus 56 ~l~~~GnLvl~d~~~~~vW~S~~~-------------------------~~~g~~~l~l~~dGnlvl~~--~------~~ 102 (115)
T 2dpf_A 56 TLLSDGNLVIYDHNNNDVWGSACW-------------------------GDNGKYALVLQKDGRFVIYG--P------VL 102 (115)
T ss_dssp EECTTSCEEEECTTCCEEEECCCC-------------------------CSSSCCEEEECTTSCEEEEC--S------EE
T ss_pred EECCCCcEEEECCCceEEEEcCCC-------------------------CCCCCEEEEEeCCCeEEEEC--C------CE
Confidence 999999999999888999999997 34788999999999987762 1 59
Q ss_pred cccccCCC
Q 041285 162 WTSFTDGK 169 (724)
Q Consensus 162 w~~~~~~~ 169 (724)
|+++++..
T Consensus 103 W~S~~~~~ 110 (115)
T 2dpf_A 103 WSLGPNGC 110 (115)
T ss_dssp ECSSTTCB
T ss_pred EECCCCCC
Confidence 99988753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-15 Score=158.51 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=96.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccc--------------hhHHHHH--------HHHHhhcccCcCcee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLA--------------EGEREFQ--------TEIKAIGRTHHRNLV 505 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~~--------~E~~~l~~l~h~niv 505 (724)
+.+...||+|++|.||+|...+|+.||||.++.... ......+ +|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456678999999999999998999999998753110 0011122 344445555333321
Q ss_pred eeeeEEecccceEEEEeeccCCChhhhcCCC-CcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC---------
Q 041285 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSP-PKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR--------- 575 (724)
Q Consensus 506 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~--------- 575 (724)
-..-+ .....+|||||+++++|.++.... ....+.||+.+|.|||+. +||||||||.|||+++++
T Consensus 177 vp~p~--~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~ 251 (397)
T 4gyi_A 177 VPEPI--AQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSIT 251 (397)
T ss_dssp CCCEE--EEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred CCeee--eccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccc
Confidence 11111 112347999999999998876533 334478999999999988 999999999999998776
Q ss_pred -CeEEccccCccccC
Q 041285 576 -YAKISDFALAKLMK 589 (724)
Q Consensus 576 -~~kl~Dfgl~~~~~ 589 (724)
.+.|+||+-+....
T Consensus 252 ~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 252 LTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECCCTTCEETT
T ss_pred cceEEEEeCCcccCC
Confidence 38999999876543
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-11 Score=105.29 Aligned_cols=103 Identities=22% Similarity=0.376 Sum_probs=78.0
Q ss_pred cccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ceEEE
Q 041285 5 SNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--ASSAS 82 (724)
Q Consensus 5 ~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~~a~ 82 (724)
.+|.+|++|.. +++|+ +|.|+|+|+.. |+|+|.+ . +.++|++++... +..++
T Consensus 2 ntL~~gq~L~~--g~~L~--~g~~~L~~q~d--------------------GnLvly~-~-~~~vW~snt~~~~~~~~l~ 55 (109)
T 3dzw_A 2 NILYSGETLSP--GEFLN--NGRYVFIMQED--------------------CNLVLYD-V-DKPIWATNTGGLDRRCHLS 55 (109)
T ss_dssp CEEETTEEECT--TCEEE--ETTEEEEECTT--------------------SCEEEEE-T-TEEEEECCCTTSSSSCEEE
T ss_pred CCcCCCCEeCC--CCEEE--CCCEEEEEcCC--------------------CcEEEEe-C-CEEEEECCcccCCCCEEEE
Confidence 47899999966 66886 79999999643 4567763 2 578898876542 34899
Q ss_pred ecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCccc
Q 041285 83 MLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYW 162 (724)
Q Consensus 83 LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw 162 (724)
|+++|||||+|.++.++|||.... ..+.|.+.++.+|++++|. ...|
T Consensus 56 l~~dGNLvl~~~~~~~~W~S~t~~-------------------------~~~~~~~~L~ddGNlvly~--------~~~W 102 (109)
T 3dzw_A 56 MQSDGNLVVYSPRNNPIWASNTGG-------------------------ENGNYVCVLQKDRNVVIYG--------TARW 102 (109)
T ss_dssp ECTTSCEEEECTTSCEEEECCCCC-------------------------SSSCEEEEECTTSCEEEEE--------SCCC
T ss_pred EeCCCCEEEECCCCCEEEECCCCC-------------------------CCCCEEEEEeCCCEEEEEC--------CCEE
Confidence 999999999999889999985321 1356889999999999873 1468
Q ss_pred cccc
Q 041285 163 TSFT 166 (724)
Q Consensus 163 ~~~~ 166 (724)
.+++
T Consensus 103 ~s~t 106 (109)
T 3dzw_A 103 ATGT 106 (109)
T ss_dssp CCCC
T ss_pred eCCC
Confidence 7654
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.8e-11 Score=103.81 Aligned_cols=98 Identities=16% Similarity=0.212 Sum_probs=74.3
Q ss_pred CCCCcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCcc--
Q 041285 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQSA-- 78 (724)
Q Consensus 1 ~~~~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~~-- 78 (724)
|-+.++|.+|++|.. +++|+| |.|.|-|- ..|+|||.+ . .++|++++....
T Consensus 3 ~~~~dtL~~gq~L~~--g~~L~s--g~~~L~~q--------------------~dGnLvl~~-~--~~vW~snt~~~~~~ 55 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYG--DGRLTA--KNHQLVMQ--------------------GDCNLVLYG-G--KYGWQSNTHGNGEH 55 (110)
T ss_dssp CCBTTEEETTCEEET--TEEEEC--SSCEEEEC--------------------TTSCEEEEC-S--SSCEECCCTTSSSS
T ss_pred ccccCEECCCCEecC--CCEEEe--CCEEEEEc--------------------CCCeEEEEC-C--eEEEECCCcCCCcC
Confidence 567899999999977 568998 44777442 126688863 2 578998865432
Q ss_pred eEEEecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeecc
Q 041285 79 SSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYP 150 (724)
Q Consensus 79 ~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~ 150 (724)
..++|+++|||||+|.+++++|||-.+- ..|.|.+.++++|++++|.
T Consensus 56 ~~l~l~~dGNLvl~d~~~~~iW~S~t~~-------------------------~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 56 CFLRLNHKGELIIKDDDFKTIWSSRSSS-------------------------KQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp CEEEECTTSCEEEECTTCCEEEECCCCC-------------------------SSSCCEEEECTTSCEEEEC
T ss_pred EEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------------CCCCEEEEEcCCccEEEec
Confidence 4899999999999999899999985311 1345889999999999873
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=8.5e-11 Score=102.19 Aligned_cols=101 Identities=13% Similarity=0.130 Sum_probs=76.4
Q ss_pred CCCCcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--c
Q 041285 1 QQGHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--A 78 (724)
Q Consensus 1 ~~~~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~ 78 (724)
|-..++|.+|+.|.. ++.|.+ |.|.|-|. ..|+|||.+...+.++|++++... +
T Consensus 3 ~~~~~tL~~gq~L~~--g~~L~~--g~~~L~~q--------------------~dGNLvL~~~~~~~~vWssnt~~~~~~ 58 (113)
T 3mez_B 3 PRVRNVLFSSQVMYD--NAQLAT--RDYSLVMR--------------------DDCNLVLTKGSKTNIVWESGTSGRGQH 58 (113)
T ss_dssp CCCSSEEETTCEEET--TCEEEE--TTEEEEEC--------------------TTSCEEEEETTTTEEEEECCCTTSCSS
T ss_pred cccCCEeCCCCEECC--CCEeEc--CCEEEEEc--------------------CCCEEEEEECCCCEEEEECCcccCCcC
Confidence 456789999999976 557864 66776653 237789984324789999987543 3
Q ss_pred eEEEecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeecc
Q 041285 79 SSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYP 150 (724)
Q Consensus 79 ~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~ 150 (724)
..++|+++|||||+|.+++++|||-.+ -..|.|.+.++.+|++++|-
T Consensus 59 ~~l~l~~dGNLVl~d~~~~~iW~S~t~-------------------------~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 59 CFMRLGHSGELDITDDRLNTVFVSNTV-------------------------GQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp CEEEECTTSCEEEECTTSCEEEECSCC-------------------------CSSSCCEEEECTTSCEEEEC
T ss_pred EEEEEeCCCcEEEECCCCCEEEECCCc-------------------------CCCCCEEEEEcCCceEEEec
Confidence 489999999999999988999998321 01356899999999999873
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-10 Score=100.24 Aligned_cols=105 Identities=12% Similarity=0.264 Sum_probs=77.5
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ceEE
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--ASSA 81 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~~a 81 (724)
+++|.+|+.|.+ ++.| .+|.|.|-|. ..|+|||. +..+ +|++++... ...+
T Consensus 2 ~~~l~~gq~L~~--g~~L--~~g~~~L~~q--------------------~dGnLvl~-~~~~--vW~snt~~~~~~~~l 54 (111)
T 3mez_A 2 NNVLLTGDVIHT--DNQL--SYESAAFVMQ--------------------GDCNLVLY-NEAG--GFQSNTHGRGVDCTL 54 (111)
T ss_dssp TTEEETTCEECT--TCEE--EETTEEEEEC--------------------TTSCEEEE-CSSC--CEECCCTTSCSSCEE
T ss_pred cCEeCCCCEeCC--CCEE--ecCCEEEEEc--------------------cCCeEEEE-CCCC--EEECCcccCCcCEEE
Confidence 568999999976 5578 3677777663 23788997 3444 999887543 2489
Q ss_pred EecCCccEEEEeCCCc-eEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCc
Q 041285 82 SMLDSGSFVLYDSDGK-VIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYS 160 (724)
Q Consensus 82 ~LldsGNlVl~~~~~~-~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~ 160 (724)
+|+++|||||+|.+++ ++|||..+ .....|.|.+.++++|++++|. ..
T Consensus 55 ~l~~dGNLVl~~~~~~~~vW~S~t~-----------------------~~~~~~~~~l~Lq~dGNlvly~--------~~ 103 (111)
T 3mez_A 55 RLNNRGQLEIHSANSNTPVWVYPRS-----------------------VNTVRGNYAATLGPDQHVTIYG--------PA 103 (111)
T ss_dssp EECTTSCEEEECSSCSSCSEEESSS-----------------------CCCCSSCCEEEECTTSCEEEEC--------SE
T ss_pred EEcCCCcEEEEeCCCCEEEEEeccc-----------------------cCCCCcCEEEEECCCCeEEEec--------cC
Confidence 9999999999998776 59999721 1123578999999999999984 34
Q ss_pred cccccc
Q 041285 161 YWTSFT 166 (724)
Q Consensus 161 yw~~~~ 166 (724)
+|.+++
T Consensus 104 ~W~s~t 109 (111)
T 3mez_A 104 IWSTPA 109 (111)
T ss_dssp EEECCC
T ss_pred EEccCC
Confidence 787653
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.2e-10 Score=98.03 Aligned_cols=90 Identities=19% Similarity=0.285 Sum_probs=66.3
Q ss_pred cccCCCCceecCCCCeeecCCCeEEEeeeecCCCCce--EEEeecCCcC--CC--------ceeEEEEeecCCCCeeEec
Q 041285 5 SNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSY--YVGVFLAGIP--EK--------NVGRIVLRSTEQGQDSIIA 72 (724)
Q Consensus 5 ~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~--ylgiW~~~~~--~~--------t~g~l~l~~~~~~~~~~~~ 72 (724)
++|.+|+.|.+ +++|+| |.|.|.|...++=--+ --.||-.+.. .. ..|+|||. +.++.++|++
T Consensus 2 n~L~~g~~L~~--g~~L~s--g~y~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~-d~~~~~vWss 76 (105)
T 4h3o_A 2 NILDNNEGLYA--GQSLDV--EPYHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVY-DSSGRSLWAS 76 (105)
T ss_dssp CEECTTEEECT--TCEEEE--TTEEEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEE-CTTCCEEEEC
T ss_pred CCcCCCCEEcC--CCEEEE--CCEEEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEE-CCCcEEEEEe
Confidence 67899999976 669988 8899999765541100 1357876532 11 12999998 6788999999
Q ss_pred CCCCc--ceEEEecCCccEEEEeCCCceEEee
Q 041285 73 DDSQS--ASSASMLDSGSFVLYDSDGKVIWQT 102 (724)
Q Consensus 73 ~~~~~--~~~a~LldsGNlVl~~~~~~~lWQS 102 (724)
+++.. +.+|+|+|+|||||++. .||||
T Consensus 77 ~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 77 HSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp CCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred cCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 87543 23899999999999964 79998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.6e-10 Score=117.36 Aligned_cols=136 Identities=14% Similarity=0.110 Sum_probs=106.6
Q ss_pred cccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCC
Q 041285 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+...++.|+.+.||+... +++.+++|............+.+|+++++.+. |..+.++++++.+.+..++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 445678888899999875 46889999987532233456899999999884 6788899999988888999999999999
Q ss_pred hhhhcCCC--CcchHHHHHHHcccccccC---------------------------------------------------
Q 041285 529 LADVYSSP--PKNNLIGIARGILYLHDEC--------------------------------------------------- 555 (724)
Q Consensus 529 L~~~l~~~--~~~~~~~ia~~l~yLH~~~--------------------------------------------------- 555 (724)
|.+.+... ....+.+++++|+.||+..
T Consensus 97 l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 176 (263)
T 3tm0_A 97 CSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp HHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHH
T ss_pred hhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHh
Confidence 98875322 2234678899999999710
Q ss_pred -----CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 -----ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 -----~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 177 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.9e-10 Score=114.12 Aligned_cols=130 Identities=15% Similarity=0.133 Sum_probs=98.4
Q ss_pred ccC-cCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCc--eeeeeeEEecccceEEEEeeccCCCh
Q 041285 453 EIG-RGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN--LVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 453 ~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.++ .|..+.||+....+|+.++||..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 354 55569999998777788999987643 2356889999999885444 56688888887889999999999988
Q ss_pred hhhcCCCC-cchHHHHHHHcccccccC-----------------------------------------------------
Q 041285 530 ADVYSSPP-KNNLIGIARGILYLHDEC----------------------------------------------------- 555 (724)
Q Consensus 530 ~~~l~~~~-~~~~~~ia~~l~yLH~~~----------------------------------------------------- 555 (724)
. +.... ...+.++++.|+.||+..
T Consensus 103 ~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 180 (264)
T 1nd4_A 103 L--SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 180 (264)
T ss_dssp T--TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred C--cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCC
Confidence 5 32222 234677888888888642
Q ss_pred --CCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 556 --ESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 556 --~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 181 ~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 181 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.99 E-value=5.8e-10 Score=96.17 Aligned_cols=97 Identities=14% Similarity=0.302 Sum_probs=71.5
Q ss_pred CCcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCC----c-----eeEEEEeecCCCCeeEecC
Q 041285 3 GHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEK----N-----VGRIVLRSTEQGQDSIIAD 73 (724)
Q Consensus 3 ~~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~----t-----~g~l~l~~~~~~~~~~~~~ 73 (724)
+.++|.+|+.|.. +++| .+|.|.|.|...++-- .|-++|-.+.... + .|+||+. +.++..+|+++
T Consensus 2 ~~dtL~~gq~L~~--g~~L--~~g~~~L~~q~dGNLv-l~~~~Wssnt~~~~~~~~l~l~~dGnLvl~-d~~~~~vWss~ 75 (109)
T 3r0e_A 2 GTNYLLSGQTLDT--EGHL--KNGDFDLVMQDDCNLV-LYNGNWQSNTANNGRDCKLTLTDYGELVIK-NGDGSTVWKSG 75 (109)
T ss_dssp CCSEEETTCEECT--TCEE--EETTEEEEECTTSCEE-EETTTEECCCTTSCSSCEEEECTTSCEEEE-CTTSCEEEECC
T ss_pred ccCCcCCCCCcCC--CCEe--ECCCEEEEEecCCeEE-EEeCeEEcCCCCCCCcEEEEEcCCCeEEEE-eCCCCEEEcCC
Confidence 5789999999966 5578 5799999986555422 3556897654321 1 2999998 55678999987
Q ss_pred CCCc--ceEEEecCCccEEEEeCCCceEEeecCCCccccccc
Q 041285 74 DSQS--ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPT 113 (724)
Q Consensus 74 ~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg 113 (724)
+... ...|+|+|+|||||++ ..+|+| .|.+||
T Consensus 76 t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 76 AQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp CCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 7542 2389999999999997 689996 666554
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.2e-09 Score=91.49 Aligned_cols=95 Identities=29% Similarity=0.475 Sum_probs=72.8
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
+|||+|||.|..|..| +.|.|.|.|+.+|+++++. .||.+..........+.++.+|.+++.
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~---------~~Wssnt~~~~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN---------GNWQSNTANNGRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET---------TTEECCCTTSCSSCEEEECTTSCEEEE
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe---------CeEEcCCCCCCCcEEEEEcCCCeEEEE
Confidence 7999999999999999 4699999999999999863 279876654444567888999999998
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+.++...... .. ......++++|+.||+|++|.
T Consensus 65 d~~~~~vWss--~t-~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 65 NGDGSTVWKS--GA-QSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp CTTSCEEEEC--CC-CCSSSCCEEEEETTTEEEEEC
T ss_pred eCCCCEEEcC--CC-cCCCcCEEEEEcCCCeEEEEe
Confidence 7655433321 11 112345789999999999995
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.3e-08 Score=87.73 Aligned_cols=97 Identities=25% Similarity=0.374 Sum_probs=72.8
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
+|||+|||.|..|..|+| |.|.|.++.+|+++++.. ..||.+..........+.+.++|.++++
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~~~-------~~vW~snt~~~~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYGG-------KYGWQSNTHGNGEHCFLRLNHKGELIIK 69 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEECS-------SSCEECCCTTSSSSCEEEECTTSCEEEE
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEECC-------eEEEECCCcCCCcCEEEEEeCCCcEEEE
Confidence 799999999999999974 679999999999988632 2589876654444457888999999998
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+.++......... .....++++|+.||+|++|.
T Consensus 70 d~~~~~iW~S~t~---~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 70 DDDFKTIWSSRSS---SKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp CTTCCEEEECCCC---CSSSCCEEEECTTSCEEEEC
T ss_pred eCCCCEEEEcCCc---CCCCCEEEEEcCCccEEEec
Confidence 7655443332211 11223789999999999985
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.8e-08 Score=87.00 Aligned_cols=91 Identities=16% Similarity=0.271 Sum_probs=66.7
Q ss_pred CcccCCCCceecCCCC-ee-ecCCCeEEEeeeecCCCCceEEEeecCCcCCC---c------eeEEEEeecCCCCeeEec
Q 041285 4 HSNINIGSSLSPNGNS-SW-LSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEK---N------VGRIVLRSTEQGQDSIIA 72 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~-~l-vS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~---t------~g~l~l~~~~~~~~~~~~ 72 (724)
...|..|++|. .++. +| +.++|++.| |.. + --||-.+.... . .|+|||. +.++.++|++
T Consensus 7 g~~L~~g~~l~-~~~~~~l~~~~dGnlvl--~~~----~--~~vW~sn~~~~~~~~~l~l~~dGNLVl~-~~~~~~~W~S 76 (110)
T 3a0c_A 7 PNSLFTGHSLE-VGPSYRLIMQGDCNFVL--YDS----G--KPVWASNTGGLGSGCRLTLHNNGNLVIY-DQSNRVIWQT 76 (110)
T ss_dssp TCEECTTCEEE-ETTTEEEEECTTSCEEE--EET----T--EEEEECCCTTSCSSCEEEECTTSCEEEE-CTTCCEEEEC
T ss_pred CCEECCCCEEE-ECCCEEEEEcCCCcEEE--EEC----C--EEEEECCCCCCCCcEEEEEeCCCCEEEE-CCCCcEEEec
Confidence 35789999998 4444 44 688999876 441 1 25787765321 1 1999999 5578899999
Q ss_pred CCCCcc--eEEEecCCccEEEEeCCCceEEeecCCCc
Q 041285 73 DDSQSA--SSASMLDSGSFVLYDSDGKVIWQTFDHPT 107 (724)
Q Consensus 73 ~~~~~~--~~a~LldsGNlVl~~~~~~~lWQSFd~Pt 107 (724)
.+..+. .+++|+|+|||||++. ++||||+||.
T Consensus 77 ~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 77 KTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp CCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 876442 2899999999999874 8999999983
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.75 E-value=3.1e-08 Score=85.60 Aligned_cols=99 Identities=21% Similarity=0.286 Sum_probs=73.0
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
+|||+|||.|..|..| +.|.|.|.|+.+|+++++... . ||.+.+........+.+..+|.++++
T Consensus 2 ~~~l~~gq~L~~g~~L---------~~g~~~L~~q~dGnLvl~~~~------~-vW~snt~~~~~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL---------SYESAAFVMQGDCNLVLYNEA------G-GFQSNTHGRGVDCTLRLNNRGQLEIH 65 (111)
T ss_dssp TTEEETTCEECTTCEE---------EETTEEEEECTTSCEEEECSS------C-CEECCCTTSCSSCEEEECTTSCEEEE
T ss_pred cCEeCCCCEeCCCCEE---------ecCCEEEEEccCCeEEEECCC------C-EEECCcccCCcCEEEEEcCCCcEEEE
Confidence 6999999999999999 369999999999999886421 2 89876654444567888999999998
Q ss_pred cCCcce-eeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFN-IRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~-~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+..+.. ....... .......++++|+.||+|++|.
T Consensus 66 ~~~~~~~vW~S~t~-~~~~~~~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 66 SANSNTPVWVYPRS-VNTVRGNYAATLGPDQHVTIYG 101 (111)
T ss_dssp CSSCSSCSEEESSS-CCCCSSCCEEEECTTSCEEEEC
T ss_pred eCCCCEEEEEeccc-cCCCCcCEEEEECCCCeEEEec
Confidence 765432 2222111 1122345789999999999995
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.75 E-value=2.6e-08 Score=99.02 Aligned_cols=139 Identities=17% Similarity=0.271 Sum_probs=90.9
Q ss_pred CCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc-ceEEEecCCccEEEEeCCCceEEeecCCCcccccccCcc
Q 041285 38 GSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS-ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRL 116 (724)
Q Consensus 38 ~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l 116 (724)
+..+.||. + ..|++++.+ .+.++|.++.... +..++|.++|||||+|.+++++|+|+.+.
T Consensus 25 ~g~f~l~f-~------~~gnl~ly~--~~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~---------- 85 (236)
T 1dlp_A 25 LSSFRFTM-Q------SDCNLVLFD--SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG---------- 85 (236)
T ss_dssp STTEEEEE-C------TTSCEEEEE--SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC----------
T ss_pred cCCEEEEE-C------CCCcEEEEE--CCEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc----------
Confidence 34588886 3 126788873 3689999886543 34889999999999999999999998751
Q ss_pred ccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCC---------------------------
Q 041285 117 LAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGK--------------------------- 169 (724)
Q Consensus 117 ~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~--------------------------- 169 (724)
+.|.|.+.++.+|+++++- ..+|.++....
T Consensus 86 ---------------~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 86 ---------------SIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp ---------------CSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEEC
T ss_pred ---------------cCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEE
Confidence 2456788999999888861 13565543311
Q ss_pred ------CCceeeeecccccEEEEcCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 170 ------GDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 170 ------~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
...+++.++.+|.+++.+... ........ ......+++|+.+|++.+|.
T Consensus 143 s~~d~s~G~~~l~l~~dG~LvL~~~~~---~~W~s~~~-~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 143 ATQSLQLSPYRLSMETDCNLVLFDRDD---RVWSTNTA-GKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp SSCCCBCSSCEEEEETTTEEEEEBTTB---CCSCCCCC-SSCSSCEEEEETTTEEEEEE
T ss_pred cCcEeecCcEEEEECCCCcEEEEcCCE---eEEeCCCc-CCCCceEEEECCCCcEEEEe
Confidence 123456667777776654331 11111111 11233578899999998885
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.73 E-value=4.1e-08 Score=85.15 Aligned_cols=100 Identities=19% Similarity=0.304 Sum_probs=74.2
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
.|||+|||.|..|..|+ .|.|.|.|+.+|+++++.... ...||.+.+........+.+..+|.++++
T Consensus 6 ~~tL~~gq~L~~g~~L~---------~g~~~L~~q~dGNLvL~~~~~----~~~vWssnt~~~~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 6 RNVLFSSQVMYDNAQLA---------TRDYSLVMRDDCNLVLTKGSK----TNIVWESGTSGRGQHCFMRLGHSGELDIT 72 (113)
T ss_dssp SSEEETTCEEETTCEEE---------ETTEEEEECTTSCEEEEETTT----TEEEEECCCTTSCSSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEECCCCEeE---------cCCEEEEEcCCCEEEEEECCC----CEEEEECCcccCCcCEEEEEeCCCcEEEE
Confidence 69999999999999994 589999999999999875321 25699876654444567888999999998
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+.++....... .. .....++++|+.||+|++|.
T Consensus 73 d~~~~~iW~S~--t~-~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 73 DDRLNTVFVSN--TV-GQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp CTTSCEEEECS--CC-CSSSCCEEEECTTSCEEEEC
T ss_pred CCCCCEEEECC--Cc-CCCCCEEEEEcCCceEEEec
Confidence 76554333221 11 11223789999999999994
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=98.71 E-value=6.1e-08 Score=84.05 Aligned_cols=93 Identities=18% Similarity=0.319 Sum_probs=67.4
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCC---c------eeEEEEeecCCCCeeEecCC
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEK---N------VGRIVLRSTEQGQDSIIADD 74 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~---t------~g~l~l~~~~~~~~~~~~~~ 74 (724)
..+|..|++|..+...--+.++|.+.| |.. . -.||-.+.... . .|+|||.+ .+.++|++.+
T Consensus 7 gq~L~~g~~L~~~~~~L~~~~dgnlvl--~~~----~--~~vW~sn~~~~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~ 76 (112)
T 1xd5_A 7 GHQLDTGGSLAEGGYLFIIQNDCNLVL--YDN----N--RAVWASGTNGKASGCVLKMQNDGNLVIYS--GSRAIWASNT 76 (112)
T ss_dssp TEEECTTCEEEETTEEEEECTTSCEEE--EET----T--EEEEECCCTTSCSSEEEEECTTSCEEEEE--TTEEEEECCC
T ss_pred CCEECCCCEEeCCCEEEEEcCCCcEEE--EEC----C--EEEEeCCCcCCCCCEEEEEeCCCCEEEEc--CCEEEEECCc
Confidence 347899999953222223788999887 442 1 26788765321 1 19999994 6779999876
Q ss_pred CCcc--eEEEecCCccEEEEeCCCceEEeecCCC
Q 041285 75 SQSA--SSASMLDSGSFVLYDSDGKVIWQTFDHP 106 (724)
Q Consensus 75 ~~~~--~~a~LldsGNlVl~~~~~~~lWQSFd~P 106 (724)
..+. ..++|+++|||||++.++.++||||+|.
T Consensus 77 ~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 77 NRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp CCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred cCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 5432 3899999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=6e-08 Score=83.59 Aligned_cols=97 Identities=22% Similarity=0.356 Sum_probs=73.0
Q ss_pred ccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEEc
Q 041285 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLN 187 (724)
Q Consensus 108 DtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~~ 187 (724)
+||+|||.|..|..|+ .|.|.|.|+.+|+++++.. ...+|.+..........+.+..+|.+++.+
T Consensus 2 ntL~~gq~L~~g~~L~---------~g~~~L~~q~dGnLvly~~------~~~vW~snt~~~~~~~~l~l~~dGNLvl~~ 66 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYDV------DKPIWATNTGGLDRRCHLSMQSDGNLVVYS 66 (109)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEET------TEEEEECCCTTSSSSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEeCCCCEEE---------CCCEEEEEcCCCcEEEEeC------CEEEEECCcccCCCCEEEEEeCCCCEEEEC
Confidence 6999999999999994 6999999999999988643 156898766544345678889999999987
Q ss_pred CCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 188 STGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
..+....... . ......++++|+.||+|++|.
T Consensus 67 ~~~~~~W~S~--t-~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 67 PRNNPIWASN--T-GGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp TTSCEEEECC--C-CCSSSCEEEEECTTSCEEEEE
T ss_pred CCCCEEEECC--C-CCCCCCEEEEEeCCCEEEEEC
Confidence 6554333221 1 112345789999999999995
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.65 E-value=4e-08 Score=104.46 Aligned_cols=135 Identities=16% Similarity=0.210 Sum_probs=97.3
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcc--ccc-chhHHHHHHHHHhhcccC--cCceeeeeeEEecc---cceEEEEee
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQ--KML-AEGEREFQTEIKAIGRTH--HRNLVRLLGYSFDV---SNKILVYEY 523 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~e~ 523 (724)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999988754 678888775 321 123457889999999886 45688999998876 348999999
Q ss_pred ccCCChhh-hcCCCCc----chHHHHHHHcccccccC-------------------------------------------
Q 041285 524 MSNGSLAD-VYSSPPK----NNLIGIARGILYLHDEC------------------------------------------- 555 (724)
Q Consensus 524 ~~~gsL~~-~l~~~~~----~~~~~ia~~l~yLH~~~------------------------------------------- 555 (724)
+++..+.+ .+..... ..+.++++.|+.||...
T Consensus 123 v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (359)
T 3dxp_A 123 VSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMD 202 (359)
T ss_dssp CCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHH
T ss_pred cCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHH
Confidence 99988854 2322221 12567888888888621
Q ss_pred ------------CCceEeCCCCCCCeeeCCCCC--eEEccccCccc
Q 041285 556 ------------ESQIIHCDIKPQNILMDENRY--AKISDFALAKL 587 (724)
Q Consensus 556 ------------~~~i~H~dlk~~NIll~~~~~--~kl~Dfgl~~~ 587 (724)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 203 ~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 203 WLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999999864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.7e-07 Score=77.20 Aligned_cols=97 Identities=25% Similarity=0.404 Sum_probs=72.6
Q ss_pred ccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCC-CceeeeecccccEEEE
Q 041285 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKG-DNVSLNLDENGHLFLL 186 (724)
Q Consensus 108 DtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~-~~~~~~~~~~g~~~~~ 186 (724)
|||+|||.|..|+.|+| |.|+|.|+.||++++|... ..+|.+.+..+. ....+.+..+|.+.++
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~~~------~~vW~ant~~~~~~~~~L~l~~dGnLvL~ 66 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYDHS------TSTWASNTEIGGKSGCSAVLQSDGNFVVY 66 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEETT------EEEEECCCCCTTCCSCEEEECTTSCEEEE
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEECC------EEEEEecCCCCCCccEEEEEeCCccEEEE
Confidence 89999999999999964 8899999999999997532 357877655433 3457888999999998
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+..+..+..... ......++++|..||+|.+|.
T Consensus 67 d~~~~~vWss~t---~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 67 DSSGRSLWASHS---TRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp CTTCCEEEECCC---CCCSSCEEEEECTTSCEEEEE
T ss_pred CCCcEEEEEecC---CCCCCCEEEEEeCCCeEEEEC
Confidence 877654433211 112334689999999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1e-06 Score=76.64 Aligned_cols=97 Identities=27% Similarity=0.467 Sum_probs=72.0
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
.|||+|||.|..|..|+ .|.|.|.++.+|++.++. . ...+|.+..........+.+.++|.+++.
T Consensus 2 ~dtl~~gq~L~~g~~L~---------~g~~~L~~~~dgnlvly~--~----~~~vW~sn~~~~~~~~~l~l~~~GnLvl~ 66 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ---------AGAYTLTIQNKCNLVKYQ--N----GRQIWASNTDRRGSGCRLTLLSDGNLVIY 66 (115)
T ss_dssp CCEEETTCEEETTEEEE---------ETTEEEEECTTSCEEEEE--T----TEEEEECSCTTSCSSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEECCCCEEE---------CCCEEEEEcCCCcEEEEe--C----CEEEEeCCCCCCCCceEEEECCCCcEEEE
Confidence 59999999999999996 589999999999998864 1 25689876654434457888999999998
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLY 221 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~ 221 (724)
+.++...... +..+ ....++++|+.||+|++|
T Consensus 67 d~~~~~vW~S--~~~~-~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 67 DHNNNDVWGS--ACWG-DNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp CTTCCEEEEC--CCCC-SSSCCEEEECTTSCEEEE
T ss_pred CCCceEEEEc--CCCC-CCCCEEEEEeCCCeEEEE
Confidence 7654433322 2211 223467999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.23 E-value=1e-07 Score=98.86 Aligned_cols=180 Identities=18% Similarity=0.187 Sum_probs=107.4
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCc--eeeeeeEEeccc---ceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRN--LVRLLGYSFDVS---NKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~~~ 525 (724)
+.++.|....||+.. ..+++|..... .....+.+|.++++.+ .+.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 357889999998753 45888876532 3456788999999887 3332 445555443333 3488999999
Q ss_pred CCChhhh-cCCCC----cchHHHHHHHcccccc-----------------------------------------------
Q 041285 526 NGSLADV-YSSPP----KNNLIGIARGILYLHD----------------------------------------------- 553 (724)
Q Consensus 526 ~gsL~~~-l~~~~----~~~~~~ia~~l~yLH~----------------------------------------------- 553 (724)
|.+|.+. +.... ...+.++++.|+.||.
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 9887642 21111 1123445555555543
Q ss_pred --------cCCCceEeCCCCCCCeeeCC--CCCeEEccccCccccCCCCcceeec-------------cccCccccC-cc
Q 041285 554 --------ECESQIIHCDIKPQNILMDE--NRYAKISDFALAKLMKPDQTRTFTG-------------IRGTRGYVA-PE 609 (724)
Q Consensus 554 --------~~~~~i~H~dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~~~-------------~~gt~~y~a-PE 609 (724)
.....++|+|+++.||++++ ...+.|+||+.+..-.......... .....+... |+
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 11246899999999999988 4567899999987543211100000 000001111 22
Q ss_pred cccCCCCCcccceeehhHHHHHhhccccCC
Q 041285 610 WHWNLPITAKADVYSFGVVLLEIICCRRCF 639 (724)
Q Consensus 610 ~~~~~~~~~k~Dv~S~Gvll~elltg~~p~ 639 (724)
.... .....+.|+++.+++++.+|..++
T Consensus 260 ~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 260 VLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1110 012358999999999999988654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.5e-06 Score=86.17 Aligned_cols=98 Identities=16% Similarity=0.216 Sum_probs=63.3
Q ss_pred CcccCCCCcee--cCCCCeeecCCCeEEEeeeecC--CCCceEE------EeecCCcC--C------CceeEEEEeecCC
Q 041285 4 HSNINIGSSLS--PNGNSSWLSPSGIYAFGFYQQS--NGSSYYV------GVFLAGIP--E------KNVGRIVLRSTEQ 65 (724)
Q Consensus 4 ~~~~~~g~~l~--~~~~~~lvS~~g~F~lGFf~~~--~~~~~yl------giW~~~~~--~------~t~g~l~l~~~~~ 65 (724)
.|++-+|+.|. ...+++|+| +.+++.|+|... ...+.+| .+|-.+-. . +..|+|++. +.+
T Consensus 136 tdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~-d~~ 213 (276)
T 3m7h_A 136 AIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVY-GAG 213 (276)
T ss_dssp TSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEE-CTT
T ss_pred ccccccccccccccccCccccc-CCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEE-eCC
Confidence 57788888822 133567866 468888888763 2223333 01211100 0 112888887 445
Q ss_pred CCeeEecCCCCcc-eEEEecCCccEEEEeCCCceEEeecCC
Q 041285 66 GQDSIIADDSQSA-SSASMLDSGSFVLYDSDGKVIWQTFDH 105 (724)
Q Consensus 66 ~~~~~~~~~~~~~-~~a~LldsGNlVl~~~~~~~lWQSFd~ 105 (724)
+..+|.+.+.... ..|+|+++|||||++. +++||||||
T Consensus 214 ~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 214 NAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp SCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 5788998765433 4899999999999976 789999997
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1e-05 Score=81.98 Aligned_cols=132 Identities=17% Similarity=0.176 Sum_probs=87.8
Q ss_pred ccCcCccc-eEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 453 EIGRGSSG-TVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 453 ~lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.+..|..+ .||+.... ++..++||+-.. ....++.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 68987764 356788887653 23457888999888773 44577889999988899999999999876
Q ss_pred hhhcCCCCc---chHHHHHHHcccccc-----------------------------------------------------
Q 041285 530 ADVYSSPPK---NNLIGIARGILYLHD----------------------------------------------------- 553 (724)
Q Consensus 530 ~~~l~~~~~---~~~~~ia~~l~yLH~----------------------------------------------------- 553 (724)
.+....... ....++++.|+-||.
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 187 (272)
T 4gkh_A 108 FQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL 187 (272)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred cccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence 554311110 011222222222221
Q ss_pred --cCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 554 --ECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 554 --~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
.....++|+|+++.|||++.++.+-|+||+.+..
T Consensus 188 ~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 188 PFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1122489999999999999877777999998753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=98.00 E-value=2.8e-05 Score=67.79 Aligned_cols=100 Identities=23% Similarity=0.319 Sum_probs=73.5
Q ss_pred cccccccCccccCCeec--cCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEE
Q 041285 107 TDTILPTQRLLAGMELF--PGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLF 184 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~--s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~ 184 (724)
+|||.||+.|..|..|+ |. .|.|.|.++.+|++.+|.. ....|.+..........+.+.++|.+.
T Consensus 8 ~~~l~~g~~L~~g~~l~~~S~-------~g~~~L~~~~dgnlvly~~------~~~vW~sn~~~~~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 8 QPDDNHPQILHATESLEILFG-------THVYRFIMQTDCNLVLYDN------NNPIWATNTGGLGNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSSSCCCCEEETTCEEEEEET-------TEEEEEEECTTSCEEEEET------TEEEEECCCTTSCSSCEEEECTTSCEE
T ss_pred CcccCCCCEEcCCCEEEEeCC-------CCCEEEEEecCCCEEEEEC------CEEEEeCCCccCCCceEEEEccCCEEE
Confidence 78999999999999998 53 6999999999999887632 246898765544334578888999999
Q ss_pred EEcCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 185 LLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+.+..+....... ..+. ...++++|+.||+|.+|.
T Consensus 75 l~d~~~~~lW~S~--~~~~-~g~~~l~l~~~Gnlvl~~ 109 (119)
T 1b2p_A 75 VITNENVTVWQSP--VAGK-AGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp EECTTCCEEEECS--CCCC-SSCEEEEECTTSCEEEEE
T ss_pred EEeCCCcEEEcCC--CCCC-CCCEEEEEECCCcEEEEC
Confidence 8876554443332 2222 224679999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=4.8e-05 Score=78.60 Aligned_cols=130 Identities=18% Similarity=0.186 Sum_probs=85.2
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC---ceeeeeeEEe-cccceEEEEeeccCC
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR---NLVRLLGYSF-DVSNKILVYEYMSNG 527 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~g 527 (724)
+.++.|....||+. ++.++||.-.. ......+.+|.+++..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 34777888889987 56688887532 23346789999999998642 3567777764 445678999999998
Q ss_pred Chhhh-cCCCCc----chHHHHHHHccccccc------------------------------------------------
Q 041285 528 SLADV-YSSPPK----NNLIGIARGILYLHDE------------------------------------------------ 554 (724)
Q Consensus 528 sL~~~-l~~~~~----~~~~~ia~~l~yLH~~------------------------------------------------ 554 (724)
.|.+. +..... ..+.++++.|+.||+.
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 87652 111110 0122222333222211
Q ss_pred ---------CCCceEeCCCCCCCeeeCC---CCC-eEEccccCccc
Q 041285 555 ---------CESQIIHCDIKPQNILMDE---NRY-AKISDFALAKL 587 (724)
Q Consensus 555 ---------~~~~i~H~dlk~~NIll~~---~~~-~kl~Dfgl~~~ 587 (724)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=3.5e-05 Score=81.44 Aligned_cols=80 Identities=9% Similarity=-0.002 Sum_probs=57.0
Q ss_pred ccc-CcCccceEEEEEee-------CCcEEEEEEccccc---chhHHHHHHHHHhhcccC-c--CceeeeeeEEecc---
Q 041285 452 EEI-GRGSSGTVYKGTMI-------NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTH-H--RNLVRLLGYSFDV--- 514 (724)
Q Consensus 452 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~--- 514 (724)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998765 26678888765432 112246788999988884 3 3577888887765
Q ss_pred cceEEEEeeccCCChhh
Q 041285 515 SNKILVYEYMSNGSLAD 531 (724)
Q Consensus 515 ~~~~lv~e~~~~gsL~~ 531 (724)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=9.3e-05 Score=79.45 Aligned_cols=74 Identities=19% Similarity=0.136 Sum_probs=48.6
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccc-------hhHHHHHHHHHhhcccCc--C-ceeeeeeEEecccceEEE
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA-------EGEREFQTEIKAIGRTHH--R-NLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~lv 520 (724)
+.||.|..+.||++... +++.++||....... .....+..|.+++..+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46999999999999764 467899997643211 123456788888887732 3 34455544 34456899
Q ss_pred EeeccCC
Q 041285 521 YEYMSNG 527 (724)
Q Consensus 521 ~e~~~~g 527 (724)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0003 Score=72.54 Aligned_cols=74 Identities=15% Similarity=0.136 Sum_probs=59.3
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC---cCceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH---HRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.|+.|....+|+... +++.++||+.... ....+..|.+.|+.|. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4689999999999886 5678888876542 3457889999888883 3578889998888888999999999876
Q ss_pred h
Q 041285 529 L 529 (724)
Q Consensus 529 L 529 (724)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00014 Score=76.01 Aligned_cols=129 Identities=21% Similarity=0.155 Sum_probs=75.2
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCc--Cceeeeee------EEecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH--RNLVRLLG------YSFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lv~e~~ 524 (724)
.|+.|..+.||+....++ .+++|+.... ..++..|+.++..+.. -.+.+++. +....+..++++||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677889999887544 5889988652 2334455555555531 12334443 122355678999999
Q ss_pred cCCChhh-----------hc-------CCC-------------Ccch-------------------------------H-
Q 041285 525 SNGSLAD-----------VY-------SSP-------------PKNN-------------------------------L- 541 (724)
Q Consensus 525 ~~gsL~~-----------~l-------~~~-------------~~~~-------------------------------~- 541 (724)
+|..+.. .+ ... .|.. +
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9865420 00 100 0100 0
Q ss_pred ---HHHHHHcccccc----------cCCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 542 ---IGIARGILYLHD----------ECESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 542 ---~~ia~~l~yLH~----------~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..+.+++.+|++ .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 012234555653 124589999999999999888889999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00021 Score=72.97 Aligned_cols=74 Identities=16% Similarity=0.260 Sum_probs=54.7
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-c--CceeeeeeEEecccceEEEEeeccCCC
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-H--RNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
+.+|.|..+.||+.++.||+.++||+-..........|..|...|+.|. . -.+.+++++ +..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 4689999999999999999999999876543344456889999888874 2 234455554 23478999998765
Q ss_pred h
Q 041285 529 L 529 (724)
Q Consensus 529 L 529 (724)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.001 Score=71.89 Aligned_cols=80 Identities=10% Similarity=-0.005 Sum_probs=47.4
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccccCccccCcccccCCC---CCcccceeehhHHHHHh
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP---ITAKADVYSFGVVLLEI 632 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvll~el 632 (724)
...++|+|+++.|||++.++ ++|+||+.+..-.........-..-...|.+|+...... .....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999998776 999999998753211110000000123456665543111 11234555777778877
Q ss_pred hccc
Q 041285 633 ICCR 636 (724)
Q Consensus 633 ltg~ 636 (724)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0013 Score=68.15 Aligned_cols=131 Identities=12% Similarity=0.093 Sum_probs=74.4
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCc--eeeeeeE------EecccceEEEEeec
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN--LVRLLGY------SFDVSNKILVYEYM 524 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~e~~ 524 (724)
.|+.|....+|+....++ .+++|..... ....++..|+.++..+.... +.+++.. ....+..+++++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788889999887655 5778887652 12345667777777663222 3333321 11234568999999
Q ss_pred cCCChhh------------------hcCC--CC---------cch-H---------------HHHHHHcccccc----cC
Q 041285 525 SNGSLAD------------------VYSS--PP---------KNN-L---------------IGIARGILYLHD----EC 555 (724)
Q Consensus 525 ~~gsL~~------------------~l~~--~~---------~~~-~---------------~~ia~~l~yLH~----~~ 555 (724)
+|..+.. .... .. |.. + ..+.+.+.++++ ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 0000 00 000 0 012223333332 12
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
...++|+|+++.|||++.+..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3478999999999999887666899998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0025 Score=66.15 Aligned_cols=75 Identities=8% Similarity=0.001 Sum_probs=48.1
Q ss_pred ccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcC--ceeeeeeE-----EecccceEEEEeecc
Q 041285 453 EIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHR--NLVRLLGY-----SFDVSNKILVYEYMS 525 (724)
Q Consensus 453 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~-----~~~~~~~~lv~e~~~ 525 (724)
.++ |....||+....+|+.+++|..... ......+..|..++..+... .+++++.. ....+..++++||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 7778899887767778999988632 12345667788877777422 24445443 112345578999998
Q ss_pred CCCh
Q 041285 526 NGSL 529 (724)
Q Consensus 526 ~gsL 529 (724)
+..+
T Consensus 111 G~~~ 114 (328)
T 1zyl_A 111 GRQF 114 (328)
T ss_dssp CEEC
T ss_pred CCCC
Confidence 7543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0017 Score=70.23 Aligned_cols=72 Identities=19% Similarity=0.188 Sum_probs=49.0
Q ss_pred cccCcCccceEEEEEeeC--------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCce-eeeeeEEecccceEEEEe
Q 041285 452 EEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL-VRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 522 (724)
+.|+.|-...+|+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457888889999998753 478888877431 111455679888888843333 567776543 28999
Q ss_pred eccCCCh
Q 041285 523 YMSNGSL 529 (724)
Q Consensus 523 ~~~~gsL 529 (724)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0048 Score=64.15 Aligned_cols=31 Identities=32% Similarity=0.381 Sum_probs=27.1
Q ss_pred CceEeCCCCCCCeeeCCC----CCeEEccccCccc
Q 041285 557 SQIIHCDIKPQNILMDEN----RYAKISDFALAKL 587 (724)
Q Consensus 557 ~~i~H~dlk~~NIll~~~----~~~kl~Dfgl~~~ 587 (724)
..++|+|+++.|||++.+ ..+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6789999999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0066 Score=65.95 Aligned_cols=73 Identities=12% Similarity=0.055 Sum_probs=46.2
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEcccccchhHHHHHHHHHhhcccCcCce-eeeeeEEecccceEEEEeeccCCCh
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL-VRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
+.|+.|-...+|+....+ ++.+++|+...... ..-...+|..++..|...++ .++++.+.. .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 457888889999998765 47788887643211 11122578888888854444 567776632 259999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0046 Score=65.39 Aligned_cols=74 Identities=12% Similarity=0.130 Sum_probs=45.6
Q ss_pred cccCcCccceEEEEEeeC--------CcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEe
Q 041285 452 EEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+. +.-..++++++.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 356677788899988752 468888886432 223456678999888884 33335677766543 9999
Q ss_pred eccCCChh
Q 041285 523 YMSNGSLA 530 (724)
Q Consensus 523 ~~~~gsL~ 530 (724)
|+++..|.
T Consensus 131 ~i~G~~l~ 138 (379)
T 3feg_A 131 YIPSRPLK 138 (379)
T ss_dssp CCSEEECC
T ss_pred EecCccCC
Confidence 99986553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0017 Score=66.52 Aligned_cols=127 Identities=17% Similarity=0.157 Sum_probs=72.7
Q ss_pred cccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCce-eeeeeEEecccceEEEEeec-cCCCh
Q 041285 452 EEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL-VRLLGYSFDVSNKILVYEYM-SNGSL 529 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~gsL 529 (724)
+.|+.|....+|+. +.+++|+-.... .......+|+..++.+....+ .+++++ +.+.-++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56788888999998 457888765421 111233567777777643233 455544 334457899999 65554
Q ss_pred hhhcCCCCcchHHHHHHHcccccc--------------------------------------------------cCCCce
Q 041285 530 ADVYSSPPKNNLIGIARGILYLHD--------------------------------------------------ECESQI 559 (724)
Q Consensus 530 ~~~l~~~~~~~~~~ia~~l~yLH~--------------------------------------------------~~~~~i 559 (724)
.............++++.|+-||. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 310000000111222222222221 112358
Q ss_pred EeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 560 IHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 560 ~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0061 Score=64.40 Aligned_cols=73 Identities=14% Similarity=0.119 Sum_probs=43.5
Q ss_pred cccCcCccceEEEEEeeC---------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCc-eeeeeeEEecccceEEEE
Q 041285 452 EEIGRGSSGTVYKGTMIN---------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~ 521 (724)
+.|+.|....+|+....+ ++.+++|...... ........|.+++..+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 357778888999988754 2678888765421 11123467888888774333 34666544 236899
Q ss_pred eeccCCCh
Q 041285 522 EYMSNGSL 529 (724)
Q Consensus 522 e~~~~gsL 529 (724)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.032 Score=58.01 Aligned_cols=32 Identities=25% Similarity=0.361 Sum_probs=27.8
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
...++|+|+.+.||+++.++.+.|+||..+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34789999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.12 Score=55.42 Aligned_cols=73 Identities=11% Similarity=0.117 Sum_probs=46.2
Q ss_pred cccCcCccceEEEEEeeC--------CcEEEEEEcccccchhHHHHHHHHHhhcccCcCc-eeeeeeEEecccceEEEEe
Q 041285 452 EEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRN-LVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e 522 (724)
+.|..|-...+|+....+ ++.+++|+..... ...-...+|..+++.+.-.+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 356677788899988753 5778888764321 11123457888887774222 345555332 378999
Q ss_pred eccCCCh
Q 041285 523 YMSNGSL 529 (724)
Q Consensus 523 ~~~~gsL 529 (724)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=80.32 E-value=0.52 Score=31.17 Aligned_cols=30 Identities=23% Similarity=0.543 Sum_probs=22.7
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
+.|. ...|-..|.|.....+..|.|++||.
T Consensus 4 d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCC-CCCCCCCCEeEcCCCceEeECCCCCc
Confidence 5676 45788888997544567899999996
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.19 E-value=0.63 Score=36.62 Aligned_cols=32 Identities=19% Similarity=0.437 Sum_probs=27.1
Q ss_pred cchHHhHHHHhhcCCccccccccC--cccccccc
Q 041285 314 KTTEQNCQEACLKDCNCEAALYKD--EECKMQRL 345 (724)
Q Consensus 314 ~~~~~~C~~~Cl~nCsC~a~~~~~--~~C~~~~~ 345 (724)
.+++++|+..|+.+=.|.||.|+. ..|.++..
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 457899999999999999999984 45887754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 724 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 7e-15 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-11 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-04 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-04 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-07 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-05 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-04 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
E +G G G V+ G VAVK L++ + F E + + H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQII 560
++ EYM NGSL D +P L IA G+ ++ + I
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H D++ NIL+ + KI+DF LA+L++ ++ G + + APE T K+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680
DV+SFG++L EI+ R + +VI Q E G +++ ++ E +
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERGY--RMVRPDNCP----EEL 239
Query: 681 IKVALWCILDEPSLRPSMKKVLLMLE 706
++ C + P RP+ + +LE
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 18/262 (6%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
F +EIG G G V+ G +N VA+K +++ A E +F E + + + H LV+L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSP----PKNNLIGIARGILY-LHDECESQIIHCDI 564
+ + LV+E+M +G L+D + L+G+ + + E+ +IH D+
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
+N L+ EN+ K+SDF + + + DQ + TG + + +PE ++K+DV+S
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 625 FGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684
FGV++ E+ + +N +V+ E + F L + + ++
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVV--EDISTGFR------LYKPRLAS----THVYQIM 235
Query: 685 LWCILDEPSLRPSMKKVLLMLE 706
C + P RP+ ++L L
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLA 257
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-60
Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 24/269 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ IG GS GTVYKG V + + + + F+ E+ + +T H N++ +G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIH 561
YS +V ++ SL A+G+ YLH + IIH
Sbjct: 72 YSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 562 CDIKPQNILMDENRYAKISDFALAKLM-KPDQTRTFTGIRGTRGYVAPEWHWNL---PIT 617
D+K NI + E+ KI DF LA + + + F + G+ ++APE P +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 618 AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677
++DVY+FG+VL E++ + + DQ+I V + + + +L ++ +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYLSPDLSKVRSNCP------ 239
Query: 678 ERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ M ++ C+ + RP ++L +E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-58
Identities = 68/275 (24%), Positives = 108/275 (39%), Gaps = 26/275 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ ++G+G G V+ GT VA+K L+ F E + + + H LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN---------LIGIARGILYLHDECESQII 560
+V EYMS GSL D IA G+ Y+ +
Sbjct: 80 V-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
H D++ NIL+ EN K++DF LA+L++ ++ G + + APE T K+
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680
DV+SFG++L E+ R + + V E G + E +
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERG------YRMPCPPECPESL 243
Query: 681 IKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPP 715
+ C EP RP+ + + LE P
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-57
Identities = 56/265 (21%), Positives = 106/265 (40%), Gaps = 24/265 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
F +E+G G G V G VA+K +++ + E EF E K + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQIIH 561
++ EYM+NG L + + + YL + +H
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 123
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+ +N L+++ K+SDF L++ + D+ + G + + PE ++K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 622 VYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681
+++FGV++ EI + + + E + Q E++
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLR----------LYRPHLASEKVY 231
Query: 682 KVALWCILDEPSLRPSMKKVLLMLE 706
+ C ++ RP+ K +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 26/277 (9%)
Query: 444 EKMTDGFKEEIGRGSSGTVYKGTMINGK----FVAVKRLQKMLAEGE-REFQTEIKAIGR 498
+ F E IGRG G VY GT+++ AVK L ++ GE +F TE +
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 499 THHRNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNLIGIARGILY-----LH 552
H N++ LLG +V YM +G L + + N + G +
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 553 DECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ---TRTFTGIRGTRGYVAPE 609
+ +H D+ +N ++DE K++DF LA+ M + TG + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 610 WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669
T K+DV+SFGV+L E++ ++ + ++ Q L++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYLLQGRR------LLQP 256
Query: 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
E + + +V L C + +RPS +++ +
Sbjct: 257 EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 6e-57
Identities = 71/311 (22%), Positives = 130/311 (41%), Gaps = 48/311 (15%)
Query: 438 FSYAELEKMTDGFKEE-----------IGRGSSGTVYKGTMI----NGKFVAVKRLQKML 482
F++ + + F +E IG G G V G + FVA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 483 AEGE-REFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN- 540
E + R+F +E +G+ H N++ L G + +++ E+M NGSL
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 541 -------LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593
L GIA G+ YL D +H D+ +NIL++ N K+SDF L++ ++ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 594 ----RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVI 649
+ G + + APE T+ +DV+S+G+V+ E++ P +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMT 238
Query: 650 LEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709
++ + ++ L + ++ L C + + RP +++ L+
Sbjct: 239 NQDVINAIEQDYRL-------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD--- 288
Query: 710 DIPIPPNPTSL 720
+ NP SL
Sbjct: 289 --KMIRNPNSL 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 32/267 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ IG+G G V G G VAVK ++ + F E + + H NLV+LLG
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 510 YSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECESQI 559
+ + +V EYM+ GSL D S ++ L + + + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
+H D+ +N+L+ E+ AK+SDF L K Q + APE + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTK 180
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679
+DV+SFG++L EI R +P V E G D
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG------YKMDAPDGCPPA 228
Query: 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706
+ +V C + ++RPS ++ LE
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 2e-55
Identities = 72/264 (27%), Positives = 113/264 (42%), Gaps = 20/264 (7%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-GKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
K ++G G G VY+G VAVK L++ E E EF E + H NLV+LL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 79
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL-----IGIARGILYLHDECESQ-IIHC 562
G ++ E+M+ G+L D + + + +A I + E + IH
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 563 DIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADV 622
D+ +N L+ EN K++DF L++LM D G + + APE + K+DV
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 623 YSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIK 682
++FGV+L EI + Q VY+ E + E E++ +
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCP------EKVYE 247
Query: 683 VALWCILDEPSLRPSMKKVLLMLE 706
+ C PS RPS ++ E
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-55
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 450 FKEE--IGRGSSGTVYKGTMING-----KFVAVKRLQKMLAEGER-EFQTEIKAIGRTHH 501
+ IG G G VYKG + VA+K L+ E +R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKN----NLIGIARGILYLHDECES 557
N++RL G +++ EYM NG+L L+G+ RGI +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 558 Q-IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ--TRTFTGIRGTRGYVAPEWHWNL 614
+H D+ +NIL++ N K+SDF L+++++ D T T +G + + APE
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
T+ +DV+SFG+V+ E++ L + V + +G D
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLPTPMDCP--- 239
Query: 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIP 712
+ ++ + C E + RP ++ +L+ + P
Sbjct: 240 ---SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 57/269 (21%), Positives = 112/269 (41%), Gaps = 17/269 (6%)
Query: 443 LEKMTDGFK--EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE-FQTEIKAIGR 498
+E D F+ E+G G+ G V+K + +G +A K + + R E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 499 THHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYL 551
+ +V G + + E+M GSL V + I + +G+ YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
++ +I+H D+KP NIL++ K+ DF ++ + +F GTR Y++PE
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERL 175
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFD-QNLPEDQVILEEWVYQCFENGNLGQLIEDE 670
+ ++D++S G+ L+E+ R + E +++ V
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 671 DVDKKQLERMIKVALWCILDEPSLRPSMK 699
+ ++ +A++ +LD P K
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-54
Identities = 63/290 (21%), Positives = 107/290 (36%), Gaps = 36/290 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+E IG+G G V++G G+ VAVK E + EI H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 510 YSFDVSNKI----LVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDEC---- 555
+ LV +Y +GSL D + + A G+ +LH E
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 556 -ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF---TGIRGTRGYVAPEWH 611
+ I H D+K +NIL+ +N I+D LA GT+ Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 612 W------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
+ +AD+Y+ G+V E I R + Q+ + V + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 666 LIEDEDVDKK---------QLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
++ ++ + L M K+ C + R + ++ L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-54
Identities = 66/268 (24%), Positives = 102/268 (38%), Gaps = 31/268 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
F EIGRGS TVYKG VA LQ + + F+ E + + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 507 LLGYSFDVSNK----ILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDEC 555
+LV E M++G+L I +G+ +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 556 ESQIIHCDIKPQNILM-DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
IIH D+K NI + KI D LA L + + GT ++APE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM-YEE 187
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
DVY+FG+ +LE+ + + Q+ + ++ DK
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-----------RVTSGVKPASFDK 236
Query: 675 KQLERMIKVALWCILDEPSLRPSMKKVL 702
+ + ++ CI R S+K +L
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 2e-53
Identities = 68/312 (21%), Positives = 121/312 (38%), Gaps = 56/312 (17%)
Query: 436 LSFSYAELEKMTDGFK--EEIGRGSSGTVYKGTMIN------GKFVAVKRLQK-MLAEGE 486
L+ LE + + +IG G+ G V++ VAVK L++ A+ +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 487 REFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN------ 540
+FQ E + + N+V+LLG L++EYM+ G L + S +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 541 -------------------------LIGIARGILYLHDECESQIIHCDIKPQNILMDENR 575
+A G+ YL E + +H D+ +N L+ EN
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177
Query: 576 YAKISDFALAKLMKP-DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC 634
KI+DF L++ + D + ++ PE + T ++DV+++GVVL EI
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 635 CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSL 694
+ ++VI +GN+ E+ + + C P+
Sbjct: 238 YGLQPYYGMAHEEVI------YYVRDGNILACPENCP------LELYNLMRLCWSKLPAD 285
Query: 695 RPSMKKVLLMLE 706
RPS + +L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-53
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 32/271 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK--MLAEGEREFQTEIKAIGRTHHRNLVR 506
IG GS G K +GK + K L M ++ +E+ + H N+VR
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 507 LLGYSFDVSNKIL--VYEYMSNGSLADVYSSPPKNN-----------LIGIARGILYLHD 553
D +N L V EY G LA V + K + + + H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 554 --ECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
+ ++H D+KP N+ +D + K+ DF LA+++ D + GT Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KAFVGTPYYMSPEQM 186
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671
+ K+D++S G +L E+ F ++ + G ++
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIPYRYS 239
Query: 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+ + ++ + + RPS++++L
Sbjct: 240 ------DELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 9e-53
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 30/268 (11%)
Query: 453 EIGRGSSGTVYKGTMIN---GKFVAVKRLQKMLAEGE--REFQTEIKAIGRTHHRNLVRL 507
E+G G+ GTV KG K VAVK L+ + E E + + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQII 560
+G + + +LV E G L + ++ G+ YL + +
Sbjct: 74 IGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPITA 618
H D+ +N+L+ YAKISDF L+K ++ D+ + T + + APE ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
K+DV+SFGV++ E + + + + V E G
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPAGCP------R 237
Query: 679 RMIKVALWCILDEPSLRPSMKKVLLMLE 706
M + C + RP V L L
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 55/268 (20%), Positives = 108/268 (40%), Gaps = 30/268 (11%)
Query: 453 EIGRGSSGTVYKGTMI---NGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLL 508
E+G G+ G+V +G VA+K L++ + + E E + + + + +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQII 560
G +LV E G L + L ++ G+ YL ++ +
Sbjct: 76 GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQT--RTFTGIRGTRGYVAPEWHWNLPITA 618
H D+ +N+L+ YAKISDF L+K + D + + + + APE ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
++DV+S+GV + E + + + + +V+ E G + +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECPPECP------P 239
Query: 679 RMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + C + + RP V +
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 48/292 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGERE-FQTEIKAIGR-THH 501
F + +G G+ G V + T VAVK L+ ERE +E+K + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 502 RNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------------------- 540
N+V LLG +++ EY G L + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 541 ----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596
+A+G+ +L + IH D+ +NIL+ R KI DF LA+ +K D
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 597 TG-IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY 655
G R ++APE +N T ++DV+S+G+ L E+ +P D Y
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----SKFY 258
Query: 656 QCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707
+ + G +++ E M + C +P RP+ K+++ ++E
Sbjct: 259 KMIKEGF--RMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-50
Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 31/264 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEG---EREFQTEIKAIGRTHHRNLV 505
+G+G G VY + +A+K L K E E + + E++ H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQ 558
RL GY D + L+ EY G++ K + + +A + Y H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKR 126
Query: 559 IIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
+IH DIKP+N+L+ KI+DF + + T GT Y+ PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHDE 183
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
K D++S GV+ E + + F+ N ++ ++ + + + V E
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQET----------YKRISRVEFTFPDFVT----E 229
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+ + PS RP +++VL
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 22/258 (8%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGY 510
E+IG+G+SGTVY + G+ VA++++ + EI + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 511 SFDVSNKILVYEYMSNGSLADVYSSPPKNN------LIGIARGILYLHDECESQIIHCDI 564
+V EY++ GSL DV + + + + +LH +Q+IH DI
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
K NIL+ + K++DF + P+Q++ + + GT ++APE K D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 625 FGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA 684
G++ +E+I + P +Y NG +L E + +
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-ELQNPEKLS-AIFRDFLN-- 251
Query: 685 LWCILDEPSLRPSMKKVL 702
C+ + R S K++L
Sbjct: 252 -RCLDMDVEKRGSAKELL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 71/341 (20%), Positives = 120/341 (35%), Gaps = 64/341 (18%)
Query: 411 YRYRVRSYRIIPGNGSARYCEDIALLS------FSYAELEKMTDGFKEEIGRGSSGTVYK 464
Y +++ ++ + + + D F LE F + +G G+ G V
Sbjct: 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLE-----FGKVLGSGAFGKVMN 55
Query: 465 GTMIN------GKFVAVKRLQKMLAEGERE-FQTEIKAIGR-THHRNLVRLLGYSFDVSN 516
T VAVK L++ ERE +E+K + + H N+V LLG
Sbjct: 56 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115
Query: 517 KILVYEYMSNGSLADVYSSPPKNN------------------------------LIGIAR 546
L++EY G L + S + +A+
Sbjct: 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175
Query: 547 GILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF-TGIRGTRGY 605
G+ +L +H D+ +N+L+ + KI DF LA+ + D R +
Sbjct: 176 GMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
+APE + T K+DV+S+G++L EI +P D Y+ +NG
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF-----YKLIQNGFKMD 287
Query: 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
E + + C + RPS + L
Sbjct: 288 QPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 29/267 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E+G G+ G VYK A K + E ++ EI + H N+V+LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQII 560
+ +N ++ E+ + G++ V + + YLH +++II
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHW-----NLP 615
H D+K NIL + K++DF ++ R + GT ++APE + P
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 191
Query: 616 ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675
KADV+S G+ L+E+ + P V L +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWS-S 243
Query: 676 QLERMIKVALWCILDEPSLRPSMKKVL 702
+ +K C+ R + ++L
Sbjct: 244 NFKDFLK---KCLEKNVDARWTTSQLL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-50
Identities = 64/264 (24%), Positives = 105/264 (39%), Gaps = 25/264 (9%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK-MLAEGEREFQTEIKAIGRTHHRNLVRL 507
+ +G G+ G V + VAVK + + + EI +H N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQII 560
G+ + + + L EY S G L D + G++YLH I
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---IT 125
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPD-QTRTFTGIRGTRGYVAPEWHWNLPI-TA 618
H DIKP+N+L+DE KISDF LA + + + + R + GT YVAPE
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
DV+S G+VL ++ +DQ Q + + + KK
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----------DWKEKKTYLNPWKKIDS 234
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+ + +++ PS R ++ +
Sbjct: 235 APLALLHKILVENPSARITIPDIK 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 58/267 (21%), Positives = 105/267 (39%), Gaps = 23/267 (8%)
Query: 450 FKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNL 504
IG G G V++G ++ VA+K + ++ RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVYS----SPPKNNLIGIARGIL-YLHDECESQI 559
V+L+G + ++ E + G L S +LI A + L +
Sbjct: 71 VKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAK 619
+H DI +N+L+ N K+ DF L++ M+ + + ++APE T+
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 620 ADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679
+DV+ FGV + EI+ Q + + V ENG + +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNCP------PT 237
Query: 680 MIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + C +PS RP ++ L
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-49
Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 450 FKEEIGRGSSGTVYKGTMING---KFVAVKRLQKMLA-EGEREFQTEIKAIGR-THHRNL 504
F++ IG G+ G V K + A+KR+++ + + R+F E++ + + HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVY-------------------SSPPKNNLIGIA 545
+ LLG L EY +G+L D S+ L+ A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 546 RGIL-YLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRG 604
+ + + Q IH D+ +NIL+ EN AKI+DF L++ + +T R
Sbjct: 134 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG--RLPVR 191
Query: 605 YVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG 664
++A E T +DV+S+GV+L EI+ + + +Y+ G
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGYRL 245
Query: 665 QLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPIPPNPTSLL 721
+ + D + + + C ++P RPS ++L+ L ++ T+L
Sbjct: 246 EKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 4e-49
Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 34/265 (12%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLVRL 507
EIG GS G VY + N + VA+K++ + ++ E++ + + H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQII 560
G LV EY + + G +G+ YLH +I
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 137
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW---HWNLPIT 617
H D+K NIL+ E K+ DF A +M P + GT ++APE
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQYD 192
Query: 618 AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677
K DV+S G+ +E+ + +Y +N + ++
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES--PALQSGHWS---- 240
Query: 678 ERMIKVALWCILDEPSLRPSMKKVL 702
E C+ P RP+ + +L
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 60/272 (22%), Positives = 114/272 (41%), Gaps = 31/272 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMIN-----GKFVAVKRLQK-MLAEGEREFQTEIKAIGRTHHRN 503
+ +G G+ GTVYKG I VA+K L++ + +E E + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 504 LVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDEC 555
+ RLLG S L+ + M G L D N + IA+G+ YL D
Sbjct: 73 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNL 614
+++H D+ +N+L+ ++ KI+DF LAKL+ ++ G + ++A E +
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
T ++DV+S+GV + E++ +P + + E G
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQPPICT--- 239
Query: 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + + C + + RP +++++
Sbjct: 240 ---IDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-48
Identities = 64/274 (23%), Positives = 104/274 (37%), Gaps = 32/274 (11%)
Query: 450 FKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHR 502
E++G GS G V +G VAVK L+ + E +F E+ A+ HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL--------IGIARGILYLHDE 554
NL+RL G +V E GSL D + L + +A G+ YL +
Sbjct: 72 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 555 CESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF--TGIRGTRGYVAPEWHW 612
IH D+ +N+L+ KI DF L + + + + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 613 NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672
+ +D + FGV L E+ + L Q++ ++ + G ED
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-----HKIDKEGERLPRPEDCP- 241
Query: 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+ + V + C +P RP+ + L
Sbjct: 242 -----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 450 FKEEIGRGSSGTVYKGT------MINGKFVAVKRLQKMLAEGER-EFQTEIKAIGRTHHR 502
E+G+GS G VY+G VA+K + + + ER EF E + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLAD-------------VYSSPPKNNLIGIARGIL 549
++VRLLG +++ E M+ G L V + P + +I +A I
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 550 Y-LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP-DQTRTFTGIRGTRGYVA 607
+ ++ +H D+ +N ++ E+ KI DF + + + D R +++
Sbjct: 144 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 608 PEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLI 667
PE + T +DV+SFGVVL EI Q L +QV+ + G L
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVMEGGL---- 253
Query: 668 EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710
D + + ++ C P +RPS +++ ++ M+
Sbjct: 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 47/293 (16%)
Query: 450 FKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLAEGE-REFQTEIKAIGRT-HH 501
+ +GRG+ G V + + VAVK L++ E R +E+K + HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 502 RNLVRLLGYSFDVSNKI-LVYEYMSNGSLADVYSSPPKNNL------------------- 541
N+V LLG + ++ E+ G+L+ S +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 542 ----IGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597
+A+G+ +L + IH D+ +NIL+ E KI DF LA+ + D
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 598 G-IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ 656
G R ++APE ++ T ++DV+SFGV+L EI P V ++E +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 657 CFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709
+ G + + M + L C EPS RP+ +++ L +
Sbjct: 249 RLKEGTRMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-45
Identities = 61/291 (20%), Positives = 114/291 (39%), Gaps = 43/291 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI--------NGKFVAVKRLQKMLAEGE-REFQTEIKAIGR-T 499
+ +G G+ G V I VAVK L+ E + + +E++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 500 HHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL------------------ 541
H+N++ LLG ++ EY S G+L + + L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 542 -IGIARGILY-LHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT-G 598
+ A + + + IH D+ +N+L+ E+ KI+DF LA+ + T
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCF 658
R ++APE ++ T ++DV+SFGV+L EI +P E +++
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLL 250
Query: 659 ENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709
+ G+ + + + C PS RP+ K+++ L+ +
Sbjct: 251 KEGHRMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-45
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 23/262 (8%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLV 505
F + +G GS TV + + A+K L+K E E + R H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQIIH 561
+L D Y NG L A + L IIH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 131
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG-IRGTRGYVAPEWHWNLPITAKA 620
D+KP+NIL++E+ + +I+DF AK++ P+ + GT YV+PE +
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680
D+++ G ++ +++ F +Q D +K +
Sbjct: 192 DLWALGCIIYQLVAGLPPFRAGNEYLI-------FQKIIKLEY-------DFPEKFFPKA 237
Query: 681 IKVALWCILDEPSLRPSMKKVL 702
+ ++ + + R +++
Sbjct: 238 RDLVEKLLVLDATKRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (410), Expect = 9e-45
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 26/264 (9%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EE+G G+ G V++ T G A K + + + EI+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQII 560
D + +++YE+MS G L + + + + +G+ ++H+ +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 561 HCDIKPQNILM--DENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H D+KP+NI+ + K+ DF L + P Q+ T GT + APE P+
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
D++S GV+ ++ F ++ N D+ E
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDET----------LRNVKSCDWNMDDSAFSGISE 254
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+L +P+ R ++ + L
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 4e-44
Identities = 59/264 (22%), Positives = 100/264 (37%), Gaps = 26/264 (9%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
EE+G G+ G V++ G+ K + + + EI + + HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQII 560
D +L+ E++S G L D ++ N + G+ ++H E I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 561 HCDIKPQNILMDENR--YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H DIKP+NI+ + + KI DF LA + PD+ T T + APE P+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGF 207
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
D+++ GV+ ++ F + +N DED
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLET----------LQNVKRCDWEFDEDAFSSVSP 257
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+ EP R ++ L
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-42
Identities = 63/277 (22%), Positives = 107/277 (38%), Gaps = 29/277 (10%)
Query: 440 YAELEKMTDGFK--EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKA 495
+ + E + D + + +G G+ V K VA+K + K EG+ + EI
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 496 IGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGI 548
+ + H N+V L + L+ + +S G L D + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 549 LYLHDECESQIIHCDIKPQNIL---MDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGY 605
YLHD I+H D+KP+N+L +DE+ ISDF L+K+ P + GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGY 175
Query: 606 VAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
VAPE P + D +S GV+ ++C F ++
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-------FEQILKAEYEF 228
Query: 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
D + I+ + +P R + ++ L
Sbjct: 229 DSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQAL 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 49/264 (18%), Positives = 103/264 (39%), Gaps = 27/264 (10%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E++GRG G V++ + K K ++ + + + EI + HRN++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPP--------KNNLIGIARGILYLHDECESQII 560
+ ++++E++S + + ++ + + + + +LH I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 561 HCDIKPQNILMDENRYA--KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITA 618
H DI+P+NI+ R + KI +F A+ +KP Y APE H + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 619 KADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLE 678
D++S G ++ ++ F + EN + DE+ K+
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMNAEYTFDEEAFKEISI 232
Query: 679 RMIKVALWCILDEPSLRPSMKKVL 702
+ ++ E R + + L
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEAL 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 4e-41
Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 25/272 (9%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGE---REFQTEIKAIGRTHHRNLV 505
E +G G V+ + + VAVK L+ LA F+ E + +H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 506 RLLGYSFDVSNKI----LVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECES 557
+ + +V EY+ +L D+ + PK + IA L+ ++
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR--TFTGIRGTRGYVAPEWHWNLP 615
IIH D+KP NI++ K+ DF +A+ + + GT Y++PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 616 ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675
+ A++DVYS G VL E++ F + P YQ + E +
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPSARHEGLS-- 242
Query: 676 QLERMIKVALWCILDEPSLRP-SMKKVLLMLE 706
+ V L + P R + ++ L
Sbjct: 243 --ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (374), Expect = 1e-40
Identities = 55/277 (19%), Positives = 107/277 (38%), Gaps = 39/277 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK---------MLAEGEREFQTEIKAIGRT 499
KE +GRG S V + K AVK + + E E+ + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 500 H-HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYL 551
H N+++L + LV++ M G L D + + + + I L
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 126
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
H + I+H D+KP+NIL+D++ K++DF + + P + + GT Y+APE
Sbjct: 127 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEII 181
Query: 612 W------NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQ 665
+ + D++S GV++ ++ F + +GN
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMIMSGNYQF 234
Query: 666 LIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
+ D ++ ++ ++ +P R + ++ L
Sbjct: 235 GSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEAL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 61/298 (20%), Positives = 110/298 (36%), Gaps = 42/298 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE---FQTEIKAIGRT-HHRNL 504
+ +G+GS G V+ +F A+K L+K + + + E + + H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 505 VRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNL-------IGIARGILYLHDECES 557
+ N V EY++ G L S K +L I G+ +L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL---HSK 122
Query: 558 QIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPIT 617
I++ D+K NIL+D++ + KI+DF + K + GT Y+APE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKYN 181
Query: 618 AKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677
D +SFGV+L E++ + F E+ F + + ++ K+
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------FHSIRMDNPFYPRWLE-KEA 230
Query: 678 ERMIKVALWCILDEPSLRPSMKKVLL------------MLEGTMDIPIPPNPTSLLTT 723
+ ++ + EP R ++ + + +D P P S
Sbjct: 231 KDLLV---KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 285
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (373), Expect = 1e-39
Identities = 54/264 (20%), Positives = 100/264 (37%), Gaps = 32/264 (12%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQK---MLAEGEREFQTE---IKAIGRTHHR 502
IGRG G VY GK A+K L K + +GE E + +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDEC 555
+V + + + M+ G L S + I G+ ++H+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 556 ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNL 614
+++ D+KP NIL+DE+ + +ISD LA + GT GY+APE +
Sbjct: 128 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGV 181
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
+ AD +S G +L +++ F Q+ +D+ ++ + +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HEIDRMTLTMAVELPDSFS- 233
Query: 675 KQLERMIKVALWCILDEPSLRPSM 698
+L +++ + + + R
Sbjct: 234 PELRSLLE---GLLQRDVNRRLGC 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 6e-39
Identities = 47/275 (17%), Positives = 85/275 (30%), Gaps = 29/275 (10%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+IG GS G +Y GT + G+ VA+K + E K + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 509 GYSFDVSNK-ILVYEYMSNGSLADVYSSPPK-------NNLIGIARGILYLHDECESQII 560
+ + ++V E + K + I Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 561 HCDIKPQNILMDENRYAKI---SDFALAKLMKPDQTRTF------TGIRGTRGYVAPEWH 611
H D+KP N LM + + DF LAK + +T + GT Y + H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671
+ + + D+ S G VL+ + + E + + + + L +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
+C +P + +
Sbjct: 246 ------SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 27/268 (10%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGER------EFQTEIKAIGRTHHR 502
EE+G G V K G A K ++K + R + + E+ + H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 503 NLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPK---NNLIGIARGIL-YLHDECESQ 558
N++ L + ++ IL+ E ++ G L D + + IL ++ Q
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 559 IIHCDIKPQNILMDENRYA----KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
I H D+KP+NI++ + KI DF LA + I GT +VAPE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 191
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674
P+ +AD++S GV+ ++ F + ++ N E
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFEDEYFSNTS 244
Query: 675 KQLERMIKVALWCILDEPSLRPSMKKVL 702
+ I+ ++ +P R +++ L
Sbjct: 245 ALAKDFIR---RLLVKDPKKRMTIQDSL 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 8e-39
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA---EGEREFQTEIKAIGRTHHRNLV 505
+G GS G V+ NG++ A+K L+K + + E + H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYS---SPPKNNLIGIARGIL-YLHDECESQIIH 561
R+ G D ++ +Y+ G L + P A + L II+
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 127
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+KP+NIL+D+N + KI+DF AK + + GT Y+APE P D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNKSID 183
Query: 622 VYSFGVVLLEIICCRRCFDQNLPEDQ 647
+SFG+++ E++ F +
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 2e-38
Identities = 53/272 (19%), Positives = 99/272 (36%), Gaps = 21/272 (7%)
Query: 452 EEIGRGSSGTVYKGTMINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
E+IG G+ G VYK G+ A+K RL+K EI + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 510 YSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQIIHCDIK 565
+LV+E++ + + + + + + +++H D+K
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 566 PQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSF 625
PQN+L++ KI+DF LA+ + I + + D++S
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 626 GVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL-------- 677
G + E++ F DQ++ + + N + E D
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 678 -------ERMIKVALWCILDEPSLRPSMKKVL 702
E I + + +P+ R + K+ L
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 60/276 (21%), Positives = 101/276 (36%), Gaps = 26/276 (9%)
Query: 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQK-----MLAEGEREFQTEIKAIGRTHHRNLV 505
+ +G G TVYK N + VA+K+++ R EIK + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN---LIGIARGIL-YLHDECESQIIH 561
LL SN LV+++M + + + L L + I+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPE-WHWNLPITAKA 620
D+KP N+L+DEN K++DF LAK R +T TR Y APE
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQV--------------ILEEWVYQCFENGNLGQL 666
D+++ G +L E++ + DQ+ + +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVL 702
I + + ++ + L P R + + L
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 34/288 (11%)
Query: 451 KEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLG 509
+ +G G +G V + + A+K LQ + RE + +A ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRAS---QCPHIVRIVD 72
Query: 510 YSFDVSNK----ILVYEYMSNGSLADVYSSPPKNNL---------IGIARGILYLHDECE 556
++ ++V E + G L I I YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129
Query: 557 SQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWN 613
I H D+KP+N+L N K++DF AK + T T YVAPE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGP 187
Query: 614 LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673
D++S GV++ ++C F N + G +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPNPEWSEV 244
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDIPIPPNPTS 719
++++ +I+ + EP+ R ++ + + + + +P P TS
Sbjct: 245 SEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 39/269 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE------FQTEIKAIGR--TH 500
+G G G+VY G + + VA+K ++K E E+ + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILY-----LHDEC 555
++RLL + + +L+ E + + +AR + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 556 ESQIIHCDIKPQNILMDENRY-AKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNL 614
++H DIK +NIL+D NR K+ DF L+K F GTR Y PEW
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYH 184
Query: 615 P-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673
A V+S G++L +++C F+ + E GQ+ + V
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHD----------------EEIIRGQVFFRQRVS 228
Query: 674 KKQLERMIKVALWCILDEPSLRPSMKKVL 702
+ + +I+ WC+ PS RP+ +++
Sbjct: 229 -SECQHLIR---WCLALRPSDRPTFEEIQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-37
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 35/283 (12%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGERE-FQTEIKAIGRTHHRNLVRLLG 509
IG G+ G V +N VA+K++ + + EIK + R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 510 Y----SFDVSNKILVYEYMSNGSLADVYSSPP------KNNLIGIARGILYLHDECESQI 559
+ + + + ++ L + + L I RG+ Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 560 IHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR--TFTGIRGTRGYVAPEWHWN-LPI 616
+H D+KP N+L++ KI DF LA++ PD T TR Y APE N
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 617 TAKADVYSFGVVLLEIICCRRCFDQNLPEDQV---------ILEEWVYQCFENGNLGQLI 667
T D++S G +L E++ R F DQ+ +E + L+
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 668 EDEDVDKKQLERMIKVA--------LWCILDEPSLRPSMKKVL 702
+K R+ A + P R +++ L
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 452 EEIGRGSSGTVYKGTMI--NGKFVAVKRLQKMLAEGEREFQT-----EIKAIGRTHHRNL 504
EIG G+ G V+K + G+FVA+KR++ E T ++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 505 VRLLGYSFDVSNK-----ILVYEYMSNGSLADVYSSP--------PKNNLIGIARGILYL 551
VRL LV+E++ + P K+ + + RG+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 552 HDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWH 611
H ++H D+KPQNIL+ + K++DF LA++ T + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVL 187
Query: 612 WNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV--ILEEWVYQCFENGNLGQLIED 669
D++S G + E+ + F + DQ+ IL+ E+ +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 670 EDVDKKQLERMIKVA-----------LWCILDEPSLRPSMKKVL 702
+ K + + K L C+ P+ R S L
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (344), Expect = 2e-36
Identities = 41/277 (14%), Positives = 88/277 (31%), Gaps = 31/277 (11%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
IG GS G +++GT ++N + VA+K + + + E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIARGILYLHDECESQII 560
Y ++ + SL D+ + + + +H E ++
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 561 HCDIKPQNILMDE-----NRYAKISDFALAKLMKPDQTRTF------TGIRGTRGYVAPE 609
+ DIKP N L+ + DF + K + T+ + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 610 WHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669
H + + D+ + G V + + + E + + ++ L +L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706
E K + P + +
Sbjct: 244 FP------EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 65/322 (20%), Positives = 116/322 (36%), Gaps = 55/322 (17%)
Query: 414 RVRSYRIIPGNGSARYCEDIALLSFSYAELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKF 472
+V + PG G R E SY + + IG GS G VY+ + +G+
Sbjct: 2 KVTTVVATPGQGPDRPQE------VSYTDTKV--------IGNGSFGVVYQAKLCDSGEL 47
Query: 473 VAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNK------ILVYEYMSN 526
VA+K++ + +R E++ + + H N+VRL + + K LV +Y+
Sbjct: 48 VAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 527 GSLADVYSSPPKNN----------LIGIARGILYLHDECESQIIHCDIKPQNI-LMDENR 575
+ + R + Y+H I H DIKPQN+ L +
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTA 160
Query: 576 YAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICC 635
K+ DF AK + + + I T+ DV+S G VL E++
Sbjct: 161 VLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 636 RRCFDQNLPEDQV---------ILEEWVYQCFENGNLGQLIEDEDVDKKQLER------M 680
+ F + DQ+ E + + N + + + ++ R
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 279
Query: 681 IKVALWCILDEPSLRPSMKKVL 702
I + + P+ R + +
Sbjct: 280 IALCSRLLEYTPTARLTPLEAC 301
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 9/206 (4%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE---FQTEIKAIGRTHHRNLV 505
+ + +G+G+ G V G++ A+K L+K + + E TE + + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 506 RLLGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQIIH 561
L V EY + G L S + A + L +++
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
DIK +N+++D++ + KI+DF L K D T GT Y+APE + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVD 187
Query: 622 VYSFGVVLLEIICCRRCFDQNLPEDQ 647
+ GVV+ E++C R F E
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERL 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-35
Identities = 53/288 (18%), Positives = 111/288 (38%), Gaps = 37/288 (12%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRL--QKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
+IG+G+ G V+K G+ VA+K++ + EIK + H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 509 GYSFDVSNKI--------LVYEYMSNGSLADVYSSPPKNN---LIGIARGIL-YLHDECE 556
++ LV+++ + + + K + + + +L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT---RTFTGIRGTRGYVAPEWHWN 613
++I+H D+K N+L+ + K++DF LA+ + +T T Y PE
Sbjct: 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195
Query: 614 -LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL--------EEWVYQCFENGNLG 664
D++ G ++ E+ N + Q+ L V+ +N L
Sbjct: 196 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 255
Query: 665 QLIEDEDVDKKQLERMIKVALW----------CILDEPSLRPSMKKVL 702
+ +E K++++ +K + ++ +P+ R L
Sbjct: 256 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 23/274 (8%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E+IG G+ G VYK + G+ VA+K RL EI + +H N+V+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGIL-----YLHDECESQIIHCD 563
+ LV+E++ + +S + + + L L +++H D
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 564 IKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVY 623
+KPQN+L++ K++DF LA+ + + D++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 624 SFGVVLLEIICCRRCFDQNLPEDQV--ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMI 681
S G + E++ R F + DQ+ I + D + R
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 682 KVALWCILDE-------------PSLRPSMKKVL 702
+ LDE P+ R S K L
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 52/274 (18%), Positives = 92/274 (33%), Gaps = 23/274 (8%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVK--RLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
E+IG G+ GTV+K + VA+K RL EI + H+N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 509 GYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECESQIIHCDI 564
LV+E+ S P+ + + + L ++H D+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 565 KPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYS 624
KPQN+L++ N K+++F LA+ + + D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 625 FGVVLLEIICCRR-CFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKV 683
G + E+ R F N +DQ+ + + + D +
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 684 AL---------------WCILDEPSLRPSMKKVL 702
+ + P R S ++ L
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 2e-32
Identities = 59/287 (20%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGR-THHRNLVRL 507
++GRG V++ I N + V VK L+ +++ + EIK + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITL 95
Query: 508 LGYSFDVSNK--ILVYEYMSNGSLADVYSSPPKNNLIGIARGIL----YLHDECESQIIH 561
D ++ LV+E+++N +Y + ++ IL Y H I+H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMH 152
Query: 562 CDIKPQNILMD-ENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLP-ITAK 619
D+KP N+++D E+R ++ D+ LA+ P Q +R + PE +
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELLVDYQMYDYS 210
Query: 620 ADVYSFGVVLLEIICCRRCF-------DQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672
D++S G +L +I + F DQ + +V+ E +Y + N+ D+
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270
Query: 673 ----DKKQLERMIKVALWCILDE-------------PSLRPSMKKVL 702
+K+ ER + ++ R + ++ +
Sbjct: 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 15/213 (7%)
Query: 450 FKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML----AEGEREFQTEIKAIGR-TH 500
+ +G G+ G V+ I GK A+K L+K A+ +TE + +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS----PPKNNLIGIARGILYLHDECE 556
LV L + L+ +Y++ G L S I + +L L +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 557 SQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEW--HWNL 614
II+ DIK +NIL+D N + ++DF L+K D+T GT Y+AP+ +
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207
Query: 615 PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQ 647
D +S GV++ E++ F + ++
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 12/206 (5%)
Query: 452 EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLA--EGEREFQTEIKAIGRTHHRNLVRLL 508
+ IG G+ G V + + VA+K+L + + E+ + +H+N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 509 GYSF------DVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGIL-YLHDECESQIIH 561
+ + LV E M + + + +L + + IIH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142
Query: 562 CDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKAD 621
D+KP NI++ + KI DF LA+ T TR Y APE + D
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGMGYKENVD 200
Query: 622 VYSFGVVLLEIICCRRCFDQNLPEDQ 647
++S G ++ E++ + F DQ
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 45/303 (14%)
Query: 438 FSYAELEKMTDGFK------EEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLA--EGERE 488
F E+ K + + +G G+ G V G VA+K+L + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 489 FQTEIKAIGRTHHRNLVRLLGY------SFDVSNKILVYEYMSNGSLADVYSSPPKNNLI 542
E++ + H N++ LL D ++ LV +M + + I
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 543 -----GIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597
+ +G+ Y+H IIH D+KP N+ ++E+ KI DF LA+ T
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMT 176
Query: 598 GIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL------ 650
G TR Y APE N + T D++S G ++ E+I + F + DQ+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 651 ---EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVA--------LWCILDEPSLRPSMK 699
E+V + + + +++KK ++ A ++ + R +
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 700 KVL 702
+ L
Sbjct: 297 EAL 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 1e-29
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 18/208 (8%)
Query: 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGERE---FQTEIKAIGRTHHRNLVRL 507
+ +G GS G V +G A+K L K ++ E + + + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 508 LGYSFDVSNKILVYEYMSNGSLADVYSSPPKNN-------LIGIARGILYLHDECESQII 560
D SN +V EY++ G + + + I YLH +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 561 HCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKA 620
+ D+KP+N+L+D+ Y +++DF AK +K + GT +APE +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 621 DVYSFGVVLLEIICCRRCFDQNLPEDQV 648
D ++ GV++ E+ F + P
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 65/304 (21%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 437 SFSYAELEK----MTDGFK--EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGE--R 487
+F EL K + + ++ +G G+ G+V G VAVK+L + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 488 EFQTEIKAIGRTHHRNLVRLLGY-----SFDVSNKILVYEYMSNGSLADVYSSPP----- 537
E++ + H N++ LL S + N + + ++ L ++
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 538 -KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596
+ + I RG+ Y+H IIH D+KP N+ ++E+ KI DF LA+
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EM 175
Query: 597 TGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV-ILEEWV 654
TG TR Y APE N + D++S G ++ E++ R F DQ+ ++ V
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILD----------------EPSLRPSM 698
E + L +M K+ + + R +
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 699 KKVL 702
+ L
Sbjct: 296 AQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 3e-24
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 29/236 (12%)
Query: 450 FKEEIGRGSSGTVYKGT-MINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL 508
++G G TV+ M+N VA+K ++ E + EIK + R + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKED 75
Query: 509 GYS---------------FDVSNKILVYEYMSNGSLADVYSSPPKNN--------LIGIA 545
+ + ++V+E + LA + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 546 RGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQT-RTFTGIRGTR 603
G+ Y+H C IIH DIKP+N+LM+ + + +A L +T TR
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 604 GYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFE 659
Y +PE P AD++S ++ E+I F+ + ++ + Q E
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 2e-22
Identities = 28/153 (18%), Positives = 45/153 (29%), Gaps = 18/153 (11%)
Query: 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAE----------GEREFQTEIKAIG 497
D + +G G V+ VK + G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 498 RTHHRNLVRLLG----YSFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHD 553
R R L +L G + ++ E + L V P L I + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 554 ECESQIIHCDIKPQNILMDENRYAKISDFALAK 586
I+H D+ N+L+ E I DF +
Sbjct: 122 RG---IVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.1 bits (174), Expect = 2e-15
Identities = 28/143 (19%), Positives = 52/143 (36%), Gaps = 30/143 (20%)
Query: 80 SASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLK 139
S + ++G+ +LY + G D+ T+ TQ L +RL
Sbjct: 2 SVVVANNGNSILYSTQG------NDNHPQTLHATQSL---------------QLSPYRLS 40
Query: 140 MQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEG 199
M+ D NL+ + ++ W++ T GKG L NG + +L + +
Sbjct: 41 METDCNLVLFDRD------DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS 94
Query: 200 ENPTEGMMYLMKIDSDGIFRLYS 222
+ Y+ + D +Y
Sbjct: 95 RSAGR---YVFVLQPDRNLAIYG 114
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.2 bits (125), Expect = 7e-09
Identities = 20/134 (14%), Positives = 36/134 (26%), Gaps = 28/134 (20%)
Query: 16 NGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDS 75
NGNS S G + S + + + +VL + S
Sbjct: 8 NGNSILYSTQGNDNHPQTLHA-TQSLQLSPYRLSMETD--CNLVLFDRDDRVWSTNTAGK 64
Query: 76 QSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGK 135
+ A + +G + + +W + S G+
Sbjct: 65 GTGCRAVLQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGR 99
Query: 136 FRLKMQNDGNLIQY 149
+ +Q D NL Y
Sbjct: 100 YVFVLQPDRNLAIY 113
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 69.1 bits (168), Expect = 7e-15
Identities = 26/138 (18%), Positives = 51/138 (36%), Gaps = 26/138 (18%)
Query: 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
+D + +L G L + G + +QND NL+ Y N W S T
Sbjct: 1 SDRLNSGHQLDTGGSL---------AEGGYLFIIQNDCNLVLYDNNRA------VWASGT 45
Query: 167 DGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLR 226
+GK L + +G+L + + + + T +N Y + + D +Y
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGN----YYLILQRDRNVVIY----- 96
Query: 227 RQNSTWQVLWESTNEKCD 244
+++ +W + +
Sbjct: 97 --DNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 49.4 bits (117), Expect = 5e-08
Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 15/113 (13%)
Query: 7 INIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVG--VFLAGIPEKNV--------- 55
+N G L G+ + G Y F N Y V+ +G K
Sbjct: 4 LNSGHQLDTGGSLA----EGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQND 59
Query: 56 GRIVLRSTEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTD 108
G +V+ S + + + + + V+YD+ IW T + +
Sbjct: 60 GNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.2 bits (161), Expect = 8e-14
Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 28/135 (20%)
Query: 100 WQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPY 159
Q D+ + T+ L + T +R MQ D NL+ Y N P
Sbjct: 7 KQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLYDNNNP----- 50
Query: 160 SYWTSFTDGKGDNVSLNLDENGHLFLLNSTGFNI-RNLTEGENPTEGMMYLMKIDSDGIF 218
W + T G G+ L +G L ++ + + ++ G+ Y++ + D
Sbjct: 51 -IWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGH----YVLVLQPDRNV 105
Query: 219 RLYSYNLRRQNSTWQ 233
+Y ++ W
Sbjct: 106 VIYG------DALWA 114
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.5 bits (102), Expect = 8e-06
Identities = 22/164 (13%), Positives = 42/164 (25%), Gaps = 53/164 (32%)
Query: 3 GHSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRS 62
+ N L + L + +Y F Q++ +VL
Sbjct: 7 KQPDDNHPQILHATESLEILFGTHVYRFIM--QTDC------------------NLVLYD 46
Query: 63 TEQGQDSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMEL 122
+ + A + G V+ ++ +WQ
Sbjct: 47 NNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQ--------------------- 85
Query: 123 FPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
S G + L +Q D N++ Y + W + T
Sbjct: 86 ----SPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 57.7 bits (139), Expect = 6e-11
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 18/118 (15%)
Query: 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167
+ + + L G L + G F MQ D NL+ Y + P W + T
Sbjct: 2 NILYSGETLSTGEFL---------NYGSFVFIMQEDCNLVLYDVDKP------IWATNTG 46
Query: 168 GKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNL 225
G + L++ +G+L + N + + + + Y+ + D +Y +
Sbjct: 47 GLSRSCFLSMQTDGNLVVYNP---SNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDR 101
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 39.2 bits (91), Expect = 2e-04
Identities = 19/100 (19%), Positives = 30/100 (30%), Gaps = 18/100 (18%)
Query: 75 SQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMEL--------FPGI 126
+ + M + + VLYD K IW T + L
Sbjct: 17 NYGSFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRS-CFLSMQTDGNLVVYNPSNKPIWA 74
Query: 127 SKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
S T G + +Q D N++ Y + W + T
Sbjct: 75 SNTGGQNGNYVCILQKDRNVVIYGTD--------RWATGT 106
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.1 bits (88), Expect = 5e-04
Identities = 17/108 (15%), Positives = 32/108 (29%), Gaps = 19/108 (17%)
Query: 10 GSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDS 69
G +LS + G + F + N Y V + + R S + +
Sbjct: 7 GETLSTGEFLN----YGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNL 62
Query: 70 IIADDSQ------------SASSASMLDSGSFVLYDSDGKVIWQTFDH 105
++ + S + + V+Y +D W T H
Sbjct: 63 VVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.4 bits (115), Expect = 1e-07
Identities = 20/92 (21%), Positives = 33/92 (35%), Gaps = 12/92 (13%)
Query: 132 STGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNSTGF 191
FR MQ+D NL+ + + W S T G L +G L +L +
Sbjct: 24 ELSSFRFTMQSDCNLVLFDSDVR------VWASNTAGAT-GCRAVLQSDGLLVILTAQNT 76
Query: 192 NI-RNLTEGENPTEGMMYLMKIDSDGIFRLYS 222
+ T+G Y++ + D +Y
Sbjct: 77 IRWSSGTKGSIGN----YVLVLQPDRTVTIYG 104
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.2 bits (112), Expect = 3e-07
Identities = 26/162 (16%), Positives = 43/162 (26%), Gaps = 48/162 (29%)
Query: 8 NIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQ 67
NI LS G+ + Q SS+ + + +VL ++
Sbjct: 2 NILFGLSHEGSHPQTLHAA-------QSLELSSFRFTMQ-------SDCNLVLFDSDVRV 47
Query: 68 DSIIADDSQSASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGIS 127
+ + A + G V+ + + W S
Sbjct: 48 WAS-NTAGATGCRAVLQSDGLLVILTAQNTIRWS-------------------------S 81
Query: 128 KTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGK 169
T S G + L +Q D + Y W S T K
Sbjct: 82 GTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNK 115
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 42.3 bits (99), Expect = 2e-05
Identities = 21/110 (19%), Positives = 34/110 (30%), Gaps = 30/110 (27%)
Query: 80 SASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLK 139
M + + VLYD +W + +
Sbjct: 22 HFIMQEDCNLVLYDHS-TSVWASNTG------------------------ILGKKGCKAV 56
Query: 140 MQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLNST 189
+Q+DGN + Y D S W S + N L L E+G++ + S
Sbjct: 57 LQSDGNFVVY-----DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD 101
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 39.2 bits (91), Expect = 2e-04
Identities = 22/149 (14%), Positives = 42/149 (28%), Gaps = 47/149 (31%)
Query: 18 NSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS 77
N L Y + ++ + V S +
Sbjct: 6 NGEGLYAGQSLDVEPYHFIMQEDCNLVLY-------DHSTSVWASNTGIL-------GKK 51
Query: 78 ASSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFR 137
A + G+FV+YD++G+ +W + + G +
Sbjct: 52 GCKAVLQSDGNFVVYDAEGRSLWASH-------------------------SVRGNGNYV 86
Query: 138 LKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166
L +Q DGN++ Y W++ T
Sbjct: 87 LVLQEDGNVVIYGS--------DIWSTGT 107
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 724 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.4 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.3 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.27 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.24 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.22 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.14 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.11 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.98 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.65 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.16 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.83 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.23 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.53 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 88.93 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 88.27 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.79 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 86.67 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.96 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 85.83 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.91 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 84.49 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 84.14 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.34 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=391.27 Aligned_cols=245 Identities=27% Similarity=0.438 Sum_probs=188.5
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.+.++||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 456889999999999999988889999999764 3455789999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|.+++... .+. .+.|||+||.|||+. +|+||||||+|||+++++.+||+|||+++..............
T Consensus 87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 163 (263)
T d1sm2a_ 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163 (263)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence 99987432 222 378999999999998 9999999999999999999999999999877654444444467
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
||+.|+|||.+.+..++.|+|||||||++|||+|++.|+....... + +.+.+..+.. ...+.. ....+
T Consensus 164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~-~~~~i~~~~~--~~~p~~----~~~~l 231 (263)
T d1sm2a_ 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----E-VVEDISTGFR--LYKPRL----ASTHV 231 (263)
T ss_dssp -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----H-HHHHHHHTCC--CCCCTT----SCHHH
T ss_pred cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----H-HHHHHHhcCC--CCCccc----cCHHH
Confidence 8999999999999999999999999999999999765554332211 1 1122222211 111222 23458
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 681 IKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.+++..||+.||++||||+||++.|+++.
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-47 Score=389.36 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=204.5
Q ss_pred HHHHhhcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 442 ELEKMTDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 442 el~~~t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
|+......+.++||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344444556789999999999999986 4789999999764 34457899999999999999999999999999999999
Q ss_pred EeeccCCChhhhcCC-----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 521 YEYMSNGSLADVYSS-----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~-----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
|||+++|+|.+++.. ..+. .+.|||+||+|||++ +|+||||||+||||++++.+||+|||+++....+
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998732 1221 267999999999998 9999999999999999999999999999987665
Q ss_pred CcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.........|++.|+|||++.+..++.|+||||||+++|||++|..|+........ +.+.+..+.....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~~~~~----- 237 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMER----- 237 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTCCCCC-----
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCCCCCC-----
Confidence 55555556789999999999999999999999999999999998877654332211 2233333311111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.......+.+++..||+.||++||||+||++.|+...
T Consensus 238 -~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 -PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122346889999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=384.85 Aligned_cols=244 Identities=28% Similarity=0.426 Sum_probs=198.0
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.++||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 34566889999999999999988889999999764 3455789999999999999999999998865 567999999999
Q ss_pred CChhhhcCC-----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSS-----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~-----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+|.+++.. ..+ ..+.||++||.|||+. +|+||||||+||||++++.+||+|||+++...........
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 999998743 222 2278999999999998 9999999999999999999999999999987655544445
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...||+.|+|||++....++.++|||||||++|||+||+.|+........ +...+..+.. ...+.. ..
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~~--~~~p~~----~~ 236 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYR--MVRPDN----CP 236 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC--CCCCTT----CC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC--CCCccc----Ch
Confidence 56789999999999999999999999999999999997776654322211 1222333211 111212 23
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
..+.+++.+||+.||++||||+||+++|+.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 458899999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-47 Score=391.40 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=192.5
Q ss_pred ccCHHHHHHhhcccc-----------cccCcCccceEEEEEeeC-C---cEEEEEEcccc-cchhHHHHHHHHHhhcccC
Q 041285 437 SFSYAELEKMTDGFK-----------EEIGRGSSGTVYKGTMIN-G---KFVAVKRLQKM-LAEGEREFQTEIKAIGRTH 500 (724)
Q Consensus 437 ~~~~~el~~~t~~f~-----------~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~ 500 (724)
.++++++.+++.+|. +.||+|+||+||+|.+.. + ..||||.+... .....++|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 356667777666553 579999999999998753 2 36899998653 3344568999999999999
Q ss_pred cCceeeeeeEEecccceEEEEeeccCCChhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeC
Q 041285 501 HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMD 572 (724)
Q Consensus 501 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~ 572 (724)
|||||+++|+|.+.+..++||||+++|+|.+++... .+. .+.|||+||.|||+. +|+||||||+||||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence 999999999999999999999999999999987442 222 278999999999998 999999999999999
Q ss_pred CCCCeEEccccCccccCCCCcce----eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcch
Q 041285 573 ENRYAKISDFALAKLMKPDQTRT----FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQ 647 (724)
Q Consensus 573 ~~~~~kl~Dfgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~ 647 (724)
.++.+||+|||+++.+....... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-- 240 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999998775433221 122467999999999999999999999999999999998 78888654321
Q ss_pred hcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 648 VILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 648 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
+ +...+..+.... ...+....+.+++.+||+.||++||||.||++.|+.++
T Consensus 241 ----~-~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 241 ----D-VINAIEQDYRLP------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ----H-HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----H-HHHHHHcCCCCC------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 122233221111 11223456889999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=383.26 Aligned_cols=248 Identities=28% Similarity=0.391 Sum_probs=190.1
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
..+.++||+|+||+||+|+.. ..||||+++.. .....++|++|++++++++|||||+++|++.+ +..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 345688999999999999864 46999998643 34456789999999999999999999999865 56899999999
Q ss_pred CCChhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-cee
Q 041285 526 NGSLADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTF 596 (724)
Q Consensus 526 ~gsL~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~ 596 (724)
+|+|.+++... .+. .+.|||+||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 99999998432 222 278999999999998 999999999999999999999999999987654332 233
Q ss_pred eccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 597 TGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|||||++.. ..++.++|||||||+||||+||+.||........ +...+..+....... ...
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~~~--~~~ 235 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLS--KVR 235 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCCGG--GSC
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCcch--hcc
Confidence 45679999999999864 3589999999999999999999999975433221 122233332211111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
......+.+++.+||+.||++||||+||++.|+.+.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 223456889999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=375.08 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=200.0
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccCCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSNGS 528 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 528 (724)
.|.++||+|+||+||+|+.++++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 366899999999999999988889999999864 3456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCC----C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 529 LADVYSSP----P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 529 L~~~l~~~----~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|..++... . ...+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++..............
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 99886322 1 12378999999999998 9999999999999999999999999999877655444444567
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLER 679 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (724)
||+.|+|||.+.+..++.|+||||||+++|||+| |+.||...... + +...+..+.. +..+.. ....
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~--~~~p~~----~~~~ 229 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLR--LYRPHL----ASEK 229 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCC--CCCCTT----CCHH
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCC--CCCccc----ccHH
Confidence 8999999999999999999999999999999998 78888654321 1 2223333321 112222 2346
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 680 MIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 680 l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
+.+++.+||+.||++|||++|+++.|..
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 8899999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=379.56 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=193.9
Q ss_pred hcccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...+.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.++++++|+|||+++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 45667899999999999999988889999999754 3455789999999999999999999999865 568999999999
Q ss_pred CChhhhcCC-----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceee
Q 041285 527 GSLADVYSS-----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFT 597 (724)
Q Consensus 527 gsL~~~l~~-----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~ 597 (724)
|+|..++.. ..+. .+.+||+||+|||+. +|+||||||+||||+.++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999988743 2332 278999999999998 9999999999999999999999999999877655444444
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
...||+.|+|||++..+.++.++||||||+++|||++|..|+........ ....+..+.... ......
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i~~~~~~~------~~~~~~ 240 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMP------CPPECP 240 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCC------CCTTSC
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCC------CCcccC
Confidence 56789999999999999999999999999999999998777654432211 112222221111 111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDIPI 713 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 713 (724)
+.+.+++.+||+.||++||+|.+|+++|+....-..
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 468899999999999999999999999998554333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=379.30 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=189.8
Q ss_pred ccccccCcCccceEEEEEeeCC-----cEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEe
Q 041285 449 GFKEEIGRGSSGTVYKGTMING-----KFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
.+.+.||+|+||+||+|.+... ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 3457899999999999988642 379999986533 3334579999999999999999999999999999999999
Q ss_pred eccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc
Q 041285 523 YMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR 594 (724)
Q Consensus 523 ~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~ 594 (724)
|+.+++|.+++.. ..+ ..+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999999887632 222 2378999999999998 9999999999999999999999999999876543322
Q ss_pred --eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 595 --TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 595 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
......||+.|||||++.+..++.++||||||+++|||++++.|+........ +.+.+..+.... .
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~~~~------~ 234 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLP------T 234 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCC------C
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhccCCCC------C
Confidence 22335689999999999999999999999999999999998777654332211 223333332111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMDI 711 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 711 (724)
+......+.+++.+||+.+|++||||.||+++|+.+++.
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 112345688999999999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=372.04 Aligned_cols=241 Identities=27% Similarity=0.368 Sum_probs=195.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.++||+|+||+||++... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 445678999999999999864 5899999999765555567899999999999999999999999999999999999999
Q ss_pred CChhhhcCCCC--c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeeccc
Q 041285 527 GSLADVYSSPP--K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGIR 600 (724)
Q Consensus 527 gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 600 (724)
|+|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..... ......
T Consensus 102 g~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~ 177 (293)
T d1yhwa1 102 GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 177 (293)
T ss_dssp CBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCC
T ss_pred CcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccc
Confidence 99998874322 1 2278999999999998 999999999999999999999999999987754332 223457
Q ss_pred cCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHHHHH
Q 041285 601 GTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQLERM 680 (724)
Q Consensus 601 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (724)
||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........+.. .+-.+. .....+
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~-~~~~~~----~~s~~~ 246 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-ELQNPE----KLSAIF 246 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CCSSGG----GSCHHH
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC-CCCCcc----cCCHHH
Confidence 9999999999999999999999999999999999999996533211 11222222211 111111 223458
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 041285 681 IKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 681 ~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+++.+||+.||++|||+.|+++
T Consensus 247 ~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 247 RDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 88999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=373.64 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=193.2
Q ss_pred cc-ccCcCccceEEEEEee---CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 451 KE-EIGRGSSGTVYKGTMI---NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 451 ~~-~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 45 5999999999999864 34579999997543 3345789999999999999999999999865 56899999999
Q ss_pred CCChhhhcCCCC----c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--
Q 041285 526 NGSLADVYSSPP----K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT-- 595 (724)
Q Consensus 526 ~gsL~~~l~~~~----~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~-- 595 (724)
+|+|.+++.... + ..+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 92 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 999999874322 1 1278999999999998 99999999999999999999999999999876544322
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDK 674 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 674 (724)
.....||+.|+|||.+....++.++|||||||++|||+| |+.||......+ +...+..+..... + .
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~--p----~ 235 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC--P----P 235 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC--C----T
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC--C----C
Confidence 223568999999999999999999999999999999998 899987543221 2233444432221 1 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 675 KQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 675 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
.....+.+++.+||+.+|++||||.+|++.|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 223468899999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=373.04 Aligned_cols=239 Identities=27% Similarity=0.355 Sum_probs=189.2
Q ss_pred cccCcCccceEEEEEeeC---CcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 452 EEIGRGSSGTVYKGTMIN---GKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998754 4689999986532 2334679999999999999999999999865 567899999999
Q ss_pred CChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce--ee
Q 041285 527 GSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT--FT 597 (724)
Q Consensus 527 gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~--~~ 597 (724)
|+|.+++.. ..+. .+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.+....... ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999998843 2222 278999999999998 99999999999999999999999999999876544332 22
Q ss_pred ccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...||+.|||||.+.+..++.++|||||||++|||++ |+.||...... + +...+..+..... +...
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~-~~~~i~~~~~~~~------p~~~ 235 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMGC------PAGC 235 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCCC------CTTC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------H-HHHHHHcCCCCCC------Cccc
Confidence 3578999999999999999999999999999999998 89998753211 1 2233333322111 1122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
...+.+++.+||+.||++||||++|+++|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 3468899999999999999999999998874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=367.21 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=190.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||+||+++.. +|+.||||++.... .+..+++.+|++++++++|||||++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 345689999999999999875 58999999986532 2334679999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ceee
Q 041285 526 NGSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RTFT 597 (724)
Q Consensus 526 ~gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~~~ 597 (724)
+|+|.+++.... . ..+.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... ....
T Consensus 87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 999999985432 1 2278999999999998 999999999999999999999999999987654332 2234
Q ss_pred ccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 598 GIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 598 ~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
...||+.|||||.+.+..+ +.++|||||||++|||++|+.||.......... .......... .+ ....
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~~--~~---~~~~ 232 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYL--NP---WKKI 232 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTTS--TT---GGGS
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCCC--Cc---cccC
Confidence 4679999999999988876 578999999999999999999997654322111 1111111110 00 0112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.||++|||++|+++
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345778899999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=364.54 Aligned_cols=236 Identities=26% Similarity=0.379 Sum_probs=192.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||+||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 446689999999999999985 57899999986422 23356789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++.. .... .+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~ 161 (263)
T d2j4za1 88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R 161 (263)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---C
T ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---c
Confidence 999999998842 2222 278999999999998 99999999999999999999999999998665432 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|||||.+.+..++.++|||||||++|||++|+.||...... + ....+..+... .+. ..
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~---~p~----~~ 227 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVEFT---FPD----FV 227 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCCC---CCT----TS
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC---CCc----cC
Confidence 3357999999999999999999999999999999999999999654211 1 12223333221 111 12
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++.+||+.||++|||++|+++
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 345788999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=372.44 Aligned_cols=241 Identities=23% Similarity=0.304 Sum_probs=192.8
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.++||+|+||+||+|... +++.||||++........+.|.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 345678999999999999875 5889999999876566677899999999999999999999999999999999999999
Q ss_pred CChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
|+|.+++.. .... .+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 999988632 2222 278999999999998 99999999999999999999999999997543211 11223
Q ss_pred cccCccccCccccc-----CCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 599 IRGTRGYVAPEWHW-----NLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 599 ~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
..||+.|+|||++. ...++.++|||||||++|||++|+.||......+. . ..+..+....+..+..
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~-~~i~~~~~~~~~~~~~-- 240 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------L-LKIAKSEPPTLAQPSR-- 240 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------H-HHHHHSCCCCCSSGGG--
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------H-HHHHcCCCCCCCcccc--
Confidence 57999999999984 45688999999999999999999999976433221 1 1222222222222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
....+.+++.+||+.||++|||++|+++
T Consensus 241 --~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 241 --WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345888999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=361.53 Aligned_cols=239 Identities=28% Similarity=0.376 Sum_probs=186.7
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec----ccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD----VSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 521 (724)
.|.++||+|+||+||+|... +++.||||.+... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999875 4789999998653 23344679999999999999999999999865 34579999
Q ss_pred eeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC-CCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD-ENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~-~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++|+|.+++.. ... ..+.||++||.|||++ .++|+||||||+|||++ +++.+||+|||+++.......
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 99999999998843 222 2378999999999987 12399999999999996 578999999999986543322
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|||||.+.+ .++.++|||||||++|||++|+.||........ ..+.+..+.....++.
T Consensus 171 ---~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~~~~~---- 236 (270)
T d1t4ha_ 171 ---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDK---- 236 (270)
T ss_dssp ---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGGGG----
T ss_pred ---CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCcccCc----
Confidence 34579999999998865 699999999999999999999999965432211 2233333322222211
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.....+.+++.+||+.||++|||++|+++
T Consensus 237 -~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 -VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 12234788999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=378.40 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=194.3
Q ss_pred hcccccccCcCccceEEEEEeeCC------cEEEEEEcccc-cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMING------KFVAVKRLQKM-LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~------~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 518 (724)
...+.+.||+|+||+||+|+.... ..||||.+... .......|.+|+.++.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 345678999999999999987532 36999998653 233446799999999998 8999999999999999999
Q ss_pred EEEeeccCCChhhhcCCCC--------------------------c----chHHHHHHHcccccccCCCceEeCCCCCCC
Q 041285 519 LVYEYMSNGSLADVYSSPP--------------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQN 568 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~~--------------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~N 568 (724)
+||||+++|+|.+++.... + ..+.||++||+|||+. +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 9999999999999984321 1 1267999999999998 99999999999
Q ss_pred eeeCCCCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcc
Q 041285 569 ILMDENRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPED 646 (724)
Q Consensus 569 Ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~ 646 (724)
||++.++.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876544332 2334568999999999999999999999999999999998 899987543322
Q ss_pred hhcHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 041285 647 QVILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLE 706 (724)
Q Consensus 647 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 706 (724)
. +.+.+..+... + .+......+.+++.+||+.||++||||+||+++|.
T Consensus 275 ~------~~~~~~~~~~~---~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 N------FYKLIQNGFKM---D---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H------HHHHHHTTCCC---C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H------HHHHHhcCCCC---C---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 12233333111 1 11122346889999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=364.24 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=180.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec--ccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--VSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 522 (724)
+.+.+.||+|+||+||+++.. +|+.||||.+... .....+.+.+|++++++++|||||++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345689999999999999874 5889999998653 23334678999999999999999999999875 456799999
Q ss_pred eccCCChhhhcCC-------CC----cchHHHHHHHcccccccC--CCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 523 YMSNGSLADVYSS-------PP----KNNLIGIARGILYLHDEC--ESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 523 ~~~~gsL~~~l~~-------~~----~~~~~~ia~~l~yLH~~~--~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
|+++|+|.+++.. .. +..+.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999998732 22 233789999999999862 1249999999999999999999999999999875
Q ss_pred CCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.+.. ......||+.|||||.+.+..++.++|||||||++|||++|+.||...... + +...+.++....+
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~-~~~~i~~~~~~~~--- 234 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------E-LAGKIREGKFRRI--- 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCCCC---
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCCCCC---
Confidence 4322 223467899999999999999999999999999999999999999753211 1 2233344433322
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122345888999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=366.48 Aligned_cols=238 Identities=22% Similarity=0.295 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||+||+|... +++.||||.+... .....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999874 5899999998753 223446799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc-ce
Q 041285 524 MSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT-RT 595 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~-~~ 595 (724)
+++|+|.+++.. .... .+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..... ..
T Consensus 90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999988742 2222 268999999999998 999999999999999999999999999998764432 22
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+... + +. .
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~-~~~~i~~~~~~--~-p~----~ 232 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------L-IFQKIIKLEYD--F-PE----K 232 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHTTCCC--C-CT----T
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------H-HHHHHHcCCCC--C-Cc----c
Confidence 33467999999999999999999999999999999999999999754211 1 12223333221 1 11 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVL 702 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl 702 (724)
....+.+++.+||+.||++|||++|++
T Consensus 233 ~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 233 FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 234578999999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=367.70 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=195.7
Q ss_pred hcccccccCcCccceEEEEEeeCC----cEEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecc-cceEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMING----KFVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-SNKILV 520 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv 520 (724)
+.+|.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++|||||+++|+|.+. ...++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 446778999999999999998542 26899999753 344457899999999999999999999998764 578999
Q ss_pred EeeccCCChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|||+++|+|.+++..... ..+.|+|+||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999998854322 2278999999999998 99999999999999999999999999998765433
Q ss_pred cc---eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 593 TR---TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 593 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.. ......||+.|+|||.+....++.++||||||+++|||++|+.|+........ +...+..+.. ...+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~--~~~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRR--LLQP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCC--CCCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCC--CCCc
Confidence 22 22335789999999999999999999999999999999998888765432211 1122233321 1122
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.. ....+.+++.+||+.||++||+|.||++.|+++.
T Consensus 257 ~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 257 EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22 2345889999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-44 Score=369.94 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=195.9
Q ss_pred ccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 449 GFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
.+.++||+|+||+||+|+.. +++.||||+++.... +..++|.+|++++++++||||++++++|.+.+..+++|
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 34588999999999999875 347899999975433 33567999999999999999999999999999999999
Q ss_pred eeccCCChhhhcCCC---------------------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCee
Q 041285 522 EYMSNGSLADVYSSP---------------------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNIL 570 (724)
Q Consensus 522 e~~~~gsL~~~l~~~---------------------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIl 570 (724)
||+++|+|.+++... . ...+.|||.||+|||+. +|+||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 999999999987321 1 11267999999999998 9999999999999
Q ss_pred eCCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhcccc-CCCCCCCcchh
Q 041285 571 MDENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRR-CFDQNLPEDQV 648 (724)
Q Consensus 571 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~-p~~~~~~~~~~ 648 (724)
|+.++.+||+|||+++....... .......|++.|+|||.+.+..++.|+|||||||++|||++|.. |+.... ...
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-~~e- 250 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-HEE- 250 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHH-
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-HHH-
Confidence 99999999999999987644332 22334568899999999999999999999999999999999965 554332 111
Q ss_pred cHHHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 649 ILEEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 649 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+...+.++..... + ...+..+.+|+..||+.+|++||||.||+++|+.+.+
T Consensus 251 -----~~~~v~~~~~~~~--p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 -----VIYYVRDGNILAC--P----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -----HHHHHHTTCCCCC--C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----HHHHHHcCCCCCC--C----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1233444443221 1 1223468899999999999999999999999998653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=364.03 Aligned_cols=258 Identities=24% Similarity=0.253 Sum_probs=192.4
Q ss_pred cccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEeccc----ceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----NKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e~ 523 (724)
.-+.++||+|+||.||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.+ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 34568899999999999997 68899999987532 22223445667777889999999999998654 57999999
Q ss_pred ccCCChhhhcCCCC--c----chHHHHHHHcccccccC-----CCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 524 MSNGSLADVYSSPP--K----NNLIGIARGILYLHDEC-----ESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 524 ~~~gsL~~~l~~~~--~----~~~~~ia~~l~yLH~~~-----~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+++|+|.++++... + ..+.++|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 99999999996433 2 23789999999999742 3599999999999999999999999999998765433
Q ss_pred cc---eeeccccCccccCcccccCCC------CCcccceeehhHHHHHhhccccCCCCCCCcc---------hhcHHHHH
Q 041285 593 TR---TFTGIRGTRGYVAPEWHWNLP------ITAKADVYSFGVVLLEIICCRRCFDQNLPED---------QVILEEWV 654 (724)
Q Consensus 593 ~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~---------~~~l~~~~ 654 (724)
.. ......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+....... .... ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-EEM 241 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-HHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH-HHH
Confidence 22 223467999999999987643 5678999999999999999988775322111 1111 112
Q ss_pred HHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 655 YQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+..-+.......+....+.+++.+||+.||++||||.||+++|+.+
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 233333322222222222345667799999999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=370.76 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=188.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||+||+|... +|+.||||+++... ....+++.+|+.++++++|||||++++++.+..+.++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 344578999999999999874 58899999987542 2334679999999999999999999999999999999999999
Q ss_pred CCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|+|.+++.. ... ..+.|+++||.|||+. .+|+||||||+||||++++.+||+|||+|+...... ...
T Consensus 88 gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~ 162 (322)
T d1s9ja_ 88 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 162 (322)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C--
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---ccc
Confidence 9999998842 222 2267999999999973 179999999999999999999999999998653221 233
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHH-HHHHH--------HHcCC--ccccc
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEE-WVYQC--------FENGN--LGQLI 667 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~-~~~~~--------~~~~~--~~~~~ 667 (724)
..||+.|+|||++.+..++.++||||+||++|||++|+.||............. ..... ...+. .....
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 579999999999999999999999999999999999999997643221100000 00000 00000 00000
Q ss_pred c-------------------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 E-------------------DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ~-------------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+ +..........+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00000112345888999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=363.69 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=183.2
Q ss_pred hcccccccCcCccceEEEEEeeC----CcEEEEEEcccccc-hhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN----GKFVAVKRLQKMLA-EGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
...+.+.||+|+||.||+|+... +..||||.++.... ...+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 45567899999999999998753 35799999875333 334679999999999999999999999864 6789999
Q ss_pred eeccCCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+++|+|.+++.. ..+. .+.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 99999999987632 2222 268999999999998 999999999999999999999999999987765444
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
.......||+.|+|||.+.+..++.++|||||||++|||++ |..|+......+ +...+..+.....
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~~------ 230 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM------ 230 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC------
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence 44445678999999999999999999999999999999998 788876543221 1222333322211
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
+......+.+++..||+.||++|||+.||++.|+.+
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112235688999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-42 Score=366.41 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=196.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||++... +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 556689999999999999874 5899999999765555566789999999999999999999999999999999999999
Q ss_pred CChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeC--CCCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMD--ENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~--~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+|.+++..... ..+.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++.+..+.. .
T Consensus 111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~ 185 (352)
T d1koba_ 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V 185 (352)
T ss_dssp CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc--e
Confidence 999987754322 1278999999999998 999999999999997 578999999999998765433 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+..... .......
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~~~---~~~~~~~ 255 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFD---EDAFSSV 255 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCCCC---SSTTTTS
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC---cccccCC
Confidence 33568999999999999999999999999999999999999997543211 1122223322111 1111122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3457899999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.7e-43 Score=367.78 Aligned_cols=242 Identities=22% Similarity=0.330 Sum_probs=195.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||.||+++.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 556789999999999999874 5899999999775555567899999999999999999999999999999999999999
Q ss_pred CChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC--CCCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE--NRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~--~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+|.+++..... ..+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+..... .
T Consensus 108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~ 182 (350)
T d1koaa2 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--V 182 (350)
T ss_dssp CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--E
T ss_pred CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--c
Confidence 999998843221 1278999999999998 9999999999999964 67899999999987754432 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|||||++.+..++.++|||||||++|||++|+.||...... +.. ..+..+..... .......
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~-~~i~~~~~~~~---~~~~~~~ 252 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETL-RNVKSCDWNMD---DSAFSGI 252 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHTCCCSC---CGGGGGC
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCCCC---cccccCC
Confidence 3357899999999999999999999999999999999999999754211 111 22222221110 0111122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
...+.+++.+||+.||++|||++|+++.
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3457889999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-43 Score=362.99 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=178.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||+||++... +++.||||.+.... ....+.+.+|+.++++++|||||++++++.+.+..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 567789999999999999875 58899999987532 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeC---CCCCeEEccccCccccCCCCcce
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~---~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
+|+|.+++... .. ..+.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++.......
T Consensus 91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~-- 165 (307)
T d1a06a_ 91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 165 (307)
T ss_dssp SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe--
Confidence 99999998432 22 2278999999999998 999999999999994 578899999999986543322
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|||||.+.+..++.++|||||||++|||++|+.||...... . ....+..+...... .....
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~-~~~~i~~~~~~~~~---~~~~~ 235 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------K-LFEQILKAEYEFDS---PYWDD 235 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHTTCCCCCT---TTTTT
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------H-HHHHHhccCCCCCC---ccccC
Confidence 23357999999999999999999999999999999999999999753211 1 12223233221111 11112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+.+++..||+.||++|||++|+++.
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 33468899999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=357.20 Aligned_cols=237 Identities=28% Similarity=0.396 Sum_probs=184.2
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc-cceEEEEeeccCC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-SNKILVYEYMSNG 527 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~~~g 527 (724)
.|.+.||+|+||.||+|.+ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+. +..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 4668899999999999998 5789999999763 3456799999999999999999999999764 5689999999999
Q ss_pred ChhhhcCC-----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 528 SLADVYSS-----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 528 sL~~~l~~-----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+|.+++.. ..+. .+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~~ 159 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 159 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC----cc
Confidence 99999843 2332 378999999999998 99999999999999999999999999998654322 22
Q ss_pred cccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHHH
Q 041285 599 IRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQL 677 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (724)
..++..|+|||++.+..++.++||||||+++|||+| |+.|+......+ + ...+..+..... .....
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~----~~~i~~~~~~~~------~~~~~ 226 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKMDA------PDGCP 226 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTCCCCC------CTTCC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCCC------CccCC
Confidence 357899999999999999999999999999999998 566665432211 1 122333322221 11223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 678 ERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 678 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
..+.+++.+||+.||++||||.||+++|+.+
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 4688999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=365.18 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=197.2
Q ss_pred hcccccccCcCccceEEEEEee------CCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
...+.++||+|+||+||+|.+. ++..||||+++... .+....|.+|++++++++|||||+++|+|...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 3446688999999999999874 25789999997532 3344579999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCCC-------------C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccc
Q 041285 520 VYEYMSNGSLADVYSSP-------------P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDF 582 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~-------------~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Df 582 (724)
||||+++|+|.+++... . ...+.++|+||.|||+. +|+||||||+|||+++++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999987321 1 12378999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCcce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC
Q 041285 583 ALAKLMKPDQTRT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG 661 (724)
Q Consensus 583 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 661 (724)
|+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+.++...... .+. ...+.++
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~-~~~i~~~ 251 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV-LRFVMEG 251 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH-HHHHHTT
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHH-HHHHHhC
Confidence 9998765433322 22346899999999999999999999999999999999996443322211 111 2233343
Q ss_pred CccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 662 NLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
..... + ......+.+++.+||+.+|++||||.||+++|++.++
T Consensus 252 ~~~~~--p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDK--P----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCC--C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCC--c----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 32221 1 1223468999999999999999999999999988755
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-42 Score=360.85 Aligned_cols=236 Identities=25% Similarity=0.326 Sum_probs=187.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+...++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 344578999999999999864 58899999987532 23345789999999999999999999999999999999999
Q ss_pred ccCCChhhhcC---CCCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYS---SPPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~---~~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|..++. ...+ ..+.||+.||.|||+. +|+||||||+||||+.++.+||+|||++......
T Consensus 97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (309)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-----
Confidence 99999876652 2222 2378999999999998 9999999999999999999999999999865432
Q ss_pred eccccCccccCcccccC---CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 597 TGIRGTRGYVAPEWHWN---LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||...... ....... .+.......
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~-~~~~~~~~~----- 236 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNESPALQS----- 236 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCCSC-----
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCCCCCCC-----
Confidence 23569999999999864 45899999999999999999999998653211 1112222 222222211
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122346889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=362.67 Aligned_cols=243 Identities=25% Similarity=0.389 Sum_probs=187.0
Q ss_pred cccccccCcCccceEEEEEeeC-Cc----EEEEEEcccc-cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN-GK----FVAVKRLQKM-LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 521 (724)
+.+.+.||+|+||+||+|.... |+ .||||+++.. ..+..++|.+|++++++++|||||+++|+|.+. ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 3455899999999999998743 33 6899988653 344567899999999999999999999999875 567889
Q ss_pred eeccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 522 EYMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 522 e~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
||+.+++|.+++.. ..+ ..+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999887732 222 2378999999999998 999999999999999999999999999998765443
Q ss_pred ce-eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccccc
Q 041285 594 RT-FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDED 671 (724)
Q Consensus 594 ~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 671 (724)
.. .....||+.|+|||.+.++.++.++||||||+++|||+| |..|+......+ +...+..+.... .+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~--~p-- 235 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLP--QP-- 235 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCCCC--CC--
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC--CC--
Confidence 22 233568999999999999999999999999999999998 677776433221 122233332111 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 041285 672 VDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEG 707 (724)
Q Consensus 672 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 707 (724)
......+.+++.+||+.+|++|||+.||++.|+.
T Consensus 236 --~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 236 --PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp --TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1223458899999999999999999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=354.78 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=183.6
Q ss_pred cccccccCcCccceEEEEEeeC--C--cEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMIN--G--KFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
..+.+.||+|+||.||+|++.. + ..||||++... ..+..++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3456889999999999998743 2 37899998653 23345689999999999999999999999976 467899
Q ss_pred EeeccCCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 521 YEYMSNGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
|||+++|+|.+++.. ..+. .+.|||+||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999999987632 2222 278999999999998 99999999999999999999999999999875544
Q ss_pred cce--eeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 593 TRT--FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 593 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...... +........+..... +
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--~ 237 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLPR--P 237 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCCC--C
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCCC--c
Confidence 322 223567889999999999999999999999999999998 89988643211 112222233211111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+.+++.+||+.||++||||.||+++|+++
T Consensus 238 ----~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 ----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12234588999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=354.45 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=192.1
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEccccc------chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML------AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 519 (724)
.+.+.+.||+|+||+||+|... +|+.||||++.... ....+.|.+|++++++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556789999999999999974 58999999986421 1234679999999999999999999999999999999
Q ss_pred EEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC----CeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR----YAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~----~~kl~Dfgl~~~~ 588 (724)
||||+++|+|.+++.. ... ..+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++...
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999998843 222 2278999999999998 999999999999998776 4999999999876
Q ss_pred CCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+......
T Consensus 168 ~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~- 237 (293)
T d1jksa_ 168 DFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFED- 237 (293)
T ss_dssp TTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCCCCH-
T ss_pred CCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCCCCCc-
Confidence 53322 233568999999999999999999999999999999999999997542111 11222222211100
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.........+.+++.+||+.||++|||++|+++
T Consensus 238 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 --EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112345789999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=359.91 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=186.5
Q ss_pred hhcccccccCcCccceEEEEEeeC------CcEEEEEEccccc-chhHHHHHHHHHhhccc-CcCceeeeeeEEecc-cc
Q 041285 446 MTDGFKEEIGRGSSGTVYKGTMIN------GKFVAVKRLQKML-AEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDV-SN 516 (724)
Q Consensus 446 ~t~~f~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 516 (724)
....+.++||+|+||.||+|.... ++.||||+++... ....+++.+|...+.++ +|+|||++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 345567899999999999998642 4689999997533 33456788888888887 789999999998765 46
Q ss_pred eEEEEeeccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC
Q 041285 517 KILVYEYMSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE 573 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~ 573 (724)
.++||||+++|+|.+++... .+ ..+.||++||.|||+. +|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 89999999999999998321 11 1267999999999998 9999999999999999
Q ss_pred CCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhcccc-CCCCCCCcchhcHH
Q 041285 574 NRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRR-CFDQNLPEDQVILE 651 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~-p~~~~~~~~~~~l~ 651 (724)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|.. |+.......
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999999876544332 2234579999999999999999999999999999999999765 554432221
Q ss_pred HHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 041285 652 EWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTM 709 (724)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 709 (724)
.+...+..+...... ......+.+++.+||+.||++|||++||+++|++++
T Consensus 245 -~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 -EFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -HHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 122333333222211 112345889999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=361.53 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=189.2
Q ss_pred ccccccCcCccceEEEEEeeC-Cc--EEEEEEcccc-cchhHHHHHHHHHhhccc-CcCceeeeeeEEecccceEEEEee
Q 041285 449 GFKEEIGRGSSGTVYKGTMIN-GK--FVAVKRLQKM-LAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
.+.++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|++++.++ +|||||+++|+|.+.+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 356889999999999998864 33 5788988643 334456799999999999 799999999999999999999999
Q ss_pred ccCCChhhhcCCC-------------------Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEc
Q 041285 524 MSNGSLADVYSSP-------------------PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKIS 580 (724)
Q Consensus 524 ~~~gsL~~~l~~~-------------------~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~ 580 (724)
+++|+|.+++... .+ ..+.|||+||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 9999999998432 11 1278999999999998 99999999999999999999999
Q ss_pred cccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHc
Q 041285 581 DFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFEN 660 (724)
Q Consensus 581 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 660 (724)
|||+++....... .....||..|+|||.+....++.++||||||+++|||++|..|+....... + +...+..
T Consensus 170 DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-----~-~~~~i~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E-LYEKLPQ 241 (309)
T ss_dssp CTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H-HHHHGGG
T ss_pred ccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-----H-HHHHHHh
Confidence 9999976532211 123468999999999999999999999999999999999876533222111 1 2233333
Q ss_pred CCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 661 GNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
+.... ........+.+++.+||+.||++||||+||++.|+++.+
T Consensus 242 ~~~~~------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 GYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 32111 111223568899999999999999999999999887543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=357.60 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=198.0
Q ss_pred HhhcccccccCcCccceEEEEEee------CCcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEecccc
Q 041285 445 KMTDGFKEEIGRGSSGTVYKGTMI------NGKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 445 ~~t~~f~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 516 (724)
.....+.++||+|+||.||+|++. .++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 345567789999999999999863 356899999975433 3445799999999999 79999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCC---------------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeee
Q 041285 517 KILVYEYMSNGSLADVYSSPP---------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILM 571 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~---------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll 571 (724)
.++||||+++|+|.+++.... + ..+.||++||+|||++ +++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999873211 1 1268999999999998 99999999999999
Q ss_pred CCCCCeEEccccCccccCCCCc-ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcH
Q 041285 572 DENRYAKISDFALAKLMKPDQT-RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVIL 650 (724)
Q Consensus 572 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l 650 (724)
+.++.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||++++.|+.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999997764433 3334467899999999999999999999999999999999966555433322211
Q ss_pred HHHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 651 EEWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
+.+.+..+.... .+ ......+.+|+.+||+.||++||||+||+++|++.
T Consensus 257 ---~~~~i~~~~~~~--~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ---FYKMIKEGFRML--SP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHHTCCCC--CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCC--Cc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122233332111 11 12235688999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=351.67 Aligned_cols=238 Identities=24% Similarity=0.281 Sum_probs=192.5
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 345688999999999999874 6899999999753 233456789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|.+++.. ... ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 87 ~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~ 162 (337)
T d1o6la_ 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred cCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence 999999988843 222 2268999999999998 999999999999999999999999999986643322 23
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ..+.+..+.... +.. .
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~-~~~~i~~~~~~~---p~~----~ 228 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEIRF---PRT----L 228 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CTT----S
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------H-HHHHHhcCCCCC---Ccc----C
Confidence 3467999999999999999999999999999999999999999764321 1 122233332211 112 2
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
...+.+++.+||+.||++||+ ++|+++
T Consensus 229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 345788999999999999995 778775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-41 Score=352.75 Aligned_cols=235 Identities=26% Similarity=0.335 Sum_probs=191.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc---cchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM---LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||+||+++.. +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 345688999999999999974 5899999999753 223456799999999999999999999999999999999999
Q ss_pred ccCCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+++|+|..++... .. ..+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---- 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---- 158 (316)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----
T ss_pred cCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc----
Confidence 9999998887432 21 2267999999999998 99999999999999999999999999998765332
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|||||.+.+..++.++|||||||++|||++|+.||...... + ....+..+.... +.. .
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~~~---p~~----~ 224 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K-TYEKILNAELRF---PPF----F 224 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHCCCCC---CTT----S
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------H-HHHHHHcCCCCC---CCC----C
Confidence 3457999999999999999999999999999999999999999754211 1 112222332211 111 2
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
...+.+++.+||+.||.+|| |++|+++
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 34578899999999999996 8999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=354.21 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=192.5
Q ss_pred hcccccccCcCccceEEEEEeeC--------CcEEEEEEcccccc-hhHHHHHHHHHhhccc-CcCceeeeeeEEecccc
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMIN--------GKFVAVKRLQKMLA-EGEREFQTEIKAIGRT-HHRNLVRLLGYSFDVSN 516 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 516 (724)
...+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.+.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 44566899999999999998643 24799999976443 3457899999999888 89999999999999999
Q ss_pred eEEEEeeccCCChhhhcCCCC-------------------c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC
Q 041285 517 KILVYEYMSNGSLADVYSSPP-------------------K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE 573 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~-------------------~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~ 573 (724)
.++||||+++|+|.+++.... + ..+.||+.||.|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 999999999999999984221 1 1267999999999998 9999999999999999
Q ss_pred CCCeEEccccCccccCCCCcc-eeeccccCccccCcccccCCCCCcccceeehhHHHHHhhc-cccCCCCCCCcchhcHH
Q 041285 574 NRYAKISDFALAKLMKPDQTR-TFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIIC-CRRCFDQNLPEDQVILE 651 (724)
Q Consensus 574 ~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~ellt-g~~p~~~~~~~~~~~l~ 651 (724)
++.+||+|||+++........ ......+++.|+|||.+.+..++.|+||||||+++|||++ |..|+..... .
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~----- 244 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E----- 244 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H-----
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-H-----
Confidence 999999999999876543332 2334578999999999999999999999999999999998 5666653321 1
Q ss_pred HHHHHHHHcCCccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 041285 652 EWVYQCFENGNLGQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGTMD 710 (724)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 710 (724)
.+.+.+..+..... +.. ....+.+++.+||+.||.+|||+.||+++|++++.
T Consensus 245 -~~~~~i~~~~~~~~--p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGHRMDK--PSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTCCCCC--CSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCC--Ccc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 12233444322111 111 23458899999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.2e-41 Score=343.98 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=188.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEeccc----ceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----NKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 519 (724)
+.+.+.||+|+||+||++... +++.||||.++... ....+.|.+|++++++++|||||++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456789999999999999864 68999999997532 223457999999999999999999999987654 3789
Q ss_pred EEeeccCCChhhhcCC---CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 520 VYEYMSNGSLADVYSS---PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~---~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
||||+++++|.+++.. ..+. .+.||++||.|||+. +|+||||||+|||++.++..+|+|||.+.......
T Consensus 89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 9999999999988732 2222 378999999999998 99999999999999999999999999987654332
Q ss_pred c--ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccc
Q 041285 593 T--RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDE 670 (724)
Q Consensus 593 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 670 (724)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +........+........
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~- 238 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPSARH- 238 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCGGGTS-
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCCchhc-
Confidence 2 2233467999999999999999999999999999999999999999753221 122333333322211111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcc
Q 041285 671 DVDKKQLERMIKVALWCILDEPSLRP-SMKKVLLMLEG 707 (724)
Q Consensus 671 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~ 707 (724)
......+.+++.+||+.||++|| |++++++.|..
T Consensus 239 ---~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 ---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 12234688899999999999999 89999988864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=351.02 Aligned_cols=236 Identities=22% Similarity=0.248 Sum_probs=182.4
Q ss_pred cccCcCccceEEEEEe-eCCcEEEEEEcccccchhHHHHHHHHHhhccc-CcCceeeeeeEEec----ccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTM-INGKFVAVKRLQKMLAEGEREFQTEIKAIGRT-HHRNLVRLLGYSFD----VSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~~ 525 (724)
+.||+|+||.||+|.. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....++||||++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 4699999999999987 45899999998642 4577899887665 89999999999865 456899999999
Q ss_pred CCChhhhcCCCC---c------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC---CCCeEEccccCccccCCCCc
Q 041285 526 NGSLADVYSSPP---K------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE---NRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 526 ~gsL~~~l~~~~---~------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~---~~~~kl~Dfgl~~~~~~~~~ 593 (724)
+|+|.+++.... . ..+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc
Confidence 999999985421 1 1278999999999998 9999999999999985 45799999999987654332
Q ss_pred ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccC
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVD 673 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 673 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....+..+. .-.+....
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~---~~~~~~~~ 241 (335)
T d2ozaa1 170 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ---YEFPNPEW 241 (335)
T ss_dssp --CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS---SSCCTTHH
T ss_pred --cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC---CCCCCccc
Confidence 234579999999999999999999999999999999999999997543222110 0011111111 10111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 674 KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 674 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 233466889999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-40 Score=340.36 Aligned_cols=241 Identities=22% Similarity=0.279 Sum_probs=190.2
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc---------hhHHHHHHHHHhhcccC-cCceeeeeeEEecccc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA---------EGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSN 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 516 (724)
+.+.+.||+|+||+||+++.. +++.||||++..... ...+.+.+|+.++++++ |||||++++++.+.+.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 345688999999999999874 688999999864311 11245889999999996 9999999999999999
Q ss_pred eEEEEeeccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 517 KILVYEYMSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
.++||||+++|+|.+++.. ... ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999842 222 2278999999999998 99999999999999999999999999998775
Q ss_pred CCCcceeeccccCccccCcccccC------CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWN------LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNL 663 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 663 (724)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+..+..
T Consensus 162 ~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~~~~ 232 (277)
T d1phka_ 162 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMSGNY 232 (277)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC
T ss_pred CCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHhCCC
Confidence 4332 234678999999998753 346889999999999999999999997543111 2233333332
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 664 GQLIEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... .......+.+.+++.+||+.+|++|||+.||++
T Consensus 233 ~~~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 QFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2111 111123356889999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=346.64 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=184.0
Q ss_pred cccCcCccceEEEEEee-CCcEEEEEEcccccch-----hHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 452 EEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAE-----GEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999975 5899999998653221 13468899999999999999999999999999999999999
Q ss_pred CCChhhhcCCC---Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSP---PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~---~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
++++..+.... .. ..+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~ 159 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTH 159 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCC
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-ccc
Confidence 98877666421 11 2278999999999998 9999999999999999999999999999876543322 223
Q ss_pred cccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc---cccc------
Q 041285 599 IRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG---QLIE------ 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~~------ 668 (724)
..||+.|+|||.+... .++.++|||||||++|||++|..||......+. +. .+.+........ ....
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~-~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LT-RIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-HHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HH-HHHHhcCCCChhhccchhccchhhh
Confidence 5689999999998754 579999999999999999999999865432211 11 111111110000 0000
Q ss_pred ---ccccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 ---DEDVD-----KKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ---~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
..... ......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00001 122356889999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-40 Score=350.33 Aligned_cols=239 Identities=22% Similarity=0.258 Sum_probs=185.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHH---HHHhhcccCcCceeeeeeEEecccceEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQT---EIKAIGRTHHRNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~lv 520 (724)
+.+.+.||+|+||.||+++.. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 345688999999999999875 58999999986421 222233444 47777888999999999999999999999
Q ss_pred EeeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 521 YEYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
|||+++|+|.+++... . +..+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 9999999999988431 1 12267999999999998 999999999999999999999999999987654322
Q ss_pred ceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccccccc
Q 041285 594 RTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDV 672 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 672 (724)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... +........ ...+.
T Consensus 163 ---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~---~~~~~-- 230 (364)
T d1omwa3 163 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA---VELPD-- 230 (364)
T ss_dssp ---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC---CCCCS--
T ss_pred ---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCC---CCCCC--
Confidence 33569999999999875 568999999999999999999999997654332211 111111111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 673 DKKQLERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 673 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
.....+.+++..||+.||++||| ++|+++
T Consensus 231 --~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 12345889999999999999999 588864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=344.18 Aligned_cols=240 Identities=19% Similarity=0.293 Sum_probs=191.4
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.+.+.||+|+||+||++... +++.||||.++.. ......+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 456689999999999999875 5789999999764 23345688999999999999999999999999999999999999
Q ss_pred CChhhhcCCCCc--------chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCC--CCeEEccccCccccCCCCccee
Q 041285 527 GSLADVYSSPPK--------NNLIGIARGILYLHDECESQIIHCDIKPQNILMDEN--RYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 527 gsL~~~l~~~~~--------~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~--~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|+|.+++..... ..+.||++||.|||+. +|+||||||+|||++.+ ..+||+|||+++....... .
T Consensus 86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--~ 160 (321)
T d1tkia_ 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--F 160 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--E
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc--c
Confidence 999999864321 1268999999999998 99999999999999854 5799999999987654332 2
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....+++.|+|||.+.+..++.++||||+||++|||++|..||...... . +...+..+..... . ......
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~-~~~~i~~~~~~~~--~-~~~~~~ 230 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------Q-IIENIMNAEYTFD--E-EAFKEI 230 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCCCCC--H-HHHTTS
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCCCC--h-hhccCC
Confidence 3356899999999999999999999999999999999999999754321 1 1122222221110 0 000012
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...+.+++..||+.||.+|||+.|+++
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-40 Score=345.64 Aligned_cols=235 Identities=22% Similarity=0.251 Sum_probs=190.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 523 (724)
+.+.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+....++|+||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 344578999999999999874 58999999986422 23346789999999999999999999999999999999999
Q ss_pred ccCCChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 524 MSNGSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 524 ~~~gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
+.+|+|..++.. ... ..+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 123 ~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~---- 195 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---- 195 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----
T ss_pred ccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc----
Confidence 999999988732 222 2378999999999998 99999999999999999999999999998765332
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKKQ 676 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (724)
....||+.|||||++.+..++.++|||||||++|||++|+.||...... . ....+..+.... +. ..
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~~~---p~----~~ 261 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------Q-IYEKIVSGKVRF---PS----HF 261 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC---CT----TC
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------H-HHHHHhcCCCCC---Cc----cC
Confidence 2356899999999999999999999999999999999999999753211 1 122222332211 11 12
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 041285 677 LERMIKVALWCILDEPSLRP-----SMKKVLL 703 (724)
Q Consensus 677 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 703 (724)
...+.+++..||+.||.+|+ |++|+++
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 34588999999999999994 8999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=345.47 Aligned_cols=237 Identities=23% Similarity=0.309 Sum_probs=189.1
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEccccc---chhHHHHHHHHHhhc-ccCcCceeeeeeEEecccceEEEEe
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML---AEGEREFQTEIKAIG-RTHHRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.+.+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++. .++|||||++++++.+.+..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456789999999999999875 58899999997532 233456777777765 6899999999999999999999999
Q ss_pred eccCCChhhhcCC---CC----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcce
Q 041285 523 YMSNGSLADVYSS---PP----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRT 595 (724)
Q Consensus 523 ~~~~gsL~~~l~~---~~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~ 595 (724)
|+++|+|.+++.. .. ...+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~ 159 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-K 159 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc-c
Confidence 9999999999842 22 12278999999999998 999999999999999999999999999986543322 2
Q ss_pred eeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccccccCHH
Q 041285 596 FTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIEDEDVDKK 675 (724)
Q Consensus 596 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +...+..+... -+. .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~---~p~----~ 225 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF---YPR----W 225 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---CCT----T
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC---CCc----c
Confidence 334579999999999999999999999999999999999999997543211 12223333221 111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 041285 676 QLERMIKVALWCILDEPSLRPSMK-KVL 702 (724)
Q Consensus 676 ~~~~l~~l~~~Cl~~~p~~RPs~~-evl 702 (724)
....+.+++.+||+.||++||++. |++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 234588999999999999999995 675
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=336.43 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=183.7
Q ss_pred cccccCcCccceEEEEEe-eCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 450 FKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
+.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+....++||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 457899999999999987 468999999986532 22346799999999999999999999999999999999999976
Q ss_pred CChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 527 GSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 527 gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+.+...... .... .+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~ 161 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTH 161 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTC
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-ccee
Confidence 544433221 2222 278999999999998 999999999999999999999999999987654322 2233
Q ss_pred cccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---ccccc---c---
Q 041285 599 IRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQLI---E--- 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~---~--- 668 (724)
..||+.|+|||.+.... .+.++|||||||++|||++|+.||......+. +.. ......... ..... +
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhcCCCchhhcccccccccccc
Confidence 57899999999877665 57899999999999999999999975432111 111 111110000 00000 0
Q ss_pred ---c-cc-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 669 ---D-ED-----VDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 669 ---~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
. .. ........+.+++.+||+.||++|||+.|+++-
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00 011223568889999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-39 Score=332.77 Aligned_cols=248 Identities=25% Similarity=0.316 Sum_probs=185.9
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeeccC
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMSN 526 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 526 (724)
...++||+|+||+||+|+..+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++++||+.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 3457899999999999999889999999986532 22356799999999999999999999999999999999999988
Q ss_pred CChhhhcCCCC---c----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeecc
Q 041285 527 GSLADVYSSPP---K----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTGI 599 (724)
Q Consensus 527 gsL~~~l~~~~---~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 599 (724)
+.+..+..... . ..+.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 85 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 160 (286)
T d1ob3a_ 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHE 160 (286)
T ss_dssp EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred hhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cccee
Confidence 87777764322 1 2278999999999998 999999999999999999999999999987654322 12234
Q ss_pred ccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---ccccc--------
Q 041285 600 RGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LGQLI-------- 667 (724)
Q Consensus 600 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-------- 667 (724)
.+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. ......... .....
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhhcccc
Confidence 689999999998765 568999999999999999999999975432111 111 111111000 00000
Q ss_pred ----cc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 668 ----ED---EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 668 ----~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011122356889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=329.13 Aligned_cols=230 Identities=24% Similarity=0.400 Sum_probs=181.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccc------hhHHHHHHHHHhhcccC--cCceeeeeeEEecccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLA------EGEREFQTEIKAIGRTH--HRNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~ 518 (724)
+.+.+.||+|+||+||+|+.. +++.||||++..... ....++.+|+.++++++ |||||++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 456789999999999999874 589999999875321 12245778999999986 899999999999999999
Q ss_pred EEEeeccC-CChhhhcCC---CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-CCCeEEccccCccccC
Q 041285 519 LVYEYMSN-GSLADVYSS---PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDE-NRYAKISDFALAKLMK 589 (724)
Q Consensus 519 lv~e~~~~-gsL~~~l~~---~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-~~~~kl~Dfgl~~~~~ 589 (724)
+||||+.+ +++.+++.. ... ..+.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999976 577666632 222 2378999999999998 9999999999999985 4789999999998754
Q ss_pred CCCcceeeccccCccccCcccccCCCC-CcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 590 PDQTRTFTGIRGTRGYVAPEWHWNLPI-TAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 590 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||... . + +..+... .
T Consensus 163 ~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~--------~-i~~~~~~---~ 223 (273)
T d1xwsa_ 163 DTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E--------E-IIRGQVF---F 223 (273)
T ss_dssp SSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H--------H-HHHCCCC---C
T ss_pred ccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h--------H-HhhcccC---C
Confidence 332 234579999999999987765 56789999999999999999998642 0 1 1112111 1
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+... ...+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 224 RQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112 345888999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-39 Score=332.80 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=181.6
Q ss_pred cccccccCcCccceEEEEEee-C-CcEEEEEEcccccc--hhHHHHHHHHHhhccc---CcCceeeeeeEEec-----cc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-N-GKFVAVKRLQKMLA--EGEREFQTEIKAIGRT---HHRNLVRLLGYSFD-----VS 515 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 515 (724)
+.+.++||+|+||+||++... + ++.||||+++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 445678999999999999873 3 56899999865322 2234567788877766 79999999999863 34
Q ss_pred ceEEEEeeccCCChhhhcCC----CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccc
Q 041285 516 NKILVYEYMSNGSLADVYSS----PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKL 587 (724)
Q Consensus 516 ~~~lv~e~~~~gsL~~~l~~----~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~ 587 (724)
..++++||++++.+...... ... ..+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 67999999998877544321 121 2378999999999998 999999999999999999999999999886
Q ss_pred cCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCC---cc
Q 041285 588 MKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGN---LG 664 (724)
Q Consensus 588 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~ 664 (724)
.... .......||+.|+|||++.+.+++.++||||+||++|||++|+.||......+ .+.. ..+...... ..
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGK-ILDVIGLPGEEDWP 240 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCGGGSC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCchhccc
Confidence 5432 22334679999999999999999999999999999999999999997543221 1111 111110000 00
Q ss_pred ------ccc--cc-----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 ------QLI--ED-----EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ------~~~--~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
... .. ..........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00 0011122345788999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=327.79 Aligned_cols=251 Identities=19% Similarity=0.241 Sum_probs=181.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEec--------ccc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFD--------VSN 516 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~ 516 (724)
+.+.++||+|+||+||+|+.. +|+.||||++... .....+++.+|++++++++|+||+++++++.. ...
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 345578999999999999974 6899999998643 22334678999999999999999999999865 345
Q ss_pred eEEEEeeccCCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccC
Q 041285 517 KILVYEYMSNGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMK 589 (724)
Q Consensus 517 ~~lv~e~~~~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~ 589 (724)
.++||||+.++.+........ +..+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 799999998887765553221 12278999999999998 99999999999999999999999999998765
Q ss_pred CCCcce---eeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC--Cc
Q 041285 590 PDQTRT---FTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG--NL 663 (724)
Q Consensus 590 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~ 663 (724)
...... .....||+.|+|||.+.+. .++.|+|||||||++|||++|+.||......... ....+....- ..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 245 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSITPEV 245 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCCChhh
Confidence 433221 2224689999999998765 6899999999999999999999999754321111 1111111100 00
Q ss_pred ccccc------------ccccCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 664 GQLIE------------DEDVDK-------KQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 664 ~~~~~------------~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
....+ ...... .....+++++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 000001 112356789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-37 Score=323.73 Aligned_cols=249 Identities=21% Similarity=0.227 Sum_probs=182.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeee-eEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLL-GYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~e~~~ 525 (724)
+.+.+.||+|+||.||+|... +++.||||.+... ...+++..|++++++++|+|++..+ ++..+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 456789999999999999874 5889999987653 3345789999999999877655554 5556677889999999
Q ss_pred CCChhhhcCC----CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeC---CCCCeEEccccCccccCCCCc-
Q 041285 526 NGSLADVYSS----PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMD---ENRYAKISDFALAKLMKPDQT- 593 (724)
Q Consensus 526 ~gsL~~~l~~----~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~---~~~~~kl~Dfgl~~~~~~~~~- 593 (724)
+++|.+.+.. .... .+.|+++||+|||++ +|+||||||+|||++ .+..+||+|||+++.+.....
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 4556555421 2221 277999999999998 999999999999985 456799999999997754322
Q ss_pred -----ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccccc
Q 041285 594 -----RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIE 668 (724)
Q Consensus 594 -----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 668 (724)
.......||+.|||||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 238 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE---- 238 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh----
Confidence 12234579999999999999999999999999999999999999997654332211111111110000000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 669 DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 669 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
......+..+.+++..|++.+|++||+++++.+.|+..
T Consensus 239 --~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 --VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01112234588899999999999999999998888753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-37 Score=321.00 Aligned_cols=249 Identities=17% Similarity=0.214 Sum_probs=190.7
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCc-CceeeeeeEEecccceEEEEeecc
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHH-RNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
+.+.++||+|+||+||+|+.. +|+.||||.+... ....++++|++.+..++| +|++.+++++.+....++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 456789999999999999975 5889999988653 334568889999999965 89999999999999999999998
Q ss_pred CCChhhhcCCC----Ccc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCC-----CCCeEEccccCccccCCCC
Q 041285 526 NGSLADVYSSP----PKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDE-----NRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 526 ~gsL~~~l~~~----~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~-----~~~~kl~Dfgl~~~~~~~~ 592 (724)
+++|.+++... ... .+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+....
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 78998887322 211 277999999999998 9999999999999974 5679999999998764332
Q ss_pred c------ceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcccc
Q 041285 593 T------RTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQL 666 (724)
Q Consensus 593 ~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 666 (724)
. .......||+.|||||.+.+..++.++||||||+++|||++|+.||..............+..........++
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 2 1223357999999999999999999999999999999999999999765433322111111111111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 041285 667 IEDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLMLEGT 708 (724)
Q Consensus 667 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 708 (724)
....+..+.+++..|++.+|++||+++.+.+.|+..
T Consensus 241 ------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 241 ------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp ------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111234578888999999999999999998888754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=328.73 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=181.0
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccc--cchhHHHHHHHHHhhcccCcCceeeeeeEEeccc------ceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKM--LAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS------NKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 518 (724)
+...++||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+ +.+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 344578999999999999874 5899999999753 2233467899999999999999999999998654 469
Q ss_pred EEEeeccCCChhhhcCCC--Cc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCC
Q 041285 519 LVYEYMSNGSLADVYSSP--PK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQ 592 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~--~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~ 592 (724)
+||||+ +.+|..+.... .. ..+.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 100 lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp EEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc-
Confidence 999999 56777666432 22 2278999999999998 9999999999999999999999999999876433
Q ss_pred cceeeccccCccccCcccccCC-CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHH-------HHHcC---
Q 041285 593 TRTFTGIRGTRGYVAPEWHWNL-PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQ-------CFENG--- 661 (724)
Q Consensus 593 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~-------~~~~~--- 661 (724)
.+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ +...... .+...
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHTCSCH
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHHhhhcch
Confidence 2345689999999998764 568999999999999999999999975432111 1110000 00000
Q ss_pred -------Cccccc--cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCC
Q 041285 662 -------NLGQLI--EDEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM--LEGTMDI 711 (724)
Q Consensus 662 -------~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~ 711 (724)
.+.... +...........+.+++.+||+.||++|||+.|+++. |++..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 000000 0000111223457889999999999999999999974 6554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=328.20 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=182.0
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccccc-chhHHHHHHHHHhhcccCcCceeeeeeEEeccc----ceEEEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML-AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVS----NKILVY 521 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 521 (724)
+...++||+|+||+||+|.. .+|+.||||++.... ....+.+++|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 34458899999999999986 468999999997532 333467899999999999999999999997643 235556
Q ss_pred eeccCCChhhhcCC--CCcc----hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcc-
Q 041285 522 EYMSNGSLADVYSS--PPKN----NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTR- 594 (724)
Q Consensus 522 e~~~~gsL~~~l~~--~~~~----~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~- 594 (724)
+|+.+|+|.+++.. .... .+.||++||+|||++ +|+||||||+||||+.++.+||+|||++.........
T Consensus 90 ~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 90 THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 77789999999843 2222 278999999999998 9999999999999999999999999999876433221
Q ss_pred -eeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCcc--------
Q 041285 595 -TFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLG-------- 664 (724)
Q Consensus 595 -~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 664 (724)
......||+.|+|||.+.. ..++.++||||+|+++|||++|+.||......+.... ...........
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHTCCCH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH---HhhhccCCChhhhhhhhhh
Confidence 1233568999999999854 4578899999999999999999999975432211110 00000000000
Q ss_pred -------cccccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 665 -------QLIEDEDV-----DKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 665 -------~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
........ .......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 11122458899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-38 Score=327.23 Aligned_cols=243 Identities=23% Similarity=0.260 Sum_probs=190.3
Q ss_pred cccccccCcCccceEEEEEee----CCcEEEEEEccccc----chhHHHHHHHHHhhcccCc-CceeeeeeEEecccceE
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI----NGKFVAVKRLQKML----AEGEREFQTEIKAIGRTHH-RNLVRLLGYSFDVSNKI 518 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 518 (724)
+.+.+.||+|+||+||++... +|+.||||.++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 556689999999999999763 37899999986431 2334678899999999966 89999999999999999
Q ss_pred EEEeeccCCChhhhcCCC---C----cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCC
Q 041285 519 LVYEYMSNGSLADVYSSP---P----KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPD 591 (724)
Q Consensus 519 lv~e~~~~gsL~~~l~~~---~----~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~ 591 (724)
+++||+.+|+|.+++... . ...+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999888432 1 12277999999999998 9999999999999999999999999999877554
Q ss_pred CcceeeccccCccccCcccccCC--CCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcCCccccccc
Q 041285 592 QTRTFTGIRGTRGYVAPEWHWNL--PITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENGNLGQLIED 669 (724)
Q Consensus 592 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 669 (724)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||........ ... +.+........
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~-i~~~~~~~~~~----- 254 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAE-ISRRILKSEPP----- 254 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHH-HHHHHHHCCCC-----
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhcccCCCC-----
Confidence 44444456799999999998765 468899999999999999999999976543322 111 11222122111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 041285 670 EDVDKKQLERMIKVALWCILDEPSLRPS-----MKKVLL 703 (724)
Q Consensus 670 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 703 (724)
........+.+++..||+.||++||| ++|+++
T Consensus 255 --~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 --YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11223456888999999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-36 Score=319.46 Aligned_cols=248 Identities=19% Similarity=0.338 Sum_probs=186.6
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecc--cceEEEEee
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDV--SNKILVYEY 523 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~ 523 (724)
+.+.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 445688999999999999874 5899999998753 3467899999999995 99999999998743 468999999
Q ss_pred ccCCChhhhcCCCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCccccCCCCcceeec
Q 041285 524 MSNGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 524 ~~~gsL~~~l~~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++++|..+........ +.||++||.|||+. +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 114 ~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~ 188 (328)
T d3bqca1 114 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNV 188 (328)
T ss_dssp CCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCS
T ss_pred cCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc--ccc
Confidence 99999998876654433 78999999999998 999999999999998655 699999999987654332 233
Q ss_pred cccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHH--H-----HHHHHHHcCCcc------
Q 041285 599 IRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILE--E-----WVYQCFENGNLG------ 664 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~--~-----~~~~~~~~~~~~------ 664 (724)
..+|+.|+|||.+.+.. ++.++||||+|++++||++|+.||............ . ............
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 56899999999987654 799999999999999999999999765432211000 0 000111110000
Q ss_pred cccc-----------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 665 QLIE-----------DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 665 ~~~~-----------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.... ...........+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001112345789999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=325.59 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=179.5
Q ss_pred hcccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccCcCceeeeeeEEecc------cceEE
Q 041285 447 TDGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV------SNKIL 519 (724)
Q Consensus 447 t~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 519 (724)
++...++||+|+||+||+|+.. +|+.||||++.... ..+.+|++++++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3445578999999999999985 58999999997532 2345799999999999999999998543 24689
Q ss_pred EEeeccCCChhhhc----CC--CCc----chHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCC-CeEEccccCcccc
Q 041285 520 VYEYMSNGSLADVY----SS--PPK----NNLIGIARGILYLHDECESQIIHCDIKPQNILMDENR-YAKISDFALAKLM 588 (724)
Q Consensus 520 v~e~~~~gsL~~~l----~~--~~~----~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~-~~kl~Dfgl~~~~ 588 (724)
||||++++.+..+. .. ..+ ..+.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544332 11 222 2378999999999998 999999999999999775 8999999999876
Q ss_pred CCCCcceeeccccCccccCcccccC-CCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHH----------HH
Q 041285 589 KPDQTRTFTGIRGTRGYVAPEWHWN-LPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVY----------QC 657 (724)
Q Consensus 589 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~----------~~ 657 (724)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +..... ..
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhh
Confidence 54332 223568999999998765 4689999999999999999999999975432211 111110 00
Q ss_pred HH----cCCccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 658 FE----NGNLGQLIED---EDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 658 ~~----~~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
.. .......... ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011110000 0111223446889999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=314.80 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=188.1
Q ss_pred ccccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecccceEEEEeecc
Q 041285 449 GFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDVSNKILVYEYMS 525 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 525 (724)
...++||+|+||+||+|+.. +++.||||+++... ....+.+++|+.++++++||||+++++++.+....++|+|++.
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~ 84 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence 34578999999999999974 67899999986432 2335688999999999999999999999999999999999999
Q ss_pred CCChhhhcCCCC-------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCcceeec
Q 041285 526 NGSLADVYSSPP-------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTFTG 598 (724)
Q Consensus 526 ~gsL~~~l~~~~-------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 598 (724)
+++|..++.... ...+.|+++||+|||+. +|+||||||+|||++.++.+||+|||.++....... ....
T Consensus 85 ~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~ 160 (292)
T d1unla_ 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSA 160 (292)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCS
T ss_pred ccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-ccee
Confidence 999888764321 12278999999999998 999999999999999999999999999987654332 1222
Q ss_pred cccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC---Ccc---cccc---
Q 041285 599 IRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG---NLG---QLIE--- 668 (724)
Q Consensus 599 ~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~---~~~~--- 668 (724)
..+++.|+|||.+.... ++.++|||||||++|||++|+.|+........ .+. .+....... ... ...+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLK-RIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHH-HHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHH-HHHhhcCCCChhhhhhhhhcccccc
Confidence 45678899999887665 68999999999999999999999754332221 111 111111110 000 0000
Q ss_pred ---------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 669 ---------DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 669 ---------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
...........+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011223356788999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-36 Score=318.38 Aligned_cols=248 Identities=24% Similarity=0.282 Sum_probs=178.5
Q ss_pred cccccCcCccceEEEEEee-CCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEec------ccceEEE
Q 041285 450 FKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFD------VSNKILV 520 (724)
Q Consensus 450 f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lv 520 (724)
+.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++|||||++++++.. ....++|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 4478999999999999875 58999999997532 2334578999999999999999999999964 3578999
Q ss_pred EeeccCCChhhhcCCCCcch----HHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCccee
Q 041285 521 YEYMSNGSLADVYSSPPKNN----LIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQTRTF 596 (724)
Q Consensus 521 ~e~~~~gsL~~~l~~~~~~~----~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~~~~ 596 (724)
|||+.++.+..+........ +.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++...... ..
T Consensus 101 ~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--~~ 175 (355)
T d2b1pa1 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MM 175 (355)
T ss_dssp EECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred EeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc--cc
Confidence 99998776665554444332 78999999999998 99999999999999999999999999988654322 22
Q ss_pred eccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHH------------------HHHH
Q 041285 597 TGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWV------------------YQCF 658 (724)
Q Consensus 597 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~------------------~~~~ 658 (724)
....+|+.|+|||.+.+..++.++||||+||+++||++|+.||........ ..... ....
T Consensus 176 ~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T d2b1pa1 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_dssp -----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH--HHHHHHhccCCCHHHHHHhhhhHHHHh
Confidence 335689999999999999999999999999999999999999865431111 00000 0111
Q ss_pred HcCC-c-----cccc----ccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 041285 659 ENGN-L-----GQLI----EDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLLM 704 (724)
Q Consensus 659 ~~~~-~-----~~~~----~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 704 (724)
.... . .... ... .........+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100 0 0000 000 1123346678999999999999999999999843
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-36 Score=318.03 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=182.6
Q ss_pred cccccccCcCccceEEEEEe-eCCcEEEEEEccccc--chhHHHHHHHHHhhcccCcCceeeeeeEEecc-----cceEE
Q 041285 448 DGFKEEIGRGSSGTVYKGTM-INGKFVAVKRLQKML--AEGEREFQTEIKAIGRTHHRNLVRLLGYSFDV-----SNKIL 519 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 519 (724)
+...++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|+|+|++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 34457899999999999986 468999999997532 23345788999999999999999999998643 34567
Q ss_pred EEeeccCCChhhhcCCCCcc------hHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCCCCc
Q 041285 520 VYEYMSNGSLADVYSSPPKN------NLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKPDQT 593 (724)
Q Consensus 520 v~e~~~~gsL~~~l~~~~~~------~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~~~~ 593 (724)
++||+.+|+|.+++...... .+.||+.||+|||+. +|+||||||+|||++.++.+|++|||++.....
T Consensus 100 i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp EEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred EEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc---
Confidence 78888899999998654322 278999999999998 999999999999999999999999999975432
Q ss_pred ceeeccccCccccCcccccCCC-CCcccceeehhHHHHHhhccccCCCCCCCcchhcHHHHHHHHHHcC-----------
Q 041285 594 RTFTGIRGTRGYVAPEWHWNLP-ITAKADVYSFGVVLLEIICCRRCFDQNLPEDQVILEEWVYQCFENG----------- 661 (724)
Q Consensus 594 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 661 (724)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ...+.......
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTTCCCH
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhhccch
Confidence 223356899999999876654 68899999999999999999999975432111 11111110000
Q ss_pred -------Ccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCC
Q 041285 662 -------NLGQLIEDE--DVDKKQLERMIKVALWCILDEPSLRPSMKKVLL--MLEGTM 709 (724)
Q Consensus 662 -------~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~L~~~~ 709 (724)
.+....... .........+.+++.+||+.||.+|||++|+++ -|.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000 000112345788999999999999999999997 354443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.7e-32 Score=290.88 Aligned_cols=264 Identities=22% Similarity=0.247 Sum_probs=182.3
Q ss_pred cccccccCcCccceEEEEEee-CCcEEEEEEcccccchhHHHHHHHHHhhcccC-----------cCceeeeeeEEecc-
Q 041285 448 DGFKEEIGRGSSGTVYKGTMI-NGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-----------HRNLVRLLGYSFDV- 514 (724)
Q Consensus 448 ~~f~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~- 514 (724)
+.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 556789999999999999874 68999999997642 33457788888888775 57899999888653
Q ss_pred -cceEEEEeeccCCChhhhc----CCCC------cchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCC------e
Q 041285 515 -SNKILVYEYMSNGSLADVY----SSPP------KNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRY------A 577 (724)
Q Consensus 515 -~~~~lv~e~~~~gsL~~~l----~~~~------~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~------~ 577 (724)
...+++++++..+...... .... +..+.||++||+|||+. .+|+||||||+||||+.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 3456667766554332221 1111 22378999999999973 28999999999999976543 8
Q ss_pred EEccccCccccCCCCcceeeccccCccccCcccccCCCCCcccceeehhHHHHHhhccccCCCCCCCcchh----cHHHH
Q 041285 578 KISDFALAKLMKPDQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVLLEIICCRRCFDQNLPEDQV----ILEEW 653 (724)
Q Consensus 578 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll~elltg~~p~~~~~~~~~~----~l~~~ 653 (724)
|++|||.+....... ....||+.|+|||.+....++.++||||+|++++||++|+.||......... .+...
T Consensus 172 kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 999999998654322 2356899999999999999999999999999999999999998754321111 11111
Q ss_pred HHH-------HHHcC----------Ccccccc-------------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 041285 654 VYQ-------CFENG----------NLGQLIE-------------DEDVDKKQLERMIKVALWCILDEPSLRPSMKKVLL 703 (724)
Q Consensus 654 ~~~-------~~~~~----------~~~~~~~-------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 703 (724)
+.. ..... .....+. ...........+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00000 0000000 01124566788999999999999999999999987
Q ss_pred H--hcc---CCCCCCCCCCC
Q 041285 704 M--LEG---TMDIPIPPNPT 718 (724)
Q Consensus 704 ~--L~~---~~~~~~p~~p~ 718 (724)
. |+. ..++..|+.|.
T Consensus 328 Hp~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 328 HPWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp CGGGTTCTTCTTCCCTTSCT
T ss_pred CcccCCCCCcccCCCCCccc
Confidence 4 443 34555565553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.4e-21 Score=187.29 Aligned_cols=169 Identities=15% Similarity=0.138 Sum_probs=121.8
Q ss_pred ccccccCcCccceEEEEEeeCCcEEEEEEccccc------------------chhHHHHHHHHHhhcccCcCceeeeeeE
Q 041285 449 GFKEEIGRGSSGTVYKGTMINGKFVAVKRLQKML------------------AEGEREFQTEIKAIGRTHHRNLVRLLGY 510 (724)
Q Consensus 449 ~f~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 510 (724)
.+.++||+|+||+||+|...+|+.||||.++... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999998889999999865310 0112235568888999999999988765
Q ss_pred EecccceEEEEeeccCCChhhhcCCCCcchHHHHHHHcccccccCCCceEeCCCCCCCeeeCCCCCeEEccccCccccCC
Q 041285 511 SFDVSNKILVYEYMSNGSLADVYSSPPKNNLIGIARGILYLHDECESQIIHCDIKPQNILMDENRYAKISDFALAKLMKP 590 (724)
Q Consensus 511 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ia~~l~yLH~~~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~~~~~ 590 (724)
. ..+++|||+++..+.++........+.|++++|+|||+. +|+||||||+|||++++ .++|+|||++.....
T Consensus 83 ~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~ 154 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGE 154 (191)
T ss_dssp E----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTS
T ss_pred c----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCC
Confidence 3 347999999988877765555556689999999999998 99999999999999865 489999999976543
Q ss_pred CCcceeeccccCccccCcccccCCCCCcccceeehhHHH
Q 041285 591 DQTRTFTGIRGTRGYVAPEWHWNLPITAKADVYSFGVVL 629 (724)
Q Consensus 591 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvll 629 (724)
......... .... ..|++ .+.++.++|+||..--+
T Consensus 155 ~~~~~~l~r--d~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 155 EGWREILER--DVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTHHHHHHH--HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcHHHHHH--HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 322111000 0000 00111 35577889999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.40 E-value=1.7e-13 Score=117.26 Aligned_cols=99 Identities=21% Similarity=0.342 Sum_probs=72.3
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCce--EEEeecCCcCCC----ce-----eEEEEeecCCCCeeEec
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSY--YVGVFLAGIPEK----NV-----GRIVLRSTEQGQDSIIA 72 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~--ylgiW~~~~~~~----t~-----g~l~l~~~~~~~~~~~~ 72 (724)
+|+|.+|+.|.+ +++|+| |.|+|+|...|+=--+ --.||..+-... ++ |+|+|.+ . +..+|++
T Consensus 1 tDtL~~gq~L~~--g~~l~~--g~~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~-~-~~~~w~s 74 (112)
T d1xd5a_ 1 SDRLNSGHQLDT--GGSLAE--GGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-SRAIWAS 74 (112)
T ss_dssp CCEEETTEEECT--TCEEEE--TTEEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-TEEEEEC
T ss_pred CCEecCCCEecC--CCEEEE--CCEEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEe-c-CCeEEEE
Confidence 478999999977 568975 9999999876652111 135676643221 11 9999984 3 4566666
Q ss_pred CCCCc-c-eEEEecCCccEEEEeCCCceEEeecCCCcc
Q 041285 73 DDSQS-A-SSASMLDSGSFVLYDSDGKVIWQTFDHPTD 108 (724)
Q Consensus 73 ~~~~~-~-~~a~LldsGNlVl~~~~~~~lWQSFd~PtD 108 (724)
+++.. . ..|+|+|+|||||+|.+++++|||+.+|+|
T Consensus 75 ~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 75 NTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp CCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred eeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 55443 2 389999999999999999999999999986
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.30 E-value=2.8e-12 Score=110.25 Aligned_cols=67 Identities=18% Similarity=0.341 Sum_probs=56.4
Q ss_pred eEEEEeecCCCCeeEecCCCCcc--eEEEecCCccEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCC
Q 041285 56 GRIVLRSTEQGQDSIIADDSQSA--SSASMLDSGSFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPST 133 (724)
Q Consensus 56 g~l~l~~~~~~~~~~~~~~~~~~--~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~ 133 (724)
|+|+|. + .+.++|++++.... ..|+|+++|||||+|.++++|||||. +.++
T Consensus 45 GNLvL~-~-~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t-------------------------~~~~ 97 (120)
T d1dlpa2 45 CNLVLF-D-RDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSA 97 (120)
T ss_dssp TEEEEE-B-TTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCC-------------------------CCSS
T ss_pred CcEEEe-c-CCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCC-------------------------CCCC
Confidence 999998 3 46778888766533 38999999999999999999999983 3457
Q ss_pred CceEEEecCCCceeec
Q 041285 134 GKFRLKMQNDGNLIQY 149 (724)
Q Consensus 134 G~f~~~~~~~g~~~~~ 149 (724)
|.|.+.||+||++.+|
T Consensus 98 ~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 98 GRYVFVLQPDRNLAIY 113 (120)
T ss_dssp SCCEEEECSSSCEEEE
T ss_pred CcEEEEECCCCcEEEe
Confidence 8899999999999987
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.27 E-value=3.5e-12 Score=107.83 Aligned_cols=94 Identities=14% Similarity=0.185 Sum_probs=70.5
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCC--ceEEEeecCCcCCCc---------eeEEEEeecCCCCeeEec
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGS--SYYVGVFLAGIPEKN---------VGRIVLRSTEQGQDSIIA 72 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~--~~ylgiW~~~~~~~t---------~g~l~l~~~~~~~~~~~~ 72 (724)
+++|.+|+.|.+ +++|. +|.|.|.|...|+=- .....||..+-...- .|+|+|. ++++.++|++
T Consensus 1 ~~~L~~g~~L~~--G~~l~--ng~~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~-~~~g~~vWsS 75 (108)
T d1jpca_ 1 DNILYSGETLST--GEFLN--YGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVY-NPSNKPIWAS 75 (108)
T ss_dssp CCEEETTEEECT--TCEEE--ETTEEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEE-CTTCCEEEEC
T ss_pred CCCccCCCEecC--CCEEE--cCCEEEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEE-CCCccceEEc
Confidence 468999999966 56885 699999998876621 112468876543221 1899998 7788999999
Q ss_pred CCCCcce--EEEecCCccEEEEeCCCceEEeecCC
Q 041285 73 DDSQSAS--SASMLDSGSFVLYDSDGKVIWQTFDH 105 (724)
Q Consensus 73 ~~~~~~~--~a~LldsGNlVl~~~~~~~lWQSFd~ 105 (724)
++..... +|+|+|+|||||++. .+||||+|
T Consensus 76 ~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 76 NTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred cccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 8654433 789999999999964 58999988
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=3.8e-12 Score=108.22 Aligned_cols=100 Identities=18% Similarity=0.277 Sum_probs=74.9
Q ss_pred CCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc-ceEEEecCCc
Q 041285 9 IGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS-ASSASMLDSG 87 (724)
Q Consensus 9 ~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~-~~~a~LldsG 87 (724)
..+.|.+ ++.| .+|.|.|.|. +.|+|||.+ .+..+|++++... +..|.|+++|
T Consensus 13 ~~~tl~~--~~~l--~~g~~~l~~q--------------------~DGNLvL~~--~~~~vW~s~t~~~~~~~l~l~~dG 66 (115)
T d1dlpa1 13 HPQTLHA--AQSL--ELSSFRFTMQ--------------------SDCNLVLFD--SDVRVWASNTAGATGCRAVLQSDG 66 (115)
T ss_dssp SCSCCCT--TCEE--CSTTEEEEEC--------------------TTSCEEEEE--SSSEEECCCCCSCSCCBCCBCSSS
T ss_pred CcceecC--CCcE--EcCCEEEEEC--------------------CCCeEEEEc--CCeeEEEcccCCCCceEEEEeccC
Confidence 3455544 4456 4577777664 347899973 4678899876543 3489999999
Q ss_pred cEEEEeCCCceEEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccC
Q 041285 88 SFVLYDSDGKVIWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTD 167 (724)
Q Consensus 88 NlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 167 (724)
||||+|.++++||||+. +.+.|.|.+.|++||++++|- ..+|.+++.
T Consensus 67 NLvl~d~~~~~vWsS~t-------------------------~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt~ 113 (115)
T d1dlpa1 67 LLVILTAQNTIRWSSGT-------------------------KGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (115)
T ss_dssp CBCCBCTTTCCSCCCCC-------------------------CCCSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred CEEEEccCCCEEEEcCC-------------------------CCCCCCEEEEECCCCcEEEeC--------CCeecCCCC
Confidence 99999999999999863 346899999999999998871 358987654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.22 E-value=1.2e-11 Score=106.22 Aligned_cols=112 Identities=24% Similarity=0.448 Sum_probs=79.1
Q ss_pred ccEEEEeCCCceEE--eecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCccccc
Q 041285 87 GSFVLYDSDGKVIW--QTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTS 164 (724)
Q Consensus 87 GNlVl~~~~~~~lW--QSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~ 164 (724)
||+|+++..+.++| +|+|.|++||.++|.|. .|.|+|.|+.||++.++..+ ..+|.+
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~~------~~vW~s 59 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDRD------DRVWST 59 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBTT------BCCSCC
T ss_pred CcEEEEeCCCeEEEcCCCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecCC------cEEEEE
Confidence 44555444444555 67899999999999993 68899999999999887432 347877
Q ss_pred ccCCCCCceeeeecccccEEEEcCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 165 FTDGKGDNVSLNLDENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 165 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
.....+....+.+..+|.+.+.+.++......... . ....++++|+.||+|++|.
T Consensus 60 ~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~--~-~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 60 NTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS--R-SAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp CCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC--C-SSSCCEEEECSSSCEEEEC
T ss_pred ccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCC--C-CCCcEEEEECCCCcEEEeC
Confidence 65555555678889999999887766544332221 1 2234589999999999983
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.14 E-value=5.6e-11 Score=100.29 Aligned_cols=94 Identities=17% Similarity=0.211 Sum_probs=68.5
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCC--ceEEEeecCCcCCC-----c-----eeEEEEeecCCCCeeEe
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGS--SYYVGVFLAGIPEK-----N-----VGRIVLRSTEQGQDSII 71 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~--~~ylgiW~~~~~~~-----t-----~g~l~l~~~~~~~~~~~ 71 (724)
.++|.+|+.|.+ +++|+ +|.|.|+|...++-- ...-.||-.+-..+ + .|+|+|. +++|.++|+
T Consensus 1 ~~~L~~g~~L~~--g~~l~--~g~~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~ 75 (109)
T d1kj1a_ 1 RNLLTNGEGLYA--GQSLD--VEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVY-DAEGRSLWA 75 (109)
T ss_dssp CCEEETTCEEET--TCEEE--ETTEEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEE-CSSSCEEEE
T ss_pred CCCccCCCEEeC--CCEEE--eCCEEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEE-eCCCcEEEE
Confidence 367999999987 55886 488999997655521 11235787643321 1 1999998 678899999
Q ss_pred cCCCCc--ceEEEecCCccEEEEeCCCceEEeecCC
Q 041285 72 ADDSQS--ASSASMLDSGSFVLYDSDGKVIWQTFDH 105 (724)
Q Consensus 72 ~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFd~ 105 (724)
++++.. ..+|+|+|+|||||++ ..+|||+-|
T Consensus 76 s~t~~~~~~~~l~L~ddGNlvly~---~~~W~S~t~ 108 (109)
T d1kj1a_ 76 SHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTGTY 108 (109)
T ss_dssp CCCCCCSSCCEEEECTTSCEEEEC---CEEEECCCC
T ss_pred EeeECCCCCEEEEEeCCCcEEEEC---CCEecCCCc
Confidence 986542 2379999999999996 469999865
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.11 E-value=1.4e-10 Score=98.68 Aligned_cols=112 Identities=21% Similarity=0.401 Sum_probs=83.4
Q ss_pred cccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEE
Q 041285 107 TDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLL 186 (724)
Q Consensus 107 tDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~ 186 (724)
||||+|||.|..|..|+ .|+|.|.|+.||+++++... ..+|.+..........+.+..+|.+.+.
T Consensus 1 tDtL~~gq~L~~g~~l~---------~g~~~l~~q~DGNLvly~~~------~~vW~s~~~~~~~~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA---------EGGYLFIIQNDCNLVLYDNN------RAVWASGTNGKASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEETT------EEEEECCCTTSCSSEEEEECTTSCEEEE
T ss_pred CCEecCCCEecCCCEEE---------ECCEEEEEcCCCCEEEEcCC------cEEEEccCccCCCCcEEEEeccccEEEE
Confidence 89999999999999995 49999999999999987532 3588877665555667889999999887
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEEEecCCCCCceeEEecccCCCCC
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYSYNLRRQNSTWQVLWESTNEKCD 244 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~~~~~~~~~~W~~~~~~p~~~Cd 244 (724)
+........ . .......++++|+.||+|++|.- .....|+...+.|+
T Consensus 66 ~~~~~~w~s---~-t~~~~~~~~l~L~ddGNlvly~~-------~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SGSRAIWAS---N-TNRQNGNYYLILQRDRNVVIYDN-------SNNAIWATHTNVGN 112 (112)
T ss_dssp ETTEEEEEC---C-CCCSCCCCEEEECTTSCEEEECT-------TSCEEEECCCCCCC
T ss_pred ecCCeEEEE---e-eccCCCceEEEEcCCCCEEEECC-------CCcEEecCCCccCC
Confidence 754332221 1 12233446899999999999841 23567888887663
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.98 E-value=1.2e-09 Score=93.15 Aligned_cols=91 Identities=20% Similarity=0.344 Sum_probs=69.4
Q ss_pred eecCCCeEEEeeeecCCCCceEEEeecCCcCCCceeEEEEeecCCCCeeEecCCCCc--ceEEEecCCccEEEEeCCCce
Q 041285 21 WLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEKNVGRIVLRSTEQGQDSIIADDSQS--ASSASMLDSGSFVLYDSDGKV 98 (724)
Q Consensus 21 lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~t~g~l~l~~~~~~~~~~~~~~~~~--~~~a~LldsGNlVl~~~~~~~ 98 (724)
.++..|.|.|.|- +.|||||. ..+.++|++++... ...+.|.++|||||.|.++++
T Consensus 25 ~~~~~~~y~l~mQ--------------------~DGNLVLy--~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~ 82 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQ--------------------TDCNLVLY--DNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVT 82 (119)
T ss_dssp EEETTEEEEEEEC--------------------TTSCEEEE--ETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCE
T ss_pred EecCCceEEEEEC--------------------CCCcEEEE--ECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcE
Confidence 4677899998874 44789997 34568899887553 348999999999999999999
Q ss_pred EEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCccccccc
Q 041285 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFT 166 (724)
Q Consensus 99 lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 166 (724)
+|+|.- .-+.|.|.+.|++||++++|- .+.|.+++
T Consensus 83 vWsS~t-------------------------~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 83 VWQSPV-------------------------AGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp EEECSC-------------------------CCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred EEECCC-------------------------cCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 998631 113578899999999999872 24787653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.79 E-value=4.7e-09 Score=89.39 Aligned_cols=104 Identities=22% Similarity=0.329 Sum_probs=79.3
Q ss_pred EEeecCCCcccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeec
Q 041285 99 IWQTFDHPTDTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLD 178 (724)
Q Consensus 99 lWQSFd~PtDtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~ 178 (724)
-||++|.|.+||-++|.|.. ..+.|+|+|.|+.||+++++... ..+|.+.....+....+.+.
T Consensus 6 s~~~~~~~~~~l~~~q~l~~-----------~~~~~~y~l~mQ~DGNLVLy~~~------~~vWssnt~~~~~~~~l~l~ 68 (119)
T d1b2pa_ 6 SKQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNLVLYDNN------NPIWATNTGGLGNGCRAVLQ 68 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEE-----------EETTEEEEEEECTTSCEEEEETT------EEEEECCCTTSCSSCEEEEC
T ss_pred eeecCCCCCCEEeCCCeEEE-----------ecCCceEEEEECCCCcEEEEECC------eEEEEecCCCCCcceEEEEE
Confidence 48999999999999999832 23589999999999999987321 45898877655556778899
Q ss_pred ccccEEEEcCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 179 ENGHLFLLNSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 179 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
.+|.+.+.+..+........ ......++++|+.||+|++|.
T Consensus 69 ~dGnLvL~d~~g~~vWsS~t---~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 69 PDGVLVVITNENVTVWQSPV---AGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp TTSCEEEECTTCCEEEECSC---CCCSSCEEEEECTTSCEEEEE
T ss_pred eCCCEEEECCCCcEEEECCC---cCCCCceEEEEcCCCCEEEEC
Confidence 99999998877655443221 122334689999999999984
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.65 E-value=3.2e-08 Score=82.91 Aligned_cols=97 Identities=23% Similarity=0.357 Sum_probs=74.5
Q ss_pred ccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCCCCceeeeecccccEEEEc
Q 041285 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGKGDNVSLNLDENGHLFLLN 187 (724)
Q Consensus 108 DtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~g~~~~~~ 187 (724)
|||+|||.|..|..|. .|+|+|.|+.||+++++... ..+|.+.....+....+.+..+|.+.+.+
T Consensus 2 ~~L~~g~~L~~G~~l~---------ng~~~l~~q~DGNLvly~~~------~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~ 66 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN---------YGSFVFIMQEDCNLVLYDVD------KPIWATNTGGLSRSCFLSMQTDGNLVVYN 66 (108)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEETT------EEEEECCCTTSCSSCEEEECTTSCEEEEC
T ss_pred CCccCCCEecCCCEEE---------cCCEEEEECCCCeEEEEeCC------ceeeEeCCCCCCCccEEEEeccceEEEEC
Confidence 8999999999999994 58999999999999987432 45898776665555678888999998888
Q ss_pred CCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 188 STGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
.++........ ......++++|..||+|++|.
T Consensus 67 ~~g~~vWsS~t---~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 67 PSNKPIWASNT---GGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp TTCCEEEECCC---CCSCSCEEEEECTTSCEEEEE
T ss_pred CCccceEEccc---cCCCCcEEEEEcCCCCEEEeC
Confidence 77655543321 122345689999999999994
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.52 E-value=1.5e-07 Score=78.77 Aligned_cols=97 Identities=22% Similarity=0.341 Sum_probs=72.2
Q ss_pred ccccccCccccCCeeccCCCCCCCCCCceEEEecCCCceeeccCCCCCCCCCcccccccCCC-CCceeeeecccccEEEE
Q 041285 108 DTILPTQRLLAGMELFPGISKTDPSTGKFRLKMQNDGNLIQYPKNTPDTAPYSYWTSFTDGK-GDNVSLNLDENGHLFLL 186 (724)
Q Consensus 108 DtlLpg~~l~~~~~L~s~~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~-~~~~~~~~~~~g~~~~~ 186 (724)
|||.|||.|..|..|+ .|.|+|.|+.||+++++... ..+|.+..... .....+.++.+|.+.+.
T Consensus 2 ~~L~~g~~L~~g~~l~---------~g~~~l~~q~dgnLvl~~~~------~~vW~ant~~~~~~~~~l~l~~dGnLvl~ 66 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD---------VEPYHFIMQEDCNLVLYDHS------TSVWASNTGILGKKGCKAVLQSDGNFVVY 66 (109)
T ss_dssp CEEETTCEEETTCEEE---------ETTEEEEECTTSCEEEEETT------EEEEECCCCCTTCCCCEEEECTTSCEEEE
T ss_pred CCccCCCEEeCCCEEE---------eCCEEEEecCCCeEEEEeCC------EEEEEeCCCCCCceeEEEEEcCCceEEEE
Confidence 8999999999999995 48999999999999987532 45897755433 23456888999999988
Q ss_pred cCCcceeeccccCCCCCCcceEEEEEccCCcEEEEE
Q 041285 187 NSTGFNIRNLTEGENPTEGMMYLMKIDSDGIFRLYS 222 (724)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~dG~l~~~~ 222 (724)
+.++......... .....++++|.+||+|++|.
T Consensus 67 ~~~g~~vW~s~t~---~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 67 DAEGRSLWASHSV---RGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp CSSSCEEEECCCC---CCSSCCEEEECTTSCEEEEC
T ss_pred eCCCcEEEEEeeE---CCCCCEEEEEeCCCcEEEEC
Confidence 8776554433211 12233689999999999983
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.16 E-value=2.1e-06 Score=72.06 Aligned_cols=89 Identities=11% Similarity=0.142 Sum_probs=62.8
Q ss_pred CcccCCCCceecCCCCeeecCCCeEEEeeeecCCCCceEEEeecCCcCCC--------ceeEEEEeecCCCCeeEecCCC
Q 041285 4 HSNINIGSSLSPNGNSSWLSPSGIYAFGFYQQSNGSSYYVGVFLAGIPEK--------NVGRIVLRSTEQGQDSIIADDS 75 (724)
Q Consensus 4 ~~~~~~g~~l~~~~~~~lvS~~g~F~lGFf~~~~~~~~ylgiW~~~~~~~--------t~g~l~l~~~~~~~~~~~~~~~ 75 (724)
..+|.++++|..+.-.-.+..+|+..| |..+ . .+|-.+-... ..|+|||. +..+..+|++.+.
T Consensus 14 ~~tl~~~~~l~~g~~~l~~q~DGNLvL--~~~~-~-----~vW~s~t~~~~~~~l~l~~dGNLvl~-d~~~~~vWsS~t~ 84 (115)
T d1dlpa1 14 PQTLHAAQSLELSSFRFTMQSDCNLVL--FDSD-V-----RVWASNTAGATGCRAVLQSDGLLVIL-TAQNTIRWSSGTK 84 (115)
T ss_dssp CSCCCTTCEECSTTEEEEECTTSCEEE--EESS-S-----EEECCCCCSCSCCBCCBCSSSCBCCB-CTTTCCSCCCCCC
T ss_pred cceecCCCcEEcCCEEEEECCCCeEEE--EcCC-e-----eEEEcccCCCCceEEEEeccCCEEEE-ccCCCEEEEcCCC
Confidence 357999999965332235789999887 5432 1 4687653321 12999998 6678899998765
Q ss_pred Ccce--EEEecCCccEEEEeCCCceEEeecC
Q 041285 76 QSAS--SASMLDSGSFVLYDSDGKVIWQTFD 104 (724)
Q Consensus 76 ~~~~--~a~LldsGNlVl~~~~~~~lWQSFd 104 (724)
.+.. +++|+++|||||++ ..+|+|-.
T Consensus 85 ~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 85 GSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 4332 79999999999984 58999853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=6.6e-06 Score=80.47 Aligned_cols=129 Identities=14% Similarity=0.096 Sum_probs=88.1
Q ss_pred CccceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEeeccCCChhhhcCC
Q 041285 457 GSSGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYEYMSNGSLADVYSS 535 (724)
Q Consensus 457 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 535 (724)
++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+.+..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 34468998865 55667888877654455556788888887773 44467888888888889999999999887654422
Q ss_pred CCc--chHHHHHHHccccccc--------------------------------------------------------CCC
Q 041285 536 PPK--NNLIGIARGILYLHDE--------------------------------------------------------CES 557 (724)
Q Consensus 536 ~~~--~~~~~ia~~l~yLH~~--------------------------------------------------------~~~ 557 (724)
... ..+.++++.++.||+. ...
T Consensus 104 ~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 183 (263)
T d1j7la_ 104 EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL 183 (263)
T ss_dssp CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCE
T ss_pred cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCc
Confidence 111 1122333333333321 012
Q ss_pred ceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 558 QIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 558 ~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 47899999999999987767799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.72 E-value=2.5e-05 Score=75.80 Aligned_cols=130 Identities=15% Similarity=0.150 Sum_probs=83.4
Q ss_pred ccCcCc-cceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccC--cCceeeeeeEEecccceEEEEeeccCCCh
Q 041285 453 EIGRGS-SGTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTH--HRNLVRLLGYSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 453 ~lg~G~-~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gsL 529 (724)
.+..|. ...||+....++..++||.-... ....+..|+..++.+. .-.+.+++++..+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 36789998877778888876542 2335677888777663 33467788888888889999999998766
Q ss_pred hhhcCCCCcchHHHHHHHccccc---------------------------------------------------c----c
Q 041285 530 ADVYSSPPKNNLIGIARGILYLH---------------------------------------------------D----E 554 (724)
Q Consensus 530 ~~~l~~~~~~~~~~ia~~l~yLH---------------------------------------------------~----~ 554 (724)
.+.... ....+.++++.|+-|| . .
T Consensus 94 ~~~~~~-~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 94 LSSHLA-PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTSCCC-HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred cccccc-HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 432100 0000111111111111 1 1
Q ss_pred CCCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 555 CESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 555 ~~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
....++|+|++|.|||++++..+-|+||+.+.
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12348999999999999987777899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00061 Score=70.27 Aligned_cols=75 Identities=20% Similarity=0.176 Sum_probs=47.5
Q ss_pred cccCcCccceEEEEEeeC-CcEEEEEEccccc-------chhHHHHHHHHHhhccc-Cc--CceeeeeeEEecccceEEE
Q 041285 452 EEIGRGSSGTVYKGTMIN-GKFVAVKRLQKML-------AEGEREFQTEIKAIGRT-HH--RNLVRLLGYSFDVSNKILV 520 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~l~g~~~~~~~~~lv 520 (724)
+.||.|....||+....+ ++.++||.-.... .........|.+.|+.+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998765 5789999643211 11223455677777665 22 345556554 44566899
Q ss_pred EeeccCCC
Q 041285 521 YEYMSNGS 528 (724)
Q Consensus 521 ~e~~~~gs 528 (724)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0006 Score=68.37 Aligned_cols=69 Identities=9% Similarity=-0.022 Sum_probs=45.7
Q ss_pred ceEEEEEeeCCcEEEEEEcccccchhHHHHHHHHHhhcccCcCce--eeeee-----EEecccceEEEEeeccCCCh
Q 041285 460 GTVYKGTMINGKFVAVKRLQKMLAEGEREFQTEIKAIGRTHHRNL--VRLLG-----YSFDVSNKILVYEYMSNGSL 529 (724)
Q Consensus 460 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~e~~~~gsL 529 (724)
-.||+...++|+.+++|..+.. ....+++..|...+..|....+ +..+. .....+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4799999999999999987653 3345677888888877743222 21111 12334557889999987443
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.53 E-value=0.0023 Score=38.91 Aligned_cols=33 Identities=30% Similarity=0.601 Sum_probs=27.1
Q ss_pred CCCCCCcccCCCCCccccCCCCCCccCCCCCccc
Q 041285 240 NEKCDPLGLCGFNSFCILNDQTPDCICLPGFVPI 273 (724)
Q Consensus 240 ~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 273 (724)
.|.|.+-..|| ||.|++--..-.|.|-+||+|.
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 36799999999 8899864456689999999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.54 E-value=0.027 Score=57.47 Aligned_cols=72 Identities=17% Similarity=0.116 Sum_probs=47.6
Q ss_pred cccCcCccceEEEEEeeCC--------cEEEEEEcccccchhHHHHHHHHHhhcccC-cCceeeeeeEEecccceEEEEe
Q 041285 452 EEIGRGSSGTVYKGTMING--------KFVAVKRLQKMLAEGEREFQTEIKAIGRTH-HRNLVRLLGYSFDVSNKILVYE 522 (724)
Q Consensus 452 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 522 (724)
+.|+.|-.-.+|+...+++ +.|.++.... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788889999887543 4566655442 223345567888888884 4334577777754 58999
Q ss_pred eccCCCh
Q 041285 523 YMSNGSL 529 (724)
Q Consensus 523 ~~~~gsL 529 (724)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.83 E-value=0.047 Score=53.48 Aligned_cols=31 Identities=23% Similarity=0.415 Sum_probs=27.7
Q ss_pred CCceEeCCCCCCCeeeCCCCCeEEccccCcc
Q 041285 556 ESQIIHCDIKPQNILMDENRYAKISDFALAK 586 (724)
Q Consensus 556 ~~~i~H~dlk~~NIll~~~~~~kl~Dfgl~~ 586 (724)
..+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4589999999999999988777899999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.23 E-value=0.035 Score=36.20 Aligned_cols=31 Identities=26% Similarity=0.676 Sum_probs=25.2
Q ss_pred CCCCC-cccCCCCCccccCCCCCCccCCCCCc
Q 041285 241 EKCDP-LGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 241 ~~Cd~-~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
|.|.. ...|..+|.|.....+..|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56765 46799999998765678999999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.53 E-value=0.084 Score=34.46 Aligned_cols=32 Identities=22% Similarity=0.440 Sum_probs=25.4
Q ss_pred CCCCCCcccCCCCCccccCCCCCCccCCCCCcc
Q 041285 240 NEKCDPLGLCGFNSFCILNDQTPDCICLPGFVP 272 (724)
Q Consensus 240 ~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~ 272 (724)
.|.|... .|+.++.|.+...+..|.|++||+.
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 4678754 4567899987777889999999975
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.93 E-value=0.11 Score=33.06 Aligned_cols=30 Identities=27% Similarity=0.618 Sum_probs=22.8
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
|.|. ...|...|.|........|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 3465 35688888897655678999999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.27 E-value=0.11 Score=33.48 Aligned_cols=31 Identities=23% Similarity=0.614 Sum_probs=24.3
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCccc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFVPI 273 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 273 (724)
|.|...+.| ..+|.+...+..|.|++||+..
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 568776667 4689876678899999999863
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.79 E-value=0.085 Score=34.56 Aligned_cols=31 Identities=23% Similarity=0.572 Sum_probs=23.8
Q ss_pred CCCCCcc-cCCCCCccccCCCCCCccCCCCCcc
Q 041285 241 EKCDPLG-LCGFNSFCILNDQTPDCICLPGFVP 272 (724)
Q Consensus 241 ~~Cd~~g-~CG~~g~C~~~~~~~~C~Cl~GF~~ 272 (724)
|.|.... .| .++.|.+...+..|.|++||+.
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~ 35 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYES 35 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEE
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCcc
Confidence 5686543 45 4789987667889999999984
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.67 E-value=0.11 Score=35.76 Aligned_cols=33 Identities=15% Similarity=0.168 Sum_probs=25.1
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCccc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFVPI 273 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 273 (724)
..|...+.|+...+|.+...+..|+|++||+..
T Consensus 12 ~~c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~ 44 (53)
T d1apqa_ 12 KSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQ 44 (53)
T ss_dssp TTCCCSSSCTTSSEEEEETTEEEEECSTTCEEC
T ss_pred CCcccCCCCCccCEeEcCCCCeEeECCCCCeEC
Confidence 345555666777799877778899999999864
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.96 E-value=0.071 Score=34.86 Aligned_cols=32 Identities=22% Similarity=0.464 Sum_probs=24.9
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCccc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFVPI 273 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 273 (724)
|.|.....| -.+.|.+...+..|.|++||+..
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 568766555 57899876667899999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=85.83 E-value=0.072 Score=34.11 Aligned_cols=24 Identities=17% Similarity=0.449 Sum_probs=20.6
Q ss_pred cCCCCCccccCCCCCCccCCCCCc
Q 041285 248 LCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 248 ~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
.|.+++.|.+...+..|.|.+||.
T Consensus 8 ~C~~~A~C~Nt~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 8 QCSVHAECRDYATGFCCRCVANYT 31 (40)
T ss_dssp GSCTTEEEEECSSCEEEEECTTEE
T ss_pred CCCCCCEeecCCCCeEeECCCCCc
Confidence 588899998766678999999996
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.91 E-value=0.16 Score=32.30 Aligned_cols=30 Identities=27% Similarity=0.757 Sum_probs=22.9
Q ss_pred CCCCCcccCCCCCccccCCCCCCccCCCCCc
Q 041285 241 EKCDPLGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 241 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
|.|.. ..|...|.|.....+..|.|++||+
T Consensus 2 d~C~~-~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECVS-NPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTTT-CCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCcC-CCCCCCCEEECCCCCEEEeCCCCCc
Confidence 45643 4688889997655678999999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.49 E-value=0.14 Score=32.56 Aligned_cols=31 Identities=23% Similarity=0.557 Sum_probs=24.5
Q ss_pred CCCCCCcccCCCCCccccCCCCCCccCCCCCc
Q 041285 240 NEKCDPLGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 240 ~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
.|+|.. ..|-..|.|........|.|++||+
T Consensus 3 ~d~C~~-~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCES-NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTTT-CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCCC-CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 466764 6698999997655678999999996
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.14 E-value=0.23 Score=33.05 Aligned_cols=31 Identities=26% Similarity=0.577 Sum_probs=24.1
Q ss_pred cCCCCCCcccCCCCCccccCCCCCCccCCCCCc
Q 041285 239 TNEKCDPLGLCGFNSFCILNDQTPDCICLPGFV 271 (724)
Q Consensus 239 p~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~GF~ 271 (724)
+.++|+- .-|. ||.|........|.|++||.
T Consensus 7 ~~~~C~~-~PC~-nG~C~~~~~~y~C~C~~G~~ 37 (48)
T d1autl1 7 LEHPCAS-LCCG-HGTCIDGIGSFSCDCRSGWE 37 (48)
T ss_dssp SCCSSSS-TTTT-SEEECCCSSCCCEEECTTEE
T ss_pred CCCcccC-CCCC-CCEEECCCCCCeEeCCCCCc
Confidence 4567875 6787 59997655678999999986
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.34 E-value=0.072 Score=34.60 Aligned_cols=27 Identities=26% Similarity=0.517 Sum_probs=21.5
Q ss_pred cccCCCCCccccCCCCCCccCCCCCccc
Q 041285 246 LGLCGFNSFCILNDQTPDCICLPGFVPI 273 (724)
Q Consensus 246 ~g~CG~~g~C~~~~~~~~C~Cl~GF~~~ 273 (724)
.+.|. ++.|.+...+-.|.|++||++.
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 45674 7899876678899999999864
|